株探米国株
英語
エドガーで原本を確認する
20-F 1 tm2418826d1_20f.htm FORM 20-F

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

 

FORM 20-F

 

 

  

¨      REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

 

OR

 

¨      ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended

 

OR

 

¨      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

x      SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of event requiring this shell company report June 28, 2024

 

Commission File No. 333-275005

 

 

 

Above Food Ingredients Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Not applicable 

(Translation of registrant’s name into English)

 

Canada 

(Jurisdiction of incorporation or organization)

 

2305 Victoria Avenue #001

Regina, Saskatchewan, S4P 0S7

306-779-2268

(Address of principal executive offices)

 

Corporation Services Company

251 Little Falls Drive

Wilmington, DE 19808

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of each class:

 

Trading Symbol(s)

 

Name of each exchange on which registered:

Common Shares   ABVE   The Nasdaq Global Market LLC
Warrants, each exercisable for one common
share
  ABVE.W   The Nasdaq Global Market LLC

 

Securities registered or to be registered pursuant to Section 12(g) of the Act: None 

 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the shell company report:

 

On June 28, 2024, the issuer had 27,804,607 common shares outstanding, without nominal or par value.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No x

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes ¨ No x

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company.

 

Large accelerated filer ¨  Accelerated filer ¨ Non-accelerated filer x Emerging growth company x 

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨ 

 

† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ¨

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ¨

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ¨

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing.

 

U.S. GAAP x International Financial Reporting Standards as issued by the International
Accounting Standards Board  ¨
Other ¨

 

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. Item 17  ¨ Item 18 ¨

 

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No ¨

 

 

 

 


 

TABLE OF CONTENTS

 

  Page

 

EXPLANATORY NOTE ii
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS iii
PART I. 1
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 1
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 5
ITEM 3. KEY INFORMATION 5
ITEM 4. INFORMATION ON THE COMPANY 6
ITEM 4A. UNRESOLVED STAFF COMMENTS 7
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 7
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 30
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 31
ITEM 8. FINANCIAL INFORMATION 32
ITEM 9. THE OFFER AND LISTING 32
ITEM 10. ADDITIONAL INFORMATION 33
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 37
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 37
PART II.   38
PART III.   39
ITEM 17. FINANCIAL STATEMENTS 39
ITEM 18. FINANCIAL STATEMENTS 39
ITEM 19. EXHIBITS 39

 

i


 

EXPLANATORY NOTE

 

On June 28, 2024 (the “Closing Date”), Above Food Ingredients Inc., a corporation organized under the laws of Alberta, Canada (“New Above Food” or “TopCo”) closed the previously announced business combination (the “Business Combination”) pursuant to that certain business combination agreement, dated as of April 29, 2023, as amended by that certain Amendment No. 1 to Business Combination Agreement dated March 12, 2024 (as amended, the “Business Combination Agreement”), by and among New Above Food, Bite Acquisition Corp., a Delaware corporation (“Bite”), Above Food Corp., a corporation existing under the laws of Alberta, Canada (“Above Food”) and Above Merger Sub, Inc., a Delaware corporation (“Merger Sub”).Capitalized terms used and not otherwise defined in this Shell Company Report on Form 20-F have the respective meanings given to those terms in the Proxy Statement/Prospectus (the “Proxy Statement/Prospectus”), forming part of the Registration Statement on Form F-4 of New Above Food, as amended (Registration No. 333-275005), which was declared effective by the SEC on April 8, 2024 (the “Registration Statement”).

 

Prior to the closing of the Business Combination (the “Closing”), Above Food continued from the laws of Saskatchewan to a corporation under the laws of the Province of Alberta pursuant to the Business Corporations Act (Alberta) and the regulations made thereunder, as now in effect and as they may be promulgated or amended from time to time (“ABCA”). On the Closing Date, several transactions were completed pursuant to the Business Combination Agreement and the plan of arrangement under the laws of Alberta, Canada that was effected pursuant to the terms of the Business Combination Agreement, including:

 

· Above Food’s shareholders effected a share exchange (the “Share Exchange”), pursuant to which, among other things, Above Food’s shareholders contributed to New Above Food all of the issued and outstanding equity of Above Food in exchange for newly issued common shares of New Above Food (“New Above Food Common Shares”), Class A Earnout Shares of New Above Food as described in the articles of New Above Food (“New Above Food Class A Earnout Shares”) and Class B Earnout Shares of New Above Food as described in the articles of New Above Food (“New Above Food Class B Earnout Shares”), and after giving effect to the Share Exchange, Above Food became a direct, wholly owned subsidiary of New Above Food;

 

· on the Closing Date and following the completion of the Share Exchange, Merger Sub merged with and into Bite (the “Merger”), with Bite surviving as a direct, wholly owned subsidiary of New Above Food; and

 

· As a result of the Merger, (i) each issued and outstanding share of Bite’s common stock was automatically converted into and exchanged for one New Above Food Common Share and (ii) each issued and outstanding warrant to purchase shares of Bite’s common stock was, pursuant to the terms of the Warrant Agreement, dated February 11, 2021, between Bite and Continental Stock Transfer & Trust Company (the “Bite Warrant Agreement”), automatically converted into one warrant to purchase New Above Food Common Shares (each, a “New Above Food Warrant”), and all rights with respect to shares of Bite’s common stock underlying such warrants were automatically converted into rights with respect to New Above Food Common Shares (each converted Bite warrant, a “New Above Food Listed Warrant”) and (iii) each outstanding warrant issued by Above Food to purchase Above Food common shares (each, a “Above Food Warrant”) automatically converted into one New Above Food Warrant, and in each case, New Above Food issued a number of New Above Food Common Shares and New Above Food Warrants in accordance with the Business Combination Agreement.

 

Prior to the Business Combination, New Above Food did not conduct any material activities other than those incidental to its formation and the matters contemplated by the Business Combination Agreement, such as the making of certain required securities law filings and the establishment of certain subsidiaries. Upon the closing of the Business Combination, New Above Food became the direct parent of Above Food, an Alberta-based innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products.

 

New Above Food Common Shares and New Above Food Listed Warrants are currently listed on the Nasdaq Global Market (“Nasdaq”) under the symbols “ABVE” and “ABVE.W”, respectively.

 

Except as otherwise indicated or required by context, references in this Shell Company Report on Form 20-F (the “Report”) to “we”, “us”, “our”, “TopCo,” “New Above Food” or the “Company” refer to Above Food Ingredients Inc., a corporation organized under the laws of Alberta, Canada, and its consolidated subsidiaries.

 

ii


 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

Certain statements made in this Report, including the description of the transactions, agreements and other information contained herein and the exhibits hereto, as well as information incorporated by reference herein are not historical facts but are “forward-looking statements” for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “could,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook,” “suggests,” “targets,” “projects,” “forecast” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding future events, the estimated or anticipated future results and benefits of New Above Food following the Business Combination, future opportunities for New Above Food, future planned products and services, business strategy and plans, objectives of management for future operations of New Above Food, market size and growth opportunities, competitive position, technological and market trends, and other statements that are not historical facts. These statements are based on the current expectations of New Above Food’s management and are not predictions of actual performance.

 

These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. All forward-looking statements are based upon estimates and forecasts and reflect the views, assumptions, expectations, and opinions of New Above Food, which are all subject to change due to various factors. Any such estimates, assumptions, expectations, forecasts, views or opinions, whether or not identified in this Report, should be regarded as indicative, preliminary and for illustrative purposes only and should not be relied upon as being necessarily indicative of future results.

 

Many actual events and circumstances are beyond the control of New Above Food. These statements are subject to a number of risks and uncertainties regarding New Above Food’s businesses and the Business Combination, and actual results may differ materially. These risks and uncertainties include, but are not limited to, general economic, political and business conditions; changes in domestic or foreign business, market, financial, political and legal conditions; failure to realize the anticipated benefits of the Business Combination, including difficulty in integrating the businesses of Bite and Above Food; the risk that the Business Combination disrupts current plans and operations or the ability of New Above Food to grow and manage growth profitably and retain its key employees including its executive team; costs related to the Business Combination; the overall level of demand for New Above Food’s services; general economic conditions and other factors affecting New Above Food’s business; New Above Food’s ability to implement its business strategy; New Above Food’s ability to manage expenses; changes in applicable laws and governmental regulation and the impact of such changes on New Above Food’s business, New Above Food’s exposure to litigation claims and other loss contingencies; the risks associated with negative press or reputational harm; New Above Food’s ability to protect patents, trademarks and other intellectual property rights; any breaches of, or interruptions in, New Above Food’s technology infrastructure; changes in tax laws and liabilities and other factors discussed under the section titled “Risk Factors” in this Report.

 

iii


 

Forward-looking statements are subject to known and unknown risks and uncertainties and are based on potentially inaccurate assumptions that could cause actual results to differ materially from those expected or implied by the forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements for many reasons, including the factors discussed under the “Risk Factors” section in this Report. Accordingly, you should not rely on these forward-looking statements, which speak only as of the date of this Report. We undertake no obligation to publicly update or revise any forward-looking statement contained in this Report to reflect circumstances or events after the date of this Report or to reflect the occurrence of unanticipated events. You should, however, review the factors and risks described in the reports we will file from time to time with the SEC after the date of this Report.

 

Although we believe the expectations reflected in the forward-looking statements were reasonable at the time made, we cannot guarantee future results, level of activity, performance or achievements. Moreover, neither we nor any other person assume responsibility for the accuracy or completeness of any of these forward-looking statements. You should carefully consider the cautionary statements contained or referred to in this section in connection with the forward looking statements contained in this Report and any subsequent written or oral forward-looking statements that may be issued by New Above Food or persons acting on its behalf.

 

iv


 

PART I.

 

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

 

A. Directors and Senior Management

 

Unless otherwise indicated, the address of each New Above Food director and executive officer is c/o Above Food Ingredients Inc., 2305 Victoria Avenue #001, Regina, Saskatchewan, S4P 0S7.

 

The board of directors of New Above Food (“New Above Food Board”) after the closing of the Business Combination consists of seven members:

 

Chief Executive Officer and Executive Chairman

 

Lionel Kambeitz is a Founder, President, Chief Executive Officer and Executive Chairman of Above Food. He has served as Above Food’s Chief Executive Officer and as a member of the Above Food board of directors (“Above Food Board”) since September 2020. Mr. Kambeitz is also a Founder of KF Kambeitz Farms Inc. and served as the Executive Chairman of the board of directors from January 2013 to January 2023. Mr. Kambeitz has also been a director of HTC Purenergy Inc. since 1996. He is also a director on the board of Kingsland Energy Corp. and has served as a director on the board of directors since 1995. Mr. Kambeitz is also Chairman of the board of Carbon RX Inc. and a director on the board of directors of Delta CleanTech Inc. Mr. Kambeitz has over three-decades of experience in agriculture, manufacturing, energy and process design as well as extensive executive leadership experience in the agriculture industry. Age 71.

 

Executive Vice President, Chief Financial Officer and Director

 

Jason Zhao has served as Above Food’s Chief Financial Officer since October 2021. He founded Odyssey Advisory Services Ltd. in January 2021. Mr. Zhao has also been the Chief Executive Officer of ISTDC Canada Inc. since 2008. From April 2018 to January 2021, Mr. Zhao served as Principal of Virtus Group, Chartered Professional Accountants & Business Advisors LLP, the largest independent Chartered Professional Accountant and Business Advisory firm in Saskatchewan, Canada. He is a Chartered Professional Accountant and a Chartered Business Valuator. Mr. Zhao received a Bachelor’s degree in Business from the University of Alberta. Mr. Zhao has over 20 years of experience building and leading finance teams in accounting firms, private equity, and international companies with significant operating scale and complexity. Age 41.

 

Non-Executive Directors

 

Felipe Gomez Garcia has spent the last 27 years of his career with Grupo Industrial Vida S.A. de C.V. (“Grupo Vida”), where he has served as a Member of the board of directors and Chief Executive Officer since January 2017. Grupo Vida, the largest oat milling company in Latin America, has its headquarters in México and also has operations in Canada and Chile. He has been President of the Food Industry Chamber in the State of Jalisco, Mexico; VP of the Confederation of Industrial Chambers in Mexico; and Member of the board of directors of Food Bank in Guadalajara among other positions dedicated to support the most needed communities in Jalisco and Mexico. Mr. Gomez has extensive executive leadership experience and experience serving on various boards of directors for companies in the agriculture industry. Age 50.

 

Garth Fredrickson is Lead Independent Director of New Above Food. He was an industrial and commercial property developer and a recognized business builder. Mr. Fredrickson has worked at Bison Properties Limited since 1990 as a co-owner and its Vice President. He has also been the President and Owner of Friona Development & Consulting Ltd since 1982. He serves on the board of directors for various private companies, including Atlantis Research Labs, where he has served since January 2015, Pure Jet, Inc., where he has served since June 2019, Bison Properties Limited, where he has served since 1997, and Friona Development & Consulting Ltd, where he has served since 1982. He also served on the Board of Governors of the University of Regina from 1998 to 2004, and as the Chairman of the Board of Governors during that period. Mr. Fredrickson received a Bachelor of Arts degree from the University of Regina in 1979. Age 68.

 

1


 

Alberto Ardura González served as Bite’s Chief Executive Officer from Bite’s inception and served on the Bite board of directors (“Bite Board”), and has served as the Chairman of the Bite Board since December 31, 2022, through the Closing of the Business Combination. He has more than 35 years of experience in the financial industry and has advised numerous companies on M&A transactions and on structuring and underwriting public and private issuances of equity and debt. From 2002 to 2009, Mr. Ardura was the Chief Country Manager and Head of Fixed Income Currencies and Commodities at Merrill Lynch Mexico, S.A. de C.V., the leading investment bank in Mexico at the time. In 2009, Mr. Ardura joined Deutsche Bank, A.G. in New York City as Head of Latin America Capital Markets and Treasury Solutions, advising over 350 clients in raising several hundred billion dollars in debt and equity financing in the public and private markets, as well as advising several clients in restructurings transactions. During such time, Mr. Ardura was also responsible for Deutsche Bank’s local operations in Brazil, Mexico, Chile, Perú and Argentina, and was a member of Deutsche Bank’s Global Emerging Markets Committee, Latin America Investment Committee, and Americas Investment Banking Executive Committee. He was later appointed as Vice Chairman of Corporate Finance for Latin America. From 2017 to 2019, he was a Managing Director leading the Latin America Investment Banking and Client Coverage division at Nomura Securities, Inc. In 2019, Mr. Ardura founded his own advisory firm, Pier A Capital Solutions, Inc., focusing on M&A and private debt and equity financing transactions for clients across Latin America. Mr. Ardura has served on several boards of directors including Banca Promex, S.A. de C.V., Valores Finamex, S.A. de C.V. Merrill Lynch México, and Casa de Bolsa, S.A. de C.V. He currently serves as an independent board member of HSBC México, S.A., the banking subsidiary of Grupo HSBC, and also serves on the boards of its insurance, broker dealer and asset manager subsidiaries. Mr. Ardura is also an independent board member of Dimex Capital, SA deCV and FinMédica, S.A, and is also a board member of Eric Kayser México, S.A.P.I. de C.V. Mr. González has over three-decades of experience in the financial industry as well as his extensive executive leadership experience and board service positions. Age 61.

  

Chief Reginald Bellerose is a political leader and business leader. Mr. Bellerose has served as a director and a member of the Audit & Finance Committees of Encanto Potash Corp. since 2020 and 2022, respectively. Mr. Bellerose is also a director at five private companies, including Carbon RX Inc., where he has served since November 2022, Atamipek, where he has served since December 2018, 102005647 Saskatchewan Ltd, where he has served since January 2017, KDM Business Development Corp., where he has served since 2009, and Saskatchewan Indian Gaming Authority, where he has served as the Chairman of the board since February 2008. Mr. Bellerose has served as the President of both Muskowekwan Resources Ltd. since 2010 and of KDM Business Development Corp. since 2009. He served for 17 consecutive years, until 2021, as Chief of Muskowekwan First Nation. Mr. Bellerose holds a Master’s Certificate in Project Management from the University of Saskatchewan and a Bachelor of Arts in History and Political Science from Concordia University in Edmonton. Mr. Bellerose has served in various leadership positions in politics, business and has extensive board service positions. Age 56.

 

Agustin Tristan Aldave is a consultant for an array of companies in the financial industry and develops restaurants, franchises, ready-to-eat and ready-to-drink products, including developing a bottling company, as well as a food delivery platform to take healthy food and beverages to industrial areas. Mr. Tristan has served as a director and the CEO at the Agrinam Acquisition Corporation since August 2021. Further, Mr. Tristan also serves as a director and the CEO of two private companies, including Lexington Capital, S.A.P.I. de C.V. (“Lexington”), where he has served since April 2017, and Demeter Capital, S.A.P.I. de C.V., where he has served since August 2016. Mr. Tristan received a Bachelor of Science in Industrial Engineering in 2008 from the University of Alabama and a Master of Business Administration from the same university in 2010. Mr. Tristan has extensive experience serving on various boards, working on food product development and consulting in the financial and manufacturing industries. Age 38.

 

The executive officers of New Above Food after the closing of the Business Combination consists of two additional individuals:

 

Vice President of Consumer Brands

 

Martin Williams is a Co-Founder of Above Food and the President and Chief Innovation Officer of AFBI, a wholly owned subsidiary of Above Food. He has served as the President and Chief Innovation Officer of AFBI since January 2021. Mr. Williams has been a visiting professor at CEDIM México since December 2018, where he teaches a class on adaptive strategy as part of the Master’s in Business Innovation program. Before founding Above Food, Mr. Williams held various leadership roles at global management consulting firms, such as Fahrenheit 212, which was acquired by Capgemini SE (PA: CAP), and Idea Couture Inc., which was acquired in 2016 by Cognizant Technology Solutions (NASDAQ: CTSH), until July 2019, including Senior Vice President and Global Head of Strategy. Mr. Williams attended OCAD University in Toronto where he studied industrial design with a specialization in applied innovation.

 

2


 

Vice President of Origination and Regenerative Agriculture

 

Tyler West is a Founder of Above Food and, since 2016, a Founder and President and Chief Executive Officer of Purely Canada Foods Corp. (“PCFC”), now a wholly owned subsidiary of Above Food. He has served as a member of the PCFC board of directors since October 2016 and as a member of the Above Food Board since January 2023 and as President and Chief Executive Officer of PCFC since October 2017. Mr. West received a Bachelor of Science degree in Agricultural Business and Management at the University of Missouri-Columbia.

 

Corporate Governance

 

New Above Food Common Shares and New Above Food Listed Warrants are currently listed on Nasdaq under the symbols “ABVE” and “ABVE.W,” respectively. As of the Closing, New Above Food is subject to the Nasdaq corporate governance requirements (the “Nasdaq Listing Rules”) on an ongoing basis.

 

The Canadian Securities Administrators (the “CSA”) have issued corporate governance guidelines pursuant to National Policy 58-201 — Corporate Governance Guidelines (the “Corporate Governance Guidelines”), together with certain related disclosure requirements pursuant to National Instrument 58-101 — Disclosure of Corporate Governance Practices (“NI 58-101”). The Corporate Governance Guidelines are recommendations respecting reporting issuer corporate governance, including the CSA’s recommendations on the composition of a company’s board of directors (or similar body for a non-corporate entity), director independence, board mandates and position descriptions for the board chair, committee chairs, and the Chief Executive Officer, orientation and continuing education, written codes of conduct or ethics, nomination of directors, compensation and regulator board assessments.

 

New Above Food recognizes that good corporate governance plays an important role in its overall success and in enhancing shareholder value and, accordingly, has adopted, certain corporate governance policies and practices that reflect its consideration of the recommended Corporate Governance Guidelines.

 

The disclosure set out below includes disclosure required by NI 58-101 describing New Above Food’s anticipated approach to corporate governance in relation to the Corporate Governance Guidelines and the Nasdaq Listing Rules.

 

3


 

Election and Appointment of Directors

 

Under the New Above Food Articles, the New Above Food Board shall consist of a minimum of 1 and a maximum of 15 directors. Under the provisions of the ABCA if New Above Food is a “reporting issuer” in any jurisdiction of Canada the New Above Food Board shall not have less than 3 directors.

 

Unless otherwise required by the ABCA or the New Above Food Articles, at all meetings of shareholders, every question will be decided by a majority of the votes cast on the question. In case of an equality of votes on any question, the chair of the meeting will not be entitled to a second or casting vote.

 

A resolution in writing signed by all the directors entitled to vote on that resolution at a meeting of directors or committee of directors is as valid as if it had been passed at a meeting of directors or committee of directors, as the case may be. A resolution in writing dealing with all matters required by the ABCA to be dealt with at a meeting of directors, and signed by all the directors entitled to vote at that meeting, satisfies all the requirements of the ABCA relating to meetings of directors.

 

Each director shall hold office until the next annual general meeting and until his or her successor is elected and duly qualified, subject to prior death, resignation, retirement, disqualification or removal from office.

 

Director Independence

 

The New Above Food Board has determined that each of Felipe Gomez Garcia, Garth Frederickson, Chief Reginald Bellerose, Alberto Ardura González and Agustin Tristan Aldave qualify as “independent directors”, as defined under the rules of Nasdaq and NI 58-101 and the New Above Food Board consists of a majority of “independent directors”, as defined under the rules of the SEC and Nasdaq relating to director independence requirements. In addition, the New Above Food Board is subject to the rules of the SEC and Nasdaq relating to the membership, qualifications, and operations of the audit committee, as discussed below.

 

Committees of the New Above Food Board of Directors

 

As of the Closing of the Business Combination, New Above Food Board established three standing committees: an audit and risk committee, nominating committee and a compensation committee. The written charter for each of the New Above Food Board committees is posted on our website at https://abovefood.com/investors/.

 

Audit and Risk Committee

 

We have established an audit and risk committee comprised of Garth Frederickson, Alberto Ardura González and Agustin Tristan Aldave, with Alberto Ardura González serving as chairperson, each of whom meet the independence requirements set forth in Rule 10A-3 under the Exchange Act and applicable Nasdaq Listing Rules. Each member of the audit committee is financially literate, and the New Above Food Board has determined that Alberto Ardura González qualifies as the “audit committee financial expert,” as such term is defined in Item 407 of Regulation S-K and qualifies as an “audit committee financial expert”, as such term is defined in the rules of the SEC and applicable Nasdaq Listing Rules.

 

The audit and risk committee is, among other things, directly responsible for the appointment, compensation, retention and oversight of the work of New Above Food’s independent auditor, including overseeing the qualifications and independence of our outside auditor, overseeing management’s conduct of our financial reporting process (including the development and maintenance of systems of internal accounting and financial controls), overseeing the integrity of our financial statements, overseeing the performance of the internal audit functions, preparing certain reports required by the rules and regulations of the SEC, reviewing the results and scope of the audit and other accounting related services, and overseeing New Above Food’s compliance with legal and regulatory requirements.

 

Compensation Committee

 

We have established a compensation committee comprised of Garth Frederickson and Agustin Tristan Aldave, with Agustin Tristan Aldave serving as chairperson, each of whom meet the independence requirements set forth in Rule 10C-1 under the Exchange Act and applicable Nasdaq Listing Rules.

 

4


 

The compensation committee is, among other things, directly responsible for reviewing and approving, or recommending to the New Above Food Board for approval, compensation of the Chief Executive Officer and other executive officers, making recommendations to the New Above Food Board with respect to director compensation, overseeing the succession planning process, overseeing the administration of New Above Food’s incentive compensation plans, and preparing any report on executive compensation required by the rules and regulations of the SEC.

 

Nominating and Governance Committee

 

We have established a nominating and governance committee comprised of independent directors, Chief Reginald Bellerose and Felipe Gomez Garcia, with Chief Reginald Bellerose serving as chairperson.

 

The nominating and governance committee is, among other things, directly responsible for overseeing the selection of persons to be nominated to serve on the New Above Food Board, making recommendations to the New Above Food Board with respect to committee members and chairs, annually evaluating the committees, and overseeing and developing New Above Food’s corporate governance practices.

 

Diversity

 

The New Above Food Board has not adopted any policies that address the identification and nomination of women or other diverse candidates to the New Above Food Board or to management of New Above Food. The New Above Food Board recognizes the importance and benefit of having a board of directors and senior management composed of highly talented and experienced individuals having regard to the need to foster and promote diversity among board members and senior management with respect to attributes such as gender, ethnicity and other factors. In support of this goal, the compensation committee intends to, when identifying candidates to nominate for election to the New Above Food Board or appoint as senior management or in its review of senior management succession planning and talent management:

 

· consider individuals who are highly qualified, based on their talents, experience, functional expertise and personal skills, character and qualities having regard to New Above Food’s current and future plans and objectives, as well as anticipated regulatory and market developments;

 

· consider criteria that promote diversity, including with regard to gender, ethnicity, and other considerations;

 

· consider the level of representation of women on its board of directors and in senior management positions, along with other markers of diversity, when making recommendations for nominees to the New Above Food Board or for appointment as senior management and in general with regard to succession planning for the New Above Food Board and senior management; and

 

· as required, engage qualified independent external advisors to assist the New Above Food Board in conducting its search for candidates that meet the board of directors’ criteria regarding skills, experience and diversity.

 

At the present time, there are no women serving on the New Above Food Board.

 

 

B. Advisers

 

Latham & Watkins LLP, 811 Main Street, Suite 3700, Houston, TX 77002, has acted as U.S. securities counsel for New Above Food and Above Food and is continuing to act as U.S. securities counsel to New Above Food following the closing of the Business Combination.

 

Gowling WLG (Canada) LLP, 1600, 421 7th Avenue SW, Calgary, Alberta, T2P 4K9, Canada, has acted as counsel for New Above Food and Above Food with respect to Canadian law and is continuing to act as counsel for New Above Food with respect to Canadian law following the closing of the Business Combination.

 

C. Auditors

 

For the fiscal years ended January 31, 2024 and 2023, Ernst & Young LLP, Chartered Professional Accountants, 409 — 3rd Ave S, Saskatoon, SK S7K 5R5, Canada, has acted and will act going forward as independent registered public accounting firm for Above Food and New Above Food, respectively.

 

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

 

Not applicable.

 

ITEM 3. KEY INFORMATION

 

A. [Reserved]

 

B. Capitalization and Indebtedness

 

The following table sets forth the capitalization of New Above Food on an unaudited pro forma combined basis as of January 31, 2024, after giving effect to the Business Combination.

 

    As of
January 31, 2024
 
      (in CAD $ million)  
Cash and cash equivalents     1.5  
Total liabilities     334.7  
Equity     (186.4 )
Share Capital     (68.9 )
Retained earnings     (117.7 )

 

5


 

C. Reasons for the Offer and Use of Proceeds

 

Not applicable.

 

D. Risk Factors

 

The risk factors related to the business and operations of New Above Food are described in the Proxy Statement/Prospectus under the section titled “Risk Factors,” which is incorporated herein by reference.

 

On December 27, 2022, the U.S. Department of the Treasury issued a notice that provides interim operating rules for the excise tax, including rules governing the calculation and reporting of the excise tax, on which taxpayers may rely until the forthcoming proposed Treasury Regulations addressing the excise tax are published. Although such notice clarifies certain aspects of the excise tax, the interpretation and operation of other aspects of the excise tax remain unclear, and such interim operating rules are subject to change.

 

ITEM 4. INFORMATION ON THE COMPANY

 

A. History and Development of the Company

 

The legal name of the company is Above Food Ingredients Inc. New Above Food was incorporated as a corporation organized under the laws of Alberta, Canada (formerly known as 2510169 Alberta Inc.) on April 18, 2023. The address of the registered office of New Above Food is 2305 Victoria Avenue #001, Regina, Saskatchewan, S4P 0S7 and the telephone number of New Above Food is +1 (306) 779-2268.

 

See “Explanatory Note” in this Report for additional information regarding New Above Food and the Business Combination. Certain additional information about New Above Food is included in the Proxy Statement/Prospectus under the section titled “Information Related to New Above Food” and is incorporated herein by reference. The material terms of the Business Combination are described in the Proxy Statement/Prospectus under the section titled “The Business Combination Proposal,” which is incorporated herein by reference.

 

New Above Food is subject to certain of the informational filing requirements of the Securities Exchange Act of 1934, as amended (“Exchange Act”). Since New Above Food is a “foreign private issuer”, it is exempt from the rules and regulations under the Exchange Act prescribing the furnishing and content of proxy statements, and the officers, directors and principal shareholders of New Above Food are exempt from the reporting and “short-swing” profit recovery provisions contained in Section 16 of the Exchange Act with respect to their purchase and sale of New Above Food Common Shares. In addition, New Above Food is not required to file reports and financial statements with the SEC as frequently or as promptly as U.S. public companies whose securities are registered under the Exchange Act. However, New Above Food is required to file with the SEC an Annual Report on Form 20-F containing financial statements audited by an independent accounting firm. The SEC also maintains a website at http://www.sec.gov that contains reports and other information that New Above Food files with or furnishes electronically to the SEC.

 

The website address of New Above Food is https://abovefood.com. The information contained on the website does not form a part of, and is not incorporated by reference into, this Report.

 

B. Business Overview

 

Prior to the Business Combination, New Above Food did not conduct any material activities other than those incidental to its formation and the matters contemplated by the Business Combination Agreement, such as the making of certain required securities law filings and the establishment of certain subsidiaries. Upon the closing of the Business Combination, New Above Food became the direct parent of, and conducts its business through Above Food, an Alberta-based innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products.

 

Information regarding the business of Above Food is included in the Proxy Statement/Prospectus under the sections titled “Business of Above Food and Certain Information about Above Food” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations of Above Food,” which are incorporated herein by reference.

 

6


 

C. Organizational Structure

 

Upon the closing of the Business Combination, Above Food became a direct, wholly owned subsidiary of New Above Food. The organizational chart of New Above Food is included on page 36 of the Proxy Statement/Prospectus and is incorporated herein by reference.

 

D. Property, Plant and Equipment

 

New Above Food’s property, plants and equipment are held through Above Food and its subsidiaries. Information regarding New Above Food’s property, plants and equipment is included in the Proxy Statement/Prospectus under the sections titled “Business of Above Food and Certain Information about Above Food—‍Manufacturing” and “Business of Above Food and Certain Information about Above Food—‍Facilities” and are incorporated herein by reference.

 

ITEM 4A. UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

 

Following and as a result of the Business Combination, the business of New Above Food is conducted through Above Food, its direct, wholly owned subsidiary, as well as the direct, and indirect subsidiaries of Above Food.

 

The following discussion and analysis of the financial condition and results of operations of Above Food for the years ended January 31, 2024 and January 31, 2023, is based on Above Food’s financial information prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”). Some of the information contained in this discussion and analysis or set forth elsewhere in this Proxy Statement/Prospectus, including information with respect to Above Food’s plans and strategy for its business, includes forward-looking statements that involve risks and uncertainties.

 

Company Overview

 

Above Food is a regenerative ingredient company with a vertically integrated supply chain that produces products made with carefully sourced ingredients, with a priority on chain of custody, nutrition, flavor and transparency. Above Food’s vision is to create a healthier world – one seed, one field, and one bite at a time. With a priority on chain of custody plant proteins, enabled by scaled operations and infrastructure in primary agriculture and ingredient processing, Above Food aims to deliver food to business and consumers with traceability, quantifiable sustainability, and nutrient density.

 

Above Food’s ingredients are inside some of the most successful branded consumer products, with products available online and in natural grocers across Canada and the USA. Our railway infrastructure, grain storage terminals, private railcar fleet, and strategic farm acres provide reliability and agility across the supply chain. From partnering to purchase next year’s planting seed to measuring the results of regenerative farming practices, we take the long view. We believe Above Food is poised to expand its platform through innovation and organic growth along with acquisition opportunities in the regenerative ingredient space.

 

Above Food has three main product lines and operates in two reportable segments: Disruptive Agriculture and Rudimentary Ingredients, and Consumer Packaged Goods (“CPG”). The Disruptive Agriculture and Rudimentary Ingredients segment concentrates on the provisioning of discrete genetics, origination, purchasing, grading, primary processing and sale of regeneratively grown grain, as well as the origination, purchase, and sale of bespoke ingredients products, processed primarily through the Company-owned ingredient facilities. The CPG segment formulates, manufactures, sells, distributes, and markets proprietary consumer product formulations in owned brands and focuses on manufacturing and distribution for private-labeled retail owned brands. The Company also has a corporate department that carries out the centralized functions of accounting, treasury, information technology, legal, and human resources. Given that this department does not undertake business activities and does not recognize revenue that are more than incidental to the Company’s activities, it is not considered to be a separate operating segment.

 

7


 

Above Food has experienced a decrease in sales for the year ended January 31, 2024 (“FY24”) in comparison to the year ended January 31, 2023 (“FY23”), with both years having a large increase over the year ended January 31, 2022 (“FY22”). Revenues decreased to $368.4 million for FY24 from $396.5 million for FY23. Revenues for FY22 were $198.9 million. Disruptive Agriculture and Rudimentary Ingredients revenues decreased to $356.4 million in FY24 from $387.0 million in FY23, which increased from $198.7 million in FY22. CPG revenues increased to $11.6 million in FY24 from $9.4 million FY23, largely due to acquisitions that closed in May and June 2022 being included in the full FY24, compared to partial inclusion in FY23 (from the respective dates of acquisition to January 31, 2023). CPG revenues in FY22 were approximately $0.2 million, as the Company launched this division towards the end of calendar 2021.

 

We have generated a net loss in each of FY24, FY23, and FY22. Net losses in FY24, FY23, and FY22 were $53.3 million, $45.5 million, and $5.8 million, respectively. The Company incurred significant losses in FY24 and FY23 due to significant professional fees relating to consulting and accounting as the Company prepared to go public, expenditures in order to fulfill sales contracts, continued investment in innovation and growth of our business, and implementation of the systems, processes and tools necessary to be publicly traded. The loss in FY22 was largely related to expenses incurred in scaling up the business and beginning the process to go public. These losses specifically relate to operations, interest, and income taxes and do not reflect specific capital expenditures or acquisitions.

 

Growth Strategy and Outlook

 

A key component of Above Food’s growth strategy is organic or internal growth with the intent of delivering profitable and sustainable revenue growth through the sale of existing higher margin products; expanding into new channels and attracting new customers; introducing higher margin products; building strategic partnerships through consumer and customer insights and investing in continuous improvement in our plants and our organization to improve efficiencies and simplify the business; growth through acquisitions; and securing long-term contracts. A significant percentage of the Disruptive Agriculture and Rudimentary Ingredients revenue is contracted over 3 to 12 months with our customers. Our contracts have terms that allow for cancellation upon events of force majeure. While we believe contractual relationships with our customers will result in revenues being stable over time, we have experienced and may experience fluctuations in our revenues.

 

The Business Combination and Public Company Costs

 

On April 29, 2023, Above Food, New Above Food and Merger Sub, entered into the Business Combination Agreement with Bite to consummate the Business Combination. Existing Above Food shareholders, including management rolled over 100% of their equity into the combined company. Following the closing of the Business Combination, Above Food shareholders remained majority shareholders with an approximate 59.74% ownership. Above Food shareholders received common shares valued at US $10.00 per share of New Above Food in the Business Combination. Upon consummation of the Business Combination, New Above Food became listed on Nasdaq, and Bite’s listing on the NYSE was terminated.

 

The Business Combination was structured as follows:

 

 

8


 

(a)             Prior to the Closing, Above Food continued from the laws of Saskatchewan to a corporation under the laws of the Province of Alberta pursuant to the ABCA; (b)             On the Closing Date and pursuant to a court-approved plan of arrangement, Above Food’s shareholders effected the Share Exchange, pursuant to which, among other things, Above Food’s shareholders contributed to New Above Food all of the issued and outstanding equity of Above Food in exchange for newly issued New Above Food Common Shares, New Above Food’s Class A Earnout Shares and New Above Food’s Class B Earnout Shares, and after giving effect to the Share Exchange, Above Food became a direct, wholly owned subsidiary of New Above Food. The New Above Food Class A Earnout Shares and New Above Food Class B Earnout Shares are convertible into common shares of New Above Food if certain vesting conditions are met. In addition, the New Above Food Common Shares issued as part of the consideration of the Merger that were issued to Smart Dine, LLC, a Delaware limited liability company (“Sponsor”), at the Closing in exchange for Bite founder shares that were held by the Sponsor, will be subject to vesting conditions identical to the New Above Food Class A Earnout Shares and New Above Food Class B Earnout Shares, and will be forfeited if such conditions are not satisfied; and

 

(c)             On the Closing Date and following the completion of the Share Exchange, Merger Sub merged with and into Bite, with Bite surviving as a direct, wholly owned subsidiary of New Above Food. As a result of the Merger, (i) each issued and outstanding share of Bite’s common stock is no longer outstanding and was automatically converted into and exchanged for one New Above Food Common Share and (ii) each issued and outstanding warrant to purchase shares of Bite’s common stock is no longer outstanding and was, pursuant to the terms of the Warrant Agreement, automatically converted into and became one warrant to purchase New Above Food Common Shares, and all rights with respect to shares of Bite’s common stock underlying such warrants were automatically converted into rights with respect to New Above Food Common Shares, in each case, with New Above Food issuing a number of New Above Food Common Shares and warrants in accordance with the Warrant Agreement.

 

(d)             Prior to the Closing Date, Above Food issued Above Food common shares in exchange for cash proceeds of USD $5.0 million and USD $5.3 million to Brotalia, S.L. (“Brotalia”) and Veg House Holdings Inc. (“Veghouse”) stockholders, respectively, and for prepaid deposit of USD $3.2 million to Veghouse for future goods or services to be provided to New Above Food. Upon completion of the Business Combination, Above Food’s existing shareholders, Bite’s public stockholders, Bite’s initial stockholders (including the Sponsor), Brotalia stockholders, Veghouse stockholders, the ANF stockholders and the lenders (“Lenders”) own the following percentages of New Above Food Common Shares, not including the Above Food Earnout Shares. The amount of New Above Food Common Shares to be owned by the Lenders represents the conversion of the USD $4.9 million of lender financing outstanding and the associated USD $1.2 million of interest accrued up to January 31, 2024 into New Above Food Common Shares at a deemed value of USD $10 per share, excluding 36,681 New Above Food Common Shares expected to be issued for the interest accrued from February 1, 2024 to the Closing Date. The equity value outlined below is calculated assuming a share price of USD $10 per share issued.

 

    $     Shares     % of Total  
Bite public stockholders   $ 504,380       50,438       0.2 %
Bite initial stockholders (1)   $ 57,900,000       5,790,000       20.8 %
Lenders (2)   $ 10,973,850       1,097,385       3.9 %
Existing Above Food shareholders   $ 166,099,810       16,609,981       59.7 %
Brotalia shareholders (3)   $ 18,000,000       1,800,000       6.5 %
Veghouse shareholders (4)   $ 8,525,500       852,550       3.1 %
ANF shareholders (5)   $ 16,042,529       1,604,253       5.8 %
Total shares issued at close (6)     278,046,069       27,804,607       100.0 %
                         
Per Share Value:                        
Shares outstanding, excluding additional dilution sources (7)     10.00                  
Shares outstanding, fully diluted (8)     9.12                  
                   
Additional dilution sources   Shares     % of Total (19)     Per share
value (20)
 
Public warrants (9)     10,000,000       19.3 %     10.40  
Private placement warrants (10)     275,000       0.5 %     10.01  
Warrants underlying Sponsor Convertible Promissory Note (11)     75,000       0.1 %     10.00  
Above Food earn out shares (12)     6,113,742       11.8 %     8.20  
Above Food restricted share units (13)     1,514,459       2.9 %     9.48  
Above Food options - Tranche 1 (14)     1,567,036       3.0 %     9.84  
Above Food options - Tranche 2 (15)     1,661,701       3.2 %     10.42  
Above Food options - Tranche 3 (16)     126,204       0.2 %     10.07  
Above Food OTM warrants (17)     2,375,455       4.6 %     10.26  
ANF earn out shares (18)     220,000       0.4 %     9.92  
Total Additional Dilution Sources (19)     23,928,597       46.0 %     9.12  
                         
Total shares assuming full dilution     51,733,204                  

 

 

(1) Consists of 5,640,000 private shares currently outstanding, plus 150,000 shares underlying the Sponsor Convertible Promissory Note (as to which the Sponsor has agreed, pursuant to the Sponsor Support Agreement, to convert $1.5 million of the outstanding principal into Bite units immediately prior to the effective time of the Merger, which units will then, in accordance with the terms of the Business Combination Agreement, convert into one New Above Food Common Share and one half of a warrant to acquire a New Above Food Common Share, with a strike price of $11.50).

 

(2) Represents the conversion of the lender financing entered into prior to the Business Combination, into New Above Food Common Shares at a deemed value of $10 per share. The interest amount was calculated as the amount accrued at the Closing Date.

 

(3) In connection with the close of the transaction with Bite, Above Food issued Above Food common shares prior to the completion of the Business Combination to obtain financing of US $5.0 million from the shareholders of Brotalia and acquire the business of Brotalia. As the acquisition of Brotalia was not deemed to be significant within the meaning of Regulation S-X Rule 3-05, this acquisition is not reflected in the Pro forma financial information included elsewhere in this 20-F and accordingly the shares issued are also not included in such pro forma financial information.

 

(4) In connection with the close of the transaction with Bite, Above Food issued 852,550 Above Food common shares prior to the completion of the Business Combination for cash proceeds of US $5.3 million from Veghouse and prepaid deposit of US $3.2 million.

 

(5) In connection with the close of the transaction with Bite, Above Food acquired the remainder of the interest in ANF it did not own. The consideration paid was settled in Above Food common shares prior to the completion of the Business Combination. As the acquisition of the remaining interest in ANF was not deemed to be significant within the meaning of Regulation S-X Rule 3-05, this acquisition is not reflected in the Pro forma financial information included elsewhere in this 20-F and accordingly the shares issued are also not included in such pro forma financial information.
   
(6) These equity values were calculated based on the number of shares outstanding at the closing of the Business Combination and the per share value of $10 per New Above Food Common Share.

 

9


 

(7) Calculation of value per share does not take into account the additional sources of dilution, as described in notes 9 through 18 below.

 

(8) Calculation of value per share takes the issuance of the maximum amount of New Above Food Common Shares in connection with the additional dilution sources, as described in notes 9 through 18 below. In addition, calculation of value per share in the rows entitled “Public Warrants” and “Private placement warrants” and “Warrants underlying Sponsor Convertible Promissory Note” is based on the applicable Total Equity Value Post-Redemptions plus the full exercise of the applicable maximum number of Warrants at $11.50 per share for a total cash exercise price of approximately $115.0 million in the row entitled “Public Warrants,” approximately $3.2 million in the row entitled “Private placement warrants” and approximately $0.9 million in the row entitled “Warrants underlying Sponsor Convertible Promissory Note.”
   
(9) This row assumes exercise of all Public Warrants outstanding as of January 31, 2024, to purchase 10,000,000 shares of Bite common stock.
   
(10) This row assumes exercise of all private placement warrants outstanding as of January 31, 2024, to purchase 275,000 shares of Bite common stock.
   
(11) This row assumes that the maximum amount permitted under the Sponsor Convertible Promissory Note to be converted into Bite units in the aggregate amount of $1,500,000 is converted into Bite units at a price of $10.00 per unit, as required by the terms of the Sponsor Support Agreement, and that the 75,000 warrants included in such units are all exercised.
   
(12) This row assumes that all of the Above Food Earnout Shares are converted into New Above Food Common Shares. The Above Food Earnout Shares will only be converted into New Above Food Common Shares if certain conditions are satisfied within five years following the Closing Date, as described in this 20-F.

 

(13) This row represents all of the 1,514,459 shares issuable to Above Food’s employees pursuant to restricted share units that will begin vesting upon the consummation of the Business Combination and pursuant to employment agreements.

 

(14) This row assumes that all of the first tranche of Above Food’s options (“Above Food Options T1”) are converted into New Above Food Common Shares.

 

(15) This row assumes that all of the second tranche of Above Food’s options (“Above Food OTM Options T2”) are converted into New Above Food Common Shares.

 

(16) This row assumes that all of the third tranche of Above Food’s options (“Above Food OTM Options T3”) are converted into New Above Food Common Shares.

 

(17) This row assumes that all of Above Food’s out-of-the-money warrants (“Above Food OTM Warrants”) are converted into New Above Food Common Shares.

 

(18) This row assumes the issuance of (i) 100,000 shares payable to ANF securityholders in the first year following the consummation of the ANF Acquisition (“ANF Year One Earnout Shares”) and (i) 120,000 shares payable to ANF securityholders in the second year following the consummation of the ANF Acquisition (“ANF Year Two Earnout Shares” and, together with the ANF Year One Earnout Shares, the “ANF Earnout Shares”). These amounts represent the estimated maximum payout in shares under these earn out arrangements to illustrate the maximum amount of dilution possible to the Bite public stockholder who elect not to redeem their shares may experience in connection with the Business Combination; however, the 220,000 ANF Earnout Shares will be issued in a private placement pursuant to Section 4(a)(2) of the Securities Act after the total number of New Above Food Common Shares payable to the ANF securityholders following the consummation of the ANF Acquisition is determined.

 

(19) This row assumes the issuance of all New Above Food Common Shares in connection with each of the additional dilution sources, which equals 23,928,597 New Above Food Common Shares. Percentages in this row represent (a) the foregoing share amount divided by (b) the sum of (i) the amounts included in the row titled “Total Shares Outstanding” plus (ii) the amounts included in the row titled “Total Additional Dilution Sources”. 23,928,597 New Above Food Common Shares in total represents the full amount of shares issuable with respect to the applicable additional dilution source in both the numerator and denominator.

 

(20) These columns assume an equity value of New Above Food of $278.0 million. These equity values were calculated based on the number of shares at close and the assumed per share value of $10 per New Above Food Common Share. The per share values are calculated assuming the exercise price is paid for each dilutive instrument (where applicable) and such value is added to the total equity value of New Above Food. The denominator was calculated as the number of shares outstanding, adjusted to include the incremental share count underlying each dilutive instrument.

 

As a result of the Business Combination, New Above Food became an SEC-registered and Nasdaq-listed company, and its operations represent a continuity of Above Food’s operations. As a public company, New Above Food will be implementing additional procedures and processes for the purpose of addressing the standards and requirements applicable to public companies. We expect to incur additional annual expenses related to being a publicly listed company including, among other things, additional directors’ and officers’ liability insurance, director fees, reporting requirements of the SEC, transfer agent fees, hiring additional accounting, legal and administrative personnel, increased auditing and legal fees and similar expenses.

 

10


 

Business Trends

 

Year Ended January 31, 2024, January 31, 2023, and January 31, 2022

 

We generated a $7.8 million greater net loss in FY24 as compared to FY23, and a $47.5 million greater net loss in FY24 as compared to FY22. The biggest drivers of the increased loss as compared to FY23 were the following:

 

· Write-offs and write-downs of inventory of approximately $3 million, contributing to the increased gross loss, including:

 

A $2.7 million write-off of oat inventory due to the discontinuance of our oat grower program; and
  o A $285,000 write-down of CPG inventory that had aged past acceptable dates for retailer.

 

· Significant contract washout and cancellation costs, totaling approximately $650K, incurred to exit unfavorable contracts. These costs are incurred for various reasons, including crop damage/failure, transloader delays at ports, and our buyers no longer needing specific product due to mill backlogs or equipment breakdown.

 

· Increased professional fees of $3.5 million, relating to increased consulting and accounting expenses assisting in the process of going public.

 

· Increased rent of $1.4 million, largely due to the increased operating leases, as well as a full period of consolidating the operations of previous acquirees who rent premises and equipment.

 

· Increased interest expense of $2.3 million, relating to the new subordinated convertible loans, the Bank of Nova Scotia loan used for the acquisition of Discovery Seed Labs, and overall increased interest rates on variable rate facilities.

 

· An increase to the equity method investment loss of $3.0 million, largely relating to $3.3 million of impairment of the investment in ANF.

 

Our decreased net loss in FY22 when compared to FY23 and FY24 is largely due to the Company having a stronger gross margin (fewer write-downs/write-offs and costs incurred to exit contracts), lesser selling, general, and administrative costs overall as we had not yet completed acquisitions, no equity method investment loss as compared to FY24 ($3.8 million) and FY23 ($0.8 million), and a lack of impairment of intangible assets as compared to FY24 ($1.8 million) and FY23 ($6.9 million).

 

Supply chains

 

We have historically experienced corresponding unfavorable effects of higher raw material costs, higher freight and logistics costs, and supply chain challenges, including supply chain disruptions resulting from labor shortages and disruptions in ingredients. These cost pressures and supply chain challenges have continued through the years ended January 31, 2024 and 2023. We expect these challenges to continue in the 2025 fiscal year. We also continued to see manufacturer and logistics challenges, largely related to ingredient shortages that have contributed to lower sales of our products due to periodic out-of-stock situations. We could experience additional lost sale opportunities if our products are not available for purchase because of continued or expanded disruptions in our supply chain relating to an inability to obtain ingredients or packaging, labor challenges at our logistics providers or our contract manufacturers, or if our customers experience delays in stocking our products.

 

We have actively engaged with our customers, suppliers, and logistics and transportation providers, to meet demand for our products and to remain informed of any challenges within our business operations. We have also instituted price increases throughout the year ended January 31, 2024. Management believes these price increases and additional cost savings initiatives will enable us to continue to invest in projects that drive growth.

 

Climate related trends

 

Our business, industry, customers and others in the agriculture value chain face long-term challenges from climate change, including increasing expectations for climate actions and reductions of GHG emissions. Physical risks from a changing climate can have an impact on our operations, our customers and our supply chain. These include more intense weather events, longer droughts, rising sea levels, and changes in average temperature and precipitation patterns. Global decarbonization ambitions and the resulting energy transition are driving carbon regulations and informing capital allocation priorities of investors. Above Food faces evolving risks related to potential regulatory changes, including carbon pricing. At the same time, a transition to a low-carbon economy could create significant opportunities for Above Food to help growers manage these impacts and improve their resilience by facilitating the adoption of climate-smart agriculture practices and developing products that can improve yields in more challenging conditions. To date, our operations have not been significantly affected by weather related risks, though prices for inputs such as pulses and grains have fluctuated as a result of weather impacts in the past. We mitigate the impact of these changes in pricing in part by using back-to-back forward contracts with price discovery mechanisms, and locking in margins in advance under a merchandising model. These derivative contracts have not been designated as accounting hedges, and thus changes in their fair value affect our earnings immediately.

 

11


 

The impact of climate changes in the operations of our customers is uncertain and may be negative due to changes in rainfall patterns and intensity, shortage of water, changes in sea levels and changes in temperature, among others. These impacts may vary depending on the location and intensity of events, comprising acute risks, including increased severity of extreme climate events, and chronic risks, deriving from long-term changes in climate patterns. The risks of climate change also depend on political, regulatory, legal, technological and market responses. Further, climate change laws could also increase our costs and have an impact on our financial condition and results of operations. We cannot assure that the loss caused by these climate effects on the crops of our growers will be recovered, even in following seasons. As a result, we may be materially adversely affected, and our financial results may significantly vary in each year.

 

Climate change may also adversely affect our transportation infrastructure and that of logistics and transportation partners. Logistics bottlenecks resulting from poor highway conditions, which are aggravated during certain key planting periods, or resulting from adverse weather conditions or other causes, may delay or prevent the delivery of our products and may have an impact on our financial condition and results of operations.

 

Acquisitions

 

The Company has completed certain acquisitions (the “Acquisitions”) in FY24, FY23, and FY22, as described below. The acquisitions were funded with a combination of cash and shares. The results of operations for these years might not be comparable as a result of these Acquisitions. Refer to Note 4 of the Financial Statements for details regarding these acquisitions.

 

Discovery Seed Labs

 

On March 23, 2023, the Company entered into a contract to acquire 100% of the issued and outstanding common shares of Discovery Seed Labs Ltd. (“DSL”), a seed testing and genomics laboratory in Saskatoon, Saskatchewan, for $3,213,563 (the “Purchase Price”). The acquisition of control was considered to be a business combination and accounted for using the acquisition method. The Company paid the Purchase Price by paying $2 million cash and issuing 502,088 class A common shares valued at $1,213,563.

 

The aggregate consideration of this acquisition has been allocated to the fair values of the acquired assets and assumed liabilities as follows:

 

     

DSL

 
Working capital   $ 545,891  
Property, plant, and equipment     93,852  
Intangible assets     549,719  
Deferred tax liability     (247,073 )
Goodwill     2,271,174  
Net assets acquired and aggregate consideration   $ 3,213,563  

 

The following table sets forth the fair values and the useful lives of the intangible assets acquired:

 

    Useful lives   DSL  
Customer relationships   5 Years   $ 315,407  
Favourable lease terms   4 Years     134,567  
Non-compete agreements with DSL management   3 Years     43,293  
Brand value   10 Years     56,452  
Total intangible assets acquired       $ 549,719  

 

12


 

ANF

 

ANF produces a variety of branded foods under its various proprietary labels. On September 7, 2021, Above Food entered into a Membership Interest Purchase and Option Agreement with ANF’s majority owner, ANF Holdco LLC, to acquire all membership interests of ANF in four separate tranches.

 

As part of the first tranche, on September 7, 2021, Above purchased 51.86 units of ANF representing 5.0% of the  membership interests, for CAD $1,500,566 (US $1,185,000).

 

On December 31, 2021, under the second tranche, Above increased its membership interests of ANF to 13.40% by purchasing 87.54 units representing 8.4% membership interests, for CAD $2,550,479 (US $2,000,000).

 

On January 20, 2023, under the third tranche, Above acquired an additional 19.66% of ANF’s membership interest for CAD $6,255,400 (USD $4,650,000), bringing Above’s total membership interest to 33.06%. The Company accounted for its investment in ANF using the equity method of accounting, until June 2024, when it acquired the remaining 66.94% interest in ANF for 1,604,253 New Above Food Common Shares.

 

FDO

 

On June 3, 2022 the Company acquired 100% of the issued and outstanding common shares of Farmer Direct Organic Foods Ltd. (“FDO”), in exchange for 1,065,305 common shares of the Company. Of these shares, 432,780 were placed in escrow pending meeting certain milestones based on a combination of revenue and EBITDA as defined within the contract.

 

The aggregate consideration of this acquisition has been allocated to the fair values of the acquired assets and assumed liabilities as follows:

 

    FDO  
Working capital   $ 1,251,916  
Property, plant, and equipment     235,122  
Intangible assets     2,782,000  
Long-term liabilities     (190,862 )
Goodwill     1,526,171  
Net assets acquired and aggregate consideration   $ 5,604,347  

 

NorQuin

 

On May 18, 2022 the Company entered into a contract to acquire 100% of the issued and outstanding common shares of NorQuin, North America’s largest supplier of quinoa, for $3,163,610 (the “Purchase Price”) plus or minus any working capital adjustments. The acquisition of control was considered to be a business combination and accounted for using the acquisition method. The Company paid the Purchase Price by issuing 1,565,595 class A common shares valued at $2,672,790 and 682,061 warrants with a total estimated fair value of $490,820.

 

The aggregate consideration of this acquisition has been allocated to the fair values of the acquired assets and assumed liabilities as follows:

 

    NorQuin  
Working capital   $ 826,146  
Property, plant, and equipment     5,927,331  
Intangible assets     725,000  
Long-term liabilities     (3,768,857 )
Lease liability     (546,010 )
Net assets acquired and aggregate consideration   $ 3,163,610  

 

 

13


 

The following table sets forth the fair values and the useful lives of the intangible assets acquired:

 

    Useful lives   NorQuin  
Brand and trademark   10 Years   $ 275,000  
Plant breeders’ rights   5 Years     450,000  
Total intangible assets acquired       $ 725,000  

 

Wood & Water

 

On July 13, 2021, the Company obtained control of Wood & Water Foods Inc., doing business as “Culcherd” (“Wood & Water”), a dairy alternative company. The consideration payable of $3,250,000 (which was reduced by a working capital adjustment of $16,590) was payable in shares of the Company, the number of which was based on the value of the Company at the time of issuance and subject to further adjustment if they were released as a result of a going public transaction. Taking into account the probability of a going public transaction, applicable share restrictions, and the working capital adjustment, the fair value of the consideration was determined to be $2,901,494 on acquisition and revalued to be $2,753,761 as at January 31, 2022, with a resulting gain on revaluation of $147,733 recorded in our consolidated statements of operations for the year ended January 31, 2022. On April 13, 2022, the Company issued 1,616,705 voting common shares to settle the consideration liability.

 

The following table describes the fair value of the assets acquired and liabilities assumed in this acquisition.

 

    Wood & Water  
Working capital   $ 79,281  
Property, plant, and equipment     10,053  
Intangible assets     463,000  
Right of use assets     45,731  
Long-term liabilities     (103,601 )
Lease liability     (45,731 )
Deferred tax liability     (85,524 )
Goodwill     2,537,303  
Net assets acquired and aggregate consideration     2,901,494  

 

The following table sets forth the fair values and the useful lives of the intangible assets acquired:

 

    Useful lives     Wood & Water  
Customer relationships     5 Years     $ 72,000  
Brand and trademark     10 Years       391,000  
Total intangible assets acquired           $ 463,000  

 

Comparability of Financial Information

 

Above Food’s results of operations and financial position in the fiscal years ended January 31, 2024, 2023, and 2022 may not be comparable as a result of the factors provided above under Business Trends, and the Acquisitions outlined above.

 

Key Financial Definitions/Components of Results

 

Revenue

 

Revenue consists primarily of commodity contracts related to forward sales of commodities such as grain and pulses, rudimentary ingredients, subleasing of farmlands, and sale of other products through consumer-packaged goods. Our main source of revenue is forward sales of commodity and ingredient contracts. As a result, our revenue levels tend to fluctuate alongside commodity prices, which are directly affected by numerous factors, including supply and demand, weather trends, geopolitical events, and government policies. These contracts generally require significant working capital, therefore limitations on working capital may also restrict revenue.

 

Cost of sales

 

Cost of goods sold consists primarily of the costs we pay to our contract growers and manufacturing partners to produce the products sold. These costs include the purchase of raw ingredients, packaging, shipping and handling, warehousing, and brokerages paid on contracts. In addition, any inventory write-down and/or spoilage are reflected as a component of cost of sales. For inventories of marketable agricultural commodities being stated at fair value, changes in the fair values of the inventory and gains/losses, both realized and unrealized, on related contracts are recognized as cost of sales. While forward commodity and foreign exchange contracts are entered into as a mechanism to hedge against fluctuations in commodity prices and foreign exchange, we are not perfectly hedged, and as such open the Company up to the possibility of significant gains or losses as a result. We anticipate our cost of goods sold to grow as a smaller proportion of our revenues as we achieve increased efficiencies and utilization within our Specialty Ingredient Centre and manage our exposures to commodity price and foreign exchange fluctuations.

 

14


 

Selling, general and administrative (“SG&A”) expenses

 

SG&A expenses are primarily comprised of wages and salaries, professional fees, selling and marketing expenses, and other non-production operating expenses. As a publicly traded company, we expect to incur higher costs related to salaries and wages, advertising and marketing fees, as well as other legal, compliance, and administrative costs. We also expect to continue to increase our selling, marketing and advertising costs as we invest in growing our revenues and our market reach. We incurred significant expenses, consisting of professional fees, diligence fees and related costs, in connection with the Business Combination and capital raising efforts in the fiscal years ended January 31, 2024 and 2023. We also incurred significant costs relating to our go-public process, an employee stock-based compensation plan, and increased rental costs associated with expansion. We anticipate significant expenditures relating to many of these costs going forward as we work to complete our transition to a public company. We have also identified and have begun to realize a number of synergies from the operations we acquired resulting from restructuring of the management teams, sharing resources, brand consolidation, and leveraging our robust supply chain in product formulations.

 

· Professional fees. Professional fees expense comprise costs paid in relation to accounting, consulting, legal, and sample testing services throughout the year, as well as special purpose professional fees relating to the Business Combination noted above.

 

· Wages and salaries. Wages and salaries expenses comprise employee salaries and benefits, as well as expenses relating to stock-based compensation.

 

· Advertising and promotion. Selling and marketing expenses comprise advertising costs and costs associated with consumer promotions incurred to acquire new customers, retain existing customers and build brand awareness.

 

· Other non-production operating expenses. Other non-production operating expenses are primarily comprised of rent, insurance, and amortization of property, plant, and equipment and intangible assets not related to production and sales of products.

 

Research and Development

 

Research & Development (“R&D”) costs consist of costs incurred to enhance our existing products and new product developments. R&D costs are expensed as incurred. We expect to continue to be active in R&D as we invest in growing our intellectual property, product offerings and expanding our market reach. However, in the near term, we expect to reduce our relative R&D cost significantly as we work to commercialize existing intellectual property in which we have already invested. We recognize the value in continuing as the leader in regenerative agriculture, and we believe the refinement of our current operations and intellectual property is crucial to our long-term growth and strategy.

 

Financing Costs / Interest Expense

 

Financing costs consist of gains and losses on swap derivatives, as well as interest expense. Interest expense represents the actual cash interest costs incurred plus any accrued interest payable at a future date. There is no certainty that these rates or instruments will continue to be available to the Company.

 

15


 

Results of Operations

 

Years Ended January 31, 2024, January 31, 2023, and January 31, 2022

 

The following discussion presents an analysis of our consolidated results of operations for the year ended January 31, 2024, 2023, and 2022.

 

    Year Ended January 31     YoY  %     Year Ended
January 31
    YoY %  
    2024     2023     Change     2022     Change  
Revenue   $ 368,423,398     $ 396,464,504       (7.1 )   $ 198,857,713       99.4  
Cost of sales     (374,322,146 )     (397,744,144 )     (5.9 )     (190,945,089 )     108.3  
Gross profit (loss)     (5,898,748 )     (1,279,640 )     (361.0 )     7,912,624       (116.2 )
Selling, general, and administrative expenses     (34,222,524 )     (31,107,404 )     10.0       (11,693,607 )     166.0  
Research and development expenses     (171,852 )     (430,666 )     (60.1 )     (235,095 )     83.2  
Impairment of goodwill and other intangible assets     (1,806,337 )     (6,866,121 )     (73.7 )           100.0  
Loss from operations     (42,099,461 )     (39,683,831 )     6.1       (4,016,078 )     888.1  
Interest revenue     245,262       296,479       (17.3 )     82,293       260.3  
Gain on revaluation of consideration payable                       147,733       (100.0 )
Interest expense     (7,670,156 )     (5,378,560 )     42.6       (2,086,274 )     157.8  
Loss before income taxes     (49,524,355 )     (44,765,912 )     10.6       (5,872,326 )     662.3  
Income tax recovery           94,051             95,088       (1.1 )
Equity method investment loss     (3,787,927 )     (812,669 )     366.1                
Loss for the year     (53,312,282 )     (45,484,530 )     17.2       (5,777,238 )     687.3  

 

Revenue

 

During FY24, revenue decreased $28.0 million, or 7.1%. The revenue decrease is almost entirely attributable to working capital constraints that capped growth, as our disruptive agriculture and rudimentary ingredients segment revenues are driven off of available working capital. As we maximized our asset backed lending line, we were unable to make additional purchases and sales as we lacked the available capital to do so. Additionally, although durum volumes increased significantly (refer to the Processed Volumes by Product table below), we saw price decreases in durum that offset this volume increase. The average price of durum in FY24 was $482.92 per metric ton, compared to $529.98 for FY23. Additionally, other high-volume commodities also saw price decreases, including peas ($567.69 in 2024 vs. $578.65 in 2023), wheat ($410.02 vs. $454.37), canary seed ($877.28 vs. $946.49), and canola ($763.33 vs. $929.17). The only high-volume commodity traded that saw a price increase was lentils ($1,095.41 vs. $991.15).

 

During FY23, revenue increased $197.6 million, or 99.4%, from $198.9 million to $396.5 million. The increase in revenue was primarily due to volume growth (162.4 thousand metric tons increase over FY22), the continued build out of our durum program (94.4 thousand metric tons of the above-noted increase) and pea ingredients in the Disruptive Ag and Rudimentary Ingredients division, as well as the Company starting to record consolidated operations from acquired companies. Further to volume increases, many commodity prices also saw increases in FY23, largely due to an enhanced focus on the importance of food and commodities coming out of the COVID-19 pandemic, the ongoing war in Ukraine, and a drought in Western Canada. Several high-volume commodities saw price increases per metric ton, including durum ($671.95 for FY23 vs. $489.77 for FY22), peas ($780.05 vs. $617.30), lentils ($1,184.77 vs. $865.85), wheat ($579.58 vs. $207.87), canary seed ($1,218.51 vs. $990.71), and canola ($1,030.27 vs. $884.74). Other factors contributing to the increase are the launch of our oat program, which contributed $2.2 million of new revenue, the acquisition of our ingredient centre facility, which contributed $3.7 million of new revenue, and our entrance into the organic CPG and bulk market, which contributed $1.7 million of new revenue. Contrarily, revenues of the CPG segment were negatively impacted due to downtime relating to the acquisition and subsequent move of FDO into our ingredient center.

 

Cost of sales

 

Cost of sales decreased $23.4 million, or 5.9%, for FY24 as compared to FY23. The Company experienced inventory write-offs of approximately $3.0 million in FY24, as well as significant costs to exit unfavorable commodity contracts that are captured within cost of sales. Both of these factors resulted in cost of sales decreasing at a lesser rate relative to the decrease in revenue.

 

16


 

Cost of sales increased $206.8 million, or 108.3%, for FY23, compared to $190.9 million for FY22. The biggest factor in our COGS increase was sales volume growth noted above, as well as higher raw material, freight, and logistics costs, and supply chain challenges. Raw material costs largely increased throughout the year as they are dependent on commodity prices at any given time – refer to the above discussion on revenue for price variances in high-volume commodities. Freight costs increased approximately $22.8 million from FY22, while logistical costs (i.e., cleaning, spoilage, brokerage fees, etc.) increased approximately $3.5 million from FY22.

 

Further to this, there were significant mark-to-market and foreign exchange losses that had a significant negative impact on our cost of goods sold in FY23. Cost of sales in FY23 includes realized losses of $3.8 million on commodity forward contracts, $1.3 million on commodity futures contracts, and $2.4 million on foreign exchange forward contracts. In comparison, FY22 had a $14.4 million gain on commodity forward contracts, which was offset by losses of $3.3 million and $1.8 million on commodity futures and foreign exchange forward contracts, respectively. Losses in FY23 were largely related to overly aggressive positions on certain commodity contracts, as well as timing differences on foreign exchange contracts. Above Food continues to implement more robust processes and controls to manage and mitigate exposures to these risks.

 

Gross profit (loss)

 

Gross loss increased $4.6 million, or 361.0%, for FY24 compared to FY23. The negative margins in the current period were largely the result of inventory impairment and write-offs of inventory. The negative margins in FY23 were largely due to losses of $13.9 million on mark-to-market and foreign exchange included in cost of sales.

 

Gross profit (loss) decreased $9.2 million (from a gross profit to a gross loss), or (116.2%), for FY23 compared to FY22, which was primarily driven by mark-to-market and foreign exchange losses included in cost of sales of $13.9 million in FY23, as noted above.

 

Selling, general, and administrative (“SG&A”) expenses

 

SG&A expenses increased only $3.1 million, or 10.0%, for FY24 compared to FY23 due to the following fluctuations:

 

· Wages and salaries. Wage and salary expenses were $14.1 million for FY24, compared to $15.6 million for FY23. The decrease in these expenses was primarily due to decreased stock option expenses of $3.8 million, offset by increases in employee wages as a result of added employees from acquisitions and to assist in the go public process.

 

· Professional fees. Professional fees were $8.1 million for FY24, compared to $4.6 million for FY23. The increase in these expenses was primarily due to significant expenses incurred relating to the business combination with Bite and the go-public process as a whole.

 

· Advertising and promotion. Advertising and promotion expenses were $0.7 million for FY24, compared to $1.5 million for FY23. The decrease in these expenses was primarily due to launching fewer new brands in 2023.

 

· Rent. Rent expenses were $2.5 million for FY24, compared to $1.1 million for the same period in FY23. The increase in these expenses was primarily due to the acquisition of businesses and temporary storage facilities used in the process of storage improvement.

 

SG&A expenses increased $19.4 million, or 166.0%, for FY23 compared to FY22 due to the following:

 

· Advertising and promotions. Advertising and promotion expenses were $1.5 million for FY23, compared to $0.5 million for FY22. The increase in these expenses was primarily due to launching of new brands in acquired businesses and the roadshows in connection with the Business Combination during FY23.

 

17


 

· Wages and salaries. Wage and salary expenses were $15.6 million for FY23, compared to $3.9 million for FY22. The increase in these expenses was primarily due to an increase in employee headcount and implementation of the employee stock options granted and expensed in FY23.

 

· Insurance. Insurance expenses were $1.6 million for FY23, compared to $0.5 million for FY22. The increase in these expenses was primarily due to operating facilities newly added in FY23.

 

· Rent. Rent expenses were $1.1 million for FY23, compared to $0.1 million for FY22. The increase in these expenses was primarily due to the acquisition of businesses and temporary storage facilities used in the process of storage improvement.

 

Impairment of goodwill and other intangible assets. Impairment expense decreased from $6.9 million to $1.8 million for FY24 compared to FY23. The assets impaired in the comparative period include goodwill relating to the acquisitions of Culcherd and FDO, as well as assets relating to trademarks/patents and brand of FDO. After these businesses were acquired, the revenues and profitability for these subsidiaries were lower than the amounts forecasted at the time of the acquisition, and as a result it was determined that the carrying value of these assets may exceed their recoverable amount. The goodwill acquired in both acquisitions was fully impaired, while the intangible assets relating to the FDO brand and trademarks/patents were partially impaired based on a discounted cash flows analysis of the business. In the current period, assets impaired included the goodwill relating to the Discovery purchase and intangible assets relating to Culcherd. This impairment was recorded due to each of the respective entities falling short of projections used in the purchase price allocations of each.

 

Impairment expense in FY22 was nil as there were no indicators of impairment in any investments or intangibles as at or during the year ended January 31, 2022.

 

Interest expense. Interest expense increased $2.3 million to $7.7 million for FY24 compared to FY23, primarily due to the new credit facilities obtained, as well as market interest rate increases on variable rate facilities. Similarly, interest expense increased from $3.3 million for FY23 compared to FY22, due to similar factors (i.e., new facilities and increased rates).

 

Equity method investment loss. The equity method investment loss increased $3.0 million to $3.8 million for FY24 compared to FY23. This increase is attributable to $3.3 million of impairment in the investment in ANF presented within this line item. This impairment was noted and recorded at the end of FY24, after ANF’s revenue and EBITDA targets used in formulating the fair value at acquisition were not being met.

 

Analysis of Results of Operations

 

Year Ended January 31, 2024, January 31, 2023, and January 31, 2022

 

Processed (sales) volumes by product for FY24, FY23, and FY22 are as follows (in 000s of metric tons):

 

    For the year ended January 31,  
    2024     2023     2022  
Durum     188.5       148.7       54.3  
Peas     76.8       70.4       47.9  
Lentils     60.0       69.6       48.3  
Wheat     60.0       58.9       54.8  
Canary Seed     52.9       46.7       42.1  
Canola     26.4       43.5       25.1  
Other (barley, beans, flax, oats, hemp)     20.1       18.6       21.5  
Total     484.7       456.4       294.0  

 

18


 

We actively manage our inventory related to demand in the market. The overall decrease in processed volumes was primarily related to working capital constraints, as the majority of our revenue is dependent on available working capital.

 

Segment Information

 

Above Food operates in two reportable segments: Disruptive Agriculture and Rudimentary Ingredients, and CPG. The Disruptive Agriculture and Rudimentary Ingredients segment concentrates on the provisioning of discrete genetics, origination, purchasing, grading, primary processing and sale of regeneratively grown grain, as well as the origination, purchase, and sale of bespoke ingredients products, processed primarily through the Company-owned ingredient facilities. The CPG segment formulates, manufactures, sells, distributes, and markets proprietary consumer product formulations in owned brands and focuses on manufacturing and distribution for private-labeled retail owned brands. The Company also has a corporate department that carries out the centralized functions of accounting, treasury, information technology, legal, and human resources. Given that this department does not undertake business activities and does not recognize revenue that are more than incidental to the Company’s activities, it is not considered to be a separate operating segment.

 

Above Food determines the composition of the reportable segments based on factors including risks and returns, internal organization, and internal reports and allocates certain expenses across segments based on reasonable considerations such as production capacities.

 

We monitor our segment results primarily by reviewing net loss. Disruptive Agriculture and Rudimentary Ingredients net loss increased from $16.1 million in FY23 to $20.4 million in FY24. The increased loss is largely due to inventory write-offs and unfavorable contract positions. CPG’s net loss decreased from $14.9 million in FY23 to $12.9 million in FY24, driven primarily by the significant impairment of intangible assets and goodwill in FY23, which was offset by increased operating expenses that were not present in FY23, incurred as a result of a full year ownership of FDO and NorQuin. Corporate and Other’s net loss increased from $14.5 million in FY23 to $20.0 million in FY24. This increased loss is attributable to a smaller proportion of stock-based compensation expenses, offset by the increased headcount within the Corporate Group and increased professional fees, as discussed above, as well as $3.3 million of impairment relating to the investment in ANF that was incurred in FY24.

 

Disruptive Agriculture and Rudimentary Ingredients net loss increased from $1.7 million in FY22 to $16.1 million in FY23, driven primarily by realized and unrealized losses on forward contracts and foreign exchange. The overly aggressive positions and timing differences discussed in the Results of Operations section above are what caused this significant change. Realized losses totaling approximately $7.5 million were recorded by this segment. At year-end, mark-to-market adjustments of inventories and contracts held at fair value resulted in an additional $6.4 million of unrealized losses on these instruments that was included in the net loss of this segment.

 

CPG’s net loss increased from $1.2 million in FY22 to $14.9 million in FY23, driven primarily by significant impairment losses on goodwill and intangible assets, as well as operating expenses that were not present in FY22, incurred as a result of the acquisitions of FDO and NorQuin, and a full year of ownership of Culcherd. The losses on goodwill and intangible assets in FY23 total $6.9 million in the CPG segment, made up of impairment of $1.8 million relating to an intangible asset acquired relating to an acquisition that ultimately did not occur, $2.5 million relating to goodwill on the Culcherd acquisition and $2.6 million relating to goodwill, customer relationships, and the brand name acquired in the FDO acquisition. These impairments were recorded as the revenues and net profits of these entities did not align with projections that the valuations of each were based on.

 

Corporate and Other’s net loss increased from $2.8 million in FY22 to $14.5 million in FY23, driven primarily by the increased employee headcount in FY23 and increased professional fees as Above Food continues to grow. Salaries and wages increased $8.0 million from FY22 to FY23. Approximately $1.1 million of this increase is related to increased staff levels as the result of acquisitions in both FY22 and FY23, as well as additional employees necessary to supplement the growing business of Above Food. The remaining $6.9 million relates to the implementation of a stock-based compensation plan. Professional fees increased $1.6 million from FY22 to FY23, relating to due diligence and acquisitions, as well as the go-public transaction which remains ongoing.

 

19


 

For Above Food’s reportable operating segments during the years ended January 31, 2024, 2023, and 2022, net losses are as follows:

 

Year ended
January 31, 2024
  Disruptive Ag &
Rudimentary
Ingredients
    CPG     Corporate and
Other
   

Inter-segment

Eliminations

    Consolidated  
Net loss for the period   $ (20,400,376 )   $ (12,901,140 )   $ (19,960,094 )   $ (50,672 )   $ (53,312,282 )

 

Year ended
January 31, 2023
  Disruptive Ag &
Rudimentary
Ingredients
    CPG     Corporate and
Other
   

Inter-segment

Eliminations

    Consolidated  
Net loss for the period   $ (16,051,802 )   $ (14,924,353 )   $ (14,508,375 )   $                           –     $ (45,484,530 )

 

Year ended
January 31, 2022
  Disruptive Ag &
Rudimentary
Ingredients
    CPG     Corporate and
Other
   

Inter-segment

Eliminations

    Consolidated  
Net loss for the period   $ (1,715,505 )   $ (1,249,470 )   $ (2,812,263 )   $                    –     $ (5,777,238 )

 

Between the two reported segments, we produce three main product lines. Revenue by product line for FY24, FY23, and FY22 are as follows:

 

    Disruptive Ag &
Rudimentary
Ingredients -
Commodities
    Disruptive Ag &
Rudimentary
Ingredients -
Ingredients
    Consumer
Package Goods
    Corporate and
Other
    Total  
Revenue   $ 223,976,243     $ 132,871,708     $ 11,571,019     $ 4,428     $ 368,423,398  

 

    Disruptive Ag &
Rudimentary
Ingredients -
Commodities
    Disruptive Ag &
Rudimentary
Ingredients -
Ingredients
    Consumer
Package Goods
    Corporate and
Other
    Total  
Revenue   $ 250,500,007     $ 136,530,965     $ 9,432,591     $ 941     $ 396,464,504  

 

    Disruptive Ag &
Rudimentary
Ingredients -
Commodities
    Disruptive Ag &
Rudimentary
Ingredients -
Ingredients
    Consumer
Package Goods
    Corporate and
Other
    Total  
Revenue   $ 123,847,068     $ 74,807,683     $ 202,962     $               –     $ 198,857,713  

 

Liquidity and capital resources

 

Above Food’s primary sources of liquidity are cash generated from operations, cash generated from equity issuances, and borrowings from various debt issuances. Above Food had an accumulated deficit of $103.9 million as of January 31, 2024 compared to an accumulated deficit of $50.6 million as at January 31, 2023 due in part to many of the activities we incurred significant expenditures on during the year to become public ready, as well as the stock-based and general compensation, and other expenses discussed above. As of January 31, 2024, Above Food had $1.0 million in cash and cash equivalents and a deficit in working capital of $85.4 million. The Company believes that the proceeds from the Business Combination, together with current available funds, will provide sufficient liquidity to fully fund future operations and any potential planned expansion of the business. Furthermore, as of January 31, 2024, the Company was in violation of restrictive covenants related to approximately $66 million of its aggregate borrowings as more fully described in the Financial Statements.

 

There can be no assurance the Company will be successful in obtaining further equity and debt financing. While the Company remains in constant contact with these lenders, and as of the date of this Management’s Discussion and Analysis of Financial Condition and Results of Operations of Above Food (“MD&A”) these debts have not been called, there can be no assurance that the Company will be able to maintain the support of these lenders, particularly as it relates to the indebtedness currently in default of restrictive covenants. The Company also expects to continue to incur recurring losses as it continues to grow its business and incurred significant costs in preparation for the go public transaction with Bite.

 

20


 

In addition, Above Food seeks to continue growing the business aggressively, requiring significant working capital and access to a larger credit facility. Above Food has incurred significant costs (including professional costs) related to the Business Combination with Bite. Management believes that the proceeds from the Business Combination, together with current available funds, will provide sufficient liquidity to fully fund future operations and any potential planned expansion of the business

 

The Company also intends to expand its existing credit facility in order to accommodate the growth in its business and to provide additional liquidity. This expansion is dependent, in part, on additional financing being raised by the Company (including in connection with the Business Combination) and there is no assurance that this additional financing will be raised.

 

If the Company is not successful in expanding the credit facility, the Company will seek additional financing, and may be forced to reduce the extent of its operations and idle certain assets.

 

The Company’s main sources of liquidity are its operations, equity issuances, and debt issuances. The funds are primarily used to finance working capital and capital expenditure requirements. The Company believes that the proceeds from the Business Combination, together with current available funds, will provide sufficient liquidity to fully fund future operations and any potential planned expansion of the business. We believe our sources of liquidity and capital will be sufficient to finance our continued operations, growth strategy and additional expenses we expect to incur for at least the next twelve months. As circumstances warrant, we may issue debt and/or equity securities from time to time on an opportunistic basis, dependent upon market conditions and available pricing. We make no assurance that we can issue and sell such securities on acceptable terms or at all.

 

Credit Agreement; Subordinated Convertible Loan

 

On July 23, 2021, we entered into a credit agreement with the Royal Bank of Canada (the “Credit Agreement”). The Credit Agreement was amended on July 1, 2023 and at that time provided for a revolving facility of $40.0 million. This was subsequently amended to $36.0 million. The interest rate on the loan is Royal Bank Prime rate plus 0.25% per annum and is secured by inventory and accounts receivables. As of January 31, 2024, the outstanding balance of the credit facility was $36.0 million.

 

On December 29, 2022, Above Food entered into a convertible subordinated loan agreement with Smart Dine, LLC and Lexington to fund the acquisition of all the outstanding shares in ANF, expenses regarding the closing of the Business Combination and working capital. Additional lenders (Grupo Vida Canada and OrionSea Enterprises (“OrionSea”)) have also advanced funds under this agreement. The term of the loan is one year and is funded in three tranches. During the year ended January 31, 2024, the Company received additional advances relating to this agreement totaling $4.3 million. As of January 31, 2024, the outstanding balance on this loan, including accrued interest, was $14.3 million. Upon the closing of the Business Combination, all the outstanding principal and unpaid interest were converted into a number of the New Above Food’s common shares equal to the outstanding balance at conversion divided by US $10. On or after the maturity date, until such time that the Business Combination is closed, the lender could have elected to convert the outstanding balance into Above Food’s shares at their discretion.

 

As a result of the closing of the Business Combination on June 28, 2024, the convertible subordinated loans from each of Lexington, Sponsor, and OrionSea have all been converted to equity, and the Company no longer has an obligation to these lenders. The remaining convertible subordinated loan from Grupo Vida remains outstanding as of the date of this filing, but could be subject to conversion or settlement in the weeks proceeding the business combination.

 

Additionally, in relation to the asset-backed lending line of credit with Royal Bank of Canada that currently has covenant violations, because the loan is secured against commoditized inventory and accounts receivable, Royal Bank of Canada has continued to work with the Company on updating terms, and have continued to extend this line. Subsequent to January 31, 2024, this line of credit limit was lowered to $35,000,000, and the maturity date has been extended to July 31, 2024.

 

21


 

Above is also looking at alternative asset-based lenders to increase the working capital available to the Company, and are currently in negotiations with lenders. Should these plans not be successful, Above would liquidate inventory as necessary, pay down the outstanding balance of the asset-backed lending line, and once working capital allows, utilize the line once again.

 

Private Placement

 

On January 19, 2021, Above Food completed its private placement of 20,216,656 Above Food Units, at a price of $2.00 per Above Food Unit for gross proceeds of $40,433,312. Each Above Food Unit consists of one Above Food Common Share and one-half of one Above Food Warrant with an exercise price of $3.75 per share and a term of the earlier of three years following a liquidity event or five years from the closing of the financing. The issue price allocated to the share portion of the Above Food Unit was $1.50 and $0.50 was allocated to each half Above Food Warrant and recorded within Above Food Common Shares and Above Food Warrants respectively. Total share issuance costs of amounted to $8,068,177 and comprises of non-cash and cash share issuances costs. Amounts of $6,051,133 and $2,017,044 have been allocated to Share Capital and Warrants respectively.

 

Broker Warrants

 

The Company also has outstanding at January 31, 2024, 1,609,332 Above Food Warrants to acquire Above Food Units for $2.00 per Unit (2022 – 1,609,332 units at $2.00) as a result of the private placement that took place on January 19, 2021. Each Above Food Unit consists of one Above Food Common Share and one-half of one Above Food Warrant with an exercise price of $3.75 per share and a term of the earlier of three years following a liquidity event or five years from the closing of the financing. Refer to Note 16, Share Capital of the Financial Statements for additional details regarding the broker warrants.

 

Derivatives

 

Currently, Above Food does not designate its derivative financial instruments as hedges for accounting purposes and does not use hedge accounting. Thus changes in fair value of derivative instruments are reflected in net loss. Refer to the “Critical accounting policies and estimates” and “Quantitative and Qualitative Disclosures About Market Risk” sections of this MD&A, as well as the Notes of the Financial Statements for further details.

 

The Company classifies the cash effects of its derivatives within the “Cash Flows From Operating Activities” section of the consolidated statements of cash flows.

 

Cash flows for the years ended January 31, 2024, 2023, 2022

 

The following table summarizes Above Food’s cash flows from operating, investing and financing activities for the years ended January 31, 2024 and 2023:

 

    For the years ended January 31,  
    2024     2023     2022  
Net cash (used in) provided by operating activities   $ 7,148,748     $ (17,876,903 )   $ (27,574,845 )
Net cash (used in) provided by investing activities   $ (4,517,944 )   $ (6,662,720 )   $ (30,589,836 )
Net cash provided by (used in) financing activities   $ (4,006,321 )   $ 24,810,398     $ 27,196,396  

 

Cash flows from operating activities

 

Net cash provided by operating activities includes net loss adjusted for non-cash expenses and movements in operating assets and liabilities. Our operating cashflows are primarily generated by revenues less cash paid for expenses, and cash used in or provided by working capital requirements.

 

22


 

The Company has incurred positive cash flows from operating activities of $7.1 million in the current year, compared to cash flows of $17.9 million used in FY24. The change compared to FY23 comes primarily from improved accounts receivable collections, significantly increased inventory turnover, and increased days in accounts payable as the Company works to manage liquidity. The comparative period saw decreased turnover in both accounts receivable and inventory, which largely contributed to the amount used in operating activities.

 

During FY23, operating activities used $17.9 million of cash. The decrease compared to FY22 comes primarily from improved accounts receivable collections and significantly increased inventory turnover. During FY22, operating activities used $27.6 million of cash, primarily consisting of changes in working capital, specifically a significant decrease in inventory turnover. Refer to the “Liquidity and Capital Resources” section of this Registration Statement/Proxy Statement for additional discussion on how the Company intends to meet cash requirements and maintain operations.

 

Cash flows from investing activities

 

During FY24, net cash used in investing activities was $4.5 million. These cash outflows consisted primarily of $3.6 million of acquisitions of property plant and equipment, largely relating to the cleaning facility and equipment being developed for the disruptive agriculture and rudimentary ingredients segment. Additionally, a net of $1.6 million of cash was used to acquire (i.e., $2.0 million paid less $0.4 million of cash in the company acquired).

 

During FY23, net cash used in investing activities was $6.7 million. This was largely the result of the purchase of property, plant, and equipment and intangible assets, as well as the investment in ANF as discussed above.

 

During FY22, net cash used in investing activities was $30.6 million. These cash outflows consisting primarily of $22.0 million of purchase in property, plant, and equipment, partially offset by $1.0 million received in proceeds from sale of existing assets. During the year, we also issued $5.4 million in loans primarily made to businesses we were planning to acquire, as well as purchased investments of $4.1 million related to the acquisition of our investment in ANF.

 

Cash flows from financing activities

 

During FY24, net cash used in financing activities was $4.0 million. During the year, we received loans totaling $6.5 million from Bank of Nova Scotia and a group of strategic investors. This was netted against the repayment of short-term debt and credit facilities ($4.9 million), the repayment of long-term debt ($2.2 million), and the repayment of amounts due to related parties ($2.2 million). There were also finance lease liability repayments of $1.2 million.

 

During FY23, net cash received from financing activities was $24.8 million. Cash inflows in this period primarily consist of $11 million received from the Bank of Nova Scotia, $8.1 million received from strategic investors, a net of $6.9 million in short-term debt and credit facilities received, and $1.1 million in net advances from related parties. These amounts were offset by $1.1 million in long-term debt repayment and $1.2 million in finance lease liability repayments.

 

During FY22, net cash received from financing activities was $27.2 million, primarily consisting of $30 million received from credit facilities, partially offset by $3.1 million in repayments on existing lease liabilities and amounts due to related parties.

 

Purchase of property, plant, and equipment

 

For the year ended January 31, 2024, purchases of property, plant, and equipment increased to $3.6 million compared to $2.4 million in the year ended January 31, 2023, an increase of $1.2 million. The increase was largely due to purchases of $2.5 million in the year ended January 31, 2024 relating to the cleaning facility discussed above. In the year ended January 31, 2023, the majority of purchases of property, plant, and equipment related to terminal equipment additions.

 

23


 

Contractual Obligations and Commitments

 

The following table summarizes our contractual obligations and other commitments for cash expenditures as of January 31, 2024, and the years in which these obligations are due (in 000s).

 

Contractual Obligations   Total     Less than
1 year
    1 - 3 years     3 - 5 years     More than
5 years
 
Accounts payable and accrued liabilities   $ 53,102     $ 53,102                    
Short-term debt and credit facilities   $ 36,000     $ 36,000                    
Bank indebtedness   $ 12,304     $ 12,304                      
Lease liabilities   $ 38,233     $ 2,370     $ 4,837     $ 3,827     $ 27,199  
Long-term debt   $ 30,969     $ 30,783     $ 186              
Total contractual obligations as of January 31, 2024   $ 170,608     $ 134,559     $ 5,023     $ 3,827     $ 27,199  

 

Related Party Transactions and Balances

 

Related party transactions include transactions with corporate investors who have representation on the Above Food Board. Refer to Note 22, “Related Party transactions and balances” of the Financial Statements for additional details regarding the related party transactions.

 

Off balance sheet arrangements

 

As of the date of this Report, Above Food does not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. The term “off-balance sheet arrangement” generally means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with Above Food is a party, under which it has any obligation arising under a guarantee contract, derivative instrument or variable interest or a retained or contingent interest in assets transferred to such entity or similar arrangement that serves as credit, liquidity or market risk support for such assets.

 

Currently, Above Food does not engage in off-balance sheet financing arrangements.

 

Critical accounting policies and estimates

 

Our Financial Statements are prepared in accordance with U.S. GAAP. Critical accounting policies are those that are the most important to the preparation of our financial condition and results of operations and that require our most difficult, subjective and complex judgments as a result of the need to make estimates about the effect of matters that are inherently uncertain. While our significant accounting policies are described in more detail in Note 2 to our Financial Statements, our most critical accounting policies are discussed below. The preparation of the Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our Financial Statements and the accompanying notes. Management believes that the estimates utilized in preparing the Financial Statements are reasonable and prudent. Actual results could differ from those estimates.

 

Inventory

 

Inventories of marketable agricultural commodities, which include inventories acquired under deferred pricing contracts, are stated at fair value due to their interchangeability, immediate marketability at quoted prices, and difficulty in obtaining appropriate costs. These agricultural commodity inventories have quoted market prices in active markets, may be sold without significant further processing, and have predictable and insignificant disposal costs. Management estimates fair value for its commodity-related assets and liabilities based on exchange-quoted prices, adjusted for differences in local markets. Inventory and commodity derivative fair value measurements are mainly based on observable market quotations.

 

Changes in the fair values of the inventory are recognized in earnings as a component of cost of sales. If management used different methods or factors to estimate market value, amounts reported could differ materially. In addition, if market conditions change subsequent to year-end, amounts reported in future periods could differ materially.

 

24


 

In addition, Above Food values inventories that are not considered to be readily marketable using the first-in, first-out (FIFO) method at the lower of cost or net realizable value because of their commodity characteristics as these commodities are not blended, nor do they have basis contracts associated with them. The Company values its consumer-packaged goods inventory at the lower of cost or net realizable value, with cost being determined using the specific lot identification method.

 

Refer to the below section “Quantitative and Qualitative Disclosures about Market Risk” for further information on commodity price risk, and sensitivity analysis therein.

 

Derivative Valuation

 

Above Food enters into derivative instruments to manage its exposure to movements associated with agricultural commodity prices and foreign currency exchange rates. Above Food’s use of these instruments is generally intended to mitigate the exposure to market variables. Additionally, commodity contracts relating to forward sales of commodities are accounted for as derivatives at fair value under ASC 815 Derivatives and Hedging.

 

The Company recognizes all of its derivative instruments as either assets or liabilities at fair value in its consolidated balance sheet and are reported as either foreign exchange forward contract or commodity forward contract assets or liabilities. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and on the type of hedging relationship. None of the Company’s derivatives have been designated as hedging instruments in the periods presented, and as such, changes in fair value of these derivatives are recognized in loss immediately.

 

Management estimates fair value for its commodity-related derivatives based on exchange quoted prices, adjusted for differences in local markets. Foreign currency exchange-related derivatives have their fair values estimated based on the value of the underlying currency. The changes in market value of such contracts have a high correlation to the price changes of the commodity/currency of the contract. If market conditions change subsequent to year-end, amounts reported in future periods could differ materially.

 

Refer to the below section “Quantitative and Qualitative Disclosures about Market Risk” for further information on both commodity price and foreign exchange risk, and sensitivity analysis therein.

 

Goodwill and Other Intangible Assets

 

The Company records goodwill when the purchase price of a business combination exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level at least annually, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. The Company performs an annual goodwill impairment test in the fourth quarter.

 

In assessing impairment, the reporting unit’s fair value is compared with its carrying amount, and an impairment charge, if any, is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the amount of goodwill associated with the reporting unit. The Company determines fair values for each of the reporting units using a discounted cash flow model (a form of the income approach) or the market approach. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate. Judgement is applied in determining appropriate discount rates, and forecasting cashflows.

 

25


 

Finite-lived intangible assets include trademarks, customer relationships and lists, and website development costs that are amortized on a straight-line basis over their contractual or legal lives, or their estimated useful lives where such lives are not determined by law or contract. The amortization period depends on the contractual terms of such agreements and management’s best estimate of their useful lives. Finite-lived intangible assets and other long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the asset might be impaired or that the estimated useful life should be changed prospectively. If impairment indicators are present, the recoverability of these assets is measured by a comparison of the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset, which is determined using a discounted cash flow approach.

 

Equity-based compensation

 

Equity-based compensation represents the cost related to equity-based awards granted to employees and non-employee consultants and provides for the granting of restricted stock units, stock options, warrants, and broker warrants. The Company recognizes compensation expenses based on the grant date fair value of the award granted.

 

Awards with time-based vesting generally vest over a two to three year period after the grant date or the date the Company’s shares start trading on a stock exchange in the United States. The resulting compensation expense related to equity awards are recognized on a straight-line basis over the requisite service period and is included within SG&A expense. We have not recorded any equity-based compensation expense related to the equity-based awards that begin vesting upon the date the Company’s shares start trading on a stock exchange in the United States in the Financial Statements.

 

The fair value of each option granted under the stock option plan of Above Food is estimated on the grant date using the Black-Scholes option pricing model, which requires the input of subjective assumptions, including the fair value of underlying shares at grant date, expected volatility, expected dividend yield, risk-free rate, and an expected life. Since we were privately held, we calculated expected volatility using comparable peer companies with publicly traded shares over a term similar to the expected term of the underlying award. At the time of grant, we had no intention to pay dividends on our common units, and therefore, the dividend yield percentage is zero. In order to estimate the fair value of our common shares, we reviewed recent transactions involving Above Food common shares where their estimated fair value was established with a third party.

 

Recent accounting pronouncements

 

See Note 3 to the Financial Statements for more information about recent accounting pronouncements, the timing of their adoption and Above Food’s assessment, to the extent it has made one, of their potential impact on Above Food’s financial condition and its results of operations and cash flows.

 

Internal Control Over Financial Reporting

 

We are not currently required to comply with SEC rules that implement Section 404(a) (“Section 404(a)”) of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”) and are therefore not required to make a formal assessment of the effectiveness of our internal controls over financial reporting for that purpose. We will not be required to formally assess our internal controls until we file our second annual report on Form 20-F and we will not be required to have our independent registered public accounting firm formally assess our internal controls for as long as we remain an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, as amended (“JOBS Act”).

 

Material weakness in internal control over financial reporting

 

Section 404(a)  of the Sarbanes-Oxley Act requires that, beginning with the second annual report following the Business Combination, management of New Above Food assess and report annually on the effectiveness of internal control over financial reporting and identify any material weaknesses in internal control over financial reporting. Management may not be able to effectively and timely implement controls and procedures that adequately respond to the increased regulatory compliance and reporting requirements that apply to us as a public company. If we are not able to implement the additional requirements of Section 404(a) in a timely manner or with adequate compliance, we may not be able to assess whether our internal control over financial reporting is effective, which may subject New Above Food to adverse regulatory consequences and could harm investor confidence and the market price of New Above Food’s securities.

 

26


 

In connection with the preparation of Above Food’s consolidated financial statements, management identified material weaknesses in our internal control over financial reporting as of January 31, 2024. Management has concluded that this material weakness is due to the fact that Above Food is a private company with limited resources. The material weakness relates to not appropriately designing and implementing controls, including maintaining sufficient written formal policies, procedures and written analyses related to complex accounting matters, including the use of appropriate technical expertise in the areas of business combinations, deferred share issuance costs, share based compensation, goodwill impairment and equity accounting, as well as the determination of fair value measurement of commodity inventory and contracts. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. These material weaknesses have not been remediated at the time of filing this Report.

 

In order to improve the effectiveness of our internal control over financial reporting, we have expended, and anticipate that we will continue to expend, significant resources, including accounting-related costs and significant management oversight, including hiring additional financial and accounting personnel, engaging outside consultants and adopting a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. New Above Food’s independent registered public accounting firm will not be required to formally attest to the effectiveness of its internal control over financial reporting until after it is no longer an “emerging growth company” as defined in Section 2(a)(19) of the Securities Act, as modified by the JOBS Act. At such time, New Above Food’s independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our internal control over financial reporting is documented, designed, or operating. Any failure to maintain effective disclosure controls and internal control over financial reporting could adversely affect New Above Food’s business and operating results and could cause a decline in investor confidence and the price of New Above Food’s securities.

 

Emerging Growth Company Status

 

We qualify as an “emerging growth company,” as defined in the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other requirements that are otherwise applicable generally to public companies. These provisions include:

 

· we are only required to include two years of audited consolidated financial statements in this prospectus, in addition to any required interim financial statements, and are only required to provide reduced disclosure in “Management’s Discussion and Analysis of Financial Condition and Results of Operations”;

 

· we are not required to engage an auditor to report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act;

 

· we are not required to submit certain executive compensation matters to stockholder advisory votes, such as “say-on-pay,” “say-on-frequency” and “say-on-golden parachutes”; and

 

· we are not required to disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the chief executive officer’s compensation to our median employee compensation.

 

We may take advantage of these provisions until the last day of the fiscal year following the fifth anniversary of the completion of this offering or such earlier time that we no longer qualify as an emerging growth company. We would cease to qualify as an emerging growth company upon the earliest of (a) the last day of the first fiscal year in which our annual gross revenue is $1.235 billion USD or more, (b) the date on which we have, during the previous rolling three-year period, issued more than $1.0 billion in non-convertible debt securities and (c) the last day of the fiscal year in which the market value of our common stock held by non-affiliates exceeded $700.0 million USD as of July 31 of such fiscal year.

 

27


 

Under the JOBS Act, emerging growth companies also can delay adopting new or revised accounting standards until such time as those standards would otherwise apply to private companies. We currently intend to take advantage of this exemption.

 

Foreign Private Issuer Status

 

Above Food qualifies as a “foreign private issuer” as defined under SEC rules. Even after Above Food no longer qualifies as an emerging growth company, as long as Above Food continues to qualify as a foreign private issuer under SEC rules, Above Food is exempt from certain SEC rules that are applicable to U.S. domestic public companies, including:

 

· the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act;

 

· the sections of the Exchange Act requiring insiders to file public reports of their share ownership and trading activities and liability for insiders who profit from trades made in a short period of time;

 

· the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial statements and other specified information, and current reports on Form 8-K upon the occurrence of specified significant events; and

 

· the selective disclosure rules by issuers of material nonpublic information under Regulation FD.

 

Notwithstanding these exemptions, Above Food intends to file with the SEC, within four months after the end of each fiscal year, or such applicable time as required by the SEC, an annual report on Form 20-F containing financial statements audited by an independent registered public accounting firm.

 

Above Food may take advantage of these exemptions until such time as Above Food is no longer a foreign private issuer. Above Food would cease to be a foreign private issuer at such time as more than 50% of its outstanding voting securities are held by U.S. residents and any of the following three circumstances applies: (i) the majority of its executive officers or directors are U.S. citizens or residents, (ii) more than 50% of its assets are located in the United States or (iii) its business is administered principally in the United States.

 

Both foreign private issuers and emerging growth companies also are exempt from certain more stringent executive compensation disclosure rules. Thus, even if Above Food no longer qualifies as an emerging growth company, but remains a foreign private issuer, Above Food will continue to be exempt from the more stringent compensation disclosures required of companies that are neither an emerging growth company nor a foreign private issuer.

 

In addition, because Above Food qualifies as a foreign private issuer under SEC rules, Above Food is permitted to follow the corporate governance practices of Canada (the jurisdiction in which Above Food is organized) in lieu of certain Nasdaq corporate governance requirements that would otherwise be applicable to Above Food.

 

If at any time Above Food ceases to be a foreign private issuer, Above Food will take all action necessary to comply with the SEC and Nasdaq Listing Rules, including by appointing a majority of independent directors to the Above Food Board and having compensation and nominating committees that are comprised solely of independent directors, subject to a permitted “phase-in” period.

 

Quantitative and Qualitative Disclosures About Market Risk

 

We are exposed to market risk, including the effects of adverse changes in commodity prices and exchange rates. Market risk refers to the risk of loss from adverse changes in market prices and interest rates. The disclosures are not meant to be precise indicators of expected future losses, but rather indicators of reasonably possible losses. All of our market risk sensitive instruments were entered into for purposes other than speculative trading.

 

28


 

Foreign currency risk. The Company is exposed to currency risk as a certain portion of sales and expenses are incurred in U.S. Dollars resulting in US denominated accounts receivable, accounts payable, some commodity derivatives, and long-term debt. These balances are, therefore, subject to gains and losses due to fluctuations in that currency in relation to the Canadian Dollar.

 

The Company entered into foreign exchange derivative contracts to mitigate these risks. This strategy minimizes the impact of U.S. Dollar fluctuations on the operating results of the Company. The Company’s derivative instruments have not been designated as hedging instruments and gain/losses are recorded within cost of sales in the consolidated statements of operations. The effect of a 5% increase in the exchange rate for the U.S. Dollar and the Canadian Dollar would have had an impact of a decrease of $0.1M on net loss for FY24, and an impact of a decrease of $2.2M on net loss for FY23, considering outstanding USD monetary asset and liability balances, as well as derivative and contracts as at the period and year ends, and assuming all other variables remain constant.

 

Credit risk. The risk of financial loss in the event of failure of a customer or counterparty to a financial instrument to meet its contractual obligation is defined as credit risk. The Company’s principal exposure to credit risk is in respect to its accounts receivable. A substantial portion of the Company’s accounts receivable is with customers in the agriculture industry and is subject to normal industry credit risks. A portion of the Company’s sales and related accounts receivable are also generated from transactions with customers in overseas markets.

 

Accounts receivable are subject to credit risk exposure and the carrying values reflect management’s assessment of the associated maximum exposure to such credit risk. The Company regularly monitors customers for changes in credit risk. The Company’s credit exposure is mitigated through the use of credit practices that limit transactions according to the customer’s credit quality and due to the accounts receivable being spread over a large number of customers. Trade receivables from international customers are insured for events of non-payment through third-party export insurance to mitigate against credit risk. In cases where the credit quality of a customer does not meet the Company’s requirements, a cash deposit or letter of credit is received before goods are shipped.

 

As of the year ended January 31, 2024, 2023, and 2022, there were no customers that represented more than 10% of revenues. The Company does not believe that any single customer group represents a significant concentration of credit risk.

 

Commodity price risk. Commodity price risk is the risk that the value of inventory and related contracts will fluctuate due to changes in market prices. A change in price and quality will have a direct affect on the value of inventory. As a grain and pulse commodity trading company, the Company has significant exposure to changes in various agricultural commodity prices. Prices for these commodities are volatile and are influenced by numerous factors beyond the Company’s control, such as supply and demand fundamentals, as well as the weather. A substantial change in prices may affect the Company’s comprehensive income and operating cash flows, if not properly managed.

 

To mitigate the risks associated with the fluctuations in the market price for agricultural commodities, the Company has a policy that commodities be hedged, when possible, through the use of purchase and sales contracts. The Company may employ derivative commodity instruments (primarily futures and options) for the purpose of managing its exposure to commodity price risk, however, they are not used for speculative or trading purposes. The Company’s actual exposure to these price risks is constantly changing as the Company’s inventories and commodity contracts change. The effect of a 10% increase in the price of various commodities traded would have had an impact of a $1.2 million increase in net loss for FY24, and a $0.7 million increase in net loss for FY23, considering outstanding contracts as at the reporting dates and assuming all other variables remain constant.

 

Liquidity risk. Liquidity risk is the risk that the Company cannot meet its financial obligations associated with financial liabilities in full. The Company’s main sources of liquidity are its operations its credit facility and other debt financing. The funds are primarily used to finance working capital and capital expenditure requirements and are adequate to meet the Company’s financial obligations associated with financial liabilities. Risk associated with debt financing is mitigated by having negotiating terms over several years and renegotiating terms before they are due.

 

29


 

Interest rate risk. Interest rate risk is the risk that the Company will be unable to finance existing debt with similar terms, as well as potential changes in the future cash flows of financial instruments. The Company’s principal exposure to interest rate risk is with respect to its short-term debt and credit facilities, long-term debt and lease liability, which bear interest at fixed and floating interest rates.

 

The effect of a 1% increase in interest rates relating to the bank indebtedness, long-term debt and lease liability of the Company would be an increase in interest expense for FY24 of approximately $1.0 million, and $1.7 million for FY23. Exposure to interest rate risk is managed through normal operating and financing activities.

 

Other risks. Although we perform services for customers located in a number of jurisdictions, we have not experienced any material difficulties in receiving funds remitted from foreign countries. However, new or modified exchange control restrictions could have an adverse effect on our ability to repatriate cash to fund our operations and make principal and interest payments, when necessary.

 

ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

 

A. Directors and Senior Management

 

Information regarding the board practices of New Above Food is included in the Proxy Statement/Prospectus under the section titled “Management of New Above Food Following the Business Combination” and is incorporated herein by reference.

 

B. Compensation

 

Compensation of New Above Food’s Directors and Executive Officers

 

Information regarding the compensation of the directors and executive officers of New Above Food for the year ended January 31, 2024, which compensation was paid for services prior to the closing of the Business Combination is included in the Proxy Statement/Prospectus under the sections titled “Executive and Director Compensation-Above Food-Historical Compensation of Above Food’s Directors” and “Executive and Director Compensation-Above Food-Historical Compensation of Above Food’s Executive Officers” and is incorporated herein by reference.

 

Executive Officer Agreements

 

In connection with the closing of the Business Combination, Above Food assigned its existing employment and consulting agreements with the executive officers of New Above Food to New Above Food. Information regarding these agreements is included in the Proxy Statement/Prospectus under the sections titled “Executive and Director Compensation-Above Food-Employment Agreements". New Above Food expects that it may enter into new employment or other agreements to supersede and replace such existing agreements, although the precise terms and conditions of such agreements have not yet been determined.

 

Equity Compensation

 

New Above Food adopted the Above Food Ingredients Inc. 2024 Incentive Award Plan (the “2024 Incentive Award Plan”) on June 28, 2024, which became immediately effective upon the consummation of the Business Combination. The 2024 Incentive Award Plan initially reserved up to 83,854,489 for issuance pursuant to awards that may be granted under the 2024 Incentive Award Plan, which amount is subject to adjustment and an annual increase as set forth under the terms of the 2024 Incentive Award Plan. No awards have yet been granted under the 2024 Incentive Award Plan. Further information regarding the 2024 Incentive Award Plan is included in the Proxy Statement/Prospectus under the section titled “New Above Food Equity Incentive Plan” and is incorporated herein by reference.

 

Prior to the Business Combination, Above Food made grants of share options and restricted share units to its executive officers, which awards have been assumed by New Above Food in connection with the Business Combination. Further information is included in the Proxy Statement/Prospectus under the section titled “Executive and Director Compensation-Above Food-Equity Compensation” and is incorporated herein by reference.

 

Indemnification

 

The Amended and Restated By-Law No. 1 of New Above Food provides for the indemnification of the executive officers and directors of New Above Food on the terms set forth therein and expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and its directors, executive officers, and other persons with respect to indemnification and advancement of expenses. New Above Food has entered into an indemnification agreements with all of its current directors and executive officers.

 

C. Board Practices

 

Information regarding the board practices of New Above Food is included in the Proxy Statement/Prospectus under the section titled “Management of New Above Food Following the Business Combination” and is incorporated herein by reference.

 

D. Employees

 

Following and as a result of the Business Combination, the business of New Above Food is conducted through Above Food, its direct, wholly owned subsidiary, as well as the direct and indirect subsidiaries of Above Food.

 

Information regarding the employees of Above Food is included in the Proxy Statement/Prospectus under the section titled “Business of Above Food and Certain Information about Above Food—Employees” and is incorporated herein by reference.

 

E. Share Ownership

 

Ownership of the Company’s shares by its directors and executive officers upon consummation of the Business Combination is set forth in Item 7.A of this Report.

 

F. Disclosure of a registrant’s action to recover erroneously awarded compensation

 

Not applicable.

 

30


 

ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

 

A. Major Shareholders

 

The following table sets forth the beneficial ownership of New Above Food Common Shares following the Business Combination:

 

(a)           each person, or group of affiliated persons, known by us to beneficially own more than 5% of outstanding New Above Food Common Shares immediately following the consummation of the Business Combination;

 

(b)           each of New Above Food’s named executive officers, or directors; and

 

(c)           all executive officers and directors of New Above Food as a group.

 

Beneficial ownership is determined in accordance with the rules and regulations of the SEC. Each person named in the table has sole voting and investment power with respect to all of the common shares shown as beneficially owned by such person, except as otherwise indicated in the table or footnotes below.

 

The beneficial ownership of New Above Food Common Shares post-Business Combination is based on 28,532,715 New Above Food Common Shares issued and outstanding as of July 5, 2024, on a non-fully diluted basis, immediately following the Business Combination.

 

Unless otherwise indicated, New Above Food believes that all persons named in the table below have sole voting and investment power with respect to all shares of capital stock beneficially owned by them. To New Above Food’s knowledge, no New Above Food Common Shares beneficially owned by any executive officer or director have been pledged as security.

 

Unless otherwise indicated, the address of each New Above Food director and executive officer is c/o Above Food Ingredients Inc., 2305 Victoria Avenue #001, Regina, Saskatchewan, S4P 0S7.

 

Name and Address of Beneficial Owners   Number of
New
Above Food
Common
Shares
  % of
total New
Above Food
Common
Shares
 
Five Percent Holders              
Kambeitz Agri Inc.(1)     2,776,516     9.73 1%
Grupo Empresarial Enhol S.L.     2,105,000     7.38 %
ANF Holdco, LLC     1,604,250     5.62 %
Smart Dine, LLC(8)     2,524,616     8.78 %
Directors and Executive Officers of New Above Food            
Lionel Kambeitz(2)     2,600,541     9.08 %
Jason Zhao(3)     354,074     1.23 %
Martin Williams(4)     513,825     1.49 %
Tyler West (5)     2,271,689     7.89 %
Garth Frederickson     0     * %
Felipe Gomez Garcia     0     * %
Chief Reginald Bellerose(6)     26,292     * %
Agustin Tristan(7)     813,151     2.84 %
Alberto Ardura González(8)     2,524,616     8.78 %
All Directors and Executive Officers of New Above Food as a group (9 Individuals)     8,769,188     30.73  

 

* Less than one percent.

 

(1) Includes (i) 2,723,931 New Above Food Common Shares held by Kambeitz Agri Inc. (“Agri”) and (ii) 52,585 New Above Food Common Shares held by KF Kambeitz Farms Inc. (“KF Farms”). Agri’s voting shares are owned by Northrange Capital Corp., a Saskatchewan private business corporation, of which Jordan Kambeitz owns 76% of the equity securities and is the sole director and officer. Gailene Kambeitz owns the remaining 24% of the equity securities of Northrange Capital Corp. KF Farms is owned by Agri. and Jordan Kambeitz is the sole director and officer of Kambeitz Farms Inc. The registered address of Agri and KF Farms is 2-2305 Victoria Ave, Regina, Saskatchewan S4P 0S7, Canada.

 

31


  

(2) Includes (i) 355,275 New Above Food Common Shares held by 10209422 Saskatchewan LTD, (ii) 2,140,096 New Above Food Common Shares held by Lionel Kambeitz and (iii) 105,170 New Above Food Common Shares subject to options exercisable within 60 days of July 5, 2024. 10209422 Saskatchewan LTD is a Saskatchewan private business corporation, of which Mr. Kambeitz owns 100% of the voting shares. Consequently, he may be deemed the beneficial owner of the shares held by 10209422 Saskatchewan LTD and has voting and dispositive control over such securities. Mr. Kambeitz disclaims beneficial ownership of any shares other than to the extent he may have a pecuniary interest therein, directly or indirectly.

 

(3) Includes 354,074 New Above Food Common Shares subject to options exercisable within 60 days of July 5, 2024.

 

(4) Includes (i) 110,671 New Above Food Common Shares held by The Larder Inc. and (ii) 403,154 New Above Food Common Shares subject to New Above Food options exercisable within 60 days of July 5, 2024. The Larder Inc. is owned by the Bosnar-Williams Family Trust, of which Martin Williams is a trustee. Consequently, he may be deemed the beneficial owner of the shares held by The Larder Inc. and has voting and dispositive control over such securities. Mr. Williams disclaims beneficial ownership of any shares other than to the extent he may have a pecuniary interest therein, directly or indirectly.

 

(5) Includes 262,927 New Above Food Common Shares subject to New Above Food options exercisable within 60 days of July 5, 2024.

  

(6) Includes 26,292 New Above Food Common Shares subject to New Above Food options exercisable within 60 days of July 5, 2024.

 

(7) Includes 709,151 New Above Food Common Shares held directly by Lexington Capital, SAPI DE CV and 104,000 New Above Food Common Shares issuable upon exercise of 104,000 Common Warrants held by Lexington Capital, SAPI DE CV. Agustin Tristan Aldave, a director on our Board, is a director and the Chief Executive Officer of Lexington Capital, SAPI DE CV. Consequently, he may be deemed the beneficial owner of the shares held by Lexington Capital, SAPI DE CV and has voting and dispositive control over such securities. Mr. Tristan Aldave disclaims beneficial ownership of any shares other than to the extent he may have a pecuniary interest therein, directly or indirectly. The address of Lexington Capital, SAPI DE CV is Insurgentes Sur 64 Piso 10 A1004, Col Juarezm, Del Cuauhtemoc, Ciudad De Mexico 06600, Mexico.

 

(8) Includes 2,293,616 New Above Food Common Shares held by Smart Dine, LLC and 231,000 Common Shares issuable upon exercise of 231,000 Common Warrants held by Smart Dine, LLC. Smart Dine, LLC is the Sponsor. Alberto Ardura González, a director on our Board, is a manager of the Sponsor. Consequently, he may be deemed the beneficial owner of the shares held by the Sponsor and has voting and disositive control over such securities. Mr. Ardura González disclaims beneficial ownership of any shares other than to the extent he may have a pecuniary interest therein, directly or indirectly. The address of Smart Dine, LLC is 720 N. State Street, Chicago, IL 60654.

 

                Immediately following the consummation of the Business Combination, there were 87 record holders, of which 53 record holders holding approximately 58.9% of New Above Food Common Shares had registered addresses in Canada. These numbers are not representative of the number of beneficial holders of our Common Shares nor are they representative of where such beneficial holders reside, since many of these New Above Food Common Shares are held of record by brokers or other nominees (including one Canadian. nominee company, CDS & Co., which held approximately 14.4% of our outstanding New Above Food Common Shares immediately following the consummation of the Business Combination).

 

B. Related Party Transactions

 

Information regarding certain related party transactions is included in the Proxy Statement/Prospectus under the section titled “Certain Relationships and Related Transactions” and is incorporated herein by reference.

 

C. Interests of Experts and Counsel

 

Not Applicable.

 

ITEM 8. FINANCIAL INFORMATION.

 

A. Consolidated Statements and Other Financial Information.

 

See Item 18 of this Report for consolidated financial statements and other financial information.

 

Information regarding legal proceedings involving New Above Food and Above Food is included in the Proxy Statement/Prospectus under the section “Business of Above Food and Certain Information About Above Food— Legal Proceedings,” and is incorporated herein by reference.

 

B. Significant Changes

 

A discussion of significant changes since January 31, 2024, is provided under Item 4 and Item 5 of this Report and is incorporated herein by reference.

 

ITEM 9. THE OFFER AND LISTING

 

A. Offer and Listing Details

 

Nasdaq Listing of New Above Food Common Shares

 

New Above Food Common Shares and New Above Food Listed Warrants are currently listed on Nasdaq under the symbols “ABVE” and “ABVE.W,” respectively. Holders of New Above Common Shares and warrants should obtain current market quotations for their securities.

 

There can be no assurance that the New Above Food Common Shares will remain listed on Nasdaq. If New Above Food fails to comply with the Nasdaq listing requirements, the New Above Food Common Shares could be delisted from Nasdaq. A delisting of the New Above Food Common Shares will likely affect the liquidity of the New Above Food Common Shares and could inhibit or restrict the ability of New Above Food to raise additional financing.

 

32


 

Lock-up Agreements

 

Information regarding the lock-up restrictions applicable to some of the New Above Food Common Shares is included in the Proxy Statement/Prospectus under the section titled “Certain Relationship and Related Person Transaction—Lock-Up Agreements” and is incorporated herein by reference.

 

Above Food and Grupo Empresarial Enhol, S.L. (“Enhol”) entered into Common Share Subscription Agreement (“Enhol Subscription Agreement”), dated June 13, 2024, included in this Report as Exhibit 10.23, under which Enhol agreed to purchase 2,377,082 Above Food common shares at a price of $2.103419 per share ($10.00 per share of New Above Food Common Shares), which Above Food common shares converted into 500,000 New Above Food Common Shares at closing of the Business Combination, and 50% of Enhol’s shares (250,000 shares) are locked up for 60 days and the remaining 50% of Enhol’s shares (250,000 shares) are locked up for 180 days after the Closing Date, as further described in that certain Lock-Up Agreement, dated June 19, 2024, by and between Above Food and Enhol, included in this Report as Exhibit 10.26.

 

Above Food entered into subscription agreements with several investors (“PIPE Subscription Agreements”), under which the investors agreed to purchase 550,000 units of Above Food at a purchase price of $10.00 per unit for a total purchase price of $5,500,000, which units included one Above Food common share and one additional Above Food common share provided from the Sponsor or from treasury (the “Advantage Shares”), which Above Food common shares, besides the Advantage Shares, converted into 530,000 New Above Food Common Shares, and 25% are locked up for 90 days from July 1, 2024. The form of PIPE Subscription Agreement is included in this Report as Exhibit 10.24.

 

Above Food, Enhol, and Gonzalo Agorreta Preciado entered into the Shares Sale and Purchase and Exchange Agreement (“Enhol SPA”), dated June 13, 2024, included in this Report as Exhibit 10.25, under which Above Food agreed that Enhol and Mr. Preciado’s shares under the Enhol Subscription Agreement would participate in the Share Exchange. The parties agreed that the shares issued pursuant to the Enhol SPA will be locked up for 12 months.

 

Other Transfer Restrictions

 

Pursuant to the terms of the plan of arrangement (the “Plan of Arrangement”) approved by the Court of King’s Bench of Alberta in the Final Order dated June 18, 2024, all New Above Food Common Shares issued to former Above Food shareholders in exchange for their Above Food common shares held immediately prior to the effective time of the Plan of Arrangement are subject to certain restrictions on transfer and exceptions, whereby 90% of each such former Above Food shareholder’s New Above Food Common Shares issued under the Plan of Arrangement may not be transferred without the consent of New Above Food, except in certain circumstances, until the earlier of the date that is: (a) (i) the six month anniversary of the effective date of the Plan of Arrangement (the “Effective Date”), or (ii) in the case of certain designated holders, the twelve month anniversary of the Effective Date; (b) such time, if ever, after 150 calendar days after the Effective Date that the volume-weighted average trading price of the New Above Food Common Shares on the national stock exchange on which such security is trading equals or exceeds $12.50 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and similar corporate events) for any 20 trading days within any 30-trading day period commencing at least 150 calendar days after the Effective Date; and (c) such date on which New Above Food completes a liquidation, merger, stock exchange or other similar transaction which results in all of the shareholders of New Above Food having the right to exchange their New Above Food Common Shares for cash, securities or other property.

 

B. Plan of Distribution

 

Not applicable.

 

C. Markets

 

New Above Food Common Shares and New Above Food Listed Warrants are currently listed on the Nasdaq under the symbols “ABVE” and “ABVE.W”.

 

D. Selling Shareholders

 

Not applicable.

 

E. Dilution

 

Not applicable.

 

F. Expenses of the Issue

 

Not applicable.

 

ITEM 10. ADDITIONAL INFORMATION

 

A. Share Capital

 

As of the date of this Report, New Above Food has an issued share capital in the amount of 34,646,457 shares, consisting of 28,532,715 New Above Common Shares, 3,056,871 New Above Food Class A Earnout Shares and 3,056,871 New Above Food Class B Earnout Share.

 

New Above Food is authorized to issue (a) an unlimited number of New Above Food Common Shares without nominal or par value, and (b) an unlimited number of New Above Food Class A Earnout Shares and New Above Food Class B Earnout Shares, each without nominal or par value.

 

33


 

B. New Above Food Articles

 

Information regarding certain material provisions of the articles of New Above Food is included in the Proxy Statement/Prospectus under the section titled “Description of New Above Food Securities” and is incorporated herein by reference.

 

C. Material Contracts

 

Information regarding certain material contracts is included in the Proxy Statement/Prospectus under the sections titled “Certain Relationships and Related Person Transactions,” and “Business of Above Food and Certain Information about Above Food,” and are incorporated herein by reference.

 

On June 13, 2024, Above Food Cop, acquired all the shares of Brotalia, S.L. from Grupo Empresarial Enhol, S.L. and Mr. Gonzalo Agorreta Preciado. Brotalia, S.L. ("Brotalia") is (A) a subsidiary of Enhol which is engaged in (a) the development, production and commercialization of (i) precooked processed animal protein products and (ii) products made with alternative protein, for human consumption, (b) the development and research of new products, technologies or processes for the manufacture of edible products for human consumption, and (c) food tech project acceleration consultancy, (the “Business”) and (B) the sole shareholder of Naturcook Innovaciones, S.L. (the “Subsidiary” and jointly with the Company, the “Companies”). The purchase price for the shares is USD $13,000,000, on the assumption that the net debt of the acquired business will be zero. The purchase price was paid by the delivery of 6,180,413 Above Food common shares at Closing pursuant to:

 

(i) the Common Share Subscription Agreement (“Enhol Subscription Agreement”), dated June 13, 2024, included in this Report as Exhibit 10.23, under which Enhol agreed to purchase 2,377,082 Above Food common shares at a price of $2.103419 per share, which Above Food common shares converted into 500,000 New Above Food Common Shares (the “Enhol Shares”) at the closing of the Business Combination and are subject to registration rights, 50% are locked up for 60 days and 50% are locked up for 180 days, as further described in that certain Lock-Up Agreement, dated June 19, 2024, by and between Above Food and Enhol, included in this Report as Exhibit 10.26; and

 

(ii) a share purchase agreement (the “Enhol SPA”), under which Above Food agreed that Enhol and Mr. Preciado’s shares under the Enhol Subscription Agreement would participate in the Share Exchange. The parties to the Enhol SPA agreed that no later than 10 business days following the Closing, Above Food would cause New Above Food to file a resale registration statement on Form F-1 to register the resale of Enhol and Mr. Preciado’s shares. The parties agreed that the shares issued pursuant to the Enhol SPA will be locked up for 12 months.

 

New Above Food and Enhol entered into a Nomination Rights Agreement dated June 19, 2024 (“Nomination Agreement”), included in this Report as Exhibit 10.27, under which New Above Food granted Enhol the right to designate one nominee to the New Above Food Board upon the closing of the Business Combination, so long as Enhol holds at least 50% of Enhol’s common shares.

 

Above Food entered into PIPE Subscription Agreements, under which the investors agreed to purchase 550,000 units of Above Food at a purchase price of $10.00 per unit for a total purchase price of $5,500,000, which units included one Above Food common share and one additional Above Food common share provided from the Sponsor or from treasury (the “Advantage Shares”), which Above Food common shares, besides the Advantage Shares, converted into 530,000 New Above Food Common Shares. In addition, at Closing, the investors received 530,000 New Above Food Common Shares in the form of Advantage Shares from the Sponsor. The form of PIPE Subscription Agreement is included in this Report as Exhibit 10.24.

 

Promissory Note, dated June 27, 2024, issued by Bite in favor of the Sponsor (“Bite Promissory Note”), included in this Report as Exhibit 10.28, amended, replaced and superseded that certain promissory note, dated January 22, 2024 between Bite and the Sponsor for $3,250,000 of cash owed to the Sponsor for working capital loans provided by the Sponsor to Bite for purposes of completing the Business Combination. Under the Bite Promissory Note, Bite promised to pay Sponsor an interest-free, principle amount of $3,500,000, but Sponsor could elect to convert the outstanding principle into Working Capital Units upon consummation of Bite's initial business combination. Sponsor converted $1,500,000 principal amount into Working Capital Units concurrently with the Closing of the Business Combination.

 

Arcadia Biosciences, Inc. (“Arcadia”), Arcadia Wellness, LLC, (“Sellers”), Above Food, and Above Food Ingredients Corp. (“Above Food Arcadia Sub”) entered into an Asset Purchase Agreement, dated May 14, 2024, included in this Report as Exhibit 10.29, under which Above Food Arcadia Sub purchased assets, including, among others, inventory and intellectual property, in exchange for a $6,000,000 promissory note to Sellers. Sellers agreed to pay $2,000,000 USD.

 

34


 

Under the Promissory Note, dated May 14, 2024, by and among Arcadia Biosciences, Inc., Arcadia Wellness, LLC, Above Food and Above Food Arcadia Sub (“Arcadia Promissory Note”), included in this Report as Exhibit 10.34, Above Food Arcadia Sub promised to pay Arcadia $6,000,000 USD by the third anniversary of the effective date of the Acadia Promissory Note, payable in yearly installments of $2,000,000 USD with interest payable on each anniversary of the effective date of the Arcadia Promissory Note at the Prime Rate. Arcadia also has the right to obtain publicly traded New Above Food Common Shares in the amount of $2,000,000 USD until the second anniversary of the Promissory Note, instead of receiving one of the installment payments in cash, and New Above Food is required to file a resale registration statement on Form F-1 within 20 days of such share issuance.

 

Above Food, NRGene Technologies Ltd. and NRGene Canada Inc. ("NRGene Canada" and together with NRG Technologies Ltd., the “Sellers”), entered into an Amendment to Asset Purchase Agreement, dated June 26, 2024, included in this Report as Exhibit 10.31, to amend that certain Asset Purchase Agreement, dated August 28, 2023, included in this Report as Exhibit 10.10, pursuant to which Above Food agreed to participate in the private financial round of NRGene Canada and allocate up to CAD $1,000,000 of excess proceeds from any sale of New Above Food Common Shares to an investment under a SAFE investment agreement. Above Food agreed to provide the Sellers a non-recourse loan in the amount of CAD$ 2,362,500, for a period of six (6) months from the date of disbursement, bearing an interest rate of 3% per annum. Above Food also agreed to deliver to the Sellers 250,000 New Above Food Common Shares.

 

New Above Food and Sponsor entered into a Secured Convertible Promissory Note, dated June 27, 2024, included in this Report as Exhibit 10.32, under which New Above Food promised to pay Sponsor $2,000,000 in principle on the maturity date of June 27, 2026, with interest accruing on the unpaid principal amount at a rate equal to six percent (6%) per quarter, compounded quaterly. The entire principle amount is convertible into New Above Food Common Shares at Sponsor’s election.

 

Above Food, New Above Food, Sponsor, Enhol and Mr. Preciado entered into the Joinder to Registration Rights Agreement, dated June 19, 2024, included in this Report as Exhibit 10.33, under which Enhol and Mr. Preciado agreed to be bound by and become parties to the Registration Rights Agreement, dated June 28, 2024, by and among Above Food, New Above Food, Sponsor, and certain other investors set forth therein.

 

Material Contracts Relating to the Business Combination

 

Business Combination Agreement

 

A description of the Business Combination Agreement is set forth in the Proxy Statement/Prospectus under the sections titled “The Business Combination Proposal—Business Combination Agreement” and is incorporated herein by reference.

 

Related Agreements

 

A description of the material provisions of certain additional agreements entered into pursuant to the Business Combination Agreement is set forth in the Proxy Statement/Prospectus under the sections titled “The Business Combination Proposal—Ancillary Agreements” and “Description of New Above Food Securities—New Above Food Warrants,” and is incorporated herein by reference.

 

D. Exchange Controls and Other Limitations Affecting Security Holders

 

Canada has no system of exchange controls. There are no Canadian governmental laws, decrees, or regulations relating to restrictions on the repatriation of capital or earnings of the Company to non-resident investors. There are no laws in Canada or exchange control restrictions affecting the remittance of dividends or other payments made by the Company in the ordinary course to non-resident holders of the New Above Food Common Shares by virtue of their ownership of such New Above Food Common Shares, except as discussed below in under “Item 10.E. - Taxation”.

 

There are no limitations under the laws of Canada or in the organizing documents of the Company on the right of foreigners to hold or vote securities of the Company, except that the Investment Canada Act may require that a “non-Canadian” not acquire “control” of the Company without prior review and approval by the Minister of Innovation, Science and Economic Development, where applicable thresholds are exceeded. The acquisition of one-third or more of the voting shares of the Company would give rise a rebuttable presumption of an acquisition of control, and the acquisition of more than fifty percent of the voting shares of the Company would be deemed to be an acquisition of control. In addition, the Investment Canada Act provides the Canadian government with broad discretionary powers in relation to national security to review and potentially prohibit, condition or require the divestiture of, any investment in the Company by a non-Canadian, including non-control level investments. “Non-Canadian” generally means an individual who is neither a Canadian citizen nor a permanent resident of Canada within the meaning of the Immigration and Refugee Protection Act (Canada) who has been ordinarily resident in Canada for not more than one year after the time at which he or she first became eligible to apply for Canadian citizenship, or a corporation, partnership, trust or joint venture that is ultimately controlled by non-Canadians.

 

Amendments to the Investment Canada Act have been passed by the Canadian government but have not yet come into force. Among other things, the amendments will broaden and strengthen the national security review provisions and require, under certain circumstances to be prescribed in regulations that have not yet been published, pre-closing notification of certain foreign investment transactions.

 

E. Taxation

 

Information regarding certain U.S. tax consequences of owning and disposing of New Above Food Common Shares and New Above Food Warrants is included in the Proxy Statement/Prospectus under the section titled “Material U.S. Federal Income Tax Considerations of the Business Combination” and is incorporated herein by reference.

35


 

F. Dividends and Paying Agents

 

New Above Food has never declared or paid any cash dividends and has no plan to declare or pay any dividends on New Above Food Common Shares in the foreseeable future. New Above Food currently intends to retain any earnings for future operations and expansion.

 

Subject to the rights of any other shares of New Above Food which are expressed to rank prior to the New Above Food Common Shares, the holders of New Above Food Common Shares are entitled to receive dividends at such times and in such amounts as the New Above Food Board may determine from time to time. The holders of the New Above Food Class A Earnout Shares and the New Above Food Class B Earnout Shares shall not be entitled to any dividends or other distributions other than in the event of a distribution of assets of the Company among its shareholders arising on the liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, or any other distribution of the assets of the Company among its shareholders for the purpose of winding up its affairs.

 

Under the ABCA, New Above Food may not pay a dividend in money or other property if there are reasonable grounds for believing that New Above Food is, or would after the payment be, unable to pay its liabilities as they become due, or the realizable value of New Above Food’s assets would thereby be less than the aggregate of its liabilities and stated capital of all classes.

 

Since New Above Food is a holding company, its ability to pay dividends will be dependent upon the financial condition, liquidity and results of operations of, and the receipt of dividends, loans or other funds from, its subsidiaries. The subsidiaries are separate and distinct legal entities and have no obligation to make funds available to New Above Food. In addition, there are various statutory, regulatory and contractual limitations and business considerations on the extent, if any, to which the subsidiaries of New Above Food may pay dividends, make loans or otherwise provide funds to New Above Food.

 

G. Statement by Experts

 

The consolidated balance sheet of New Above Food as of January 31, 2024, incorporated by reference in this Report has been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their report thereon, appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing. The consolidated financial statements of Above Food at January 31, 2024 and 2023, and for each of the three years in the period ended January 31, 2024, appearing in this Report have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their report thereon (which contains an explanatory paragraph describing conditions that raise substantial doubt about Above Food’s ability to continue as a going concern as described in Note 2 to the consolidated financial statements) appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing.

 

The financial statements of Bite as of and for the fiscal years ended December 31, 2023 and 2022, incorporated by reference in this report, have been audited by Marcum LLP, independent registered public accounting firm, as set forth in their report thereon appearing elsewhere herein, which includes an explanatory paragraph as to Bite’s ability to continue as a going concern, and are included in reliance on such report given on the authority of such firm as an expert in accounting and auditing.

 

H. Documents on Display

 

We are subject to certain of the informational filing requirements of the Exchange Act. Because we are a “foreign private issuer,” we are exempt from the rules and regulations under the Exchange Act prescribing the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions contained in Section 16 of the Exchange Act, with respect to their purchase and sale of our shares. In addition, we are not required to file reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. However, we are required to file with the SEC an Annual Report on Form 20-F containing financial statements audited by an independent accounting firm. We may, but are not required, to furnish to the SEC, on Form 6-K, unaudited financial information after each of our first three fiscal quarters. The SEC also maintains a website at http://www.sec.gov that contains reports and other information that we file with or furnish electronically with the SEC. You may read and copy any report or document we file, including the exhibits, at the SEC’s public reference room located at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room.

 

I. Subsidiary Information.

 

Not applicable.

 

36


 

ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Information regarding quantitative and qualitative disclosure about market risk is included in the audited consolidated financial statements of Above Food for the year ended January 31, 2024, which form part of this Report.

 

ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

 

Information regarding New Above Food Warrants is included in the Proxy Statement/Prospectus under the section titled “Description of New Above Food Securities—New Above Food Warrants” and is incorporated herein by reference.

 

37


 

PART II.

 

Item 16A. Audit Committee Financial Expert

 

The New Above Food Board has determined that Alberto Ardura González is an “audit committee financial expert,” within the meaning of the current rules of the U.S. Securities and Exchange Commission. Alberto Ardura González is “independent” as required by the Nasdaq Listing Rules.

 

Item 16B. Code of Ethics

 

We have adopted a code of ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. Pursuant to our Code of Ethics, officers of New Above Food covered by New Above Food’s Code of Ethics are required to promptly bring to the attention of the appropriate personnel, including officers, the General Counsel, outside counsel for the Company and the New Above Food Board or the relevant committee thereof, any information concerning any violations of the Code of Ethics.

 

Item 16G. Corporate Governance

 

Our common shares and warrants are listed on Nasdaq and as a Nasdaq-listed company, we are required to comply with certain corporate governance standards under applicable Nasdaq Listing Rules. However, as a foreign private issuer, pursuant to Nasdaq Listing Rule 5615(a)(3), we are permitted to follow home country practice in lieu of certain provisions of the Nasdaq Listing Rules.

 

Our corporate governance practices differ in certain significant respects from those that U.S. companies must adopt in order to maintain a Nasdaq listing and, in accordance with Nasdaq Listing Rule 5615(a)(3), we provide a brief, general summary of such differences.

 

Pursuant to Nasdaq Listing Rule 5615(a)(3), the Company has elected to follow certain Canadian practices consistent with the requirements of the ABCA in lieu of the requirements of (i) NASDAQ Listing Rule 5620(c) (Quorum Rule) and (ii) Nasdaq Rule 5635, which sets forth the circumstances under which shareholder approval is required prior to an issuance of securities in certain circumstances as set out therein.

 

Nasdaq Listing Rule 5620(c) requires that the minimum quorum requirement for a shareholder meeting is one-third of the outstanding common shares. In addition, a company listed on Nasdaq is required to state its quorum requirement in its bylaws. New Above Food’s quorum requirement is set forth in its organizational documents, which provides that if the Company has more than 15 shareholders, quorum for the transaction of business at a meeting of shareholders is shareholders holding not less than twenty five (25%) percent of the shares of the Company entitled to vote at that meeting being present in person or represented by proxy, where two or more joint holders are counted as one shareholder.

 

The shareholder approval requirements set forth in Nasdaq Listing Rule 5635 are different than those required by the Canadian Rules. New Above Food intends to comply with such Canadian Rules in lieu of the requirements set forth in Nasdaq Listing Rule 5635.

 

Other than the home country practices described above, we are not aware of any significant ways in which our corporate governance practices differ from those followed by U.S. domestic companies under the Nasdaq listing rules.

 

 

38


 

PART III.

 

ITEM 17. FINANCIAL STATEMENTS

 

We have elected to provide financial statements and related information pursuant to “Item 18 Financial Statements.”

 

ITEM 18. FINANCIAL STATEMENTS

 

The audited consolidated financial statements of Bite for the fiscal year ended December 31, 2023, are incorporated by reference to pages F 3–F 24 in Amendment No. 4 to the Registration Statement on Form F-4, filed with the SEC on April 2, 2024 (“Amendment No. 4”).

 

The audited consolidated financial statements of Above Food for the fiscal year ended January 31, 2024, form part of this Report.

 

The audited consolidated financial statements of New Above Food for the fiscal year ended January 31, 2024, are incorporated by reference to pages F 116–F 119 in Amendment No. 4.

 

The unaudited pro forma condensed combined financial statements of New Above Food as of and for the year ended January 31, 2024 are attached as Exhibit 15.1 to this Report.

 

ITEM 19. EXHIBITS.

 

Exhibit 
Number

 

Description

     
1.1*   Amended and Restated Articles of Above Food Ingredients Inc.
     
1.2*   Amended and Restated By-law No.1 of Above Food Ingredients Inc., dated June 28, 2024.
     
2.1†   Business Combination Agreement, dated as of April 29, 2023, by and among Bite Acquisition Corp., 2510169 Alberta Inc., Above Merger Sub, Inc. and Above Food Corp. (incorporated by reference as Annex A-1 to the Registration Statement on Form F-4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
2.2   Amendment No. 1 to Business Combination Agreement, dated as of March 12, 2024, by and among Bite Acquisition Corp., Above Food Ingredients Inc., Above Merger Sub, Inc. and Above Food Corp.(incorporated by reference as Annex A-2 to the Registration Statement on Form F-4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
2.3   Plan of Arrangement (incorporated by reference included as Exhibit D to the Business Combination Agreement, which is included as Annex A-1 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
4.1*   Amended and Restated Warrant Agreement, by and between Above Food Ingredients Inc., Bite Acquisition Corp., Continental Stock Transfer & Trust Company and Odyssey Transfer and Trust, dated June 28, 2024.
     
4.2*   Amended and Restated Warrant Indenture, by and between Above Food Ingredients Inc., Above Food Corp. and Odyssey Trust Company, dated June 28, 2024.
     
10.1*   Stock Escrow Assignment, Assumption and Amendment Agreement, dated June 28, 2024, by and among Bite Acquisition Corp., Above Food Ingredients Inc., Smart Dine, LLC, Continental Stock Transfer & Trust Company, and Odyssey Transfer and Trust Company.
     
10.2*   Stock Escrow Agreement, dated February 11, 2021, among Bite Acquisition Corp., Continental Stock Transfer & Trust Company and certain security holders.

 

39


 

Exhibit 
Number

 

Description

     
10.3*   Registration Rights Agreement, dated June 28, 2024, by and among Above Food Corp., Above Food Ingredients Inc., Smart Dine, LLC and certain other investors set forth therein.
     
10.4*   Form of Indemnification and Advancement Agreement.
     
10.5   Form of General Security Agreement (incorporated by reference as Exhibit 10.6 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.6   Form of Release to the General Security Agreement (incorporated by reference as Exhibit 10.7 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.7♦   Escrow Agreement, dated December 29, 2022, between Above Food corp., Lexington Capital, S.A.P.I. de C.V. and McDougall Gauley LLP. (incorporated by reference as Exhibit 10.13 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.8   Pledge Agreement, dated December 29, 2022, between Above Food USA Corp. and Lexington Capital, S.A.P.I. de C.V. (incorporated by reference as Exhibit 10.14 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.9▲   Supplier Agreement, between Farmer Direct Organic Foods Ltd. and United Natural Foods, Inc. (incorporated by reference as Exhibit 10.15 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.10   Asset Purchase Agreement, dated August 28, 2023, between NRGene Technologies Ltd., NRGene Canada Inc., and Above Food Corp. (incorporated by reference as Exhibit 10.16 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.11†♦   Amended and Restated Agreement for Lease, dated May 5, 2023, by and among Purely Canada Terminals Corp., Purely Canada Foods Corp. and Kambeitz Agri Inc. (incorporated by reference as Exhibit 10.17(a) to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.12   Amended and Restated Agreement for Lease, dated June 3, 2023, by and among Purely Canada Terminals Corp. and Purely Canada Foods Corp. (incorporated by reference as Exhibit 10.17(b) to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.13   Lease Agreement, dated June 12, 2017, between Matrix Equities Inc., as Landlord, and Northern Quinoa Production Corporation, as Tenant (incorporated by reference as Exhibit 10.18 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.14   Amendment of Lease to the Lease Agreement, dated January 13, 2021, between Matrix Equities Inc., as Landlord, and Northern Quinoa Production Corporation, as Tenant (incorporated by reference as Exhibit 10.19 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.15   Renewal of Lease to the Lease Agreement, dated October 17, 2022, between Matrix Equities Inc., by its duly authorized agent, Triovest Realty Advisors Inc., as Landlord, and Northern Quinoa Production Corporation, as Tenant (incorporated by reference as Exhibit 10.20 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.16†♦   Industrial Lease (Multi-Tenant), dated October 17, 2019, between 1057041 Ontario Inc., as Landlord, and Wood & Water Foods Inc., as Tenant (incorporated by reference as Exhibit 10.21 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).

 

40


 

Exhibit 
Number

 

Description

     
10.17   First Amending Lease Agreement to the Industrial Lease, dated September 30, 2021, between 1057041 Ontario Inc., as Landlord, and Wood and Water Foods Inc., as Tenant (incorporated by reference as Exhibit 10.22 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.18   Second Amending Lease Agreement to the Industrial Lease, dated November 30, 2022, between 1057041 Ontario Inc., as Landlord, and Wood and Water Foods Inc., as Tenant, dated November 30, 2022 Tenant (incorporated by reference as Exhibit 10.23 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.19†▲♦   Lease Agreement, dated December 31, 2021, by and between Midatlantic Warehouse & Storage, LLC, as landlord and Atlantic Natural Foods, LLC, as tenant (110 Industry Drive, Nash County, Nashville, North Carolina) (incorporated by reference as Exhibit 10.24 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.20   Above Food Corp. Stock Option Plan (incorporated by reference as Exhibit 10.25 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.21   Above Food Corp. Restricted Share Unit Plan (incorporated by reference as Exhibit 10.26 to the Registration Statement on Form F 4/A (Reg. No. 333-275005), filed with the SEC on April 8, 2024).
     
10.22*   Above Food Ingredients Inc. Equity Incentive Plan, dated June 28, 2024.
     
10.23*▲♦   Common Share Subscription Agreement, dated June 13, 2024, by and between Above Food Corp. and Grupo Empresarial Enhol, S.L.
     
10.24*▲♦   Form of Common Share Subscription Agreement, dated June 21, 2024, by and between Above Food Corp. and various investors.
     
10.25*†   Shares Sale and Purchase and Exchange Agreement, dated June 13, 2024, by and among Above Food Corp., Grupo Empresarial Enhol, S.L., and Gonzalo Agorreta Preciado.
     
10.26*   Lock-Up Agreement, dated June 19, 2024, by and between Above Food Corp. and Grupo Empresarial Enhol, S.L.
     
10.27*   Nomination Rights Agreement, dated June 19, 2024, by and between Above Food Ingredients Inc. and Grupo Empresarial Enhol, S.L.
     
10.28*   Promissory Note, dated June 27, 2024, issued by Bite Acquisition Corp. in favor of Smart Dine, LLC.
     
10.29*▲♦   Asset Purchase Agreement, dated May 14, 2024, by and among Arcadia Biosciences, Inc., Arcadia Wellness, LLC, Above Food Corp., and Above Food Ingredients Corp.
     
10.30*   Promissory Note, dated May 14, 2024, by and among Arcadia Biosciences, Inc., Arcadia Wellness, LLC, Above Food Corp. and Above Food Ingredients Corp.
     
10.31*†   Amendment to Asset Purchase Agreement, dated June 26, 2024, by and among Above Food Corp., NRGene Technologies Ltd. and NRGene Canada Inc.
     
10.32*   Secured Convertible Promissory Note, dated June 27, 2024, by and between Above Food Ingredients Inc. and Smart Dine, LLC.
     
10.33*   Joinder to Registration Rights Agreement, dated June 19, 2024, by and among Above Food Corp., Above Food Ingredients Inc., Smart Dine, LLC, Grupo Empresarial Enhol, S.L., and Gonzalo Agorreta Preciado.
     
15.1*   Unaudited pro forma condensed combined financial statements.
     
23.1*   Consent of Ernst & Young LLP, auditor to Above Food Corp. and Above Food Ingredients Inc.
     
23.2*   Consent of Marcum, LLP, auditor to Bite Acquisition Corp.

 

 

 

Schedules to this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Registrant hereby agrees to furnish a copy of any omitted schedules to the Commission upon request.

 

Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The Registrant hereby agrees to furnish a copy of any omitted portion to the Commission upon request.

 

Portions of this exhibit have been omitted pursuant to Item 601(a)(6) of Regulation S-K. The Registrant hereby agrees to furnish a copy of any omitted portion to the Commission upon request.

 

* Filed herewith.

 

41


 

SIGNATURES

 

The registrant certifies that it meets all of the requirements for filing on Form 20-F and has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: July 8, 2024 Above Food Ingredients Inc.
   
  By: /s/ Lionel Kambeitz
    Name: Lionel Kambeitz
    Title: Chief Executive Officer

 

42


 

ABOVE FOOD CORP.

 

Consolidated Financial Statements

 

as of January 31, 2024 and 2023 and for the years ended January 31, 2024, 2023 and 2022

 

 


 

CONTENTS

 

  Page
Report of Independent Registered Public Accounting Firm (PCOAB ID 1263) F-2
Consolidated Balance Sheets F-3
Consolidated Statements of Operations and Comprehensive Loss F-4
Consolidated Statements of Changes in Shareholders’ Equity (Expressed in Canadian dollars) F-5
Consolidated Statements of Cash Flows (Expressed in Canadian dollars) F-6
Notes to the Consolidated Financial Statements F-7
1. Nature of the business F-7
2. Summary of Significant Accounting Policies F-7
3. Recent Accounting Pronouncements F-19
4. Acquisitions and dispositions F-20
5. Inventory F-24
6. Investment in affiliate F-24
7. Other current assets F-25
8. Other non-current assets F-25
9. Loans receivable F-25
10. Property, plant and equipment F-25
11. Goodwill and intangible assets F-26
12. Short-term debt and credit facilities F-27
13. Long-term debt F-28
14. Derivative instruments F-32
15. Leases F-33
16. Share capital

F-34

17. Stock Compensation F-36
18. Income taxes F-38
19. Segment information F-39
20. Revenue F-40
21. Fair value measurements F-41
22. Related Party transactions and balances F-44
23. Selling, general and administrative expenses F-45
24. Commitments and Contingencies F-45
25. Loss per share F-45
26. Subsequent events F-46

 

F-1


 

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and Board of Directors of Above Food Corp.

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of Above Food Corp. (the “Company”), as of January 31, 2024 and 2023, the related consolidated statements of operations and comprehensive loss, changes in equity and cash flows, for each of the years in the three year period ended January 31, 2024, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at January 31, 2024 and 2023, and the results of its operations and its cash flows for each of the years in the three year period ended January 31, 2024, in conformity with U.S. generally accepted accounting principles.

 

The Company’s ability to Continue as a Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the consolidated financial statements, the Company has suffered recurring losses from operations, has a working capital deficiency, has violated covenant requirements under its lending agreements as at January 31, 2024 and has stated that substantial doubt exists about the Company’s ability to continue as a going concern. Management's evaluation of the events and conditions and management’s plans regarding these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

 

/s/ Ernst & Young LLP

Charterred Professional Accountants

 

We have served as the Company’s auditor since 2021.

 

Saskatoon, Canada

May 31, 2024, except for Note 26, as to which the date is July 8, 2024.

 

F-2


 

Consolidated Balance Sheets

(Expressed in Canadian dollars)

 

As at   Note(s)     January 31,  2024     January 31,  2023  
ASSETS                      
Current Assets:                      
Cash         $ 952,280     $ 2,327,797  
Accounts receivable, net           24,028,576       33,664,121  
Loans receivable   9       671,500       552,003  
Inventory   5       26,009,438       47,919,591  
Commodity forward contracts   14       15,187,459       14,030,350  
Foreign exchange forward contracts   14       359,973       542,862  
Other assets   7       1,227,012       3,458,705  
            68,436,238       102,495,429  
                       
Investment in affiliate   6       5,873,574       9,541,713  
Property, plant and equipment, net   10       27,249,328       26,377,900  
Intangible assets, net   11       2,448,489       2,938,340  
Operating lease right-of-use assets   15       6,745,324       5,702,190  
Finance lease right-of-use assets   15       31,552,824       32,475,705  
Goodwill   4, 11       871,174        
Due from related parties   22             302,406  
Other assets   8       711,004       1,055,693  
Total Assets         $ 143,887,955     $ 180,889,376  
                       

LIABILITIES AND EQUITY

                     
Current Liabilities:                      
Accounts payable and accrued liabilities   14     $ 53,101,833     $ 47,396,393  
Customer deposit           8,676,662       2,671,068  
Short-term debt and credit facilities   12       36,000,000       47,500,000  
Bank indebtedness           12,304,272       5,745,489  
Long-term debt, current portion   13       30,783,203       23,259,226  
Due to related parties   22       6,017,600       8,480,516  
Operating lease liabilities, current portion   15       1,179,839       796,801  
Lease liabilities, current portion   15       1,190,708       1,203,809  
Commodity forward contracts   14       3,250,260       977,331  
Foreign exchange forward contracts   14       1,346,133       3,124,828  
            153,850,510       141,155,461  
                       
Long-term debt   13       186,104       577,517  
Operating lease liabilities   15       5,434,482       4,905,388  
Finance lease liabilities   15, 22       30,428,018       31,620,032  
Deferred tax liabilities   18       247,073       -  
Commitments and contingencies   24                  
            190,146,187       178,258,398  
Shareholders’ equity:                      
Voting common shares, $0.00001 par value, unlimited shares authorized; 78,032,167 and 77,452,927 shares issued and outstanding as of January 31, 2024 and 2023, respectively. In connection with the acquisition of FDO (Note 4) 432,780 shares are held in escrow and to be released contingently upon the satisfaction of certain conditions   16       781       775  
Additional paid-in capital   16       45,777,474       41,474,196  
Warrants   16       11,676,046       11,676,046  
Retained deficit           (103,880,258 )     (50,567,976 )
Accumulated other comprehensive income           167,725       47,937  
Total shareholders’ equity           (46,258,232 )     2,630,978  
Total liabilities and shareholders’ equity         $ 143,887,955     $ 180,889,376  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3


 

Consolidated Statements of Operations and Comprehensive Loss

(Expressed in Canadian dollars)

 

        Year Ended January 31  
    Note(s)     2024     2023     2022  
Revenue   20       368,423,398     $ 396,464,504     $ 198,857,713  
Cost of sales   14, 21       374,322,146       397,744,144       190,945,089  
Gross profit (loss)           (5,898,748 )     (1,279,640 )     7,912,624  
                               
Expenses                              
Selling, general and administrative   23       34,222,524       31,107,404       11,693,607  
Research and development   2       171,852       430,666       235,095  
Impairment of goodwill and other intangible assets   11       1,806,337       6,866,121        
            36,200,713       38,404,191       11,928,702  
Loss from operations           (42,099,461 )     (39,683,831 )     (4,016,078 )
                               
Interest revenue           245,262       296,479       82,293  
Gain on revaluation of consideration payable   4                   147,733  
Interest expense   14       (7,670,156 )     (5,378,560 )     (2,086,274 )
Net loss before income taxes           (49,524,355 )     (44,765,912 )     (5,872,326 )
                               
Income tax recovery                              
Current   18             (15,370 )      
Deferred   18             (78,681 )     (95,088 )
Income tax recovery                 (94,051 )     (95,088 )
Equity method investment loss and impairment   6       3,787,927       812,669       -  
Net loss for the year         $ (53,312,282 )   $ (45,484,530 )   $ (5,777,238 )
                               
Net loss per share of common share                              
Basic and diluted   25     $ (0.69 )   $ (0.60 )   $ (0.08 )
                               
Weighted-average common shares outstanding                              
Basic and diluted   25       77,512,765       76,039,262       72,304,200  
                               
Other comprehensive income                              
Cumulative translation adjustments           152,131       65,667        
Tax effect           (32,343 )     (17,730 )      
Total other comprehensive income         $ 119,788     $ 47,937     $  
                               
Comprehensive loss for the year         $ (53,192,494 )   $ (45,436,593 )   $ (5,777,238 )

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4


 

Consolidated Statements of Changes in Shareholders’ Equity

(Expressed in Canadian dollars)

 

        Common Stock     Additional         Retained Earnings     Accumulated
Other
Comprehensive
    Total
Shareholders’
 
    Note   Shares     Amount     Paid-in Capital     Warrants     (Deficit)     income (loss)     Equity  
Balance, January 31, 2021         72,107,488     $ 721     $ 25,931,978     $ 11,135,226     $ 693,792           $ 37,761,717  
                                                             
Private placement         100,000       1       149,999       50,000                     200,000  
Net loss for the year                                 (5,777,238 )           (5,777,238 )
Balance, January 31, 2022         72,207,488     $ 722     $ 26,081,977     $ 11,185,226     $ (5,083,446 )         $ 32,184,479  
                                                           
Issuance to WestOak Naturals Inc.         997,835       10       1,995,660                         1,995,670  
Issuance for acquisition of Culcherd         1,616,705       16       2,753,745                         2,753,761  
Issuance for acquisition of NorQuin         1,565,595       16       2,672,774       490,820                   3,163,610  
Issuance for acquisition of FDO         1,065,304       11       1,057,808                         1,057,819  
Stock compensation expense                     6,912,232                         6,912,232  
Net loss for the year                                 (45,484,530 )           (45,484,530 )
Other comprehensive income                                                 47,937       47,937  
Balance, January 31, 2023         77,452,927     $ 775     $ 41,474,196     $ 11,676,046     $ (50,567,976 )   $ 47,937     $ 2,630,978  
                                                           
Issuance for acquisition of Discovery Seed Labs   4     502,088       5       1,213,558                         1,213,563  
Stock compensation expense   17     77,152       1       3,089,720                         3,089,721  
Net loss for the year                                 (53,312,282 )           (53,312,282 )
Other comprehensive income                                       119,788       119,788  
Balance, January 31, 20241         78,032,167     $ 781     $ 45,777,474     $ 11,676,046     $ (103,880,258 )   $ 167,725     $ (46,258,232 )

 

 

1 In connection with the acquisition of FDO (Note 4), 432,780 shares are held in escrow and to be released contingently upon the satisfaction of certain conditions.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5


 

Consolidated Statements of Cash Flows

(Expressed in Canadian dollars)

 

      Years ended January 31  
    Note   2024     2023     2022  
Cash flows used in operating activities:                            
Net loss       $ (53,312,282 )   $ (45,484,530 )   $ (5,777,238 )
Items not affecting cash:                            
Depreciation and amortization   10, 11, 15     3,606,284       2,959,017       1,366,074  
Stock compensation expense   17     3,089,721       6,912,232        
Deferred taxes   18           (78,681 )     (95,088 )
Gain on revaluation of consideration payable   4                 (147,733 )
Gain on sale of assets   4, 10     (20,212 )     (25,005 )     (137,492 )
Impairment of goodwill and other intangible assets   11     1,806,337       6,866,121        
Non-cash interest expense         2,832,042       298,458        
Non-cash lease expense   15     1,107,267       787,334       1,190,478  
Equity method investment loss and impairment   6     3,787,927       812,669        
Changes in operating assets and liabilities:                            
Accounts receivable         9,810,618       (8,707,755 )     (9,771,404 )
Inventory   5     21,910,153       5,548,114       (25,994,985 )
Commodity forward contracts   14     1,115,820       1,737,689       (14,381,486 )
Foreign exchange forward contracts   14     (1,595,806 )     2,734,486       1,985,734  
Corporate tax receivable   18           53,670       61,374  
Other assets   8     2,576,382       (1,684,854 )     (2,022,187 )
Operating lease liabilities   15     (1,238,268 )     (772,275 )     (640,185 )
Accounts payable and accrued liabilities         5,667,171       8,084,074       26,200,558  
Customer deposits         6,005,594       2,082,333       588,735  
          7,148,748       (17,876,903 )     (27,574,845 )
Cash flows used in investing activities:                            
Purchase of investments in affiliates   6           (6,255,400 )     (4,051,045 )
Loans received (issued)   9     (119,497 )     13,340       (5,414,510 )
Business acquisitions, net of cash acquired   4     (1,590,913 )     (282,032 )     20,988  
Purchase of intangible assets   11     (60,496 )     (328,760 )     (135,972 )
Proceeds from sale of assets   4     843,298       2,578,353       989,042  
Purchase of property, plant and equipment   10     (3,590,336 )     (2,388,221 )     (21,998,339 )
          (4,517,944 )     (6,662,720 )     (30,589,836 )
Cash flows from financing activities:                            
Advance from (repayment of) short-term debt and credit facilities   12     (11,500,000 )     4,500,000       29,992,113  
Advance from bank overdraft         6,558,783       2,407,330        
Capital raise net of share issuance costs   16                 200,000  
Proceeds from issuance of long-term debt   13     6,473,395       19,066,428       77,000  
Repayment of long-term debt   13     (2,172,873 )     (1,080,667 )     (540,761 )
Advance (repayment) of amounts due from (to) related parties   22     (2,160,510 )     1,114,702       (1,560,627 )
Repayment of finance lease liabilities   15     (1,205,116 )     (1,197,395 )     (971,329 )
          (4,006,321 )     24,810,398       27,196,396  
                             
Decrease in cash during the period         (1,375,517 )     270,775       (30,968,285 )
Cash – beginning of period         2,327,797       2,057,022       33,025,307  
Cash – end of period       $ 952,280     $ 2,327,797     $ 2,057,022  
                             
Included in operating activities                            
Cash interest paid       $ 4,838,116     $ 5,080,102     $ 2,086,274  
Income taxes paid                      

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6


 

Notes to the Consolidated Financial Statements

For the years ended January 31, 2024 and January 31, 2023

 

1. Nature of the business

 

Above Food Corp. (“Above”, “AFC” or the “Company”) and its subsidiaries’ commercial business is the purchase and sale of crop commodities, the development, aggregation and commercialization of related product, the production and sale of plant based dairy products.

 

On April 29, 2023, the Company entered into a business combination agreement (“Business Combination” or “Agreement”) with Bite Acquisition Corp. (“Bite”) and Above Food Ingredients Inc. (formerly 2510169 Alberta Inc.) (“TopCo”), pursuant to which Bite and the Company agreed to combine in a business combination that will result in each of Bite and the Company becoming a wholly owned subsidiary of TopCo. The closing of the transactions contemplated by the Agreement are conditional on several items, including requisite pre-approvals by Bite’s shareholders. Upon the closing of the transactions contemplated by the Agreement, TopCo’s common shares and warrants will be listed on the New York Stock Exchange. On the date of the closing, the Company’s shareholders will effect a share exchange pursuant to which the Company’s shareholders will contribute to TopCo all of the issued and outstanding equity of the Company in exchange for newly issued TopCo common shares, TopCo class A earnout shares and TopCo class B earnout shares, resulting in the Company becoming a direct, wholly owned subsidiary of TopCo. As a result of this share exchange, a number of TopCo common shares equal to USD $206,000,000 divided by USD $10.00, will be issued to the Company’s shareholders or allocated to holders of the Company’s stock options, restricted share units and warrants for issuance upon exercise thereof. There can be no assurance however that the foregoing transaction will be successfully consummated and no assurance that BITE will obtain the necessary approvals to amend its charter to extend beyond its current termination date of August 17, 2024.

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).

 

The Company’s presentational currency is the Canadian dollar and amounts presented in these consolidated financial statements are in Canadian dollars unless otherwise indicated.

 

Liquidity and Going Concern

 

The consolidated financial statements have been prepared assuming the Company will continue to operate as a going concern, which contemplates the realization of assets and settlement of liabilities in the normal course of business. For the year ended January 31, 2024, the Company incurred a net loss of $53,312,282. As at January 31, 2024, the Company had an retained deficit of $103,880,258 and had a working capital deficiency of $85,414,272. Furthermore, as of January 31, 2024, the Company was in violation of restrictive covenants related to approximately $66 million of its aggregate borrowings as more fully described in notes 12 and 13. As of the date of these consolidated financial statements, the Company remains in violation of these restrictive covenants. Since January 31, 2024, the Company has extended the repayment date for the loans payable to Lexington Capital to June 30, 2024, and the loans payable to Grupo Vida Canada and SmartDine to July 31, 2024. Additionally, the revolving credit loan held with RBC (see Note 12) was also extended to July 31, 2024.

 

Historically, the Company’s activities and growth have been supplemented through private placements of equity securities and debt, however there can be no assurance the Company will be successful in obtaining further equity and debt financing nor can there be any assurance that the Company will be able to maintain the support of its current lenders, particularly as it relates to the indebtedness currently in default of restrictive covenants and monetary default. The Company also expects to continue to incur recurring losses as it continues to grow its business and has incurred significant costs in preparation for the business combination with Bite. The Company also has certain convertible debt repayable in cash in the event the go public transaction does not proceed (see Note 13). These conditions raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date of issuance of these consolidated financial statements.

 

F-7


 

The Company intends to ensure sufficient capital to finance its growth and operations by raising capital through the proposed transaction with Bite (see Note 1), which would, if successfully completed, also reduce the cash burden of certain debt obligations outstanding (see Note 13) as some of these obligations can contractually be settled in shares of the public company that emerges following the contemplated business combination with Bite. There can be no assurance that the foregoing business combination will be successfully consummated.

 

If the going concern assumption were not appropriate for these consolidated financial statements, then adjustments would be necessary to the carrying value of assets and liabilities, the reported revenue and expenses, and the classifications used in the consolidated statements of financial position. The consolidated financial statements do not include adjustments that would be necessary if the going concern assumption were not appropriate.

 

Principles of Consolidation

 

These consolidated financial statements include the accounts of the Company and its subsidiaries as follows:

 

Entity   Location     Ownership
interest
    Status
Purely Canada Foods Corp.     Canada       100 %   Consolidated subsidiary
Purely Canada Lands Corp.     Canada       100 %   Consolidated subsidiary
Purely Canada Kindersley Ingredients Inc.     Canada       100 %   Consolidated subsidiary
Above Food Brands Inc.     Canada       100 %   Consolidated subsidiary
Wood + Water Food Inc.     Canada       100 %   Consolidated subsidiary
Northern Quinoa Production Corporation (Note 4)     Canada       100 %   Consolidated subsidiary
Farmer Direct Organic Ltd. (Note 4)     Canada       100 %   Consolidated subsidiary
Discovery Seed Labs Ltd. (Note 4)     Canada       100 %   Consolidated subsidiary
Above Food Ingredients Inc.     Canada       100 %   Consolidated subsidiary
Discovery Earth Sciences Inc.     Canada       100 %   Consolidated subsidiary
Above Regenerative Agriculture Corp.     Canada       100 %   Consolidated subsidiary
Above Food USA Corp.     USA       100 %   Consolidated subsidiary
Above Food Ingredients Corp.(USA)     USA       100 %   Consolidated subsidiary
Discovery Regenerative Agriculture Corp. (USA)     USA       100 %   Consolidated subsidiary
Above Merger Sub, Inc.     USA       100 %   Consolidated subsidiary

 

Each of these entities is assessed for consolidation based on its specific facts and circumstances. The Company consolidates all entities that it controls either through a majority voting interest or where it is the primary beneficiary of a VIE. The Company evaluates (1) whether it holds a variable interest in an entity, (2) whether the entity is a VIE, and (3) whether the Company’s involvement would make it the primary beneficiary.

 

For those entities where the Company holds a variable interest, the Company determines whether each of these entities qualifies as a VIE and, if so, whether or not the Company is the primary beneficiary. The assessment of whether the entity is a VIE is generally performed qualitatively, which requires judgment. These judgments include: (a) determining whether the equity investment at risk is sufficient to permit the entity to finance its activities without additional subordinated financial support, (b) evaluating whether the equity holders, as a group, can make decisions that have a significant effect on the economic performance of the entity, (c) determining whether two or more parties’ equity interests should be aggregated, and (d) determining whether the equity investors have proportionate voting rights to their obligations to absorb losses or rights to receive returns from an entity. Significant judgement involves analysis of the risks and rewards the VIE’s operations generate and the nature of the Company’s involvement with and interest in the VIE.

 

F-8


 

For entities that are determined to be VIEs, the Company consolidates those entities where it has concluded it is the primary beneficiary. The primary beneficiary is defined as the variable interest holder with (a) the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and (b) the obligation to absorb losses of the entity or the right to receive benefits from the entity that could potentially be significant to the VIE. In evaluating whether the Company is the primary beneficiary, the Company evaluates its economic interests in the entity held either directly or indirectly by the Company.

 

The Company holds a variable interest in a VIE which are not consolidated as it is determined that the Company is not the primary beneficiary. The Company’s involvement with this entity is in the form of direct equity interests and loan investments. The maximum exposure to loss represents the loss of assets recognized by the Company relating to the non-consolidated VIE. The Company’s maximum exposure to loss relating to the non-consolidated VIE was as follows:

 

    January 31,
2024
    January 31,
2023
 
Investment in affiliate   $ 5,873,574     $ 9,541,713  
Loans receivable     671,500       552,003  
Maximum exposure to loss   $ 6,545,074     $ 10,093,716  

 

Entities that do not qualify as VIEs are generally assessed for consolidation as voting interest entities. Under the voting interest entity model, the Company consolidates those entities it controls through a majority voting interest.

 

All inter-company transactions and balances are eliminated on consolidation.

 

Subsidiaries are included in the consolidated financial statements from the date control commences until the date control ceases.

 

Use of Estimates and Judgement

 

The preparation of financial statements in conformity with U.S. GAAP requires us to make certain estimates, judgments and assumptions that affect the amounts reported in the consolidated financial statements. These estimates, judgments and assumptions are evaluated on an ongoing basis. Management bases our estimates on historical experience and on various other assumptions that management believes are reasonable at that time, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Changes in those estimates could materially impact the consolidated financial statements, and actual results may differ from those estimates. In particular, key estimates, judgements and assumptions include, but are not limited to (i) the valuation of inventories, (ii) fair value of financial instruments, (iii) valuation and impairment of goodwill and other intangible assets, and (iv) fair value of stock options.

 

Cash

 

Cash includes balances in banks and cash on hand. The fair value of cash approximates the carrying amount shown in the consolidated financial statements.

 

F-9


 

Accounts Receivable

 

The Company maintains an allowance for doubtful accounts equal to the expected credit losses on amounts receivable based on its historical collection experience, current conditions and future forecasts. Receivables are written-off and charged against the recorded allowance when the Company has exhausted collection efforts without success. The allowance for expected credit losses is as follows:

 

Balance, January 31, 2023   $ 471,988  
Writeoffs charged against the allowance   $ (471,988 )
Provision for expected credit losses   $ 205,000  
Balance, January 31, 2024   $ 205,000  

 

Loans Receivable

 

The loans receivables are made to an equity investee and carried at amortized cost. When assessing loans receivable for impairment, the Company considers the underlying assets and the income generating ability of the entities to which loans have been advanced. There were no expected credit losses as of January 31, 2024 and January 31, 2023. Interest income on the loans receivable are recognized on an accrual basis.

 

Inventory

 

Inventories of marketable agricultural commodities are stated at fair value because of their interchangeability, immediate marketability at quoted prices, and difficulty in obtaining relevant costs. These agricultural commodity inventories have quoted market prices in active markets, may be sold without significant further processing, and have predictable and insignificant disposal costs. Changes in the fair values of the inventory are recognized in earnings as a component of cost of sales.

 

In addition, the Company values inventories that are not considered to be readily marketable, such as feed and organic grains, using the first-in, first-out (FIFO) method at the lower of cost or net realizable value because of their commodity characteristics as these commodities are not blended, nor do they have basis contracts associated with them. The Company values its consumer-packaged goods inventory at the lower of cost or net realizable value, with cost being determined using the specific lot identification method.

 

Fair Value Measurements

 

The Company determines fair value based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The levels that are established within the hierarchy as it relates to determining fair value are as follows:

 

· Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities.

 

· Level 2: Observable inputs, including Level 1 prices that have been adjusted; quoted prices for similar assets or liabilities; quoted prices in markets that are less active than traded exchanges; and other inputs that are observable or can be substantially corroborated by observable market data.

 

· Level 3: Unobservable inputs that are supported by little or no market activity and that are a significant component of the fair value of the assets or liabilities.

 

In evaluating the significance of fair value inputs, the Company generally classifies assets or liabilities as Level 3 when their fair value is determined using unobservable inputs that, individually or when aggregated with other unobservable inputs, are significant to the fair value of the assets or liabilities. Judgment is required in evaluating both quantitative and qualitative factors in the determination of significance for purposes of fair value level classification. Level 3 amounts can include assets and liabilities whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as assets and liabilities for which the determination of fair value requires significant management judgment or estimation.

 

Based on historical experience with the Company’s suppliers and customers and the Company’s own credit risk and knowledge of current market conditions, the Company used its nonperformance risk as an input to fair value for its forward commodity purchase and sale contracts. The estimation of nonperformance risk results in these fair value estimates being considered a Level 3 measurement.

 

F-10


 

In many cases, a valuation technique used to measure fair value includes inputs from multiple levels of the fair value hierarchy. The lowest level of input that is a significant component of the fair value measurement determines the placement of the entire fair value measurement in the hierarchy. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the classification of fair value assets and liabilities within the fair value hierarchy levels.

 

The Company’s policy regarding the timing of transfers between levels, including both transfers into and transfers out of Level 3, is to measure and record the transfers at the end of the reporting period.

 

Investments

 

The Company applies the equity method of accounting to investments when it has significant influence, but not controlling interest, in an investee. In determining the level of influence over each equity method investment judgement is applied including consideration of key factors such as ownership interest, representation on the board of directors, participation in policy-making decisions, and material intercompany transactions. The Company’s proportionate share of the net income (loss) resulting from these investments is reported under the line item captioned “equity method investment income (loss)” in the consolidated statements of operations and comprehensive loss. The Company’s equity method investment is reported at cost and adjusted each period for the Company’s share of the investee’s income or loss and distributions paid, if any. The Company applies the cost method of accounting to investments when it does not have significant influence or a controlling interest in an investee and the fair value of the investment is not readily determinable.

 

The Company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. Management reviewed the underlying net assets of the investments during the year ended January 31, 2024 and determined that the Company’s proportionate economic interest in the investments indicate that the investments were other than temporarily impaired. The carrying values of the equity method investments are reported as “investments” on the consolidated balance sheets (see Note 6 – Investments).

 

Derivatives

 

Above enters into derivative instruments to manage its exposure to movements associated with agricultural commodity prices and foreign currency exchange rates. Above’s use of these instruments is generally intended to mitigate the exposure to market variables (see Note 14 - Derivative Instruments). Additionally, commodity contracts relating to forward sales of commodities are accounted for as derivatives at fair value under ASC 815 Derivatives and Hedging (see Revenue Recognition below).

 

The Company recognizes all of its derivative instruments as either assets or liabilities at fair value in its consolidated balance sheet and are reported as either foreign exchange forward contract or commodity forward contract assets or liabilities. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and on the type of hedging relationship. None of the Company’s derivatives have been designated as hedging instruments in the periods presented, and as such, changes in fair value of these derivatives are recognized in loss immediately.

 

Warrants

 

The Company accounts for warrants issued in accordance with the guidance in ASC Topic 480 Distinguishing Liabilities from Equity. The warrants are assessed for whether they represent a mandatory redeemable obligation to settle in cash, an obligation to repurchase the shares by transferring assets or an obligation to issue a variable number of shares to settle a fixed monetary amount. Such obligations would be classified as a liability and measured at fair value. Otherwise, warrants are classified as equity, and are measured at fair value on the grant date. The Company determines the fair value of the warrants using the Black-Scholes valuation method. The fair values of the warrants are considered to be a Level 3 fair value measurement due to the use of unobservable inputs.

 

F-11


 

Property, Plant and Equipment

 

Property, plant and equipment, is stated at cost less accumulated depreciation. Significant improvements that extend either the life, capacity, efficiency, or improve the safety of an asset are capitalized, while maintenance and repairs are expensed as incurred. Interest costs on borrowings during construction/completion periods of major capital projects are also capitalized. When the Company acquires a group of assets, the total consideration paid is allocated to the assets acquired utilizing a relative fair value approach.

 

Depreciation is computed based on the straight-line method over the estimated useful lives of the assets. Estimated useful lives for property, plant and equipment are as follows:

 

Asset class   Useful lives
Equipment   3 - 5 years
Buildings   5 – 30 years
Rail   20 years
Railcars   30 years
Hopper bins   10 years

 

Goodwill

 

The Company records goodwill when the purchase price of a business combination exceeds the estimated fair value of identified tangible and intangible assets acquired and liabilities assumed. Goodwill is tested for impairment at the reporting unit level at least annually, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. The Company performs an annual goodwill impairment test as of the end of the fourth quarter on January 31, 2024 and 2023.

 

When testing goodwill for impairment, the Company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If the Company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, additional quantitative testing is required. If additional quantitative testing is required, the reporting unit’s fair value is compared with its carrying amount, and an impairment charge, if any, is recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the amount of goodwill associated with the reporting unit. The Company determines fair values for each of the reporting units using a discounted cash flow model (a form of the income approach) or the market approach. Under the income approach, fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate.

 

Other Intangible Assets

 

Finite-lived intangible assets include brand and trademarks, customer relationships, website development costs, and breeder rights that are amortized on a straight-line basis over their contractual or legal lives, or their estimated useful lives where such lives are not determined by law or contract (see Note 11 - Intangible Assets).

 

Deferred stock issuance costs

 

Deferred stock issuance costs represent amounts paid for legal, consulting, and other offering expenses in conjunction with the raising of additional capital. These costs are initially recorded in other assets and netted against additional paid-in capital upon closing of the respective equity transaction.

 

F-12


 

Leases

 

Accounting Standards Codification Topic 842, Leases, (“ASC 842”) requires lessees to recognize a right-of-use, or ROU, asset and a lease liability on the balance sheet for substantially all leases, except for leases with terms of less than twelve months.

 

Operating lease right-of-use, or ROU, assets and lease liabilities are recognized based on the present value of lease payments over the lease term. As a practical expedient, the Company made an accounting policy election not to separate lease components (e.g. payments for rent) from non-lease components (e.g. common-area maintenance costs) which the Company has applied to all leases. As a result, the Company includes both lease and non-lease components with fixed payments to calculate the right-of-use asset and related lease liability. For both operating and finance leases, the initial ROU asset equals the lease liability, plus initial direct costs, less lease incentives received. The Company’s lease agreements may include options to extend or terminate the lease, which are included in the lease term at the commencement date when it is reasonably certain that the options will be exercised.

 

The Company routinely leases storage facilities, land, and office facilities which are classified as either operating or finance leases. The leases are classified as finance leases if the lease meets any of the following criteria:

 

1. the lease transfers ownership of the underlying asset to the Company by the end of the lease term;

 

2. the lease contains an option to purchase the underlying asset that the Company is reasonably certain to exercise;

 

3. the lease term is for the major part of the remaining economic life of the underlying asset;

 

4. the present value of the sum of the lease payments and any residual value guaranteed by the lessee that is not already reflected in the lease payments equals or exceeds substantially all of the fair value of the underlying asset; or

 

5. the underlying asset is of such a specialized nature that it is expected to have no alternative use to the lessor at the end of the lease term.

 

All other leases are considered operating leases. Operating leases with terms greater than twelve months are included as operating lease ROU assets and the associated lease liabilities within current maturities of operating lease liabilities and operating lease liabilities on the consolidated balance sheets. Finance leases with terms greater than twelve months are included as finance ROU assets and the associated finance lease liabilities within current maturities of finance lease liabilities and finance lease liabilities on the consolidated balance sheets. The Company’s accounting policy deems leases with an initial term of twelve months or less, as short-term leases. The Company recognizes lease expense for short-term lease payments on a straight-line basis over the term of the lease.

 

The accounting for some of the Company’s leases may require significant judgment when determining whether a contract is or contains a lease, the lease term, and the likelihood of exercising renewal or termination options. As of the lease commencement date, the lease liability is initially measured as the present value of lease payments not yet paid. The lease asset is initially measured equal to the lease liability and adjusted for lease payments made at or before lease commencement (e.g., prepaid rent), lease incentives, and any initial direct costs. Over time, the lease liability is reduced for lease payments made and the lease asset is reduced through expense, and classified as Selling, general and administrative expense and Cost of sales depending on the use of the lease. Lease. Lease assets are subject to review for impairment in a manner consistent with property, plant and equipment.

 

The Company’s leases range in length of term. Renewal options are generally exercisable solely at the Company’s discretion. When a renewal option is reasonably certain to be exercised, such additional terms are considered when calculating the associated operating lease asset and liability. When determining the lease liability at commencement of the lease, the present value of lease payments is based on the Company’s incremental borrowing rate as the rate implicit in the lease is generally not readily determinable. The incremental borrowing rate is determined using a portfolio approach and the Company’s incremental cost of debt, adjusted to arrive at the rate in the applicable country and for the applicable term of the lease. See Note 15 for additional information related to the Company’s leases.

 

F-13


 

Income taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates and laws expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals, or material deviation from its position. The Company’s fiscal years ended January 31, 2024 and 2023 remain subject to income tax examinations by major taxing authorities.

 

Impairment of long-lived assets

 

The Company assesses long-lived assets for impairment in accordance with the provisions of ASC 360, Property, Plant and Equipment. Long-lived assets, such as property, plant and equipment, intangible assets with finite useful lives and ROU assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If an impairment indicator occurs, the Company performs a test of the recoverability by comparing the carrying amount of the asset to the undiscounted future cash flows expected to result from the use and eventual disposition of the asset. The amount of impairment loss, if any, is measured as the difference between the carrying value of the asset and its estimated fair value. Fair value is determined through various valuation techniques, including discounted cash flow models, quoted market values, and third-party independent appraisals, as considered necessary. Estimated future cash flows requires significant judgement and projections may vary from actual cash flows eventually realized, which could impact our ability to accurately assess whether an asset has been impaired.

 

Revenue

 

The Company’s revenue comprises sales from commodity contracts that are accounted for under ASC 815, rental revenue that is accounted for under ASC 842, and sales of other products including CPG sales are accounted for under ASC 606, Revenue from Contracts with Customers (“ASC 606”).

 

Commodity contracts

 

Revenue from commodity contracts primarily relates to forward sales of commodities such as grain and pulses accounted for as derivatives at fair value under ASC 815. These forward sales meet the definition of a derivative under ASC 815 as they have an underlying (e.g. the price of canola), a notional amount (e.g. metric tons), no initial net investment, and can be net settled since the commodity is readily convertible to cash. Above does not apply the normal purchase and normal sale exception available under ASC 815 to these contracts.

 

F-14


 

Revenue from commodity contracts is recognized in revenue for the contracted amount when the contracts are settled at a point in time by transferring control of the commodity to the customer. Sales contracts provide for the transfer of control based on the specific shipping terms within each contract. Transfer of control can occur at the time and point of shipment, at a specific transfer point or at the time and point of delivery and acceptance of the product being sold. From inception through settlement, these forward sales arrangements are recorded at fair value under ASC 815 with unrealized gains and losses recognized in Cost of sales and carried on the consolidated balance sheets as current assets or current liabilities, respectively. Further information about the fair value of these contracts is presented in Note 21 - Fair Value Measurements.

 

Rental revenue

 

The Company acts as a lessor when it subleases farmland. When the Company acts as a lessor, it determines at the lease inception whether each lease is a finance lease or an operating lease.

 

The Company’s leases have been classified as operating leases and the lease income is recognized on a straight-line basis over the term of the lease. Each lease is for 10 years with a 5-year option to renew at the option of the lessee.

 

Other Products

 

The Company generates revenue from the sale of consumer products such as pulses, quinoa, and oats to distributors. At inception of the contract with the customer, the Company assesses the goods and services promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a good or service (or bundle of goods or services) that is distinct. To identify the performance obligations, the Company considers all of the goods or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. Generally, the Company’s contracts related to consumer-packaged good sales have a single performance obligation of delivering ordered consumer-packaged goods to its customers.

 

The transaction price is allocated to performance obligations on the basis of the relative standalone selling price of the products. Revenue is measured based on the consideration specified in the contract with a customer. The company may grant certain customers sales incentives, such as rebates or discounts, which are accounted for as variable consideration. Most of such sales incentives are predetermined based on promotion plans known at the time the performance obligation is satisfied and therefore require minimal judgment in estimation of the amount of variable consideration.

 

Payment is generally due at the time of shipment or delivery, or within a specified time frame after shipment or delivery, which is generally 30-60 days. The Company’s contracts generally provide customers the right to reject any products that do not meet agreed quality specifications. Product returns and refunds are not material.

 

Warranties provided to customers are generally accounted for assurance-type warranties and the Company does not provide service-type warranties to customers.

 

The Company recognizes revenue from these contracts at a point in time when it satisfies a performance obligation by transferring control of a product to a customer, generally when legal title and risks and rewards transfer to the customer. The determination of control transfer is based on whether the control is transferred to the customer at the time of shipment or at the time of delivery and acceptance of the product depending on the sales terms agreed upon with the customer. Shipping and handling costs related to the revenue are accounted for as a fulfillment activity and are included within cost of sales.

 

Interest Income

 

Interest income from investments and loans receivable is recognized as it comes due.

 

F-15


 

Cost of Sales

 

Cost of sales primarily include the cost of production, purchase and delivery for raw materials and finished goods inventory, gains and losses on forward contracts, as well as direct salaries, wages and benefits and overhead, and other operational expenses.

 

Selling, General and Administrative (“SG&A”) Expenses

 

SG&A expenses are primarily comprised of selling, marketing expenses and administrative expenses, non-manufacturing rent expense, and other non-production operating expenses. Selling and marketing expenses include advertising costs and costs associated with consumer promotions incurred to acquire new customers, retain existing customers and build brand awareness. Administrative expenses include the expenses related to accounting, legal, IT, and other office functions. Advertising costs are expensed as incurred.

 

Research and Development

 

Research and development costs, which includes enhancements to existing products and new product development, are expensed in the period incurred. Research and development expenses for the years ended January 31, 2024, January 31, 2023, and January 31, 2022 were $171,852, $430,666 and $235,095 respectively.

 

Stock Compensation

 

The Company’s stock compensation plans provide for the granting of restricted stock units, stock options, warrants, and broker warrants. The Company recognizes expense for its stock compensation based on the calculated value of the awards that are granted. The calculated value utilizes the historical volatility of an appropriate industry sector index. The calculated values of stock options and restricted stock units are estimated at the date of grant using the Black-Scholes option valuation model, which requires the input of subjective assumptions including the fair value of underlying shares at grant date, exercise price and assumptions regarding the risk-free interest rate, expected volatility of the underlying common shares based on historical volatility, and expected term as estimated using the simplified method. The Company used the simplified method for all the outstanding stock options because the Company does not have historical exercise data to provide a reasonable basis upon which to estimate the expected term. Measured compensation cost, net of forfeitures, is recognized ratably over the vesting period of the related stock compensation award.

 

The Company classifies stock compensation expense in its consolidated statements of operations and comprehensive loss as SG&A expenses, as this is consistent with the way the award recipients’ payroll costs are classified.

 

Foreign currency transactions and balances

 

Transactions in foreign currencies are initially recorded at their respective functional currency spot rates at the date the transaction first qualifies for recognition. Monetary assets and liabilities denominated in foreign currencies are translated at the functional currency spot rates of exchange at the reporting date. Differences arising on settlement or translation of monetary items are recognized in profit or loss.

 

Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the dates of the initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value is determined. The gain or loss arising on translation of non-monetary items measured at fair value is treated in line with the recognition of the gain or loss on the change in fair value of the item.

 

Foreign operations are translated into Canadian Dollars at the rate of exchange prevailing at the reporting date. The exchange differences arising on translation are recognized in OCI.

 

F-16


 

Operating Segments

 

The Company has two reportable operating segments: Disruptive Agriculture and Rudimentary Ingredients, and Consumer Packaged Goods (“CPG”). The Disruptive Agriculture and Rudimentary Ingredients segment concentrates on the provisioning of discrete genetics, origination, purchasing, grading, primary processing and sale of regeneratively grown grain, as well as the origination, purchase, and sale of bespoke ingredients products, processed primarily through the Company-owned ingredient facilities. The CPG segment formulates, manufactures, sells, distributes, and markets proprietary consumer product formulations in owned brands and focuses on manufacturing and distribution for private-labeled retail owned brands. The Company also has a corporate department that carries out the centralized functions of accounting, treasury, information technology, legal, and human resources. Given that this department does not undertake business activities and does not recognize revenue that are more than incidental to the Company’s activities, it is not considered to be a separate operating segment.

 

The Company determines the composition of the reportable segments based on factors including risks and returns, internal organization, and internal reports and allocates certain expenses across segments based on reasonable considerations such as production capacities.

 

The Company’s Chief Operating Decision Maker (“CODM”) uses net loss to measure performance and allocate resources to the operating segments. The CODM considers net loss to be a meaningful measure as it encompasses the entirety of business activities.

 

Loss Per Share

 

The Company complies with accounting and disclosure requirements of ASC Topic 260, Earnings Per Share, (“ASC 260”). The Company has issued one class of common shares, which are referred to as Class A ordinary shares. Loss per share is calculated by dividing the net income by the weighted average ordinary shares outstanding for the applicable period. Diluted loss per share excludes the effects of all outstanding potentially dilutive securities, that have anti-dilutive effects.

 

Business Combinations

 

The Company applies the provisions of ASC Topic 805, Business Combinations (“ASC 805”), in the accounting for acquisitions. The Company accounts for acquisitions using the acquisition method. The Company allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill and allocated to reporting units based on the expected benefit from the business combination. Allocation of purchase consideration to identifiable assets and liabilities affects the depreciation and amortization expense, as acquired finite-lived intangible assets are amortized over the useful life, whereas any indefinite-lived intangible assets, including goodwill, are not amortized. During the measurement period, which is not to exceed one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill as more information is received regarding the acquired assets and assumed liabilities. Upon the conclusion of the measurement period, any subsequent adjustments are recorded to earnings. Acquisition-related expenses are recognized separately from business combinations and are expensed as incurred.

 

The Company includes the operating results of each acquired business in the consolidated financial statements from the date of acquisition.

 

Credit Risk

 

The risk of financial loss in the event of failure of a customer or counterparty to a financial instrument to meet its contractual obligation is defined as credit risk. The Company’s principal exposure to credit risk is in respect to its accounts receivable and commodity forward contracts receivable. A substantial portion of the Company’s accounts receivable is with customers in the agriculture industry and is subject to normal industry credit risks. A portion of the Company’s sales and related accounts receivable are also generated from transactions with customers in overseas markets.

 

F-17


 

Accounts receivable are subject to credit risk exposure and the carrying values reflect management’s assessment of the associated maximum exposure to such credit risk. The Company regularly monitors customers for changes in credit risk. The Company’s credit exposure is mitigated through the use of credit practices that limit transactions according to the customer’s credit quality and due to the accounts receivable being spread over a large number of customers. Trade receivables from international customers are insured for events of non-payment through third-party export insurance to mitigate against credit risk. In cases where the credit quality of a customer does not meet the Company’s requirements, a cash deposit or letter of credit is received before goods are shipped.

 

During the years ended January 31, 2024 and January 31, 2023 there were no customers that represented more than 10% of revenue. The Company does not believe that any single customer group represents a significant concentration of credit risk.

 

Currency Risk

 

The Company is exposed to currency risk as a certain portion of sales and expenses are incurred in US dollars resulting in US denominated accounts receivable, accounts payable and some of the commodity derivatives and long-term debt. These balances are, therefore, subject to gains and losses due to fluctuations in that currency in relation to the Canadian dollar.

 

The Company entered into foreign exchange derivative contracts to mitigate these risks. This strategy attempts to minimize the impact of US dollar fluctuations on the operating results of the Company. The Company’s derivative instruments have not been designated as hedging instruments and gain/losses are recorded within cost of sales in the consolidated statements of operations and comprehensive loss.

 

Interest rate risk

 

Changes in the future cash flows of financial instruments and the possibility the Company will be unable to refinance existing debt with similar terms represents interest rate risk. The Company’s principal exposure to interest rate risk is with respect to its short-term debt and credit facilities, long-term debt and lease liability, which bear interest at fixed and floating interest rates.

 

A 1% increase in interest rates relating to the bank indebtedness and long-term debt of the Company would increase interest expense for the year ended January 31, 2024 by approximately $961,890 (January 31, 2023 - $1,735,750). Exposure to interest rate risk is managed through normal operating and financing activities.

 

Commodity Price Risk

 

Commodity price risk is the risk that the value of inventory and related contracts will fluctuate due to changes in market prices. A change in price will have a direct affect on the value of inventory. As a grain and pulse commodity trading company, the Company has significant exposure to changes in various agricultural commodity prices. Prices for these commodities are volatile and are influenced by numerous factors beyond the Company’s control, such as supply and demand fundamentals, as well as the weather. A substantial change in prices may affect the Company’s comprehensive income and operating cash flows, if not properly managed.

 

To mitigate the risks associated with the fluctuations in the market price for agricultural commodities, the Company has a policy that grains be managed, when possible, through the use of purchase and sales contracts. The Company may employ derivative commodity instruments (primarily futures and options) for the purpose of managing its exposure to commodity price risk. The Company’s actual exposure to these price risks is constantly changing as the Company’s inventories and commodity contracts change. The fair value of derivative contracts outstanding at January 31, 2024, resulted in the recognition of a commodity futures contract asset of $15,187,459 (January 31, 2023 – $14,030,350), a foreign exchange forward contract asset of $359,973 (January 31, 2023 – $542,862), a foreign exchange forward contract liability of $1,346,133 (January 31, 2023 – $3,124,828), as well as a commodity forward contract liability of $3,250,260 (January 31, 2023 – $977,331).

 

F-18


 

Liquidity risk

 

Liquidity risk is the risk that the Company cannot meet its financial obligations associated with financial liabilities in full. The Company’s main sources of liquidity are its operations, its credit facility and other debt financing. The funds are primarily used to finance working capital and capital expenditure requirements and are adequate to meet the Company’s financial obligations associated with financial liabilities. Risk associated with debt financing is mitigated by having negotiating terms over several years and renegotiating terms before they are due.

 

3. Recent Accounting Pronouncements

 

Accounting pronouncements issued and adopted

 

On February 1, 2023, the Company adopted Accounting Standards Update (“ASU”) 2016-13, Financial Instruments-Credit Losses (Topic 326), which introduces a new accounting model, referred to as the current expected credit losses (“CECL”) model, for estimating credit losses on certain financial instruments and expands the disclosure requirements for estimating such credit losses. Under the new model, an entity is required to estimate the credit losses expected over the life of an exposure (or pool of exposures). The guidance also amends the current impairment model for debt securities classified as available-for-sale securities.

 

The Company has identified the following types of financial assets that are within the scope of ASU 2016-13:

 

· Accounts receivable

 

· Loan receivable

 

The adoption of ASU 2016-13 did not have a material impact on our consolidated financial statement presentation or disclosures.

 

Accounting pronouncements issued but not yet adopted

 

ASU 2021-08, Business Combinations

 

In October 2021, the Financial Accounting Standards Board (“FASB”) issued ASU 2021-08 – Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (“ASU 2021-08”). Under current accounting standards, contract assets and contract liabilities acquired in a business combination are to be recorded at fair value using the ASC 805 measurement principle. ASU 2021-08 requires the acquirer to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606: Revenue from Contracts with Customers as if the acquirer had originated the contracts rather than at fair value. ASU 2021-08 is effective for Emerging Growth Companies (“EGCs”) in fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.

 

ASU 2020-06, Convertible Debt

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, “Debt –Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging –Contracts in Entity’s Own Equity (Subtopic 815 –40)”(“ASU 2020-06”). ASU 2020-06, which simplifies the guidance on accounting for convertible debt instruments by removing the separation models for (1) convertible debt with a cash conversion feature and (2) convertible instruments with a beneficial conversion feature. ASU 2020-06 is effective for Emerging Growth Companies (“EGCs”) in fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.

 

F-19


 

ASU 2023-09, Improvements to Income tax disclosures (Topic 740)

 

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). The standard requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The new requirements apply to all entities subject to income taxes and will be effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively and early adoption is permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

ASU 2023-07, Segment Reporting – Improvements to Reportable Segment Disclosures (Topic 280)

 

In November 2023, the FASB issued ASU 2023-07, Segment Reporting—Improvements to Reportable Segment Disclosures (Topic 280). The standard requires incremental disclosures related to reportable segments, including disaggregated expense information and the title and position of the company’s chief operating decision maker (“CODM”), as identified for purposes of segment determination. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Entities must adopt the changes to the segment reporting guidance on a retrospective basis. Early adoption is permitted. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

4. Acquisitions and dispositions

 

Business combinations

 

Wood & Water Foods Inc.

 

On July 13, 2021, the Company obtained control of Wood & Water Foods Inc., operating as Culcherd, a dairy alternative company (see Note 2). The consideration payable of $3,250,000 (which was reduced by a working capital adjustment of $16,590) was payable in shares of the Company, the number of which was based on the value of the Company at the time of issuance and subject to further adjustment if they were released as a result of a going public transaction. Taking into account the probability of a going public transaction, the share restrictions, and the working capital adjustment, the fair value on the acquisition date of the consideration was determined to be $2,901,494 on acquisition and revalued to be $2,753,761 as at January 31, 2022, with a resulting gain on revaluation of $147,733 recorded in consolidated statements of operations and comprehensive loss for the year ended January 31, 2022.

 

On April 13, 2022, the Company issued 1,616,705 voting common shares to settle the consideration liability, and the total consideration paid on that date reclassified to additional paid-in capital.

 

Effective July 13, 2021, results from Culcherd’s operations have been included in the consolidated statements of operations and comprehensive loss. For the year ended January 31, 2022, $111,887 of revenue and $65,139 of net loss were included in the consolidated statements of operations and comprehensive loss. In conjunction with the acquisition, the Company incurred $30,003 and $2,066 of acquisition-related costs, including advisory, legal, accounting, valuation and other professional and consulting fees, which were recorded in selling, general, and administrative expenses in the consolidated statements of operations and comprehensive loss for the years ended January 31, 2022 and 2023, respectively. Goodwill in the acquisition is recorded in the Culcherd reporting unit (part of the CPG reporting segment) and was attributable to the assembled workforce and the expected benefits of the synergies of the Company’s scale and vertically integrated strategy and the supply chain of customer-facing dairy free products. No goodwill is deductible for tax purposes. During the year ended January 31, 2023, the goodwill in Culcherd reporting unit was fully impaired.

 

F-20


 

On a pro forma basis, if the Company had consolidated Wood & Water Foods Inc. starting February 1, 2021, the revenue and earnings of the combined entity would be as follows for the year ended January 31, 2022:

 

    Year ended January 31, 2022  
    Wood &
Water Foods
Inc. historical
(unaudited)
    Combined entity
pro forma
(unaudited)
 
Revenue   $ 172,134     $ 198,917,960  
Net loss     (142,363 )     (5,854,462 )

 

The supplemental pro forma earnings for the combined entity were adjusted for depreciation and amortization of differences between the historical carrying value and the estimated fair value of tangible and intangible assets and the related deferred tax recovery on the differences.

 

Northern Quinoa Production Corporation

 

On May 18, 2022 the Company entered into a contract (“the Purchase Agreement”) to acquire 100% of the issued and outstanding common shares of Northern Quinoa Production Corporation (“NorQuin”), for $3,163,610 (“Purchase Price”). The acquisition of control was considered to be a business combination and accounted for using the acquisition method. The Company paid the Purchase Price by issuing 1,565,595 voting common shares with an estimated value of $2,672,790 and 682,061 warrants with a total estimated fair value of $490,820. In determining the fair value of the Purchase Price, the Company considered the restrictions that were imposed on the shares and warrants.

 

NorQuin’s acquisition is aligned with the Company’s approach to becoming a distinguished vertically integrated plant-based food company.

 

The aggregate consideration of this acquisition has been allocated to the fair values of the acquired assets and assumed liabilities as follows:

 

Working capital   $ 826,146  
Property, plant, and equipment     5,927,331  
Intangible assets other than goodwill     725,000  
Long-term liabilities     (3,768,857 )
Lease liability     (546,010 )
Net assets acquired and aggregate consideration   $ 3,163,610  

 

The following table sets forth the fair values and the useful lives of the intangible assets acquired:

 

    Useful lives      
Brand and trademark   10 Years   $ 275,000  
Plant breeders’ rights   5 Years     450,000  
Total intangible assets acquired       $ 725,000  

 

Effective May 15, 2022, results from NorQuin’s operations have been included in the consolidated statements of operations and comprehensive loss. For the year ended January 31, 2023, $3,946,676 of revenue and $2,032,983 of net loss were included in the consolidated statements of operations and comprehensive loss. In conjunction with the acquisition, the Company incurred $47,726 of acquisition-related costs which were recorded in selling, general, and administrative expenses in the consolidated statements of operations and comprehensive loss for the year ended January 31, 2023.

 

F-21


 

Farmer Direct Organic Ltd.

 

On June 3, 2022 the Company acquired 100% of the issued and outstanding common shares of Farmer Direct Organic Foods Ltd. (“FDO”), a supplier of Regenerative Organic CertifiedTM grains, in exchange for 1,065,304 voting common shares of the Company. Of these shares, 432,780 were placed in escrow pending meeting certain milestones based on a combination of revenue and EBITDA as defined within the contract. As of the date of acquisition, management has estimated that revenue and EBITDA milestones will not be achieved, and as a result, no value has been assigned to the 432,780 shares. The shares will be cancelled at each milestone date that the related milestones are not met. The acquisition of control was considered to be a business combination and accounted for using the acquisition method. In determining the fair value of the purchase price, the Company considered the restrictions that were imposed on the shares and warrants.

 

The acquisition of FDO complements the Company’s preexisting brand strategy. Goodwill in the acquisition is recorded in the FDO reporting unit and attributable to the expected benefits from the synergies of gaining increased control over the supply chain of the Company’s organic plant protein and ancient grain product portfolios. No goodwill is deductible for tax purposes. During the year ended January 31, 2023, the goodwill in the FDO reporting unit was fully impaired. In addition, during the year ended January 31, 2023, the intangible asset relating to customer relationships was impaired by $854,377, while the intangible asset relating to brand and trademarks was impaired by $197,150.

 

The aggregate consideration of this acquisition has been allocated to the fair values of the acquired assets and assumed liabilities as follows:

 

    FDO  
Working capital   $ 1,251,916  
Property, plant, and equipment     235,122  
Intangible assets other than goodwill     2,782,000  
Long-term liabilities     (190,862 )
Goodwill     1,526,171  
Net assets acquired and aggregate consideration   $ 5,604,347  

 

Consideration paid   FDO  
Common shares issued     1,057,819  
Accounts payable settled by the Company     418,761  
Loan receivable due from FDO     4,127,767  
Aggregate consideration   $ 5,604,347  

 

The following table sets forth the fair values and the useful lives of the intangible assets acquired:

 

    Useful lives   FDO  
Customer relationships   5 Years   $ 2,280,000  
Brand and trademark   10 Years     502,000  
Total intangible assets acquired       $ 2,782,000  

 

Effective June 3, 2022, results from FDO’s operations have been included in the consolidated statements of operations and comprehensive loss. For the year ended January 31, 2023, $1,660,286 of revenue and $3,579,613 of net loss were included in the consolidated statements of operations and comprehensive loss. In conjunction with the acquisition, the Company incurred $114,251 and $17,123 of acquisition-related costs which were recorded in selling, general, and administrative expenses in the consolidated statements of operations and comprehensive loss for the year ended January 31, 2022 and 2023 respectively.

 

F-22


 

On a pro forma basis, if the Company had consolidated FDO and NorQuin starting February 1, 2021, the revenue and earnings of the combined entity would be as follows for the year ended January 31, 2023 and January 31, 2022:

 

    Year ended January 31, 2023     Year ended January 31, 2022  
    FDO/NQ
historical
(unaudited)
    Combined
entity pro
forma
(unaudited)
    FDO/NQ
historical
(unaudited)
    Combined
entity pro
forma
(unaudited)
 
Revenue   $ 10,297,487     $ 401,155,029     $ 19,096,376     $ 217,954,089  
Net income (loss)     (9,214,998 )     (49,086,932 )     (7,399,846 )     (13,177,084 )

 

The supplemental pro forma earnings for the combined entity were adjusted for depreciation and amortization of differences between the historical carrying value and the estimated fair value of tangible and intangible assets.

 

Discovery Seed Labs Ltd.

 

On March 23, 2023 the Company entered into a contract (“the Purchase Agreement”) to acquire 100% of the issued and outstanding common shares of Discovery Seed Labs Ltd. (“Discovery”), for $3,213,563 (“Purchase Price”). The acquisition of control was considered to be a business combination and accounted for using the acquisition method. The Company paid the Purchase Price via a cash payment of $2,000,000 and issuing 502,088 voting common shares with an estimated value of $1,213,563. In determining the fair value of the Purchase Price, the Company considered the restrictions that were imposed on the shares.

 

Discovery’s acquisition is aligned with the Company’s approach to becoming a vertically integrated plant-based food company.

 

The aggregate consideration of this acquisition has been allocated to the fair values of the acquired assets and assumed liabilities as follows:

 

    Discovery  
Working capital   $ 545,891  
Property, plant, and equipment     93,852  
Intangible assets other than goodwill     549,719  
Deferred tax liability     (247,073 )
Goodwill     2,271,174  
Net assets acquired and aggregate consideration   $ 3,213,563  

 

The following table sets forth the fair values and the useful lives of the intangible assets other than goodwill acquired:

 

    Useful lives   Discovery  
Customer relationships   5 Years   $ 315,407  
Brand   10 Years     56,452  
Favourable lease terms   4 Years     134,567  
Other intangibles   3 Years     43,293  
Total intangible assets acquired       $ 549,719  

 

Effective March 23, 2023, results from Discovery’s operations have been included in the consolidated statements of operations and comprehensive loss. For the year ended January 31, 2024, $1,007,795 of revenue and $1,420,704 of net loss were included in the consolidated statements of operations and comprehensive loss. In conjunction with the acquisition, the Company incurred $35,949 of acquisition-related costs which were recorded in selling, general, and administrative expenses in the consolidated statements of operations and comprehensive loss for the year ended January 31, 2024. Additionally, on January 31, 2024 the Company conducted goodwill impairment testing, and subsequently recognized goodwill impairment of $1,400,000 relating to Discovery in the year ended January 31, 2024.

 

F-23


 

On a pro forma basis, if the Company had consolidated Discovery starting February 1, 2022, the revenue and earnings of the combined entity would be as follows for the years ended January 31, 2024 and 2023:

 

    Year ended January 31, 2024     Year ended January 31, 2023  
    Discovery
historical
(unaudited)
    Combined
entity pro
forma (unaudited)
    Discovery
historical
(unaudited)
    Combined
entity pro
forma
(unaudited)
 
Revenue   $ 1,313,721     $ 368,729,324     $ 1,286,884     $ 397,751,388  
Net income (loss)     (1,197,159 )     (53,539,952 )     (82,602 )     (45,567,132 )

 

The supplemental pro forma earnings for the combined entity were adjusted for depreciation and amortization of differences between the historical carrying value and the estimated fair value of tangible and intangible assets.

 

5. Inventory

 

    January 31,
2024
    January 31,
2023
 
Commodity inventories carried at fair value   $ 22,648,381     $ 36,522,144  
Commodity inventories carried at cost     1,936,101       4,851,694  
Finished goods carried at cost     1,424,956       6,545,753  
Inventory   $ 26,009,438     $ 47,919,591  

 

6. Investment in affiliate

 

    January 31, 2024     January 31, 2023  
    Membership
interest
    Carrying
amount
    Membership
interest
    Carrying
amount
 
Equity method investment in Atlantic Natural Foods LLC     33.06 %     5,873,574       33.06 %   $ 9,541,713  

 

Atlantic Natural Foods, LLC (“ANF”) produces various branded foods under its proprietary labels. Effective September 7, 2021, Above entered into a Membership Interest Purchase and Option Agreement (“Agreement”) with ANF’s majority owner, ANF Holdco LLC, to acquire all membership interests of ANF in four separate tranches. The Company accounts for its interest in ANF using the equity method of accounting as ANF is an LLC which maintains specific ownership accounts for each investor.

 

As part of the first tranche, on September 7, 2021, Above purchased 51.86 units of ANF representing 5.0% of the membership interests, for CAD $1,500,566 (USD $1,185,000). On December 31, 2021, under the second tranche, Above increased its membership interests of ANF to 13.40% by purchasing 87.54 units representing 8.4% membership interests, for CAD $2,550,479 (USD $2,000,000).

 

On January 20, 2023, under the third tranche, Above increased its membership interests of ANF to 33.06% by purchasing 203.53 units representing 19.66% membership interests, for CAD $6,255,400 ($USD $4,650,000).

 

No amounts have been paid to date of these financial statements to purchase the remaining 66.94% of ANF under the fourth tranche.

 

The Company’s current ownership interest of ANF as well as future purchases of ANF have been pledged as security to Lexington Capital (see Note 13).

 

The approximate CAD $9.4 million (USD $7 million) difference in value between the consideration paid to acquire ANF and the Company’s share of underlying carrying value of the net assets of ANF relates to incremental fair market value of inventory which is recorded as the inventory is sold, identifiable intangible assets (customer relationships and brand) with definite lives amortized over the related assets’ remaining useful lives, and equity method goodwill that is not amortized.

 

F-24


  

During the year ended January 31, 2024, Above recognized an equity method investment loss of $3,787,927 (2023 – loss of $812,669) attributable to its investment in ANF. During Q4 of the year ended January 31, 2024, the Company identified potential indicators of other than temporary impairment in the investment in ANF, as revenue and EBITDA targets used in formulating the fair values at acquisition were not being met. As such, the Company determined the fair values based on management’s estimate of ANF’s enterprise value. This resulted in the recognition of impairment of $3,349,250 relating to the investment in ANF, which is presented within the equity method investment loss and impairment.

 

The Company did not receive distributions from ANF during the years ended January 31, 2024 and 2023.

 

The changes in the carrying value of investments in affiliates during the years ended January 31, 2024 and 2023 are as follows:

 

Balance, January 31, 2022   $ 4,051,045  
Acquisition     6,255,400  
Equity method loss     (812,669 )
Foreign currency translation adjustment, net of tax     47,937  
Balance, January 31, 2023   $ 9,541,713  
Equity method loss     (438,677 )
Foreign currency translation adjustment, net of tax     119,788  
Impairment     (3,349,250 )
Balance, January 31, 2024   $ 5,873,574  

 

7. Other current assets

 

    January 31,
2024
    January 31,
2023
 
Prepaid expenses   $ 1,227,012     $ 1,967,126  
Note receivable due from Sonic Milling Systems Ltd., at an interest rate of prime rate + 2%, repayable by January 15, 2024     -       1,491,579  
    $ 1,227,012     $ 3,458,705  

 

8. Other non-current assets

 

    January 31,
2024
    January 31,
2023
 
Deferred stock issuance costs   $ 675,717     $ 946,087  
Deposits     35,287       109,606  
    $ 711,004     $ 1,055,693  

 

9. Loans receivable

 

    January 31,
2024
    January 31,
2023
 
Loan receivable due from Atlantic Natural Foods, LLC., bearing simple interest at a rate of 7% per annum, payable monthly   $ 671,500     $ 552,003  

  

10. Property, plant and equipment

 

The following table outlines the cost and accumulated depreciation of property, plant and equipment as at January 31, 2024:

 

    Cost     Accumulated
Depreciation
    Net book value  
Equipment   $ 11,249,698     $ 2,093,584     $ 9,156,114  
Buildings     16,498,489       1,469,565       15,028,925  
Railcar     1,199,416       118,821       1,080,594  
Rail     2,021,489       190,552       1,830,937  
Hopper Bins     62,508       4,750       57,758  
Land     95,000       -       95,000  
Total   $ 31,126,600     $ 3,877,272     $ 27,249,328  

 

F-25


  

The following table outlines the cost and accumulated depreciation of property, plant and equipment as at January 31, 2023:

 

    Cost     Accumulated
Depreciation
    Net book value  
Equipment   $ 8,181,177     $ 796,312     $ 7,384,865  
Vehicles     492,342       114,638       377,704  
Buildings     16,014,315       865,423       15,148,892  
Railcar     1,207,574       69,874       1,137,700  
Rail     2,014,000       123,078       1,890,922  
Hopper Bins     361,876       19,059       342,817  
Land     95,000       -       95,000  
Total   $ 28,366,284     $ 1,988,384     $ 26,377,900  

 

The Company recognized depreciation expense of $1,989,674 during the year ended January 31, 2024 (January 31, 2023 - $1,415,744, January 31, 2022 – $471,377).

 

11. Goodwill and intangible assets

 

Goodwill relates to the Discovery reporting unit. The changes in the carrying amount of goodwill during the period ended January 31, 2024 as follows:

 

    Gross     Accumulated
impairment losses
    Net book value  
Balance, January 31, 2022   $ 2,537,303     $ -     $ 2,537,303  
Acquisition (Note 4)     1,526,171       -       1,526,171  
Impairment loss (Culcherd)     -       (2,537,303 )     (2,537,303 )
Impairment loss (FDO)     -       (1,526,171 )     (1,526,171 )
Balance, January 31, 2023     4,063,474       (4,063,474 )     -  
Acquisition (Note 4)     2,271,174       -       2,271,174  
Impairment loss (Discovery)     -       (1,400,000 )     (1,400,000 )
Balance, January 31, 2024   $ 6,334,648     $ (5,463,474 )   $ 871,174  

 

The goodwill impairment loss is recorded for the amount by which the carrying value of the reporting unit exceeds the fair value of the reporting unit and is presented as Impairment of goodwill and other intangible assets in the Consolidated Statements of Operations and Comprehensive Loss.

 

During the year ended January 31, 2023, the Company identified that the Culcherd and FDO reporting units’ cash flows were below budget, and as part of its goodwill impairment test for the quarter ended October 31, 2022, recorded goodwill impairment of $4,063,474. The Company determined fair values for both the Culcherd and FDO reporting units using an income approach, whereby fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate.

 

During the year ended January 31, 2024, the Company identified that the Discovery reporting unit’s cash flows were below budget, and as part of its annual goodwill impairment test, recorded goodwill impairment of $1,400,000. The Company determined fair values for the Discovery reporting unit using an income approach, whereby fair value is determined based on the present value of estimated future cash flows, discounted at an appropriate risk-adjusted rate.

 

F-26


 

 

The following table sets forth the intangible assets other than goodwill:

 

    Website development     Customer relationships     Brand and trademarks     Breeder rights     Favourable lease terms     Non-compete Agreement     Total  
Useful Life (years)     5       5       10       5       4       3          
Cost:                                                        
Balance, January 31, 2021   $ -     $ -     $ -     $ -     $ -     $ -     $ -  
Acquisitions (Note 4)     -       72,000       391,000               -       -       463,000  
Additions     139,507       -       -       -       -       -       139,507  
Balance, January 31, 2022   $ 139,507     $ 72,000     $ 391,000     $ -     $ -     $ -     $ 602,507  
Acquisitions (Note 4)     -       2,280,000       777,000       450,000       -       -       3,507,000  
Additions     285,413       2,015,385       23,632       -       -       -       2,324,430  
Balance, January 31, 2023     424,920       4,367,385       1,191,632       450,000       -       -       6,433,937  
Acquisitions (Note 4)     -       315,407       56,452       -     $ 134,567     $ 43,293       549,719  
Additions     33,121       -       27,375       -       -       -       60,496  
Balance, January 31, 2024   $ 458,041     $ 4,682,792     $ 1,275,459     $ 450,000     $ 134,567     $ 43,293     $ 7,044,152  
Accumulated amortization and impairment loss:                                                        
Balance, January 31, 2021   $ -     $ -     $ -     $ -     $ -     $ -     $ -  
Amortization     13,690       7,200       19,550       -       -       -       40,440  
Balance, January 31, 2022   $ 13,690     $ 7,200     $ 19,550     $ -     $ -     $ -     $ 40,440  
Amortization     54,027       414,136       93,978       90,369       -       -       652,510  
Impairment     -       2,605,497       197,150       -       -       -       2,802,647  
Balance, January 31, 2023     67,717       3,026,833       310,678       90,369                       3,495,597  
Amortization     83,199       385,895       94,563       90,001       28,035       12,036       693,729  
Impairment     63,580       39,570       303,187       -       -       -       406,337  
Balance, January 31, 2024   $ 214,496     $ 3,452,298     $ 708,428     $ 180,370     $ 28,035     $ 12,036     $ 4,595,663  
Carrying amounts:                                                        
Balance, January 31, 2022   $ 125,817     $ 64,800     $ 371,450     $ -     $ -     $ -     $ 562,067  
Balance, January 31, 2023   $ 357,203     $ 1,340,552     $ 880,954     $ 359,631     $ -     $ -     $ 2,938,340  
Balance, January 31, 2024   $ 243,545     $ 1,230,494     $ 567,031     $ 269,630     $ 106,532     $ 31,257     $ 2,448,489  

  

The estimated future aggregate amortization expense over the next five years ended January 31, is as follows:

 

    $  
2025     663,863  
2026     663,863  
2027     650,848  
2028     164,402  
2029     80,196  

 

12. Short-term debt and credit facilities

 

The Company’s short-term borrowings are typically sourced from various banking institutions. The weighted-average interest rates on short-term borrowings at January 31, 2024, and January 31, 2023, were 7.25% and 6.95% respectively.

 

    January 31,
2024
    January 31,
2023
 
Revolving credit loan   $ 36,000,000     $ 47,500,000  

 

The Company holds a revolving credit loan, via Purely Canada Food Corp. (“PCFC”), with the Royal Bank of Canada (“RBC”) with a limit of $36,000,000 (January 31, 2023 - $50,000,000) and a term that matures July 31, 2024. Subsequent to January 31, 2024 the limit has been reduced to $35,000,000. The interest rate on the loan is Royal Bank Prime rate plus 0.25% (January 31, 2023 – 0.25%) per annum and secured by inventory and accounts receivable. This revolving credit loan is secured by the present and future assets of PCFC, Purely Canada Kindersley Inc. (“PCKI”) and Purely Canada Land Corp. (“PCLC”), with RBC having priority over inventory and accounts receivables, with secondary priority over other assets.

 

The borrowing base is a certain percentage of sales accounts and inventory of the Company, minus a percentage of accounts payable reserves.

 

In accordance with the debt agreement with RBC, the Company must maintain a) fixed charge coverage ratio of 1.1:1.0 or greater, and b) a tangible net worth equal or greater than $11,000,000, both of which are tested monthly. The Company has violated this covenant (as well as the requirement to provide audited financial statements by the required deadline) and therefore the debt is presented as short-term.

 

F-27


  

At January 31, 2024, the prime rate was 7.20% (January 31, 2023 – 6.70%). The bank indebtedness balances reflected on the balance sheet includes overdrawn chequing accounts of $12,304,272 (January 31, 2023 - $5,745,489).

 

13. Long-term debt

 

    January 31, 2024     January 31, 2023  
    Book value     Fair value
Level 2
    Book value     Fair value
Level 2
 
Loan payable to Battle River Railway NGC Inc., with interest at the ATB Financial prime rate plus 0.20%, repayable in thirty-six equal monthly instalments commencing July 2, 2021   $ 333,334     $ 333,334     $ 1,000,000     $ 1,000,000  
                                 
Loan payable to Business Development Bank of Canada (BDC) with interest at 7.18%, repayable in sixty equal monthly instalments commencing January 10, 2021 and matures December 10, 2025.     23,000       22,269       35,000       33,687  
                                 
Loan payable to Bank of Montreal pursuant to the Canada Emergency Business Account (CEBA) program, with no interest and matured December 31, 2023. The Company is in default of the repayment terms as the loan was not repaid by December 31, 2023.     40,000       40,000       70,000       65,432  
                                 
Demand note payable to Ingredion Inc. with interest at 5%, maturing at the date of Above’s business combination with Bite (Note 1)     3,988,319       3,988,319       3,911,464       3,907,909  
                                 
Government contribution through the Business Scale-up and Productivity (BSP) program, with no interest and repayable in sixty equal monthly instalments commencing April 1, 2023     230,400       184,753       276,480       224,630  
                                 
Banker’s Acceptance from Bank of Nova Scotia (“BNS”), with interest at the prevailing rate plus 1.75%, maturing on June 13, 2024. The Company must maintain a) fixed charge coverage ratio of 1.1:1.0 or greater, and b) a tangible net worth equal or greater than $11,000,000, both of which are tested monthly. This loan is secured by the present and future assets of PCFC, PCKI and PCLC, with BNS having priority over all assets except for inventory and accounts receivable, for which BNS has secondary priority after RBC. The Company is in violation of these covenants (as well as the requirement to provide audited financial statements by the required deadline).     9,910,000       9,910,000       10,698,000       10,679,118  
                                 
Convertible subordinated loan payable to Lexington Capital, denominated in US Dollars, with interest of 10% (if paid in cash) or 18% (if paid in shares), secured by the Company’s interest in ANF (see Note 6). Principal and interest maturing and payable at the earlier of the consummation of the Business Combination or 1 year from the initial advance of the loan (January 3, 2024), subsequently extended to June 30, 2024. As a result of the covenant violations under the lending agreements with RBC and BNS, the Company is in default of the terms of this agreement as well (as well as the requirement to provide audited financial statements by the required deadline).     3,838,709       3,838,709       2,607,304       2,607,304  

 

F-28


 

    January 31, 2024     January 31, 2023  
    Book value     Fair value
Level 2
    Book value     Fair value
Level 2
 
Convertible subordinated loan payable to Grupo Vida Canada, denominated in US Dollars, with interest of 18% in shares (or in cash if the Business Combination is not consummated 1 year from the initial advance of the loan). Principal and interest maturing and payable at the earlier of the consummation of the Business Combination or 1 year from the initial advance of the loan (January 27, 2024), subsequently extended to July 31, 2024. As a result of the covenant violations under the lending agreements with RBC and BNS, the Company is in default of the terms of this agreement as well (as well as the requirement to provide audited financial statements by the required deadline).     6,370,063       6,370,063       5,238,495       5,238,495  
                                 
Convertible subordinated loan payable to SmartDine LLC, denominated in US Dollars, with interest of 18% in shares (or in cash if the Business Combination is not consummated 1 year from the initial advance of the loan). Principal and interest maturing and payable at the earlier of the consummation of the Business Combination or 1 year from the initial advance of the loan (May 3, 2024), subsequently extended to July 31, 2024. As a result of the covenant violations under the lending agreements with RBC and BNS, the Company is in default of the terms of this agreement (as well as the requirement to provide audited financial statements by the required deadline).     3,485,406       3,485,406       -       -  
                                 
Convertible subordinated loan payable to Orionsea Enterprises, denominated in US Dollars, with interest of 18% in shares (or in cash if the Business Combination is not consummated 1 year from the initial advance of the loan). Principal and interest maturing and payable at the earlier of the consummation of the Business Combination or 1 year from the initial advance of the loan (June 30, 2024). As a result of the covenant violations under the lending agreements with RBC and BNS, the Company is in default of the terms of this agreement as well (as well as the requirement to provide audited financial statements by the required deadline).     743,076       743,706       -       -  

 

F-29


 

    January 31, 2024     January 31, 2023  
    Book value     Fair value
Level 2
    Book value     Fair value
Level 2
 
Banker’s Acceptance from Bank of Nova Scotia (“BNS”), with interest at the prevailing rate plus 1.75%, maturing on June 17, 2024. The Company must maintain a) fixed charge coverage ratio of 1.1:1.0 or greater, and b) a tangible net worth equal or greater than $11,000,000, both of which are tested monthly. This loan is secured by the present and future assets of PCFC, PCKI and PCLC, with BNS having priority over all assets except for inventory and accounts receivable, for which BNS has secondary priority after RBC. The Company is in violation of these covenants (as well as the requirement to provide audited financial statements by the required deadline)     2,007,000       2,007,000       -       -  
                                 
Total long-term debt, including current portion     30,969,307               23,836,743          
Less current portion     30,783,203               23,259,226          
Long-term debt   $ 186,104             $ 577,517          

  

F-30


 

The Lexington Capital, Grupo Vida Canada, SmartDine LLC, and Orionsea Enterprises loans are convertible to common shares at $10USD per common share if the business combination with Bite is successfully consummated. Lexington Capital has general security over the property of the Company, subordinated to RBC and BNS.

 

At January 31, 2024, the ATB Financial prime rate was 7.20% (January 31, 2023 – 6.70%) and BNS prime rate was 7.20%.

 

Principal payments due in future years are as follows:

 

    $  
2025     30,783,203  
2026     66,296  
2027     55,296  
2028     55,296  
2029     9,216  
    $ 30,969,307  

 

During the period ended January 31, 2024, the Company and Ingredion agreed to extend the maturity of the note payable until the Company’s next financing transaction.

 

The outstanding principal and interest of the convertible subordinated loan payable to Lexington Capital and Grupo Vida Canada are automatically converted into common shares of TopCo (as defined in Note 1) at a price of $10.00 per share upon the closing of the business combination contemplated in the Agreement (as defined in Note 1), which may occur in the period ending January 31, 2025. If the Company does not complete the go public transaction pursuant to the Agreement, the portion of the loan held by Grupo Vida Canada is due to be repaid in cash, and the portion of the loan held by Lexington Capital may be converted into the Company’s shares at the option of the holder on or after the maturity date.

 

F-31


 

14. Derivative instruments

 

The Company’s derivative instruments have not been designated as hedging instruments. The Company uses exchange-traded futures and exchange-traded and OTC options contracts to manage its net position of merchandisable agricultural product inventories and forward cash purchase and sales contracts in an attempt to reduce price risk caused by market fluctuations in agricultural commodities and foreign currencies. The Company also uses exchange-traded futures and exchange-traded and OTC options contracts as components of merchandising strategies designed to mitigate fluctuations in the prices of commodities. The results of these strategies can be significantly impacted by factors such as the correlation between the value of exchange-traded commodities futures contracts and the value of the underlying commodities, counterparty contract defaults, and volatility of freight markets.

  

Effective May 11, 2022, the Company entered into an interest swap contract with an aggregate notional amount of $5,220,000 as of January 31, 2024 to manage variability in the amount of cash payments related to portions of its variable rate debt. The Company pays a fixed rate of 3.9% to the counterparty and receives floating interest payments based on 3-month Bank Acceptance’s Canadian Dollar Offered Rate.

 

Derivatives, including exchange traded contracts and physical purchase or sale contracts, and inventories of merchandisable agricultural products, which include amounts acquired under deferred pricing contracts, are stated at fair value. Inventory is not a derivative and therefore fair values of and changes in fair values of inventories are not included in the tables below.

 

The following table sets forth the fair value of derivatives not designated as hedging instruments as of January 31, 2024 and January 31, 2023.

 

    January 31, 2024     January 31, 2023  
    Assets     Liabilities     Assets     Liabilities  
Commodity forward contracts   $ 15,157,459     $ 3,250,260     $ 14,030,350     $ 977,331  
Foreign exchange forward contracts     359,973       1,346,133       542,862       3,124,828  
Interest swap contract (included in
Accounts payable and accrued liabilities)
            21,105       -       144,283  
Balance, end of period   $ 15,547,432     $ 4,617,498     $ 14,573,212     $ 4,246,442  

 

The following tables set forth the gains (losses) on derivatives not designated as hedging instruments as of January 31, 2024 and January 31, 2023:

 

    For year ended January 31, 2024  
    Cost of sales     Interest expense     Total gain (loss)
recognized in
earnings
 
Commodity forward contracts   $ (1,427,442 )     -     $ (1,427,442 )
Commodity futures contracts     (932,541 )     -       (932,541 )
Foreign exchange forward contracts     2,697,103       -       2,697,103  
Interest swap contract     -       123,178       123,178  
Total gain (loss) recognized in earnings   $ 337,120       123,178     $ 460,298  

  

    For year ended January 31, 2023  
    Cost of sales     Interest expense     Total gain (loss)
recognized in
earnings
 
Commodity forward contracts   $ (3,831,421 )     -     $ (3,831,421 )
Commodity futures contracts     (1,343,603 )     -       (1,343,603 )
Foreign exchange forward contracts     (2,365,050 )     -       (2,365,050 )
Interest swap contract     -       (144,283 )     (144,283 )
Total gain (loss) recognized in earnings   $ (7,540,074 )     (144,283 )   $ (7,684,357 )

 

    For year ended January 31, 2022  
    Cost of sales     Interest expense     Total gain (loss)
recognized in
earnings
 
Commodity forward contracts   $ 14,381,486       -     $ 14,381,486  
Commodity futures contracts     (3,318,737 )     -       (3,318,737 )
Foreign exchange forward contracts     (1,807,302 )     -       (1,807,302 )
Interest swap contract     -       -       -  
Total gain (loss) recognized in earnings   $ 9,255,447       -     $ 9,255,447  

 

F-32


 

15. Leases

 

Lessee Accounting

 

The following table sets forth the amounts relating to the Company’s total lease cost and other information.

 

   

Year ended
January 31, 2024

   

Year ended
January 31, 2023

   

Year ended
January 31, 2022

 
Operating lease cost:                        
Operating lease cost(1)   $ 1,420,890     $ 943,331     $ 640,185  
Non-Lease components(1)     -       -       13,387  
    $ 1,420,890     $ 943,331     $ 653,572  
Short-term lease cost(3)     -     $ 3,600     $ 25,447  
Finance lease cost:                        
Amortization   $ 916,636     $ 890,763     $ 854,257  
Interest on lease liabilities     1,149,459       1,186,716       1,212,634  
    $ 2,066,095     $ 2,077,479     $ 2,066,891  
Total lease cost   $ 3,486,985     $ 3,024,410     $ 2,745,910  
Other information:                        
Sublease income (2)   $ 1,026,800     $ 405,741     $ 539,757  
Lease liability principal payments:                        
Finance leases   $ 1,202,509     $ 1,197,395     $ 338,576  
Operating leases     1,238,270       772,275       526,693  
    $ 2,440,779     $ 1,969,670     $ 865,269  
Right-of-use assets obtained in exchange for lease obligations:                        
Finance leases   $ -     $ 189,505     $ -  
Operating leases     2,288,534       3,734,640       127,104  
    $ 1,851,287     $ 3,924,145     $ 127,104  
Weighted-average remaining lease term (in years)     6.87       7.96       8.75  
Weighted average discount rate     3.60 %     3.58 %     3.57 %

 

 

(1) Operating lease expenses comprising interest on operating lease liabilities and amortization, are reported under Selling, general and administrative expenses on the Consolidated Statements of Operations and Comprehensive Loss.

 

(2) Sublease income is reported under Revenue on the Consolidated Statements of Operations and Comprehensive Loss.

 

(3) Short-term leases are expensed and are reported under Selling, general and administrative expenses on the Consolidated Statements of Operations and Comprehensive Loss.

 

The maturity analysis of the lease liabilities at January 31, 2024 is as follows:

 

    Operating Leases     Finance Leases  
2025     1,537,837       2,296,408  
2026     1,475,675       2,313,717  
2027     1,441,175       2,176,719  
2028     1,378,892       2,133,766  
2029     347,783       2,090,861  
Thereafter     1,677,872       27,378,439  
Total lease payments(1)     7,859,234       38,389,910  
Less impact of discounting(2)     1,244,913       6,771,185  
Lease liability     6,614,321       31,618,725  

  

 

(1) Minimum lease payments have not been reduced by minimum sublease income receipts of $4.0 million due in future periods under non-cancelable subleases as of January 31, 2024. Non-cancelable subleases primarily relate to agreements with third parties for the use of land with remaining sublease terms of approximately five years.

 

(2) Calculated using the implicit rate of the lease, if available, or the incremental borrowing rate that is appropriate for the tenor and geography of the lease.

 

F-33


 

The Company subleases land that it leased in 2018. The following table sets out a maturity analysis of the lease receivables, showing the undiscounted lease payments to be received after the reporting date:

 

    $  
2025     1,001,754  
2026     1,001,754  
2027     1,001,754  
2028     1,001,754  
Total undiscounted lease payments receivable     4,007,016  

 

16. Share capital

 

Authorized share capital

 

At January 31, 2024 and January 31, 2023, the Company had authorized an unlimited number of common shares and preferred shares. The Company has no preferred shares issued and outstanding.

 

Private placement

 

On January 19, 2021, the Company completed its brokered and non-brokered private placement of 20,216,656 Units, at a price of $2.00 per Unit for gross proceeds of $40,433,312 of which $200,000 was received after January 31, 2021 and recorded in the year ended January 31, 2022. Each unit consists of one common share of the Company and one-half of one common share purchase warrant with an exercise price of $3.75 per share and a term of the earlier of three years following a liquidity event or five years from the closing of the financing. The issue price allocated to the share portion of the Unit was $1.50 and $0.50 was allocated to each half warrant and recorded within common stock (in additional paid in capital) and warrants respectively.

 

Marketing Rights

 

On February 1, 2022, the Company issued 997,835 voting common shares rto secure an arrangement whereby the Company would act as the marketing agent for WestOak Naturals Inc. (“WestOak”) products and be entitled to commissions on sales to third parties. In contemplation of this arrangement, the Company recognized $1,995,670 in other intangible assets on its balance sheet on the date of the share issuance. On November 15, 2022, WestOak entered receivership and the Company recognized an impairment loss of $1,751,120, equal to the remaining unamortized intangible asset, and is presented as Impairment of goodwill and other intangible assets in the Consolidated Statements of Operations and Comprehensive Loss.

 

F-34


 

Warrants

 

The Company has issued two types of warrants:

 

Share warrants entitling the holder to acquire additional common shares of the Company at a fixed ratio of one for one (the “Warrants”); and

  

Broker warrants entitling holders to acquire additional Units of the Company at a fixed ratio of one for one (the “Broker Warrants”).

 

A summary of the status of the Warrants outstanding is as follows:

 

   

Number

   

Weighted Average
Exercise Price

 
Outstanding at January 31, 2021     10,561,244     $ 3.75  
Warrants issued     50,000     $ 3.75  
Outstanding at January 31, 2022     10,611,244     $ 3.75  
Warrants issued (Note 4)     682,061     $ 3.75  
Outstanding at January 31, 2023     11,293,305     $ 3.75  
Outstanding at January 31, 2024     11,293,305     $ 3.75  

 

On January 19, 2021, between the private placement Units of 10,108,328 and corporate finance fee Units of 502,916, the Company issued 10,611,244 Warrants pursuant to the Private Placement. Each warrant entitles the holder to purchase one common share at $3.75 per share until the date (the “Expiry Date”) that is the earlier of: (i) the three year anniversary of the date of a liquidity event; and (ii) the five year anniversary of the date of issuance of the Warrants. The Company may elect to accelerate the Expiry Date to the date that is thirty days following the date on which the Company issues a news release announcing the acceleration of the Expiry Date upon the ten consecutive trading day volume weighted average price of the common shares on a recognized exchange being equal to or exceeding $5.00, and within ten days of the end of such period.

 

Pursuant to the Private Placement on January 19, 2021, the Company also has outstanding at January 31, 2024, 1,609,332 Broker Warrants to acquire Units for $2.00 per Unit (2023 – 1,609,332 units at $2.00), which were issued 1,609,332 Broker Warrants to intermediaries as compensation for the Unit placement. Each unit consists of one common share of AFC and one-half of one common share purchase warrant with an exercise price of $3.75 per share and a term of the earlier of three years following a liquidity event or five years from the closing of the financing. The Company may elect to accelerate the Expiry Date to the date that is thirty days following the date on which the Company issues a news release announcing the acceleration of the Expiry Date upon the ten consecutive trading day volume weighted average price of the common shares on a recognized exchange being equal to or exceeding $5.00, and within ten days of the end of such period. These Broker Warrants are separate from the Warrants and not included in the table above.

 

F-35


 

The following tables summarize the warrants that remain outstanding as at January 31, 2024:

 

Warrants

   

Exercise Price

   

Expiry

  11,293,305     $ 3.75     The earlier of: (i) the three year anniversary of the date of a liquidity event; and (ii) the five year anniversary of the date of issuance of the Warrants of January 19, 2021 (10,611,244 warrants) and May 15, 2022 (682,061 warrants) as further outlined in Note 4.

 

Broker Warrants     Exercise Price     Expiry
  1,609,332     $ 2.00     The earlier of: (i) the three year anniversary of the date of a liquidity event; and (ii) the five year anniversary of the date of issuance of the Warrants

 

17. Stock Compensation

 

The Company’s employee stock compensation plans provide for the granting of options to employees to purchase common stock of the Company pursuant to the Company’s 2021 Stock Option Plan.

 

During the year ended January 31, 2023, 7,975,000 options were granted with an exercise price of $5.00 (“Tranche 2”). These options vest over three-year period starting the grant date and expire five years after the grant date. The grant date fair value for the Company’s Tranche 2 stock options for the year ended January 31, 2024 were based on the following assumptions used within the Black-Scholes option pricing model:

 

Expected dividend yield     0 %
Expected volatility     73 %
Risk-free interest rate     2.13 %
Expected term     2.9 years  
Weighted average grant date fair value   $ 0.51  

 

The average expected life represents the period of time that option grants are expected to be outstanding, calculated using the simplified method (see Note 2).

 

A summary of Tranche 2 activity during the year ended January 31, 2024 is presented below:

 

Options   Shares     Weighted Average
Exercise Price
 
Outstanding as of January 31, 2023     7,825,000     $ 5.00  
Granted     -       -  
Exercised     -       -  
Forfeited or expired     1,225,000       5.00  
Outstanding as of January 31, 2024     6,600,000       5.00  
Exercisable as of January 31, 2024     2,199,995       5.00  

 

The weighted-average remaining contractual term of options outstanding as of January 31, 2024, is 2 years.

 

For the year ended January 31, 2024, stock compensation expense of $1,103,152 (2023 - $1,328,866) has been recorded related to Tranche 2. As of January 31, 2024, the total unrecognized compensation expense related to Tranche 2 granted was $1.1 million. The Company expects to recognize these unrecognized compensation expense over a remaining weighted average period of 1.0 years.

 

F-36


 

In the year ended January 31, 2022, 7,450,000 options were granted with an exercise price of $2.00 (“Tranche 1”). The original vesting terms for the Tranche 1 options were to commence vesting on the date upon which the Company’s common shares begin to trade on a stock exchange in Canada or the United States. During the year ended January 31, 2023, the Company modified the vesting start date for Tranche 1 to the original grant date. The Tranche 1 options vested over two- or three-year periods after the grant date and expire five years after the date of grant. The modification date fair value for the Company’s Tranche 1 stock options for the year ended January 31, 2024 were based on the following assumptions used within the Black-Scholes option pricing model:

 

Expected dividend yield     0 %
Expected volatility     73 %
Risk-free interest rate     0.7 %
Expected term     2.7 years  
Weighted average modification date fair value   $ 0.91  

  

The average expected life represents the period of time that option grants are expected to be outstanding, calculated using the simplified method (see Note 2).

 

As a result of the modification, the Company recognized additional compensation expense of $5.4 million for the year ended January 31, 2023. In the year ended January 31, 2024, stock compensation expense of $1,451,705 has been recorded related to Tranche 1. As of January 31, 2024, the total unrecognized compensation expense related to Tranche 1 granted was $0.1 million. The Company expects to recognize these unrecognized compensation expense over a remaining weighted average period of 0.1 years.

 

A summary of Tranche 1 activity during the period ended January 31, 2024 is presented below:

 

Options   Shares     Weighted Average
Exercise Price
 
Outstanding as of January 31, 2023     7,450,000     $ 2.00  
Granted     -       -  
Exercised     -       -  
Forfeited or expired     -       -  
Outstanding as of January 31, 2024     7,450,000       2.00  
Exercisable as of January 31, 2024     6,716,667       2.00  

 

The weighted-average remaining contractual term of options outstanding and exercisable as of January 31, 2024, is 2 years.

 

In the year ended January 31, 2023, 600,000 options were granted with an exercise price of $7.63 (“Tranche 3”). The Tranche 3 options vest over a period of three years that is triggered upon a listing on an exchange. In the years ended January 31, 2024 and 2023, no stock compensation expense has been recorded related to the Tranche 3 options as the vesting period is conditional upon the Company’s common shares trading on a stock exchange in Canada or the United States.

 

During the year ended January 31, 2024, 1,375,000 options were granted with an exercise price of $5.00 (“Tranche 4”). These options vest over a 1.1 year period, beginning on the grant date and expire 2.1 years after the grant date. The grant date fair value for the Company’s Tranche 4 stock options for the year ended January 31, 2024 were based on the following assumptions used within the Black-Scholes option pricing model:

 

Expected dividend yield     0 %
Expected volatility     80 %
Risk-free interest rate     3.99 %
Expected term     1.3 years  
Weighted average grant date fair value   $ 0.55  

 

A summary of Tranche 4 activity during the year ended January 31, 2024 is presented below:

 

Options   Shares     Weighted Average
Exercise Price
 
Outstanding as of January 31, 2023     -     $ -  
Granted     1,375,000       5.00  
Exercised     -       -  
Forfeited or expired     -       -  
Outstanding as of January 31, 2024     1,375,000       5.00  
Exercisable as of January 31, 2024     458,333       5.00  

 

F-37


 

The weighted-average remaining contractual term of options outstanding as of January 31, 2024, is 2 years.

 

For the year ended January 31, 2024, stock compensation expense of $505,083 has been recorded related to Tranche 4. As of January 31, 2024, the total unrecognized compensation expense related to Tranche 4 granted was $0.3 million. The Company expects to recognize these unrecognized compensation expense over a remaining weighted average period of 1.0 years.

 

The Company’s Restricted Share Unit Plan provides for the granting of restricted stock and restricted stock units (Restricted Stock Awards) at no cost to certain officers and key employees. During the year ended January 31, 2024, no Restricted Stock Awards were granted (2023 – no Restricted Stock Awards). The Restricted Stock Awards were made in common stock or stock units over a vesting period of two years that is triggered upon a listing on an exchange. In the years ended January 31, 2024 and 2023, no stock compensation expense has been recorded related to the restricted stock awards as the vesting period is conditional upon the Company’s common shares trading on a stock exchange in Canada or the United States.

 

18. Income taxes

 

Income tax recovery comprises of:

 

    Year ending  
    January 31, 2024     January 31, 2023     January 31, 2022  
Current tax recovery   $ -     $ (15,370 )   $ -  
Deferred tax recovery     -       (78,681 )     -  
Origination and reversal of temporary differences     -       -       (95,088 )
Income tax recovery   $          -     $ (94,051 )   $ (95,088 )

 

The income tax expense differs from the amount computed by applying Canadian statutory rates to income before taxes for the following reasons:

 

    Year ending
January 31, 2024
    Year ending
January 31, 2023
    Year ending
January 31, 2022
 
Loss after Equity method investment loss before income taxes   $ (53,312,282 )   $ (45,578,581 )   $ (5,872,326 )
At the Company’s statutory income tax rate of 27%     (14,394,316 )     (12,306,217 )     (1,585,528 )
Tax effect of the following:                        
Change in valuation allowance     13,510,293       9,519,156       1,566,355  
Permanent differences and others     884,023       2,693,010       (75,915 )
Income tax recovery   $ -     $ (94,051 )   $ (95,088 )

 

Deferred income tax assets and liabilities are made up of the timing differences on the following items:

 

    January 31,
2024
    January 31,
2023
 
Property, plant and equipment   $ (932,028 )   $ (523,041 )
Intangibles     66,261       (24,451 )
Non-capital loss carry forward     39,338,679       26,265,308  
Share issue costs     43,990       248,323  
Investment under significant influence     1,129,068       138,670  
Forward contracts     (2,956,780 )     (2,827,185 )
Inventory     (431,682 )     (283,336 )
Valuation allowance     (36,504,581 )     (22,994,288 )
Net deferred tax liabilities   $ (247,073 )   $ -  

 

F-38


 

As of January 31, 2024, and January 31, 2023, management assessed the realizability of deferred tax assets and evaluated the need for an amount of a valuation allowance for deferred tax assets on a jurisdictional basis. This evaluation utilizes the framework contained in ASC 740, Income Taxes, pursuant to which management analyzed all positive and negative evidence available at the balance sheet date to determine whether all or some portion of the deferred tax assets will not be realized. Under this guidance, a valuation allowance must be established for deferred tax assets when it is more likely than not (a probability level of more than 50%) that they will not be realized. Based upon available evidence, it was concluded on a more-likely-than-not basis that certain deferred tax assets were not realizable as of January 31, 2023. Accordingly, a valuation allowance of $36,504,581 has been recorded to offset these deferred tax assets.

 

As at January 31, 2024, the Company has Canadian non-capital loss carry-forwards of approximately $145,698,811 (January 31, 2023 – $97,094,450) which may be carried forward to apply against future income tax for Canadian income tax purposes. These non-capital loss carry-forwards begin to expire in 2040. Deferred tax assets have been recognized on these non-capital loss carry-forwards to the extent that they eliminate deferred tax liabilities. Deferred tax assets on the remaining non-capital loss carry-forwards in respect of these items have been fully provided for because it is unknown as to what future taxable profit will be available which the Company can utilize the benefits therefrom.

 

Description  

Balance at
Beginning of
Fiscal Year

   

Additions
Charged to
Costs and
Expenses

   

Acquisitions,
Divestitures,
and Others

   

Balance at
End of Fiscal
Year

 
Fiscal Year 2024:                                
Valuation allowance on DTA     22,994,288       13,757,366       (247,073 )     36,504,581  
Fiscal Year 2023:                                
Valuation allowance on DTA     5,206,457       9,519,156       8,268,675       22,994,288  
Fiscal Year 2022:                                
Valuation allowance on DTA    

3,640,102

     

1,566,355

     

-

     

5,206,457

 

 

19. Segment information

 

For the Company’s reportable operating segments during the year ended January 31, 2024, revenue and net loss are as follows:

 

January 31, 2024   Disruptive
Agriculture &
Rudimentary
Ingredients
    CPG     Corporate
and Other
    Inter-segment
Eliminations
    Consolidated  
Revenue   $ 362,730,828     $ 15,391,498     $ 4,428     $ (9,703,356 )   $ 368,423,398  
Net loss for the year   $ (20,400,376 )   $ (12,901,140 )   $ (19,960,094 )   $ (50,672 )   $ (53,312,282 )
Assets   $ 134,359,310     $ 17,910,208     $ 10,653,780     $ (19,035,343 )   $ 143,887,955  

 

For the Company’s reportable operating segments during the year ended January 31, 2023, net earnings (loss) are as follows:

 

January 31, 2023  

Disruptive

Agriculture &
Rudimentary
Ingredients

    CPG     Corporate
and Other
    Inter-segment
Eliminations
    Consolidated  
Revenue   $ 392,430,824     $ 9,579,047     $ 941     $ (5,546,308 )   $ 396,464,504  
Net loss for the year   $ (16,051,802 )   $ (14,924,353 )   $ (14,508,375 )   $ -     $ (45,484,530 )
Assets   $ 149,336,997     $ 23,176,014     $ 14,114,352     $ (5,737,987 )   $ 180,889,376  

 

F-39


 

For the Company’s reportable operating segments during the year ended January 31, 2022, net earnings (loss) are as follows:

  

January 31, 2022   Disruptive
Agriculture &
Rudimentary
Ingredients
    CPG     Corporate
and Other
    Consolidated  
Revenue   $ 198,654,751     $ 202,962     $ -     $ 198,857,713  
Net loss for the year   $ (1,715,505 )   $ (1,249,470 )   $ (2,812,263 )   $ (5,777,238 )
Assets   $ 155,969,937     $ 4,006,528     $ 11,342,006     $ 171,318,471  

 

Intersegment sales have been recorded at cost plus a margin. Net loss for each segment is based on revenue less identifiable expenses. Note that prior to the 2023 fiscal year, there were no intersegment transactions/balances to eliminate.

 

Geographic area information for net sales to external customers, determined based on the location of the customers to which the Company made the sales follows:

 

For the Years Ended   Year ended
January 31, 2024
    Year ended
January 31, 2023
    Year ended
January 31, 2022
 
Canada     141,040,609       159,191,812       98,245,468  
United States     72,650,287       87,691,635       36,690,542  
Mexico     38,284,772       37,436,222       26,807,762  
China     49,630,336       33,545,954       1,319,079  
France     15,377,435       15,284,057       8,334,567  
Turkey     5,134,907       11,981,465       7,255,828  
Rest of the world     46,305,052       51,333,359       20,204,467  
Total     368,423,398       396,464,504       198,857,713  

 

As at January 31, 2024 and 2023 all long-lived assets other than the investment in affiliate are located in Canada.

 

20. Revenue

 

The following tables present revenues from external customers disaggregated by timing of recognition and segment for the years ended January 31, 2024 and 2023.

 

    Year Ended January 31, 2024  
    Revenue from
contracts with
customers (Topic
606 Revenue,
point in time)
    Commodity
contracts (Topic
815 Revenue)
    Land rent (Topic
842 Revenue)
    Total Revenue  
Disruptive Agriculture & Rudimentary Ingredients                                
Durum     -       105,245,392       -       105,245,392  
Peas     -       59,339,111       -       59,339,111  
Lentils     -       71,370,483       -       71,370,483  
Wheat     -       26,275,606       -       26,275,606  
Canary Seed     -       59,608,200       -       59,608,200  
Canola     -       21,208,747       -       21,208,747  
Other     -       12,773,612       1,026,800       13,800,412  
Total Disruptive Agriculture & Rudimentary Ingredients     -       355,821,151       1,026,800       356,847,951  
Total CPG     11,571,019       -       -       11,571,019  
Total Corporate and Other     4,428       -       -       4,428  
Total Revenue     11,575,447       355,821,151       1,026,800       368,423,398  

 

F-40


 

    Year Ended January 31, 2023  
    Revenue from
contracts with
customers (Topic
606 Revenue,
point in time)
    Commodity
contracts (Topic
815 Revenue)
    Land rent (Topic
842 Revenue)
    Total Revenue  
Disruptive Agriculture & Rudimentary Ingredients                                
Durum     -       99,918,425       -       99,918,425  
Peas     -       54,915,488       -       54,915,488  
Lentils     -       82,460,004       -       82,460,004  
Wheat     -       34,137,384       -       34,137,384  
Canary Seed     -       56,904,224       -       56,904,224  
Canola     -       44,816,622       -       44,816,622  
Other     -       13,473,085       405,741       13,878,826  
Total Disruptive Agriculture & Rudimentary Ingredients     -       386,625,231       405,741       387,030,972  
Total CPG     9,432,591       -       -       9,432,591  
Total Corporate and Other     941       -       -       941  
Total Revenue     9,433,532       386,625,231       405,741       396,464,504  

  

    Year Ended January 31, 2022  
    Revenue from
contracts with
customers (Topic
606 Revenue,
point in time)
    Commodity
contracts (Topic
815 Revenue)
    Land rent (Topic
842 Revenue)
    Total Revenue  
Disruptive Agriculture & Rudimentary Ingredients                                
Durum     -       26,594,259       -       26,594,259  
Peas     -       29,568,660       -       29,568,660  
Lentils     -       41,820,787       -       41,820,787  
Wheat     -       20,369,584       -       20,369,584  
Canary Seed     -       41,708,979       -       41,708,979  
Canola     -       22,206,864       -       22,206,864  
Other     -       15,845,861       539,757       16,385,618  
Total Disruptive Agriculture & Rudimentary Ingredients     -       198,114,994       539,757       198,654,751  
Total CPG     202,962       -       -       202,962  
Total Corporate and Other     -       -       -       -  
Total Revenue     202,962       198,114,994       539,757       198,857,713  

 

21. Fair value measurements

 

The Company’s various financial instruments include certain components of working capital such as trade accounts receivable and trade accounts payable. Additionally, the Company uses short and long-term debt to fund operating requirements. Trade accounts receivable, trade accounts payable, and short-term debt are each stated at their carrying values. As these financial instruments have maturities of less than twelve-months, the carrying values are reasonable proxies of fair value. The Company’s financial instruments also include derivative instruments, which are stated at fair value. For a definition of fair value and the associated fair value levels, refer to Note 1- Nature of Business, Basis of Presentation and Significant Accounting Policies.

 

F-41


 

The following tables set forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis:

 

    Fair Value Measurements at January 31, 2024  
    Level 1     Level 2     Level 3     Total  
Assets:                                
Inventories carried at fair value   $               -     $ 13,249,169     $ 9,399,212     $ 22,648,381  
Unrealized derivative gains:                                
Commodity contracts     -       -       15,187,459       15,187,459  
Foreign exchange contracts     -       359,973       -       359,973  
Total Assets   $ -     $ 13,609,142     $ 24,586,671     $ 38,195,813  
Liabilities:                                
Unrealized derivative losses:                                
Commodity contracts   $ -     $ -     $ 3,250,260     $ 3,250,260  
Foreign exchange contracts     -       1,346,133       -       1,346,133  
Interest swap contract     -       21,105               21,105  
Total Liabilities   $ -     $ 1,367,328     $ 3,250,260     $ 4,617,498  

 

    Fair Value Measurements at January 31, 2023  
    Level 1     Level 2     Level 3     Total  
Assets:                        
Inventories carried at fair value   $               -     $ 32,268,912     $ 4,253,232     $ 36,522,144  
Unrealized derivative gains:                                
Commodity contracts     -       -       14,030,350       14,030,350  
Foreign exchange contracts     -       542,862       -       542,862  
Total Assets   $ -     $ 32,811,774     $ 18,283,582     $ 51,095,356  
Liabilities:                                
Unrealized derivative losses:                                
Commodity contracts   $ -     $ -     $ 977,331     $ 977,331  
Foreign exchange contracts     -       3,124,828       -       3,124,828  
Interest swap contract     -       144,283       -       144,283  
Total Liabilities   $ -     $ 3,269,111     $ 977,331     $ 4,246,442  

 

Estimated fair values for inventories carried at fair value and forward commodity purchase and sale contracts are based on exchange-quoted or broker-quoted prices (observable inputs), adjusted for differences in local markets and quality, referred to as basis (unobservable inputs). Market valuations for the Company’s inventories and forward commodity purchase and sale contracts are adjusted for location and quality (basis) because the exchange-quoted prices represent contracts that have standardized terms for commodity, quantity, future delivery period, delivery location, and commodity quality or grade. The basis adjustments are generally determined using inputs from broker or dealer quotations or market transactions in either listed or over the counter (OTC) markets and are considered observable. In some cases, the basis adjustments are unobservable because they are supported by little to no market activity. When observable inputs are available for the commodity it is classified in Level 2. When unobservable inputs have a significant impact (more than 10%) on the measurement of fair value, the inventory or forward commodity purchase and sale contracts are classified in Level 3. Changes in the fair value of inventories and forward commodity purchase and sale contracts are recognized in the consolidated statements of operations and comprehensive loss as a component of cost of sales.

 

Derivatives also include contracts for foreign currencies and interest rate swaps. Foreign currency contracts are valued based on broker-quotes for foreign currencies and interest rate swaps are based on swap curves. As observable inputs are available for these derivatives they have been classified in Level 2. Changes in the fair value of foreign currency-related derivatives are recognized in the consolidated statements of operations and comprehensive loss as a component of cost of sales and changes in the fair value of interest rate swap derivatives are recognized in the consolidated statements of operations and comprehensive loss as a component of interest expense.

 

F-42


 

The following tables present a roll forward of the activity of all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the years ended January 31, 2024 January 31, 2023:

 

    Fair Value Measurements at January 31, 2024  
    Inventories Carried
at Fair Value
    Commodity
Derivative
Contracts, Net
    Total  
Balance, January 31, 2023   $ 4,253,232     $ 13,053,019     $ 17,306,251  
Total increase (decrease) in net realized/ unrealized gains included in cost of products sold     1,382       (1,700,758 )     (1,699,376 )
Purchases     90,681,045       -       90,681,045  
Sales     (93,760,509 )     -       (93,760,509 )
Settlements     -       584,938       584,938  
Transfer into Level 3     8,224,062       -       8,224,062  
Transfer out of Level 3     -       -       -  
Ending balance, January 31, 2024   $ 9,399,212     $ 11,937,199     $ 21,336,411  

 

    Fair Value Measurements at January 31, 2023  
    Inventories Carried
at Fair Value
    Commodity
Derivative
Contracts, Net
    Total  
Balance, January 31, 2022   $ 15,755,973     $ 14,790,708     $ 30,546,681  
Total increase (decrease) in net realized/ unrealized gains included in cost of products sold     (2,542,916 )     (3,649,531 )     (6,192,447 )
Purchases     241,575,075       -       241,575,075  
Sales     (242,016,500 )     -       (242,016,500 )
Settlements     -       1,911,842       1,911,842  
Transfer into Level 3     2,089,634       -       2,089,634  
Transfer out of Level 3     (10,608,034 )     -       (10,608,034 )
Ending balance, January 31, 2023   $ 4,253,232     $ 13,053,019     $ 17,306,251  

 

    Fair Value Measurements at January 31, 2022  
    Inventories Carried
at Fair Value
    Commodity
Derivative
Contracts, Net
    Total  
Balance, January 31, 2021   $ 4,696,097     $ 409,222     $ 5,593,058  
Total increase (decrease) in net realized/ unrealized gains included in cost of products sold     452,501       14,381,486       15,243,209  
Purchases     54,240,073       -       54,240,073  
Sales     (45,635,791 )     -       (45,635,791 )
Settlements     -       -       (409,222 )
Transfer into Level 3     4,859,554       -       4,859,554  
Transfer out of Level 3     (2,856,461 )     -       (2,856,461 )
Ending balance, January 31, 2022   $ 15,755,973     $ 14,790,708     $ 30,546,681  

 

Transfers into Level 3 of assets and liabilities previously classified in Level 2 were due to a significant increase in the relative value of unobservable inputs to the total fair value measurement of certain inventories. Transfers out of Level 3 were primarily due to a significant decrease in the relative value of unobservable inputs to the total fair value measurement of certain inventories and thus permitting reclassification to Level 2.

 

F-43


 

The following table outlines the weighted average percentage of the unobservable price components included in the Company’s Level 3 valuations as of January 31, 2024 and 2023. The Company’s Level 3 measurements for inventory and forward commodity purchase and sale contracts include adjustments for differences in market zones which are unobservable inputs and are impacted by location, local markets and quality. In some cases the commodity prices are considered unobservable because they are supported by little to no market activity.

  

    Market zone adjustments as weighted average % of total fair value  
    January 31, 2024     January 31, 2023     January 31, 2022  
Description   Assets     Liabilities     Assets     Liabilities     Assets     Liabilities  
Inventories carried at fair value     14.5 %     --%       14.5 %     --%       11.3 %     --%  
Commodity contracts     7.8 %     11.2 %     13.3 %     10.5 %     31.0 %     16.7 %

 

If the Company used different methods or inputs to determine fair values, amounts reported as unrealized gains and losses on derivative contracts and inventories carried at fair value in the consolidated balance sheets and consolidated statements of operations and comprehensive loss could differ. Factors such as the ability to substitute products, weather, fuel costs or contract specific terms could impact the judgments of the unobservable market zone adjustments. Additionally, if market conditions change subsequent to the reporting date, amounts reported in future periods as unrealized gains and losses on derivative contracts and inventories carried at fair value in the consolidated balance sheets and consolidated statements of operations and comprehensive loss could differ.

 

22. Related Party transactions and balances

 

Related party transactions include transactions with corporate investors who have representation on the Company’s Board.

 

Kambeitz Agri Inc. (“Agri”) is considered a related party due to one common director. At January 31, 2024, there are amounts owing of $178,500 (January 31, 2023 – $178,500) included in due to related parties. In the absence of set repayment terms on the amount due to Agri, there is no term that prevents Agri from demanding repayment. Accordingly, the amount has been classified as a current liability.

 

KF Kambeitz Farms Inc. (“KF Farms”) is considered a related party due to one common director. Commodity purchases and grain handling service provided by KF Farms during the year ended January 31, 2024 was $12,879,861 (January 31, 2023 – $19,224,028, January 31, 2022 - $13,764,246) and are recognized in the consolidated statements of operations and comprehensive loss as a component of cost of sales. KF Farms provided selling, general and administrative services amounting to $62,625 (January 31, 2023 – $28,895, January 31, 2022 - $117,557). Commodity sales to KF Farms during the year ended January 31, 2024 amounted to $689,283 (January 31, 2023 – $271,170, January 31, 2022 - $2,403,633). At January 31, 2024 there are amounts receivable of $nil (January 31, 2023 – $159,960) and payable of $5,907,681 (January 31, 2023 – $8,302,016) included in due from or to related parties. While there is no set repayment term on the amount due from KF Farms, these are not expected to be collected within twelve months of year-end. Accordingly, the amount has been classified within non-current assets.

 

KF Capital Corp (“KF Capital”) is considered a related party due to one common director. During the year ended January 31, 2024, the Company purchased $87,226 of property, plant and equipment assets from KF Capital. At January 31, 2024, this amount is included in due to related parties.

 

KF Hemp Corp (“KF Hemp”) is considered a related party due to one common director. During the year ended January 31, 2024, the Company had no transactions with KF Hemp. At January 31, 2024, there is an amount receivable of $159,960 relating to sales in previous years. This amount is included in due to related parties.

 

Purely Canada Terminal Corp (“PCTC”) is considered a related party to due to one common director. Prior to leasing the terminal as described below, Above utilized grain handling, storage, and project management services provided by PCTC. As a result of the lease, during the years ended January 31, 2024 and 2023, grain handling, storage, and project management services in the amount $nil were provided by PCTC. At January 31, 2024 there is an amount receivable of $nil (January 31, 2023 – $142,446) that is included in due from related parties. While there is no set repayment term on the amount due from PCTC, these are not expected to be collected within twelve months of year-end. Accordingly, the amount has been classified within non-current assets.

 

F-44


 

Above also has a lease with PCTC for use of the Grain Terminal at Lajord for a period of ten (10) years which commenced November 30, 2020 and may be renewed for an additional three ten (10) year terms. Basic rent is equal to the exact monthly BDC mortgage payment payable of principal, and interest as well as the monthly RBC prime rate of interest multiplied by the shareholder loan balance of $12,800,000. There is an option to purchase the Grain Terminal at the conclusion of the first ten (10) year term for a purchase price of $34,850,000 minus all principal payments made as part of the basic rent. Lease and utilities payments made to PCTC during year ended January 31, 2024 was $3,109,578 (January 31, 2023 – $2,647,497). At January 31, 2024 the lease liability remaining was equal to $31,500,445 (January 31, 2023 – $32,665,304).

 

23. Selling, general and administrative expenses

 

    January 31, 2024     January 31, 2023     January 31, 2022  
Depreciation and amortization   $ 2,333,969     $ 1,817,286     $ 511,816  
Wages and salaries (including stock compensation expense)     14,115,663       15,627,230       3,947,636  
Professional services     8,068,129       4,567,076       4,379,672  
Advertising and promotions     742,617       1,534,451       551,863  
Insurance     2,174,446       1,552,871       494,789  
Rent     2,490,718       1,067,331       117,670  
Supplies and utilities     1,977,222       1,491,994       834,794  
Repairs and maintenance     475,807       477,845       151,915  
Bad debt     409,556       879,205       777  
Meals and entertainment     330,990       293,710       36,281  
Bank charges     384,535       221,742       147,496  
Business fees and licenses     81,174       117,950       54,775  
Contracts and development fees     174,418       157,791       48,675  
Courier and postage     159,824       162,932       100,554  
Motor vehicle expenses     247,768       238,944       56,602  
Subscription and memberships     174,522       131,277       45,642  
Travel     207,976       187,385       95,854  
Property taxes     271,901       71,168       50,412  
Other expense (income)     (598,711 )     509,216       66,384  
Selling, general and administrative   $ 34,222,524     $ 31,107,404     $ 11,693,607  

 

24. Commitments and Contingencies

 

In the ordinary course of business, the Company may be involved in various legal proceedings and subject to claims that arise. The results of litigation and claims are inherently unpredictable and uncertain, the Company is not currently a party to any legal proceedings which may have a probable or estimatable outflow of economic resources.

 

25. Loss per share

 

The Company computes basic loss per share using the weighted average number of common shares outstanding during the year. Diluted loss per share is computed using the weighted average number of common shares and common share equivalents of potentially dilutive securities that are outstanding during the year, except in years in which the Company incurs a net loss. The Company’s potentially dilutive securities consist of warrants, stock options, and restricted stock units.

 

F-45


 

The weighted average share impact of warrants, broker warrants, restricted stock units, stock options, and convertible loans that were excluded from the calculation of diluted shares outstanding, because they are anti-dilutive for the years ended January 31, 2024 and 2023, are as follows:

 

Anti-dilutive common share equivalents   January 31, 2024     January 31, 2023     January 31, 2022  
Warrants     11,293,305       11,293,305       10,611,244  
Broker warrants     1,609,332       1,609,332       1,609,332  
Restricted stock units     7,200,000       7,200,000       7,200,000  
Stock Options     16,025,000       16,025,000       7,450,000  
Convertible debt     5,504,566       2,842,825       -  
      41,632,203       38,970,462       26,870,576  

 

26. Subsequent events

 

On August 28, 2023, Above entered into an asset-purchase agreement pursuant to which Above will purchase certain AI-based genomic assets, intellectual property, and trait development technology licensing rights from NRGene Technologies Ltd. (“NRGene”). NRGene will receive a combination of $2.5 million cash and $10 million in common shares of TopCo, calculated as of the date of the IPO, as well as royalties from commercialization of specific projects. By July 5, 2024, the entire consideration was settled in shares.

 

On May 14, 2024, Above Food Ingredients Corp. (USA), a wholly owned subsidiary of Above Food Corp., entered into an asset purchase agreement with Arcadia Biosciences, Inc. (“Arcadia”), and their wholly owned subsidiary, Arcadia Wellness, LLC. The acquired assets were comprised primarily of cash, commodity inventory and intangible assets (trademarks and patents). In exchange for these assets, the Company issued a promissory note for USD $6.0 million. The promissory note is repayable by the third anniversary, payable in yearly installments of USD $2.0 million with interest payable on each anniversary of the effective date at the prime rate. Arcadia also has the right to obtain publicly traded TopCo common shares in the amount of USD $2.0 million until the second anniversary of the promissory note, instead of receiving one of the installment payments in cash.

 

On June 13, 2024, Above issued 2,377,082 common shares in exchange for cash proceeds of USD $5 million to Grupo Empresarial Enhol, S.L (“Enhol”). Concurrently, Above issued 6,180,413 common shares to Enhol as consideration for 100% of Brotalia, S.L., a wholly owned subsidiary of Enhol.

 

On June 28, 2024, the Business Combination with Bite (Note 1) was finalized. Concurrent with the Business Combination with BITE:

 

a) TopCo and Bite entered into subscription agreements with certain investors (the “PIPE Investors”) pursuant to which the PIPE investors agreed to purchase common shares of TopCo at a purchase price of USD $10 per share. TopCo issued 530,000 common shares to the shareholders of Veg House Holdings Inc. for cash proceeds of USD $5.3 million. Concurrently, TopCo issued additional 322,550 common shares to the same group of shareholders as a deposit for a potential future transaction.

 

b) The convertible subordinated loans payable to Lexington Capital, SmartDine LLC, and Orionsea enterprises were converted into 1,097,385 common shares of TopCo.

 

c) TopCo issued 1,604,253 common shares to acquire the remaining interest of ANF. Upon closing, ANF became a wholly owned subsidiary of TopCo.

 

d) TopCo assumed USD $2.0 million of convertible debt payable to Smart Dine, LLC. TopCo promised to pay Smart Dine, LLC USD $2.0 million in principle on the maturity date of June 27, 2026, with interest accruing on the unpaid principal amount at a rate equal to six percent per quarter, compounded quarterly. The entire principle amount is convertible into TopCo Common Shares at Smart Dine, LLC’s election.

 

F-46

 

EX-1.1 2 tm2418826d1_ex1-1.htm EXHIBIT 1.1

 

Exhibit 1.1

 

  BUSINESS CORPORATIONS ACT FORM 1

 

ALBERTA REGISTRIES     ARTICLES OF INCORPORATION  

 

1. NAME OF CORPORATION.

 

2510169 ALBERTA INC.

 

2. THE CLASSES AND ANY MAXIMUM NUMBER OF SHARES THAT THE CORPORATION IS AUTHORIZED TO ISSUE.

 

See Share Structure Schedule attached hereto.

 

3. RESTRICTIONS IF ANY ON SHARE TRANSFERS.

 

None.

 

4. NUMBER (OR MINIMUM AND MAXIMUM NUMBER) OF DIRECTORS.

 

The Corporation shall have a minimum of One (1) and a maximum of Fifteen (15) directors.

 

5. IF THE CORPORATION IS RESTRICTED FROM CARRYING ON A CERTAIN BUSINESS, SPECIFY THESE RESTRICTIONS.

 

No restrictions.

 

6. OTHER PROVISIONS IF ANY.

 

See Other Rules or Provisions Schedule attached hereto.

 

7. DATE:    18th day of April, 2023

 

INCORPORATOR   ADDRESS     SIGNATURE
Sharagim Habibi   1600, 421 – 7th Avenue SW  
Calgary, Alberta T2P 4K9    
  /s/ Sharagim Habibi  

 

FOR DEPARTMENTAL USE ONLY

 

CORPORATION ACCESS NO.   INCORPORATION DATE

 

 


 

SHARE STRUCTURE SCHEDULE

REFERRED TO IN THE FOREGOING

ARTICLES OF INCORPORATION

 

COMMON SHARES

 

The Corporation is authorized to issue an unlimited number of Common shares without nominal or par value.

 

Subject to the rights of any other shares of the Corporation which are expressed to rank prior to the Common shares, the Common shares shall be subject to the following rights, privileges, restrictions and conditions, namely:

 

(a) The holders of the Common shares shall be entitled to vote at any meeting of shareholders of the Corporation;

 

(b) The holders of the Common shares shall be entitled to receive any dividend declared by the Corporation; and

 

(c) The holders of the Common shares shall be entitled to receive the remaining property of the Corporation on dissolution.

 

 


 

OTHER RULES OR PROVISIONS SCHEDULE

REFERRED TO IN THE FOREGOING

ARTICLES OF INCORPORATION

 

OTHER PROVISIONS, IF ANY

 

The directors may, between annual general meetings, appoint one or more additional directors of the Corporation to serve until the next annual general meeting, but the number of additional directors shall not at any time exceed one-third of the number of directors who held office at the expiration of the last annual meeting of the Corporation.

 

 


 

  BUSINESS CORPORATIONS ACT FORM 4

 

ALBERTA REGISTRIES   ARTICLES OF AMENDMENT
       
1. NAME OF CORPORATION 2. CORPORATE ACCESS NO.
       
  2510169 ALBERTA INC.   2025101698

 

3. THE ARTICLES OF THE ABOVE NAMED CORPORATION ARE AMENDED AS FOLLOWS:

 

Pursuant to Section 173(3) of the Business Corporations Act (Alberta), the Articles of the Corporation are hereby amended by changing the name of the Corporation from 2510169 ALBERTA INC. to:

 

ABOVE FOOD INGREDIENTS INC.

 

DATE   SIGNATURE   TITLE
May 18, 2023   /s/ Lionel Kambeitz     CEO
    Print Name: Lionel Kambeitz    
FOR DEPARTMENTAL USE       FILED

 

 


 

  BUSINESS CORPORATIONS ACT FORM 4

 

ALBERTA REGISTRIES   ARTICLES OF AMENDMENT
       
1. Name of Corporation 2. Corporate Access No.
       
  ABOVE FOOD INGREDIENTS INC.   2025101698

 

3. THE ARTICLES OF THE ABOVE NAMED CORPORATION ARE AMENDED AS FOLLOWS:

 

1.            In accordance with Subsection 173(1)(e) of the Business Corporations Act (Alberta)(“ABCA”), THE CLASSES, AND ANY MAXIMUM NUMBER OF SHARES THAT THE CORPORATION IS AUTHORIZED TO ISSUE, of the Articles of the Corporation are hereby amended as follows:

 

(a) the rights, restrictions, privileges and conditions attached to the Common Shares be replaced in their entirety with the rights, restrictions, privileges as detailed in the new Share Structure Schedule attached hereto and by reference made a part hereof;

 

2.            In accordance with Subsection 173(1)(d) of the ABCA, THE CLASSES, AND ANY MAXIMUM NUMBER OF SHARES THAT THE CORPORATION IS AUTHORIZED TO ISSUE, of the Articles of the Corporation are hereby amended as follows:

 

(a) the following new classes of preferred shares are hereby created, the holders of which are entitled to the rights, restrictions, privileges and conditions as contained in the new Share Structure Schedule attached hereto and by reference made a part hereof:

 

an unlimited number of Class A Earnout Shares; and

an unlimited number of Class B Earnout Shares.

 

DATE   SIGNATURE   TITLE
June 27, 2024   /s/ Lionel Kambeitz     CEO
    Print Name: Lionel Kambeitz    
FOR DEPARTMENTAL USE       FILED

 

 


 

SHARE STRUCTURE SCHEDULE

REFERRED TO IN THE FOREGOING

ARTICLES OF AMENDMENT

 

PART 1 DEFINITIONS

1.1 Definitions:

 

(a) “Adjusted EBITDA” means, for the applicable measurement period, determined in a manner consistent with the Company Audited Year-End Financial Statements for the fiscal year ended January 31, 2022, earnings before interest expense, taxes, depreciation, amortization adjusted for non-recurring items in the company’s normal operations resulting from discontinued operations, extraordinary items, unusual or infrequent items, and changes resulting from changes in accounting policies/principles.

 

(b) “Affiliate” means, with respect to any specified Person, any Person that, directly or indirectly, controls, is controlled by, or is under common control with, such specified Person, whether through one or more intermediaries or otherwise. The term “control” (including the terms “controlling”, “controlled by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 

(c) “Automatic Conversion” means the automatic conversion into Common Shares of the Class A Earnout Shares and Class B Earnout Shares, as applicable, each in accordance with the terms and conditions set forth in PART 4 of these Articles.

 

(d) “Automatic Conversion Date” has the meaning set forth in Section 4.3.

 

(e) “Business Combination Agreement” means the business combination agreement dated April 29, 2023 between Above Food Corp., 2510169 Alberta Inc., Above Merger Sub, Inc. and Bite Acquisition Corp.

 

(f) “Business Combination Agreement Earnout Shares” means the earnout shares issuable under the Business Combination Agreement.

 

(g) “Change of Control” a merger, consolidation, business combination, recapitalization, reorganization, or other similar transaction, however effected, resulting in any Person or group (as defined under Section 13 of the Exchange Act) acquiring at more than least 50% of the combined voting power of the then outstanding securities of the Corporation.

 

(h) “Class A Earnout Shares” means the Class A Earnout Shares in the capital of the Corporation.

 

(i) “Class B Earnout Shares” means the Class B Earnout Shares in the capital of the Corporation.

 

(j) “Common Shares” means the common shares in the capital of the Corporation.

 

(k) “Company Audited Year-End Financial Statements” means the audited consolidated balance sheet of the Group Companies as of January 31, 2022 and July 31, 2020, and the related audited consolidated statements of operations, consolidated statement of changes in shareholders’ equity and consolidated statement of cash flows for the fiscal years ended January 31, 2022 and July 31, 2020.

 

 


 

(l) “Conversion Rate” has the meaning set forth in Section 3.9.

 

(m) “Corporation” means the corporation to which these articles are in respect of.

 

(n) “Earnout Shares” means, collectively, the Class A Earnout Shares and Class B Earnout Shares.

 

(o) “Exchange Act” means the United States Securities Exchange Act of 1934.

 

(p) “Group Companies” means, collectively, the Above Food Corp., Atlantic Natural Foods, LLC and each of their respective Subsidiaries.

 

(q) “holder” of any share referred to herein means the holder of such share as registered on the central securities register of the Corporation and, in respect of shares held by joint holders, means all such joint holders.

 

(r) “Liquidation Distribution” means a distribution of assets of the Corporation among its shareholders arising on the liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary, or any other distribution of the assets of the Corporation among its shareholders for the purpose of winding up its affairs.

 

(s) “Original Issue Date” means the date on which the first Earnout Share is issued.

 

(t) “Permitted Transfer” means, in respect of a proposed Transfer by a holder of Earnout Shares:

 

(i) in the case of an individual, by gift to a member of one of the individual’s immediate family, to a trust, the beneficiaries of which are members of the individual’s immediate family or an Affiliate of such individual, in each case for estate planning purposes;

 

(ii) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual;

 

(iii) in the case of an individual, pursuant to a qualified domestic relations order;

 

(iv) by virtue of the holder’s organizational documents upon liquidation or dissolution of the holder; or

 

(v) subject to the provisions of Section 3.8, a Transfer to the officers or directors of such holder, the members or partners of such holder, any Affiliates of such holder or any employee of such Affiliate.

 

(u) “Permitted Transferee” means any transferee arising from a Permitted Transfer.

 

(v) “Person” means an individual, partnership, corporation, limited liability company, joint stock company, unincorporated organization or association, trust, joint venture or other similar entity, whether or not a legal entity.

 

(w) “Redemption Price” with respect to each Class A Earnout Share and Class B Earnout Share shall be equal to US$0.00000000001 per share.

 

 


 

(x) “Redemption Time” has the meaning set forth in Section 3.7.

 

(y) “Subsidiary” means, with respect to a Person, any corporation, general or limited partnership, limited liability company, joint venture or other entity in which such Person, directly or indirectly, (a) owns or controls fifty percent (50%) or more of the outstanding voting securities, profits interest or capital interest, (b) is entitled to elect at least a majority of the board of directors or similar governing body or (c) in the case of a limited partnership, limited liability company or similar entity, is a general partner or managing member and has the power to direct the policies, management and affairs of such entity, respectively.

 

(z) “Trading Day” means any day on which the Trading Market is open for trading.

 

(aa) “Trading Market” means, with respect to any security, the national stock exchange on which such security is trading.

 

(bb) “Trading Price” means, with respect to any security trading on the Trading Market, the dollar volume-weighted average price for such shares traded on the Trading Market during the period beginning at 9:30:01 a.m., New York time on such Trading Day and ending at 4:00:00 p.m., New York time on such Trading Day, as reported by Bloomberg through its “HP” function (set to weighted average).

 

(cc) “Transfer” means any, direct or indirect, sale, transfer, assignment, pledge, mortgage, exchange, hypothecation, grant of a security interest or encumbrance in or disposition of an interest (whether with or without consideration, whether voluntarily or involuntarily or by operation of law or otherwise, provided that a Permitted Transfer as contemplated in Section 1.1(t)(i) and Section 1.1(t)(v) shall be without consideration or for nominal consideration).

 

PART 2 COMMON SHARES

 

2.1 Common Shares. The Corporation is authorized to issue an unlimited number of Common Shares without nominal or par value.

 

2.2 Voting. The holders of the Common Shares shall be entitled to one vote for each Common Share held at all meetings of shareholders of the Corporation, other than meetings at which only the holders of another class or series of shares are entitled to vote separately as a class or series.

 

2.3 Dividends. Subject to the prior rights of any other class ranking senior to the Common Shares, the holders of the Common Shares shall be entitled to receive and the Corporation shall pay thereon, as and when declared by the directors of the Corporation out of moneys of the Corporation properly applicable to the payment of dividends, such non-cumulative dividends as the directors may from time to time declare.

 

2.4 Liquidation Distribution. In the event of any Liquidation Distribution, subject to the prior rights of the holders of the shares of any other class ranking senior to the Common Shares, the holders of the Common Shares shall be entitled to receive all remaining property and assets of the Corporation.

 

 


 

PART 3 EARNOUT SHARES

 

3.1 Earnout Shares. The Corporation is authorized to issue an unlimited number of Class A Earnout Shares and Class B Earnout Shares without nominal or par value.

 

3.2 Non-Voting. The holders of the Earnout Shares shall not be entitled to any voting rights except as otherwise required under the Business Corporations Act (Alberta).

 

3.3 Dividends. The holders of the Earnout Shares shall not be entitled to any dividends or other distributions other than a Liquidation Distribution.

 

3.4 Liquidation Distribution. In the event of any Liquidation Distribution, the holders of Earnout Shares shall be entitled to receive, before any repayment of capital or any distribution of any part of the assets of the Corporation to the holders of the Common Shares, and any shares ranking junior to the Earnout Shares, an amount per Earnout Share equal to the Redemption Price. After payment to the holders of the Earnout Shares of the amount so payable to them as above provided, the holders of the Earnout Shares shall not be entitled to share in any further distribution of the property or assets of the Corporation.

 

3.5 Redemption of Class A Earnout Shares. Subject to Section 36(2) of the Business Corporations Act (Alberta), the Corporation shall:

 

(a) at any time after a Change of Control where the applicable value of the Common Shares is less than US$12.50 per Common Share; or

 

(b) at any time after the five year anniversary of the Original Issue Date;

 

without notice, redeem at any time the whole of the then outstanding Class A Earnout Shares on payment, in respect of each Class A Earnout Share to be redeemed, of the Redemption Price thereon (provided that the ability to redeem Class A Earnout Shares shall not apply in respect of any Class A Earnout Shares which are automatically converted into Common Shares in accordance with the provisions of PART 4).

 

3.6 Redemption of Class B Earnout Shares. Subject to Section 36(2) of the Business Corporations Act (Alberta), the Corporation shall:

 

(a) at any time after a Change of Control where the applicable value of the Common Shares is less than US$15.00 per Common Share; or

 

(b) at any time after the five year anniversary of the Original Issue Date;

 

without notice, redeem at any time the whole of the then outstanding Class B Earnout Shares on payment, in respect of each Class B Earnout Share to be redeemed, of the Redemption Price thereon (provided that the ability to redeem Class B Earnout Shares shall not apply in respect of any Class B Earnout Shares which are automatically converted into Common Shares in accordance with the provisions of PART 4).

 

3.7 Redemption General. Subject to Section 36(2) of the Business Corporations Act (Alberta), in the event that any holder of Earnout Shares breaches any covenant of such holder, in respect of its ownership of the Earnout Shares, such holder’s Earnout Shares shall be deemed to be immediately redeemed, without notice or formality, whereupon such holder shall cease to hold any rights in respect of such Earnout Shares and shall only be entitled to receive an amount equal to the aggregate of the Redemption Price in respect of such holder’s Earnout Shares. Any such redemption of Earnout Shares shall be immediate upon the occurrence of such breach (the “Redemption Time”), and such holder’s only rights in respect thereof shall be to receive the Redemption Price in respect of such Earnout Shares. For greater certainty, after the Redemption Time, the rights in respect of Earnout Shares of such holder shall no longer be exercisable by such holder in respect thereof. The Corporation shall thereafter deliver to such holder of Earnout Shares the Redemption Price thereon.

 

 


 

3.8 Limits on Transferability. None of the Earnout Shares may be Transferred without the prior approval of the board of directors, which shall only be given if:

 

(a) the board of directors is satisfied that the Transfer is a Permitted Transfer; and

 

(b) the transferring holder and the Permitted Transferee enter into a written agreement in form and substance reasonably satisfactory to the Corporation providing such assurances as the Corporation may require relating to, among other things:

 

(i) the eligibility of the Transfer as a Permitted Transfer;

 

(ii) the Permitted Transferee’s acknowledgement of the transfer restrictions in respect of the Earnout Shares being transferred; and

 

(iii) the Permitted Transferee’s agreement to be bound by all of the covenants, agreements and obligations of the transferring holder to the Corporation in respect of (x) matters relating to the Earnout Shares and (y) the transferring holder’s ownership of the Earnout Shares.

 

The Corporation shall not register, and no holder shall have any right to request, any Transfer of the registered ownership of any Earnout Shares without such approval. For greater certainty, no holder shall be entitled to pledge, mortgage, exchange, hypothecate or grant a security interest or encumbrance in any Earnout Shares.

 

Notwithstanding the foregoing, any holder or proposed holder of Earnout Shares may, at such Person’s option, at any time (whether before or after the issuance of any Earnout Shares to such Person) provide an irrevocable direction and agreement (the “Direction”) in favour of the Corporation, that a proposed Transfer contemplated in Section 1.1(t)(v) shall be deemed not be a Permitted Transfer in respect of any Earnout Shares held or proposed to be held by such Person (and, for greater certainty, such Direction may (but need not) also provide that any other proposed Transfer contemplated in Section 1.1(t)(v) shall be conditional upon the proposed transferee executing an identical Direction), whereupon the Corporation shall thereafter disregard any request by such Person for a Transfer to be made pursuant to Section 1.1(t)(v) unless such request complies with such Direction.

 

3.9 Conversion Provisions. Unless and until adjusted as provided for in this Section 3.9, for all conversions of Earnout Shares, each Earnout Share shall be converted into Common Shares on a 1:1 basis (the “Conversion Rate”).

 

(a) No fractional Common Shares shall be issued upon conversion of the Earnout Shares. All Common Shares (including fractions thereof) issuable upon conversion of more than one Earnout Share by a holder thereof shall be aggregated for the purpose of determining whether the conversion would result in the issuance of any fractional share. If, after the aforementioned aggregation, the conversion would result in the issuance of any fractional Common Share, the holder shall be entitled to the number of Common Shares determined by rounding the entitlement down to the nearest whole number.

 

 


 

(b) If the Corporation shall at any time or from time to time after the Original Issue Date effect a subdivision of the outstanding Common Shares, the Earnout Shares shall be similarly subdivided at the same time (failing which the Conversion Rate shall be adjusted accordingly). If the Corporation shall at any time or from time to time after the Original Issue Date effect a consolidation of the outstanding Common Shares, the Earnout Shares shall be similarly consolidated at the same time (failing which the Conversion Rate shall be adjusted accordingly). In each case, the dollar values set forth in PART 4 shall be appropriately adjusted to provide the holders of the Earnout Shares the same economic effect as contemplated by these Articles prior to such event.

 

(c) If the Common Shares of the Corporation shall be changed into the same or a different number of shares of any class, whether by capital reorganization, reclassification, or otherwise (other than a subdivision or combination of shares, or a reorganization, merger, amalgamation, arrangement, consolidation, business combination or sale of assets provided for below), then in the event that any Earnout Shares are thereafter converted into Common Shares, the holders of the Earnout Shares shall be entitled to receive the kind and amount of shares or other securities or property receivable, upon such reorganization, reclassification or other change, that would have otherwise been receivable by the holders of the number of Common Shares into which such Earnout Shares would have been converted immediately prior to such reorganization, reclassification or change, all subject to further adjustment as provided herein.

 

(d) In case of any merger, amalgamation, consolidation, arrangement, reorganization or other business combination involving the Corporation and any other corporation or other entity or Person (in each case, other than a Change of Control), then in the event that any Earnout Shares are thereafter converted into Common Shares, such Earnout Shares shall thereafter be convertible (or shall be converted into a security which shall be convertible) into the kind and amount of shares or other securities or property to which a holder of the number of Common Shares of the Corporation that would have otherwise been deliverable upon conversion of such Earnout Shares would have been entitled upon such event; and, in such case, appropriate adjustment (as determined in good faith by the board of directors of the Corporation) shall be made in the application of the provisions in this Section 3.9(d) set forth with respect to the rights and interest thereafter of the holders of the Earnout Shares, to the end that the provisions set forth in this Section 3.9(d) (including provisions with respect to changes in and other adjustments of the Conversion Rate) shall thereafter be applicable, as nearly as reasonably may be, in relation to any shares or other securities or property thereafter deliverable upon the conversion of the Earnout Shares.

 

(e) Upon any Earnout Shares being converted as herein provided, all rights with respect to such shares, including the rights, if any, to receive notices and to vote, shall immediately cease and terminate on the Automatic Conversion Date, other than the right of the holders thereof to receive Common Shares in exchange therefor.

 

 


 

PART 4 AUTOMATIC CONVERSIONS OF EARNOUT SHARES

 

4.1 Class A Earnout Shares. Class A Earnout Shares shall be converted automatically into Common Shares in accordance with the provisions set forth in this PART 4 and Section 3.9 on the first date that any of the following occur:

 

(a) on any twenty (20) Trading Days within any thirty (30) Trading Day period, the Trading Price of the Common Shares is greater than or equal to US$12.50 (as adjusted for share splits, reverse share splits, sub-divisions, rights issuances, stock dividends, reorganizations, recapitalizations and other similar transactions);

 

(b) the Adjusted EBITDA of the Corporation for the fiscal year ending January 31, 2025 is greater than or equal to US$21,200,000 based on the audited consolidated financial statements for such period; or

 

(c) there occurs any transaction resulting in a Change of Control with a valuation of the Common Shares that is greater than or equal to US$12.50 per Common Share (such value per share to be calculated without giving effect to the conversion of any Business Combination Agreement Earnout Shares).

 

4.2 Class B Earnout Shares. Class B Earnout Shares shall be converted automatically into Common Shares in accordance with the provisions set forth in this PART 4 and Section 3.9 on the first date that any of the following occur:

 

(a) on any twenty (20) Trading Days within any thirty (30) Trading Day period, the Trading Price of the Common Shares is greater than or equal to US$15.00 (as adjusted for share splits, reverse share splits, sub-divisions, rights issuances, stock dividends, reorganizations, recapitalizations and other similar transactions)

 

(b) the Adjusted EBITDA of the Corporation for the fiscal year ending January 31, 2026 is greater than or equal to US$32,900,000 based on the audited consolidated financial statements for such period; or

 

(c) there occurs any transaction resulting in a Change of Control with a valuation of the Common Shares that is greater than or equal to US$15.00 per Common Share (such value per share to be calculated without giving effect to the conversion of any Business Combination Agreement Earnout Shares).

 

4.3 Automatic Conversion. Upon the occurrence of an Automatic Conversion under the foregoing Sections, all the then issued and outstanding Earnout Shares of the applicable class shall be converted automatically without any further action by the holders thereof and whether or not the certificates (if any) representing such shares are surrendered to the Corporation or its transfer agent; provided, however, that in each case all holders of Earnout Shares being converted shall be given written notice of the occurrence of an Automatic Conversion, including the date such event occurred (the “Automatic Conversion Date”), and the Corporation shall not be obligated to issue certificates evidencing the Common Shares issuable upon such conversion unless certificates evidencing such Earnout Shares being converted, if any, are either delivered to the Corporation, or its transfer agent, or the holder notifies the Corporation, or its transfer agent, that such certificates have been lost, stolen or destroyed and executes an agreement satisfactory to the Corporation to indemnify the Corporation (and its transfer agent, if applicable) from any loss incurred by it in connection therewith.

 

 


 

4.4 Effect of Automatic Conversion. On the Automatic Conversion Date, all rights with respect to the Earnout Shares so converted shall terminate, except for any of the rights of the holder thereof, upon surrender of the holder’s certificate or certificates therefor, to receive certificates for the number of Common Shares into which such Earnout Shares have been converted. Upon the automatic conversion of the applicable Earnout Shares, the holders of such Earnout Shares shall surrender the certificates representing such shares at the registered office of the Corporation or of its transfer agent. Upon surrender of such certificates, the Corporation shall promptly issue and deliver to such holder, in such holder’s name as shown on such surrendered certificate or certificates, a certificate or certificates for the number of Common Shares into which the Earnout Shares surrendered were converted on the Automatic Conversion Date. Such conversion shall be deemed to have been made upon the occurrence of the Automatic Conversion and the Person or Persons entitled to receive the Common Shares issuable upon conversion shall be treated for all purposes as the record holder or holders of such Common Shares at such time.

 

 

 

EX-1.2 3 tm2418826d1_ex1-2.htm EXHIBIT 1.2

 

EXHIBIT 1.2

 

     
 

 

AMENDED AND RESTATED BY-LAW NO. 1

 

A by-law relating generally to the
transaction of the business and affairs of

 

ABOVE FOOD INGREDIENTS INC.

 

(the “Corporation”)

 

 
     

 

 

 


 

TABLE OF CONTENTS

 

Page

 

ARTICLE 1 INTERPRETATION 1
     
1.1 Definitions 1
1.2 Articles Govern 1
     
ARTICLE 2 BOARD 1
     
2.1 Fixed Board and Election of Directors 1
2.2 Floating Board and Election of Directors 2
2.3 Advance Notice of Nominations of Directors 2
     
ARTICLE 3 MEETINGS OF DIRECTORS 4
     
3.1 First Meeting of New Board 4
3.2 Place and Notice of Meetings 4
3.3 Meeting by Electronic Means, etc. 4
3.4 Quorum 4
3.5 Chair of a Meeting 4
3.6 Votes to Govern 5
3.7 Action by Sole Director 5
     
ARTICLE 4 PROTECTION OF DIRECTORS, OFFICERS AND OTHERS 5
     
4.1 Indemnity 5
     
ARTICLE 5 MEETINGS OF SHAREHOLDERS 6
     
5.1 Place of Meetings 6
5.2 Meeting by Electronic Means, etc. 6
5.3 Notice of Meetings 6
5.4 Chair of a Meeting, Secretary and Scrutineers 6
5.5 Quorum 7
5.6 Votes to Govern 7
5.7 Right to Vote 7
5.8 Manner of Voting 7
     
ARTICLE 6 MISCELLANEOUS 8
     
6.1 Repeal 8

 

-i-


 

ARTICLE 1 INTERPRETATION

 

1.1 Definitions

 

In this By-law, any capitalized term used, but not otherwise defined, has the meaning given to that term in the Act. In addition, the following terms have the following meanings:

 

1.1.1 “Act” means the Business Corporations Act (Alberta) and all regulations made under that Act, as it may be amended or replaced, and any reference to a particular provision of that Act will be deemed also to be a reference to any similar provision resulting from its amendment or replacement;

 

1.1.2 “Annual Meeting of Shareholders” means the annual meeting of shareholders of the Corporation held as prescribed by section 132(1) of the Act;

 

1.1.3 “Board” means the board of directors of the Corporation;

 

1.1.4 “By-law” means this by-law, as amended or restated;

 

1.1.5 “Corporation” means Above Food Ingredients Inc.;

 

1.1.6 "Meeting Notice Date" means the date on which the first notice to the shareholders or first public announcement of the date of the meeting of shareholders was issued by the Corporation.

 

1.1.7 “Meeting of Shareholders” means an Annual Meeting of Shareholders or a Special Meeting of Shareholders;

 

1.1.8 “Special Meeting of Shareholders” means a meeting of the holders of any class or series of shares and a special meeting of all shareholders entitled to vote at an Annual Meeting of Shareholders; and

 

1.2 Articles Govern

 

Where any provision of this By-law conflicts with the Articles, the Articles, will govern.

 

ARTICLE 2 BOARD

 

2.1 Fixed Board and Election of Directors

 

Where the Articles provide for a fixed number of directors, the number to be elected to the Board will be the number set out in the Articles.

 

- 2 -

 

2.2 Floating Board and Election of Directors

 

Where the Articles provide for a minimum and maximum number of directors, the number to be elected to the Board will be the number within that minimum and maximum elected at the Annual Meeting of Shareholders.

 

2.3 Advance Notice of Nominations of Directors.

 

2.3.1 Nomination Procedures - Subject only to the Act, applicable securities law and the articles of the Corporation, only persons who are nominated in accordance with the following procedures shall be eligible for election as directors of the Corporation. Nominations of persons for election to the Board may be made at any Annual Meeting of Shareholders, or at any Special Meeting of Shareholders if the election of directors is a matter specified in the notice of meeting,

 

2.3.1.1 by or at the direction of the Board, including pursuant to a notice of meeting;

 

2.3.1.2 by or at the direction or request of one or more shareholders pursuant to a proposal made in accordance with the provisions of the Act, or a requisition of a shareholders meeting by one or more of the shareholders made in accordance with the provisions of the Act; or

 

2.3.1.3 by any person (a “Nominating Shareholder”) who (A) at the close of business on the date of the giving of the notice provided for in this section 2.3 and on the record date for notice of such meeting, is entered in the securities register as a holder of one or more shares carrying the right to vote at such meeting or who beneficially owns shares that are entitled to be voted at such meeting and provides evidence of such beneficial ownership to the Corporation, and (B) complies with the notice procedures set forth below in this section 2.3.

 

2.3.2 Timely notice - In addition to any other applicable requirements, for a nomination to be made by a Nominating Shareholder, the Nominating Shareholder must have given timely notice thereof in proper written form to the secretary of the Corporation in accordance with this section 2.3.

 

2.3.3 Manner of timely notice - To be timely, a Nominating Shareholder’s notice must be given:

 

2.3.3.1 in the case of an Annual Meeting of Shareholders (including any Meeting of Shareholders), not less than 30 days prior to the date of the meeting; provided, however, that in the event that the meeting is to be held on a date that is less than 50 days after the Meeting Notice Date, notice by the Nominating Shareholder shall be made not later than the close of business on the tenth day following the Meeting Notice Date; and

 

2.3.3.2 in the case of a Special Meeting of Shareholders (which is not also an Annual Meeting of Shareholders) called for the purpose of electing directors (whether or not also called for other purposes), not later than the close of business on the fifteenth day following the Meeting Notice Date,

 

provided that, in either case, if the Corporation uses “notice-and-access” (as defined in National Instrument 54-101 – Communication with Beneficial Owners of Securities of a Reporting Issuer) to send proxy-related materials to shareholders in respect of a meeting described above in subsection 2.3.3.1 or subsection 2.3.3.2, and the Notice Date is not less than 50 days before the date of the applicable meeting, the Nominating Shareholder’s notice must be received not later than the close of business on the 40th day before the date of the applicable meeting.

 

- 3 -

 

2.3.4 Proper form of notice - To be in proper written form, a Nominating Shareholder’s notice must set forth:

 

2.3.4.1 as to each person whom the Nominating Shareholder proposes to nominate for election as a director, (A) the name, age, business address and residential address of the person; (B) the principal occupation or employment of the person for the past five years; (C) the status of the person as a resident Canadian; (D) the class or series and number of shares which are controlled or which are owned beneficially or of record by the person as of the record date for the meeting of shareholders (if such date shall then have been made publicly available and shall have occurred) and as of the date of such notice; (E) full particulars regarding any contract, agreement, arrangement, understanding or relationship (collectively, “Arrangements”), including without limitation financial, compensation and indemnity related Arrangements, between the proposed nominee or any associate or affiliate of the proposed nominee and any Nominating Shareholder or any of its representatives; (F) whether such person is a party to any existing or proposed relationship, agreement, arrangement or understanding with any competitor, supplier, officer, employee or other person having or involved in any contractual or fiduciary relationship with the Corporation or any affiliate thereof or any other third party which may give rise to an actual or perceived conflict of interest between the interest of the nominee and the interests of the Corporation or any affiliate thereof; and (G) any other information relating to the person that would be required to be disclosed in a dissident’s proxy circular in connection with solicitations of proxies for election of directors pursuant to the Act or any applicable securities laws; and

 

2.3.4.2 as to the Nominating Shareholder: (A) the name and record address of the Nominating Shareholder; (B) the number of securities of each class of voting securities of the Corporation or any of its subsidiaries beneficially owned, or controlled or directed, directly or indirectly, by such person or any other person with whom such person is acting jointly or in concert with respect to the Corporation or any of its securities, as of the record date for the meeting (if such date shall then have been made publicly available and shall have occurred) and as of the date of such notice; (C) full particulars regarding any proxy, contract, arrangement, understanding or relationship pursuant to which such Nominating Shareholder has a right to vote or to direct or to control the voting of any shares of the Corporation; (D) any other information relating to such Nominating Shareholder that would be required to be made in a dissident’s proxy circular in connection with solicitations of proxies for election of directors pursuant to the Act or any applicable securities laws; (E) any derivatives or other economic or voting interests in the Corporation and any hedges implemented with respect to the Nominating Shareholders’ interests in the Corporation; and (F) whether the Nominating Shareholder intends to deliver a proxy circular and form of proxy to any shareholders of the Corporation in connection with the election of directors.

 

Such notice must be accompanied by the written consent of each nominee to being named as a nominee and to serve as a director, if elected.

 

- 4 -

 

References to “Nominating Shareholder” in this section 2.3.4 shall be deemed to refer to each shareholder that nominates a person for election as a director in the case of a nomination proposal where more than one shareholder is involved in making such nomination proposal.

 

ARTICLE 3 MEETINGS OF DIRECTORS

 

3.1 First Meeting of New Board

 

Immediately following any Meeting of Shareholders electing directors, the Board may, without notice, hold its first meeting for any business that may come before the meeting, provided a quorum of the Board is present.

 

3.2 Place and Notice of Meetings

 

Unless the Articles otherwise provide, meetings of the Board may be held at the registered office of the Corporation or at any other place within or outside Alberta, as determined by the Board. Subject to the Act, the by-laws and any resolution of the Board, notice of the time and place of a meeting of the Board will be given to each director not less than 48 hours before the time when the meeting is to be held but if any one of the President, the Managing Director and the Chief Executive Officer considers it a matter of urgency that a meeting of the Board be convened, he or she may give notice of a meeting by electronic means, telephone or other communication facility no less than 1 day before the meeting. No notice of a meeting will be necessary if all the directors in office are present or if those absent waive notice of that meeting, except where a director attends a meeting for the express purpose of objecting to the transaction of any business on the grounds that the meeting is not lawfully called. Subject to the Act, a notice of a meeting of the Board need not specify the purpose of or the business to be transacted at the meeting.

 

3.3 Meeting by Electronic Means, etc.

 

If all the directors of the Corporation consent, a meeting of the Board or of a committee of the Board may be held by electronic means, telephone or other communication facilities that permit all persons participating in the meeting to hear each other, and a director participating in a meeting by those means is deemed to be present at that meeting.

 

3.4 Quorum

 

Subject to the Articles, a majority of the number of directors of the Corporation in office at the time the meeting is held constitutes a quorum at any meeting of the Board.

 

3.5 Chair of a Meeting

 

The chair of any meeting of the Board will be selected in descending order from the following list of officers, with the position going to the first selected officer who has been appointed, who is a director, and who is present at the meeting:

 

3.5.1 the Chairperson of the Board;

 

- 5 -

 

3.5.2 the Chief Executive Officer;

 

3.5.3 the President; and

 

3.5.4 a Vice-President.

 

If all those officers are absent, or unable or unwilling to act, the directors present at the meeting will choose one of their number to be chair of the meeting.

 

3.6 Votes to Govern

 

Unless otherwise required by the Act or the Articles, at all meetings of the Board, every question will be decided by a majority of the votes cast on the question. In case of an equality of votes on any question, the chair of the meeting will not be entitled to a second or casting vote.

 

3.7 Action by Sole Director

 

Where the Corporation has only one director, where action may be or is required to be taken by the Board or any two directors or any director acting together with any officer, that action may be taken by the sole director of the Corporation.

 

ARTICLE 4 PROTECTION OF DIRECTORS, OFFICERS AND OTHERS

 

4.1 Indemnity

 

4.1.1 Subject to the Act, the Corporation will indemnify a director or officer of the Corporation, a former director or officer of the Corporation, or a person who acts or acted at the Corporation’s request as a director or officer of a body corporate of which the Corporation is or was a shareholder or creditor, and the director’s or officer’s heirs and legal representatives, against all costs, charges and expenses, including an amount paid to settle an action or satisfy a judgment, reasonably incurred by the director or officer in respect of any civil, criminal or administrative action or proceeding to which the director or officer is made a party by reason of being or having been a director or officer of the Corporation or body corporate, if:

 

4.1.1.1 the director or officer acted honestly and in good faith with a view to the best interests of the Corporation; and

 

4.1.1.2 in the case of a criminal or administrative action or proceeding that is enforced by a monetary penalty, the director or officer had reasonable grounds for believing that the director’s or officer’s conduct was lawful.

 

4.1.2 The right to indemnity provided in this Section 4.1 will include the right to the advance of moneys from the Corporation for the costs, charges and expenses of a proceeding referred to in Section 4.1.1, which moneys must be repaid by the person to whom they were advanced unless he or she:

 

4.1.2.1 was substantially successful on the merits in the person’s defence of the action or proceeding;

 

- 6 -

 

4.1.2.2 fulfils the conditions set out in Section 4.1.1; and

 

4.1.2.3 is fairly and reasonably entitled to indemnity.

 

4.1.3 The Corporation will also indemnify the persons listed in Section 4.1.1 in any other circumstances that the Act permits or requires. Nothing in this By-law will limit the right of any person entitled to indemnity to claim indemnity apart from the provisions of this By-law.

 

ARTICLE 5 MEETINGS OF SHAREHOLDERS

 

5.1 Place of Meetings

 

Subject to the Act and the Articles, Meetings of Shareholders will be held within our outside Alberta, at the place, on the dates and at the times as determined by the Board.

 

5.2 Meeting by Electronic Means, etc.

 

Any person entitled to attend a Meeting of Shareholders may participate in the Meeting of Shareholders, in accordance with the Act, by electronic means, telephone or other communication facilities that permit all participants to hear or otherwise communicate with each other during the meeting. A person participating in a Meeting of Shareholders by those means is deemed, for the purposes of the Act, to be present at the meeting. In addition, if the Board or the shareholders of the Corporation call a Meeting of Shareholders under the Act, the Board or shareholders, as the case may be, may determine that the meeting will be held, in accordance with the Act, entirely by electronic means, telephone or other communication facility that permits all participants to hear or otherwise communicate adequately with each other during the meeting.

 

5.3 Notice of Meetings

 

Notice of the time and place of each Meeting of Shareholders will be given, not less than 21 days and not more than 50 days before the date of the meeting, to each director, to the auditor of the Corporation, and to each shareholder who is entitled to vote at the meeting. Notice of a Meeting of Shareholders called for any business other than consideration of the financial statements and auditor’s report, fixing the number of directors for the following year, election of directors and reappointment of the incumbent auditor, will state the nature of that business in sufficient detail to permit the shareholder to form a reasoned judgment on that business, and will state the text of any special resolution or by-law to be submitted to the meeting. A shareholder and any other person entitled to attend a Meeting of Shareholders may, in any manner and at any time, waive notice of a Meeting of Shareholders.

 

5.4 Chair of a Meeting, Secretary and Scrutineers

 

The chair of any Meeting of Shareholders will be selected in descending order from the following list of officers, with the position going to the first selected officer who has been appointed, who is a director, and who is present at the meeting:

 

5.4.1 the Chairperson of the Board;

 

5.4.2 the Chief Executive Officer;

 

- 7 -

 

5.4.3 the President; and

 

5.4.4 a Vice-President.

 

If none of those officers is present within 15 minutes after the time appointed for holding the meeting, the persons present and entitled to vote at the meeting will choose a person from their number to be chair of the meeting. The Secretary of the Corporation will be secretary of any Meeting of Shareholders, but if the Secretary of the Corporation is not present, the chair of the meeting will appoint a person, who need not be a shareholder, to act as secretary of the meeting. If desired, one or more scrutineers, who need not be shareholders, may be appointed by a resolution or by the chair of the meeting with the consent of the shareholders and persons present and entitled to vote at the meeting.

 

5.5 Quorum

 

In the event the Corporation has fewer than 15 shareholders of the Corporation, two or more joint holders being counted as one shareholder, then shareholders holding a majority of the shares of the Corporation entitled to vote at that meeting being present in person or represented by proxy at the meeting shall constitute quorum for that meeting. In the event the Corporation has 15 or more shareholders of the Corporation, two or more joint holders being counted as one shareholder, then Shareholders holding not less than twenty five (25%) percent of the shares of the Corporation entitled to vote at that meeting being present in person or represented by proxy at the meeting shall constitute quorum for that meeting. If a quorum is present at the opening of a Meeting of Shareholders, the shareholders present or represented may proceed with the business of the meeting, even if a quorum is not present throughout the meeting. If a quorum is not present at the time appointed for a Meeting of Shareholders, or within any reasonable time following that time as the shareholders present or represented may determine, the shareholders present or represented may adjourn the meeting to a fixed time and place not less than seven days later but may not transact any other business. At that adjourned meeting the holders of shares carrying voting rights who are present or represented will constitute a quorum (whether or not they hold a majority of the shares entitled to vote at the adjourned meeting or twenty five (25%) percent of the issued shares of the Corporation entitled to vote at that meeting, as applicable) and may transact the business for which the meeting was originally called, even if this quorum is not present throughout the meeting.

 

5.6 Votes to Govern

 

Unless otherwise required by the Act or the Articles, at all Meetings of Shareholders, every question will be decided by a majority of the votes cast on the question. In case of an equality of votes on any question, the chair of the meeting will not be entitled to a second or casting vote.

 

5.7 Right to Vote

 

Unless the Articles otherwise provide, each share of the Corporation entitles its holder to one vote at a Meeting of Shareholders. Subject to the exceptions provided under the Act, a holder of a fractional share is not entitled to exercise voting rights in respect of the fractional share.

 

5.8 Manner of Voting

 

5.8.1 Voting at a Meeting of Shareholders will be by show of hands, except where a ballot is demanded by a shareholder or proxyholder entitled to vote at the meeting. Even if a vote has already been taken by a show of hands, any shareholder or proxyholder entitled to vote at the meeting on that matter may require a ballot on that matter and the subsequent ballot result will be the decision of the shareholders with respect to that matter.

 

- 8 -

 

5.8.2 Where no ballot is demanded or required following a vote by a show of hands upon a question, a declaration by the chair of the meeting that the vote upon the question has been carried, carried by a particular majority or not carried, and an entry to that effect in the minutes of the meeting, will be prima facie evidence of the fact without proof of the number or proportion of the votes recorded in favour of or against any resolution or other proceeding in respect of that question, and the result of the vote taken will be the decision of the shareholders with respect to that question.

 

5.8.3 A ballot, if demanded or required, will be taken in the manner the chair of the meeting directs. A demand or requirement for a ballot may be withdrawn at any time before the taking of the ballot. If a ballot is taken, each person present will be entitled, in respect of the shares which he is entitled to vote at the meeting upon the question, to that number of votes provided by the Act or the Articles, and the result of the ballot will be the decision of the shareholders with respect to that question.

 

5.8.4 If a Meeting of Shareholders is held by electronic means or telephone or other communication facility, then any person participating in, and entitled to vote at, that meeting may vote, in accordance with the Act, by electronic means or telephone or other communication facility that the Corporation has made available for that purpose. Any vote at a Meeting of Shareholders may be held in accordance with the Act entirely by electronic means or telephone or other communication facility if the Corporation makes available that communication facility.

 

ARTICLE 6 MISCELLANEOUS

 

6.1 Repeal

 

By-law No. 1 of the Corporation is repealed. The repeal of By-law No. 1 will not affect the validity of any act done or right, privilege, obligation or liability acquired or incurred under it or the validity of any contract or agreement made under it. All resolutions of the shareholders, the Board or committees of the Board with continuing effect passed under repealed By-law No. 1 will continue in effect except to the extent inconsistent with this By-law.

 

ENACTED by the directors of the Corporation under the Act.

 

CONFIRMED by all the shareholders of the Corporation entitled to vote under the Act.

 

DATED June 28, 2024.  
       
      /s/ Lionel Kambeitz
      Lionel Kambeitz, CEO

 

 

EX-4.1 4 tm2418826d1_ex4-1.htm EXHIBIT 4.1

 

Exhibit 4.1

 

AMENDED & RESTATED WARRANT AGREEMENT

 

This amended and restated warrant agreement (“Agreement”) is made as of June 28, 2024 by and among Above Food Ingredients Inc., a corporation organized under the laws of Alberta, Canada (the “Company”), Bite Acquisition Corp., a Delaware corporation (“Bite”), Continental Stock Transfer & Trust Company, a limited purpose trust company (“Continental”), and Odyssey Transfer and Trust Company, a Minnesota corporation, as warrant agent (the “Successor Warrant Agent”, also referred to herein as the “Transfer Agent”).

 

WHEREAS, Bite and Continental are parties to that certain Warrant Agreement, made as of February 11, 2021 (the “Existing Warrant Agreement”);

 

WHEREAS, Section 9.8 of the Existing Warrant Agreement provides that the parties thereto may amend the Existing Warrant Agreement without the consent of any registered holder (as defined therein) for the purpose of curing any ambiguity, or curing, correcting or supplementing any defective provision contained therein or adding or changing any other provisions with respect to matters or questions arising under the Existing Warrant Agreement as the parties thereto may deem necessary or desirable and that the parties thereto deem shall not adversely affect the interest of the registered holders (as defined therein);

 

WHEREAS, in accordance with Section 9.8 of the Existing Warrant Agreement, Bite and Continental agree to amend and restate the Existing Warrant Agreement in its entirety as contemplated hereunder;

 

WHEREAS, in accordance with Section 8.2.1 of the Existing Warrant Agreement, Continental has agreed to resign its duties as the Warrant Agent as of the date hereof, and Successor Warrant Agent has agreed to serve as successor Warrant Agent from and after the date hereof (in such capacity the “Warrant Agent” and also referred to herein as the “Transfer Agent”);

 

WHEREAS, pursuant to the Existing Warrant Agreement, Bite issued 10,275,000 warrants as part of its initial public offering, including (i) 10,000,000 warrants sold by Bite to the public (the “Public Warrants”) and (ii)(x) 260,000 warrants included as part of the 520,000 private placement units sold by Bite to Smart Dine, LLC (the “Sponsor’) and (y) 15,000 warrants included as part of the 30,000 private placement units sold by Bite to EarlyBird Capital, Inc. (“EarlyBirdCapital” and, together with Sponsor, the “initial purchasers”) (collectively, the “Private Placement Warrants”);

 

WHEREAS, Bite issued an unsecured promissory note in the principal amount of up to $3,250,000 to Sponsor, and up to $1,500,000 of such loan may be converted into an additional 75,000 Private Placement Warrants as part of Sponsor’s option to convert such loan into units (the “Working Capital Warrants”), which Working Capital Warrants shall be treated as Private Placement Warrants for all purposes hereunder;

 

WHEREAS, on April 29, 2023, Bite, the Company, Above Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Above Food Corp., a corporation organized under the laws of Saskatchewan, Canada, entered into that certain Business Combination Agreement (as amended on March 12, 2024, and as may be further amended or supplemented from time to time pursuant to the terms thereof, the “Business Combination Agreement,” and the transactions contemplated thereby, the “Business Combination”);

 

 

 


 

WHEREAS, at the effective time of the SPAC Merger (as defined below) (the “SPAC Merger Effective Time”) and upon the terms and subject to the conditions of the Business Combination Agreement, Merger Sub shall merge with and into Bite (the “SPAC Merger”), with Bite continuing as the surviving company after the SPAC Merger and a direct, wholly owned subsidiary of the Company; WHEREAS, by virtue of, and upon the consummation of the SPAC Merger, and without any action on the part of the parties to the Business Combination Agreement or any of their respective shareholders and in accordance with Section 4.5 of the Existing Warrant Agreement, the Public Warrants and the Private Placement Warrants (collectively, the “Warrants”) issued thereunder shall remain outstanding but will no longer be exercisable for common stock of Bite, par value $0.0001 per share (the “Bite Common Stock”) but instead will be exercisable (on the terms and subject to the conditions of this Agreement) for a number of common shares in the capital of the Company (the “Common Shares”) equal to the number of Bite Common Stock for which such warrants were exercisable immediately prior to the SPAC Merger subject to adjustment as described herein as if the Company assumed the Warrants; and

 

WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption, and exercise of the Warrants; and

 

WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

 

WHEREAS, all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding, and legal obligations of the Company, and to authorize the execution and delivery of this Agreement.

 

NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

 

1. Assignment and Assumption; Consent; Appointment of Warrant Agent.

 

1.1            Assignment and Assumption. Pursuant to the SPAC Merger, Bite assigns to the Company all of Bite’s right, title and interest in and to the Existing Warrant Agreement (as amended hereby) and the Warrants as of the SPAC Merger Effective Time. Pursuant to the SPAC Merger, the Company assumes, and agrees to pay, perform, satisfy and discharge in full, as the same become due, all of Bite’s liabilities and obligations under the Existing Warrant Agreement (as amended hereby) and the Warrants arising from and after the SPAC Merger Effective Time.

1.2            Consent. Continental hereby consents to the assignment of the Existing Warrant Agreement (as amended hereby) and the Warrants by Bite to the Company pursuant to the SPAC Merger and Section 1.1 hereof, effective as of the SPAC Merger Effective Time, the assumption of the Warrants by the Company from Bite pursuant to the SPAC Merger and Section 1.1 hereof, effective as of the SPAC Merger Effective Time, and the continuation of the Warrants in full force and effect from and after the SPAC Merger Effective Time, subject at all times to this Agreement and to all of the provisions, covenants, agreements, terms and conditions of this Agreement.

1.3            Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.

2. Warrants.

2.1            Form of Warrant. Each Warrant shall be issued in registered form only, shall be in substantially the form of Exhibit A hereto, the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairman of the Board of Directors or Chief Executive Officer and the Chief Financial Officer, Treasurer, Secretary or Assistant Secretary of the Company and shall bear a facsimile of the Company’s seal. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance.

2

2.2            Uncertificated Warrants. Notwithstanding anything herein to the contrary, any Warrant may be issued in uncertificated or book-entry form through the Warrant Agent and/or the facilities of The Depository Trust Company or other book-entry depositary system, in each case as determined by the Board of Directors of the Company or by an authorized committee thereof. Any Warrant so issued shall have the same terms, force and effect as a certificated Warrant that has been duly countersigned by the Warrant Agent in accordance with the terms of this Agreement.

2.3            Effect of Countersignature. Except with respect to uncertificated Warrants as described above, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no effect and may not be exercised by the holder thereof.

2.4            Registration.

2.4.1            Warrant Register. The Warrant Agent shall maintain books (“Warrant Register”) for the registration of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered to the Warrant Agent by the Company.

2.4.2            Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name such Warrant is then registered in the Warrant Register (“registered holder”) as the absolute owner of such Warrant and of each Warrant represented thereby (notwithstanding any notation of ownership or other writing on the Warrant certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

2.5            Private Warrant and Working Capital Warrant Attributes. The Private Warrants and Working Capital Warrants are identical to the Public Warrants but they (i) are not redeemable by the Company and (ii) may be exercised for cash or on a cashless basis at the holder’s option, in either case as long as they are held by the initial purchasers or their Permitted Transferees (as defined below). Once a Private Warrant or Working Capital Warrant is transferred to a holder other than an affiliate or Permitted Transferee, it shall be treated as a Public Warrant hereunder for all purposes. “Permitted Transferee” shall mean transferees in transfers (i) among the initial stockholders or to the Company’s or the initial stockholders’ members, officers, directors, consultants or their affiliates, (ii) to a holder’s stockholders or members upon the holder’s liquidation, in each case if the holder is an entity, (iii) by bona fide gift to a member of the holder’s immediate family or to a trust, the beneficiary of which is the holder or a member of the holder’s immediate family, in each case for estate planning purposes, (iv) by virtue of the laws of descent and distribution upon death, (v) pursuant to a qualified domestic relations order, (vi) in the event that, subsequent to the date hereof, the Company completes a liquidation, merger, capital stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their Common Stock for cash, securities or other property, in each case (except for clause (vi) or with the Company’s prior written consent) on the condition that prior to such transfer, the Warrant Agent shall be presented with written documentation pursuant to which each Permitted Transferee or the trustee or legal guardian for such Permitted Transferee agrees to be bound by the transfer restrictions contained in this Agreement and any other applicable agreement the transferor is bound by.

3

3. Terms and Exercise of Warrants.

3.1            Warrant Price. Each whole Warrant shall, when countersigned by the Warrant Agent (except with respect to uncertificated Warrants), entitle the registered holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the number of Common Shares stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant Price” as used in this Agreement refers to the price per share at which Common Shares may be purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than twenty (20) days on which banks in New York City are generally open for normal business (a “Business Day”); provided, that the Company shall provide at least twenty (20) days’ prior written notice of such reduction to registered holders of the Warrants and, provided further that any such reduction shall be applied consistently to all of the Warrants.

3.2            Duration of Warrants. A Warrant may be exercised only during the period commencing on 30 days after the date hereof and terminating at 5:00 p.m., New York City time on the earlier to occur of (i) five years from the date hereof, (ii) the Redemption Date as provided in Section 6.2 and (iii) the liquidation of the Company (the “Expiration Date”). The period of time from the date the Warrants will first become exercisable until the expiration of the Warrants shall hereafter be referred to as the “Exercise Period.” Except with respect to the right to receive the Redemption Price (as set forth in Section 6 hereunder), as applicable, each Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this Agreement shall cease at 5:00 p.m., New York City time, on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided, however, that the Company will provide at least twenty (20) days’ prior written notice of any such extension to registered holders and, provided further that any such extension shall be applied consistently to all of the Warrants.

3.3            Exercise of Warrants.

3.3.1            Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant, when countersigned by the Warrant Agent, may be exercised by the registered holder thereof by surrendering it, at the office of the Warrant Agent, or at the office of its successor as Warrant Agent, in the United States, with the subscription form, as set forth in the Warrant, duly executed, and by paying in full the Warrant Price for each Common Share as to which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the Common Shares and the issuance of such Common Shares, as follows:

(a)            in lawful money of the United States, by good certified check or wire payable to the Warrant Agent; or

(b)            in the event of redemption pursuant to Section 6 hereof in which the Company’s management has elected to force all holders of Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrants for that number of Common Shares equal to the quotient obtained by dividing (x) the product of the number of Common Shares underlying the Warrants, multiplied by the difference between the Warrant Price and the “Fair Market Value” (defined below) by (y) the Fair Market Value.

4

Solely for purposes of this Section 3.3.1(b), the “Fair Market Value” shall mean the average reported last sale price of the Common Shares for the five (5) trading days ending on the third trading day prior to the date on which the notice of redemption is sent to holders of the Warrants pursuant to Section 6 hereof; or (c)            with respect to any Private Warrants or Working Capital Warrants, so long as such Private Warrants or Working Capital Warrants are held by the initial purchasers, by surrendering such Private Warrants or Working Capital Warrants for that number of Common Shares equal to the quotient obtained by dividing (x) the product of the number of Common Shares underlying the Warrants, multiplied by the difference between the exercise price of the Warrants and the “Fair Market Value” by (y) the Fair Market Value; provided, however, that no cashless exercise shall be permitted unless the Fair Market Value is equal to or higher than the exercise price. Solely for purposes of this Section 3.3.1(c), the “Fair Market Value” shall mean the average reported last sale price of the Common Shares for the five (5) trading days ending on the third trading day prior to the date of exercise; or

(d)            in the event the registration statement required by Section 7.4 hereof is not effective and current within ninety (90) days after the date hereof, by surrendering such Warrants for that number of Common Shares equal to the quotient obtained by dividing (x) the product of the number of Common Shares underlying the Warrants, multiplied by the difference between the exercise price of the Warrants and the “Fair Market Value” by (y) the Fair Market Value; provided, however, that no cashless exercise shall be permitted unless the Fair Market Value is equal to or higher than the exercise price. Solely for purposes of this Section 3.3.1(d), the “Fair Market Value” shall mean the average reported last sale price of the Common Shares for the five (5) trading days ending on the trading day prior to the date of exercise.

3.3.2            Issuance of Common Shares. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment of the Warrant Price (if any), the Company shall issue to the registered holder of such Warrant a certificate or certificates, or book entry position, for the number of Common Shares to which he, she or it is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised in full, a new countersigned Warrant, or book entry position, for the number of shares as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, in no event will the Company be required to net cash settle the Warrant exercise. No Warrant shall be exercisable for cash and the Company shall not be obligated to issues Common Shares upon exercise of a Warrant unless the Common Shares issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Warrants. In the event that the condition in the immediately preceding sentence is not satisfied with respect to a Warrant, the holder of such Warrant shall not be entitled to exercise such Warrant for cash and such Warrant may have no value and expire worthless. Warrants may not be exercised by, or securities issued to, any registered holder in any state in which such exercise would be unlawful.

3.3.3            Valid Issuance. All Common Shares issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued, fully paid and nonassessable.

3.3.4            Date of Issuance. Each person in whose name any book entry position or certificate for Common Shares is issued shall for all purposes be deemed to have become the holder of record of such shares on the date on which the Warrant, or book entry position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate, except that, if the date of such surrender and payment is a date when the share transfer books of the Company or book entry system of the Warrant Agent are closed, such person shall be deemed to have become the holder of such shares at the close of business on the next succeeding date on which the share transfer books or book entry system are open.

5

3.3.5            Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained in this subsection 3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder’s Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge, would beneficially own in excess of 9.8% (the “Maximum Percentage”) of the Common Shares outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of Common Shares beneficially owned by such person and its affiliates shall include the number of Common Shares issuable upon exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude Common Shares that would be issuable upon (x) exercise of the remaining, unexercised portion of the Warrant beneficially owned by such person and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding Common Shares, the holder may rely on the number of outstanding Common Shares as reflected in (1) the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q, current report on Form 6-K or other public filing with the SEC as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of Common Shares outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing to such holder the number of Common Shares then outstanding. In any case, the number of outstanding Common Shares shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its affiliates since the date as of which such number of outstanding Common Shares was reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such holder to any other percentage specified in such notice; provided, however, that any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

4. Adjustments.

4.1            Share Dividends; Split Ups. If after the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding Common Shares is increased by a stock dividend payable in Common Shares, or by a split up of Common Shares, or other similar event, then, on the effective date of such stock dividend, split up or similar event, the number of Common Shares issuable on exercise of each Warrant shall be increased in proportion to such increase in outstanding Common Shares.

4.2            Aggregation of Shares. If after the date hereof, the number of outstanding Common Shares is decreased by a consolidation, combination, reverse stock split or reclassification of Common Shares or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of Common Shares issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding Common Shares.

6

4.3            Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or make a distribution in cash, securities or other assets to the holders of the Common Shares or other shares of the Company’s capital stock into which the Warrants are convertible (an “Extraordinary Dividend”), then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and the fair market value (as determined by the Company’s Board of Directors, in good faith) of any securities or other assets paid in respect of such Extraordinary Dividend divided by all outstanding shares of the Company at such time (whether or not any shareholders waived their right to receive such dividend); provided, however, that none of the following shall be deemed an Extraordinary Dividend for purposes of this provision: (a) any adjustment described in subsection 4.1 above or (b) any cash dividends or cash distributions which, when combined on a per share basis with all other cash dividends and cash distributions paid on the Common Shares during the 365-day period ending on the date of declaration of such dividend or distribution does not exceed $0.50 per share (taking into account all of the outstanding shares of the Company at such time (whether or not any shareholders waived their right to receive such dividend) and as adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of Common Shares issuable on exercise of each Warrant) but only with respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50. Solely for purposes of illustration, if the Company, at a time while the Warrants are outstanding and unexpired, pays a cash dividend of $0.35 and previously paid an aggregate of $0.40 of cash dividends and cash distributions on the Common Shares during the 365-day period ending on the date of declaration of such $0.35 dividend, then the Warrant Price will be decreased, effectively immediately after the effective date of such $0.35 dividend, by $0.25 (the absolute value of the difference between $0.75 (the aggregate amount of all cash dividends and cash distributions paid or made in such 365-day period, including such $0.35 dividend) and $0.50 (the greater of (x) $0.50 and (y) the aggregate amount of all cash dividends and cash distributions paid or made in such 365-day period prior to such $0.35 dividend)). Furthermore, solely for the purposes of illustration, if there are a of total 100,000,000 Common Shares outstanding and the Company paid a $1.00 dividend to 17,500,000 of such shares (with the remaining 82,500,000 shares waiving their right to receive such dividend), then no adjustment to the Warrant Price would occur as a $17.5 million dividend payment divided by 100,000,000 shares equals $0.175 per share which is less than $0.50 per share.

4.4            Adjustments in Exercise Price. Whenever the number of Common Shares purchasable upon the exercise of the Warrants is adjusted, as provided in Sections 4.1 and 4.2 above, the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of Common Shares purchasable upon the exercise of the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of Common Shares so purchasable immediately thereafter.

4.5            Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding Common Shares (other than a change covered by Section 4.1, 4.2 or 4.3 hereof or that solely affects the par value of the Common Shares), or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding Common Shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the Warrant holders shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the Common Shares of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the Warrant holder would have received if such Warrant holder had exercised his, her or its Warrant(s) immediately prior to such event. If any reclassification also results in a change in the Common Shares covered by Sections 4.1, 4.2 or 4.3, then such adjustment shall be made pursuant to Sections 4.1, 4.2, 4.3, 4.4 and this Section 4.5. The provisions of this Section 4.5 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the Warrant.

7

4.6            Issuance in connection with a Business Combination. To the extent, in connection with the Business Combination, Bite (a) issued additional shares of Bite Common Stock or equity-linked securities at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price as determined by Bite’s Board of Directors, in good faith, and in the case of any such issuance to the Sponsor, the initial stockholders or their affiliates, without taking into account any shares of Bite Common Stock issued prior to the initial public offering of Bite and held by the initial stockholders or their affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (b) the aggregate gross proceeds from such issuances represented more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Business Combination on the date of the consummation of such Business Combination (net of redemptions), and (c) the Market Value (as defined below) was below $9.20 per share, then the exercise price of the warrants were adjusted (to the nearest cent) to be equal to 115% of the greater of (i) the Market Value or (ii) Newly Issued Price, and the Redemption Trigger Price (as defined below) were adjusted (to the nearest cent) to be equal to 180% of the greater of (i) the Market Value or (ii) the Newly Issued Price. Solely for purposes of this Section 4.6, the “Market Value” shall mean the volume weighted average trading price of Bite Common Stock during the twenty (20) trading day period starting on the trading day prior to the date of the consummation of the Business Combination.

4.7            Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares issuable upon exercise of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3, 4.4, or 4.5, then, in any such event, the Company shall give written notice to each Warrant holder, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

4.8            No Fractional Warrants or Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional shares upon exercise of Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round up to the nearest whole number of Common Shares to be issued to the Warrant holder.

4.9            Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants initially issued pursuant to this Agreement. However, the Company may at any time in its sole discretion make any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

4.10           Other Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections of this Section 4 are strictly applicable, but which would require an adjustment to the terms of the Warrants in order to (i) avoid an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall appoint a firm of independent public accountants, investment banking or other appraisal firm of recognized national standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in such opinion.

8

5. Transfer and Exchange of Warrants.

5.1            Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, properly endorsed with signatures, in the case of certificated Warrants, properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request.

5.2            Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, either in certificated form or in book entry position, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants, or book entry positions, as requested by the registered holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that in the event that a Warrant surrendered for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange therefor until the Warrant Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend.

5.3            Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which will result in the issuance of a warrant certificate or book-entry position for a fraction of a warrant.

5.4            Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

5.5            Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement, the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the Warrant Agent, will supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

6. Redemption.

6.1            Redemption. Subject to Section 6.4 hereof, not less than all of the outstanding Warrants may be redeemed, at the option of the Company, at any time during the Exercise Period, at the office of the Warrant Agent, upon the notice referred to in Section 6.2, at the price of $0.01 per Warrant (“Redemption Price”), provided that the last sales price of the Common Shares equals or exceeds $18.00 per share (subject to adjustment in accordance with Section 4 hereof) (the “Redemption Trigger Price”), on each of twenty (20) trading days within any thirty (30) trading day period commencing after the Warrants become exercisable and ending on the third trading day prior to the date on which notice of redemption is given and provided that there is an effective registration statement covering the Common Shares issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the 30-day redemption or the Company has elected to require the exercise of the Warrants on a “cashless basis” pursuant to subsection 3.3.1(b); provided, however, that if and when the Public Warrants become redeemable by the Company, the Company may not exercise such redemption right if the issuance of Common Shares upon exercise of the Public Warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification.

9

6.2            Date Fixed for, and Notice of, Redemption. In the event the Company shall elect to redeem all of the Warrants that are subject to redemption, the Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date to the registered holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the registered holder received such notice.

6.3            Exercise After Notice of Redemption. The Public Warrants may be exercised, for cash (or on a “cashless basis” in accordance with Section 3 of this Agreement) at any time after notice of redemption shall have been given by the Company pursuant to Section 6.2 hereof and prior to the Redemption Date. In the event the Company determines to require all holders of Public Warrants to exercise their Warrants on a “cashless basis” pursuant to Section 3.3.1(b), the notice of redemption will contain the information necessary to calculate the number of Common Shares to be received upon exercise of the Warrants, including the “Fair Market Value” in such case. On and after the Redemption Date, the record holder of the Warrants shall have no further rights except to receive, upon surrender of the Warrants, the Redemption Price.

6.4            Exclusion of Certain Warrants. The Company agrees that the redemption rights provided in this Section 6 shall not apply to the Private Warrants and Working Capital Warrants if at the time of the redemption such Private Warrants or Working Capital Warrants continue to be held by the initial purchasers. However, with respect to the Private Warrants or Working Capital Warrants, once such Private Warrants or Working Capital Warrants are transferred, the Company may redeem the Private Warrants and Working Capital Warrants in the same manner as the Public Warrants.

7. Other Provisions Relating to Rights of Holders of Warrants.

7.1            No Rights as Stockholder. A Warrant does not entitle the registered holder thereof to any of the rights of a stockholder of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter.

7.2            Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

7.3            Reservation of Common Shares. The Company shall at all times reserve and keep available a number of its authorized but unissued Common Shares that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

10

7.4            Registration of Common Shares. The Company agrees that as soon as practicable after the date hereof, it shall use its best efforts to file with the SEC a registration statement for the registration, under the Act, of the Common Shares issuable upon exercise of the Warrants, and it shall use its best efforts to take such action as is necessary to register or qualify for sale, in those states in which the Warrants were initially offered by the Company and in those states where holders of Warrants then reside, the Common Shares issuable upon exercise of the Warrants, to the extent an exemption is not available. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement until the expiration of the Warrants in accordance with the provisions of this Agreement. If any such registration statement has not been declared effective by the 90th day following date hereof, holders of the Warrants shall have the right, during the period beginning on the 91st day after the date hereof and ending upon such registration statement being declared effective by the SEC, and during any other period when the Company shall fail to have maintained an effective registration statement covering the Common Shares issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis” as determined in accordance with Section 3.3.1(d). The Company shall provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i) the exercise of the Warrants on a cashless basis in accordance with this Section 7.4 is not required to be registered under the Act and (ii) the Common Shares issued upon such exercise will be freely tradable under U.S. federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Act) of the Company and, accordingly, will not be required to bear a restrictive legend. For the avoidance of any doubt, unless and until all of the Warrants have been exercised on a cashless basis, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences of this Section 7.4. The provisions of this Section 7.4 may not be modified, amended, or deleted without the prior written consent of EarlyBirdCapital.

8. Concerning the Warrant Agent and Other Matters.

8.1            Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of Common Shares upon the exercise of Warrants, but the Company shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares.

8.2            Resignation, Consolidation, or Merger of Warrant Agent.

8.2.1            Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of the Warrant (who shall, with such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation or other entity organized and existing under the laws of the United States, in good standing and having its principal office in the United States of America, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations.

11

8.2.2            Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent and the Transfer Agent for the Common Shares not later than the effective date of any such appointment.

8.2.3            Merger or Consolidation of Warrant Agent. Any entity into which the Warrant Agent may be merged or with which it may be consolidated or any entity resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without any further act.

8.3            Fees and Expenses of Warrant Agent.

8.3.1            Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and will reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the execution of its duties hereunder.

8.3.2            Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement.

8.4            Liability of Warrant Agent.

8.4.1            Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a statement signed by the Chief Executive Officer, Chief Financial Officer, any Executive Vice President or the Chairperson of the Board of Directors of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered in good faith by it pursuant to the provisions of this Agreement.

8.4.2            Indemnity. The Warrant Agent shall be liable hereunder only for its own fraud, gross negligence, willful misconduct or bad faith. The Company agrees to indemnify the Warrant Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees, for anything done or omitted by the Warrant Agent in the execution of this Agreement except as a result of the Warrant Agent’s fraud, gross negligence, willful misconduct, or bad faith.

8.4.3            Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution of any Warrant (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant; nor shall it be responsible to make any adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any Common Shares to be issued pursuant to this Agreement or any Warrant or as to whether any Common Shares will, when issued, be valid and fully paid and nonassessable.

12

8.5            Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of Common Shares through the exercise of Warrants.

9. Miscellaneous Provisions.

9.1            Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective successors and assigns.

9.2            Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows:

Above Food Ingredients Inc.
2305 Victoria Avenue $001
Regina, Saskatchewan, S4P 0S7
Attn: Lionel Kambeitz
Email: lionel@abovefood.com
With a copy (which shall not constitute notice) to:

Michelle Westerman
Email: michelle@abovefood.com

With a copy (which shall not constitute notice) to:
Latham & Watkins LLP
811 Main Street, Suite 3700
Houston, TX 77002
Attention: Ryan J. Lynch
Email: Ryan.Lynch@lw.com

and
Gowling WLG (Canada) LLP
1 First Canadian Place
100 King Street West
Suite 1600
Toronto, Ontario M5X 1G5
Attention: Peter Simeon
Email: peter.simeon@gowlingwlg.com

Any notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company), as follows:

13

Odyssey Transfer and Trust Company
2155 Woodlane Drive, Suite 100
Woodbury, MN 55125
Email: clientsus@odysseytrust.com

9.3            Applicable Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. Subject to applicable law, the Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement, including under the Act, shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum.

Any person or entity purchasing or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section 9.3. If any action, the subject matter of which is within the scope the forum provisions above, is filed in a court other than a court located within the State of New York or the United States District Court for the Southern District of New York (a “foreign action”) in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located within the State of New York or the United States District Court for the Southern District of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder’s counsel in the foreign action as agent for such warrant holder.

9.4            Persons Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person, corporation or other entity other than the parties hereto and the registered holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto (and EarlyBirdCapital with respect to Sections 7.4, 9.4, 9.8 hereof) and their successors and assigns and of the registered holders of the Warrants.

9.5            Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in the United States of America, for inspection by the registered holder of any Warrant. The Warrant Agent may require any such holder to submit his Warrant for inspection by it.

9.6            Counterparts. This Agreement may be executed in any number of original or electronic copy counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

14

9.7            Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation thereof.

9.8            Amendments. This Agreement may be amended by the parties hereto without the consent of any registered holder for the purpose of (i) curing any ambiguity or to correct any mistake, including to conform the provisions hereof to the description of the terms of the Warrants and this Agreement set forth in the Prospectus, or curing, correcting or supplementing any defective provision contained herein or (ii) adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest of the registered holders. All other modifications or amendments, including any amendment to increase the Warrant Price or shorten the Exercise Period, shall require the written consent or vote of the registered holders of at least 50% of the then outstanding Public Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1 and 3.2, respectively, without the consent of the registered holders.

9.9            Trust Account Waiver. Each of Continental and the Warrant Agent (if other than Continental) acknowledges and agrees that it shall not make any claims or proceed against the trust account established by Bite in connection with its initial public offering (“Trust Account”), including by way of set-off, and shall not be entitled to any funds in the Trust Account under any circumstance. In the event that Continental or the Warrant Agent (if different than Continental) has a claim against Bite or the Company under this Agreement, Continental and the Warrant Agent will pursue such claim solely against the Bite or Company and not against the property held in the Trust Account.

9.10            Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

Exhibit A - Form of Warrant Certificate IN WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the day and year first above written.

[Signature Page Follows]

15

ABOVE FOOD INGREDIENTS INC.
By: /s/ Lionel Kambeitz
Name: Lionel Kambeitz
Title: Chief Executive Officer

BITE ACQUISITION CORP.
By: /s/Alberto Ardura Gonzalez
Name: Alberto Ardura Gonzalez
Title: Chief Executive Officer

CONTINENTAL STOCK TRANSFER & TRUST COMPANY,
as Warrant Agent
By: /s/ Henry Farrell
Name: Henry Farrell
Title: Vice President

ODYSSEY TRANSFER AND TRUST COMPANY
By: /s/ Becky Paulson
Name: Becky Paulson
Title: President

[Signature Page to Warrant Agreement]

EXHIBIT AFORM OF WARRANT CERTIFICATE

[See attached]

NUMBER

___________-

(SEE REVERSE SIDE FOR LEGEND) WARRANTS

THIS WARRANT WILL BE VOID IF NOT EXERCISED PRIOR TO
THE EXPIRATION DATE (DEFINED BELOW)

ABOVE FOOD INGREDIENTS INC.

CUSIP 00373V118
WARRANT

THIS CERTIFIES THAT, for value received

is the registered holder of a warrant or warrants (the “Warrant(s)”) of Above Food Ingredients Inc., a corporation organized under the laws of Alberta, Canada (the “Company”) to purchase one fully paid and non-assessable common share in the capital of the Company (“Shares”) for each whole Warrant evidenced by this Warrant Certificate. The Warrant is issued pursuant to an Amended and Restated Warrant Agreement made as of June 28, 2024 (the “Warrant Agreement”). The Warrant entitles the holder thereof to purchase from the Company, commencing on 30 days after the date of the Warrant Agreement, such number of Shares of the Company at the Warrant Price (as defined below), upon surrender of this Warrant Certificate and payment of the Warrant Price at the office or agency of Odyssey Transfer and Trust Company, 2155 Woodlane Drive, Suite 100, Woodbury, MN 55125 (the “Warrant Agent”), but only subject to the conditions set forth herein and in the Warrant Agreement. In no event will the Company be required to net cash settle any warrant exercise. The term “Warrant Price” as used in this Warrant Certificate refers to the price per Share at which Shares may be purchased at the time the Warrant is exercised. The initial Warrant Price per Share is equal to $11.50 per share. The Warrant Agreement provides that upon the occurrence of certain events the Warrant Price, the Redemption Trigger Price (as defined below) and the number of Shares purchasable hereunder, set forth on the face hereof, may, subject to certain conditions, be adjusted.

No fraction of a Share will be issued upon any exercise of a Warrant. If the holder of a Warrant would be entitled to receive a fraction of a Share upon any exercise of a Warrant, the Company shall, upon such exercise, round up to the nearest whole number the number of Shares to be issued to such holder.

Upon any exercise of the Warrant for less than the total number of full Shares provided for herein, there shall be issued to the registered holder hereof or the registered holder’s assignee a new Warrant Certificate covering the number of Shares for which the Warrant has not been exercised.

Warrant Certificates, when surrendered at the office or agency of the Warrant Agent by the registered holder in person or by attorney duly authorized in writing, may be exchanged in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants.

Upon due presentment for registration of transfer of the Warrant Certificate at the office or agency of the Warrant Agent, a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants shall be issued to the transferee in exchange for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any applicable tax or other governmental charge.

The Company and the Warrant Agent may deem and treat the registered holder as the absolute owner of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the registered holder, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

1

This Warrant does not entitle the registered holder to any of the rights of a stockholder of the Company.

The Company reserves the right to call the Warrant at any time prior to its exercise with a notice of call in writing to the holders of record of the Warrant, giving at least 30 days’ notice of such call, at any time while the Warrant is exercisable, if the last sale price of the Shares has been at least $18.00 per share (the “Redemption Trigger Price”) on each of 20 trading days within any 30 trading day period (the “30-day trading period”) ending on the third business day prior to the date on which notice of such call is given and if, and only if, there is a current registration statement in effect with respect to the Shares underlying the Warrants commencing five business days prior to the 30-day trading period and continuing each day thereafter until the date of redemption. The call price of the Warrants is to be $0.01 per Warrant. Any Warrant either not exercised or tendered back to the Company by the end of the date specified in the notice of call shall be canceled on the books of the Company and have no further value except for the $0.01 call price.

By:  
Chief Executive Officer   Chief Financial Officer

2

SUBSCRIPTION FORM

To Be Executed by the Registered Holder in Order to Exercise Warrants

The undersigned Registered Holder irrevocably elects to exercise ______________ Warrants represented by this Warrant Certificate, and to purchase the Common Shares issuable upon the exercise of such Warrants, and requests that Certificates for such shares shall be issued in the name of

(PLEASE TYPE OR PRINT NAME AND ADDRESS)
 

(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER)

and be delivered to

(PLEASE PRINT OR TYPE NAME AND ADDRESS)

and, if such number of Warrants shall not be all the Warrants evidenced by this Warrant Certificate, that a new Warrant Certificate for the balance of such Warrants be registered in the name of, and delivered to, the Registered Holder at the address stated below:

Dated:
(SIGNATURE)
(ADDRESS)
(TAX IDENTIFICATION NUMBER)

3

ASSIGNMENT

To Be Executed by the Registered Holder in Order to Assign Warrants

For Value Received, _______________________ hereby sells, assigns and transfers unto

(PLEASE TYPE OR PRINT NAME AND ADDRESS)
 

(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER)

and be delivered to

(PLEASE PRINT OR TYPE NAME AND ADDRESS)

______________________ of the Warrants represented by this Warrant Certificate, and hereby irrevocably constitutes and appoints _________________________________ Attorney to transfer this Warrant Certificate on the books of the Company, with full power of substitution in the premises.

Dated:
(SIGNATURE)

THE SIGNATURE TO THE ASSIGNMENT OF THE SUBSCRIPTION FORM MUST CORRESPOND TO THE NAME WRITTEN UPON THE FACE OF THIS WARRANT CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATSOEVER, AND MUST BE GUARANTEED BY A COMMERCIAL BANK OR TRUST COMPANY OR A MEMBER FIRM OF THE NYSE AMERICAN, NASDAQ, NEW YORK STOCK EXCHANGE, PACIFIC STOCK EXCHANGE, OR CHICAGO STOCK EXCHANGE.

4

EX-4.2 5 tm2418826d1_ex4-2.htm EXHIBIT 4.2

 

EXHIBIT 4.2

 

ABOVE FOOD INGREDIENTS INC.

 

as the Corporation

 

and

 

ABOVE FOOD CORP.

 

as the Subsidiary

 

and

 

ODYSSEY TRUST COMPANY

 

as the Warrant Agent

 

AMENDED AND RESTATED WARRANT INDENTURE
Providing for the Issue of Warrants of the Corporation

 

Dated as of June 28, 2024

 


 

TABLE OF CONTENTS

Page

 

ARTICLE 1 INTERPRETATION 3
1.1 Definitions 3
1.2 Gender and Number 8
1.3 Headings, Etc. 8
1.4 Day not a Business Day 9
1.5 Time of the Essence 9
1.6 Monetary References 9
1.7 Applicable Law 9
ARTICLE 2 ISSUE OF WARRANTS 9
2.1 Creation and Issue of Warrants 9
2.2 Terms of Warrants 9
2.3 Warrantholder not a Shareholder 10
2.4 Warrants to Rank Pari Passu 10
2.5 Form of Warrants 10
2.6 Book Entry Only Warrants 11
2.7 Warrant Certificate 12
2.8 Legends 14
2.9 Register of Warrants 16
2.10 Issue in Substitution for Warrant Certificates Lost, etc. 17
2.11 Exchange of Warrant Certificates 17
2.12 Transfer and Ownership of Warrants 17
2.13 Cancellation of Surrendered Warrants 19
2.14 Assumption by Transferee and Release of Transferor 19
ARTICLE 3 EXERCISE OF WARRANTS 19
3.1 Right of Exercise 19
3.2 Warrant Exercise 20
3.3 Prohibition on Exercise by U.S. Persons; Legended Certificates 22
3.4 Transfer Fees and Taxes 23
3.5 Warrant Agency 23
3.6 Effect of Exercise of Warrant Certificates 24
3.7 Partial Exercise of Warrants; Fractions 24
3.8 Expiration of Warrants 24

 

-i-


 

TABLE OF CONTENTS

(continued)

Page

 

3.9 Accounting and Recording 25
3.10 Securities Restrictions 25
ARTICLE 4 ADJUSTMENT OF NUMBER OF COMMON SHARES AND EXERCISE PRICE 25
4.1 Adjustment of Number of Common Shares and Exercise Price 25
4.2 Entitlement to Common Shares on Exercise of Warrant 29
4.3 No Adjustment for Certain Transactions 29
4.4 Determination by Independent Firm 29
4.5 Proceedings Prior to any Action Requiring Adjustment 29
4.6 Certificate of Adjustment 30
4.7 Notice of Special Matters 30
4.8 No Action after Notice 30
4.9 Other Action 30
4.10 Protection of Warrant Agent 30
4.11 Participation by Warrantholder 31
ARTICLE 5 RIGHTS OF THE CORPORATION AND COVENANTS 31
5.1 Optional Purchases by the Corporation 31
5.2 General Covenants 31
5.3 Warrant Agent’s Remuneration and Expenses 32
5.4 Performance of Covenants by Warrant Agent 32
5.5 Enforceability of Warrants 32
ARTICLE 6 ENFORCEMENT 33
6.1 Suits by Registered Warrantholders 33
6.2 Suits by the Corporation 33
6.3 Immunity of Shareholders, etc. 33
6.4 Waiver of Default 33
ARTICLE 7 MEETINGS OF WARRANTHOLDERS 34
7.1 Right to Convene Meetings 34
7.2 Notice 34
7.3 Chairperson 34
7.4 Quorum 34
7.5 Power to Adjourn 35
7.6 Show of Hands 35

 

-ii-


 

TABLE OF CONTENTS

(continued)

Page

 

7.7 Poll and Voting 35
7.8 Regulations 35
7.9 Corporation and Warrant Agent May be Represented 36
7.10 Powers Exercisable by Extraordinary Resolution 36
7.11 Meaning of Extraordinary Resolution 37
7.12 Powers Cumulative 38
7.13 Minutes 38
7.14 Instruments in Writing 38
7.15 Binding Effect of Resolutions 38
7.16 Holdings by Corporation Disregarded 38
ARTICLE 8 SUPPLEMENTAL INDENTURES 39
8.1 Provision for Supplemental Indentures for Certain Purposes 39
8.2 Successor Entities 40
ARTICLE 9 CONCERNING THE WARRANT AGENT 40
9.1 Indenture Legislation 40
9.2 Rights and Duties of Warrant Agent 40
9.3 Evidence, Experts and Advisers 41
9.4 Documents, Monies, etc. Held by Warrant Agent 42
9.5 Actions by Warrant Agent to Protect Interest 42
9.6 Warrant Agent Not Required to Give Security 42
9.7 Protection of Warrant Agent 42
9.8 Replacement of Warrant Agent; Successor by Merger 43
9.9 Conflict of Interest 44
9.10 Acceptance of Agency 44
9.11 Warrant Agent Not to be Appointed Receiver 44
9.12 Authorization to Carry on Business 44
9.13 Warrant Agent Not Required to Give Notice of Default 45
9.14 Anti-Money Laundering 45
9.15 Compliance with Privacy Code 45
9.16 Securities Exchange Commission Certification 46
ARTICLE 10 GENERAL 46
10.1 Notice to the Corporation and the Warrant Agent 46

 

-iii-


 

TABLE OF CONTENTS

(continued)

Page

 

10.2 Notice to Warrantholders 47
10.3 Ownership of Warrants 48
10.4 Counterparts and Electronic Copies 48
10.5 Satisfaction and Discharge of Indenture 48
10.6 Provisions of Indenture and Warrants for the Sole Benefit of Parties and Warrantholders 48
10.7 Warrants Owned by the Corporation – Certificate to be Provided 49
10.8 Severability 49
10.9 Force Majeure 49
10.10 Assignment, Successors and Assigns 49
10.11 Rights of Rescission and Withdrawal for Holders 50
SCHEDULE A Form of Warrant A-1

 

-iv-


 

AMENDED AND RESTATED WARRANT INDENTURE

 

THIS AMENDED AND RESTATED WARRANT INDENTURE (this “Amended and Restated Warrant Indenture”) is dated as of June 28, 2024.

 

BETWEEN:

 

ABOVE FOOD INGREDIENTS INC., a company existing under the laws of the Province of Alberta, Canada

 

(the “Corporation”),

 

- and -

 

ABOVE FOOD CORP., a company existing under the laws of the Province of Alberta, Canada

 

(the “Subsidiary”),

 

- and -

 

ODYSSEY TRUST COMPANY, a trust company continued under the laws of Canada

 

(the “Warrant Agent”)

 

WHEREAS:

 

A. The Subsidiary and the Warrant Agent are parties to that certain warrant indenture dated January 18, 2021 (the “Original Warrant Indenture”) as amended by a supplement warrant indenture dated May 6, 2024 (the “Supplemental Warrant Indenture” and collectively with the Original Warrant Indenture, the “Warrant Indenture”), providing for the issue of up to 11,416,244 common share purchase warrants of the Subsidiary (the “Subsidiary Warrants”), with each whole Subsidiary Warrant exercisable to acquire one common share in the capital of the Subsidiary (each, a “Subsidiary Share”) at an exercise price of C$3.75 per Subsidiary Share, payable in immediately available Canadian funds or upon a Cashless Exercise (as such term is defined herein), subject to adjustment in accordance with the provisions of Article 4 of the Warrant Indenture, at any time prior to the Expiry Time on the Expiry Date (as such terms are defined herein).

 

B. On April 29, 2023, the Subsidiary, the Corporation, Above Merger Sub, Inc., a Delaware corporation (“Merger Sub”) and Bite Acquisition Corp., a Delaware corporation (“Bite”), entered into a business combination agreement (as amended on March 12, 2024, and as may be further amended or supplemented from time to time pursuant to the terms thereof, the “Business Combination Agreement,” and the transactions contemplated thereby, the “Business Combination”.

 

C. Pursuant to the terms of a statutory plan of arrangement (the “Plan of Arrangement”) under Part 15 of the Business Corporations Act (Alberta) (the “ABCA”), and subject to the terms and conditions of the Business Combination Agreement, at the effective time of the Plan of Arrangement (the “Effective Time”) on June 28, 2024 (the “Effective Date”), among other things:

 

 

  2  

 

(i) each Subsidiary Share held by a holder of Subsidiary Shares (a “Subsidiary Shareholder”) (other than a Dissenting Shareholder (as such term is defined herein) immediately prior to the Effective Time of the Plan of Arrangement will be transferred and assigned to the Corporation in exchange for such number of common shares of the Corporation (“Common Shares”) equal to such number of Subsidiary Shares held immediately prior to the Effective Time multiplied by the Exchange Ratio (as such term is defined herein), and such number of class A earnout shares of the Corporation (“Class A Shares”) and class B earnout shares of the Corporation (“Class B Shares”), in each case, equal to such number of Subsidiary Shares held immediately prior to the Effective Time multiplied by the Earnout Ratio (as such term is defined herein), subject to and in accordance with the Plan of Arrangement; and

 

(ii) each Subsidiary Warrant outstanding immediately prior to the Effective Time will be automatically converted into a common share purchase warrant of the Corporation (each, a “Warrant”) exercisable to receive such number of Common Shares equal to such number of Subsidiary Shares underlying such Subsidiary Warrant immediately prior to the Effective Time multiplied by the Exchange Ratio (rounded down to the nearest whole share), at the Exercise Price or upon a Cashless Exercise (as such terms are defined herein), and upon the due exercise of a Warrant, the holder thereof shall be entitled to receive such number of Class A Shares and Class B Shares, in each case, equal to the number of Subsidiary Shares underlying such Subsidiary Warrant immediately prior to the Effective Time multiplied by the Earnout Ratio, subject to and in accordance with the Plan of Arrangement.

 

D. Pursuant to the terms and subject to the conditions of this Amended and Restated Warrant Indenture and in accordance with the Plan of Arrangement, each full Warrant shall, subject to adjustment, entitle the holder thereof to acquire such number of Common Shares equal to such number of Subsidiary Shares underlying such Subsidiary Warrant held immediately prior to the Effective Time multiplied by the Exchange Ratio (rounded down to the nearest whole share), at the Exercise Price or upon a Cashless Exercise (as such terms are defined herein, as evidenced by such certificate of adjustment to be delivered to the Warrant Agent pursuant to Section 4.6 hereof, and upon the due exercise of a Warrant, the holder thereof shall be entitled to receive such number of Class A Shares and Class B Shares, in each case, equal to the number of Subsidiary Shares underlying such Subsidiary Warrant immediately prior to the Effective Time multiplied by the Earnout Ratio, subject to and in accordance with the Plan of Arrangement.

 

E. Section 8.2 of the Warrant Indenture provides that, among other things, in the event of an arrangement or a transfer of the undertaking or assets of the Subsidiary as an entirety or substantially as an entirety to or with another entity, the successor entity resulting therefrom (if not the Subsidiary) shall expressly assume, by a form of supplemental indenture satisfactory in form to the Warrant Agent and execute and delivered to the Warrant Agent, the due and punctual performance and observance of each and every covenant and condition of the Warrant Indenture to be performed and observed by the Subsidiary.

 

F. The Subsidiary and the Corporation desire the Warrant Agent to act on behalf of the Corporation, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants to be issued to former holders of Subsidiary Warrants pursuant to the Plan of Arrangement.

 

G. The Corporation is duly authorized to create and issue the Warrants to be issued in accordance with the terms and subject to the conditions of this Amended and Restated Warrant Indenture and the Plan of Arrangement.

 

 

  3  

 

H. All acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Corporation and countersigned by or on behalf of the Warrant Agent, as provided herein, the valid, binding and legal obligations of the Corporation, and to authorize the execution and delivery of this Amended and Restated Warrant Indenture.

 

I. The foregoing recitals are made as representations and statements of fact by the Corporation and not by the Warrant Agent.

 

NOW THEREFORE, in consideration of the premises and mutual covenants hereinafter contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Corporation hereby appoints the Warrant Agent as warrant agent to hold the rights, interests and benefits contained herein for and on behalf of those persons who from time to time become the holders of Warrants issued pursuant to this Amended and Restated Warrant Indenture and the parties hereto agree as follows:

 

ARTICLE 1 INTERPRETATION

 

1.1 Definitions.

 

In this Amended and Restated Warrant Indenture, including the recitals and schedules hereto, and in all indentures supplemental hereto:

 

“Acceleration Notice” has the meaning ascribed thereto in Section 2.2(2) of this Amended and Restated Warrant Indenture.

 

“Adjusted EBITDA” means, for the applicable measurement period, determined in a manner consistent with the Corporation’s Audited Year-End Financial Statements, earnings before interest expense, taxes, depreciation, amortization adjusted for non-recurring items in the company’s normal operations resulting from discontinued operations, extraordinary items, unusual or infrequent items, and changes resulting from changes in accounting policies/principles.

 

“Adjustment Period” means the period from the Effective Date up to and including the Expiry Time.

 

“Allocation Schedule” means the allocation schedule to be delivered by the Subsidiary to Bite (and to be delivered by Bite to Odyssey Trust Company, as depositary, thereafter) in accordance with Section 2.5 of the Business Combination Agreement.

 

“Applicable Legislation” means any statute of Canada or a province thereof, and the regulations under any such named or other statute, relating to warrant indentures or to the rights, duties and obligations of warrant agents under warrant indentures, to the extent that such provisions are at the time in force and applicable to this Amended and Restated Warrant Indenture.

 

“Auditors” means a firm of chartered accountants duly appointed as auditors of the Corporation, from time to time.

 

“Authenticated” means (a) with respect to the issuance of a Warrant Certificate, one which has been duly signed by the Corporation (manually or by electronic means) and authenticated by manual signature of an authorized officer of the Warrant Agent, and (b) with respect to the issuance of an Uncertificated Warrant, one in respect of which the Warrant Agent has completed all Internal Procedures such that the particulars of such Uncertificated Warrant as required by Section 2.7 are entered in the register of holders of Warrants, “Authenticate”, “Authenticating” and “Authentication” have the appropriate correlative meanings.

 

 

  4  

 

“Book Entry Only Participants” means institutions that participate directly or indirectly in the Depository’s book entry registration system for the Warrants.

 

“Book Entry Only Warrants” means Warrants that are to be held only by or on behalf of the Depository.

 

“Business Day” means any day other than Saturday, Sunday or a statutory or civic holiday, or any other day on which the banks are not open for business in Calgary, Alberta, and if the Common Shares are listed on a Stock Exchange shall be a day on which such Stock Exchange is open for trading.

 

“Cashless Exercise” has the meaning set forth in Section 3.2(12).

 

“CDS Global Warrants” means Warrants representing all or a portion of the aggregate number of Warrants issued in the name of the Depository represented by an Uncertificated Warrant, or if requested by the Depository or the Corporation, by a Warrant Certificate.

 

“Certificated Warrant” means a Warrant evidenced by a writing or writings substantially in the form of Schedule A, attached hereto.

 

“Change of Control” means a merger, consolidation, business combination, recapitalization, reorganization, or other similar transaction, however effected, resulting in any Person or group (as defined under Section 13 of the Exchange Act) acquiring at more than least 50% of the combined voting power of the then outstanding securities of the Corporation.

 

“Common Share Delivery Date” has the meaning set forth in Section 3.6(2).

 

“Common Share Reorganization” has the meaning set forth in Section 4.1.

 

“Common Shares” means, subject to Article 4, fully paid and non-assessable common shares of the Corporation as presently constituted.

 

“Confirmation” has the meaning set forth in Section 3.2(2).

 

“Corporation’s Audited Year-End Financial Statements” means the audited consolidated balance sheet of the Corporation and the related audited consolidated statements of operations, consolidated statement of changes in shareholders’ equity and consolidated statement of cash flows.

 

“Counsel” means a barrister or solicitor or a firm of barristers and solicitors retained by the Warrant Agent or retained by the Corporation and acceptable to the Warrant Agent, which may or may not be counsel for the Corporation.

 

“Current Market Price” of the Common Shares means, at any date, the volume weighted average price per share at which the Common Shares have traded:

 

(i) following a Liquidity Event, on a Stock Exchange; or

 

 

  5  

 

(ii) if the Common Shares are not listed on any stock exchange, on any over-the-counter market on which the Common Shares are trading, as may be selected for this purpose by the Directors of the Corporation acting reasonably,

 

during the 10 consecutive Trading Days ending the Trading Day before such date. If the Common Shares are not listed on any stock exchange or traded on any over-the-counter market, the Current Market Price shall be determined by the Directors, acting in good faith.

 

“Depository” means CDS Clearing and Depository Services Inc. or such other person as is designated in writing by the Corporation to act as depository in respect of the Warrants.

 

“Directors” means the board of directors of the Corporation.

 

“Dissent Rights” means the rights of dissent described in the Plan of Arrangement.

 

“Dissenting Shareholder” means a registered holder of Subsidiary Shares immediately prior to the Effective Time who has duly and validly exercised the Dissent Rights in respect of all Subsidiary Shares held and who has not withdrawn or been deemed to have withdrawn such exercise of Dissent Rights as of the applicable time of determination.

 

“Dividends” means any dividends paid by the Corporation.

 

“Earnout Period” means any time during the five-year period following the Effective Date.

 

“Earnout Ratio” at any time means the number of Class A Shares and the number of Class B Shares which a holder is entitled to receive upon the due exercise of one whole Warrant, which initially is 0.0349264 of a Class A Share and 0.0349264 of a Class B Share, respectively, being the earnout ratio set forth in the Allocation Schedule, subject to adjustment in accordance with the provisions of Article 4.

 

“Earnout Shares” means, collectively, Class A Shares and Class B Shares, and “Earnout Share” means any one of them.

 

“Effective Date” means the date of this Amended and Restated Warrant Indenture.

 

“Exchange Act” means the United States Securities Exchange Act of 1934.

 

“Exchange Ratio” at any time means the number of Common Shares which a holder may purchase by the due exercise of one whole Warrant, which initially is 0.2103419 of a Common Share, being the exchange ratio set forth in the Allocation Schedule, subject to adjustment in accordance with the provisions of Article 4.

 

“Exercise Date” means, in relation to a Warrant, the Business Day on which such Warrant is validly exercised or deemed to be validly exercised in accordance with Article 3 hereof.

 

“Exercise Notice” has the meaning set forth in Section 3.2(1).

 

“Exercise Price” at any time means the price at which a whole Common Share may be purchased by the exercise of Warrants, payable in United States funds, subject to adjustment in accordance with the provisions of Article 4 hereof, which is initially US$13.31 per Common Share;

 

“Expiry Date” means the earlier of the date that is:

 

 

  6  

 

(i) January 18, 2026; and

 

(iii) provided for in Section 2.2(2) of this Amended and Restated Warrant Indenture, in which case the Expiry Date shall be the date that is the 30th day following the issuance of the Acceleration Notice.

 

“Expiry Time” means 5:00 p.m. (Calgary time) on the Expiry Date.

 

“Extraordinary Resolution” has the meaning set forth in Section 7.11.

 

“First Tranche Earnout Target” with respect to Class A Shares means that each Class A Share will convert into a Common Share on a one-for-one basis if: (i) on any 20 trading days within any 30 trading day period, the trading price of the Common Shares is greater than or equal to US$12.50 (as adjusted for share splits, reverse share splits, sub-divisions, rights issuances, stock dividends, reorganizations, recapitalizations and other similar transactions); (ii) the Adjusted EBITDA of the Corporation for the fiscal year ending January 31, 2025 is greater than or equal to US$21,200,000 based on the audited consolidated financial statements for such period; or (iii) there occurs any transaction resulting in a Change of Control with a valuation of the Common Shares that is greater than or equal to US$12.50 per Common Share (such value per share to be calculated without giving effect to the conversion of any applicable Earnout Shares).

 

“Internal Procedures” means in respect of the making of any one or more entries to, changes in or deletions of any one or more entries in the register at any time (including without limitation, original issuance or registration of transfer of ownership) the minimum number of the Warrant Agent’s internal procedures customary at such time for the entry, change or deletion made to be complete under the operating procedures followed at the time by the Warrant Agent.

 

“Issue Date” for a particular Warrant means the date on which the Warrant is actually issued by or on behalf of the Corporation.

 

“Liquidity Event” means the listing of the Common Shares on a Stock Exchange.

 

“person” means an individual, body corporate, partnership, trust, agent, executor, administrator, legal representative or any unincorporated organization.

 

“register” means the one set of records and accounts maintained by the Warrant Agent pursuant to Section 2.9.

 

“Registered Warrantholders” means the persons who are registered owners of Warrants as such names appear on the register, and for greater certainty, shall include the Depository as well as the holders of Uncertificated Warrants appearing on the register of the Warrant Agent.

 

“Regulation D” means Regulation D under the U.S. Securities Act.

 

“Regulation S” means Regulation S under the U.S. Securities Act.

 

“Second Tranche Earnout Target” with respect to Class B Shares means that each Class B Share will convert into a Common Share on a one-for-one basis if: (i) on any 20 trading days within any 30 trading day period, the trading price of the Common Shares is greater than or equal to US$15.00 (as adjusted for share splits, reverse share splits, sub-divisions, rights issuances, stock dividends, reorganizations, recapitalizations and other similar transactions); (ii) the Adjusted EBITDA of the Corporation the fiscal year ending January 31, 2026 is greater than or equal to US$32,900,000 based on the audited consolidated financial statements for such period; or (iii) there occurs any transaction resulting in a Change of Control with a valuation of the Common Shares that is greater than or equal to US$15.00 per Common Share (such value per share to be calculated without giving effect to the conversion of any applicable Earnout Shares).

 

 

  7  

 

“Shareholders” mean registered holders of Common Shares.

 

“Stock Exchange” means, following the occurrence of a Liquidity Event, the Toronto Stock Exchange, the TSX Venture Exchange, the Canadian Securities Exchange, the NYSE American LLC, or such other recognized stock exchange in Canada or the United States on which the Common Shares are or become listed and which forms the primary trading market for such shares.

 

“this Amended and Restated Warrant Indenture”, “this Warrant Indenture”, “this Indenture”, “this Agreement”, “hereto” “herein”, “hereby”, “hereof” and similar expressions mean and refer to this Amended and Restated Warrant Indenture and any indenture, deed or instrument supplemental hereto; and the expressions “Article”, “Section”, “subsection” and “paragraph” followed by a number, letter or both mean and refer to the specified article, section, subsection or paragraph of this Amended and Restated Warrant Indenture.

 

“Trading Day” means, provided that the Common Shares are listed on a Stock Exchange, a day on which the Stock Exchange is open for trading; and if the Common Shares are not listed on a Stock Exchange, a day on which an over-the-counter market where such shares are traded is open for business.

 

“Uncertificated Warrant” means any Warrant which is not a Certificated Warrant.

 

“United States” means the United States of America, its territories and possessions, any state of the United States, and the District of Columbia.

 

“U.S. Exchange Act” means the United States Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“U.S. Person” means a “U.S. person” as set forth in Regulation S and includes, subject to certain exclusions set out therein, the following: (i) any natural person resident in the United States; (ii) any partnership or corporation organized or incorporated under the laws of the United States; (iii) any estate of which any executor or administrator is a U.S. Person; (iv) any trust of which any trustee is a U.S. Person; (v) any agency or branch of a foreign entity located in the United States; (vi) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. Person; (vii) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; (viii) any partnership or corporation if (A) organized or incorporated under the laws of any jurisdiction other than the United States and (B) formed by a U.S. Person principally for the purpose of investing in securities not registered under the U.S. Securities Act, unless it is organized or incorporated, and owned, by “accredited investors” (as defined in Rule 501(a) of Regulation D) who are not natural persons, estates or trusts.

 

“U.S. Securities Act” means the United States Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

 

  8  

 

“U.S. Warrantholder” means any Registered Warrantholder that is a U.S. Person, acquired Warrants in the United States or for the account or benefit of any U.S. Person or person in the United States.

 

“Warrant Agency” means the principal offices of the Warrant Agent in the City of Calgary or such other place as may be designated in accordance with Section 3.5.

 

“Warrant Agent” means Odyssey Trust Company, in its capacity as warrant agent of the Warrants, or its successors from time to time.

 

“Warrant Certificate” means a certificate, substantially in the form set forth in Schedule A hereto or such other form as may be approved by the Corporation and the Warrant Agent, to evidence those Warrants that will be evidenced by a certificate.

 

“Warrantholders”, or “holders” without reference to Warrants, means the warrantholders as, and in respect of Warrants registered in the name of the Depository and includes owners of Warrants who beneficially hold securities entitlements in respect of Warrants through a Book Entry Only Participant or means, at a particular time, the persons entered in the register hereinafter mentioned as holders of Warrants outstanding at such time.

 

“Warrantholders’ Request” means an instrument signed in one or more counterparts by Registered Warrantholders holding in the aggregate not less than 25% of the aggregate number of all Warrants then unexercised and outstanding, requesting the Warrant Agent to take some action or proceeding specified therein.

 

“Warrants” means the Common Share purchase warrants created by and authorized by and issuable under this Amended and Restated Warrant Indenture, to be issued and Authenticated hereunder as a Certificated Warrant and/or Uncertificated Warrant, entitling the holder thereof to purchase such number of Common Shares multiplied by the Exchange Ratio (rounded down to the nearest whole share) (subject to adjustment as herein provided) per Warrant at the Exercise Price or upon a Cashless Exercise prior to the Expiry Time.

 

“written order of the Corporation”, “written request of the Corporation”, “written consent of the Corporation” and “certificate of the Corporation” mean, respectively, a written order, request, consent and certificate signed in the name of the Corporation by any duly authorized signatory of the Corporation and may consist of one or more instruments so executed.

 

1.2 Gender and Number.

 

Words importing the singular number or masculine gender shall include the plural number or the feminine or neuter genders, and vice versa.

 

1.3 Headings, Etc.

 

The division of this Amended and Restated Warrant Indenture into Articles and Sections, the provision of a Table of Contents and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation of this Amended and Restated Warrant Indenture or of the Warrants.

 

 

  9  

 

1.4 Day not a Business Day.

 

If any day on or before which any action or notice is required to be taken or given hereunder is not a Business Day, then such action or notice shall be required to be taken or given on or before the requisite time on the next succeeding day that is a Business Day.

 

1.5 Time of the Essence.

 

Time shall be of the essence of this Amended and Restated Warrant Indenture.

 

1.6 Monetary References.

 

Whenever any amounts of money are referred to herein, such amounts shall be deemed to be in lawful money of Canada unless otherwise expressed.

 

1.7 Applicable Law.

 

This Amended and Restated Warrant Indenture, the Warrants, the Warrant Certificates (including all documents relating thereto, which by common accord have been and will be drafted in English) shall be construed in accordance with the laws of the Province of Alberta and the federal laws applicable therein. Each of the parties hereto, which shall include the Warrantholders, irrevocably attorns to the exclusive jurisdiction of the courts of the Province of Alberta with respect to all matters arising out of this Amended and Restated Warrant Indenture and the transactions contemplated herein.

 

ARTICLE 2 ISSUE OF WARRANTS

 

2.1 Creation and Issue of Warrants.

 

A maximum of 11,416,244 Warrants (subject to adjustment as herein provided) are hereby created and authorized to be issued on one or more closing dates in accordance with the terms and conditions hereof. By written order of the Corporation, the Warrant Agent shall deliver Authenticated Warrants in certificated or uncertificated form pursuant to Section 2.5 hereof to Registered Warrantholders and record the name of the Registered Warrantholders on the Warrant register. Registration of interests in Warrants held by the Depository may be evidenced by a position appearing on the register for Warrants of the Warrant Agent for an amount representing the aggregate number of such Warrants outstanding from time to time.

 

2.2 Terms of Warrants.

 

(1) Subject to the applicable conditions for exercise set out in Article 3 having been satisfied and subject to adjustment in accordance with Article 4, each whole Warrant shall entitle each Warrantholder thereof, upon exercise at any time after the Issue Date and prior to the Expiry Time, to acquire 0.2103419 of a Common Share, and, if applicable, 0.0349264 of a Class A Share and/or 0.0349264 of a Class B Share, upon payment of the Exercise Price or upon a Cashless Exercise.

 

(2) Notwithstanding Section 2.2(1) and any other provisions herein, if, at any time following a Liquidity Event, the Current Market Price of the Common Shares on a Stock Exchange equals or exceeds US$5.00, the Corporation shall be entitled, at its option, within 10 days following such 10-Trading Day period, to accelerate the exercise period through the issuance by the Corporation of a press release specifying the new Expiry Date (the “Acceleration Notice”) and, in such case, the new Expiry Date shall be deemed to be the 30th day following the issuance of the Acceleration Notice. From and after the new Expiry Date specified in such Acceleration Notice, no Warrants may be issued or exercised, and all unexercised Warrants shall be void and of no effect following the new Expiry Date.

 

 

  10  

 

(3) No fractional Warrants shall be issued or otherwise provided for hereunder and Warrants may only be exercised in a sufficient number to acquire whole numbers of Common Shares. Any fractional Warrants shall be rounded down to the nearest whole number and the holder shall not be entitled to any compensation in respect of any fractional Warrants not issued.

 

(4) Each Warrant shall entitle the holder thereof to such other rights and privileges as are set forth in this Amended and Restated Warrant Indenture.

 

(5) The number of Common Shares which may be purchased pursuant to the Warrants and the Exercise Price and Cashless Exercise therefor shall be adjusted upon the events and in the manner specified in Article 4.

 

(6) Neither the Corporation nor the Warrant Agent shall have any obligation to deliver Common Shares upon the exercise of any Warrant if the person to whom such shares are to be delivered is a resident of a country or political subdivision thereof in which the Common Shares may not lawfully be issued pursuant to applicable securities legislation. The Corporation or the Warrant Agent may require any person to provide proof of an applicable exemption from such applicable securities legislation to the Corporation and Warrant Agent before Common Shares are delivered pursuant to the exercise of any Warrant.

 

2.3 Warrantholder not a Shareholder.

 

Except as may be specifically provided herein, nothing in this Amended and Restated Warrant Indenture or in the holding of a Warrant Certificate, entitlement to a Warrant or otherwise, shall, in itself, confer or be construed as conferring upon a Warrantholder any right or interest whatsoever as a Shareholder, including, but not limited to, the right to vote at, to receive notice of, or to attend, meetings of Shareholders or any other proceedings of the Corporation, or the right to Dividends and other allocations.

 

2.4 Warrants to Rank Pari Passu.

 

All Warrants shall rank equally and without preference over each other, whatever may be the actual date of issue thereof.

 

2.5 Form of Warrants.

 

(1) The Warrants may be issued in both certificated and uncertificated form. Each Warrant originally issued to a U.S. Warrantholder will be evidenced in certificated form only and bear the applicable legends set forth in Section 2.8(1). All Certificated Warrants shall be evidenced by a Warrant Certificate (including all replacements issued in accordance with this Amended and Restated Warrant Indenture), substantially in the form set out in Schedule A hereto, which shall be dated as of the Issue Date, shall bear such distinguishing letters and numbers as the Corporation may, with the approval of the Warrant Agent, prescribe, and shall be issuable in any denomination excluding fractions. All Warrants issued to the Depository may be in either a certificated or uncertificated form, such uncertificated form being evidenced by a book position on the register of Warrantholders to be maintained by the Warrant Agent in accordance with Section 2.9.

 

 

  11  

 

(2) Each Warrantholder by purchasing such Warrant acknowledges and agrees that the terms and conditions set forth in the form of the Warrant Certificate set out in Schedule A hereto shall apply to all Warrants and Warrantholders regardless of whether such Warrants are issued in certificated or uncertificated form or whether such Warrantholders are Registered Warrantholders or owners of Warrants who beneficially hold security entitlements in respect of the Warrants through a Depository.

 

2.6 Book Entry Only Warrants.

 

(1) Registration of beneficial interests in and transfers of Warrants held by the Depository shall be made only through the book entry registration system and no Warrant Certificates shall be issued in respect of such Warrants except where physical certificates evidencing ownership in such securities are required or as set out herein or as may be requested by the Depository, as determined by the Corporation, from time to time. Except as provided in this Section 2.6, owners of beneficial interests in any CDS Global Warrants shall not be entitled to have Warrants registered in their names and shall not receive or be entitled to receive Warrants in definitive form or to have their names appear in the register referred to in Section 2.9 herein. Notwithstanding any terms set out herein, Warrants having the legend set forth in Section 2.8(1) herein may not be held in the name of the Depository or in the form of Uncertificated Warrants.

 

(2) Notwithstanding any other provision in this Amended and Restated Warrant Indenture, no CDS Global Warrants may be exchanged in whole or in part for registered Warrants, and no transfer of any CDS Global Warrants in whole or in part may be registered, in the name of any person other than the Depository for such CDS Global Warrants or a nominee thereof unless:

 

(a) the Depository notifies the Corporation that it is unwilling or unable to continue to act as depository in connection with the Book Entry Only Warrants and the Corporation is unable to locate a qualified successor;

 

(b) the Corporation determines that the Depository is no longer willing, able or qualified to discharge properly its responsibilities as holder of the CDS Global Warrants and the Corporation is unable to locate a qualified successor;

 

(c) the Depository ceases to be a clearing agency or otherwise ceases to be eligible to be a depository and the Corporation is unable to locate a qualified successor;

 

(d) the Corporation determines that the Warrants shall no longer be held as Book Entry Only Warrants through the Depository;

 

(e) such right is required by applicable law, as determined by the Corporation and the Corporation’s Counsel; or

 

(f) the Warrant is to be Authenticated to or for the account or benefit of a U.S. Warrantholder;

 

following which, Warrants for those holders requesting the same shall be registered and issued to the beneficial owners of such Warrants or their nominees as directed by the holder. The Corporation shall provide a certificate of the Corporation giving notice to the Warrant Agent of the occurrence of any event outlined in this Section 2.6(2).

 

(3) Subject to the provisions of this Section 2.6, any exchange of CDS Global Warrants for Warrants which are not CDS Global Warrants may be made in whole or in part in accordance with the provisions of Section 2.12, mutatis mutandis. All such Warrants issued in exchange for a CDS Global Warrant or any portion thereof shall be registered in such names as the Depository for such CDS Global Warrants shall direct and shall be entitled to the same benefits and subject to the same terms and conditions (except insofar as they relate specifically to CDS Global Warrants or to any legend required by Section 2.8(1) and the restrictions set out in such legend) as the CDS Global Warrants or portion thereof surrendered upon such exchange.

 

 

  12  

 

(4) Every Warrant that is Authenticated upon registration or transfer of a CDS Global Warrant, or in exchange for or in lieu of a CDS Global Warrant or any portion thereof, whether pursuant to this Section 2.6, or otherwise, shall be Authenticated in the form of, and shall be, a CDS Global Warrant, unless such Warrant is registered in the name of a person other than the Depository for such CDS Global Warrant or a nominee thereof.

 

(5) Notwithstanding anything to the contrary in this Amended and Restated Warrant Indenture, subject to applicable law, the CDS Global Warrant will be issued as an Uncertificated Warrant, unless otherwise requested in writing by the Depository or the Corporation.

 

(6) The rights of beneficial owners of Warrants who hold securities entitlements in respect of the Warrants through the book entry registration system shall be limited to those established by applicable law and agreements between the Depository and the Book Entry Only Participants and between such Book Entry Only Participants and the beneficial owners of Warrants who hold securities entitlements in respect of the Warrants through the book entry registration system, and such rights must be exercised through a Book Entry Only Participant in accordance with the rules and procedures of the Depository.

 

(7) Notwithstanding anything herein to the contrary, neither the Corporation nor the Warrant Agent nor any agent thereof shall have any responsibility or liability for:

 

(a) the electronic records maintained by the Depository relating to any ownership interests or any other interests in the Warrants or the depository system maintained by the Depository, or payments made on account of any ownership interest or any other interest of any person in any Warrant represented by an electronic position in the book entry registration system (other than the Depository or its nominee);

 

(b) maintaining, supervising or reviewing any records of the Depository or any Book Entry Only Participant relating to any such interest; or

 

(c) any advice or representation made or given by the Depository or those contained herein that relate to the rules and regulations of the Depository or any action to be taken by the Depository on its own direction or at the direction of any Book Entry Only Participant.

 

(8) The Corporation may terminate the application of this Section 2.6 in its sole discretion in which case all Warrants shall be evidenced by Warrant Certificates registered in the name of a person other than the Depository.

 

2.7 Warrant Certificate.

 

(1) For Warrants issued in certificated form, the form of certificate representing Warrants shall be substantially as set out in Schedule A hereto or such other form as is authorized from time to time by the Warrant Agent and the Corporation. Each Warrant Certificate shall be Authenticated manually by or on behalf of the Warrant Agent. Each Warrant Certificate shall be signed by any one duly authorized signatory of the Corporation whose signature shall appear on the Warrant Certificate and may be printed, lithographed or otherwise mechanically reproduced thereon and, in such event, certificates so signed are as valid and binding upon the Corporation as if it had been signed manually. Any Warrant Certificate which has the applicable signature as hereinbefore provided shall be valid notwithstanding that the person whose signature is printed, lithographed or mechanically reproduced no longer holds office at the date of issuance of such certificate. The Warrant Certificates may be engraved, printed or lithographed, or partly in one form and partly in another, as the Warrant Agent may determine.

 

 

  13  

 

(2) The Warrant Agent shall Authenticate Uncertificated Warrants (whether upon original issuance, exchange, registration of transfer, or otherwise) by completing its Internal Procedures and the Corporation shall, and hereby acknowledges that it shall, thereupon be deemed to have duly and validly issued such Uncertificated Warrants under this Amended and Restated Warrant Indenture. Such Authentication shall be conclusive evidence that such Uncertificated Warrant has been duly issued hereunder and that the holder or holders are entitled to the benefits of this Amended and Restated Warrant Indenture. The register shall be final and conclusive evidence as to all matters relating to Uncertificated Warrants with respect to which this Amended and Restated Warrant Indenture requires the Warrant Agent to maintain records or accounts. In case of differences between the register at any time and any other time the register at the later time shall be controlling, absent manifest error and such Uncertificated Warrants are binding on the Corporation.

 

(3) Any Warrant Certificate validly issued in accordance with the terms of this Amended and Restated Warrant Indenture in effect at the time of issue of such Warrant Certificate shall, subject to the terms of this Amended and Restated Warrant Indenture and applicable law, validly entitle the holder to acquire Common Shares, notwithstanding that the form of such Warrant Certificate may not be in the form currently required by this Amended and Restated Warrant Indenture.

 

(4) No Warrant shall be considered issued and shall be valid or obligatory or shall entitle the holder thereof to the benefits of this Amended and Restated Warrant Indenture, until it has been Authenticated by the Warrant Agent. Authentication by the Warrant Agent, including by way of entry on the register, shall not be construed as a representation or warranty by the Warrant Agent as to the validity of this Amended and Restated Warrant Indenture or of such Warrant Certificates or Uncertificated Warrants (except the due Authentication thereof) or as to the performance by the Corporation of its obligations under this Amended and Restated Warrant Indenture and the Warrant Agent shall in no respect be liable or answerable for the use made of the Warrants or any of them or of the consideration thereof. Authentication by the Warrant Agent shall be conclusive evidence as against the Corporation that the Warrants so Authenticated have been duly issued hereunder and that the holder thereof is entitled to the benefits of this Amended and Restated Warrant Indenture.

 

(5) No Certificated Warrant shall be considered issued and shall be obligatory or shall entitle the holder thereof to the benefits of this Amended and Restated Warrant Indenture, until it has been Authenticated by manual signature by or on behalf of the Warrant Agent substantially in the form of the Warrant set out in Schedule A. Such Authentication on any such Certificated Warrant shall be conclusive evidence that such Certificated Warrant is duly Authenticated and is valid and a binding obligation of the Corporation and that the holder is entitled to the benefits of this Amended and Restated Warrant Indenture.

 

(6) No Uncertificated Warrant shall be considered issued and shall be obligatory or shall entitle the holder thereof to the benefits of this Amended and Restated Warrant Indenture, until it has been Authenticated by entry on the register of the particulars of the Uncertificated Warrant. Such entry on the register of the particulars of an Uncertificated Warrant shall be conclusive evidence that such Uncertificated Warrant is a valid and binding obligation of the Corporation and that the holder is entitled to the benefits of this Amended and Restated Warrant Indenture.

 

 

  14  

 

2.8 Legends.

 

(1) Neither the Warrants nor the Common Shares issuable upon exercise of the Warrants have been or will be registered under the U.S. Securities Act or under any United States state securities laws. All Warrant Certificates issued for the benefit or account of a U.S. Warrantholder, each Warrant Certificate issued in exchange therefor or in substitution thereof (including Warrant Certificates issued to subsequent transferees of the Warrants who are U.S. Warrantholders), and any certificates representing the Common Shares issuable upon exercise thereof, and any certificates issued in exchange therefor or in substitution thereof, shall, until such time as the same is no longer required under applicable requirements of the U.S. Securities Act or applicable state securities laws, bear a legend in substantially the following form:

 

“THE SECURITIES REPRESENTED HEREBY [if for Warrants shall also include: AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF] HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE CORPORATION THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED ONLY (A) TO THE CORPORATION, (B) OUTSIDE THE UNITED STATES IN COMPLIANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT AND IN COMPLIANCE WITH LOCAL LAWS AND REGULATIONS, (C) IN COMPLIANCE WITH THE EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER, IF AVAILABLE, AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS, OR (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE U.S. SECURITIES ACT OR ANY APPLICABLE STATE LAWS AND REGULATIONS GOVERNING THE OFFER AND SALE OF SECURITIES, AND IN THE CASE OF (C) OR (D) THE HOLDER HAS PRIOR TO SUCH SALE FURNISHED TO THE CORPORATION AN OPINION OF COUNSEL OR OTHER EVIDENCE OF EXEMPTION IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE CORPORATION TO SUCH EFFECT.

 

THE PRESENCE OF THIS LEGEND MAY IMPAIR THE ABILITY OF THE HOLDER HEREOF TO EFFECT “GOOD DELIVERY” OF THE SECURITIES REPRESENTED HEREBY ON A STOCK EXCHANGE IN CANADA OR THE UNITED STATES.”;

 

For Warrants include:

 

“THIS WARRANT MAY NOT BE EXERCISED IN THE UNITED STATES OR BY OR FOR THE ACCOUNT OR BENEFIT OF A U.S. PERSON OR PERSON IN THE UNITED STATES AND THE UNDERLYING SHARES MAY NOT BE DELIVERED WITHIN THE UNITED STATES UNLESS THE WARRANT AND THE UNDERLYING SHARES HAVE BEEN REGISTERED UNDER THE U.S. SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR UNLESS AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS IS AVAILABLE, AND THE HOLDER HAS DELIVERED AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE CORPORATION TO SUCH EFFECT. “UNITED STATES” AND “U.S. PERSON” ARE USED HEREIN AS SUCH TERMS ARE DEFINED BY REGULATION S UNDER THE U.S. SECURITIES ACT.”

 

 

  15  

 

provided that, if any such Warrants and any such Common Shares issued on exercise of such Warrants, are being sold outside the United States in accordance with Rule 904 of Regulation S under the U.S. Securities Act, if available, and in compliance with applicable state securities laws, the legend may be removed by providing a declaration to the Warrant Agent in the form set forth in Schedule B attached hereto, or as the Warrant Agent or the Corporation may prescribe from time to time, together with such documentation as the Corporation may reasonably request; provided further that, if any such securities are being sold pursuant to Rule 144 under the U.S. Securities Act, if available, or with the prior written consent of the Corporation pursuant to another exemption from registration under the U.S. Securities Act and applicable state securities laws, the legend may be removed by delivery to the Corporation and to the Warrant agent of an opinion of counsel of recognized standing, satisfactory in form and substance to the Corporation, to the effect that such legend is no longer required under applicable requirements of the U.S. Securities Act or state securities laws.

 

The Warrant Agent shall be entitled to request any other documents that it may require in accordance with its internal policies for the removal of the legend set forth above.

 

(2) Each CDS Global Warrant originally issued in Canada on a certificated basis and held by the Depository, and each CDS Global Warrant issued in exchange therefor or in substitution thereof shall bear or be deemed to bear the following legend or such variations thereof as the Corporation may prescribe from time to time:

 

“UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF CDS CLEARING AND DEPOSITORY SERVICES INC. (“CDS”) TO ABOVE FOOD INGREDIENTS INC. (THE “CORPORATION”) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IN RESPECT THEREOF IS REGISTERED IN THE NAME OF CDS & CO, OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF CDS (AND ANY PAYMENT IS MADE TO CDS & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF CDS), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED HOLDER HEREOF, CDS & CO., HAS A PROPERTY INTEREST IN THE SECURITIES REPRESENTED BY THIS CERTIFICATE HEREIN AND IT IS A VIOLATION OF ITS RIGHTS FOR ANOTHER PERSON TO HOLD, TRANSFER OR DEAL WITH THIS CERTIFICATE.”

 

(3) Each CDS Global Warrant, each Warrant Certificate and any certificate or other evidence of any Common Shares issued in exchange therefor shall bear or be deemed to bear the following legend:

 

“UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS AND A DAY AFTER THE LATER OF (I) [CLOSING DATE], AND (II) THE DATE THE CORPORATION BECAME A REPORTING ISSUER IN ANY PROVINCE OR TERRITORY”

 

(4) Notwithstanding any other provisions of this Amended and Restated Warrant Indenture, in processing and registering transfers of Warrants, no duty or responsibility whatsoever shall rest upon the Warrant Agent to determine the compliance by any transferor or transferee with the terms of the legends contained in subsections 2.8(1), 2.8(2) or 2.8(3), or with the relevant securities laws or regulations, including, without limitation, Regulation S, and the Warrant Agent shall be entitled to assume that all transfers that are processed in accordance with this Amended and Restated Warrant Indenture are legal and proper.

 

 

  16  

 

2.9 Register of Warrants

 

(1) The Warrant Agent shall maintain records and accounts concerning the Warrants, whether certificated or uncertificated, which shall contain the information called for below with respect to each Warrant, together with such other information as may be required by law or as the Warrant Agent may elect to record. All such information shall be kept in one set of accounts and records which the Warrant Agent shall designate (in such manner as shall permit it to be so identified as such by an unaffiliated party) as the register of the holders of Warrants. The information to be entered for each account in the register of Warrants at any time shall include (without limitation):

 

(a) the name and address of the Registered Warrantholder, the date of Authentication thereof and the number Warrants;

 

(b) whether such Warrant is a Certificated Warrant or an Uncertificated Warrant and, if represented by a Warrant Certificate, the unique number or code assigned to and imprinted thereupon and, if an Uncertificated Warrant, the unique number or code assigned thereto if any;

 

(c) whether such Warrant has been cancelled; and

 

(d) a register of transfers in which all transfers of Warrants and the date and other particulars of each transfer shall be entered.

 

The register shall be available for inspection by the Corporation and or any Registered Warrantholder during the Warrant Agent’s regular business hours on a Business Day and upon payment to the Warrant Agent of its reasonable fees. Any Registered Warrantholder exercising such right of inspection shall first provide an affidavit in form satisfactory to the Corporation and the Warrant Agent stating the name and address of the Registered Warrantholder and agreeing not to use the information therein except in connection with an effort to call a meeting of Warrantholders or to influence the voting of Warrantholders at any meeting of Warrantholders.

 

(2) Once an Uncertificated Warrant has been Authenticated, the information set forth in the register with respect thereto at the time of Authentication may be altered, modified, amended, supplemented or otherwise changed only to reflect exercise or proper instructions to the Warrant Agent from the holder as provided herein, except that the Warrant Agent may act unilaterally to make purely administrative changes internal to the Warrant Agent and changes to correct errors. Each person who becomes a holder of an Uncertificated Warrant, by his, her or its acquisition thereof shall be deemed to have irrevocably (i) consented to the foregoing authority of the Warrant Agent to make such minor error corrections and (ii) agreed to pay to the Warrant Agent, promptly upon written demand, the full amount of all loss and expense (including without limitation reasonable legal fees of the Corporation and the Warrant Agent plus interest, at an appropriate then prevailing rate of interest to the Warrant Agent), sustained by the Corporation or the Warrant Agent as a proximate result of such error if but only if and only to the extent that such present or former holder realized any benefit as a result of such error and could reasonably have prevented, forestalled or minimized such loss and expense by prompt reporting of the error or avoidance of accepting benefits thereof whether or not such error is or should have been timely detected and corrected by the Warrant Agent; provided, that no person who is a bona fide purchaser shall have any such obligation to the Corporation or to the Warrant Agent.

 

 

  17  

 

2.10 Issue in Substitution for Warrant Certificates Lost, etc.

 

(1) If any Warrant Certificate becomes mutilated or is lost, destroyed or stolen, the Corporation, subject to applicable law, shall issue and thereupon the Warrant Agent shall certify and deliver, a new Warrant Certificate of like tenor, and bearing the same legend, if applicable, as the one mutilated, lost, destroyed or stolen in exchange for and in place of and upon cancellation of such mutilated Warrant Certificate, or in lieu of and in substitution for such lost, destroyed or stolen Warrant Certificate, and the substituted Warrant Certificate shall be in a form approved by the Warrant Agent and the Warrants evidenced thereby shall be entitled to the benefits hereof and shall rank equally in accordance with its terms with all other Warrants issued or to be issued hereunder.

 

(2) The applicant for the issue of a new Warrant Certificate pursuant to this Section 2.10 shall bear the cost of the issue thereof and in the case of mutilation shall, as a condition precedent to the issue thereof, deliver to the Warrant Agent the mutilated Warrant Certificate; and in case of loss, destruction or theft shall, as a condition precedent to the issuance thereof, furnish to the Corporation and to the Warrant Agent such evidence of ownership and of the loss, destruction or theft of the Warrant Certificate so lost, destroyed or stolen as shall be satisfactory to the Corporation and to the Warrant Agent, in their sole discretion, acting reasonably, and such applicant shall also be required to furnish an indemnity and surety bond in amount and form satisfactory to the Corporation and the Warrant Agent, in their sole discretion, and shall pay the reasonable charges of the Corporation and the Warrant Agent in connection therewith.

 

2.11 Exchange of Warrant Certificates.

 

(1) Any one or more Warrant Certificates representing any number of Warrants may, upon compliance with applicable securities legislation and the reasonable requirements of the Warrant Agent, be exchanged for one or more other Warrant Certificates representing the same aggregate number of Warrants, and bearing the same legend, if applicable, as represented by the Warrant Certificate or Warrant Certificates so exchanged.

 

(2) Warrant Certificates may be exchanged only at the Warrant Agency or at any other place that is designated by the Corporation with the approval of the Warrant Agent. Any Warrant Certificate tendered for exchange shall be cancelled and surrendered to the Warrant Agent.

 

(3) Warrant Certificates exchanged for Warrant Certificates that bear the legend set forth in Section 2.8(1) shall bear the same legend.

 

2.12 Transfer and Ownership of Warrants.

 

(1) The Warrants may only be transferred on the register kept by the Warrant Agent at the Warrant Agency by the holder or its legal representatives or its attorney duly appointed by an instrument in writing in form and execution satisfactory to the Warrant Agent only upon:

 

(a) in the case of a Warrant Certificate, surrendering to the Warrant Agent at the Warrant Agency the Warrant Certificates representing the Warrants to be transferred together with a duly executed transfer form as set forth in Schedule A hereto (together with a declaration for removal of legend or opinion of counsel, if required by Section 2.8(1));

 

(b) in the case of Book Entry Only Warrants, in accordance with procedures prescribed by the Depository under the book entry registration system, and

 

(c) upon compliance with:

 

 

  18  

 

(i) the conditions herein;

 

(ii) such reasonable requirements as the Warrant Agent may prescribe; and

 

(iii) all applicable securities legislation and requirements of regulatory authorities;

 

and such transfer shall be duly noted in such register by the Warrant Agent. Upon compliance with such requirements, the Warrant Agent shall issue to the transferee of a Certificated Warrant, a Warrant Certificate, representing the Warrants transferred. The transferee of a Book Entry Only Warrant shall be recorded through the relevant Book Entry Only Participant in accordance with the book entry registration system as the entitlement holder in respect of such Warrants.

 

(2) If a Warrant Certificate tendered for transfer bears the legend set forth in Section 2.8(1), the Warrant Agent shall not register such transfer unless the transferor has provided the Warrant Agent with the Warrant Certificate and such securities may be transferred only: (A) to the Corporation, (B) outside the United States in accordance with Rule 904 of Regulation S, if available, and in compliance with applicable local securities laws and regulations (C) in accordance with the exemption from registration under the U.S. Securities Act provided by (I) Rule 144 or (II) Rule 144A, in each case, if available, and in compliance with applicable state securities laws, or (D) with the prior written consent of the Corporation pursuant to another exemption from registration under the U.S. Securities Act and applicable state securities laws after first providing to the Corporation and the Warrant Agent (1) in the case of a transfer pursuant to clause B, a declaration in the form of Schedule B hereto together with such additional documentation as the Corporation and the Warrant Agent may reasonably prescribe, and (2) in the case of a transfer pursuant to clause C or clause D, an opinion of U.S. counsel of recognized standing in form and substance satisfactory to the Corporation that the offer, sale, pledge or other transfer does not require registration under the U.S. Securities Act or applicable state securities laws. Warrants and, if applicable, the Common Shares issuable upon exercise thereof, issued to, or for the account or benefit of, a U.S. Warrantholder (and any certificates issued in replacement thereof or in substitution therefor) must be issued only in individually certificated form.

 

(3) Subject to the provisions of this Amended and Restated Warrant Indenture and applicable law, the Warrantholder shall be entitled to the rights and privileges attaching to the Warrants, and the issue of Common Shares by the Corporation upon the exercise of Warrants in accordance with the terms and conditions herein contained shall discharge all responsibilities of the Corporation and the Warrant Agent with respect to such Warrants and neither the Corporation nor the Warrant Agent shall be bound to inquire into the title of any such holder.

 

(4) The Corporation will be entitled, and may direct the Warrant Agent, to refuse to recognize any transfer, or enter the name of any transferee, of any Warrant on the register kept by the Warrant Agent, if such transfer would constitute a violation of applicable securities laws or the rules, regulations or policies of any regulatory authority having jurisdiction. The Warrant Agent is entitled to assume compliance with all applicable securities laws unless otherwise notified in writing by the Corporation. No duty shall rest with the Warrant Agent to determine compliance of the transferee or transferor of any Warrant with securities laws.

 

(5) Any Warrant Certificate issued to a transferee upon transfers contemplated by this section shall bear the appropriate legends, as required by applicable securities laws, as set forth in Section 2.8.

 

 

  19  

 

2.13 Cancellation of Surrendered Warrants.

 

All Warrant Certificates surrendered pursuant to Article 3 or transferred or exchanged pursuant to Article 2 shall be cancelled by the Warrant Agent and upon such circumstances all such Uncertificated Warrants shall be deemed cancelled and so noted on the register by the Warrant Agent. Upon request by the Corporation, the Warrant Agent shall furnish to the Corporation a cancellation certificate identifying the Warrant Certificates so cancelled, the number of Warrants evidenced thereby, the number of Common Shares, if any, issued pursuant to such Warrants, as applicable, and the details of any Warrant Certificates issued in substitution or exchange for such Warrant Certificates cancelled.

 

2.14 Assumption by Transferee and Release of Transferor.

 

Upon becoming a Warrantholder in accordance with the provisions of this Amended and Restated Warrant Indenture, the transferee thereof shall be deemed to have acknowledged and agreed to be bound by this Amended and Restated Warrant Indenture. Upon the registration of such transferee as the Warrantholder of a Warrant, the transferor shall cease to have any further rights under this Amended and Restated Warrant Indenture with respect to such Warrant or the Common Shares issuable upon exercise thereof.

 

ARTICLE 3 EXERCISE OF WARRANTS

 

3.1 Right of Exercise.

 

Subject to the provisions hereof, each Warrantholder may exercise the right conferred on such holder to subscribe for and purchase such number of Common Shares multiplied by the Exchange Ratio (rounded down to the nearest whole share), at the Exercise Price or upon a Cashless Exercise, for each Warrant after the Effective Date and prior to the Expiry Time, subject to adjustment, and in accordance with the conditions herein; provided however, that if a Warrant tendered for exercise bears the legend set forth in Section 2.8(1), such exercise must be permitted under applicable United States securities laws; and upon the due exercise of a Warrant during the Earnout Period, such Warrantholder shall be entitled to receive such number of Class A Shares and Class B Shares, in each case, equal to the number of Subsidiary Shares underlying such Subsidiary Warrant immediately prior to the Effective Time multiplied by the Earnout Ratio, subject to and in accordance with the Plan of Arrangement, provided, however, that (x) no Class A Shares or Class B Shares will be issuable to Warrantholders upon exercise of Warrants if, prior to such exercise, the Class A Shares or Class B Shares are redeemed pursuant to the Articles of the Corporation, (y) no Class A Shares will be issuable to Warrantholders upon exercise of Warrants if, prior to such exercise, the First Tranche Earnout Target has been achieved, and (z) no Class B Shares will be issuable to Warrantholders upon exercise of Warrants if, prior to such exercise, the Second Tranche Earnout Target has been achieved; and upon the closing of the Business Combination, the Warrant Agent shall receive a certificate of adjustment with respect to the foregoing pursuant to Section 4.6 hereof.

 

 

  20  

 

3.2 Warrant Exercise.

 

(1) Holders of Certificated Warrants who wish to exercise the Warrants held by them in order to acquire Common Shares must, if permitted pursuant to the terms and conditions hereunder and as set forth in any applicable legend, complete the exercise form (the “Exercise Notice”) which form is attached to the Warrant Certificate which may be amended by the Corporation with the consent of the Warrant Agent, if such amendment does not, in the reasonable opinion of the Corporation and the Warrant Agent, relying on the advice of counsel, materially and adversely affect the rights, entitlements and interests of the Warrantholders, and deliver such certificate(s), the executed Exercise Notice and a certified cheque, bank draft or money order payable to or to the order of the Corporation for the aggregate Exercise Price to the Warrant Agent at the Warrant Agency. The Warrants represented by a Warrant Certificate shall be deemed to be surrendered upon personal delivery of such certificate, Exercise Notice and aggregate Exercise Price or, if such documents are sent by mail or other means of transmission, upon actual receipt thereof by the Warrant Agent at the office referred to above. If the Warrants are exercised pursuant to Box (B) or (C) of the Exercise Notice, the Warrant Agent will promptly forward the Exercise Notice and related materials to the Corporation together with the request for the Corporation to confirm (a) whether the exercise is approved, and (b) whether the U.S. Securities Act legend set forth in Section 2.8(1) hereof should be imposed on the Common Shares issuable on exercise of the Warrants. The Warrant Agent agrees not to issue any Common Shares upon exercise pursuant to Box (B) or (C) of the Exercise Notice without the approval of the Corporation.

 

(2) A beneficial holder of Uncertificated Warrants evidenced by a security entitlement in respect of Warrants in the book entry registration system who desires to exercise his or her Warrants must do so by causing a Book Entry Only Participant to deliver to the Depository on behalf of the beneficial holder, notice of the beneficial holder’s intention to exercise Warrants in a manner acceptable to the Depository. Forthwith upon receipt by the Depository of such notice, as well as payment for the Exercise Price, the Depository shall deliver to the Warrant Agent confirmation of its intention to exercise Warrants (“Confirmation”) in a manner acceptable to the Warrant Agent, including by electronic means through the book entry registration system. An electronic exercise of the Warrants initiated by a Book Entry Only Participant through the book entry registration system on behalf of a beneficial owner shall constitute a representation to both the Corporation and the Warrant Agent that, at the time of exercise of such Warrants, the Warrantholder (i) is not in the United States; (ii) is not a U.S. Person and is not exercising such Warrants on behalf of a U.S. Person or a person in the United States; and (iii) did not execute or deliver the notice of the owner’s intention to exercise such Warrants in the United States. If the Book Entry Only Participant is not able to make or deliver the foregoing representations by initiating the electronic exercise of the Warrants, then such Warrants shall be withdrawn from the book entry registration system by the Book Entry Only Participant and an individually registered Warrant Certificate shall be issued by the Warrant Agent to such beneficial holder of the Uncertificated Warrants or Book Entry Only Participant and the exercise procedures set forth in Sections 3.2(1) shall be followed.

 

(3) Payment representing the aggregate Exercise Price must be provided to the appropriate office of the Book Entry Only Participant in a manner acceptable to it. A notice in form acceptable to the Book Entry Only Participant and payment from such beneficial holder should be provided to the Book Entry Only Participant sufficiently in advance so as to permit the Book Entry Only Participant to deliver notice and payment to the Depository and for the Depository in turn to deliver notice and payment to the Warrant Agent prior to Expiry Time. The Depository will initiate the exercise by way of the Confirmation and forward the aggregate Exercise Price electronically to the Warrant Agent and the Warrant Agent will execute the exercise by causing the issuance to the Depository through the book entry registration system of the Common Shares to which the exercising Warrantholder is entitled pursuant to the exercise. Any expense associated with the exercise process will be for the account of the entitlement holder exercising the Warrants and/or the Book Entry Only Participant exercising the Warrants on its behalf.

 

(4) By causing a Book Entry Only Participant to deliver notice to the Depository, a beneficial holder shall be deemed to have irrevocably surrendered his or her Warrants so exercised and appointed such Book Entry Only Participant to act as his or her exclusive settlement agent with respect to the exercise and the receipt of Common Shares in connection with the obligations arising from such exercise.

 

 

  21  

 

(5) Any notice which the Depository determines to be incomplete, not in proper form or not duly executed shall for all purposes be void and of no effect and the exercise to which it relates shall be considered for all purposes not to have been exercised thereby. A failure by a Book Entry Only Participant to exercise or to give effect to the settlement thereof in accordance with the beneficial holder’s instructions will not give rise to any obligations or liability on the part of the Corporation or Warrant Agent to the Book Entry Only Participant or the beneficial owner.

 

(6) The Exercise Notice referred to in this Section 3.2 shall be signed by the Registered Warrantholder, or its executors or administrators or other legal representatives or an attorney of the Registered Warrantholder, duly appointed by an instrument in writing satisfactory to the Warrant Agent but such Exercise Notice need not be executed by the Depository.

 

(7) Any exercise referred to in this Section 3.2 shall require that the entire Exercise Price for Common Shares subscribed for must be paid at the time of subscription and such Exercise Price and original Exercise Notice executed by the Registered Warrantholder or the Confirmation from the Depository must be received by the Warrant Agent prior to the Expiry Time.

 

(8) Notwithstanding the foregoing in this Section 3.2, Warrants may only be exercised pursuant to this Section 3.2 by or on behalf of a Warrantholder (excluding the Depository), who is permitted to and makes the certifications set forth on the Exercise Notice and delivers, if applicable, any opinion or other evidence as required by the Corporation.

 

(9) If the form of Exercise Notice set forth in the Warrant Certificate shall have been amended, the Corporation shall cause the amended Exercise Notice to be forwarded to all Registered Warrantholders.

 

(10) Exercise Notices and Confirmations must be delivered to the Warrant Agent at any time during the Warrant Agent’s actual business hours on any Business Day prior to the Expiry Time. Any Exercise Notice or Confirmations received by the Warrant Agent after business hours on any Business Day will be deemed to have been received by the Warrant Agent on the next following Business Day.

 

(11) Any Warrant with respect to which an Exercise Notice or Confirmation is not received by the Warrant Agent before the Expiry Time shall be deemed to have expired and become void and all rights with respect to such Warrants shall terminate and be cancelled.

 

(12) Notwithstanding anything to the contrary in this Section 3.2, if at any time prior to the Expiry Time, the Current Market Price exceeds the Exercise Price, each Warrantholder may elect to receive Common Shares pursuant to a “cashless exercise” (a “Cashless Exercise”), in lieu of a cash exercise, equal to the value of a Warrant determined in the manner described below (or of any portion thereof remaining unexercised) by surrender of a Warrant and an Exercise Notice, in which event the Corporation shall issue to the Warrantholder the number of Common Shares computed using the following formula:

 

 X = (Y)(A-B)

(A)

 

Where:

 

(a) X = the number of Common Shares to be issued to the Warrantholder.

 

 

  22  

 

(b) Y = the number of Common Shares that the Warrantholder elects to purchase under a Warrant (at the date of such calculation) in accordance with the Exchang Ratio.

 

(c) A = the Current Market Price on the trading day immediately preceding the date of the receipt by the Warrant Agent of the Cashless Exercise Notice.

 

(d) B = the Exercise Price per Common Share of such Warrant, as adjusted.

 

The issue price for each such Common Share to be issued pursuant to the Cashless Exercise of a Warrant will be equal to (B), as defined above, and the total issue price for the aggregate number of Common Shares issued pursuant to the Cashless Exercise of a Warrant will be paid and satisfied in full by the surrender to the Corporation of such Warrant and an Exercise Notice.

 

Upon a Cashless Exercise of a Warrant during the Earnout Period, such Warrantholder shall be entitled to receive such number of Class A Shares and Class B Shares, in each case, as is equal to the number of Common Shares issuable upon Cashless Exercise divided by the Exchange Ratio multiplied by the Earnout Ratio.

 

Notwithstanding the foregoing, (x) no Class A Shares or Class B Shares will be issuable to Warrantholders upon a Cashless Exercise if, prior to such exercise, the Class A Shares or Class B Shares are redeemed pursuant to the Articles of the Corporation, (y) no Class A Shares will be issuable to Warrantholders upon a Cashless Exercise if, prior to such exercise, the First Tranche Earnout Target has been achieved, and (z) no Class B Shares will be issuable to Warrantholders upon a Cashless Exercise if, prior to such exercise, the Second Tranche Earnout Target has been achieved.

 

3.3 Prohibition on Exercise by U.S. Persons; Legended Certificates

 

(1) The Warrants and the Common Shares issuable upon exercise thereof have not been and will not be registered under the U.S. Securities Act or the securities laws of any state of the United States, and the Warrants may not be exercised by or on behalf of any person in the United States or by or on behalf of any U.S. Person unless an exemption from the registration requirements of the U.S. Securities Act and the securities laws of all applicable states is available. The Warrant Agent shall not issue or register Common Shares or the certificates representing such Common Shares unless the Warrantholder provides:

 

(a) a written certification that the Warrantholder at the time of exercise of the Warrants (a) is not in the United States; (b) is not a U.S. Person and is not exercising the Warrants on behalf of, or for the account or benefit of, a U.S. Person or a person in the United States; and (c) represents and warrants that the exercise of the Warrants and the acquisition of the Common Shares issuable upon exercise thereof occurred in an “offshore transaction” (as defined under Regulation S under the U.S. Securities Act);

 

(b) a written confirmation that the Warrantholder (a) is an original U.S. purchaser who purchased the Warrants directly from the Corporation pursuant to Rule 506(b) of Regulation D under the U.S. Securities Act, (b) is an ”accredited investor” as defined in Rule 501(a) of Regulation D under the U.S. Securities Act, and (c) and confirms, as of the date of exercise, each of the representations, warranties, certifications and agreements made by it in connection with its acquisition of such Warrants as though such representations, warranties, certifications and agreements were made on the date thereof and in respect of the acquisition of the Common Shares issuable upon exercise of the Warrants; or

 

 

  23  

 

(c) an opinion of counsel of recognized standing in form and substance reasonably satisfactory to the Corporation to the effect that the exercise of the Warrants and the issuance of the Common Shares issuable upon the exercise thereof are exempt from registration under the U.S. Securities Act or any applicable state securities laws.

 

(2) No certificates representing Common Shares will be registered or delivered to an address in the United States unless the Warrantholder complies with the requirements set forth in Section 3.3(1)(b) or 3.3(1)(c) and, in the case of Section 3.3(1)(c), the Corporation has confirmed in writing to the Warrant Agent that the opinion of counsel and such other evidence required by the Corporation is reasonably satisfactory to the Corporation. The certificates representing any Common Shares issued in connection with the exercise of Warrants pursuant to Sections 3.3(1)(b) or 3.3(1)(c) shall bear the legends set forth in Section 2.8(1) of this Amended and Restated Warrant Indenture. Certificates representing Common Shares issued in connection with the exercise of Warrants pursuant to Section 3.3(1)(a) shall not bear the legend set forth in Section 2.8(1).

 

(3) Common Shares, issued to, or for the account or benefit of, a U.S. Warrantholder (and any certificates issued in replacement thereof or in substitution therefor) must be issued only in individually certificated form.

 

(4) Certificates representing Common Shares issued upon the exercise of Warrants which bear the legend set forth in Section 2.8(1) and which are issued and delivered pursuant to Sections 3.3(1)(b) or 3.3(1)(c) (and each certificate issued in exchange therefor or in substitution thereof) shall bear the legend set forth in Section 2.8(1).

 

(5) Any unexercised Warrants must be re-issued in certificated form and bear the legend set out in Section 2.8(1).

 

3.4 Transfer Fees and Taxes.

 

If any of the Common Shares subscribed for are to be issued to a person or persons other than the Registered Warrantholder, the Registered Warrantholder shall execute the form of transfer and will comply with such reasonable requirements as the Warrant Agent may stipulate and will pay to the Corporation or the Warrant Agent on behalf of the Corporation, all applicable transfer or similar taxes and the Corporation will not be required to issue or deliver certificates evidencing Common Shares unless or until such Warrantholder shall have paid to the Corporation or the Warrant Agent on behalf of the Corporation, the amount of such tax or shall have established to the satisfaction of the Corporation and the Warrant Agent that such tax has been paid or that no tax is due.

 

3.5 Warrant Agency.

 

To facilitate the exchange, transfer or exercise of Warrants and compliance with such other terms and conditions hereof as may be required, the Corporation has appointed the Warrant Agency, as the agency at which Warrants may be surrendered for exchange or transfer or at which Warrants may be exercised and the Warrant Agent has accepted such appointment. The Corporation may from time to time designate alternate or additional places as the Warrant Agency (subject to the Warrant Agent’s prior approval) and will give notice to the Warrant Agent of any proposed change of the Warrant Agency. Branch registers shall also be kept at such other place or places, if any, as the Corporation, with the approval of the Warrant Agent, may designate. The Warrant Agent will from time to time when requested to do so by the Corporation or any Registered Warrantholder, subject to Section 2.9(1), upon payment of the Warrant Agent’s reasonable charges, furnish a list of the names and addresses of Registered Warrantholders showing the number of Warrants held by each such Registered Warrantholder.

 

 

  24  

 

3.6 Effect of Exercise of Warrant Certificates.

 

(1) Upon the exercise of Warrants pursuant to and in compliance with Section 3.2 and subject to Sections 3.3 and 3.4, the securities to be issued pursuant to the Warrants exercised shall be deemed to have been issued and the person or persons to whom such securities are to be issued shall be deemed to have become the holder or holders of such securities as of the Exercise Date, unless the register shall be closed on such date, in which case the securities subscribed for shall be deemed to have been issued and such person or persons deemed to have become the holder or holders of record of such securities, on the date on which such register is reopened.

 

(2) As soon as practicable, and in any event no later than within five Business Days after the Exercise Date with respect to a Warrant (the “Common Share Delivery Date”), the Warrant Agent shall cause to be delivered or mailed to the person or persons in whose name or names the Warrant is registered or, if so specified in writing by the holder, subject to the Warrant Agency being open to the public at such time, cause to be delivered to such person or persons at the Warrant Agency where the Warrant Certificate was surrendered, a certificate or certificates for the appropriate number of securities subscribed for, or any other appropriate evidence of the issuance of securities to such person or persons in respect of securities issued under the book entry registration system.

 

3.7 Partial Exercise of Warrants; Fractions.

 

(1) The holder of any Warrants may exercise his right to acquire a number of whole Common Shares less than the aggregate number which the holder is entitled to acquire. In the event of any exercise of a number of Warrants less than the number which the holder is entitled to exercise, the holder of Warrants upon such exercise shall, in addition, be entitled to receive, without charge therefor, one or more new Warrant Certificates, bearing the same legend, if applicable, or other appropriate evidence of Warrants, in respect of the balance of the Warrants held by such holder and which were not then exercised.

 

(2) Notwithstanding anything herein contained including any adjustment provided for in Article 4, the Corporation shall not be required, upon the exercise of any Warrants, to issue fractions of Common Shares. Warrants may only be exercised in a sufficient number to acquire whole numbers of Common Shares. Any fractional Common Shares shall be rounded down to the nearest whole number and the holder of such Warrants shall not be entitled to any compensation in respect of any fractional Common Share which is not issued.

 

3.8 Expiration of Warrants.

 

(1) Immediately after the Expiry Time, all rights under any Warrant in respect of which the right of acquisition provided for herein shall not have been exercised shall cease and terminate and each Warrant shall be void and of no further force or effect.

 

 

  25  

 

3.9 Accounting and Recording.

 

(1) The Warrant Agent shall promptly account to the Corporation with respect to Warrants exercised, and shall forward, as soon as practicable, to the Corporation (or into an account or accounts of the Corporation with the bank or trust company designated by the Corporation for that purpose), all monies received by the Warrant Agent on the subscription of Common Shares through the exercise of Warrants. All such monies and any securities or other instruments, from time to time received by the Warrant Agent shall be received for the benefit of, and shall be segregated and kept apart by the Warrant Agent for, the Warrantholders and the Corporation as their interests may appear.

 

(2) The Warrant Agent shall record the particulars of Warrants exercised, which particulars shall include the names and addresses of the persons who become holders of Common Shares on exercise and the Exercise Date, in respect thereof. The Warrant Agent shall provide such particulars in writing to the Corporation within five Business Days of any request by the Corporation therefor.

 

3.10 Securities Restrictions.

 

Notwithstanding anything herein contained, Common Shares will be issued upon exercise of a Warrant only in compliance with the securities laws of any applicable jurisdiction.

 

ARTICLE 4 ADJUSTMENT OF NUMBER OF COMMON SHARES AND EXERCISE PRICE

 

4.1 Adjustment of Number of Common Shares and Exercise Price.

 

The subscription rights in effect under the Warrants for Common Shares issuable upon the exercise of the Warrants shall be subject to adjustment from time to time as follows:

 

(a) if, at any time during the Adjustment Period, the Corporation shall:

 

(i) subdivide, re-divide or change its outstanding Common Shares into a greater number of Common Shares;

 

(ii) consolidate, reduce or combine its outstanding Common Shares into a lesser number of Common Shares;

 

(iii) issue Common Shares or securities exchangeable for or convertible into Common Shares to all or substantially all of the holders of Common Shares by way of a stock Dividend or other distribution (other than a Dividend paid in the ordinary course or a distribution of Common Shares upon the exercise of any outstanding warrants, options or other incentive securities of the Corporation);

 

(any of such events in Section 4.1(a) being called a “Common Share Reorganization”) then the Exercise Price shall be adjusted as of the effective date or record date of such subdivision, re-division, change, consolidation, reduction, combination or distribution, as the case may be, shall in the case of the events referred to in (i) or (iii) above be decreased in proportion to the number of outstanding Common Shares resulting from such subdivision, re-division, change or distribution, or shall, in the case of the events referred to in (ii) above, be increased in proportion to the number of outstanding Common Shares resulting from such reduction, combination or consolidation by multiplying the Exercise Price in effect immediately prior to such effective date or record date by a fraction, the numerator of which shall be the number of Common Shares outstanding on such effective date or record date before giving effect to such Common Share Reorganization and the denominator of which shall be the number of Common Shares outstanding as of the effective date or record date after giving effect to such Common Share Reorganization (including, in the case where securities exchangeable for or convertible into Common Shares are distributed, the number of Common Shares that would have been outstanding had such securities been exchanged for or converted into Common Shares on such record date or effective date).

 

 

  26  

 

Such adjustment shall be made successively whenever any event referred to in this Section 4.1(a) shall occur. Upon any adjustment of the Exercise Price pursuant to Section 4.1(a), each of the Exchange Ratio and the Earnout Ratio will be adjusted immediately after such record date so that it will equal the rate determined by multiplying the Exchange Ratio or the Earnout Ratio, as applicable, in effect on such record date by a fraction, of which the numerator shall be the Exercise Price in effect immediately prior to such adjustment and the denominator shall be the Exercise Price resulting from such adjustment;

 

(b) if and whenever at any time during the Adjustment Period, the Corporation shall fix a record date for the issuance of rights, options or warrants to all or substantially all the holders of its outstanding Common Shares entitling them, for a period expiring not more than 45 days after such record date, to subscribe for or purchase Common Shares (or securities convertible or exchangeable into Common Shares) at a price per Common Share (or having a conversion or exchange price per Common Share) less than 95% of the Current Market Price on such record date (a “Rights Offering”), the Exercise Price shall be adjusted immediately after such record date so that it shall equal the amount determined by multiplying the Exercise Price in effect on such record date by a fraction, of which the numerator shall be the total number of Common Shares outstanding on such record date plus a number of Common Shares equal to the number arrived at by dividing the aggregate price of the total number of additional Common Shares offered for subscription or purchase (or the aggregate conversion or exchange price of the convertible or exchangeable securities so offered) by such Current Market Price, and of which the denominator shall be the total number of Common Shares outstanding on such record date plus the total number of additional Common Shares offered for subscription or purchase or into which the convertible or exchangeable securities so offered are convertible or exchangeable; any Common Shares owned by or held for the account of the Corporation shall be deemed not to be outstanding for the purpose of any such computation; such adjustment shall be made successively whenever such a record date is fixed; to the extent that no such rights or warrants are exercised prior to the expiration thereof, the Exercise Price shall be readjusted to the Exercise Price which would then be in effect if such record date had not been fixed or, if any such rights or warrants are exercised, to the Exercise Price which would then be in effect based upon the number of Common Shares (or securities convertible or exchangeable into Common Shares) actually issued upon the exercise of such rights or warrants, as the case may be. Upon any adjustment of the Exercise Price pursuant to this Section 4.1(b), each of the Exchange Ratio and the Earnout Ratio will be adjusted immediately after such record date so that it will equal the rate determined by multiplying the Exchange Ratio or the Earnout Ratio, as applicable, in effect on such record date by a fraction, of which the numerator shall be the Exercise Price in effect immediately prior to such adjustment and the denominator shall be the Exercise Price resulting from such adjustment. Such adjustment will be made successively whenever such a record date is fixed, provided that if two or more such record dates referred to in this Section 4.1(b) are fixed within a period of 25 Trading Days, such adjustment will be made successively as if each of such record dates occurred on the earliest of such record dates;

 

 

  27  

 

(c) if and whenever at any time during the Adjustment Period the Corporation shall fix a record date for the making of a distribution to all or substantially all the holders of its outstanding Common Shares of (i) securities of any class, whether of the Corporation or any other entity (other than Common Shares), (ii) rights, options or warrants to subscribe for or purchase Common Shares (or other securities convertible into or exchangeable for Common Shares), other than pursuant to a Rights Offering; (iii) evidences of its indebtedness or (iv) any property or other assets then, in each such case, the Exercise Price shall be adjusted immediately after such record date so that it shall equal the price determined by multiplying the Exercise Price in effect on such record date by a fraction, of which the numerator shall be the total number of Common Shares outstanding on such record date multiplied by the Current Market Price on such record date, less the excess, if any, of the fair market value on such record date, as determined by the Corporation (subject to the approval of any Stock Exchange on which the Common Shares are then listed for trading), of such securities or other assets so issued or distributed over the fair market value of any consideration received therefor by the Corporation from the holders of the Common Shares, and of which the denominator shall be the total number of Common Shares outstanding on such record date multiplied by such Current Market Price; and Common Shares owned by or held for the account of the Corporation shall be deemed not to be outstanding for the purpose of any such computation; such adjustment shall be made successively whenever such a record date is fixed; to the extent that such distribution is not so made, the Exercise Price shall be readjusted to the Exercise Price which would then be in effect if such record date had not been fixed. Upon any adjustment of the Exercise Price pursuant to this Section 4.1(c), each of the Exchange Ratio and the Earnout Ratio will be adjusted immediately after such record date so that it will equal the rate determined by multiplying the Exchange Ratio or the Earnout Ratio, as applicable, in effect on such record date by a fraction, of which the numerator shall be the Exercise Price in effect immediately prior to such adjustment and the denominator shall be the Exercise Price resulting from such adjustment;

 

(d) if and whenever at any time during the Adjustment Period, there is a reclassification of the Common Shares or a capital reorganization of the Corporation other than as described in Section 4.1(a) or a consolidation, amalgamation, arrangement or merger of the Corporation with or into any other body corporate, trust, partnership or other entity, or a sale or conveyance of the property and assets of the Corporation as an entirety or substantially as an entirety to any other body corporate, trust, partnership or other entity, any Warrantholder who has not exercised its right of acquisition prior to the effective date of such reclassification, capital reorganization, consolidation, amalgamation, arrangement or merger, sale or conveyance, upon the exercise of such right thereafter, shall be entitled to receive upon payment of the Exercise Price (or upon a Cashless Exercise as set forth in Section 3.2(12)) and shall accept, in lieu of the number of Common Shares that prior to such effective date the Warrantholder would have been entitled to receive, the number of shares or other securities or property of the Corporation or of the body corporate, trust, partnership or other entity resulting from such merger, amalgamation, arrangement or consolidation, or to which such sale or conveyance may be made, as the case may be, that such Warrantholder would have been entitled to receive on such reclassification, capital reorganization, consolidation, amalgamation, arrangement or merger, sale or conveyance, if, on the effective date thereof, as the case may be, the Warrantholder had been the registered holder of the number of Common Shares to which prior to such effective date it was entitled to acquire upon the exercise of the Warrants. If determined appropriate by the Corporation, relying on advice of Counsel, to give effect to or to evidence the provisions of this Section 4.1(d), the Corporation, its successor, or such purchasing body corporate, partnership, trust or other entity, as the case may be, shall, prior to or contemporaneously with any such reclassification, capital reorganization, consolidation, amalgamation, arrangement, merger, sale or conveyance, enter into an indenture which shall provide, to the extent possible, for the application of the provisions set forth in this Amended and Restated Warrant Indenture with respect to the rights and interests thereafter of the Warrantholders to the end that the provisions set forth in this Amended and Restated Warrant Indenture shall thereafter correspondingly be made applicable, as nearly as may reasonably be, with respect to any shares, other securities or property to which a Warrantholder is entitled on the exercise of its acquisition rights thereafter. Any indenture entered into between the Corporation, any successor to the Corporation or such purchasing body corporate, partnership, trust or other entity and the Warrant Agent pursuant to the provisions of this Section 4.1(d) shall be a supplemental indenture entered into pursuant to the provisions of Article 8 hereof. Any indenture entered into between the Corporation, any successor to the Corporation or such purchasing body corporate, partnership, trust or other entity and the Warrant Agent shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided in this Section 4.1 and which shall apply to successive reclassifications, capital reorganizations, amalgamations, consolidations, mergers, sales or conveyances;

 

 

  28  

 

(e) in any case in which this Section 4.1 shall require that an adjustment shall become effective immediately after a record date for an event referred to herein, the Corporation may defer, until the occurrence of such event, issuing to the Warrantholder of any Warrant exercised after the record date and prior to completion of such event the additional Common Shares issuable by reason of the adjustment required by such event before giving effect to such adjustment; provided, however, that the Corporation shall deliver to such Warrantholder an appropriate instrument evidencing such Warrantholder’s right to receive such additional Common Shares upon the occurrence of the event requiring such adjustment and the right to receive any distributions made on such additional Common Shares declared in favour of holders of record of Common Shares on and after the relevant date of exercise or such later date as such Warrantholder would, but for the provisions of this Section 4.1(e), have become the holder of record of such additional Common Shares pursuant to Section 4.1;

 

(f) in any case in which Section 4.1(a)(iii), Section 4.1(b) or Section 4.1(c) require that an adjustment be made to the Exercise Price, no such adjustment shall be made if the Warrantholders of the outstanding Warrants receive, subject to the approval of the Stock Exchange if required, the rights or warrants referred to in Section 4.1(a)(iii), Section 4.1(b) or the shares, rights, options, warrants, evidences of indebtedness or assets referred to in Section 4.1(c), as the case may be, in such kind and number as they would have received if they had been holders of Common Shares on the applicable record date or effective date, as the case may be, by virtue of their outstanding Warrant having then been exercised into Common Shares at the Exercise Price in effect on the applicable record date or effective date, as the case may be;

 

(g) the adjustments provided for in this Section 4.1 are cumulative, and shall, in the case of adjustments to the Exercise Price be computed to the nearest whole cent and shall apply to successive subdivisions, re-divisions, reductions, combinations, consolidations, distributions, issues or other events resulting in any adjustment under the provisions of this Section 4.1, provided that, notwithstanding any other provision of this Section, no adjustment of the Exercise Price shall be required unless such adjustment would require an increase or decrease of at least 1% in the Exercise Price then in effect or the number of Common Shares purchasable upon exercise by at least one one-hundredth (1/100th) of a Common Share; provided, however, that any adjustments which by reason of this Section 4.1(g) are not required to be made shall be carried forward and taken into account in any subsequent adjustment; and

 

 

  29  

 

(h) after any adjustment pursuant to this Section 4.1, the term “Common Shares” where used in this Amended and Restated Warrant Indenture shall be interpreted to mean securities of any class or classes which, as a result of such adjustment and all prior adjustments pursuant to this Section 4.1, the Warrantholder is entitled to receive upon the exercise of his Warrant, and the number of Common Shares indicated by any exercise made pursuant to a Warrant shall be interpreted to mean the number of Common Shares or other property or securities a Warrantholder is entitled to receive, as a result of such adjustment and all prior adjustments pursuant to this Section 4.1, upon the full exercise of a Warrant.

 

4.2 Entitlement to Common Shares on Exercise of Warrant.

 

All Common Shares or shares of any class or other securities, which a Warrantholder is at the time in question entitled to receive on the permitted exercise of its Warrant, whether or not as a result of adjustments made pursuant to this Article 4, shall, for the purposes of the interpretation of this Amended and Restated Warrant Indenture, be deemed to be Common Shares which such Warrantholder is entitled to acquire pursuant to such Warrant.

 

Notwithstanding any other provision to the contrary, (x) no Class A Shares or Class B Shares will be issuable to Warrantholders upon exercise of Warrants if, prior to such exercise, the Class A Shares or Class B Shares are redeemed pursuant to the Articles of the Corporation, (y) no Class A Shares will be issuable to Warrantholders upon exercise of Warrants if, prior to such exercise, the First Tranche Earnout Target has been achieved, and (z) no Class B Shares will be issuable to Warrantholders upon exercise of Warrants if, prior to such exercise, the Second Tranche Earnout Target has been achieved.

 

4.3 No Adjustment for Certain Transactions.

 

Notwithstanding anything in this Article 4, no adjustment shall be made in the acquisition rights attached to the Warrants if the issue of Common Shares is being made pursuant to this Amended and Restated Warrant Indenture or in connection with (a) any share incentive plan or restricted share plan or share purchase plan in force from time to time for directors, officers, employees, consultants or other service providers of the Corporation; or (b) the satisfaction of existing instruments issued at the date hereof.

 

4.4 Determination by Independent Firm.

 

In the event of any question or dispute arising with respect to the adjustments provided for in this Article 4 such question or dispute shall be conclusively determined by an independent firm of chartered accountants other than the Auditors, who shall have access to all necessary records of the Corporation, and such determination shall be binding upon the Corporation, the Warrant Agent, all holders and all other persons interested therein.

 

4.5 Proceedings Prior to any Action Requiring Adjustment.

 

As a condition precedent to the taking of any action which would require an adjustment in any of the acquisition rights pursuant to any of the Warrants, including the number of Common Shares which are to be received upon the exercise thereof, the Corporation shall take any action which may, in the opinion of Counsel, be necessary in order that the Corporation has unissued and reserved in its authorized capital and may validly and legally issue as fully paid and non-assessable all the Common Shares which the holders of such Warrants are entitled to receive on the full exercise thereof in accordance with the provisions hereof.

 

 

  30  

 

4.6 Certificate of Adjustment.

 

The Corporation shall from time to time immediately after the occurrence of any event which requires an adjustment or readjustment as provided in Article 4, deliver a certificate of the Corporation to the Warrant Agent specifying the nature of the event requiring the same and the amount of the adjustment or readjustment necessitated thereby and setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. The Warrant Agent shall rely, and shall be protected in so doing, upon the certificate of the Corporation and any other document filed by the Corporation pursuant to this Article 4 for all purposes.

 

4.7 Notice of Special Matters.

 

The Corporation covenants with the Warrant Agent that, so long as any Warrant remains outstanding, it will give notice to the Warrant Agent and to the Registered Warrantholders of its intention to fix a record date that is prior to the Expiry Date for any matter for which an adjustment may be required pursuant to Section 4.1. Such notice shall specify the particulars of such event and the record date for such event, provided that the Corporation shall only be required to specify in the notice such particulars of the event as shall have been fixed and determined on the date on which the notice is given. The notice shall be given in each case not less than 14 days prior to such applicable record date. If notice has been given and the adjustment is not then determinable, the Corporation shall promptly, after the adjustment is determinable, file with the Warrant Agent a computation of the adjustment and give notice to the Registered Warrantholders of such adjustment computation.

 

4.8 No Action after Notice.

 

The Corporation covenants with the Warrant Agent that it will not close its transfer books or take any other corporate action which might deprive the Warrantholder of the opportunity to exercise its right of acquisition pursuant thereto during the period of 14 days after the giving of the certificate or notices set forth in Section 4.6 and Section 4.7.

 

4.9 Other Action.

 

If the Corporation, after the date hereof, shall take any action affecting the Common Shares other than action described in Section 4.1, which in the reasonable opinion of the Directors would materially affect the rights of Warrantholders, the Exercise Price, Exchange Ratio and/or the Earnout Ratio, the number of Common Shares which may be acquired upon exercise of the Warrants shall be adjusted in such manner and at such time, by action of the Directors, acting reasonably and in good faith, in their sole discretion as they may determine to be equitable to the Warrantholders in the circumstances, provided that no such adjustment will be made unless any requisite prior approval of any stock exchange on which the Common Shares are listed for trading has been obtained.

 

4.10 Protection of Warrant Agent.

 

The Warrant Agent shall not:

 

(a) at any time be under any duty or responsibility to any Warrantholder to determine whether any facts exist which may require any adjustment contemplated by Section 4.1, or with respect to the nature or extent of any such adjustment when made, or with respect to the method employed in making the same;

 

 

  31  

 

(b) be accountable with respect to the validity or value (or the kind or amount) of any Common Shares or of any other securities or property which may at any time be issued or delivered upon the exercise of the rights attaching to any Warrant;

 

(c) be responsible for any failure of the Corporation to issue, transfer or deliver Common Shares or certificates for the same upon the surrender of any Warrants for the purpose of the exercise of such rights or to comply with any of the covenants contained in this Article; and

 

(d) incur any liability or be in any way responsible for the consequences of any breach on the part of the Corporation of any of the representations, warranties or covenants herein contained or of any acts of the directors, officers, employees, agents or servants of the Corporation.

 

4.11 Participation by Warrantholder.

 

No adjustments shall be made pursuant to this Article 4 if the Warrantholders are entitled to participate in any event described in this Article 4 on the same terms, mutatis mutandis, as if the Warrantholders had exercised their Warrants prior to, or on the effective date or record date of, such event and any such participation will be subject to the prior approval of the Stock Exchange, if applicable.

 

ARTICLE 5 RIGHTS OF THE CORPORATION AND COVENANTS

 

5.1 Optional Purchases by the Corporation.

 

Subject to compliance with applicable securities legislation and approval of applicable regulatory authorities, the Corporation may from time to time purchase by private contract or otherwise any of the Warrants. Any such purchase shall be made at the lowest price or prices at which, in the opinion of the Directors, such Warrants are then obtainable, plus reasonable costs of purchase, and may be made in such manner, from such persons and on such other terms as the Corporation, in its sole discretion, may determine. In the case of Certificated Warrants, Warrant Certificates representing the Warrants purchased pursuant to this Section 5.1 shall forthwith be delivered to and cancelled by the Warrant Agent and reflected accordingly on the register of Warrants. In the case of Uncertificated Warrants, the Warrants purchased pursuant to this Section 5.1 shall be reflected accordingly on the register of Warrants in accordance with procedures prescribed by the Depository under the book entry registration system. No Warrants shall be issued in replacement thereof.

 

5.2 General Covenants.

 

The Corporation covenants with the Warrant Agent and the Warrantholders that so long as any Warrants remain outstanding:

 

(a) it will reserve and keep available a sufficient number of Common Shares for the purpose of enabling it to satisfy its obligations to issue Common Shares upon the exercise of the Warrants;

 

(b) it will cause the Common Shares from time to time acquired pursuant to the exercise of the Warrants to be duly issued and delivered in accordance with the Warrants and the terms hereof;

 

 

  32  

 

(c) all Common Shares which shall be issued upon exercise of the right to acquire provided for herein shall be fully paid and non-assessable, free and clear of all encumbrances;

 

(d) it will use reasonable commercial efforts to maintain its existence and carry on its business in the ordinary course;

 

(e) it will give notice to the Warrant Agent and Warrantholders of a default under the terms of this Amended and Restated Warrant Indenture which remains unrectified for more than 10 Business Days following its occurrence;

 

(f) generally, it will well and truly perform and carry out all of the acts or things to be done by it as provided in this Amended and Restated Warrant Indenture;

 

(g) the Corporation will promptly notify the Warrant Agent and the Warrantholders in writing of any default under the terms of this Amended and Restated Warrant Indenture which remains unrectified for more than five days following its occurrence; and

 

(h) it will make all requisite filings under and otherwise take all requisite steps under and satisfy applicable Canadian securities legislation including those filings and other steps necessary to remain not in default in each of the provinces and other Canadian jurisdictions where it becomes a reporting issuer.

 

5.3 Warrant Agent’s Remuneration and Expenses.

 

The Corporation covenants that it will pay to the Warrant Agent from time to time reasonable remuneration for its services hereunder and will pay or reimburse the Warrant Agent upon its request for all reasonable expenses, disbursements and advances incurred or made by the Warrant Agent in the administration or execution of the duties hereby created (including the reasonable compensation and the disbursements of its Counsel and all other advisers and assistants not regularly in its employ) both before any default hereunder and thereafter until all duties of the Warrant Agent hereunder shall be finally and fully performed. Any amount owing hereunder and remaining unpaid after 30 days from the invoice date will bear interest at the then current rate charged by the Warrant Agent against unpaid invoices and shall be payable upon demand. This Section shall survive the resignation or removal of the Warrant Agent and/or the termination of this Amended and Restated Warrant Indenture.

 

5.4 Performance of Covenants by Warrant Agent.

 

If the Corporation shall fail to perform any of its covenants contained in this Amended and Restated Warrant Indenture, the Warrant Agent may notify the Warrantholders of such failure on the part of the Corporation and may itself perform any of the covenants capable of being performed by it but, subject to Section 9.2, shall be under no obligation to perform said covenants or to notify the Warrantholders of such performance by it. All sums expended or advanced by the Warrant Agent in so doing shall be repayable as provided in Section 5.3. No such performance, expenditure or advance by the Warrant Agent shall relieve the Corporation of any default hereunder or of its continuing obligations under the covenants herein contained.

 

5.5 Enforceability of Warrants.

 

The Corporation covenants and agrees that it is duly authorized to create and issue the Warrants to be issued hereunder and that the Warrants, when issued and Authenticated as herein provided, will be valid and enforceable against the Corporation in accordance with the provisions hereof and the terms hereof and that, subject to the provisions of this Amended and Restated Warrant Indenture, the Corporation will cause the Common Shares from time to time acquired upon exercise of Warrants issued under this Amended and Restated Warrant Indenture to be duly issued and delivered in accordance with the terms of this Amended and Restated Warrant Indenture.

 

 

  33  

 

ARTICLE 6 ENFORCEMENT

 

6.1 Suits by Registered Warrantholders.

 

All or any of the rights conferred upon any Registered Warrantholder by any of the terms of this Amended and Restated Warrant Indenture may be enforced by the Registered Warrantholder by appropriate proceedings but without prejudice to the right which is hereby conferred upon the Warrant Agent to proceed in its own name to enforce each and all of the provisions herein contained for the benefit of the Registered Warrantholders.

 

6.2 Suits by the Corporation.

 

The Corporation shall have the right to enforce full payment of the Exercise Price of all Common Shares issued to a Warrantholder hereunder and shall be entitled to demand such payment from the Warrantholder or alternatively to instruct the Warrant Agent to cause the cancellation of the share certificates representing such Common Shares and amend the securities register of the Corporation accordingly.

 

6.3 Immunity of Shareholders, etc.

 

The Warrant Agent and, by the acceptance of the Warrants and as part of the consideration for the issue of the Warrants, the Warrantholders hereby waive and release any right, cause of action or remedy now or hereafter existing in any jurisdiction against any incorporator or any past, present or future shareholder, director, trustee, employee or agent of the Corporation or any successor entity to the Corporation for the creation and issue of the Common Shares pursuant to any Warrant or any covenant, agreement, representation or warranty by the Corporation herein or in the Warrant Certificates contained and only the property of the Corporation (or any successor person) shall be bound in respect hereof.

 

6.4 Waiver of Default.

 

Upon the happening of any default hereunder:

 

(a) the Registered Warrantholders of not less than 51% of the Warrants then outstanding shall have power (in addition to the powers exercisable by Extraordinary Resolution) by requisition in writing to instruct the Warrant Agent to waive any default hereunder and the Warrant Agent shall thereupon waive the default upon such terms and conditions as shall be prescribed in such requisition; or

 

(b) the Warrant Agent shall have power to waive any default hereunder upon such terms and conditions as the Warrant Agent may deem advisable, on the advice of Counsel, if, in the Warrant Agent’s opinion, based on the advice of Counsel, the same shall have been cured or adequate provision made therefor;

 

provided that no delay or omission of the Warrant Agent or of the Registered Warrantholders to exercise any right or power accruing upon any default shall impair any such right or power or shall be construed to be a waiver of any such default or acquiescence therein and provided further that no act or omission either of the Warrant Agent or of the Registered Warrantholders in the premises shall extend to or be taken in any manner whatsoever to affect any subsequent default hereunder of the rights resulting therefrom.

 

 

  34  

 

ARTICLE 7 MEETINGS OF WARRANTHOLDERS

 

7.1 Right to Convene Meetings.

 

The Warrant Agent may at any time and from time to time, and shall on receipt of a written request of the Corporation or of a Warrantholders’ Request and upon being indemnified and funded to its reasonable satisfaction by the Corporation or by the Registered Warrantholders signing such Warrantholders’ Request against the costs which may be incurred in connection with the calling and holding of such meeting, convene a meeting of the Registered Warrantholders. If the Warrant Agent fails to so call a meeting within seven days after receipt of such written request of the Corporation or such Warrantholders’ Request and the indemnity and funding given as aforesaid, the Corporation or such Registered Warrantholders, as the case may be, may convene such meeting. Every such meeting shall be held in the City of Calgary, or at such other place as may be mutually approved or determined by the Warrant Agent and the Corporation.

 

7.2 Notice.

 

At least 21 days’ prior written notice of any meeting of Registered Warrantholders shall be given to the Registered Warrantholders in the manner provided for in Section 10.2 and a copy of such notice shall be sent by mail to the Warrant Agent (unless the meeting has been called by the Warrant Agent) and to the Corporation (unless the meeting has been called by the Corporation). Such notice shall state the time when and the place where the meeting is to be held, shall state briefly the general nature of the business to be transacted thereat and shall contain such information as is reasonably necessary to enable the Registered Warrantholders to make a reasoned decision on the matter, but it shall not be necessary for any such notice to set out the terms of any resolution to be proposed or any of the provisions of this Section 7.2.

 

7.3 Chairperson.

 

An individual (who need not be a Registered Warrantholder) designated in writing by the Warrant Agent and the Corporation shall be chairperson of the meeting and if no individual is so designated, or if the individual so designated is not present within fifteen minutes from the time fixed for the holding of the meeting, the Registered Warrantholders present in person or by proxy shall choose an individual present to be chairperson.

 

7.4 Quorum.

 

Subject to the provisions of Section 7.11, at any meeting of the Registered Warrantholders a quorum shall consist of Registered Warrantholder(s) present in person or by proxy and holding at least 25% of the aggregate number of all the then outstanding Warrants. If a quorum of the Registered Warrantholders shall not be present within thirty (30) minutes from the time fixed for holding any meeting, the meeting, if summoned by Registered Warrantholders or on a Warrantholders’ Request, shall be dissolved; but in any other case the meeting shall be adjourned to the same day in the next week (unless such day is not a Business Day, in which case it shall be adjourned to the next following Business Day) at the same time and place and no notice of the adjournment need be given. Any business may be brought before or dealt with at an adjourned meeting which might have been dealt with at the original meeting in accordance with the notice calling the same. No business shall be transacted at any meeting unless a quorum be present at the commencement of business. At the adjourned meeting the Registered Warrantholders present in person or by proxy shall form a quorum and may transact the business for which the meeting was originally convened, notwithstanding that they may not be holding at least 25% of the aggregate number of all then outstanding Warrants.

 

 

  35  

 

7.5 Power to Adjourn.

 

The chairperson of any meeting at which a quorum of the Registered Warrantholders is present may, with the consent of the meeting, adjourn any such meeting, and no notice of such adjournment need be given except such notice, if any, as the meeting may prescribe.

 

7.6 Show of Hands.

 

Every question submitted to a meeting shall be decided in the first place by a majority of the votes given on a show of hands except that votes on an Extraordinary Resolution shall be given in the manner hereinafter provided. At any such meeting, unless a poll is duly demanded as herein provided, a declaration by the chairperson that a resolution has been carried or carried unanimously or by a particular majority or lost or not carried by a particular majority shall be conclusive evidence of the fact.

 

7.7 Poll and Voting.

 

(1) On every Extraordinary Resolution, and on any other question submitted to a meeting and after a vote by show of hands when demanded by the chairperson or by one or more of the Registered Warrantholders acting in person or by proxy and holding in the aggregate at least 5% of all the Warrants then outstanding, a poll shall be taken in such manner as the chairperson shall direct. Questions other than those required to be determined by Extraordinary Resolution shall be decided by a majority of the votes cast on the poll.

 

(2) On a show of hands, every person who is present and entitled to vote, whether as a Registered Warrantholder or as proxy for one or more absent Registered Warrantholders, or both, shall have one vote. On a poll, each Registered Warrantholder present in person or represented by a proxy duly appointed by instrument in writing shall be entitled to one vote in respect of each Warrant then held or represented by it. A proxy need not be a Registered Warrantholder. The chairperson of any meeting shall be entitled, both on a show of hands and on a poll, to vote in respect of the Warrants, if any, held or represented by him.

 

7.8 Regulations.

 

(1) The Warrant Agent, or the Corporation with the approval of the Warrant Agent, may from time to time make and from time to time vary such regulations as it shall think fit for:

 

(a) the setting of the record date for a meeting for the purpose of determining Warrantholders entitled to receive notice of and to vote at the meeting;

 

(b) the deposit of instruments appointing proxies at such place and time as the Warrant Agent, the Corporation or the Warrantholders convening the meeting, as the case may be, may in the notice convening the meeting direct;

 

(c) the deposit of instruments appointing proxies at some approved place or places other than the place at which the meeting is to be held and enabling particulars of such instruments appointing proxies to be mailed or telecopied before the meeting to the Corporation or to the Warrant Agent at the place where the same is to be held and for the voting of proxies so deposited as though the instruments themselves were produced at the meeting;

 

 

  36  

 

(d) the form of the instrument of proxy; and

 

(e) generally for the calling of meetings of Warrantholders and the conduct of business thereat.

 

(2) Any regulations so made shall be binding and effective and the votes given in accordance therewith shall be valid and shall be counted. Save as such regulations may provide, the only persons who shall be recognized at any meeting as a Registered Warrantholder, or be entitled to vote or be present at the meeting in respect thereof (subject to Section 7.9), shall be Registered Warrantholders or proxies of Registered Warrantholders.

 

7.9 Corporation and Warrant Agent May be Represented.

 

The Corporation and the Warrant Agent, by their respective directors, officers, agents and employees and the Counsel for the Corporation and for the Warrant Agent may attend any meeting of the Registered Warrantholders.

 

7.10 Powers Exercisable by Extraordinary Resolution.

 

In addition to all other powers conferred upon them by any other provisions of this Amended and Restated Warrant Indenture or by law, the Registered Warrantholders at a meeting shall, subject to the provisions of Section 7.11, have the power exercisable from time to time by Extraordinary Resolution:

 

(a) to agree to any modification, abrogation, alteration, compromise or arrangement of the rights of Registered Warrantholders or the Warrant Agent in its capacity as warrant agent hereunder (subject to the Warrant Agent’s prior consent, acting reasonably) or on behalf of the Registered Warrantholders against the Corporation whether such rights arise under this Amended and Restated Warrant Indenture or otherwise;

 

(b) to amend, alter or repeal any Extraordinary Resolution previously passed or sanctioned by the Warrantholders;

 

(c) to direct or to authorize the Warrant Agent, subject to Section 9.2(2) hereof, to enforce any of the covenants on the part of the Corporation contained in this Amended and Restated Warrant Indenture or to enforce any of the rights of the Registered Warrantholders in any manner specified in such Extraordinary Resolution or to refrain from enforcing any such covenant or right;

 

(d) to waive, and to direct the Warrant Agent to waive, any default on the part of the Corporation in complying with any provisions of this Amended and Restated Warrant Indenture either unconditionally or upon any conditions specified in such Extraordinary Resolution;

 

(e) to restrain any Registered Warrantholder from taking or instituting any suit, action or proceeding against the Corporation for the enforcement of any of the covenants on the part of the Corporation in this Amended and Restated Warrant Indenture or to enforce any of the rights of the Registered Warrantholders;

 

 

  37  

 

(f) to direct any Registered Warrantholder who, as such, has brought any suit, action or proceeding to stay or to discontinue or otherwise to deal with the same upon payment of the costs, charges and expenses reasonably and properly incurred by such Registered Warrantholder in connection therewith;

 

(g) to assent to any change in or omission from the provisions contained in this Amended and Restated Warrant Indenture or any ancillary or supplemental instrument which may be agreed to by the Corporation, and to authorize the Warrant Agent to concur in and execute any ancillary or supplemental indenture embodying the change or omission;

 

(h) with the consent of the Corporation, such consent not to be unreasonably withheld, to remove the Warrant Agent or its successor in office and to appoint a new warrant agent or warrant agents to take the place of the Warrant Agent so removed; and

 

(i) to assent to any compromise or arrangement with any creditor or creditors or any class or classes of creditors, whether secured or otherwise, and with holders of any shares or other securities of the Corporation.

 

7.11 Meaning of Extraordinary Resolution.

 

(1) The expression “Extraordinary Resolution” when used in this Amended and Restated Warrant Indenture means, subject as hereinafter provided in this Section 7.11 and in Section 7.14, a resolution: (i) proposed at a meeting of Registered Warrantholders duly convened for that purpose and held in accordance with the provisions of this Article 7 at which there are present in person or by proxy Registered Warrantholders holding at least 25% of the aggregate number of all then outstanding Warrants and passed by the affirmative votes of Registered Warrantholders holding not less than 66⅔% of the aggregate number of all then outstanding Warrants represented at the meeting and voted on the poll upon such resolution; or (ii) in writing signed by the holders of at least 66 2/3% of the then outstanding Warrants on any matter that would otherwise be voted upon at a meeting called to approve such resolution as contemplated in this Section 7.11(1).

 

(2) If, at the meeting at which an Extraordinary Resolution is to be considered, Registered Warrantholders holding at least 25% of the aggregate number of all then outstanding Warrants are not present in person or by proxy within 30 minutes after the time appointed for the meeting, then the meeting, if convened by Registered Warrantholders or on a Warrantholders’ Request, shall be dissolved; but in any other case it shall stand adjourned to such day, being not less than 15 or more than 60 days later, and to such place and time as may be appointed by the chairperson. Not less than 14 days’ prior notice shall be given of the time and place of such adjourned meeting in the manner provided for in Section 10.2. Such notice shall state that at the adjourned meeting the Registered Warrantholders present in person or by proxy shall form a quorum but it shall not be necessary to set forth the purposes for which the meeting was originally called or any other particulars. At the adjourned meeting the Registered Warrantholders present in person or by proxy shall form a quorum and may transact the business for which the meeting was originally convened and a resolution proposed at such adjourned meeting and passed by the requisite vote as provided in Section 7.11(1) shall be an Extraordinary Resolution within the meaning of this Amended and Restated Warrant Indenture notwithstanding that Registered Warrantholders holding at least 25% of the aggregate number of all the then outstanding Warrants are not present in person or by proxy at such adjourned meeting.

 

(3) Subject to Section 7.14, votes on an Extraordinary Resolution shall always be given on a poll and no demand for a poll on an Extraordinary Resolution shall be necessary.

 

 

  38  

 

7.12 Powers Cumulative.

 

Any one or more of the powers or any combination of the powers in this Amended and Restated Warrant Indenture stated to be exercisable by the Registered Warrantholders by Extraordinary Resolution or otherwise may be exercised from time to time and the exercise of any one or more of such powers or any combination of powers from time to time shall not be deemed to exhaust the right of the Registered Warrantholders to exercise such power or powers or combination of powers then or thereafter from time to time.

 

7.13 Minutes.

 

Minutes of all resolutions and proceedings at every meeting of Registered Warrantholders shall be made and duly entered in books to be provided from time to time for that purpose by the Warrant Agent at the expense of the Corporation, and any such minutes as aforesaid, if signed by the chairperson or the secretary of the meeting at which such resolutions were passed or proceedings had shall be prima facie evidence of the matters therein stated and, until the contrary is proved, every such meeting in respect of the proceedings of which minutes shall have been made shall be deemed to have been duly convened and held, and all resolutions passed thereat or proceedings taken shall be deemed to have been duly passed and taken.

 

7.14 Instruments in Writing.

 

All actions which may be taken and all powers that may be exercised by the Registered Warrantholders at a meeting held as provided in this Article 7 may also be taken and exercised by Registered Warrantholders holding at least 66⅔% of the aggregate number of all of the then outstanding Warrants by an instrument in writing signed in one or more counterparts by such Registered Warrantholders in person or by attorney duly appointed in writing, and the expression “Extraordinary Resolution” when used in this Amended and Restated Warrant Indenture shall include an instrument so signed by holders of at least 66 2/3% of the aggregate number of all of the then outstanding Warrants.

 

7.15 Binding Effect of Resolutions.

 

Every resolution and every Extraordinary Resolution passed in accordance with the provisions of this Article 7 at a meeting of Registered Warrantholders shall be binding upon all the Warrantholders, whether present at or absent from such meeting, and every instrument in writing signed by Registered Warrantholders in accordance with Section 7.14 shall be binding upon all the Warrantholders, whether signatories thereto or not, and each and every Warrantholder and the Warrant Agent (subject to the provisions for indemnity herein contained) shall be bound to give effect accordingly to every such resolution and instrument in writing.

 

7.16 Holdings by Corporation Disregarded.

 

In determining whether Registered Warrantholders holding Warrants evidencing the required number of Warrants are present at a meeting of Registered Warrantholders for the purpose of determining a quorum or have concurred in any consent, waiver, Extraordinary Resolution, Warrantholders’ Request or other action under this Amended and Restated Warrant Indenture, Warrants owned legally or beneficially by the Corporation shall be disregarded in accordance with the provisions of Section 10.7.

 

 

  39  

 

ARTICLE 8 SUPPLEMENTAL INDENTURES

 

8.1 Provision for Supplemental Indentures for Certain Purposes.

 

From time to time, the Corporation (when authorized by action of the Directors) and the Warrant Agent may, subject to Stock Exchange approval, if applicable, and to the provisions hereof and they shall, when so directed in accordance with the provisions hereof, execute and deliver by their proper officers, indentures or instruments supplemental hereto, which thereafter shall form part hereof, for any one or more or all of the following purposes:

 

(a) providing for the issuance of additional Warrants hereunder and any consequential amendments hereto as may be required by the Warrant Agent relying on the advice of Counsel;

 

(b) setting forth any adjustments resulting from the application of the provisions of Article 4;

 

(c) adding to the provisions hereof such additional covenants and enforcement provisions as, in the opinion of Counsel, are necessary or advisable in the premises, provided that the same are not in the opinion of the Warrant Agent, relying on the advice of Counsel, prejudicial to the interests of the Registered Warrantholders;

 

(d) giving effect to any Extraordinary Resolution passed as provided in Section 7.11;

 

(e) making such provisions not inconsistent with this Amended and Restated Warrant Indenture as may be necessary or desirable with respect to matters or questions arising hereunder or for the purpose of obtaining a listing or quotation of the Warrants on any stock exchange, provided that such provisions are not, in the opinion of the Warrant Agent, relying on the advice of Counsel, prejudicial to the interests of the Registered Warrantholders;

 

(f) adding to or altering the provisions hereof in respect of the transfer of Warrants, making provision for the exchange of Warrants, and making any modification in the form of the Warrant Certificates which does not affect the substance thereof;

 

(g) modifying any of the provisions of this Amended and Restated Warrant Indenture, including relieving the Corporation from any of the obligations, conditions or restrictions herein contained, provided that such modification or relief shall be or become operative or effective only if, in the opinion of the Warrant Agent, relying on the advice of Counsel, such modification or relief in no way prejudices any of the rights of the Registered Warrantholders or of the Warrant Agent, and provided further that the Warrant Agent may in its sole discretion decline to enter into any such supplemental indenture which in its opinion may not afford adequate protection to the Warrant Agent when the same shall become operative;

 

(h) for any other purpose not inconsistent with the terms of this Amended and Restated Warrant Indenture, including the correction or rectification of any ambiguities, defective or inconsistent provisions, errors, mistakes or omissions herein, provided that in the opinion of the Warrant Agent, relying on the advice of Counsel, the rights of the Warrant Agent and of the Registered Warrantholders are in no way prejudiced thereby; and

 

(i) providing for any amendments as may be required to ensure that the terms of this Amended and Restated Warrant Indenture are consistent with the Plan of Arrangement.

 

 

  40  

 

8.2 Successor Entities.

 

In the case of the consolidation, amalgamation, arrangement, merger or transfer of the undertaking or assets of the Corporation as an entirety or substantially as an entirety to or with another entity (“successor entity”), the successor entity resulting from such consolidation, amalgamation, arrangement, merger or transfer (if not the Corporation) shall expressly assume, by supplemental indenture satisfactory in form to the Warrant Agent and executed and delivered to the Warrant Agent, the due and punctual performance and observance of each and every covenant and condition of this Amended and Restated Warrant Indenture to be performed and observed by the Corporation.

 

ARTICLE 9 CONCERNING THE WARRANT AGENT

 

9.1 Indenture Legislation.

 

(1) If and to the extent that any provision of this Amended and Restated Warrant Indenture limits, qualifies or conflicts with a mandatory requirement of Applicable Legislation, such mandatory requirement shall prevail.

 

(2) The Corporation and the Warrant Agent agree that each will, at all times in relation to this Amended and Restated Warrant Indenture and any action to be taken hereunder, observe and comply with and be entitled to the benefits of Applicable Legislation.

 

9.2 Rights and Duties of Warrant Agent.

 

(1) In the exercise of the rights and duties prescribed or conferred by the terms of this Amended and Restated Warrant Indenture, the Warrant Agent shall act honestly and in good faith and exercise that degree of care, diligence and skill that a reasonably prudent warrant agent would exercise in comparable circumstances. No provision of this Amended and Restated Warrant Indenture shall be construed to relieve the Warrant Agent from liability for its own gross negligent action, wilful misconduct, bad faith or fraud under this Amended and Restated Warrant Indenture.

 

(2) The obligation of the Warrant Agent to commence or continue any act, action or proceeding for the purpose of enforcing any rights of the Warrant Agent or the Registered Warrantholders hereunder shall be conditional upon the Registered Warrantholders furnishing, when required by notice by the Warrant Agent, sufficient funds to commence or to continue such act, action or proceeding and an indemnity reasonably satisfactory to the Warrant Agent to protect and to hold harmless the Warrant Agent and its officers, directors, employees and agents, against the costs, charges and expenses and liabilities to be incurred thereby and any loss and damage it may suffer by reason thereof. None of the provisions contained in this Amended and Restated Warrant Indenture shall require the Warrant Agent to expend or to risk its own funds or otherwise to incur financial liability in the performance of any of its duties or in the exercise of any of its rights or powers unless indemnified and funded as aforesaid.

 

(3) The Warrant Agent may, before commencing or at any time during the continuance of any such act, action or proceeding, require the Registered Warrantholders, at whose instance it is acting to deposit with the Warrant Agent the Warrants Certificates held by them, for which Warrant Certificates the Warrant Agent shall issue receipts.

 

(4) Every provision of this Amended and Restated Warrant Indenture that by its terms relieves the Warrant Agent of liability or entitles it to rely upon any evidence submitted to it is subject to the provisions of Applicable Legislation.

 

 

  41  

 

9.3 Evidence, Experts and Advisers.

 

(1) In addition to the reports, certificates, opinions and other evidence required by this Amended and Restated Warrant Indenture, the Corporation shall furnish to the Warrant Agent such additional evidence of compliance with any provision hereof, and in such form, as may be prescribed by Applicable Legislation or as the Warrant Agent may reasonably require by written notice to the Corporation.

 

(2) In the exercise of its rights and duties hereunder, the Warrant Agent may, if it is acting in good faith, rely as to the truth of the statements and the accuracy of the opinions expressed in statutory declarations, opinions, reports, written requests, consents, or orders of the Corporation, certificates of the Corporation or other evidence furnished to the Warrant Agent pursuant to a request of the Warrant Agent, provided that such evidence complies with the Applicable Legislation and that the Warrant Agent complies with Applicable Legislation and that the Warrant Agent examines the same and determines that such evidence complies with the applicable requirements of this Amended and Restated Warrant Indenture.

 

(3) Whenever it is provided in this Amended and Restated Warrant Indenture or under Applicable Legislation that the Corporation shall deposit with the Warrant Agent resolutions, certificates, reports, opinions, requests, orders or other documents, it is intended that the truth, accuracy and good faith on the effective date thereof and the facts and opinions stated in all such documents so deposited shall, in each and every such case, be conditions precedent to the right of the Corporation to have the Warrant Agent take the action to be based thereon.

 

(4) Whenever Applicable Legislation requires that evidence referred to in subsection (1) be in the form of a statutory declaration, the Warrant Agent may accept such statutory declaration in lieu of a certificate of the Corporation required by any provision hereof. Any such statutory declaration may be made by one or more authorised officers of the Corporation.

 

(5) The Warrant Agent may employ or retain such Counsel, accountants, appraisers or other experts or advisers as it may reasonably require for the purpose of discharging its duties or determining its rights hereunder and may pay reasonable remuneration for all services so performed by any of them, without taxation of costs of any Counsel, and shall not be responsible for any misconduct or negligence on the part of any such experts or advisers who have been appointed with due care by the Warrant Agent. The Corporation shall pay or reimburse the Warrant Agent for any reasonable fees, expenses and disbursements of such counsel or advisors.

 

(6) The Warrant Agent may act and rely and shall be protected in acting and relying in good faith on the opinion or advice of or information obtained from any Counsel, accountant, appraiser, engineer or other expert or adviser, whether retained or employed by the Corporation or by the Warrant Agent, in relation to any matter arising in the administration of the agency hereof.

 

(7) Proof of the execution of an instrument in writing, including a Warrantholders’ Request, by any Warrantholder may be made by the certificate of a notary, solicitor or commissioner for oaths, or other officer with similar powers, that the person signing such instrument acknowledged to him the execution thereof, or by an affidavit of a witness to such execution or in any other manner which the Warrant Agent may consider adequate and in respect of a corporate Warrantholder, shall include a certificate of incumbency of such Warrantholder together with a certified resolution authorizing the person who signs such instrument to sign such instrument.

 

 

  42  

 

9.4 Documents, Monies, etc. Held by Warrant Agent.

 

Any monies, securities, documents of title or other instruments that may at any time be held by the Warrant Agent shall be placed in the deposit vaults of the Warrant Agent or of any Canadian chartered bank listed in Schedule I of the Bank Act (Canada), or deposited for safekeeping with any such bank. Any monies held pending the application or withdrawal thereof under any provisions of this Amended and Restated Warrant Indenture, shall be held in a segregated non-interest bearing account.

 

9.5 Actions by Warrant Agent to Protect Interest.

 

The Warrant Agent shall have power to institute and to maintain such actions and proceedings as it may consider necessary or expedient to preserve, protect or enforce its interests and the interests of the Warrantholders.

 

9.6 Warrant Agent Not Required to Give Security.

 

The Warrant Agent shall not be required to give any bond or security in respect of the execution of the agency and powers of this Amended and Restated Warrant Indenture or otherwise in respect of the premises.

 

9.7 Protection of Warrant Agent.

 

By way of supplement to the provisions of any law for the time being relating to warrant agents it is expressly declared and agreed as follows:

 

(a) the Warrant Agent shall not be liable for or by reason of any statements of fact or recitals in this Amended and Restated Warrant Indenture or in the Warrant Certificates (except the representation contained in Section 9.9 or in the authentication of the Warrant Agent on the Warrant Certificates) or be required to verify the same, but all such statements or recitals are and shall be deemed to be made by the Corporation;

 

(b) nothing herein contained shall impose any obligation on the Warrant Agent to see to or to require evidence of the registration or filing (or renewal thereof) of this Amended and Restated Warrant Indenture or any instrument ancillary or supplemental hereto;

 

(c) the Warrant Agent shall not be bound to give notice to any person or persons of the execution hereof;

 

(d) the Warrant Agent shall not incur any liability or responsibility whatever or be in any way responsible for the consequence of any breach on the part of the Corporation of any of its covenants herein contained or of any acts of any directors, officers, employees, agents or servants of the Corporation; and

 

(e) the Corporation hereby indemnifies and agrees to hold harmless the Warrant Agent, its affiliates, their current and former officers, directors, employees, agents, successors and assigns from and against any and all liabilities, losses, damages, penalties, claims, actions, suits, costs, expenses and disbursements, including reasonable legal fees and disbursements of whatever kind and nature which may at any time be imposed on or incurred by or asserted against the Warrant Agent, whether groundless or otherwise, arising from or out of any act, omission or error of the Warrant Agent, provided that the Corporation shall not be required to indemnify the Warrant Agent in the event of the gross negligence, wilful misconduct or fraud of the Warrant Agent, and this provision shall survive the resignation or removal of the Warrant Agent or the termination or discharge of this Amended and Restated Warrant Indenture.

 

 

  43  

 

(f) The Warrant Agent shall not be liable for any error in judgment or for any act done or step taken or omitted by it in good faith or for any mistake, in fact or law, or for anything which it may do or refrain from doing in connection herewith except out of its own gross negligence, bad faith or willful misconduct.

 

(g) Notwithstanding the foregoing or any other provision of this Amended and Restated Warrant Indenture, any liability of the Warrant Agent, other than for gross negligence, wilful misconduct and fraud, shall be limited, in the aggregate, to the amount of annual retainer fees paid by the Corporation to the Warrant Agent under this Amended and Restated Warrant Indenture in the twelve (12) months immediately prior to the Warrant Agent receiving the first notice of the claim. Notwithstanding any other provision of this Amended and Restated Warrant Indenture, and whether such losses or damages are foreseeable or unforeseeable, the Warrant Agent shall not be liable under any circumstances whatsoever for any (a) breach by any other party of securities law or other rule of any securities regulatory authority, (b) lost profits or (c) special, indirect, incidental, consequential, exemplary, aggravated or punitive losses or damages.

 

(h) The forwarding of a cheque or the sending of funds by wire transfer by the Warrant Agent will satisfy and discharge the liability of any amounts due to the extent of the sum represented thereby unless such cheque is not honoured on presentation, provided that in the event of the non-receipt of such cheque by the payee, or the loss or destruction thereof, the Warrant Agent, upon being furnished with reasonable evidence of such non-receipt, loss or destruction and indemnity reasonably satisfactory to it, will issue to such payee a replacement cheque for the amount of such cheque.

 

9.8 Replacement of Warrant Agent; Successor by Merger.

 

(1) The Warrant Agent may resign its agency and be discharged from all further duties and liabilities hereunder, subject to this Section 9.8, by giving to the Corporation not less than 60 days’ prior notice in writing or such shorter prior notice as the Corporation may accept as sufficient. The Registered Warrantholders by Extraordinary Resolution and in accordance with Section 7.10(h) shall have power at any time to remove the existing Warrant Agent and to appoint a new Warrant Agent. In the event of the Warrant Agent resigning or being removed as aforesaid or being dissolved, becoming bankrupt, going into liquidation or otherwise becoming incapable of acting hereunder, the Corporation shall forthwith appoint a new Warrant Agent unless a new Warrant Agent has already been appointed by the Registered Warrantholders; failing such appointment by the Corporation, the retiring Warrant Agent or any Registered Warrantholder may apply to a judge of the Court of King’s Bench of Alberta on such notice as such judge may direct, for the appointment of a new Warrant Agent; but any new Warrant Agent so appointed by the Corporation or by the Court shall be subject to removal as aforesaid by the Registered Warrantholders. Any new Warrant Agent appointed under any provision of this Section 9.8 shall be an entity authorized to carry on the business of a trust company in one or more of the provinces of Canada and, if required by the Applicable Legislation for any provinces in such provinces. On any such appointment, the new warrant agent shall be vested with the same powers, rights, duties and responsibilities as if it had been originally named herein as Warrant Agent hereunder.

 

(2) Upon the appointment of a successor Warrant Agent, the Corporation shall promptly notify the Registered Warrantholders thereof in the manner provided for in Section 10.2.

 

 

  44  

 

(3) Any Warrant Certificates Authenticated but not delivered by a predecessor Warrant Agent may be Authenticated by the successor Warrant Agent in the name of the predecessor or successor Warrant Agent.

 

(4) Any corporation into which the Warrant Agent may be merged or consolidated or amalgamated or to which all or substantially all of its corporate trust business is sold or otherwise transferred, or any corporation resulting therefrom to which the Warrant Agent shall be a party, or any corporation succeeding to substantially the corporate trust business of the Warrant Agent shall be the successor to the Warrant Agent hereunder without any further act on its part or any of the parties hereto, provided that such corporation would be eligible for appointment as successor Warrant Agent under Section 9.8(1).

 

9.9 Conflict of Interest.

 

(1) The Warrant Agent represents to the Corporation that at the time of execution and delivery hereof no material conflict of interest exists between its role as a warrant agent hereunder and its role in any other capacity and agrees that in the event of a material conflict of interest arising hereafter it will, within 60 days after ascertaining that it has such material conflict of interest, either eliminate the same or assign its agency hereunder to a successor Warrant Agent approved by the Corporation and meeting the requirements set forth in Section 9.8(1). Notwithstanding the foregoing provisions of this Section 9.9(1), if any such material conflict of interest exists or hereafter shall exist, the validity and enforceability of this Amended and Restated Warrant Indenture and the Warrant Certificate shall not be affected in any manner whatsoever by reason thereof.

 

(2) Subject to Section 9.9(1), the Warrant Agent, in its personal or any other capacity, may buy, lend upon and deal in securities of the Corporation and generally may contract and enter into financial transactions with the Corporation without being liable to account for any profit made thereby.

 

9.10 Acceptance of Agency

 

The Warrant Agent hereby accepts the agency in this Amended and Restated Warrant Indenture declared and provided for and agrees to perform the same upon the terms and conditions herein set forth.

 

9.11 Warrant Agent Not to be Appointed Receiver.

 

The Warrant Agent and any person related to the Warrant Agent shall not be appointed a receiver, a receiver and manager or liquidator of all or any part of the assets or undertaking of the Corporation.

 

9.12 Authorization to Carry on Business

 

The Warrant Agent represents to the Corporation that as at the date of the execution and delivery of this Amended and Restated Warrant Indenture, it is duly authorized and qualified to carry on the business of a trust company in each of the Provinces of Canada.

 

 

  45  

 

9.13 Warrant Agent Not Required to Give Notice of Default.

 

The Warrant Agent shall not be bound to give any notice or do or take any act, action or proceeding by virtue of the powers conferred on it hereby unless and until it shall have been required so to do under the terms hereof; nor shall the Warrant Agent be required to take notice of any default hereunder, unless and until notified in writing of such default, which notice shall distinctly specify the default desired to be brought to the attention of the Warrant Agent and in the absence of any such notice the Warrant Agent may for all purposes of this Amended and Restated Warrant Indenture conclusively assume that no default has been made in the observance or performance of any of the representations, warranties, covenants, agreements or conditions contained herein. Any such notice shall in no way limit any discretion herein given to the Warrant Agent to determine whether or not the Warrant Agent shall take action with respect to any default.

 

9.14 Anti-Money Laundering.

 

(1) Each party to this Agreement other than the Warrant Agent hereby represents to the Warrant Agent that any account to be opened by, or interest to be held by the Warrant Agent in connection with this Agreement, for or to the credit of such party, either (i) is not intended to be used by or on behalf of any third party; or (ii) is intended to be used by or on behalf of a third party, in which case such party hereto agrees to complete and execute forthwith a declaration in the Warrant Agent’s prescribed form as to the particulars of such third party.

 

(2) The Warrant Agent shall retain the right not to act and shall not be liable for refusing to act if, due to a lack of information or for any other reason whatsoever, the Warrant Agent, in its sole judgment, determines that such act might cause it to be in non-compliance with any applicable anti-money laundering, anti-terrorist legislation, economic sanctions, regulation or guideline. Further, should the Warrant Agent, in its sole judgment, determine at any time that its acting under this Amended and Restated Warrant Indenture has resulted in its being in non-compliance with any applicable anti-money laundering, anti-terrorist or economic sanctions legislation, regulation or guideline, then it shall have the right to resign on 10 days written notice to the other parties to this Amended and Restated Warrant Indenture, provided (i) that the Warrant Agent’s written notice shall describe the circumstances of such non-compliance; (ii) that if such circumstances are rectified to the Warrant Agent’s satisfaction within such 10 day period, then such resignation shall not be effective.

 

9.15 Compliance with Privacy Code.

 

The parties acknowledge that the Warrant Agent may, in the course of providing services hereunder, collect or receive financial and other personal information about such parties and/or their representatives, as individuals, or about other individuals related to the subject matter hereof, and use such information for the following purposes:

 

(a) to provide the services required under this Amended and Restated Warrant Indenture and other services that may be requested from time to time;

 

(b) to help the Warrant Agent manage its servicing relationships with such individuals;

 

(c) to meet the Warrant Agent’s legal and regulatory requirements; and

 

(d) if Social Insurance Numbers are collected by the Warrant Agent, to perform tax reporting and to assist in verification of an individual’s identity for security purposes.

 

Each party acknowledges and agrees that the Warrant Agent may receive, collect, use and disclose personal information provided to it or acquired by it in the course of its acting as agent hereunder for the purposes described above and, generally, in the manner and on the terms described in its privacy code, which the Warrant Agent shall make available on its website or upon request, including revisions thereto. Further, the Corporation agrees that it shall not provide or cause to be provided to the Warrant Agent any personal information relating to an individual who is not a party to this Amended and Restated Warrant Indenture unless the Corporation has assured itself that such individual understands and has consented to the aforementioned uses and disclosures.

 

 

  46  

 

9.16 Securities Exchange Commission Certification.

 

The Corporation confirms that as at the date of execution of this Amended and Restated Warrant Indenture it does not have a class of securities registered pursuant to Section 12 of the U.S. Exchange Act or have a reporting obligation pursuant to Section 15(d) of the U.S. Exchange Act. The Corporation covenants that in the event that (i) any class of its securities shall become registered pursuant to Section 12 of the U.S. Exchange Act or the Corporation shall incur a reporting obligation pursuant to Section 15(d) of the U.S. Exchange Act, or (ii) any such registration or reporting obligation shall be terminated by the Corporation in accordance with the U.S. Exchange Act, the Corporation shall promptly deliver to the Warrant Agent an officers’ certificate (in a form provided by the Warrant Agent) notifying the Warrant Agent of such registration or termination and such other information as the Warrant Agent may require at the time. The Corporation acknowledges that Warrant Agent is relying upon the foregoing representation and covenants in order to meet certain United States Securities and Exchange Commission (“SEC”) obligations with respect to those clients who are filing with the SEC.

 

ARTICLE 10 GENERAL

 

10.1 Notice to the Corporation and the Warrant Agent.

 

(1) Unless herein otherwise expressly provided, any notice to be given hereunder to the Corporation or the Warrant Agent shall be deemed to be validly given if delivered, sent by registered letter, postage prepaid, emailed or faxed:

 

(a) If to the Corporation:

 

Above Food Ingredients Inc.
1600, 421 7th Avenue SW

Calgary, Alberta, T2P 4K9

 

Attention:      Lionel Kambeitz
Email:              lionel@abovefood.com

 

with a copy to:

 

Gowling WLG (Canada) LLP

1600, 421 7th Avenue SW

Calgary, Alberta, T2P 4K9

 

Attention:      Sharagim Habibi
Email:              Sharagim.Habibi@gowlingwlg.com

 

(b) If to the Warrant Agent:

 

Odyssey Trust Company
Suite 1230, 300 5th Avenue SW
Calgary, Alberta
T2P 3C4

 

 

  47  

 

Attention:      Corporate Trust
Email:              corptrust@odysseytrust.com

 

and any such notice delivered in accordance with the foregoing shall be deemed to have been received and given on the date of delivery or, if mailed, on the fifth Business Day following the date of mailing such notice or, if emailed, faxed or transmitted by other electronic means, on the date of transmission, unless transmission was made after 4:00 pm or such day is not a Business Day, and in those cases it will be deemed to be received on the next Business Day following the date of transmission.

 

(2) The Corporation or the Warrant Agent, as the case may be, may from time to time notify the other in the manner provided in Section 10.1(1) of a change of address which, from the effective date of such notice and until changed by like notice, shall be the address of the Corporation or the Warrant Agent, as the case may be, for all purposes of this Amended and Restated Warrant Indenture.

 

(3) If, by reason of a strike, lockout or other work stoppage, actual or threatened, involving postal employees, any notice to be given to the Warrant Agent or to the Corporation hereunder could reasonably be considered unlikely to reach its destination, such notice shall be valid and effective only if it is delivered to the named officer of the party to which it is addressed, as provided in Section 10.1(1), or given by email, fax or other means of prepaid, transmitted and recorded communication.

 

10.2 Notice to Warrantholders.

 

(1) Unless otherwise provided herein, notice to the Registered Warrantholders under the provisions of this Amended and Restated Warrant Indenture shall be valid and effective if delivered or sent by ordinary post addressed to such holders at their post office addresses appearing on the register hereinbefore mentioned and shall be deemed to have been effectively received and given on the date of delivery or, if mailed, on the third Business Day following the date of mailing such notice. In the event that Warrants are held in the name of the Depository, a copy of such notice shall also be sent by electronic communication to the Depository and shall be deemed received and given on the day it is so sent.

 

(2) If, by reason of a strike, lockout or other work stoppage, actual or threatened, involving postal employees, any notice to be given to the Registered Warrantholders hereunder could reasonably be considered unlikely to reach its destination, such notice shall be valid and effective only if it is delivered to such Registered Warrantholders to the address for such Registered Warrantholders contained in the register maintained by the Warrant Agent or such notice may be given, at the Corporation’s expense, by means of publication in the Globe and Mail or any other English language daily newspaper or newspapers of general circulation in Canada, in each two successive weeks, and any such notice published shall be deemed to have been received and given on the latest date the publication takes place.

 

(3) Accidental error or omission in giving notice or accidental failure to mail notice to any Registered Warrantholder will not invalidate any action or proceeding founded thereon.

 

 

  48  

 

10.3 Ownership of Warrants.

 

The Corporation and the Warrant Agent may deem and treat the Registered Warrantholders as the absolute owner thereof for all purposes, and the Corporation and the Warrant Agent shall not be affected by any notice or knowledge to the contrary except where the Corporation or the Warrant Agent is required to take notice by statute or by order of a court of competent jurisdiction. The receipt of any such Registered Warrantholder of the Common Shares which may be acquired pursuant thereto shall be a good discharge to the Corporation and the Warrant Agent for the same and neither the Corporation nor the Warrant Agent shall be bound to inquire into the title of any such holder except where the Corporation or the Warrant Agent is required to take notice by statute or by order of a court of competent jurisdiction.

 

10.4 Counterparts and Electronic Copies.

 

This Amended and Restated Warrant Indenture may be executed in several counterparts, each of which when so executed shall be deemed to be an original and such counterparts together shall constitute one and the same instrument and notwithstanding their date of execution they shall be deemed to be dated as of the date hereof.

 

Each of the parties hereto shall be entitled to rely on delivery of a PDF copy of this Amended and Restated Warrant Indenture and acceptance by each such party of any such PDF copy shall be legally effective to create a valid and binding agreement between the parties hereto in accordance with the terms hereof.

 

10.5 Satisfaction and Discharge of Indenture.

 

Upon the earlier of:

 

(a) the date by which there shall have been delivered to the Warrant Agent for exercise or cancellation all Warrants theretofore Authenticated hereunder, in the case of Certificated Warrants or by way of standard processing through the book entry only system in the case of a CDS Global Warrant; and

 

(b) the Expiry Time;

 

and if all certificates or other entry on the register representing Common Shares required to be issued in compliance with the provisions hereof have been issued and delivered hereunder or to the Warrant Agent in accordance with such provisions, this Amended and Restated Warrant Indenture shall cease to be of further effect and the Warrant Agent, on demand of and at the cost and expense of the Corporation and upon delivery to the Warrant Agent of a certificate of the Corporation stating that all conditions precedent to the satisfaction and discharge of this Amended and Restated Warrant Indenture have been complied with, shall execute proper instruments acknowledging satisfaction of and discharging this Amended and Restated Warrant Indenture. Notwithstanding the foregoing, the indemnities provided to the Warrant Agent by the Corporation hereunder shall remain in full force and effect and survive the termination of this Amended and Restated Warrant Indenture.

 

10.6 Provisions of Indenture and Warrants for the Sole Benefit of Parties and Warrantholders.

 

Nothing in this Amended and Restated Warrant Indenture or in the Warrants, expressed or implied, shall give or be construed to give to any person other than the parties hereto and the Registered Warrantholders, as the case may be, any legal or equitable right, remedy or claim under this Amended and Restated Warrant Indenture, or under any covenant or provision herein or therein contained, all such covenants and provisions being for the sole benefit of the parties hereto and the Registered Warrantholders.

 

 

  49  

 

10.7 Warrants Owned by the Corporation – Certificate to be Provided.

 

For the purpose of disregarding any Warrants owned legally or beneficially by the Corporation in Section 7.16, the Corporation shall provide to the Warrant Agent, from time to time, a certificate of the Corporation setting forth as at the date of such certificate:

 

(a) the names (other than the name of the Corporation) of the Registered Warrantholders which, to the knowledge of the Corporation, are owned by or held for the account of the Corporation; and

 

(b) the number of Warrants owned legally or beneficially by the Corporation;

 

and the Warrant Agent, in making the computations in Section 7.16, shall be entitled to rely on such certificate without any additional evidence.

 

10.8 Severability

 

If, in any jurisdiction, any provision of this Amended and Restated Warrant Indenture or its application to any party or circumstance is restricted, prohibited or unenforceable, such provision will, as to such jurisdiction, be ineffective only to the extent of such restriction, prohibition or unenforceability without invalidating the remaining provisions of this Amended and Restated Warrant Indenture and without affecting the validity or enforceability of such provision in any other jurisdiction or without affecting its application to other parties or circumstances.

 

10.9 Force Majeure

 

No party shall be liable to the other, or held in breach of this Amended and Restated Warrant Indenture, if prevented, hindered, or delayed in the performance or observance of any provision contained herein by reason of act of God, riots, terrorism, acts of war, epidemics, governmental action or judicial order, earthquakes, or any other similar causes (including, but not limited to, mechanical, electronic or communication interruptions, disruptions or failures). Performance times under this Amended and Restated Warrant Indenture shall be extended for a period of time equivalent to the time lost because of any delay that is excusable under this Section.

 

10.10 Assignment, Successors and Assigns

 

Neither of the parties hereto may assign its rights or interest under this Amended and Restated Warrant Indenture without the consent of the other party, except as provided in Section 9.8 in the case of the Warrant Agent, or as provided in Section 8.2 in the case of the Corporation. Subject thereto, this Amended and Restated Warrant Indenture shall enure to the benefit of and be binding upon the parties hereto and their respective successors and permitted assigns.

 

 

  50  

 

10.11 Rights of Rescission and Withdrawal for Holders

 

Should a holder of Warrants exercise any legal, statutory, contractual or other right of withdrawal or rescission that may be available to it, and the holder’s funds which were paid on exercise have already been released to the Corporation by the Warrant Agent, the Warrant Agent shall not be responsible for ensuring the exercise is cancelled and a refund is paid back to the holder. In such cases, the holder shall seek a refund directly from the Corporation and subsequently, the Corporation, upon surrender to the Warrant Agent of any underlying shares that may have been issued, or such other procedure as agreed to by the parties hereto, shall instruct the Warrant Agent in writing, to cause the cancellation of the exercise transaction and any such underlying shares on the register, which may have already been issued upon the Warrant exercise. In the event that any payment is received from the Corporation by virtue of the holder being a shareholder for such Warrants that were subsequently rescinded, the Warrant Agent shall not be under any duty or obligation to take any steps to ensure or enforce that the funds are returned pursuant to this section, nor shall the Warrant Agent be in any other way responsible in the event that any payment is not delivered or received pursuant to this section. Notwithstanding the foregoing, in the event that the Corporation provides the refund to the Warrant Agent for distribution to the holder, the Warrant Agent shall return such funds to the holder as soon as reasonably practicable, and in so doing, the Warrant Agent shall incur no liability with respect to the delivery or non-delivery of any such funds.

 


 

IN WITNESS WHEREOF the parties hereto have executed this Amended and Restated Warrant Indenture under the hands of their proper officers in that behalf as of the date first written above.

 

    ABOVE FOOD INGREDIENTS INC.
     
  By: /s/ Lionel Kambeitz
    Name: Lionel Kambeitz
    Title: Chief Executive Officer
     
     
    ABOVE FOOD CORP.
     
  By: /s/ Lionel Kambeitz
    Name: Lionel Kambeitz
    Title: Chief Executive Officer
     
     
    ODYSSEY TRUST COMPANY
     
  By: /s/ Dan Sander
    Name: Dan Sander
    Title: President, Corporate Trust
     
     
  By: /s/ Amy Douglas
    Name: Amy Douglas
    Title: Senior Director, Corporate Trust

 


 

SCHEDULE A
Form of Warrant

 

UNLESS PERMITTED UNDER SECURITIES LEGISLATION, THE HOLDER OF THIS SECURITY MUST NOT TRADE THE SECURITY BEFORE THE DATE THAT IS 4 MONTHS AND A DAY AFTER THE LATER OF (I) JUNE 28, 2024, AND (II) THE DATE THE CORPORATION BECAME A REPORTING ISSUER IN ANY PROVINCE OR TERRITORY.

 

For all Warrants originally issued for the benefit or account of a U.S. Warrantholder, and each Warrant Certificate issued in exchange therefor or in substitution thereof, also include the following legends:

 

THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE CORPORATION THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED ONLY (A) TO THE CORPORATION, (B) OUTSIDE THE UNITED STATES IN COMPLIANCE WITH RULE 904 OF REGULATION S UNDER THE U.S. SECURITIES ACT AND IN COMPLIANCE WITH LOCAL LAWS AND REGULATIONS, (C) IN COMPLIANCE WITH THE EXEMPTION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER, IF AVAILABLE, AND IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS, OR (D) IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE U.S. SECURITIES ACT OR ANY APPLICABLE STATE LAWS AND REGULATIONS GOVERNING THE OFFER AND SALE OF SECURITIES, AND IN THE CASE OF (C) OR (D) THE HOLDER HAS PRIOR TO SUCH SALE FURNISHED TO THE CORPORATION AN OPINION OF COUNSEL OR OTHER EVIDENCE OF EXEMPTION IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE CORPORATION TO SUCH EFFECT.

 

THE PRESENCE OF THIS LEGEND MAY IMPAIR THE ABILITY OF THE HOLDER HEREOF TO EFFECT “GOOD DELIVERY” OF THE SECURITIES REPRESENTED HEREBY ON A STOCK EXCHANGE IN CANADA OR THE UNITED STATES.

 

THIS WARRANT MAY NOT BE EXERCISED IN THE UNITED STATES OR BY OR FOR THE ACCOUNT OR BENEFIT OF A U.S. PERSON OR PERSON IN THE UNITED STATES AND THE UNDERLYING SHARES MAY NOT BE DELIVERED WITHIN THE UNITED STATES UNLESS THE WARRANT AND THE UNDERLYING SHARES HAVE BEEN REGISTERED UNDER THE U.S. SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR UNLESS AN EXEMPTION FROM SUCH REGISTRATION REQUIREMENTS IS AVAILABLE, AND THE HOLDER HAS DELIVERED AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE CORPORATION TO SUCH EFFECT. “UNITED STATES” AND “U.S. PERSON” ARE USED HEREIN AS SUCH TERMS ARE DEFINED BY REGULATION S UNDER THE U.S. SECURITIES ACT.

 

WARRANT

 

To acquire Common Shares of

 

ABOVE FOOD INGREDIENTS INC.

 

(a company existing under the laws of the province of Alberta)

 

 

  A-2  

 

Warrant
Certificate No. ●
Certificate for ________________
Warrants, each entitling the holder to acquire 0.2103419 of a Common Share, and, if applicable, 0.0349264 of a Class A Share and/or 0.0349264 of a Class B Share (subject to adjustment as provided for in the Amended and Restated Warrant Indenture (as defined below))

 

THIS IS TO CERTIFY THAT, for value received,

 

 

(the “Warrantholder”) is the registered holder of the number of common share purchase warrants (the “Warrants”) of Above Food Ingredients Inc. (the “Corporation”) specified above, and is entitled, on exercise of these Warrants upon and subject to the terms and conditions set forth herein and in the Amended and Restated Warrant Indenture (as defined herein), to purchase at any time before 5:00 p.m. (Calgary time) (the “Expiry Time”) on the Expiry Date, 0.2103419 of a fully paid and non-assessable common share (each such whole share, a “Common Share”), and, if applicable, 0.0349264 of a fully paid and non-assessable class A earnout share (each such whole share, a “Class A Share”) and/or 0.0349264 of a fully paid and non-assessable class B earnout share (each such whole share, a “Class B Share”) without par value in the capital of the Corporation as constituted on the date hereof, for each Warrant, subject to adjustment in accordance with the terms of the Amended and Restated Warrant Indenture.

 

If, at any time following a Liquidity Event, the Current Market Price of the Common Shares on a Stock Exchange equals or exceeds US$5.00, the Corporation shall be entitled, at its option, within 10 days following such 10-Trading Day period, to accelerate the exercise period through the issuance by the Corporation of a press release specifying the new Expiry Date (the “Acceleration Notice”) and, in such case, the new Expiry Date shall be deemed to be the 30th day following the issuance of the Acceleration Notice. From and after the new Expiry Date specified in such Acceleration Notice, no Warrants may be issued or exercised, and all unexercised Warrants shall be void and of no effect following the new Expiry Date.

 

The Warrants evidenced hereby are exercisable at or before the Expiry Time on the Expiry Date after which time the Warrants evidenced hereby shall be deemed to be void and of no further force or effect.

 

This Warrant Certificate evidences Warrants of the Corporation issued or issuable under the provisions of an amended and restated warrant indenture (which indenture together with all other instruments supplemental or ancillary thereto is herein referred to as the “Amended and Restated Warrant Indenture”) dated as of June 28, 2024 between the Corporation and Odyssey Trust Company, as Warrant Agent. Reference is hereby made to the Amended and Restated Warrant Indenture for particulars of the rights of the holders of Warrants of the Corporation and of the Warrant Agent in respect thereof and of the terms and conditions on which the Warrants are issued and held, all to the same effect as if the provisions of the Amended and Restated Warrant Indenture were herein set forth, to all of which the Warrantholder, by acceptance hereof, assents. The Corporation will furnish to the holder, on request and without charge, a copy of the Amended and Restated Warrant Indenture. In the event of a conflict between the terms and conditions of this Warrant Certificate and the Amended and Restated Warrant Indenture, the provisions of the Amended and Restated Warrant Indenture shall govern.

 

 

  A-3  

 

Unless otherwise defined herein, capitalized terms will have the meanings set forth in the Amended and Restated Warrant Indenture.

 

The right to purchase Common Shares may only be exercised by the Warrantholder within the time set forth above by:

 

(a) duly completing and executing the exercise form (the “Exercise Form”) attached hereto; and

 

(b) surrendering this warrant certificate (the “Warrant Certificate”), with the Exercise Form to the Warrant Agent at the principal office of the Warrant Agent, in the city of Calgary, together with a certified cheque, bank draft or money order in lawful money of Canada payable to or to the order of the Corporation in an amount equal to the purchase price of the Common Shares so subscribed for.

 

The surrender of this Warrant Certificate, the duly completed Exercise Form and payment as provided above will be deemed to have been effected only on personal delivery thereof to, or if sent by mail or other means of transmission on actual receipt thereof by, the Warrant Agent at its principal offices as set out above.

 

Subject to adjustment thereof in the events and in the manner set forth in the Amended and Restated Warrant Indenture hereinafter referred to, the exercise price payable for each Common Share upon the exercise of Warrants shall be the Exercise Price as such term is defined in the Amended and Restated Warrant Indenture.

 

Certificates for the Common Shares subscribed for will be mailed to the persons specified in the Exercise Form at their respective addresses specified therein or, if so specified in the Exercise Form, delivered to such persons at the office, subject to the Warrant Agency being open to the public at such time, where this Warrant Certificate is surrendered. If fewer Common Shares are purchased than the number that can be purchased pursuant to this Warrant Certificate, the holder hereof will be entitled to receive without charge a new Warrant Certificate in respect of the balance of the Warrants not then exercised. No fractional Common Shares will be issued upon exercise of any Warrant.

 

On presentation at the principal offices of the Warrant Agent as set out above, subject to the provisions of the Amended and Restated Warrant Indenture and on compliance with the reasonable requirements of the Warrant Agent, one or more Warrant Certificates may be exchanged for one or more Warrant Certificates reflecting in the aggregate the same number of Warrants as the Warrant Certificate(s) so exchanged.

 

The Amended and Restated Warrant Indenture contains provisions for the adjustment of the Exercise Price payable for each Common Share upon the exercise of Warrants and the number of Common Shares issuable upon the exercise of Warrants in the events and in the manner set forth therein.

 

The Amended and Restated Warrant Indenture also contains provisions making binding on all holders of Warrants outstanding thereunder resolutions passed at meetings of holders of Warrants held in accordance with the provisions of the Amended and Restated Warrant Indenture and instruments in writing signed by Warrantholders of Warrants holding a specific majority of the all then outstanding Warrants.

 

Pursuant to Section 3.2(12) of the Warrant Indenture, if at any time prior to the Expiry Time, the Current Market Price exceeds the Exercise Price, each Warrantholder may elect to receive Common Shares pursuant to a “cashless exercise” (a “Cashless Exercise”), in lieu of a cash exercise, equal to the value of a Warrant determined in the manner described below (or of any portion thereof remaining unexercised) by surrender of a Warrant and an Exercise Form , in which event the Corporation shall issue to the Warrantholder the number of Common Shares computed using the following formula:

 

 

  A-4  

 

X = (Y)(A-B)

(A)

 

Where:

 

(a) X = the number of Common Shares to be issued to the Warrantholder.

 

(b) Y = the number of Common Shares that the Warrantholder elects to purchase under a Warrant (at the date of such calculation).

 

(c) A = the Current Market Price on the trading day immediately preceding the date of the receipt by the Warrant Agent of the Cashless Exercise Form.

 

(d) B = the Exercise Price per Common Share of such Warrant, as adjusted.

 

The issue price for each such Common Share to be issued pursuant to the Cashless Exercise of a Warrant will be equal to (B), as defined above, and the total issue price for the aggregate number of Common Shares issued pursuant to the Cashless Exercise of a Warrant will be paid and satisfied in full by the surrender to the Corporation of such Warrant and an Exercise Form.

 

Upon a Cashless Exercise of a Warrant during the Earnout Period, such Warrantholder shall be entitled to receive such number of Class A Shares and Class B Shares, in each case, as is equal to the number of Common Shares issuable upon Cashless Exercise divided by the Exchange Ratio multiplied by the Earnout Ratio.

 

Notwithstanding the foregoing, (x) no Class A Shares or Class B Shares will be issuable to Warrantholders upon a Cashless Exercise if, prior to such exercise, the Class A Shares or Class B Shares are redeemed pursuant to the Articles of the Corporation, (y) no Class A Shares will be issuable to Warrantholders upon a Cashless Exercise if, prior to such exercise, the First Tranche Earnout Target has been achieved, and (z) no Class B Shares will be issuable to Warrantholders upon a Cashless Exercise if, prior to such exercise, the Second Tranche Earnout Target has been achieved.

 

Nothing contained in this Warrant Certificate, the Amended and Restated Warrant Indenture or elsewhere shall be construed as conferring upon the holder hereof any right or interest whatsoever as a holder of Common Shares or any other right or interest except as herein and in the Amended and Restated Warrant Indenture expressly provided.

 

Warrants may only be transferred in compliance with the conditions of the Amended and Restated Warrant Indenture on the register to be kept by the Warrant Agent in Calgary, Alberta, or such other registrar as the Corporation, with the approval of the Warrant Agent, may appoint at such other place or places, if any, as may be designated, upon surrender of this Warrant Certificate to the Warrant Agent or other registrar accompanied by a written instrument of transfer in form and execution satisfactory to the Warrant Agent or other registrar and upon compliance with the conditions prescribed in the Amended and Restated Warrant Indenture and with such reasonable requirements as the Warrant Agent or other registrar may prescribe and upon the transfer being duly noted thereon by the Warrant Agent or other registrar. Time is of the essence hereof.

 

The Warrants and the Amended and Restated Warrant Indenture shall be governed by and performed, construed and enforced in accordance with the laws of the Province of Alberta and the federal laws of Canada applicable therein and shall be treated in all respects as Alberta contracts.

 

 

  A-5  

 

This Warrant Certificate will not be valid for any purpose until it has been countersigned by or on behalf of the Warrant Agent from time to time under the Amended and Restated Warrant Indenture.

 

The parties hereto have declared that they have required that this certificate and all other documents related hereto be in the English language. Les parties aux présentes déclarent qu’elles ont exigé que la présente convention, de même que tous les documents s’y rapportant, soient rédigés en anglais.

 

[Remainder of page intentionally left blank]

 

 

  A-6  

 

IN WITNESS WHEREOF the Corporation has caused this Warrant Certificate to be duly executed as of the ____ day of _______________, 20___.

 

      ABOVE FOOD INGREDIENTS INC.
         
      By:  
        Authorized Signatory
         
         
Countersigned and Registered by:      
       
ODYSSEY TRUST COMPANY      
         
By:        
  Authorized Signatory      
         
Date:        

 

 

  A-7  

 

FORM OF TRANSFER

 

ANY TRANSFER OF WARRANTS WILL REQUIRE COMPLIANCE WITH APPLICABLE SECURITIES LEGISLATION. TRANSFERORS AND TRANSFEREES ARE URGED TO CONTACT LEGAL COUNSEL BEFORE EFFECTING ANY SUCH TRANSFER.

 

TO:      ODYSSEY TRUST COMPANY

 

FOR VALUE RECEIVED the undersigned hereby sells, assigns and transfers to

 

 

 

 

(print name and address) the Warrants of ABOVE FOOD INGREDIENTS INC. (the “Corporation”) represented by this Warrant Certificate and hereby irrevocable constitutes and appoints __________________________ as its attorney with full power of substitution to transfer the said securities on the appropriate register of the Warrant Agent.

 

THE UNDERSIGNED TRANSFEROR HEREBY CERTIFIES AND DECLARES that the Warrants are not being offered, sold or transferred to, or for the account or benefit of, a “U.S. person” or a person within the “United States” (as such terms are defined in Regulation S under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”)) unless registered under the U.S. Securities Act and any applicable state securities laws or an exemption from such registration is available.

 

In the case of a warrant certificate that contains a U.S. restrictive legend, the undersigned hereby represents, warrants and certifies that (one (only) of the following must be checked):

 

¨  (A) the transfer is being made only to the Corporation;

 

¨ (B) the transfer is being made outside the United States in accordance with Rule 904 of Regulation S under the U.S. Securities Act, and in compliance with any applicable local securities laws and regulations and the holder has provided herewith the Declaration for Removal of Legend attached as Schedule B to the Amended and Restated Warrant Indenture, or

 

¨ (C) the transfer is being made within the United States or to, or for the account or benefit of, U.S. Persons, in accordance with a transaction that does not require registration under the U.S. Securities Act or any applicable state securities laws and the undersigned has furnished to the Corporation and the Warrant Agent an opinion of counsel of recognized standing in form and substance reasonably satisfactory to the Corporation to such effect.

 

In the case of a Warrant Certificate that does not contain a U.S. restrictive legend, if the proposed transfer is to, or for the account or benefit of a U.S. Person or to a person in the United States, the undersigned hereby represents, warrants and certifies that the transfer of the Warrants is being completed pursuant to an exemption from the registration requirements of the U.S. Securities Act and any applicable state securities laws, in which case the undersigned has furnished to the Corporation and the Warrant Agent an opinion of counsel of recognized standing in form and substance reasonably satisfactory to the Corporation to such effect.

 

In the event of the transfer of the Warrants represented by this Warrant Certificate to a Warrantholder that is in the United States or to, or for the account or benefit of a U.S. Person, the undersigned acknowledges and agrees that the Warrant Certificates representing such Warrants issued in the name of the transferee will be endorsed with the legend required by Section 2.8(1) of the Amended and Restated Warrant Indenture.

 

 

  A-8  

 

DATED this ____ day of ______________, 20__.

 

SPACE FOR GUARANTEES OF   )  
SIGNATURES (BELOW)   )  
    )  
    )
    ) Signature of Transferor
    )  
  )
Guarantor’s Signature/Stamp   ) Name of Transferor
    )  
    )  

 

Warrants shall only be transferable in accordance with the Amended and Restated Warrant Indenture and all applicable laws.

 

CERTAIN REQUIREMENTS RELATING TO TRANSFERS – READ CAREFULLY

 

The signature(s) of the transferor(s) must correspond with the name(s) as written upon the face of this certificate(s), in every particular, without alteration or enlargement, or any change whatsoever. The signature(s) on this form must be guaranteed in accordance with the transfer agent’s then current guidelines and requirements at the time of transfer. Notarized or witnessed signatures are not acceptable as guaranteed signatures. As at the time of closing, you may choose one of the following methods (although subject to change in accordance with industry practice and standards):

 

A Medallion Signature Guarantee obtained from a member of an acceptable Medallion Signature Guarantee Program (STAMP, SEMP, NYSE MSP). Many commercial banks, savings banks, credit unions, and all broker dealers participate in a Medallion Signature Guarantee Program. The Guarantor must affix a stamp bearing the actual words “Medallion Guaranteed”, with the correct prefix covering the face value of the certificate.

 

A Signature Guarantee obtained from the Guarantor must affix a stamp bearing the actual words “Signature Guaranteed”. Signature Guarantees are not accepted from Treasury Branches, Credit Unions or Caisse Populaires unless they are members of a Medallion Signature Guarantee Program. For corporate holders, corporate signing resolutions, including certificate of incumbency, are also required to accompany the transfer, unless there is a “Signature & Authority to Sign Guarantee” Stamp affixed to the transfer (as opposed to a “Signature Guarantee” Stamp) obtained from an authorized officer of a major Canadian Schedule I chartered bank.

 

For holders located outside North America, present the certificates(s) and/or document(s) that require a guarantee to a local financial institution that has a corresponding Canadian or American affiliate which is a member of an acceptable Medallion Signature Guarantee Program. The corresponding affiliate will arrange for the signature to be over-guaranteed.

 


 

WARRANT EXERCISE FORM

 

ANY TRANSFER OF WARRANTS WILL REQUIRE COMPLIANCE WITH APPLICABLE SECURITIES LEGISLATION. TRANSFERORS AND TRANSFEREES ARE URGED TO CONTACT LEGAL COUNSEL BEFORE EFFECTING ANY SUCH TRANSFER.

 

TO: ABOVE FOOD INGREDIENTS INC. (the “Corporation”)
AND TO: ODYSSEY TRUST COMPANY (the “Warrant Agent”)

 

The undersigned holder of the Warrants evidenced by this Warrant Certificate hereby exercises: [Please complete (a) or (b) below.]

 

(a) _______________ (A) Warrants, each Warrant entitling the holder thereof to acquire 0.2103419 of a Common Share and, if applicable, 0.0349264 of a Class A Share and/or 0.0349264 of a Class B Share, pursuant to the right of such holder to be issued, and hereby subscribes for, the Shares that are issuable pursuant to the exercise of such Warrants on the terms specified in such Warrant Certificate and in the Warrant Indenture for the aggregate exercise price:

 

Exercise Price Payable:      _________________________________________________; or
                                   ((A) multiplied by US$13.31, subject to adjustment)

 

(b) _______________ Warrants, if permitted pursuant to Section 3.2(12) of the Warrant Indenture, by means of a “cashless exercise” in which the Warrantholder shall be entitled to receive a number of Common Shares equal to the quotient obtained by dividing [(Y)(A-B)] by (A), where (i) (Y) equals the number of Common Shares that the Warrantholder elects to purchase under a Warrant (at the date of such calculation); (ii) (A) equals the Current Market Price on the trading day immediately preceding the date of the receipt by the Warrant Agent of the Cashless Exercise Form; and (iii) (B) equals the Exercise Price per Common Share of such Warrant, as adjusted, and the undersigned hereby surrenders all such Warrants to the Corporation in full payment and satisfaction of the total issue price for such Common Shares pursuant to this cashless exercise of such Warrants.

 

Upon a Cashless Exercise of a Warrant during the Earnout Period, such Warrantholder shall be entitled to receive such number of Class A Shares and Class B Shares, in each case, as is equal to the number of Common Shares issuable upon Cashless Exercise divided by the Exchange Ratio multiplied by the Earnout Ratio.

 

Notwithstanding the foregoing, (x) no Class A Shares or Class B Shares will be issuable to Warrantholders upon a Cashless Exercise if, prior to such exercise, the Class A Shares or Class B Shares are redeemed pursuant to the Articles of the Corporation, (y) no Class A Shares will be issuable to Warrantholders upon a Cashless Exercise if, prior to such exercise, the First Tranche Earnout Target has been achieved, and (z) no Class B Shares will be issuable to Warrantholders upon a Cashless Exercise if, prior to such exercise, the Second Tranche Earnout Target has been achieved.

 

The undersigned hereby exercises the right of such holder to be issued, and hereby subscribes for, Common Shares that are issuable pursuant to the exercise of such Warrants on the terms specified in such Warrant Certificate and in the Amended and Restated Warrant Indenture.

 

The undersigned hereby represents, warrants and certifies as follows (one (only) of the following must be checked):

 


 

A. ¨ The undersigned holder at the time of exercise of the Warrants (a) is not in the United States; (b) is not a U.S. Person and is not exercising the Warrants on behalf of, or for the account of, a U.S. Person or a person in the United States; and (c) represents and warrants that the exercise of the Warrants and the acquisition of the Common Shares upon exercise thereof occurred in an “offshore transaction” (as defined under Regulation S under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”));

 

B. ¨ A written confirmation that the Warrantholder (a) is an original U.S. purchaser who purchased the Warrants directly from the Corporation pursuant to Rule 144A under the U.S. Securities Act, (b) is a “qualified institutional buyer” as defined in rule 144A under the U.S. Securities Act, and (c) and confirms, as of the date of exercise, each of the representations, warranties, certifications and agreements made by it in connection with its acquisition of such Warrants as though such representations, warranties, certifications and agreements were made on the date thereof and in respect of the acquisition of the Common Shares issuable upon exercise of the Warrants; OR

 

C. ¨ The undersigned holder has delivered to the Warrant Agent an opinion of counsel of recognized standing in form and substance reasonably satisfactory to the Corporation to the effect that the exercise of the Warrants and the issuance of the Common Shares upon exercise thereof does not require registration under the U.S. Securities Act or any applicable state securities laws.

 

The undersigned holder understands that unless Box A above is checked, the certificate representing the Common Shares will be issued in definitive physical certificated form and bear a legend restricting transfer without registration under the U.S. Securities Act and applicable state securities laws unless an exemption from registration is available (in the form set out in the Amended and Restated Warrant Indenture and the subscription documents).

 

“U.S. Person” and “United States” are as defined under Regulation S under the U.S. Securities Act.

 

The undersigned hereby irrevocably directs that the said Common Shares be issued, registered and delivered as follows:

 

Name(s) in Full Address(es) Number of Common Shares
______________________ ______________________ ______________________
______________________ ______________________ ______________________
______________________ ______________________ ______________________
______________________ ______________________ ______________________
______________________ ______________________ ______________________

 

Please print full name in which certificates representing the Common Shares are to be issued. If any Common Shares are to be issued to a person or persons other than the registered holder, the registered holder must pay to the Warrant Agent all exigible transfer taxes or other government charges, if any, and the Form of Transfer must be duly executed.

 

Once completed and executed, this Exercise Form must be mailed or delivered to Above Food Ingredients Inc. c/o ODYSSEY TRUST COMPANY Suite 1230, 300 5th Avenue SW, Calgary, Alberta, T2P 3C4.

 

[Remainder of page intentionally left blank]

 


 

DATED this ____day of _______________, 20__.

 

    )  
  )
Witness   ) (Signature of Warrantholder, to be the
    ) same as it appears on the face of this
    ) Warrant Certificate. If an entity, the
    ) signatory represents that he or she has
    ) authority to bind such entity and duly
    ) execute this form.)
       
       
       
      Name of Warrantholder

 

¨ Please check if the certificates representing the Common Shares are to be delivered at the office where this Warrant Certificate is surrendered, failing which such certificates will be mailed to the address set out above. Certificates will be delivered or mailed as soon as practicable after the surrender of this Warrant Certificate to the Warrant Agent.

 


 

SCHEDULE B

 

FORM OF DECLARATION FOR REMOVAL OF LEGEND

 

TO: Above Foods Ingredients Inc.

c/o Odyssey Trust Company

Suite 1230, 300 5th Avenue SW
Calgary, Alberta
T2P 3C4

 

The undersigned (a) acknowledges that the sale of the securities of Above Food Ingredients Inc. (the "Corporation") to which this declaration relates is being made in reliance on Rule 904 of Regulation S ("Regulation S") under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") and (b) certifies that (1) it is not an affiliate of the Corporation (as defined in Rule 405 under the U.S. Securities Act), (2) the offer of such securities was not made to a person in the United States and either (A) at the time the buy order was originated, the buyer was outside the United States, or the seller and any person acting on its behalf reasonably believe that the buyer was outside the United States, or (B) the transaction was executed on or through the facilities of a Canadian stock exchange and neither the seller nor any person acting on its behalf knows that the transaction has been prearranged with a buyer in the United States, (3) neither the seller nor any affiliate of the seller nor any person acting on any of their behalf has engaged or will engage in any directed selling efforts in the United States in connection with the offer and sale of such securities, (4) the sale is bona fide and not for the purpose of "washing off" the resale restrictions imposed because the securities are "restricted securities" (as such term is defined in Rule 144(a)(3) under the U.S. Securities Act), (5) the seller does not intend to replace the securities sold in reliance on Rule 904 of the U.S. Securities Act with fungible unrestricted securities, and (6) the sale was not a transaction, or part of a series of transactions which, although in technical compliance with Regulation S, is part of a plan or scheme to evade the registration provisions of the U.S. Securities Act. Terms used herein have the meanings given to them by Regulation S.

 

Dated:     By:  
      Name:  
      Title:  

 

Affirmation By Seller's Broker-Dealer (required for sales in accordance with Section (b)(2)(B) above)

 

We have read the foregoing representations of our customer, _________________________ (the "Seller") dated _______________________, with regard to our sale, for such Seller's account, of the securities of the Corporation described therein, and on behalf of ourselves we certify and affirm that (A) we have no knowledge that the transaction had been prearranged with a buyer in the United States, (B) the transaction was executed on or through the facilities of designated offshore securities market, (C) neither we, nor any person acting on our behalf, engaged in any directed selling efforts in connection with the offer and sale of such securities, and (D) no selling concession, fee or other remuneration is being paid to us in connection with this offer and sale other than the usual and customary broker's commission that would be received by a person executing such transaction as agent. Terms used herein have the meanings given to them by Regulation S.

 

Name of Firm  
   
By:    
  Authorized officer  

 

Date:    

 

 

EX-10.1 6 tm2418826d1_ex10-1.htm EXHIBIT 10.1

 

Exhibit 10.1

 

STOCK ESCROW ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT

 

This STOCK ESCROW ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT (this “Agreement”) is entered into as of June 28, 2024 (the “Effective Date”), by and among Bite Acquisition Corp., a Delaware corporation (“Bite”), Above Food Ingredients Inc., a corporation organized under the laws of Alberta, Canada (the “Company”), Smart Dine, LLC, a Delaware limited liability company (the “Sponsor”), Continental Stock Transfer & Trust Company, a New York corporation (“Resigning Escrow Agent”), and Odyssey Transfer and Trust Company, a Minnesota corporation (“Odyssey”).

 

WHEREAS, Bite and the Sponsor previously entered into a stock escrow agreement, dated February 11, 2021, with Resigning Escrow Agent, as escrow agent, (which agreement and any and all agreements heretofore supplemental thereto are herein collectively referred to as the “Stock Escrow Agreement”), governing the terms of the escrow; capitalized terms used but not otherwise defined herein shall have the meanings given to such terms in the Stock Escrow Agreement;

 

AND WHEREAS, Bite hereby grants, conveys, transfers and assigns to the Company, and its successors and assigns, effective as of the date hereof, all of the Company’s rights and obligations under this Agreement, and the Company hereby assumes and agrees to become responsible for, and to pay, perform or discharge, as appropriate, effective as of the date hereof, all of Bite’s obligations pursuant to, in accordance with and subject to the terms and conditions of this Agreement;

 

AND WHEREAS, Resigning Escrow Agent agreed to transfer to Odyssey the appointment as escrow agent under the Stock Escrow Agreement, subject to the agreement of Bite, the Company and the Sponsor;

 

AND WHEREAS, to give effect to the foregoing, Resigning Escrow Agent desires, in accordance with the terms of the Stock Escrow Agreement, to resign as escrow agent thereunder and to be discharged from the rights, powers, duties and obligations thereof, and to transfer to Odyssey all of Resigning Escrow Agent’s rights, powers, duties and obligations under the Stock Escrow Agreement; AND WHEREAS, the parties wish to execute this Agreement for the purpose of providing for the resignation of Resigning Escrow Agent as escrow agent and for its replacement by Odyssey, such resignation and replacement to take effect as of the Effective Date;

 

AND WHEREAS, Bite is prepared to accept such resignation and to appoint Odyssey as the successor escrow agent, and Odyssey is prepared to accept such appointment;

 

AND WHEREAS, the foregoing recitals are made as representations and statements of fact by Bite and the Sponsor, and not by the Resigning Escrow Agent or Odyssey;

 

AND WHEREAS, Section 6.3 of the Stock Escrow Agreement provides that Bite, the Sponsor, and the Resigning Escrow Agent may amend the Stock Escrow Agreement in writing signed by each of the parties thereto;

 

 


 

 

NOW THEREFORE, THIS AGREEMENT WITNESSES that in consideration of the premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the parties hereto, the parties covenant and agree as follows:

 

1. The Resigning Escrow Agent hereby resigns as escrow agent under, and is hereby discharged from the rights, powers, duties and obligations of the escrow agent, the Stock Escrow Agreement, effective as of the Effective Date.

 

2. Bite and the Sponsor hereby accept such resignation.

 

3. Bite and the Sponsor hereby appoint Odyssey as successor escrow agent under the Stock Escrow Agreement in the place and stead of Resigning Escrow Agent and with like effect as if originally named as escrow agent under the Stock Escrow Agreement, effective as of the Effective Date and Odyssey hereby accepts (and the Company hereby agrees to) such appointment. Bite and the Company each hereby agree that Resigning Escrow Agent shall not be responsible for any liabilities that may arise pursuant to Odyssey’s administration of the escrow agency after the Effective Date.

 

4. The Resigning Escrow Agent hereby transfers and assigns to Odyssey, upon the agency expressed in the Stock Escrow Agreement, all rights, powers, duties and obligations of the Resigning Escrow Agent under the Stock Escrow Agreement, effective as of the Effective Date. All references to the “Escrow Agent” in the Stock Escrow Agreement (including all exhibits thereto) shall be references to Odyssey.

 

5. Odyssey hereby represents that it meets all the qualifications required for a new escrow agent under the Stock Escrow Agreement.

 

6. Notwithstanding any of the foregoing, the resignation, discharge, appointment, transfers, assignments and other agreements provided for herein will not be effective unless this Agreement has been executed by all of the parties hereto, whether upon the original instrument, by facsimile or in counterparts, or any combination thereof, and unless all preconditions to such resignation, discharge, appointment, transfers, assignments and other agreements as may be set forth in the Stock Escrow Agreement have been fulfilled.

 

7. Any provision in the Stock Escrow Agreement specifying the address of the Escrow Agent is hereby amended to record the address as:

 

Odyssey Transfer and Trust Company 

2155 Woodlane Drive, Suite 100 

Woodbury, MN 55125 

Email: clientsus@odysseytrust.com

 

2


 

8. Any provision in the Stock Escrow Agreement specifying the address of the Company is hereby amended to record the address as:

 

Above Food Ingredients Inc. 

2305 Victoria Avenue #001 

Regina, Saskatchewan, S4P 0S7 

Email: lionel@abovefood.com; jason.zhao@abovefood.com

 

9. Each party hereto agrees to execute and deliver all such documents and instruments and do such other acts as may be necessary or advisable to give effect to the terms hereof.

 

10. This Agreement supplements and amends the Stock Escrow Agreement and shall be read in conjunction therewith. Except only insofar as the same may be inconsistent with the express provisions of this Agreement, all the provisions of the Stock Escrow Agreement shall apply to and shall have effect in the same manner as if they and the provisions of this Agreement were contained in one instrument.

 

11. Odyssey as successor escrow agent hereby assumes the rights, powers, duties and obligations in the Stock Escrow Agreement declared and provided and agrees to perform the same upon the terms and conditions herein and in the Stock Escrow Agreement and be bound by the terms of the Stock Escrow Agreement in every way as if Odyssey had been the original party thereto in place of Resigning Escrow Agent.

 

12. The Company as successor to Bite hereby assumes the rights, powers, duties and obligations in the Stock Escrow Agreement declared and provided and agrees to perform the same upon the terms and conditions herein and in the Stock Escrow Agreement and be bound by the terms of the Stock Escrow Agreement in every way as if the Company had been the original party thereto in place of Bite and “Above Food Ingredients Inc.” shall be substituted for any and all references to Bite or the Company in the Stock Escrow Agreement.

 

13. Notwithstanding the foregoing, the protection and indemnities, including those contained in Section 5.2 of the Stock Escrow Agreement, provided to the Resigning Escrow Agent thereunder, and the waiver set forth in Section 5.8 of the Stock Escrow Agreement, shall survive the resignation of the Resigning Escrow Agent and termination or discharge of the Stock Escrow Agreement. The Resigning Escrow Agent shall continue to be bound by the waiver set forth in Section 5.8 of the Stock Escrow Agreement.

 

14. Section 4.3 of the Stock Escrow Agreement is amended in its entirety as follows:

 

“Restrictions on Transfer. During the Escrow Period, the only permitted transfers of the Escrow Shares will be (i) among the Founders or to the Company’s or the Founders’ members, officers, directors, consultants or their affiliates, (ii) to a Founder’s stockholders or members upon such Founder’s liquidation, in each case if the Founder is an entity, (iii) by bona fide gift to a member of a Founder’s immediate family or to a trust, the beneficiary of which is a Founder or a member of a Founder’s immediate family, in each case for estate planning purposes, (iv) by virtue of the laws of descent and distribution upon death, (v) pursuant to a qualified domestic relations order, (vi) to the Company for no value for cancellation in connection with the consummation of a Business Combination, (vii) in connection with the consummation of a Business Combination at prices no greater than the price at which the Escrow Shares were originally purchased or (viii) to Grupo Comercial e Industrial Marzam, S.A.P.I. de C.V, Gibart, S.A. de C.V. and Genomma Lab Internacional, S.A.B. de C.V.; provided, however, that except for clause (vi) or with the Company’s prior written consent, such permitted transfers may be implemented only upon the respective transferee’s written agreement to be bound by the terms and conditions of this Agreement.”

 

3


 

15. Section 6.1 of the Stock Escrow Agreement is amended in its entirety as follows:

 

“Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Minnesota, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. As to any claim, cross-claim, or counterclaim in any way relating to this Agreement, each party waives the right to trial by jury.”

 

16. This Agreement shall ensure to the benefit of and be binding upon the parties hereto and their successors and permitted assigns.

 

17. This Agreement shall be governed by the laws of the State of Minnesota applicable therein.

 

[Signature page follows.]

 

4


 

In witness whereof this Agreement has been duly executed by the parties hereto as of the date first above written.

 

  BITE ACQUISITION CORP.
     
     
  By: /s/ Alberto Ardura González
  Name: Alberto Arudra González
  Title: Chief Executive Officer
     
     
  SMART DINE, LLC
     
     
  By: /s/ Jose Luis Guerrero Cortes
  Name: Jose Luis Guerrero Cortes
  Title: CFO
     
     
  CONTINENTAL STOCK TRANSFER & TRUST COMPANY
     
     
  By: /s/ Henry Farrell
  Name: Henry Farrell
  Title: Vice President
     
     
  ODYSSEY TRANSFER AND TRUST COMPANY
     
  By: /s/ Rebecca Paulson
  Name: Rebecca Paulson
  Title: President
     
     
  ABOVE FOOD INGREDIENTS INC.
     
     
  By: /s/ Lionel Kambeitz
  Name: Lionel Kambeitz
  Title: Chief Executive Officer

 

[Signature Page to Stock Escrow Assignment, Assumption and Amendment]

 

 

EX-10.2 7 tm2418826d1_ex10-2.htm EXHIBIT 10.2

 

Exhibit 10.2

 

STOCK ESCROW AGREEMENT

 

STOCK ESCROW AGREEMENT, dated as of February 11, 2021 (the “Agreement”), by and among BITE ACQUISITION CORP., a Delaware corporation (the “Company”), SMART DINE, LLC, a Delaware limited liability company (the “Sponsor”), the stockholders of the Company listed on Exhibit A hereto (together with Sponsor and any permitted transferee of the Sponsor or such stockholders after the date hereof in accordance with the terms hereof being referred to as, the “Founders”) and CONTINENTAL STOCK TRANSFER & TRUST COMPANY, a New York limited purpose trust company (the “Escrow Agent”).

 

WHEREAS, the Company was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination (a “Business Combination”) with one or more businesses or entities.

 

WHEREAS, the Company has entered into an Underwriting Agreement, dated as of February 11, 2021 (the “Underwriting Agreement”), with EarlyBirdCapital, Inc. (the “Representative”) acting as representative of the several underwriters (collectively, the “Underwriters”), pursuant to which, among other matters, the Underwriters have agreed to purchase 17,500,000 units (the “Units”) of the Company, plus an additional 2,625,000 Units if the Underwriters exercise their over-allotment option in full. Each Unit consists of one share of the Company’s common stock, par value $0.0001 per share (“Common Stock”), and one-half of one warrant (“Warrant”), each whole Warrant to purchase one share of Common Stock, all as more fully described in the Company’s prospectus, comprising part of the Company’s Registration Statement on Form S-1 (File No. 333-252406) under the Securities Act of 1933, as amended (the “Registration Statement”), declared effective on February 11, 2021 (the “Effective Date”).

 

WHEREAS, the Founders have agreed as a condition of the sale of the Units to deposit their shares common stock, par value $0.0001 per share, of the Company (the “Founder Shares”) in escrow as hereinafter provided.

 

WHEREAS, the Company and the Founders desire that the Escrow Agent accept the Founder Shares, in escrow, to be held and disbursed as hereinafter provided.

 

IT IS AGREED:

 

1. Appointment of Escrow Agent. The Company and the Founders hereby appoint the Escrow Agent to act in accordance with and subject to the terms of this Agreement and the Escrow Agent hereby accepts such appointment and agrees to act in accordance with and subject to such terms.

 

2. Deposit of Shares. On or before the Effective Date, the Founders’ respective Founder Shares set forth on Exhibit A hereto shall be deposited in escrow, to be held and disbursed subject to the terms and conditions of this Agreement. The Founders acknowledge that the shares deposited in escrow will be legended to reflect the deposit of such shares under this Agreement.

 

3. Disbursement of the Escrow Shares.

 

3.1 If the over-allotment option to purchase all or a portion of the additional 2,250,000 Units of the Company is not exercised in full within 45 days of the date of the Registration Statement (as described in the Underwriting Agreement), the Sponsor agrees that the Escrow Agent shall return to the Company for cancellation, at no cost, the number of Founder Shares held by the Sponsor determined by multiplying 562,500 by a fraction, (i) the numerator of which is 2,250,000 minus the number of Units purchased by the Underwriters upon the exercise of the over-allotment option, and (ii) the denominator of which is 2,250,000. The Company shall promptly provide notice to the Escrow Agent of the expiration or termination of the over-allotment option and the number of Units, if any, purchased by the Underwriters in connection with the exercise thereof.

 

 


 

3.2 Except as otherwise set forth herein, the Escrow Agent shall hold the Founder Shares remaining after any cancellation required pursuant to Section 3.1 above (such remaining shares to be referred to herein as the “Escrow Shares”) until the earlier of one year after the date of the consummation of an initial Business Combination and the date on which the closing price of the Common Stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing 150 days after the consummation of an initial Business Combination (such period of time during which the Escrow Shares are held in escrow, the “Escrow Period”). The Company shall promptly provide notice of the consummation of an initial Business Combination to the Escrow Agent. Upon completion of the Escrow Period, the Escrow Agent shall disburse such amount of each Founder’s Escrow Shares to the applicable Founder; provided, however, that if, after the consummation of an initial Business Combination and during the Escrow Period, the Company (or the surviving entity) consummates a liquidation, merger, stock exchange or other similar transaction which results in all of the stockholders of such entity having the right to exchange their shares of Common Stock for cash, securities or other property, then the Escrow Agent will, upon receipt of a notice executed by the Chairman of the Board, Chief Executive Officer or other authorized officer of the Company (or the surviving entity), in form reasonably acceptable to the Escrow Agent, certifying that such transaction is then being consummated or such conditions have been achieved, as applicable, release the Escrow Shares to the Founders. The Escrow Agent shall have no further duties hereunder after the disbursement of the Escrow Shares in accordance with this Section 3.2.

 

3.3 If the Escrow Agent is notified by the Company pursuant to Section 6.7 hereof that the Company’s Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the Company and the Escrow Agent as trustee thereunder) is being liquidated, then the Escrow Agent shall deliver the certificates representing the Escrow Shares to the Founders promptly after the public stockholders are paid the liquidating distributions and shall have no further duties hereunder.

 

4. Rights of Founders in Escrow Shares.

 

4.1 Voting Rights as a Stockholder. Subject to the terms of the Insider Letter described in Section 4.4 hereof and except as herein provided, the Founders shall retain all of their rights as stockholders of the Company as long as any shares are held in escrow pursuant to this Agreement, including, without limitation, the right to vote such shares.

 

4.2 Dividends and Other Distributions in Respect of the Escrow Shares. For as long as any shares are held in escrow pursuant to this Agreement, all dividends payable in cash with respect to the Escrow Shares shall be paid to the Founders, but all dividends payable in stock or other non-cash property (“Non-Cash Dividends”) shall be delivered to the Escrow Agent to hold in accordance with the terms hereof. As used herein, the term “Escrow Shares” shall be deemed to include the Non-Cash Dividends distributed thereon, if any.

 

4.3 Restrictions on Transfer. During the Escrow Period, the only permitted transfers of the Escrow Shares will be (i) among the Founders or to the Company’s or the Founders’ members, officers, directors, consultants or their affiliates, (ii) to a Founder’s stockholders or members upon such Founder’s liquidation, in each case if the Founder is an entity, (iii) by bona fide gift to a member of a Founder’s immediate family or to a trust, the beneficiary of which is a Founder or a member of a Founder’s immediate family, in each case for estate planning purposes, (iv) by virtue of the laws of descent and distribution upon death, (v) pursuant to a qualified domestic relations order, or (vi) to the Company for no value for cancellation in connection with the consummation of a Business Combination, (vii) in connection with the consummation of a Business Combination at prices no greater than the price at which the Escrow Shares were originally purchased; provided, however, that except for clause (vi) or with the Company’s prior written consent, such permitted transfers may be implemented only upon the respective transferee’s written agreement to be bound by the terms and conditions of this Agreement and of the Insider Letter.

 

4.4 Insider Letter. The Founders have executed a letter agreement with the Company, dated as of the date hereof, the form of which is filed as an exhibit to the Registration Statement (“Insider Letter”), respecting the rights and obligations of such Founders in certain events, including, but not limited to, the liquidation of the Company.

 

5. Concerning the Escrow Agent.

 

5.1 Good Faith Reliance. The Escrow Agent shall not be liable for any action taken or omitted by it in good faith and in the exercise of its own best judgment, and may rely conclusively and shall be protected in acting upon any order, notice, demand, certificate, opinion or advice of counsel (including counsel chosen by the Escrow Agent), statement, instrument, report or other paper or document (not only as to its due execution and the validity and effectiveness of its provisions, but also as to the truth and acceptability of any information therein contained) which is believed by the Escrow Agent in good faith to be genuine and to be signed or presented by the proper person or persons. The Escrow Agent shall not be bound by any notice or demand, or any waiver, modification, termination or rescission of this Agreement unless evidenced by a writing delivered to the Escrow Agent signed by the proper party or parties and, if the duties or rights of the Escrow Agent are affected, unless it shall have given its prior written consent thereto.

 

2 


 

5.2 Indemnification. Subject to Section 5.8 below, the Escrow Agent shall be indemnified and held harmless by the Company from and against any expenses, including reasonable counsel fees and disbursements, or loss suffered by the Escrow Agent in connection with any action, suit or other proceeding involving any claim which in any way, directly or indirectly, arises out of or relates to this Agreement, the services of the Escrow Agent hereunder, or the Escrow Shares held by it hereunder, other than expenses or losses arising from the gross negligence, fraud or willful misconduct of the Escrow Agent. Promptly after the receipt by the Escrow Agent of notice of any demand or claim or the commencement of any action, suit or proceeding, the Escrow Agent shall notify the other parties hereto in writing. In the event of the receipt of such notice, the Escrow Agent, in its sole discretion, may commence an action in the nature of interpleader in an appropriate court to determine ownership or disposition of the Escrow Shares or it may deposit the Escrow Shares with the clerk of any appropriate court or it may retain the Escrow Shares pending receipt of a final, non-appealable order of a court having jurisdiction over all of the parties hereto directing to whom and under what circumstances the Escrow Shares are to be disbursed and delivered. The provisions of this Section 5.2 shall survive in the event the Escrow Agent resigns or is discharged pursuant to Sections 5.5 or 5.6 below.

 

5.3 Compensation. Subject to Section 5.8 below, the Escrow Agent shall be entitled to reasonable compensation from the Company for all services rendered by it hereunder. The Escrow Agent shall also be entitled to reimbursement from the Company for all reasonable expenses paid or incurred by it in the administration of its duties hereunder including, but not limited to, all counsel, advisors’ and agents’ fees and disbursements and all taxes or other governmental charges.

 

5.4 Further Assurances. From time to time on and after the date hereof, the Company and the Founders shall deliver or cause to be delivered to the Escrow Agent such further documents and instruments and shall do or cause to be done such further acts as the Escrow Agent shall reasonably request to carry out more effectively the provisions and purposes of this Agreement, to evidence compliance herewith or to assure itself that it is protected in acting hereunder.

 

5.5 Resignation. The Escrow Agent may resign at any time and be discharged from its duties as escrow agent hereunder by its giving the other parties hereto written notice and such resignation shall become effective as hereinafter provided. Such resignation shall become effective at such time that the Escrow Agent shall turn the Escrow Shares over to a successor escrow agent appointed by the Company and approved by the Representative, which approval will not be unreasonably withheld, conditioned or delayed. If no new escrow agent is so appointed within the 60-day period following the giving of such notice of resignation, the Escrow Agent may deposit the Escrow Shares with any court it reasonably deems appropriate in the State of New York.

 

5.6 Discharge of Escrow Agent. The Escrow Agent shall resign and be discharged from its duties as escrow agent hereunder if so requested in writing at any time by all of the other parties hereto; provided, however, that such resignation shall become effective only upon the appointment of a successor escrow agent selected by the Company and approved by the Representative, which approval will not be unreasonably withheld, conditioned or delayed.

 

5.7 Liability. Notwithstanding anything herein to the contrary, the Escrow Agent shall not be relieved from liability hereunder for its own gross negligence, fraud or willful misconduct.

 

5.8 Waiver. The Escrow Agent hereby waives any right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or to any distribution of, the Trust Account and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever.

 

3 


 

6. Miscellaneous.

 

6.1 Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of New York, Borough of Manhattan, for purposes of resolving any disputes hereunder. As to any claim, cross-claim, or counterclaim in any way relating to this Agreement, each party waives the right to trial by jury.

 

6.2 Third Party Beneficiaries. Each of the parties to this Agreement hereby acknowledges that the Representative is a third party beneficiary of this Agreement.

 

6.3 Entire Agreement. This Agreement contains the entire agreement of the parties hereto with respect to the subject matter hereof and, except as expressly provided herein, may only be changed, amended, or modified by a writing signed by each of the parties hereto.

 

6.4 Headings. The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation thereof.

 

6.5 Binding Effect. This Agreement shall be binding upon and inure to the benefit of the respective parties hereto and their legal representatives, successors and assigns.

 

6.6 Notices. Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery, by email or by electronic transmission:

 

If to the Company, to:

 

Bite Acquisition Corp.

30 West Street, No. 28F

New York, New York 10004

Attn: Alberto Ardura Gonzalez and Axel Molet Warschawski

Email: alberto.ardura@yahoo.com

Email: axelmolet@gmail.com

 

If to a Founder, to his/her/its address set forth in Exhibit A.

 

and if to the Escrow Agent, to:

 

Continental Stock Transfer & Trust Company

1 State Street

New York, New York 10004

Attn: Chairman

Email: jkiszka@continentalstock.com

 

A copy of any notice sent hereunder shall be sent to:

 

EarlyBirdCapital, Inc.

366 Madison Ave., 8th Floor

New York, NY 10017

Attn: Steven Levine

Email: slevine@ebccap.com

 

with a copy to:

 

Greenberg Traurig, P.A.

333 S.E. 2nd Avenue

Miami, FL 33131

Attn: Alan I. Annex, Esq.

Fax No.: (305) 579-0717

Email: annexa@gtlaw.com

 

4 


 

and:

 

Graubard Miller

The Chrysler Building

405 Lexington Avenue

New York, New York 10174

Attn: David Alan Miller, Esq.

Fax No.: (212) 818-8881

Email: dmiller@graubard.com

 

The parties may change the persons and addresses to which the notices or other communications are to be sent by giving written notice to any such change in the manner provided herein for giving notice.

 

6.7 Liquidation of the Trust Account. The Company shall give the Escrow Agent written notification of the liquidation of the Trust Account in the event that the Company fails to consummate a Business Combination within the time period specified in the Company’s Amended and Restated Certificate of Incorporation, as the same may be amended from time to time.

 

6.8 Counterparts. This Agreement may be executed in several counterparts, each one of which shall constitute an original and may be delivered by facsimile transmission and together shall constitute one instrument.

 

[Signature Page Follows]

 

5 


 

WITNESS the execution of this Agreement as of the date first above written.

 

  BITE ACQUISITION CORP.
   
  By: /s/ Alberto Ardura Gonzalez
    Name:  Alberto Ardura Gonzalez
    Title:    Chief Executive Officer
   
   
  CONTINENTAL STOCK TRANSFER & TRUST
COMPANY, as Escrow Agent
   
  By: /s/ James F. Kiszka
    Name:  James F. Kiszka
    Title:    Vice President
   
  FOUNDERS:
   
  SMART DINE, LLC
   
  By: /s/ Axel Molet Warschawski
    Name:  Axel Molet Warschawski
    Title:    Chief Financial Officer

 

 

    /s/ Randall Hiatt
    Randall Hiatt
     
     
    /s/ Joseph C. Essa
    Joseph C. Essa
     
     
    /s/ Julia A. Stewart
    Julia A. Stewart

 

[Signature Page to Stock Escrow Agreement]

 

 


 

EXHIBIT A

 

Name and Address of Founder   Number of Shares  
       
Smart Dine, LLC
30 West Street, No. 28F
New York, New York 10004
    4,961,251  
         
Randall Hiatt
150 Monte Vista Drive
Napa, CA 94559
    23,333  
         
Joseph C. Essa
2220 Villefort Court
Las Vegas, NV 89117
    23,333  
         
Julia A. Stewart
1165 Linda Glen Dr.
Pasadena, CA 91105
    23,333  

 

 


 

EX-10.3 8 tm2418826d1_ex10-3.htm EXHIBIT 10.3

Exhibit 10.3 

 

REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 28, 2024, is made and entered into by and among Above Food Ingredients Inc., an Alberta corporation (the “Company”) and the direct parent company of Above Food Corp., an Alberta corporation (“Above Food”), Smart Dine, LLC, a Delaware limited liability company (the “Sponsor”), the undersigned parties listed under “SPAC Holders” on the signature page(s) hereto (the Sponsor and each such party, a “SPAC Holder,” and, such parties collectively, including the Sponsor, the “SPAC Holders”), and the undersigned parties listed under “Above Food Holders” on the signature page(s) hereto (each such party, an “Above Food Holder,” and, collectively, the “Above Food Holders”). The Sponsor, the other SPAC Holders, the Above Food Holders, and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 or Section 5.10 of this Agreement, are each referred to herein as a “Holder,” and, collectively, the “Holders.”

 

RECITALS

 

WHEREAS, the Company has entered into that certain Business Combination Agreement, dated as of April 22, 2023, (as it may be amended or supplemented from time to time pursuant to the terms thereof, the “Business Combination Agreement”), by and among Bite Acquisition Corp. (“SPAC”), the Company, Above Merger Sub, Inc., a Delaware corporation and direct, wholly owned subsidiary of the Company (“Merger Sub”), and Above Food, pursuant to which and subject to the terms and conditions thereof, among other things, on or about the date hereof, (i) Above Food will continue from the laws of Saskatchewan to a corporation continued under the laws of the Province of Alberta; (ii) pursuant to the Share Exchange, the holders of Above Food common shares will contribute to the Company all of the issued and outstanding shares of Above Food in exchange for newly issued Common Shares, whereby Above Food will become a direct, wholly owned subsidiary of the Company; and (iii) Merger Sub will merge with and into SPAC (the “Merger”) with SPAC continuing as the surviving corporation after the Merger, whereby SPAC will become a direct, wholly owned subsidiary of the Company;

 

WHEREAS, at the Share Exchange Effective Time, pursuant to the transactions contemplated by the Business Combination Agreement, the Above Food Holders will receive Common Shares in such amounts as set forth in the Business Combination Agreement;

 

WHEREAS, at the Merger Effective Time, pursuant to the transactions contemplated by and as set forth in the Business Combination Agreement, the Sponsor and the other SPAC Holders will receive, as consideration therefor, an aggregate of (i) 5,640,000 Common Shares, which includes 1,100,000 Common Shares that are subject to vesting conditions as set forth in Section 2.8 of the Business Combination Agreement (such Common Shares that are subject to vesting conditions, the “Sponsor Earnout Shares”) and (ii) 275,000 warrants representing the right to acquire Common Shares (the “Sponsor Warrants”);

 

WHEREAS, upon the terms and subject to the conditions set forth in the Business Combination Agreement, the Above Food Holders have a contingent right to receive up to 6,114,620 Common Shares in the aggregate upon the occurrence of certain events set forth in the Business Combination Agreement (such Common Shares and the Sponsor Earnout Shares, collectively, the “Earnout Shares”); WHEREAS, SPAC, the Sponsor and the other SPAC Holders are parties to that certain Registration Rights Agreement, dated as of February 11, 2021 (the “Original RRA”); and

 

 


 

 

WHEREAS, upon consummation of the transactions contemplated by the Business Combination Agreement, the parties to the Original RRA desire to terminate the Original RRA.

 

NOW, THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

 

ARTICLE I

 

DEFINITIONS

 

1.1            Definitions. Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement. The terms defined in this Article I shall, for all purposes of this Agreement, have the respective meanings set forth below:

 

“Above Food” shall have the meaning given in the Recitals hereto.

 

“Above Food Holders” shall have the meaning given in the Preamble hereto.

 

“Additional Holder” shall have the meaning given in Section 5.10.

 

“Additional Holder Common Shares” shall have the meaning given in Section 5.10.

 

“Adverse Disclosure” shall mean any public disclosure of material non-public information, which disclosure, in the good faith judgment of the Board, Chief Executive Officer or the Chief Financial Officer of the Company, after consultation with counsel to the Company, (i) would be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading, (ii) would not be required to be made at such time if the Registration Statement or Prospectus were not being filed, declared effective or used, as the case may be and (iii) the Company has a bona fide business purpose for not making such information public.

 

“Agreement” shall have the meaning given in the Preamble hereto.

 

“Block Trade” shall have the meaning given in Section 2.4.1.

 

“Board” shall mean the Board of Directors of the Company.

 

 


 

“Business Combination Agreement” shall have the meaning given in the Recitals hereto.

 

“Closing” shall have the meaning given in the Business Combination Agreement.

 

“Closing Date” shall have the meaning given in the Business Combination Agreement.

 

“Commission” shall mean the Securities and Exchange Commission.

 

“Common Shares” shall mean the common shares in the capital of the Company.

 

“Company” shall have the meaning given in the Preamble hereto and includes the Company’s successors by recapitalization, merger, consolidation, spin-off, reorganization or similar transaction.

 

“Competing Registration Rights” shall have the meaning given in Section 5.7.

 

“Demanding Holder” shall have the meaning given in Section 2.1.4.

 

“EarlyBird” shall mean EarlyBirdCapital, Inc.

 

“Earnout Shares” shall have the meaning given in the Recitals hereto.

 

“EDGAR” shall have the meaning given in Section 3.1.3.

 

“Exchange Act” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.

 

“Form F-1 Shelf” shall have the meaning given in Section 2.1.1.

 

“Form F-3 Shelf” shall have the meaning given in Section 2.1.1.

 

“Holder Information” shall have the meaning given in Section 4.1.2.

 

“Holders” shall have the meaning given in the Preamble hereto, for so long as such person or entity holds any Registrable Securities.

 

“Joinder” shall have the meaning given in Section 5.2.5.

 

“Lock-Up Agreement” shall mean that certain Lock-Up Agreement, dated as of the date hereof, by and among the Company, the Sponsor and certain holders of Common Shares party thereto.

 

“Lock-Up Period” shall have the meaning given in the Lock-Up Agreement.

 

“Maximum Number of Securities” shall have the meaning given in Section 2.1.5.

 

“Merger” shall have the meaning given in the Recitals hereto.

 

“Merger Sub” shall have the meaning given in the Recitals hereto.

 

 


 

“Minimum Takedown Threshold” shall have the meaning given in Section 2.1.4.

 

“Misstatement” shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement or Prospectus or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light of the circumstances under which they were made) not misleading.

 

“New Registration Statement” shall have the meaning given in Section 2.1.7.

 

“Original RRA” shall have the meaning given in the Recitals hereto.

 

“Other Coordinated Offering” shall have the meaning given in Section 2.4.1.

 

“own” or “ownership” (and derivatives of such terms) shall mean (i) ownership of record and (ii) “beneficial ownership” as defined in Rule 13d-3 or Rule 16a-1(a)(2) promulgated by the Commission under the Exchange Act (but without regard to any requirement for a security or other interest to be registered under Section 12 of the Securities Act).

 

“Permitted Transferees” shall mean, with respect to each Holder and its Permitted Transferees, (i) prior to the expiration of the Lock-Up Period, any person or entity to whom such Holder is permitted to transfer such Registrable Securities prior to the expiration of the Lock-Up Period pursuant to Section 2 of the Lock-Up Agreement and (ii) after the expiration of the Lock-Up Period, any person or entity to whom such Holder is permitted to transfer such Registrable Securities, subject to and in accordance with any applicable agreement between such Holder and/or their respective Permitted Transferees and the Company and any transferee thereafter.

 

“Piggyback Registration” shall have the meaning given in Section 2.2.1.

 

“Prospectus” shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus.

 

“Registrable Security” shall mean (a) any issued and outstanding Common Shares and any other equity security (including Common Shares issued or issuable upon the exercise or conversion of any other equity security, including warrants to purchase Common Shares) of the Company held by a Holder immediately following the Closing (including the Sponsor Warrants and any Earnout Shares to the extent such Earnout Shares have vested or have been issued by the Company pursuant to the Business Combination Agreement and other securities distributable pursuant to Section 2.8 of the Business Combination Agreement); (b) any outstanding Common Shares or any other equity security (including warrants to purchase Common Shares and Common Shares issued or issuable upon the exercise or conversion of any other equity security) of the Company acquired by a Holder following the date hereof to the extent that such securities are “restricted securities” (as defined in Rule 144) or are otherwise held by an “affiliate” (as defined in Rule 144) of the Company; (c) any Additional Holder Common Shares; and (d) any other equity security of the Company or any of its subsidiaries issued or issuable with respect to any securities referenced in clause (a), (b) or (c) above by way of a stock dividend or stock split or in connection with a recapitalization, merger, consolidation, spin-off, reorganization or similar transaction; provided, however, that, as to any particular Registrable Security, such securities shall cease to be Registrable Securities upon the earliest to occur of: (A) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement by the applicable Holder; (B) (i) such securities shall have been otherwise transferred (other than to a Permitted Transferee), (ii) new certificates for such securities not bearing (or book entry positions not subject to) a legend restricting further transfer shall have been delivered by the Company and (iii) subsequent public distribution of such securities shall not require registration under the Securities Act; (C) such securities shall have ceased to be outstanding; (D) such securities may be sold without registration pursuant to Rule 144 or any successor rule promulgated under the Securities Act (but with no volume or other restrictions or limitations including as to manner or timing of sale); and (E) such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction.

 

 


 

“Registration” shall mean a registration, including any related Shelf Takedown, effected by preparing and filing a registration statement, Prospectus or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective.

 

“Registration Expenses” shall mean the documented, out-of-pocket expenses of a Registration, including, without limitation, the following:

 

(A)            all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.) and any national securities exchange on which the Common Shares are then listed;

 

(B)            fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of outside counsel for the Underwriters in connection with blue sky qualifications of Registrable Securities);

 

(C)            printing, messenger, telephone and delivery expenses;

 

(D)            reasonable fees and disbursements of counsel for the Company;

 

(E)            reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with such Registration; and

 

(F)            in an Underwritten Offering or Other Coordinated Offering, reasonable and documented fees and expenses not to exceed $30,000 in the aggregate for each such Registration, of one (1) legal counsel selected by the majority-in-interest of the Demanding Holders with the approval of the Company, which approval shall not be unreasonably withheld.

 

“Registration Statement” shall mean any registration statement that covers any of the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

 

“SEC Guidance” shall have the meaning given in Section 2.1.7.

 

 


 

“Securities Act” shall mean the Securities Act of 1933, as amended from time to time.

 

“Shelf” shall have the meaning given in Section 2.1.1.

 

“Shelf Registration” shall mean a registration of securities pursuant to a registration statement filed with the Commission in accordance with and pursuant to Rule 415 promulgated under the Securities Act (or any successor rule then in effect).

 

“Shelf Takedown” shall mean an Underwritten Shelf Takedown or any proposed transfer or sale using a Registration Statement, including a Piggyback Registration.

 

“SPAC” shall have the meaning given in the Recitals hereto.

 

“SPAC Holders” shall have the meaning given in the Preamble hereto.

 

“Sponsor” shall have the meaning given in the Preamble hereto.

 

“Sponsor Earnout Shares” shall have the meaning given in the Recitals hereto.

 

“Sponsor Support Agreement” shall mean that certain Sponsor Support Agreement, dated as of April 22, 2023, by and among the Sponsor, SPAC and Above Food.

 

“Sponsor Warrants” shall have the meaning given in the Recitals hereto.

 

“Subsequent Shelf Registration Statement” shall have the meaning given in Section 2.1.2.

 

“Transfer” shall mean the (a) sale or assignment of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act, and the rules and regulations of the Commission promulgated thereunder, with respect to, any security, (b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b).

 

“Underwriter” shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such dealer’s market-making activities.

 

“Underwritten Offering” shall mean a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public.

 

“Underwritten Shelf Takedown” shall have the meaning given in Section 2.1.4.

 

“Withdrawal Notice” shall have the meaning given in Section 2.1.6.

 

 


 

ARTICLE II

 

REGISTRATIONS AND OFFERINGS

 

2.1            Shelf Registration.

 

2.1.1            Filing. Within thirty (30) calendar days following the Closing Date, the Company shall submit to or file with the Commission a Registration Statement for a Shelf Registration on Form F-1 (the “Form F-1 Shelf”) or a Registration Statement for a Shelf Registration on Form F-3 (the “Form F-3 Shelf,” and together with the Form F-1 Shelf, the New Registration Statement and any Subsequent Shelf Registration Statement, the “Shelf”), if the Company is then eligible to use a Form F-3 Shelf, in each case, covering the public resale of all the Registrable Securities (determined as of two (2) business days prior to such submission or filing) on a delayed or continuous basis and shall use its commercially reasonable efforts to have such Shelf declared effective as soon as practicable after the filing thereof, but no later than the earlier of (a) the ninetieth (90th) calendar day following the filing date thereof if the Commission notifies the Company that it will “review” the Registration Statement and (b) the tenth (10th) business day after the date the Company is notified (orally or in writing, whichever is earlier) by the Commission that the Registration Statement will not be “reviewed” or will not be subject to further review. Such Shelf shall provide for the resale of the Registrable Securities included therein pursuant to any method or combination of methods legally available to, and requested by, any Holder named therein. In the event the Company files a Form F-1 Shelf, the Company shall use its commercially reasonable efforts to convert the Form F-1 Shelf (and any Subsequent Shelf Registration Statement) to a Form F-3 Shelf as soon as practicable after the Company is eligible to use Form F-3. The Company shall maintain a Shelf in accordance with the terms hereof, and shall use commercially reasonable efforts to prepare and file with the Commission such amendments, including post-effective amendments, and supplements as may be necessary to keep a Shelf continuously effective, available for use to permit the Holders named therein to sell their Registrable Securities included therein and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities. The Company’s obligation under this Section 2.1.1, shall, for the avoidance of doubt, be subject to Section 3.4.

 

2.1.2            Subsequent Shelf Registration. If any Shelf ceases to be effective under the Securities Act for any reason at any time while Registrable Securities are still outstanding, the Company shall, subject to Section 3.4, use its commercially reasonable efforts to as promptly as is reasonably practicable cause such Shelf to again become effective under the Securities Act with respect to the public resale of all the Registrable Securities (including using its commercially reasonable efforts to obtain the prompt withdrawal of any order suspending the effectiveness of such Shelf), and shall use its commercially reasonable efforts to as promptly as is reasonably practicable amend such Shelf in a manner reasonably expected to result in the withdrawal of any order suspending the effectiveness of such Shelf or file an additional registration statement as a Shelf Registration (a “Subsequent Shelf Registration Statement”) registering the resale of all Registrable Securities (determined as of two (2) business days prior to such filing), and pursuant to any method or combination of methods legally available to, and requested by, any Holder named therein. If a Subsequent Shelf Registration Statement is filed, the Company shall use its commercially reasonable efforts to (i) cause such Subsequent Shelf Registration Statement to become effective under the Securities Act as promptly as is reasonably practicable after the filing thereof (it being agreed that the Subsequent Shelf Registration Statement shall be an automatic shelf registration statement (as defined in Rule 405 promulgated under the Securities Act) if the Company is a well-known seasoned issuer (as defined in Rule 405 promulgated under the Securities Act) at the most recent applicable eligibility determination date) at the time of filing and (ii) keep such Subsequent Shelf Registration Statement continuously effective, available for use to permit the Holders named therein to sell their Registrable Securities included therein and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities. Any such Subsequent Shelf Registration Statement shall be on Form F-3 to the extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration Statement shall be on another appropriate form. The Company’s obligation under this Section 2.1.2, shall, for the avoidance of doubt, be subject to Section 3.4.

 

 


 

2.1.3            Additional Registrable Securities. Subject to Section 3.4, in the event that any Holder holds Registrable Securities that are not registered for resale on a delayed or continuous basis, the Company, upon written request of a SPAC Holder or an Above Food Holder, shall promptly use its commercially reasonable efforts to cause the resale of such Registrable Securities to be covered by either, at the Company’s option, any then available Shelf (including by means of a post-effective amendment) or by filing a Subsequent Shelf Registration Statement and cause the same to become effective as soon as practicable after such filing and such Shelf or Subsequent Shelf Registration Statement shall be subject to the terms hereof; provided, however, that the Company shall only be required to cause such additional Registrable Securities to be so covered twice per calendar year for each of the Sponsor, the other SPAC Holders (as a group) and the Above Food Holders (as a group).

 

2.1.4            Requests for Underwritten Shelf Takedowns. Subject to Section 3.4, at any time and from time to time after the expiration of any Lock-Up Period to which a Holder’s shares are subject and when an effective Shelf is on file with the Commission, one or more SPAC Holders or one or more Above Food Holders, or their respective Permitted Transferee (any of the SPAC Holders or Above Food Holders or respective Permitted Transferees being in such case, a “Demanding Holder”) may request to sell all or any portion of its Registrable Securities in an Underwritten Offering that is registered pursuant to the Shelf (each, an “Underwritten Shelf Takedown”); provided that the Company shall only be obligated to effect an Underwritten Shelf Takedown if such offering shall include Registrable Securities proposed to be sold by the Demanding Holder, either individually or together with other Demanding Holders, with an aggregate offering price, net of underwriting discounts and commissions, reasonably expected to exceed at least $50 million (the “Minimum Takedown Threshold”). All requests for Underwritten Shelf Takedowns shall be made by giving written notice to the Company at least 48 hours prior to the public announcement of the Underwritten Shelf Takedown (a “Shelf Takedown Notice”), which Shelf Takedown Notice shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten Shelf Takedown and the expected price range (net of underwriting discounts and commissions) of such Underwritten Shelf Takedown. Subject to Section 2.4.4, the Company shall have the right to select the Underwriters for such offering (which shall consist of one or more reputable nationally recognized investment banks), subject to the initial Demanding Holder’s prior approval (which shall not be unreasonably withheld, conditioned or delayed). The Sponsor and other SPAC Holders (and their respective Permitted Transferees), as a group, may demand not more than one (1) Underwritten Shelf Takedown and the Above Food Holders (and their Permitted Transferees), as a group, may demand not more than three (3) Underwritten Shelf Takedowns, in each case, pursuant to this Section 2.1.4 in any twelve (12) month period. Notwithstanding anything to the contrary in this Agreement, the Company may consummate an Underwritten Offering pursuant to any then effective Registration Statement, including a Form F-3, that is then available for such offering. Notwithstanding anything to the contrary in this Agreement, EarlyBird may demand an Underwritten Shelf Takedown pursuant to this Section 2.1.4 in only one (1) occasion and only during the period commencing on the date of this Agreement and ending on February 11, 2026, and, thereafter, will no longer have any rights under this Section 2.1.4.

 

 


 

2.1.5            Reduction of Underwritten Offering. If the managing Underwriter or Underwriters in an Underwritten Shelf Takedown advise the Demanding Holders in writing that marketing factors require a limitation of the number of shares to be underwritten, then the Demanding Holders shall so advise all Holders of Registrable Securities that would otherwise be underwritten pursuant hereto, and the number of shares of Registrable Securities that may be included in the underwriting (such maximum number of such securities, the “Maximum Number of Securities”) shall be allocated among all participating Holders thereof, including the Demanding Holders, in proportion (as nearly as practicable) to the amount of Registrable Securities of the Company owned by each participating Holder; provided, however, that the number of shares of Registrable Securities to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting.

 

2.1.6            Withdrawal. Prior to the filing of the applicable “red herring” prospectus or prospectus supplement used for marketing such Underwritten Shelf Takedown, a majority-in-interest of the Demanding Holders initiating an Underwritten Shelf Takedown shall have the right to withdraw from such Underwritten Shelf Takedown for any or no reason whatsoever upon written notification (a “Withdrawal Notice”) to the Company and the Underwriter or Underwriters (if any) of their intention to withdraw from such Underwritten Shelf Takedown; provided that the remaining Demanding Holders may elect to have the Company continue an Underwritten Shelf Takedown if the Minimum Takedown Threshold would still be satisfied by the Registrable Securities proposed to be sold in the Underwritten Shelf Takedown by the remaining Demanding Holders. If withdrawn, a demand for an Underwritten Shelf Takedown shall constitute a demand for an Underwritten Shelf Takedown by the withdrawing Demanding Holder for purposes of Section 2.1.4, unless either (i) such Demanding Holder has not previously withdrawn any Underwritten Shelf Takedown or (ii) such Demanding Holder reimburses the Company for all Registration Expenses with respect to such Underwritten Shelf Takedown (or, if there is more than one Demanding Holder, a pro rata portion of such Registration Expenses based on the respective number of Registrable Securities that each Demanding Holder has requested be included in such Underwritten Shelf Takedown); provided that, if one or more Demanding Holders elect to continue an Underwritten Shelf Takedown pursuant to the proviso in the immediately preceding sentence, such Underwritten Shelf Takedown shall instead count as an Underwritten Shelf Takedown demanded by such remaining Demanding Holders, as applicable, for purposes of Section 2.1.4. Following the receipt of any Withdrawal Notice, the Company shall promptly forward such Withdrawal Notice to any other Holders that had elected to participate in such Shelf Takedown. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Shelf Takedown prior to its withdrawal under this Section 2.1.6, other than if a Demanding Holder elects to pay such Registration Expenses pursuant to clause (ii) of the second sentence of this Section 2.1.6.

 

 


 

2.1.7            New Registration Statement. Notwithstanding the registration obligations set forth in this Section 2.1, in the event the Commission informs the Company that all of the Registrable Securities cannot, as a result of the application of Rule 415 under the Securities Act, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly (a) inform each of the holders thereof and use its commercially reasonable efforts to file amendments to the Shelf Registration as required by the Commission and/or (b) withdraw the Shelf Registration and file a new registration statement (a “New Registration Statement”), on Form F-3, or if Form F-3 is not then available to the Company for such registration statement, on such other form available to register for resale the Registrable Securities as a secondary offering; provided, however, that prior to filing such amendment or New Registration Statement, the Company shall use its commercially reasonable efforts to advocate with the Commission for the registration of all of the Registrable Securities in accordance with any publicly-available written or oral guidance, comments, requirements or requests of the Commission staff (the “SEC Guidance”). Notwithstanding any other provision of this Agreement, if any SEC Guidance sets forth a limitation of the number of Registrable Securities permitted to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that the Company used commercially reasonable efforts to advocate with the Commission for the registration of all or a greater number of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable Securities to register a lesser amount of Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced on a pro rata basis based on the total number of Registrable Securities held by the Holders. In the event the Company amends the Shelf Registration or files a New Registration Statement, as the case may be, under clause (a) or (b) above, the Company will use its commercially reasonable efforts to file with the Commission, as promptly as allowed by Commission or provided by SEC Guidance to the Company or to registrants of securities in general, one or more registration statements on Form F-3 or such other form available to register for resale those Registrable Securities that were not registered for resale on the Shelf Registration, as amended, or the New Registration Statement.

 

2.2            Piggyback Registration.

 

2.2.1            Piggyback Rights. If (but without any obligation to do so) the Company proposes to register (including for this purpose a registration effected by the Company for holders of capital stock other than the Holders) any Common Shares or other equity securities of the Company under the Securities Act in connection with the public offering of such securities solely for cash (including, for this purpose, an Underwritten Shelf Takedown pursuant to Section 2.1) (other than a registration relating solely to the sale of securities to participants in a Company stock plan or a transaction covered by Rule 145 under the Securities Act, a registration in which the only shares being registered is Common Shares issuable upon conversion of debt securities which are also being registered, or any registration on any form which does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities), then the Company shall give written notice of such proposed offering to all of the Holders of Registrable Securities as soon as practicable but not less than ten (10) calendar days before the anticipated filing date of such Registration Statement or, in the case of an Underwritten Offering pursuant to a Shelf Registration, the applicable “red herring” prospectus or prospectus supplement used for marketing such offering, which notice shall (A) describe the amount and type of securities to be included in such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering, and (B) offer to all of the Holders of Registrable Securities the opportunity to include in such registered offering such number of Registrable Securities as such Holders may request in writing within five (5) calendar days after receipt of such written notice (such registered offering, a “Piggyback Registration”). Subject to Section 2.2.2, the Company shall, in good faith, cause such Registrable Securities to be included in such Piggyback Registration and, if applicable, shall use its commercially reasonable efforts to cause the managing Underwriter or Underwriters of such Piggyback Registration to permit the Registrable Securities requested by the Holders pursuant to this Section 2.2.1 to be included therein on the same terms and conditions as any similar securities of the Company included in such registered offering and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. The inclusion of any Holder’s Registrable Securities in a Piggyback Registration shall be subject to such Holder agreement to enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering. Notwithstanding anything to the contrary, the Holders shall have no rights under this Section 2.2.1 if the registration statement the Company proposes to file is solely for purposes of a delayed or continuous offering pursuant to Rule 415 under the Securities Act and, at the time of the filing of such registration statement, the Company is in compliance with its obligations under Section 2.1.

 

 


 

2.2.2            Reduction of Piggyback Registration. If the total amount of securities, including Registrable Securities, requested by holders of Registrable Securities to be included in such offering exceeds the amount of securities sold other than by the Company that the underwriters determine in their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the underwriters determine in their sole discretion will not jeopardize the success of the offering (the securities so included to be apportioned pro rata among the selling security holders according to the total amount of securities entitled to be included therein owned by each selling security holder or in such other proportions as shall mutually be agreed to by such selling security holders). For purposes of the preceding parenthetical concerning apportionment, for any selling security holder which is a holder of Registrable Securities and which is a partnership or corporation, the partners, retired partners and holders of capital stock of such holder, or the estates and family members of any such partners and retired partners and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single “selling security holder,” and any pro-rata reduction with respect to such “selling security holder” shall be based upon the aggregate amount of shares carrying registration rights owned by all entities and individuals included in such “selling security holder,” as defined in this sentence.

 

2.2.3            Piggyback Registration Withdrawal. Any Holder of Registrable Securities (other than a Demanding Holder, whose right to withdraw from an Underwritten Shelf Takedown, and related obligations, shall be governed by Section 2.1.6) shall have the right to withdraw all or any portion of its Registrable Securities from a Piggyback Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw such Registrable Securities from such Piggyback Registration prior to the effectiveness of the Registration Statement filed with the Commission with respect to such Piggyback Registration or, in the case of a Piggyback Registration pursuant to a Shelf Registration, the filing of the applicable “red herring” prospectus or prospectus supplement with respect to such Piggyback Registration used for marketing such transaction. The Company (whether on its own good faith determination or as the result of a request for withdrawal by persons or entities pursuant to separate written contractual obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration (which, in no circumstance, shall include a Shelf) at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement (other than Section 2.1.6), the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration prior to its withdrawal under this Section 2.2.3.

 

 


 

2.2.4            Unlimited Piggyback Registration Rights. For purposes of clarity, subject to Section 2.1.6, any Piggyback Registration effected pursuant to Section 2.2 hereof shall not be counted as a demand for an Underwritten Shelf Takedown under Section 2.1.4 hereof. Notwithstanding anything to the contrary in this Agreement, EarlyBird may participate in a Piggyback Registration only during the period commencing on the date of this Agreement and ending on February 11, 2028, and, thereafter, will no longer have any rights thereof.

 

2.3            Market Stand-off. In connection with any Underwritten Offering of equity securities of the Company (other than a Block Trade or Other Coordinated Offering), if requested by the managing Underwriters, each Holder participating in such Underwritten Offering that is an executive officer, director or Holder holding in excess of five percent (5%) of the outstanding Common Shares (and for which it is customary for such a Holder to agree to a lock-up) agrees that it shall not Transfer any Common Shares, the Sponsor Warrants or other equity securities of the Company (other than those included in such offering pursuant to this Agreement), without the prior written consent of the Company, during the ninety (90)-calendar day period (or such shorter time agreed to by the managing Underwriters) beginning on the date of pricing of such offering, except as expressly permitted by such lock-up agreement or in the event the managing Underwriters otherwise agree by written consent. Each such Holder agrees to execute a customary lock-up agreement in favor of the Underwriters to such effect (in each case on substantially the same terms and conditions as all such Holders).

 

2.4            Block Trades; Other Coordinated Offerings.

 

2.4.1            Notwithstanding any other provision of this Article II, but subject to Section 3.4, at any time and from time to time when an effective Shelf is on file with the Commission, if a Demanding Holder wishes to engage in (a) an underwritten registered offering not involving a “roadshow,” an offer commonly known as a “block trade” (a “Block Trade”) or (b) an “at the market” or similar registered offering through a broker, sales agent or distribution agent, whether as agent or principal, (an “Other Coordinated Offering”), in each case, either (x) with an aggregate offering price reasonably expected to be at least the Minimum Takedown Threshold or (y) of all remaining Registrable Securities held by the Demanding Holder, then such Demanding Holder only needs to notify the Company of the Block Trade or Other Coordinated Offering at least five (5) business days prior to the day such offering is to commence and the Company shall use its commercially reasonable efforts to facilitate such Block Trade or Other Coordinated Offering; provided that the Demanding Holders representing a majority of the Registrable Securities wishing to engage in the Block Trade or Other Coordinated Offering shall use commercially reasonable efforts to work with the Company and any Underwriters, brokers, sales agents or placement agents prior to making such request in order to facilitate preparation of the registration statement, prospectus and other offering documentation related to the Block Trade or Other Coordinated Offering. For the avoidance of doubt, neither a Block Trade nor an Other Coordinated Offering shall include an offering of Registrable Securities in which a negative assurance letter of counsel to the Company or a comfort letter of the accountants of the Company is to be delivered to the Underwriter or Underwriters, brokers, sales agents or distribution agents, as applicable.

 

 


 

2.4.2            Prior to the filing of the applicable “red herring” prospectus or prospectus supplement used in connection with a Block Trade or Other Coordinated Offering, a majority-in-interest of the Demanding Holders initiating such Block Trade or Other Coordinated Offering shall have the right to submit a Withdrawal Notice to the Company, the Underwriter or Underwriters (if any) and any brokers, sales agents or placement agents (if any) of their intention to withdraw from such Block Trade or Other Coordinated Offering. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with a Block Trade or Other Coordinated Offering prior to its withdrawal under this Section 2.4.2.

 

2.4.3            Notwithstanding anything to the contrary in this Agreement, Section 2.2 shall not apply to a Block Trade or Other Coordinated Offering initiated by a Demanding Holder pursuant to this Agreement.

 

2.4.4            The Demanding Holder in a Block Trade or Other Coordinated Offering shall have the right to select the Underwriters and any brokers, sales agents or placement agents (if any) for such Block Trade or Other Coordinated Offering (in each case, which shall consist of one or more reputable nationally recognized investment banks).

 

2.4.5            A Holder in the aggregate may demand no more than two (2) Block Trades or Other Coordinated Offerings pursuant to this Section 2.4 in any twelve (12) month period. For the avoidance of doubt, any Block Trade or Other Coordinated Offering effected pursuant to this Section 2.4 shall not be counted as a demand for an Underwritten Shelf Takedown pursuant to Section 2.1.4 hereof, and the procedures set forth in Section 2.1.4 with respect to an Underwritten Shelf Takedown shall not apply with respect thereto.

 

ARTICLE III

 

COMPANY PROCEDURES

 

3.1            General Procedures. In connection with any Shelf and/or Shelf Takedown, the Company shall use its commercially reasonable efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall:

 

3.1.1            prepare and file with the Commission as soon as reasonably practicable a Registration Statement with respect to such Registrable Securities and use its commercially reasonable efforts to cause such Registration Statement to become effective and remain effective until the earlier of (i) when all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration Statement or have ceased to be Registrable Securities or (ii) the termination of this Agreement;

 

3.1.2            prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the Prospectus, as may be reasonably requested by any Holder that holds at least five (5%) of the Registrable Securities registered on such Registration Statement or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus or have ceased to be Registrable Securities;

 

 


 

3.1.3            prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters, if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such other documents as the Underwriters and the Holders of Registrable Securities included in such Registration or the legal counsel for any such Holders may reasonably request in order to facilitate the disposition of the Registrable Securities owned by such Holders; provided that the Company shall have no obligation to furnish any documents publicly filed or furnished with the Commission pursuant to the Electronic Data Gathering, Analysis and Retrieval System (“EDGAR”);

 

3.1.4            prior to any public offering of Registrable Securities, use its commercially reasonable efforts to (i) register or qualify the Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution) may reasonably request (or provide evidence satisfactory to such Holders that the Registrable Securities are exempt from such registration or qualification) and (ii) take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject;

 

3.1.5            use commercially reasonable efforts to cause all such Registrable Securities to be listed on each national securities exchange on which similar securities issued by the Company are then listed;

 

3.1.6            provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration Statement;

 

3.1.7            advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any proceeding for such purpose and promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop order should be issued;

 

 


 

3.1.8            at least three (3) calendar days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such Registration Statement or Prospectus (or such shorter period of time as may be (a) necessary in order to comply with the Securities Act, the Exchange Act, and the rules and regulations promulgated under the Securities Act or Exchange Act, as applicable or (b) advisable in order to reduce the number of days that sales are suspended pursuant to Section 3.4), furnish a copy thereof to each seller of such Registrable Securities or its counsel (excluding any exhibits thereto and any filing made under the Exchange Act that is to be incorporated by reference therein);

 

3.1.9            advise each Holder of Registrable Securities covered by such Registration Statement, promptly after the Company receives notice thereof, of the time when such Registration Statement has been declared effective or a supplement to any Prospectus forming a part of such Registration Statement has been filed;

 

3.1.10            notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, and then to correct such Misstatement as set forth in Section 3.4;

 

3.1.11            in the event of an Underwritten Offering, a Block Trade, an Other Coordinated Offering or sale by a broker, placement agent or sales agent pursuant to such Registration, on the date the Registrable Securities are delivered for sale pursuant to such Registration, permit a representative of the Holders, the Underwriters or other financial institutions facilitating such Underwritten Offering, Block Trade, Other Coordinated Offering or other sale pursuant to such Registration, if any, and any attorney, consultant or accountant retained by such Holders or Underwriter to participate, at each such person’s or entity’s own expense, in the preparation of the Registration Statement, and cause the Company’s officers, directors and employees to supply all information reasonably requested by any such representative, Underwriter, financial institution, attorney, consultant or accountant in connection with the Registration; provided, however, that such representatives, Underwriters or financial institutions agree to enter into confidentiality arrangements in form and substance reasonably satisfactory to the Company, prior to the release or disclosure of any such information;

 

3.1.12            obtain a “cold comfort” letter from the Company’s independent registered public accountants in the event of an Underwritten Offering, a Block Trade, an Other Coordinated Offering or sale by a broker, placement agent or sales agent pursuant to such Registration (subject to such broker, placement agent or sales agent providing such certification or representation reasonably requested by the Company’s independent registered public accountants and the Company’s counsel) in customary form and covering such matters of the type customarily covered by “cold comfort” letters as the managing Underwriter or Underwriters may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating Holders;

 

3.1.13            in the event of an Underwritten Offering, a Block Trade, an Other Coordinated Offering or sale by a broker, placement agent or sales agent pursuant to such Registration, on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the participating Holders, the broker, placement agents or sales agent, if any and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of which such opinion is being given as the participating Holders, broker, placement agent, sales agent or Underwriter may reasonably request and as are customarily included in such opinions and negative assurance letters;

 

 


 

3.1.14            in the event of any Underwritten Offering, a Block Trade, an Other Coordinated Offering or sale by a broker, placement agent or sales agent pursuant to such Registration, enter into and perform its obligations under an underwriting agreement or other purchase or sales agreement, in usual and customary form, with the managing Underwriter or Underwriters or the broker, placement agent or sales agent of such offering or sale;

 

3.1.15            make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule then in effect), and which requirement will be deemed to be satisfied if the Company timely files complete and accurate information on Forms 10-Q and 10-K and Current Report on 8-K under the Exchange Act and otherwise complies with Rule 158 under the Securities Act (or any successor rule then in effect);

 

3.1.16            with respect to an Underwritten Offering pursuant to Section 2.1.4, if such offering involving gross proceeds in excess of $50 million, use its commercially reasonable efforts to make available senior executives of the Company to participate in customary “roadshow” presentations that may be reasonably requested by the Underwriter in such Underwritten Offering; and

 

3.1.17            otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the participating Holders, consistent with the terms of this Agreement, in connection with such Registration.

 

Notwithstanding the foregoing, the Company shall not be required to provide any documents or information to an Underwriter or broker, sales agent or placement agent if such Underwriter or broker, sales agent or placement agent has not then been named with respect to the applicable Underwritten Offering or other offering involving a registration as an Underwriter or broker, sales agent or placement agent, as applicable.

 

3.2            Registration Expenses. The Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,” all reasonable fees and expenses of any legal counsel representing the Holders.

 

 


 

3.3            Requirements for Participation in Registration Statement in Offerings. Notwithstanding anything in this Agreement to the contrary, if any Holder does not provide the Company with its requested Holder Information, the Company may exclude such Holder’s Registrable Securities from the applicable Registration Statement or Prospectus if the Company determines, based on the advice of counsel, that such information is necessary to effect the registration and such Holder continues thereafter to withhold such information. No person or entity may participate in any Underwritten Offering or other offering for equity securities of the Company pursuant to a Registration initiated by the Company hereunder unless such person or entity (i) agrees to sell such person’s or entity’s securities on the basis provided in any underwriting, sales, distribution or placement arrangements approved by the Company and (ii) completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting or other agreements and other customary documents as may be reasonably required under the terms of such underwriting, sales, distribution or placement arrangements. The exclusion of a Holder’s Registrable Securities as a result of this Section 3.3 shall not affect the registration of the other Registrable Securities to be included in such Registration.

 

3.4            Suspension of Sales; Adverse Disclosure; Restrictions on Registration Rights.

 

3.4.1            Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement or, in the opinion of counsel for the Company, it is necessary to supplement or amend such Prospectus to comply with law, each of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or amendment as soon as reasonably practicable after the time of such notice), or until it is advised in writing by the Company that the use of the Prospectus may be resumed.

 

3.4.2            If the filing, initial effectiveness or continued use of a Registration Statement in respect of any Registration at any time would (a) require the Company to make an Adverse Disclosure, (b) require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons beyond the Company’s control or (c) in the good faith judgment of the Board, the Chief Executive Officer or the Chief Financial Officer of the Company, such Registration Statement would be seriously detrimental to the Company and it is therefore in the best interest of the Company to defer such submission, filing, initial effectiveness or continued use at such time, the Company shall have the right, upon giving prompt written notice of such action to the Holders (which notice shall not specify the nature of the event giving rise to such delay or suspension), delay the submission, filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of time, but in no event more than ninety (90) days, determined in good faith by the Company to be necessary for such purpose. In the event the Company exercises its rights under this Section 3.4.2, the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their use of the Prospectus relating to any Registration in connection with any sale or offer to sell Registrable Securities until such Holder receives written notice from the Company that such sales or offers of Registrable Securities may be resumed, and in each case maintain the confidentiality of such notice and its contents.

 

 


 

3.4.3            (a) During the period starting with the date ninety (90) calendar days prior to the Company’s good faith estimate of the date of the filing of, and ending on a date one hundred and twenty (120) calendar days after the effective date of, a Company-initiated Registration and provided that the Company continues to actively employ, in good faith, all commercially reasonable efforts to maintain the effectiveness of the applicable Shelf Registration, or (b) if, pursuant to Section 2.1.4, Holders have requested an Underwritten Shelf Takedown and the Company and such Holders are unable to obtain the commitment of underwriters to firmly underwrite such offering, the Company may, upon giving prompt written notice of such action to the Holders, delay any other registered offering pursuant to Section 2.1.4 or 2.4 for not more than ninety (90) consecutive calendar days or more than one hundred and twenty (120) total calendar days in each case during any twelve (12)-month period.

 

3.5            Reporting Obligations. As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under the Exchange Act, covenants to use commercially reasonable efforts to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings; provided that any documents publicly filed or furnished with the Commission pursuant to EDGAR shall be deemed to have been furnished or delivered to the Holders pursuant to this Section 3.5. The Company further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required from time to time to enable such Holder to sell the Common Shares held by such Holder without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor rule then in effect). Upon the request of any Holder, the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements.

 

3.6            Foreign Private Issuer Status. As of such time as the Company ceases to be a “foreign private issuer” (as defined in Rule 12b-2 under the Exchange Act), (i) all references in this Agreement to a Form F-1 Shelf shall thereafter be deemed to refer to a shelf registration on Form S-1, (ii) all references in this Agreement to a Form F-3 Shelf shall thereafter be deemed to refer to a shelf registration on Form S-3 and (iii) the Company shall promptly take all actions reasonably necessary to ensure the Holders gain the expected benefit of this Agreement, including by filing (and making effective) any post-effective amendment to an existing Registration Statement or a Subsequent Shelf Registration Statement.

 

ARTICLE IV

 

INDEMNIFICATION AND CONTRIBUTION

 

4.1            Indemnification.

 

4.1.1            The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers, directors and agents and each person or entity who controls such Holder (within the meaning of the Securities Act), against all losses, claims, damages, liabilities and out-of-pocket expenses (including, without limitation, reasonable and documented outside attorneys’ fees) resulting from any untrue or alleged untrue statement of material fact contained in or incorporated by reference in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same are caused by or contained in any information or affidavit so furnished in writing to the Company by such Holder expressly for use therein. The Company shall indemnify the Underwriters, their officers and directors and each person or entity who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to the indemnification of the Holder.

 

 


 

4.1.2            In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish (or cause to be furnished) to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus (the “Holder Information”) and, to the extent permitted by law, shall indemnify the Company, its directors, officers and agents and each person or entity who controls the Company (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and out-of-pocket expenses (including, without limitation, reasonable and documented outside attorneys’ fees) resulting from any untrue or alleged untrue statement or omission of material fact contained or incorporated by reference in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that such untrue statement is contained in (or not contained in, in the case of an omission) any information or affidavit so furnished in writing by or on behalf of such Holder expressly for use therein; provided, however, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement, except in the case of fraud or willful misconduct by such Holder. The Holders of Registrable Securities shall indemnify the Underwriters, their officers, directors and each person or entity who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to indemnification of the Company.

 

4.1.3            Any person or entity entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s or entity’s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (ii) unless in such indemnified party’s reasonable, good faith judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable, good faith judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement) or which settlement includes a statement or admission of fault and culpability on the part of such indemnified party or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

 

 


 

4.1.4            The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director or controlling person or entity of such indemnified party and shall survive the transfer of securities. The Company and each Holder of Registrable Securities participating in an offering also agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party in the event the Company’s or such Holder’s indemnification is unavailable for any reason.

 

4.1.5            If the indemnification provided under Section 4.1 from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and out-of-pocket expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and out-of-pocket expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by (or not made by, in the case of an omission), or relates to information supplied by (or not supplied by in the case of an omission), such indemnifying party or indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided, however, that the liability of any Holder under this Section 4.1.5 shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations set forth in Sections 4.1.1, 4.1.2 and 4.1.3 above, any legal or other fees, charges or out-of-pocket expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 4.1.5 were determined by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations referred to in this Section 4.1.5. No person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 4.1.5 from any person or entity who was not guilty of such fraudulent misrepresentation.

 

ARTICLE V

 

MISCELLANEOUS

 

5.1            Notices. Any notice or communication under this Agreement must be in writing and given by (i) deposit in the United States mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii) delivery in person or by courier service providing evidence of delivery, or (iii) transmission by hand delivery, electronic mail or facsimile. Each notice or communication that is mailed, delivered, or transmitted in the manner described above shall be deemed sufficiently given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered by courier service, hand delivery, electronic mail or facsimile, at such time as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation. Any notice or communication under this Agreement must be addressed as follows:

 

 


 

If to the Company, to:

 

Above Food Ingredients Inc.

001-2305 Victoria Avenue

 

Regina, Saskatchewan S4P 0S7, Canada
Attention: Lionel Kambeitz
E-mail: lionel@abovefood.com

 

with a copy (which will not constitute notice) to:

 

Michelle Westerman 

E-mail: michelle@abovefood.com

 

And to:

 

Latham & Watkins LLP 

811 Main Street, Suite 3700 

Houston, Texas 77002 

  Attention:   Ryan J. Maierson
      Ryan J. Lynch
  Email:   ryan.maierson@lw.com
      ryan.lynch@lw.com

 

If to any Holder, to:

 

Such Holder’s address, electronic mail address or facsimile number as set forth in the Company’s books and records.

 

Any party may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30) calendar days after delivery of such notice as provided in this Section 5.1.

 

5.2            Assignment; No Third Party Beneficiaries.

 

5.2.1            This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or in part.

 

 


 

5.2.2            Subject to Section 5.2.4 and Section 5.2.5, this Agreement and the rights, duties and obligations of the Holders of Registrable Securities hereunder may be assigned or delegated in whole or in part by such Holder in conjunction with and to the extent of any Transfer of Registrable Securities by any such Holder; provided, that, with respect to the Above Food Holders, the Sponsor and the other SPAC Holders, the rights hereunder that are personal to such Holders may not be assigned or delegated in whole or in part, except that (x) each of the Above Food Holders shall be permitted to transfer its rights hereunder as the Above Food Holders to one or more affiliates or any direct or indirect partners, members or equity holders of such Above Food Holder (it being understood that no such transfer shall reduce any rights of such Above Holder or such transferees) and (y) the Sponsor and the other SPAC Holders shall be permitted to transfer their respective rights hereunder as the Sponsor or the other SPAC Holders, as applicable, to one or more of their respective affiliates or any direct or indirect partners, members or equity holders of the Sponsor or the other SPAC Holders, as applicable (it being understood that no such transfer shall reduce or multiply any rights of the Sponsor or the other SPAC Holders or such transferees).

 

5.2.3            This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties hereto and their successors and the permitted assigns of the Holders, which shall include Permitted Transferees.

 

5.2.4            This Agreement shall not confer any rights or benefits on any persons or entities that are not parties hereto, other than as expressly set forth in this Agreement and Section 5.2.

 

5.2.5            No assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall have received (i) written notice of such assignment as provided in Section 5.1 hereof and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may be accomplished by delivery of an executed joinder in substantially the same form as Exhibit A attached hereto (a “Joinder”)). Any transfer or assignment of this Agreement, or of any rights, duties or obligations hereunder, made other than as provided in this Section 5.2 shall be null and void.

 

5.3            Headings; Counterparts. The headings in this Agreement are for convenience only and shall not be considered a part of or affect the construction or interpretation of any provision of this Agreement. This Agreement may be executed in two or more counterparts, and by different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document, but all of which together shall constitute one and the same instrument. Copies of executed counterparts of this Agreement transmitted by electronic transmission (including by email or in .pdf format) or facsimile as well as electronically or digitally executed counterparts (such as DocuSign) shall have the same legal effect as original signatures and shall be considered original executed counterparts of this Agreement.

 

5.4            Governing Law; Venue. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT (1) THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION AND (2) THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE EXCLUSIVELY IN THE SUPREME COURT OF THE STATE OF NEW YORK, NEW YORK COUNTY, AND ANY STATE APPELLATE COURT THEREFROM WITHIN THE STATE OF NEW YORK, NEW YORK COUNTY, OR IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK.

 

 


 

5.5            TRIAL BY JURY. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND, THEREFORE, EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.

 

5.6            Amendments and Modifications. Upon the written consent of (a) the Company and (b) the Holders of a majority of the total Registrable Securities at such time (for the avoidance of doubt, the Registrable Securities held by EarlyBird shall only be included in determining whether a majority of such Holders have consented hereunder if EarlyBird has rights under Section 2.1.4 and Section 2.2.4), compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding the foregoing, any amendment hereto or waiver hereof shall also require the written consent of the Sponsor so long as the Sponsor and its affiliates hold Registrable Securities representing, in the aggregate, at least five percent (5%) of the outstanding Common Shares; and provided, further, that notwithstanding the foregoing, any amendment hereto or waiver hereof shall also require the written consent of each Above Food Holder so long as such Above Food Holder and its affiliates hold Registrable Securities representing, in the aggregate, at least five percent (5%) of the outstanding Common Shares; provided, further, that any amendment hereto or waiver hereof that adversely affects one Holder, solely in its capacity as a holder of the shares of capital stock of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate or be construed as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder by such party.

 

5.7            Other Registration Rights. The Company represents and warrants that no person or entity, other than a Holder of Registrable Securities, has any right to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration Statement filed by the Company for the sale of securities for its own account or for the account of any other person or entity. For so long as (a) the Sponsor and its affiliates hold Registrable Securities representing, in the aggregate, at least five percent (5%) of the outstanding Common Shares, the Company hereby agrees and covenants that it will not grant rights to register any Common Shares (or securities convertible into or exchangeable for Common Shares) pursuant to the Securities Act that are more favorable, pari passu or senior to those granted to the Holders hereunder (such rights “Competing Registration Rights”) without the prior written consent of the Sponsor, and (b) an Above Food Holder and its affiliates hold Registrable Securities representing, in the aggregate, at least five percent (5%) of the outstanding Common Shares, the Company hereby agrees and covenants that it will not grant Competing Registration Rights without the prior written consent of such Above Food Holder. Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms of this Agreement shall prevail.

 

 


 

5.8            Term. This Agreement shall terminate on the earlier of (a) the seventh anniversary of the date of this Agreement or (b) with respect to any Holder, on the date that such Holder no longer holds any Registrable Securities. The provisions of Section 3.5 and Article IV shall survive any termination.

 

5.9            Holder Information. Each Holder agrees, if requested in writing, to represent to the Company the total number of Registrable Securities held by such Holder in order for the Company to make determinations hereunder.

 

5.10            Additional Holders; Joinder. In addition to persons or entities who may become Holders pursuant to Section 5.2 hereof, subject to the prior written consent of the Sponsor and each Above Food Holder (in each case, so long as such Holder and its affiliates hold Registrable Securities representing, in the aggregate, at least five percent (5%) of the outstanding Common Shares), the Company may make any person or entity who acquires Common Shares or rights to acquire Common Shares after the date hereof a party to this Agreement (each such person or entity, an “Additional Holder”) by obtaining an executed Joinder to this Agreement from such Additional Holder. Such Joinder shall specify the rights and obligations of the applicable Additional Holder under this Agreement. Upon the execution and delivery and subject to the terms of a Joinder by such Additional Holder, the Common Shares then owned, or underlying any rights then owned, by such Additional Holder (the “Additional Holder Common Shares”) shall be Registrable Securities to the extent provided herein and therein and such Additional Holder shall be a Holder under this Agreement with respect to such Additional Holder Common Shares.

 

5.11            Construction.

 

5.11.1            Unless the context of this Agreement otherwise requires or unless otherwise specified, (i) words of any gender shall be construed as masculine, feminine, neuter or any other gender, as applicable; (ii) words using the singular or plural number also include the plural or singular number, respectively; (iii) the terms “hereof,” “herein,” “hereby,” “herewith,” “hereto” and derivative or similar words refer to this entire Agreement; (iv) the term “Section” refers to the specified Section of this Agreement; (v) the term “Exhibit” refers to the specified Exhibit of this Agreement; (vi) the words “including,” “included,” or “includes” shall mean “including, without limitation;” (vii) the word “extent” in the phrase “to the extent” means the degree to which a subject or thing extends, and such phrase shall not simply mean “if;” (viii) the word “or” shall be disjunctive but not exclusive; and (ix) references to “written” or “in writing” include in electronic form.

 

 


 

5.11.2            Unless the context of this Agreement otherwise requires, references in this Agreement to any law shall include all rules and regulations promulgated thereunder and shall be deemed to refer to such law as amended, reenacted, supplemented or superseded in whole or in part and in effect from time to time.

 

5.11.3            References to “$” are to the lawful currency of the United States of America.

 

5.11.4            Time periods in calendar days within or following which any act is to be done under this Agreement shall be calculated by excluding the calendar day on which the period commences and including the calendar day on which the period ends, and by extending the period to the next following business day if the last calendar day of the period is not a business day.

 

5.11.5            The parties hereto and their respective counsels have reviewed and negotiated this Agreement as the joint agreement and understanding of the parties hereto, and the language used in this Agreement shall be deemed to be the language chosen by the parties hereto to express their mutual intent, and no rule of strict construction shall be applied against any person.

 

5.12            Severability. The provisions of this Agreement shall be deemed severable and the illegality, invalidity or unenforceability of any provision shall not affect the legality, validity or enforceability of the other provisions of this Agreement. If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this Agreement shall remain in full force and effect. The parties further agree that if any provision contained herein is, to any extent, held invalid or unenforceable in any respect under the laws governing this Agreement, they shall take any actions necessary to render the remaining provisions of this Agreement valid and enforceable to the fullest extent permitted by law and, to the extent necessary, shall amend or otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable provision giving effect to the intent of the parties.

 

5.13            Entire Agreement. This Agreement constitutes the full and entire agreement and understanding between the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings relating to such subject matter, including the Original RRA.

 

5.14            Adjustments. If, and as often as, there are changes in the Registrable Securities by way of stock split, stock dividend, combination or reclassification, or through merger, consolidation, reorganization, recapitalization or sale, or by any other means, appropriate adjustment shall be made in the provisions of this Agreement, as may be required, so that the rights, privileges, duties and obligations hereunder shall continue with respect to the Registrable Securities as so changed.

 

[SIGNATURE PAGES FOLLOW]

 

 


 

IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.

 

  COMPANY:
     
  Above Food Ingredients Inc.
  an Alberta corporation
   
  By: /s/ Lionel Kambeitz
    Name: Lionel Kambeitz
    Title: Chief Executive Officer
     
  SPONSOR:
     
  Smart Dine, LLC
  a Delaware limited liability company
   
  By: /s/ Jose Luis Guerrero Cortes
    Name: Jose Luis Guerrero Cortes
  Title: CFO
     
  SPAC HOLDERS:
     
  /s/ Alberto Ardura González
  /s/ Alberto Ardura González
     
  /s/ Joseph C. Essa
  /s/ Joseph C. Essa
     
  /s/ Randall Hiatt
  /s/ Randall Hiatt
     
  /s/ Agustin Tristan Aldave
  /s/ Agustin Tristan Aldave
     
  /s/ Julia A. Stewart
  /s/ Julia A. Stewart

 

[Signature Page to Registration Rights Agreement]

 

 


 

  ABOVE FOOD HOLDERS:
     
  By: /s/ Donato Sferra
    Name: Donato Sferra
     
  By: /s/ Chief Reginal Bellerose
    Name: Chief Reginal Bellerose
     
  By: /s/ Garth Fredrickson
    Name: Garth Fredrickson
     
  By: /s/ Jason Zhao
    Name: Jason Zhao
     
  By: /s/ Martin Williams
    Name: Martin Williams
     
  By: /s/ Tyler West
    Name: Tyler West
     
  By: /s/ Lionel Kambeitz
    Name: Lionel Kambeitz
     
  Kameitz Agri Inc.
     
  By: /s/ Jordan Kambeitz
    Name: Jordan Kambeitz
    Title: President and Chief Executive Officer

 

[Signature Page to Amended and Restated Registration and Shareholder Rights Agreement]

 

 


 

Exhibit A

 

REGISTRATION RIGHTS AGREEMENT JOINDER

 

The undersigned is executing and delivering this joinder (this “Joinder”) pursuant to the Registration Rights Agreement, dated as of June 27, 2024 (as the same may hereafter be amended, the “Registration Rights Agreement”), among Above Food Ingredients Inc., an Alberta corporation and the direct parent company of Above Food Corp., an Alberta corporation (the “Company”), and the other persons or entities named as parties therein. Capitalized terms used but not otherwise defined herein shall have the meanings provided in the Registration Rights Agreement.

 

By executing and delivering this Joinder to the Company, and upon acceptance hereof by the Company upon the execution of a counterpart hereof, the undersigned hereby agrees to become a party to, to be bound by, and to comply with the Registration Rights Agreement as a Holder of Registrable Securities in the same manner as if the undersigned were an original signatory to the Registration Rights Agreement, and the undersigned’s Common Shares shall be included as Registrable Securities under the Registration Rights Agreement to the extent provided therein; provided, however, that the undersigned and its permitted assigns (if any) shall not have any rights as Holders, and the undersigned’s (and its transferees’) Common Shares shall not be included as Registrable Securities, for purposes of the Excluded Sections.

 

For purposes of this Joinder, “Excluded Sections” shall mean [            ].

 

Accordingly, the undersigned has executed and delivered this Joinder as of the __________ day of __________, 20__.

 

   
  Signature of Stockholder
   
  Print Name of Stockholder
  Its:

 

  Address:  
     
     

 

Agreed and Accepted as of
____________, 20__

 

Above Food Ingredients Inc.  
   
By:    
Name:  
Its:  

 

 

 

EX-10.4 9 tm2418826d1_ex10-4.htm EXHIBIT 10.4

EXHIBIT 10.4

 

FORM OF INDEMNIFICATION AND ADVANCEMENT AGREEMENT

 

This Indemnification and Advancement Agreement (“Agreement”) is made as of June 28, 2024 by and between Above Food Ingredients Inc. (formerly known as 2510169 Alberta Inc.), a corporation organized under the laws of Alberta, Canada (the “Company”), and ______________, [a member of the Board of Directors/an officer] of the Company (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering indemnification and advancement of expenses.

 

RECITALS

 

WHEREAS, the Board of Directors of the Company (the “Board”) believes that highly competent persons have become more reluctant to serve publicly-held corporations as directors, officers, or in other capacities unless they are provided with adequate protection through insurance or adequate indemnification and advancement of expenses against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of the corporation;

 

WHEREAS, the Board has determined that, in order to attract and retain qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance has been a customary and widespread practice among corporations and other business enterprises similar to the Company, the Company believes that, given current market conditions and trends, such insurance may be available to it in the future only at higher premiums and with more exclusions. At the same time, directors, officers, and other persons in service to corporations or business enterprises are being increasingly subjected to expensive and time-consuming litigation relating to, among other things, matters that traditionally would have been brought only against the Company or business enterprise itself. The Company’s Bylaws provide for the indemnification of the officers and directors of the Company on the terms set forth therein and expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and its directors, officers, and other persons with respect to indemnification and advancement of expenses;

 

WHEREAS, the uncertainties relating to such insurance, to indemnification, and to advancement of expenses may increase the difficulty of attracting and retaining such persons;

 

WHEREAS, the Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company and its shareholders and that the Company should act to assure such persons that there will be increased certainty of such protection in the future;

 

WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be so indemnified; WHEREAS, this Agreement is a supplement to, and in furtherance of, the Bylaws, and any resolutions adopted pursuant thereto, as well as any rights of Indemnitee under any directors’ and officers’ liability insurance policy and any other indemnification provided in favor of the Indemnitee by any subsidiary of the Company, and is not a substitute therefor, and does not diminish or abrogate any rights of Indemnitee thereunder;

 

 


 

 

WHEREAS, to the extent applicable, the Company also may extend rights, benefits and obligations under this Agreement to officers and directors of any of its subsidiaries; and

 

WHEREAS, Indemnitee does not regard the protection available under the Bylaws and insurance as adequate in the present circumstances, and may not be willing to serve or continue to serve as an officer or director of the Company or any of its subsidiaries without adequate additional protection, and the Company desires Indemnitee to serve or continue to serve in such capacities. Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that Indemnitee be so indemnified and advanced expenses.

 

NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:

 

Section 1.      Services to the Company. Indemnitee agrees to serve as a director or officer of the Company. Indemnitee may at any time and for any reason resign from such position (subject to any other contractual obligation or any obligation imposed by operation of law). This Agreement does not create any obligation on the Company to continue Indemnitee in such position and is not an employment contract between the Company (or any of its subsidiaries or any Enterprise) and Indemnitee.

 

Section 2.      Definitions. As used in this Agreement:

 

(a)           “Agent” means any person who is authorized by the Company or an Enterprise to act for or represent the interests of the Company or an Enterprise.

 

(b)            A “Change in Control” occurs upon the earliest to occur after the date of this Agreement of any of the following events:

 

i.            Acquisition of Shares by Third Party. Any Person (as defined below) is or becomes the Beneficial Owner (as defined below), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company’s then outstanding securities unless the change in relative beneficial ownership of the Company’s securities by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of directors;

 

ii.          Change in Board of Directors. During any period of two (2) consecutive years (not including any period prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in Sections 2(b)(i), 2(b)(iii) or 2(b)(iv) of this Agreement) whose election by the Board or nomination for election by the Company’s shareholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the members of the Board;

 

-2-


 

 

iii.            Corporate Transactions. The effective date of a merger or consolidation of the Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such merger or consolidation and with the power to elect at least a majority of the board of directors or other governing body of such surviving entity;

 

iv.             Liquidation. The approval by the shareholders of the Company of a complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets; and

 

v.            Other Events. There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement, unless such event was a result of the conversion of shares held by shareholders of the Company pursuant to any recapitalization, reorganization or similar event of the Company.

 

vi.            For purposes of this Section 2(b), the following terms have the following meanings:

 

1 “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time.

 

2 “Person” has the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act; provided, however, that Person excludes (i) the Company, (ii) any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii) any entity owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of stock of the Company.

 

3 “Beneficial Owner” has the meaning given to such term in Rule 13d-3 under the Exchange Act; provided, however, that Beneficial Owner excludes any Person otherwise becoming a Beneficial Owner by reason of the shareholders of the Company approving a merger of the Company with another entity.

 

(c)            “Corporate Status” describes the status of a person who is or was acting as a director, officer, employee, fiduciary or Agent of the Company or an Enterprise.

 

-3-


 

(d)           “Disinterested Director” means a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee.

 

(e)           “Enterprise” means or any other corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other entity for which Indemnitee is or was serving at the request of the Company as a director, officer, employee, or Agent.

 

(f)           “Expenses” includes all reasonable attorneys’ fees, retainers, court costs, transcript costs, fees and other costs of experts and other professionals, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any payments under this Agreement, ERISA excise taxes and penalties, and all other disbursements, obligations, or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding. Expenses also include (i) Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, and (ii) for purposes of Section 14(d) of this Agreement only, Expenses incurred by Indemnitee in connection with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement, by litigation or otherwise. The parties agree that for the purposes of any advancement of Expenses for which Indemnitee has made written demand to the Company in accordance with this Agreement, all Expenses included in such demand that are certified by affidavit of Indemnitee’s counsel as being reasonable in the good faith judgment of such counsel will be presumed conclusively to be reasonable. Expenses, however, do not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.

 

(g)           “Independent Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently is, nor in the past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning the Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements) or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” does not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement. The Company agrees to pay the reasonable fees and expenses of the Independent Counsel.

 

(h)            “Proceeding” includes any threatened, pending or completed action, suit, claim, counterclaim, cross claim, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing, or any other actual, threatened or completed proceeding, whether brought in the right of the Company or otherwise and whether of a civil, criminal, administrative, legislative, regulatory, or investigative (formal or informal) nature, including any appeal therefrom, in which Indemnitee was, is, or will be involved as a party, potential party, non-party witness, or otherwise by reason of Indemnitee’s Corporate Status or by reason of any action taken by Indemnitee (or a failure to take action by Indemnitee) or of any action (or failure to act) on Indemnitee’s part while acting pursuant to Indemnitee’s Corporate Status, in each case whether or not serving in such capacity at the time any liability or Expense is incurred for which indemnification, reimbursement, or advancement of Expenses can be provided under this Agreement. A Proceeding also includes a situation the Indemnitee believes in good faith may lead to, or culminate in, the institution of a Proceeding.

 

-4-


 

Section 3.      Indemnity in Third-Party Proceedings. The Company will indemnify Indemnitee in accordance with the provisions of this Section 3 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section 3, the Company will indemnify Indemnitee to the fullest extent permitted by applicable law against all Expenses, judgments, fines and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with, or in respect of, such Expenses, judgments, fines and amounts paid in settlement) actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company of any Enterprise and, in the case of a criminal Proceeding, had no reasonable cause to believe that Indemnitee’s conduct was unlawful.

 

Section 4.     Indemnity in Proceedings by or in the Right of the Company. The Company will indemnify Indemnitee in accordance with the provisions of this Section 4 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section 4, the Company will indemnify Indemnitee to the fullest extent permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in, or not opposed to, the best interests of the Company. The Company will not indemnify Indemnitee for Expenses under this Section 4 related to any claim, issue or matter in a Proceeding for which Indemnitee has been finally adjudged by a court of competent jurisdiction to be liable to the Company, unless, and only to the extent that, the a court of competent jurisdiction in Canada in which the Proceeding was brought determines upon application by Indemnitee that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification.

 

Section 5.      Indemnification for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provisions of this Agreement, to the fullest extent permitted by applicable law, the Company will indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee in connection with any Proceeding to the extent that Indemnitee is successful, on the merits or otherwise. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company will indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with or related to each successfully resolved claim, issue or matter to the fullest extent permitted by applicable law. For purposes of this Section 5 and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, will be deemed to be a successful result as to such claim, issue or matter.

 

Section 6.      Indemnification for Expenses of a Witness. Notwithstanding any other provisions of this Agreement, to the fullest extent permitted by applicable law, the Company will indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with any Proceeding to which Indemnitee is not a party but to which Indemnitee is a witness, deponent, interviewee, or otherwise asked to participate or provide information.

 

-5-


 

Section 7.      Partial Indemnification. If Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of Expenses, but not, however, for the total amount thereof, the Company will indemnify Indemnitee for the portion thereof to which Indemnitee is entitled.

 

Section 8.      Additional Indemnification. Notwithstanding any limitation in Sections 3, 4, or 5 of this Agreement, the Company will indemnify Indemnitee to the fullest extent permitted by applicable law if Indemnitee is a party to, or threatened to be made a party to, any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor).

 

Section 9.      Exclusions. Notwithstanding any provision in this Agreement, the Company is not obligated under this Agreement to make any indemnification payment to Indemnitee in connection with any Proceeding:

 

(a)          for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except to the extent provided in Section 15(b) of this Agreement and except with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision;

 

(b)         for (i) an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act (as defined in Section 2(b) hereof) or similar provisions of state statutory law or common law; (ii) reimbursement of the Company by the Indemnitee of any bonus or other incentive-based or equity-based compensation or of any profits realized by the Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), or the payment to the Company of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act) or (iii) any reimbursement of the Company by Indemnitee of any compensation pursuant to any compensation recoupment or clawback policy adopted by the Board or the compensation committee of the Board, including but not limited to any such policy adopted to comply with stock exchange listing requirements implementing Section 10D of the Exchange Act; or

 

(c)          initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i) the Proceeding or part of any Proceeding is to enforce Indemnitee’s rights to indemnification or advancement, of Expenses, including a Proceeding (or any part of any Proceeding) initiated pursuant to Section 14 of this Agreement, (ii) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (iii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law.

 

Section 10.    Advances of Expenses.

 

-6-


 

(a)           The Company will advance, to the extent not prohibited by applicable law, the Expenses incurred by Indemnitee in connection with any Proceeding (or any part of any Proceeding) not initiated by Indemnitee or any Proceeding (or any part of any Proceeding) initiated by Indemnitee if (i) the Proceeding or part of any Proceeding is to enforce Indemnitee’s rights to obtain indemnification or advancement of Expenses from the Company or Enterprise, including a proceeding initiated pursuant to Section 14 of this Agreement, or (ii) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation. The Company will advance the Expenses within thirty (30) days after the receipt by the Company of a statement or statements requesting such advances from time to time, whether prior to or after final disposition of any Proceeding.

 

(b)           Advances will be unsecured and interest free. Indemnitee hereby undertakes to repay any amounts so advanced (without interest) to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company, thus Indemnitee qualifies for advances upon the execution of this Agreement and delivery to the Company. No other form of undertaking is required other than the execution of this Agreement. The Company will make advances without regard to Indemnitee’s ability to repay the Expenses and without regard to Indemnitee’s ultimate entitlement to indemnification under the other provisions of this Agreement.

 

Section 11.    Procedure for Notification of Claim for Indemnification or Advancement.

 

(a)           Indemnitee will notify the Company in writing of any Proceeding with respect to which Indemnitee intends to seek indemnification or advancement of Expenses hereunder as soon as reasonably practicable following the receipt by Indemnitee of written notice thereof. Indemnitee will include in the written notification to the Company a description of the nature of the Proceeding and the facts underlying the Proceeding and provide such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the final disposition of such Proceeding. Indemnitee’s failure to notify the Company will not relieve the Company from any obligation it may have to Indemnitee under this Agreement, and any delay in so notifying the Company will not constitute a waiver by Indemnitee of any rights under this Agreement. The Secretary of the Company will, promptly upon receipt of such a request for indemnification or advancement, advise the Board in writing that Indemnitee has requested indemnification or advancement.

 

(b)           The Company will be entitled to participate in the Proceeding at its own expense.

 

Section 12.     Procedure Upon Application for Indemnification.

 

(a)           Unless a Change in Control has occurred, the determination of Indemnitee’s entitlement to indemnification will be made:

 

i.            by a majority vote of the Disinterested Directors, even though less than a quorum of the Board;

 

ii.           by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Board;

 

-7-


 

iii.            if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by written opinion provided by Independent Counsel selected by the Board; or

 

iv.            if so directed by the Board, by the shareholders of the Company.

 

(b)           If a Change in Control has occurred, the determination of Indemnitee’s entitlement to indemnification will be made by written opinion provided by Independent Counsel selected by Indemnitee (unless Indemnitee requests such selection be made by the Board)

 

(c)          The party selecting Independent Counsel pursuant to subsection (a)(iii) or (b) of this Section 12 will provide written notice of the selection to the other party. The notified party may, within ten (10) days after receiving written notice of the selection of Independent Counsel, deliver to the selecting party a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Section 2 of this Agreement, and the objection will set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected will act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction in Canada has determined that such objection is without merit. If, within thirty (30) days after the later of submission by Indemnitee of a written request for indemnification pursuant to Section 11(a) of this Agreement and the final disposition of the Proceeding, Independent Counsel has not been selected or, if selected, any objection to such selection has not been resolved, either the Company or Indemnitee may petition a court of competent jurisdiction in Canada for resolution of any objection made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by such court or by such other person as such court designates. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 14(a) of this Agreement, Independent Counsel will be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).

 

(d)          Indemnitee will cooperate with the person, persons or entity making the determination with respect to Indemnitee’s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. The Company will advance and pay any Expenses incurred by Indemnitee in so cooperating with the person, persons or entity making the indemnification determination irrespective of the determination as to Indemnitee’s entitlement to indemnification and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom. The Company promptly will advise Indemnitee in writing of the determination that Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification has been denied and providing a copy of any written opinion provided to the Board by Independent Counsel.

 

-8-


 

(e)           If it is determined that Indemnitee is entitled to indemnification, the Company will make payment to Indemnitee within thirty (30) days after such determination.

 

Section 13.    Presumptions and Effect of Certain Proceedings.

 

(a)          In making a determination with respect to entitlement to indemnification under this Agreement, the person or persons or entity making such determination will, to the fullest extent not prohibited by applicable law, presume Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 11(a) of this Agreement, and the Company will, to the fullest extent not prohibited by applicable law, have the burden of proof to overcome that presumption. Neither the failure of the Company (including by its directors or Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, will be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.

 

(b)           If the determination of the Indemnitee’s entitlement to indemnification has not been made pursuant to Section 12 of this Agreement within sixty (60) days after the later of (i) receipt by the Company of Indemnitee’s request for indemnification pursuant to Section 11(a) of this Agreement and (ii) the final disposition of the Proceeding for which Indemnitee requested indemnification (the “Determination Period”), the requisite determination of entitlement to indemnification will, to the fullest extent not prohibited by applicable law, be deemed to have been made and Indemnitee will be entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification or (ii) a prohibition of such indemnification under applicable law. The Determination Period may be extended for a reasonable time, not to exceed an additional thirty (30) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto; and provided, further, the Determination Period will not apply (i) if the determination of entitlement to indemnification is to be made by the shareholders pursuant to Section 12(a)(iv) of this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for such determination the Board has resolved to submit such determination to the shareholders for their consideration at an annual meeting thereof to be held within seventy-five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of shareholders is called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting is held for such purpose within sixty (60) days after having been so called and such determination is made thereat, or (ii) if the determination of entitlement to indemnification is to be made by Independent Counsel.

 

(c)          The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, will not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that Indemnitee’s conduct was unlawful.

 

-9-


 

(d)           For purposes of any determination of good faith, Indemnitee will be deemed to have acted in good faith if Indemnitee acted based on the records or books of account of the Company, its subsidiaries, or an Enterprise, including financial statements, or on information supplied to Indemnitee by the directors or officers of the Company, its subsidiaries, or an Enterprise in the course of their duties, or on the advice of legal counsel for the Company, its subsidiaries, or an Enterprise or on information or records given or reports made to the Company or an Enterprise by an independent certified public accountant or by an appraiser, financial advisor or other expert selected with reasonable care by or on behalf of the Company, its subsidiaries, or an Enterprise. Further, Indemnitee will be deemed to have acted in a manner “not opposed to the best interests of the Company,” as referred to in this Agreement if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan. The provisions of this Section 13(d) are not exclusive and do not limit in any way the other circumstances in which the Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.

 

(e)           The knowledge and/or actions, or failure to act, of any director, officer, trustee, partner, managing member, fiduciary, Agent or employee of the Enterprise may not be imputed to Indemnitee for purposes of determining Indemnitee’s right to indemnification under this Agreement.

 

Section 14.    Remedies of Indemnitee.

 

(a)           Indemnitee may commence litigation against the Company in a court of competent jurisdiction in Canada to obtain indemnification or advancement of Expenses provided by this Agreement in the event that (i) a determination is made pursuant to Section 12 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) the Company does not advance Expenses pursuant to Section 10 of this Agreement, (iii) the determination of entitlement to indemnification is not made pursuant to Section 12 of this Agreement within the Determination Period, (iv) the Company does not indemnify Indemnitee pursuant to Section 5 or 6 or the second to last sentence of Section 12(d) of this Agreement within thirty (30) days after receipt by the Company of a written request therefor, (v) the Company does not indemnify Indemnitee pursuant to Section 3, 4, 7, or 8 of this Agreement within thirty (30) days after a determination has been made that Indemnitee is entitled to indemnification, or (vi) in the event that the Company or any other person takes or threatens to take any action to declare this Agreement void or unenforceable, or institutes any litigation or other action or Proceeding designed to deny, or to recover from, the Indemnitee the benefits provided or intended to be provided to the Indemnitee hereunder. Alternatively, Indemnitee or the Company, at Indemnitee’s or the Company’s option as the case may be, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the rules of the Canadian Arbitration Association then in effect. Any party requesting arbitration must commence such Proceeding seeking an adjudication or an award in arbitration within one hundred and eighty (180) days following the date on which such party first has the right to commence such Proceeding pursuant to this Section 14(a); provided, however, that the foregoing clause does not apply in respect of a Proceeding brought by Indemnitee to enforce Indemnitee’s rights under Section 5 of this Agreement. The Company will not oppose Indemnitee’s right to seek any such adjudication or award in arbitration.

 

-10-


 

(b)           If a determination is made pursuant to Section 12 of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 14 will be conducted in all respects as a de novo trial, or arbitration, on the merits and Indemnitee may not be prejudiced by reason of that adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Section 14 the Company will have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be, and will not introduce evidence of the determination made pursuant to Section 12 of this Agreement.

 

(c)           If a determination is made pursuant to Section 12 of this Agreement that Indemnitee is entitled to indemnification, the Company will be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section 14 absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law.

 

(d)           The Company is, to the fullest extent not prohibited by applicable law, precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 14 that the procedures and presumptions of this Agreement are not valid, binding, or enforceable and will stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement.

 

(e)           It is the intent of the Company that, to the fullest extent permitted by applicable law, the Indemnitee not be required to incur legal fees or other Expenses associated with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement by litigation or otherwise because the cost and expense thereof would substantially detract from the benefits intended to be extended to the Indemnitee under this Agreement. The Company, to the fullest extent permitted by applicable law, will (within thirty (30) days after receipt by the Company of a written request therefor) advance to Indemnitee such Expenses which are incurred by Indemnitee in connection with any action concerning this Agreement, Indemnitee’s rights to indemnification or advancement of Expenses from the Company, or concerning any directors’ and officers’ liability insurance policies maintained by the Company, and will indemnify Indemnitee against any and all such Expenses unless the court determines that Indemnitee’s claims in such action were made in bad faith or were frivolous or are prohibited by law.

 

Section 15.    Non-exclusivity; Survival of Rights; Insurance; Subrogation.

 

(a)           The indemnification and advancement of Expenses provided by this Agreement are not exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Bylaws, any agreement, a vote of shareholders or a resolution of the directors, or otherwise. The indemnification and advancement of Expenses provided by this Agreement may not be limited or restricted by any amendment, alteration or repeal of this Agreement in any way with respect to any action taken or omitted by Indemnitee in Indemnitee’s Corporate Status occurring prior to any amendment, alteration or repeal of this Agreement. To the extent that a change in Canadian law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the Bylaws or this Agreement, it is the intent of the parties hereto that Indemnitee enjoy by this Agreement the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy is cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, will not prevent the concurrent assertion or employment of any other right or remedy.

 

-11-


 

(b)           The Company hereby acknowledges that Indemnitee may have certain rights to indemnification, advancement of Expenses and/or insurance provided by one or more other Persons with whom or which Indemnitee may be associated. The relationship between the Company and such other Persons, other than an Enterprise, with respect to the Indemnitee’s rights to indemnification, advancement of Expenses, and insurance is described by this subsection, subject to the provisions of subsection (d) of this Section 15 with respect to a Proceeding concerning Indemnitee’s Corporate Status with an Enterprise.

 

i.            The Company hereby acknowledges and agrees:

 

1)            the Company’s obligations to Indemnitee are primary and any obligation of any other Persons, other than an Enterprise, are secondary (i.e., the Company is the indemnitor of first resort) with respect to any request for indemnification or advancement of Expenses made pursuant to this Agreement concerning any Proceeding;

 

2)            the Company is primarily liable for all indemnification and indemnification or advancement of Expenses obligations for any Proceeding, whether created by law, the Bylaws, contract (including this Agreement) or otherwise;

 

3)            any obligation of any other Persons with whom or which Indemnitee may be associated to indemnify Indemnitee and/or advance Expenses to Indemnitee in respect of any proceeding are secondary to the Company’s obligations; and

 

4)            the Company will indemnify Indemnitee and advance Expenses to Indemnitee hereunder to the fullest extent provided herein without regard to any rights Indemnitee may have against any other Person with whom or which Indemnitee may be associated or any insurer of any such Person;

 

ii.           The Company irrevocably waives, relinquishes and releases (A) any other Person with whom or which Indemnitee may be associated from any claim of contribution, subrogation, reimbursement, exoneration or indemnification, or any other recovery of any kind in respect of amounts paid by the Company to Indemnitee pursuant to this Agreement and (B) any right to participate in any claim or remedy of Indemnitee against any Person, whether or not such claim, remedy or right arises in equity or under contract, statute or common law, including, without limitation, the right to take or receive from any Person, directly or indirectly, in cash or other property or by set-off or in any other manner, payment or security on account of such claim, remedy or right.

 

iii.            In the event any other Person with whom or which Indemnitee may be associated or their insurers advances or extinguishes any liability or loss for Indemnitee, the payor has a right of subrogation against the Company or its insurers for all amounts so paid which would otherwise be payable by the Company or its insurers under this Agreement. In no event will payment by any other Person with whom or which Indemnitee may be associated or their insurers affect the obligations of the Company hereunder or shift primary liability for the Company’s obligation to indemnify or advance Expenses to any other Person with whom or which Indemnitee may be associated.

 

-12-


 

iv.            Any indemnification or advancement of Expenses provided by any other Person with whom or which Indemnitee may be associated is specifically in excess over the Company’s obligation to indemnify and advance Expenses or any valid and collectible insurance (including but not limited to any malpractice insurance or professional errors and omissions insurance) provided by the Company.

 

(c)           To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, employees, or agents of the Company, and the Company will obtain a policy or policies covering Indemnitee to the maximum extent of the coverage available for any such director, officer, employee or agent under such policy or policies, including coverage in the event the Company does not or cannot, for any reason, indemnify or advance Expenses to Indemnitee as required by this Agreement. If, at the time of the receipt of a notice of a claim pursuant to this Agreement, the Company has director and officer liability insurance in effect, the Company will give prompt notice of such claim or of the commencement of a Proceeding, as the case may be, to the insurers in accordance with the procedures set forth in the respective policies. The Company will thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies. Indemnitee agrees to assist the Company’s efforts to cause the insurers to pay such amounts and will comply with the terms of such policies, including selection of approved panel counsel, if required.

 

(d)           The Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee for any Proceeding concerning Indemnitee’s Corporate Status with an Enterprise will be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such Enterprise. The Company and Indemnitee intend that any such Enterprise (and its insurers) be the indemnitor of first resort with respect to indemnification and advancement of Expenses for any Proceeding related to or arising from Indemnitee’s Corporate Status with such Enterprise. The Company’s obligation to indemnify and advance Expenses to Indemnitee is secondary to the obligations the Enterprise or its insurers owe to Indemnitee. Indemnitee agrees to take all reasonably necessary and desirable action to obtain from an Enterprise indemnification and advancement of Expenses for any Proceeding related to or arising from Indemnitee’s Corporate Status with such Enterprise.

 

(e)           In the event of any payment made by the Company under this Agreement, the Company will be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee from any Enterprise or its insurance carrier. Indemnitee will execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights.

 

(f)            In the event that the Indemnitee has a right to be indemnified against or to receive Expenses under this Agreement, the Bylaws or any resolutions adopted pursuant thereto, any rights of Indemnitee under any directors’ and officers’ liability insurance policy or any other indemnification provided in favor of the Indemnitee by any subsidiary of the Company, the Indemnitee shall not be entitled to recover such Expenses or otherwise obtain reimbursement or restitution more than once in respect of the same loss arising from any one matter.

 

-13-


 

Section 16.    Duration of Agreement. This Agreement continues until and terminates upon the later of: (a) ten (10) years after the date that Indemnitee ceases to serve as a director or officer of the Company or (b) one (1) year after the final termination of any Proceeding then pending in respect of which Indemnitee is granted rights of indemnification or advancement of Expenses hereunder and of any Proceeding commenced by Indemnitee pursuant to Section 14 of this Agreement relating thereto. The indemnification and advancement of Expenses rights provided by or granted pursuant to this Agreement are (i) binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company), (ii) continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or of any other Enterprise, and (iii) inure to the benefit of Indemnitee and Indemnitee’s spouse, assigns, heirs, devisees, executors and administrators and other legal representatives.

 

Section 17.    Severability. If any provision or provisions of this Agreement is held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) will not in any way be affected or impaired thereby and remain enforceable to the fullest extent permitted by applicable law; (b) such provision or provisions will be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) will be construed so as to give effect to the intent manifested thereby.

 

Section 18.    Interpretation. Any ambiguity in the terms of this Agreement will be resolved in favor of Indemnitee and in a manner to provide the maximum indemnification and advancement of Expenses permitted by applicable law. The Company and Indemnitee intend that this Agreement provide to the fullest extent permitted by applicable law for indemnification and advancement of Expenses in excess of that expressly provided, without limitation, by the Bylaws, vote of the Company’s shareholders or disinterested directors, or applicable law.

 

Section 19.    Enforcement.

 

(a)           The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving or continuing to serve as a director or officer of the Company.

 

(b)          This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof; provided, however, that this Agreement is a supplement to and in furtherance of the Bylaws, any directors’ and officers’ insurance maintained by the Company, and applicable law, and it does not substitute therefor, nor diminish or abrogate any rights of Indemnitee thereunder.

 

-14-


 

Section 20.    Modification and Waiver. No supplement, modification or amendment of this Agreement is binding unless executed in writing by the parties hereto. No waiver of any of the provisions of this Agreement will be deemed to or constitute a waiver of any other provision of this Agreement nor will any waiver constitute a continuing waiver.

 

Section 21.    Notice by Indemnitee. Indemnitee agrees promptly to notify the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company does not relieve the Company of any obligation which it may have to the Indemnitee under this Agreement or otherwise.

 

Section 22.    Notices. All notices, requests, demands and other communications under this Agreement will be in writing and will be deemed to have been duly given if (a) delivered by hand to the other party, (b) sent by reputable overnight courier to the other party or (c) sent by facsimile transmission or electronic mail, with receipt of oral confirmation that such communication has been received:

 

(a)           If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee provides to the Company.

 

(b)           If to the Company to:

 

Above Food Ingredients Inc.:

Address: 2305 Victoria Avenue #001

Regina, Saskatchewan, S4P 0S7

Attention: Lionel Kambeitz

Email: lionel@abovefood.com

 

with copies (which shall not constitute notice) to: 

Latham & Watkins LLP 

811 Main Street, Suite 3700 

Houston, TX 77002 

Attention: Ryan Maierson; Ryan Lynch 

Email: Ryan.Maierson@lw.com; Ryan.Lynch@lw.com

 

Above Food Ingredients Inc.: 

Address: 2305 Victoria Avenue #001 

Regina, Saskatchewan, S4P 0S7 

Attention: Michelle Westerman 

Email: michelle.westerman@abovefood.com

 

or to any other address as may have been furnished to Indemnitee by the Company.

 

-15-


 

Section 23.    Contribution. To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, will contribute to the amount incurred by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (a) the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (b) the relative fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s).

 

Section 24.    Applicable Law and Consent to Jurisdiction. This Agreement and the legal relations among the parties are governed by, and construed and enforced in accordance with, the laws of Canada, without regard to its conflict of laws rules and principles. Except with respect to any arbitration commenced by Indemnitee pursuant to Section 14(a) of this Agreement, the Company and Indemnitee hereby irrevocably and unconditionally (a) agree that any action or Proceeding between the parties arising out of or in connection with this Agreement may be brought only in Canada and not in any other state or federal court in any other jurisdiction or any court in any other country, (b) consent to submit to the exclusive jurisdiction of the Canada court for purposes of any action or Proceeding arising out of or in connection with this Agreement, (c) waive any objection to the laying of venue of any such action or Proceeding in the Canada court, and (d) waive, and agree not to plead or to make, any claim that any such action, claim, or proceeding brought in the Canada court has been brought in an improper or inconvenient forum.

 

Section 25.    Identical Counterparts. This Agreement may be executed in one or more counterparts, each of which will for all purposes be deemed to be an original but all of which together constitutes one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.

 

Section 26.    Headings. The headings of this Agreement are inserted for convenience only and do not constitute part of this Agreement or affect the construction thereof.

 

IN WITNESS WHEREOF, the parties have caused this Agreement to be signed as of the day and year first above written.

 

COMPANY       INDEMNITEE
         
By:      
Name: Lionel Kambeitz   Name:  
Office: Chief Executive Officer   Address:  
         
         
         

 

-16-

EX-10.22 10 tm2418826d1_ex10-22.htm EXHIBIT 10.22

 

 

Exhibit 10.22

 

 

ABOVE FOOD INGREDIENTS INC.

 

2024 INCENTIVE AWARD PLAN

 

ARTICLE I. PURPOSE

 

The Plan’s purpose is to enhance the Company’s ability to attract, retain and motivate persons who make (or are expected to make) important contributions to the Company by providing these individuals with equity ownership opportunities and/or equity-linked compensatory opportunities. Capitalized terms used in the Plan are defined in Article XI.

 

ARTICLE II. ELIGIBILITY

 

Service Providers are eligible to be granted Awards under the Plan, subject to the limitations described herein.

 

ARTICLE III. ADMINISTRATION AND DELEGATION

 

3.1              Administration. The Plan is administered by the Administrator. The Administrator has authority to determine which Service Providers receive Awards, grant Awards and set Award terms and conditions, subject to the conditions and limitations in the Plan. The Administrator also has the authority to take all actions and make all determinations under the Plan, to interpret the Plan and Award Agreements and to adopt, amend and repeal Plan administrative rules, guidelines and practices as it deems advisable. The Administrator may correct defects and ambiguities, supply omissions and reconcile inconsistencies in the Plan or any Award Agreement as it deems necessary or appropriate to administer the Plan and any Awards. The Administrator’s determinations under the Plan are in its sole discretion and will be final and binding on all persons having or claiming any interest in the Plan or any Award.

 

3.2              Appointment of Committees. To the extent Applicable Laws permit, the Board or the Administrator may delegate any or all of its powers under the Plan to one or more Committees or committees of officers of the Company or any of its Subsidiaries. The Board or the Administrator, as applicable, may rescind any such delegation, abolish any such committee or Committee and/or re-vest in itself any previously delegated authority at any time.

 

ARTICLE IV. STOCK AVAILABLE FOR AWARDS

 

4.1              Number of Shares. Subject to adjustment under Article VIII and the terms of this Article IV, Awards may be made under the Plan covering up to the Overall Share Limit Shares issued under the Plan may consist of authorized but unissued Shares, Shares purchased on the open market or treasury Shares. From and after the effectiveness of this Plan, the Company will not grant awards under the Above Food Corp. Stock Option Plan or the Above Food Corp. Restricted Share Unit Plan (each, as may be amended from time to time, a “Prior Plan”); provided, however, that awards previously granted under such Prior Plan that are assumed by the Company in connection with the Business Combination (the “Prior Plan Awards”) will remain subject to the terms of such Prior Plan; provided further that Shares subject to an award previously granted under a Prior Plan that is assumed by the Company in connection with the Business Combination and that, immediately prior to the closing of the Business Combination was a Company Out-of-the-Money / Unvested Option (as defined in the BCA) shall count against the Shares that are authorized for issuance pursuant to this Plan (but, for the avoidance of doubt, other Prior Plan Awards shall not count against the Shares that are authorized for issuance pursuant to this Plan).

 

 

 

4.2             Share Recycling. If all or any part of an Award or Prior Plan Award expires, lapses or is terminated, exchanged for or settled in cash, surrendered, repurchased, canceled without having been fully exercised or forfeited, in any case, in a manner that results in the Company acquiring Shares covered by the Award or Prior Plan Award at a price not greater than the price (as adjusted to reflect any Equity Restructuring) paid by the Participant for such Shares or not issuing any Shares covered by the Award or Prior Plan Award, the unused Shares covered by the Award or Prior Plan Award will, as applicable, become or again be available for Award grants under the Plan, provided that such recycled Shares shall not be available for Award grants to Canadian Participants. Further, Shares delivered (either by actual delivery or attestation) to the Company by a Participant to satisfy the applicable exercise or purchase price of an Award or Prior Plan Award and/or to satisfy any applicable tax withholding obligation with respect to an Award (including Shares retained by the Company from the Award or Prior Plan Award being exercised or purchased and/or creating the tax obligation) will again be available for Award grants under the Plan, provided that such recycled Shares shall not be available for Award grants to Canadian Participants. The payment of Dividend Equivalents in cash in conjunction with any outstanding Awards or Prior Plan Awards shall not count against the Overall Share Limit.

 

4.3             Incentive Stock Option Limitations. Notwithstanding anything to the contrary herein, no more than 27,659,567 Shares may be issued pursuant to the exercise of Incentive Stock Options.

 

4.4             Substitute Awards. In connection with an entity’s merger or consolidation with the Company or the Company’s acquisition of an entity’s property or stock, the Administrator may grant Awards in substitution for any options or other stock or stock-based awards granted before such merger or consolidation by such entity or its affiliate. Substitute Awards may be granted on such terms as the Administrator deems appropriate, notwithstanding limitations on Awards in the Plan. Substitute Awards will not count against the Overall Share Limit (nor shall Shares subject to a Substitute Award be added to the Shares available for Awards under the Plan as provided above), except that Shares acquired by exercise of substitute Incentive Stock Options will count against the maximum number of Shares that may be issued pursuant to the exercise of Incentive Stock Options under the Plan. Additionally, in the event that a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines has shares available under a pre-existing plan approved by stockholders and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such pre-existing plan (as adjusted, to the extent appropriate, using the exchange ratio or other adjustment or valuation ratio or formula used in such acquisition or combination to determine the consideration payable to the holders of common stock of the entities party to such acquisition or combination) may be used for Awards under the Plan and shall not reduce the Shares authorized for grant under the Plan (and Shares subject to such Awards shall not be added to the Shares available for Awards under the Plan as provided above); provided that Awards using such available shares shall not be made after the date awards or grants could have been made under the terms of the pre-existing plan, absent the acquisition or combination, and shall only be made to individuals who were not Employees, Consultants or Directors prior to such acquisition or combination.

 

ARTICLE V. STOCK OPTIONS AND STOCK APPRECIATION RIGHTS

 

5.1            General. The Administrator may grant Options or Stock Appreciation Rights to U.S.-based Service Providers and Options to Canada-based Service Providers subject to the limitations in the Plan, including any limitations in the Plan that apply to Incentive Stock Options. The Administrator will determine the number of Shares covered by each Option and Stock Appreciation Right, the exercise price of each Option and Stock Appreciation Right and the conditions and limitations applicable to the exercise of each Option and Stock Appreciation Right. A Stock Appreciation Right will entitle the Participant (or other person entitled to exercise the Stock Appreciation Right) to receive from the Company upon exercise of the exercisable portion of the Stock Appreciation Right an amount determined by multiplying the excess, if any, of the Fair Market Value of one Share on the date of exercise over the exercise price per Share of the Stock Appreciation Right by the number of Shares with respect to which the Stock Appreciation Right is exercised, subject to any limitations of the Plan or that the Administrator may impose and shall be payable in cash, Shares valued at Fair Market Value or a combination of the two as the Administrator may determine or provide in the Award Agreement.

 

  2  

 

5.2            Exercise Price. The Administrator will establish each Option’s and Stock Appreciation Right’s exercise price and specify the exercise price in the Award Agreement. Unless otherwise determined by the Administrator, the exercise price will not be less than 100% of the Fair Market Value on the grant date of the Option (subject to Section 5.6) or Stock Appreciation Right. Notwithstanding the foregoing, in the case of an Option or a Stock Appreciation Right that is a Substitute Award, the exercise price per share of the Shares subject to such Option or Stock Appreciation Right, as applicable, may be less than the Fair Market Value per share on the date of grant; provided that the exercise price of any Substitute Award shall be determined in accordance with the applicable requirements of Sections 424 and 409A of the Code.

 

5.3            Duration. Each Option or Stock Appreciation Right will be exercisable at such times and as specified in the Award Agreement, provided that, unless otherwise determined by the Administrator, the term of an Option or Stock Appreciation Right will not exceed ten years. Notwithstanding the foregoing and unless determined otherwise by the Company, in the event that on the last business day of the term of an Option or Stock Appreciation Right (other than an Incentive Stock Option) (a) the exercise of the Option or Stock Appreciation Right is prohibited by Applicable Law, as determined by the Company, or (b) Shares may not be purchased or sold by the applicable Participant due to any Company insider trading policy (including blackout periods) or a “lock-up” agreement undertaken in connection with an issuance of securities by the Company, then the term of the Option or Stock Appreciation Right shall be extended, except to the extent that such extension would violate Section 409A, until the date that is 30 days after the end of the legal prohibition, black-out period or lock-up agreement, as determined by the Company; provided, however, that unless otherwise determined by the Administrator in no event shall the extension last beyond the ten year term of the applicable Option or Stock Appreciation Right. Notwithstanding the foregoing, to the extent permitted under Applicable Laws, if the Participant, prior to the end of the term of an Option or Stock Appreciation Right, violates in any material respect the non-competition, non-solicitation, confidentiality or other similar restrictive covenant provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the Participant and the Company or any of its Subsidiaries (and such violation is not cured within 30 days following receipt by the Participant of written notice from the Company of such violation), the right of the Participant and the Participant’s transferees to exercise any Option or Stock Appreciation Right issued to the Participant shall terminate immediately upon such violation, unless the Company otherwise determines.

 

5.4            Exercise. Options and Stock Appreciation Rights may be exercised by delivering to the Company a written notice of exercise, in a form the Administrator approves (which may be electronic), signed by the person authorized to exercise the Option or Stock Appreciation Right, together with, as applicable, payment in full (a) as specified in Section 5.5 for the number of Shares for which the Award is exercised and (b) as specified in Section 9.5 for any applicable taxes. Unless the Administrator otherwise determines, an Option or Stock Appreciation Right may not be exercised for a fraction of a Share.

 

  3  

 

5.5            Payment Upon Exercise. Subject to Sections 9.10 and 10.8, any Company insider trading policy (including blackout periods) and Applicable Laws, the exercise price of an Option must be paid by:

 

(a)            cash, wire transfer of immediately available funds or by check payable to the order of the Company, provided that the Company may limit the use of one of the foregoing payment forms if one or more of the payment forms below is permitted;

  

(b)            if there is a public market for Shares at the time of exercise, unless the Company otherwise determines, (i) delivery (including electronically or telephonically to the extent permitted by the Company) of an irrevocable and unconditional undertaking by a broker acceptable to the Company to deliver promptly to the Company sufficient funds to pay the exercise price, or (ii) the Participant’s delivery to the Company of a copy of irrevocable and unconditional instructions to a broker acceptable to the Company to deliver promptly to the Company cash or a check sufficient to pay the exercise price; provided that such amount is paid to the Company at such time as may be required by the Administrator;

 

(c)            to the extent permitted by the Administrator, delivery (either by actual delivery or attestation) of Shares owned by the Participant valued at their fair market value;

 

(d)            to the extent permitted by the Administrator, surrendering Shares then issuable upon the Option’s exercise valued at their fair market value on the exercise date;

 

(e)            to the extent permitted by the Administrator and under Applicable Law, delivery of a promissory note or any other property that the Administrator determines is good and valuable consideration; or

 

(f)            to the extent permitted by the Company, any combination of the above payment forms approved by the Administrator.

 

5.6            Additional Terms of Incentive Stock Options. The Administrator may grant Incentive Stock Options only to employees of the Company, any of its present or future parent or subsidiary corporations, as defined in Sections 424(e) or (f) of the Code, respectively, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code. If an Incentive Stock Option is granted to a Greater Than 10% Stockholder, the exercise price will not be less than 110% of the Fair Market Value on the Option’s grant date, and the term of the Option will not exceed five years. All Incentive Stock Options will be subject to and construed consistently with Section 422 of the Code. By accepting an Incentive Stock Option, the Participant agrees to give prompt written notice to the Company of dispositions or other transfers (other than in connection with a Change in Control) of Shares acquired under the Option made within (a) two years from the grant date of the Option or (b) one year after the transfer of such Shares to the Participant, specifying the date of the disposition or other transfer and the amount the Participant realized, in cash, other property, assumption of indebtedness or other consideration, in such disposition or other transfer. Neither the Company nor the Administrator will be liable to a Participant, or any other party, if an Incentive Stock Option fails or ceases to qualify as an “incentive stock option” under Section 422 of the Code. Any Incentive Stock Option or portion thereof that fails to qualify as an “incentive stock option” under Section 422 of the Code for any reason, including becoming exercisable with respect to Shares having a fair market value exceeding the $100,000 limitation under Treasury Regulations Section 1.422-4, will be a Non-Qualified Stock Option.

 

ARTICLE VI. RESTRICTED STOCK; RESTRICTED STOCK UNITS

 

6.1            General. The Administrator may grant Restricted Stock, or the right to purchase Restricted Stock, to any Service Provider, subject to the Company’s right to repurchase all or part of such Shares at their issue price or other stated or formula price from the Participant (or to require forfeiture of such Shares) if conditions the Administrator specifies in the Award Agreement are not satisfied before the end of the applicable restriction period or periods that the Administrator establishes for such Award. In addition, the Administrator may grant to Service Providers Restricted Stock Units, which may be subject to vesting and forfeiture conditions during the applicable restriction period or periods, as set forth in an Award Agreement. The Administrator will determine and set forth in the Award Agreement the terms and conditions for each Restricted Stock and Restricted Stock Unit Award, subject to the conditions and limitations contained in the Plan.

 

  4  

 

6.2            Restricted Stock.

 

(a)            Dividends. Participants holding Shares of Restricted Stock will be entitled to all ordinary cash dividends paid with respect to such Shares, unless the Administrator provides otherwise in the Award Agreement. In addition, unless the Administrator provides otherwise, if any dividends or distributions are paid in Shares, or consist of a dividend or distribution to holders of Common Stock of property other than an ordinary cash dividend, the Shares or other property will be subject to the same restrictions on transferability and forfeitability as the Shares of Restricted Stock with respect to which they were paid. Notwithstanding anything to the contrary herein, with respect to any Award of Restricted Stock, dividends which are paid to holders of Common Stock prior to vesting shall only be paid out to the Participant holding such Restricted Stock to the extent that the vesting conditions are subsequently satisfied. All such dividend payments will be made no later than March 15 of the calendar year following the calendar year in which the right to the dividend payment becomes nonforfeitable.

 

(b)            Stock Certificates. The Company may require that the Participant deposit in escrow with the Company (or its designee) any stock certificates issued in respect of Shares of Restricted Stock, together with a stock power endorsed in blank.

 

6.3            Restricted Stock Units.

 

(a)            Settlement. The Administrator may provide that settlement of Restricted Stock Units will occur upon or as soon as reasonably practicable after the Restricted Stock Units vest or will instead be deferred, on a mandatory basis or at the Participant’s election, in a manner intended to comply with Section 409A.

 

(b)            Stockholder Rights. A Participant will have no rights of a stockholder with respect to Shares subject to any Restricted Stock Unit unless and until the Shares are delivered in settlement of the Restricted Stock Unit.

 

ARTICLE VII. OTHER STOCK OR CASH BASED AWARDS; DIVIDEND EQUIVALENTS

 

7.1            Other Stock or Cash Based Awards. Other Stock or Cash Based Awards may be granted to Participants, including Awards entitling Participants to receive Shares to be delivered in the future and including annual or other periodic or long-term cash bonus awards (whether based on specified Performance Criteria or otherwise), in each case subject to any conditions and limitations in the Plan. Such Other Stock or Cash Based Awards will also be available as a payment form in the settlement of other Awards, as standalone payments and as payment in lieu of compensation to which a Participant is otherwise entitled. Other Stock or Cash Based Awards may be paid in Shares, cash or other property, as the Administrator determines. Subject to the provisions of the Plan, the Administrator will determine the terms and conditions of each Other Stock or Cash Based Award, including any purchase price, performance goal (which may be based on the Performance Criteria), transfer restrictions, and vesting conditions, which will be set forth in the applicable Award Agreement.

 

  5  

 

7.2            Dividend Equivalents. A grant of Restricted Stock Units or Other Stock or Cash Based Award may provide a Participant with the right to receive Dividend Equivalents, and no Dividend Equivalents shall be payable with respect to Options or Stock Appreciation Rights. Dividend Equivalents may be paid currently or credited to an account for the Participant, settled in cash or Shares and subject to the same restrictions on transferability and forfeitability as the Award with to which the Dividend Equivalents are paid and subject to other terms and conditions as set forth in the Award Agreement. Notwithstanding anything to the contrary herein, Dividend Equivalents with respect to an Award shall only be paid out to the Participant to the extent that the vesting conditions are subsequently satisfied. All such Dividend Equivalent payments will be made no later than March 15 of the calendar year following calendar year in which the right to the Dividend Equivalent payment becomes nonforfeitable, unless determined otherwise by the Administrator or unless deferred in a manner intended to comply with Section 409A.

 

ARTICLE VIII. ADJUSTMENTS FOR CHANGES IN COMMON STOCK AND CERTAIN OTHER EVENTS

 

8.1            Equity Restructuring. In connection with any Equity Restructuring, notwithstanding anything to the contrary in this Article VIII, the Administrator will equitably adjust each outstanding Award as it reasonably and in good faith deems appropriate to reflect the Equity Restructuring, which may include adjusting the number and type of securities subject to each outstanding Award and/or the Award’s exercise price or grant price (if applicable), granting new Awards to Participants, and making a cash payment to Participants. The adjustments provided under this Section 8.1 will be nondiscretionary and final and binding on the affected Participant and the Company; provided that the Administrator will reasonably and in good faith determine whether an adjustment is equitable.

 

8.2            Corporate Transactions. In the event of any dividend (other than ordinary cash dividends) or other distribution (whether in the form of cash, Common Stock, other securities, or other property), reorganization, merger, consolidation, combination, amalgamation, repurchase, recapitalization, liquidation, dissolution, or sale, transfer, exchange or other disposition of all or substantially all of the assets of the Company, or sale or exchange of Common Stock or other securities of the Company, Change in Control, issuance of warrants or other rights to purchase Common Stock or other securities of the Company, other similar corporate transaction or event, other unusual or nonrecurring transaction or event affecting the Company or its financial statements or any change in any Applicable Laws or accounting principles, the Administrator, on such terms and conditions as it reasonably and in good faith deems appropriate, either by the terms of the Award or by action taken prior to the occurrence of such transaction or event (except that action to give effect to a change in Applicable Law or accounting principles may be made within a reasonable period of time after such change), is hereby authorized to take any one or more of the following actions whenever the Administrator reasonably and in good faith determines that such action is appropriate to (x) prevent dilution or enlargement of the benefits or potential benefits intended by the Company to be made available under the Plan or with respect to any Award granted or issued under the Plan, (y) to facilitate such transaction or event or (z) give effect to such changes in Applicable Laws or accounting principles:

 

(a)            To provide for the cancellation of any such Award in exchange for either an amount of cash or other property with a fair market value equal to the amount that could have been obtained upon the exercise or settlement of the vested portion of such Award or realization of the Participant’s rights under the vested portion of such Award, as applicable; provided that, if the amount that could have been obtained upon the exercise or settlement of the vested portion of such Award or realization of the Participant’s rights, in any case, is equal to or less than zero, then the Award may be terminated without payment;

 

  6  

 

(b)            To provide that such Award shall vest and, to the extent applicable, be exercisable as to all Shares covered thereby, notwithstanding anything to the contrary in the Plan or the provisions of such Award;

 

(c)            To provide that such Award be assumed by the successor or survivor corporation, or a parent or subsidiary thereof, or shall be substituted for by awards covering the stock of the successor or survivor corporation, or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares and/or applicable exercise or purchase price, in all cases, as determined by the Administrator;

 

(d)           To make adjustments in the number and type of Shares (or other securities or property) subject to outstanding Awards and/or with respect to which Awards may be granted under the Plan (including, but not limited to, adjustments of the limitations in Article IV on the maximum number and kind of shares which may be issued) and/or in the terms and conditions of (including the grant or exercise price or applicable performance goals), and the criteria included in, outstanding Awards;

 

(e)           To replace such Award with other rights or property of equivalent value selected by the Administrator; and/or

 

(f)            To provide that the Award will terminate and cannot vest, be exercised or become payable after the applicable event.

 

8.3            Administrative Stand Still. In the event of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other extraordinary transaction or change affecting the Shares or the share price of Common Stock, including any Equity Restructuring or any securities offering or other similar transaction, for administrative convenience, the Administrator may refuse to permit the exercise of any Award for up to 60 days before or after such transaction.

 

8.4            General. Except as expressly provided in the Plan or the Administrator’s action under the Plan, no Participant will have any rights due to any subdivision or consolidation of Shares of any class, dividend payment, increase or decrease in the number of Shares of any class or dissolution, liquidation, merger, or consolidation of the Company or other corporation. Except as expressly provided with respect to an Equity Restructuring under Section 8.1 or the Administrator’s action under the Plan, no issuance by the Company of Shares of any class, or securities convertible into Shares of any class, will affect, and no adjustment will be made regarding, the number of Shares subject to an Award or the Award’s grant or exercise price. The existence of the Plan, any Award Agreements and the Awards granted hereunder will not affect or restrict in any way the Company’s right or power to make or authorize (a) any adjustment, recapitalization, reorganization or other change in the Company’s capital structure or its business, (b) any merger, consolidation dissolution or liquidation of the Company or sale of Company assets or (c) any sale or issuance of securities, including securities with rights superior to those of the Shares or securities convertible into or exchangeable for Shares. The Administrator may treat Participants and Awards (or portions thereof) differently under this Article VIII.

 

  7  

ARTICLE IX. GENERAL PROVISIONS APPLICABLE TO AWARDS

 

9.1            Transferability. Except as the Administrator may determine or provide in an Award Agreement or otherwise for Awards other than Incentive Stock Options, Awards may not be sold, assigned, transferred, pledged or otherwise encumbered, either voluntarily or by operation of law, except by will or the laws of descent and distribution, or, subject to the Administrator’s consent, pursuant to a domestic relations order, and, during the life of the Participant, will be exercisable only by the Participant. References to a Participant, to the extent relevant in the context, will include references to a Participant’s authorized transferee that the Administrator specifically approves.

 

9.2            Documentation. Each Award will be evidenced in an Award Agreement, which may be written or electronic, as the Administrator determines. Each Award may contain terms and conditions in addition to those set forth in the Plan.

 

9.3            Discretion. Except as the Plan otherwise provides, each Award may be made alone or in addition or in relation to any other Award. The terms of each Award to a Participant need not be identical, and the Administrator need not treat Participants or Awards (or portions thereof) uniformly.

 

9.4            Termination of Status. The Administrator will determine how the Disability, death, retirement or authorized leave of absence or any other change or purported change in a Participant’s Service Provider status affects an Award and the extent to which, and the period during which the Participant, the Participant’s legal representative, conservator, guardian or Designated Beneficiary may exercise rights under the Award, if applicable.

 

9.5            Withholding. Each Participant must pay the Company or make provision satisfactory to the Administrator for payment of any taxes required by Applicable Law to be withheld in connection with such Participant’s Awards by the date of the event creating the tax liability. The Company may deduct an amount sufficient to satisfy such tax obligations based on the applicable statutory withholding rates (or such other rate as may be determined by the Company reasonably and in good faith after considering any accounting consequences or costs) from any payment of any kind otherwise due to a Participant. Subject to Section 10.8 and any Company insider trading policy (including blackout periods), Participants may satisfy such tax obligations (a) in cash, by wire transfer of immediately available funds, by check made payable to the order of the Company, provided that the Company may limit the use of the foregoing payment forms if one or more of the payment forms below is permitted, (b) to the extent permitted by the Administrator, in whole or in part by delivery of Shares, including Shares delivered by attestation and Shares retained from the Award creating the tax obligation, valued at their fair market value on the date of delivery, (c) if there is a public market for Shares at the time the tax obligations are satisfied, unless the Company otherwise determines, (i) delivery (including electronically or telephonically to the extent permitted by the Company) of an irrevocable and unconditional undertaking by a broker acceptable to the Company to deliver promptly to the Company sufficient funds to satisfy the tax obligations, or (ii) delivery by the Participant to the Company of a copy of irrevocable and unconditional instructions to a broker acceptable to the Company to deliver promptly to the Company cash or a check sufficient to satisfy the tax withholding; provided that such amount is paid to the Company at such time as may be required by the Administrator, or (d) to the extent permitted by the Company, any combination of the foregoing payment forms approved by the Administrator. If any tax withholding obligation will be satisfied under clause (b) above by the Company’s retention of Shares from the Award creating the tax obligation and there is a public market for Shares at the time the tax obligation is satisfied, the Company may elect to instruct any brokerage firm determined acceptable to the Company for such purpose to sell on the applicable Participant’s behalf some or all of the Shares retained and to remit the proceeds of the sale to the Company or its designee, and each Participant’s acceptance of an Award under the Plan will constitute the Participant’s authorization to the Company and instruction and authorization to such brokerage firm to complete the transactions described in this sentence.

 

9.6            Amendment of Award; Repricing. The Administrator may amend, modify or terminate any outstanding Award, including by substituting another Award of the same or a different type, changing the exercise or settlement date, and converting an Incentive Stock Option to a Non-Qualified Stock Option. The Participant’s consent to such action will be required unless (a) the action, taking into account any related action, does not materially and adversely affect the Participant’s rights under the Award, or (b) the change is permitted under Article VIII or pursuant to Section 10.6.

 

  8  

 

9.7            Conditions on Delivery of Stock. The Company will not be obligated to deliver any Shares under the Plan or remove restrictions from Shares previously delivered under the Plan until (a) all Award conditions have been met or removed to the Company’s satisfaction, (b) as determined reasonably and in good faith by the Company, all other legal matters regarding the issuance and delivery of such Shares have been satisfied, including any applicable securities laws and stock exchange or stock market rules and regulations, and (c) the Participant has executed and delivered to the Company such representations or agreements as the Administrator deems reasonably necessary or appropriate to satisfy any Applicable Laws. The Company’s inability after commercially reasonable good faith effort to obtain authority from any regulatory body having jurisdiction, which the Administrator determines is necessary to the lawful issuance and sale of any securities, will relieve the Company of any liability for failing to issue or sell such Shares as to which such requisite authority has not been obtained.

 

9.8            Acceleration. The Administrator may at any time provide that any Award will become immediately vested and fully or partially exercisable, free of some or all restrictions or conditions, or otherwise fully or partially realizable.

 

9.9            Cash Settlement. Without limiting the generality of any other provision of the Plan, the Administrator may provide, in an Award Agreement or subsequent to the grant of an Award, in its discretion, that any Award may be settled in cash, Shares or a combination thereof.

 

9.10          Broker-Assisted Sales. In the event of a broker-assisted sale of Shares in connection with the payment of amounts owed by a Participant under or with respect to the Plan or Awards, including amounts to be paid under the final sentence of Section 9.5: (a) any Shares to be sold through the broker-assisted sale will be sold on the day the payment first becomes due, or as soon thereafter as practicable; (b) such Shares may be sold as part of a block trade with other Participants in the Plan in which all Participants receive an average price; (c) if determined by the Administrator, the applicable Participant will be responsible for all broker’s fees and other costs of sale, and by accepting an Award, each Participant agrees to indemnify and hold the Company harmless from any losses, costs, damages, or expenses relating to any such sale; (d) to the extent the Company or its designee receives proceeds of such sale that exceed the amount owed, the Company will pay such excess in cash to the applicable Participant as soon as reasonably practicable; (e) the Company and its designees are under no obligation to arrange for such sale at any particular price; and (f) in the event the proceeds of such sale are insufficient to satisfy the Participant’s applicable obligation, the Participant may be required to pay immediately upon demand to the Company or its designee an amount in cash sufficient to satisfy any remaining portion of the Participant’s obligation.

 

ARTICLE X. MISCELLANEOUS

 

10.1            No Right to Employment or Other Status. No person will have any claim or right to be granted an Award, and the grant of an Award will not be construed as giving a Participant the right to continued employment or any other relationship with the Company or any of its Subsidiaries. The Company and its Subsidiaries expressly reserves the right at any time to dismiss or otherwise terminate its relationship with a Participant free from any liability or claim under the Plan or any Award, except as expressly provided in an Award Agreement or in the Plan.

 

10.2            No Rights as Stockholder; Certificates. Subject to the Award Agreement, no Participant or Designated Beneficiary will have any rights as a stockholder with respect to any Shares to be distributed under an Award until becoming the record holder of such Shares. Notwithstanding any other provision of the Plan, unless the Administrator otherwise determines or Applicable Laws require, the Company will not be required to deliver to any Participant certificates evidencing Shares issued in connection with any Award and instead such Shares may be recorded in the books of the Company (or, as applicable, its transfer agent or stock plan administrator). The Company may place legends on stock certificates issued under the Plan that the Administrator deems necessary or appropriate to comply with Applicable Laws.

 

  9  

 

10.3            Effective Date and Term of Plan. Unless earlier terminated by the Board, the Plan will become effective upon the consummation of the transactions contemplated by that certain Business Combination Agreement (the “BCA”) entered into on April 25, 2023, by and among the Company, Above Food Corp., Bite Acquisition Corp., and Above Merger Sub, Inc. (the “Business Combination,” and the date that the Plan becomes effective, the “Effective Date”), subject to the approval of the Company’s stockholders, and will remain in effect until the tenth anniversary of the earlier of (a) the date the Board adopted the Plan and (b) the date the Company’s stockholders approved the Plan, provided that Awards previously granted may extend beyond that date in accordance with the Plan. If the Plan is not approved by the Company’s stockholders, the Plan will not become effective, and no Awards will be granted under the Plan.

 

10.4            Amendment of Plan. The Administrator may amend, suspend or terminate the Plan at any time; provided that no amendment, other than an increase to the Overall Share Limit, may materially and adversely affect the rights of a Participant with respect to any Award outstanding at the time of such amendment without the affected Participant’s consent. No Awards may be granted under the Plan during any suspension period or after the Plan’s termination. Awards outstanding at the time of any Plan suspension or termination will continue to be governed by the Plan and the Award Agreement, as in effect before such suspension or termination. The Board will obtain stockholder approval of any Plan amendment to the extent necessary to comply with Applicable Laws.

 

10.5            Provisions for Foreign Participants. The Administrator may modify Awards granted to Participants who are foreign nationals or employed outside the United States or establish subplans or procedures under the Plan to address differences in laws, rules, regulations or customs of such foreign jurisdictions with respect to tax, securities, currency, employee benefit or other matters.

 

10.6            Section 409A.

 

(a)            General. The Company intends that all Awards be structured to comply with, or be exempt from, Section 409A, such that no adverse tax consequences, interest, or penalties under Section 409A apply, and the Plan shall be construed and interpreted in accordance with such intent. Each payment under an Award shall be treated as a separate payment for purposes of Section 409A. Notwithstanding anything in the Plan or any Award Agreement to the contrary, the Administrator may, without a Participant’s consent, amend this Plan or Awards, adopt policies and procedures, or take any other actions (including amendments, policies, procedures and retroactive actions) as are necessary or appropriate to preserve the intended tax treatment of Awards, including any such actions intended to (i) exempt this Plan or any Award from Section 409A, or (ii) comply with Section 409A, including regulations, guidance, compliance programs and other interpretative authority that may be issued after an Award’s grant date. The Company makes no representations or warranties as to an Award’s tax treatment under Section 409A or otherwise. The Company will have no obligation under this Section 10.6 or otherwise to avoid the taxes, penalties or interest under Section 409A with respect to any Award and will have no liability to any Participant or any other person if any Award, compensation or other benefits under the Plan are determined to constitute noncompliant “nonqualified deferred compensation” subject to taxes, penalties or interest under Section 409A.

 

  10  

 

(b)            Separation from Service. If an Award constitutes “nonqualified deferred compensation” under Section 409A, any payment or settlement of such Award upon a termination of a Participant’s Service Provider relationship will, to the extent necessary to avoid taxes under Section 409A, be made only upon the Participant’s “separation from service” (within the meaning of Section 409A), whether such “separation from service” occurs upon or after the termination of the Participant’s Service Provider relationship. For purposes of this Plan or any Award Agreement relating to any such payments or benefits, references to a “termination,” “termination of employment” or like terms means a “separation from service.”

 

(c)            Payments to Specified Employees; Installments. Notwithstanding any contrary provision in the Plan or any Award Agreement, any payment(s) of “nonqualified deferred compensation” required to be made under an Award to a “specified employee” (as defined under Section 409A and as the Administrator determines) due to the Participant’s “separation from service” will, to the extent necessary to avoid taxes under Section 409A(a)(2)(B)(i) of the Code, be delayed for the six-month period immediately following such “separation from service” (or, if earlier, until the specified employee’s death) and will instead be paid (as set forth in the Award Agreement) on the day immediately following such six-month period or as soon as administratively practicable thereafter (without interest). Any payments of “nonqualified deferred compensation” under such Award payable more than six months following the Participant’s “separation from service” will be paid at the time or times the payments are otherwise scheduled to be made.

 

10.7            Limitations on Liability. Notwithstanding any other provisions of the Plan, no individual acting as a Director, officer, other Employee or agent of the Company or any Subsidiary will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for any claim, loss, liability, or expense incurred in connection with the Plan or any Award, and such individual will not be personally liable with respect to the Plan because of any contract or other instrument executed in such individual’s capacity as an Administrator, Director, officer, other Employee or agent of the Company or any Subsidiary. The Company will indemnify and hold harmless each Director, officer, other Employee and agent of the Company or any Subsidiary that has been or will be granted or delegated any duty or power relating to the Plan’s administration or interpretation, against any cost or expense (including attorneys’ fees) or liability (including any sum paid in settlement of a claim with the Administrator’s approval) arising from any act or omission concerning this Plan unless arising from such person’s own fraud or bad faith.

 

10.8            Lock-Up Period. The Company may, at the request of any underwriter representative or otherwise, in connection with registering the offering of any Company securities under the Securities Act, prohibit Participants from, directly or indirectly, selling or otherwise transferring any Shares or other Company securities during a period of up to 180 days following the effective date of a Company registration statement filed under the Securities Act, or such longer period as determined by the underwriter.

 

10.9            Data Privacy. As a condition for receiving any Award, each Participant explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of personal Data as described in this section by and among the Company and its Subsidiaries and affiliates exclusively for implementing, administering and managing the Participant’s participation in the Plan. The Company and its Subsidiaries and affiliates may hold certain personal information about a Participant, including the Participant’s name, address and telephone number; birthdate; social security, insurance number or other identification number; salary; nationality; job title(s); any Shares held in the Company or its Subsidiaries and affiliates; and Award details, to implement, manage and administer the Plan and Awards (the “Data”). The Company and its Subsidiaries and affiliates may transfer the Data amongst themselves as necessary to implement, administer and manage a Participant’s participation in the Plan, and the Company and its Subsidiaries and affiliates may transfer the Data to third parties assisting the Company with Plan implementation, administration and management. These recipients may be located in the Participant’s country, or elsewhere, and the Participant’s country may have different data privacy laws and protections than the recipients’ country. By accepting an Award, each Participant authorizes such recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, to implement, administer and manage the Participant’s participation in the Plan, including any required Data transfer to a broker or other third party with whom the Company or the Participant may elect to deposit any Shares. The Data related to a Participant will be held only as long as necessary to implement, administer, and manage the Participant’s participation in the Plan. A Participant may, at any time, view the Data that the Company holds regarding such Participant, request additional information about the storage and processing of the Data regarding such Participant, recommend any necessary corrections to the Data regarding the Participant or refuse or withdraw the consents in this Section 10.9 in writing, without cost, by contacting the local human resources representative. If the Participant refuses or withdraws the consents in this Section 10.9, the Company may cancel Participant’s ability to participate in the Plan and, in the Administrator’s discretion, the Participant may forfeit any outstanding Awards. For more information on the consequences of refusing or withdrawing consent, Participants may contact their local human resources representative.

 

  11  

  

10.10           Severability. If any portion of the Plan or any action taken under it is held illegal or invalid for any reason, the illegality or invalidity will not affect the remaining parts of the Plan, and the Plan will be construed and enforced as if the illegal or invalid provisions had been excluded, and the illegal or invalid action will be null and void.

 

10.11           Governing Documents. If any contradiction occurs between the Plan and any Award Agreement or other written agreement between a Participant and the Company (or any Subsidiary) that the Administrator has approved, the Plan will govern, unless it is expressly specified in such Award Agreement or other written document that a specific provision of the Plan will not apply or that the Award Agreement or other written document will govern.

 

10.12           Governing Law. The Plan and all Awards will be governed by and interpreted in accordance with the laws of the province of Alberta and the laws of Canada applicable in that province, disregarding any state’s or province’s choice-of-law principles requiring the application of a jurisdiction’s laws other than the laws of the province of Alberta and the laws of Canada applicable in that province.

 

10.13           Claw-back Provisions. All Awards (including, without limitation, any proceeds, gains or other economic benefit actually or constructively received by Participant upon any receipt or exercise of any Award or upon the receipt or resale of any Shares underlying the Award) shall be subject to the provisions of any claw-back policy implemented by the Company, including, without limitation, any claw-back policy adopted to comply with Applicable Laws (including the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and any rules or regulations promulgated thereunder) as and to the extent set forth in such claw-back policy or the Award Agreement.

 

10.14           Titles and Headings. The titles and headings in the Plan are for convenience of reference only and, if any conflict, the Plan’s text, rather than such titles or headings, will control.

 

10.15           Conformity to Securities Laws. Participant acknowledges that the Plan is intended to conform to the extent necessary with Applicable Laws. Notwithstanding anything herein to the contrary, the Plan and all Awards will be administered only in conformance with Applicable Laws. To the extent Applicable Laws permit, the Plan and all Award Agreements will be deemed amended as necessary to conform to Applicable Laws.

 

10.16           Relationship to Other Benefits. No payment under the Plan will be taken into account in determining any benefits under any pension, retirement, savings, profit sharing, group insurance, welfare or other benefit plan of the Company or any Subsidiary except as expressly provided in writing in such other plan or an agreement thereunder.

  

  12  

 

ARTICLE XI. DEFINITIONS

 

As used in the Plan, the following words and phrases will have the following meanings:

 

11.1            “Administrator” means the Board or a Committee to the extent that the Board’s powers or authority under the Plan have been delegated to such Committee.

 

11.2            “Applicable Laws” means the requirements relating to the administration of equity incentive plans under U.S. federal and state securities, tax and other applicable laws, rules and regulations, the applicable rules of any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws and rules of any foreign country or other jurisdiction where Awards are granted.

 

11.3            “Award” means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Dividend Equivalents, or Other Stock or Cash Based Awards.

 

11.4            “Award Agreement” means a written agreement evidencing an Award, which may be electronic, that contains such terms and conditions as the Administrator determines, consistent with and subject to the terms and conditions of the Plan.

 

11.5            “Board” means the Board of Directors of the Company.

 

11.6            “Cause” means (a) if a Participant is a party to a written employment or consulting agreement with the Company or any of its Subsidiaries or an Award Agreement in which the term “Cause” is defined (a “Relevant Agreement”), “Cause” as defined in the Relevant Agreement, and (b) if no Relevant Agreement exists, (i) the Administrator’s determination that the Participant failed to substantially perform the Participant’s duties (other than a failure resulting from the Participant’s Disability); (ii) the Administrator’s determination that the Participant failed to carry out, or comply with any lawful and reasonable directive of the Board or the Participant’s immediate supervisor; (iii) the occurrence of any act or omission by the Participant that could reasonably be expected to result in (or has resulted in) the Participant’s conviction, plea of no contest, plea of nolo contendere, or imposition of unadjudicated probation for any felony or indictable offense or crime involving moral turpitude; (iv) the Participant’s unlawful use (including being under the influence) or possession of illegal drugs on the premises of the Company or any of its Subsidiaries or while performing the Participant’s duties and responsibilities for the Company or any of its Subsidiaries; (v) the Participant’s breach of any agreement with the Company or a Subsidiary thereof (including, without limitation, any confidentiality, non-competition, non-solicitation or assignment of inventions agreement); (vi) the Participant’s breach of any material policy or code of conduct established by a member of the Company or any of its Subsidiaries and applicable to the Participant, including any policy or code of conduct provision relating to discrimination, harassment or retaliation; or (vii) the Administrator’s determination that the Participant committed an act of fraud, embezzlement, misappropriation, or misconduct, or breached a fiduciary duty against the Company or any of its Subsidiaries. The Administrator, in its absolute discretion, shall determine the effect of all matters and questions relating to whether a Participant has been discharged for Cause.

 

  13  

 

11.7            “Change in Control” means and includes each of the following:

 

(a)            A transaction or series of transactions (other than an offering of Common Stock to the general public through a registration statement filed with the Securities and Exchange Commission or a transaction or series of transactions that meets the requirements of clauses (i) and (ii) of subsection (c) below) whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act) (other than the Company, any of its Subsidiaries, an employee benefit plan maintained by the Company or any of its Subsidiaries or a “person” that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act) of securities of the Company possessing more than 50% of the total combined voting power of the Company’s securities outstanding immediately after such acquisition;

 

(b)            During any period of two consecutive years, individuals who, at the beginning of such period, constitute the Board together with any new Director(s) (other than a Director designated by a person who shall have entered into an agreement with the Company to effect a transaction described in subsections (a) or (c)) whose election by the Board or nomination for election by the Company’s stockholders was approved (other than in connection with the settlement of an actual or threatened hostile proxy contest) by a vote of at least two-thirds of the Directors then still in office who either were Directors at the beginning of the two-year period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof; or

 

(c)            The consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (x) a merger, consolidation, reorganization, or business combination, (y) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions or (z) the acquisition of assets or stock of another entity, in each case other than a transaction:

 

(i)            that results in the Company’s voting securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Company or the person that, as a result of the transaction, controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all of the Company’s assets or otherwise succeeds to the business of the Company (the Company or such person, the “Successor Entity”)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction in substantially the same proportions as immediately prior to the transaction, and

 

(ii)           after which no person or group beneficially owns voting securities representing 50% or more of the combined voting power of the Successor Entity; provided, however, that no person or group shall be treated for purposes of this clause (ii) as beneficially owning 50% or more of the combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation of the transaction.

 

Notwithstanding the foregoing, in no event shall the Business Combination or the transactions occurring in connection therewith constitute a Change in Control and if a Change in Control constitutes a payment event with respect to any Award (or portion of any Award) that provides for the deferral of compensation that is subject to Section 409A, to the extent required to avoid the imposition of additional taxes under Section 409A, the transaction or event described in subsection (a), (b) or (c) with respect to such Award (or portion thereof) shall only constitute a Change in Control for purposes of the payment timing of such Award if such transaction also constitutes a “change in control event,” as defined in Treasury Regulations Section 1.409A-3(i)(5).

 

  14  

 

The Administrator shall have full and final authority, which shall be exercised in its discretion, to determine conclusively whether a Change in Control has occurred pursuant to the above definition, the date of the occurrence of such Change in Control and any incidental matters relating thereto; provided that any exercise of authority in conjunction with a determination of whether a Change in Control is a “change in control event” as defined in Treasury Regulations Section 1.409A-3(i)(5) shall be consistent with such regulation.

 

11.8            “Code” means the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder.

 

11.9            “Committee” means one or more committees or subcommittees of the Board, which may include one or more Company directors or executive officers, to the extent Applicable Laws permit. To the extent required to comply with the provisions of Rule 16b-3, it is intended that each member of the Committee will be, at the time the Committee takes any action with respect to an Award that is subject to Rule 16b-3, a “non-employee director” within the meaning of Rule 16b-3; however, a Committee member’s failure to qualify as a “non-employee director” within the meaning of Rule 16b-3 will not invalidate any Award granted by the Committee that is otherwise validly granted under the Plan.

 

11.10            “Common Stock” means the common shares in the capital of the Company.

 

11.11            “Company” means Above Food Ingredients Inc., a corporation organized under the laws of Alberta, Canada, or any successor.

 

11.12            “Consultant” means any person, including any adviser, engaged by the Company or any of its Subsidiaries to render services to such entity if the consultant or adviser: (a) renders bona fide services to the Company; (b) renders services not in connection with the offer or sale of securities in a capital-raising transaction and does not directly or indirectly promote or maintain a market for the Company’s securities; and (c) is a natural person.

 

11.13            “Designated Beneficiary” means the beneficiary or beneficiaries the Participant designates, in a manner the Administrator determines, to receive amounts due or exercise the Participant’s rights if the Participant dies or becomes incapacitated. Without a Participant’s effective designation, “Designated Beneficiary” will mean the Participant’s estate.

 

11.14            “Director” means a Board member.

 

11.15            “Disability” means a permanent and total disability under Section 22(e)(3) of the Code, as amended.

 

11.16            “Dividend Equivalents” means a right granted to a Participant under the Plan to receive the equivalent value (in cash or Shares) of dividends paid on Shares.

 

11.17            “Employee” means any employee of the Company or its Subsidiaries.

 

11.18            “Equity Restructuring” means, as determined by the Administrator, a non-reciprocal transaction between the Company and its stockholders, such as a stock dividend, stock split, spin-off or recapitalization through a large, nonrecurring cash dividend, or other large, nonrecurring cash dividend, that affects the number or kind of Shares (or other securities of the Company) or the share price of Common Stock (or other securities of the Company) and causes a change in the per share value of the Common Stock underlying outstanding Awards.

 

  15  

 

11.19            “Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

11.20            “Fair Market Value” means, as of any date, the value of a share of Common Stock determined as follows: (a) if the Common Stock is listed on any established stock exchange, its Fair Market Value will be the closing sales price for such Common Stock as quoted on such exchange for such date, or if no sale occurred on such date, the last day preceding such date during which a sale occurred, as reported in The Wall Street Journal or another source the Administrator deems reliable; (b) if the Common Stock is not traded on a stock exchange but is quoted on a national market or other quotation system, the closing sales price on such date, or if no sales occurred on such date, then on the last date preceding such date during which a sale occurred, as reported in The Wall Street Journal or another source the Administrator deems reliable; or (c) without an established market for the Common Stock, the Administrator will determine the Fair Market Value in its discretion.

 

11.21            “Greater Than 10% Stockholder” means an individual then owning (within the meaning of Section 424(d) of the Code) more than 10% of the total combined voting power of all classes of stock of the Company or its parent or subsidiary corporation, as defined in Section 424(e) and (f) of the Code, respectively.

 

11.22            “Incentive Stock Option” means an Option intended to qualify as an “incentive stock option” as defined in Section 422 of the Code.

 

11.23            “Non-Qualified Stock Option” means an Option, or portion thereof, not intended or not qualifying as an Incentive Stock Option.

 

11.24            “Option” means an option to purchase Shares, which will either be an Incentive Stock Option or a Non-Qualified Stock Option.

 

11.25            “Other Stock or Cash Based Awards” means cash awards, awards of Shares, and other awards valued wholly or partially by referring to, or are otherwise based on, Shares or other property awarded to a Participant under Article VII.

 

11.26            “Overall Share Limit” means the sum of (i) 5,531,914 Shares and (ii) an annual increase on the first day of each calendar year beginning January 1, 2025 and ending on and including January 1, 2034, equal to the lesser of (A) 5% of the aggregate number of Shares outstanding on the final day of the immediately preceding calendar year and (B) such smaller number of Shares as is determined by the Board.

 

11.27            “Participant” means a Service Provider who has been granted an Award.

 

11.28            “Performance Criteria” mean the criteria (and adjustments) that the Administrator may select for an Award to establish performance goals for a performance period, which may include the following: net earnings or losses (either before or after one or more of interest, taxes, depreciation, amortization, and non-cash equity-based compensation expense); gross or net sales or revenue or sales or revenue growth; net income (either before or after taxes) or adjusted net income; profits (including but not limited to gross profits, net profits, profit growth, net operation profit or economic profit), profit return ratios or operating margin; budget or operating earnings (either before or after taxes or before or after allocation of corporate overhead and bonus); cash flow (including operating cash flow and free cash flow or cash flow return on capital); return on assets; return on capital or invested capital; cost of capital; return on stockholders’ equity; total stockholder return; return on sales; costs, reductions in costs and cost control measures; expenses; working capital; earnings or loss per share; adjusted earnings or loss per share; price per share or dividends per share (or appreciation in or maintenance of such price or dividends); regulatory achievements or compliance; implementation, completion or attainment of objectives relating to research, development, regulatory, commercial, or strategic milestones or developments; market share; economic value or economic value added models; division, group or corporate financial goals; customer satisfaction/growth; customer service; employee satisfaction; recruitment and maintenance of personnel; human resources management; supervision of litigation and other legal matters; strategic partnerships and transactions; financial ratios (including those measuring liquidity, activity, profitability or leverage); debt levels or reductions; sales-related goals; financing and other capital raising transactions; cash on hand; acquisition activity; investment sourcing activity; and marketing initiatives, any of which may be measured in absolute terms or as compared to any incremental increase or decrease. Such performance goals also may be based solely by reference to the Company’s performance or the performance of a Subsidiary, division, business segment or business unit of the Company or a Subsidiary or based upon performance relative to performance of other companies or upon comparisons of any of the indicators of performance relative to performance of other companies. The Committee may provide for exclusion of the impact of an event or occurrence which the Committee determines should appropriately be excluded, including (a) restructurings, discontinued operations, extraordinary items, and other unusual, infrequently occurring or non-recurring charges or events, (b) asset write-downs, (c) litigation or claim judgments or settlements, (d) acquisitions or divestitures, (e) reorganization or change in the corporate structure or capital structure of the Company, (f) an event either not directly related to the operations of the Company, Subsidiary, division, business segment or business unit or not within the reasonable control of management, (g) foreign exchange gains and losses, (h) a change in the fiscal year of the Company, (i) the refinancing or repurchase of bank loans or debt securities, (j) unbudgeted capital expenditures, (k) the issuance or repurchase of equity securities and other changes in the number of outstanding shares, (l) conversion of some or all of convertible securities to Common Stock, (m) any business interruption event (n) the cumulative effects of tax or accounting changes in accordance with U.S. generally accepted accounting principles, or (o) the effect of changes in other laws or regulatory rules affecting reported results.

 

  16  

 

11.29            “Plan” means this 2023 Incentive Award Plan, as amended from time to time.

 

11.30            “Restricted Stock” means Shares awarded to a Participant under Article VI subject to certain vesting conditions and other restrictions.

 

11.31            “Restricted Stock Unit” means an unfunded, unsecured right to receive, on the applicable settlement date, one Share or an amount in cash or other consideration determined by the Administrator to be of equal value as of such settlement date awarded to a Participant under Article VI subject to certain vesting conditions and other restrictions.

 

11.32            “Rule 16b-3” means Rule 16b-3 promulgated under the Exchange Act.

 

11.33            “Section 16 Persons” means those officers, directors or other persons who are subject to Section 16 of the Exchange Act.

 

11.34            “Section 409A” means Section 409A of the Code and all regulations, guidance, compliance programs and other interpretative authority thereunder.

 

11.35            “Securities Act” means the Securities Act of 1933, as amended.

 

11.36            “Service Provider” means an Employee, Consultant or Director.

 

11.37            “Shares” means shares of Common Stock.

 

11.38            “Stock Appreciation Right” means a stock appreciation right granted under Article V.

 

  17  

 

11.39            “Subsidiary” means any entity (other than the Company), whether domestic or foreign, in an unbroken chain of entities beginning with the Company if each of the entities other than the last entity in the unbroken chain beneficially owns, at the time of the determination, securities or interests representing at least 50% of the total combined voting power of all classes of securities or interests in one of the other entities in such chain.

 

11.40            “Substitute Awards” means Awards granted or Shares issued by the Company in assumption of, or in substitution or exchange for, awards previously granted, or the right or obligation to make future awards, in each case by a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines.

 

11.41            “Termination of Service” means the date the Participant ceases to be a Service Provider.

 

* * * * *

 

  18  

EX-10.23 11 tm2418826d1_ex10-23.htm EXHIBIT 10.23

Exhibit 10.23

 

 

***CERTAIN MATERIAL (INDICATED BY THREE ASTERISKS IN BRACKETS) HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS BOTH (1) NOT MATERIAL AND (2) THE TPYE THAT THE REGISTRANTS TREATS AS PRIVATE OR CONFIDENTIAL. IN ADDITION, CERTAIN PERSONALLY IDENTIFIABLE INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT PURSUANT TO ITEM 601(A)(6) OF REGULATION S-K. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

 

NOTICE TO PROSPECTIVE SUBSCRIBER

 

ABOVE FOOD CORP. (THE “CORPORATION”) IS NOT A REPORTING ISSUER UNDER CANADIAN SECURITIES LEGISLATION NOR HAVE THE SECURITIES TO BE PURCHASED UNDER THIS SUBSCRIPTION AGREEMENT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR APPLICABLE STATE SECURITIES LAWS, AND ARE PROPOSED TO BE ISSUED IN RELIANCE UPON AN EXEMPTION OR AN EXCLUSION FROM THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT. PURCHASING SECURITIES UNDER THIS SUBSCRIPTION AGREEMENT MEANS THAT YOU ARE ACQUIRING SECURITIES OF A CORPORATION WHOSE SHARES ARE NOT FREELY TRADABLE. THE CORPORATION IS NOT A REPORTING ISSUER IN ANY JURISDICTION AND NO ASSURANCE CAN BE GIVEN THAT THE CORPORATION WILL BECOME A REPORTING ISSUER. IF THE CORPORATION DOES NOT BECOME A REPORTING ISSUER THE SECURITIES ACQUIRED UNDER THIS SUBSCRIPTION AGREEMENT WILL BE SUBJECT TO RESTRICTIONS ON RESALE FOR AN INDEFINITE PERIOD.

 

The Corporation and Bite Acquisition Corp. (NYSE AMERICAN: BITE) (“Bite”), a special purpose acquisition company, entered into a definitive business combination agreement on April 29, 2023, as amended on March 12, 2024. Above Food Ingredients Inc, an Alberta corporation and a wholly owned subsidiary of the Corporation (“New Above”), filed a Registration Statement on Form F-4 (“Registration Statement”), which became effective on April 8, 2024. The Corporation is also in the process of filing a Canadian prospectus and seeking court approval of the business combination in the form of a plan of arrangement (“Plan of Arrangement”). Upon receipt of the interim court order, the Corporation will seek shareholders’ approval of the Plan of Arrangement. After shareholders’ approval, the Corporation intends to obtain final court approval of the Plan of Arrangement, at which time the Corporation will be able to complete the Business Combination. The Subscriber is subscribing for the Common Shares, and agrees that the Common Shares, upon the closing of the Business Combination, will be exchanged for common shares of New Above at a ratio equal to the product of (x) the Common Shares held by the Investor times (y) 0.2103419 (“New Above Shares”), which reflects an implied value of $10 USD per New Above Share, in accordance with the Plan of Arrangement.

 

 

 

ABOVE FOOD CORP.
(An Alberta Corporation)

 

COMMON SHARE SUBSCRIPTION AGREEMENT
Dated for Reference: MAY 2024

 

TO: ABOVE FOOD CORP. (the “Corporation”)

 

RE: Purchase of 2,377,082 Common Shares of the Corporation at a Subscription Price of US$2.103419 per Common Share (the “Offering”).

 

- 2

 

The undersigned (the “Investor”) hereby irrevocably subscribes for and agrees to purchase from the Corporation, on the terms and conditions set forth in this agreement (the “Subscription Agreement”), that number of Common Shares of the Corporation set out below at a price of US$2.103419 per Common Share, for the total subscription price set forth below (the “Subscription Price”).

 

Terms not defined herein shall have the meanings ascribed to such terms in Section 2 hereof. Unless otherwise indicated, all monetary references are in United States Dollars.

 

REGISTRATION AND DELIVERY INSTRUCTIONS

 

  Number of Common Shares of the Corporation  2,377,082
   
  US$2.103419 per Common Shares for a total Subscription Price of US$ 5,000,000.00
  EXECUTION BY SUBSCRIBER:      
         
  /s/ [ *** ]    
  Signature of individual (if Subscriber is an individual)   Address of Subscriber (residence)  
         
  [ *** ]   [ *** ]  
  Authorized signatory (if Subscriber is not an individual)   Address of Subscriber  
         
  Grupo Empresarial Enhol, S.L.   [ *** ]  
  Name of Subscriber (please print)   Telephone number of Subscriber  
         
  [ *** ]   [ *** ]  
  Name of authorized signatory (please print)   E-mail address of Subscriber  

 

Register the Common Shares as follows:   Deliver the Common Shares as follows:
Grupo Empresarial Enhol, S.L. Grupo Empresarial Enhol, S.L.
(Name) (Name)
(Account reference, if applicable) (Account reference, if applicable)
[ *** ] [ *** ]
(Contact Name) (Contact Name)
[ *** ] [ *** ]
(Address) (Address)

 

- 3

 

Insider Status

 

The Subscriber is either [check appropriate box]:

 

 ¨   an “insider” of the Corporation as defined in the Securities Act (Ontario) (see below); or
 ¨   not an “insider” of the Corporation as defined in the Securities Act (Ontario).

 

Note:

 

The definition of “insider” includes a person that:

 

(i) is a director or officer of the Corporation;

 

(ii) is a director or officer of a person or company that is itself an insider or subsidiary of the Corporation;

 

(iii) is a person or a company that has:

 

a. beneficial ownership of, or control or direction over, directly or indirectly; or

 

b. a combination of beneficial ownership of, and control or direction over, directly or indirectly,

 

securities of an issuer carrying more than 10% of the voting rights attached to all the Corporation’s outstanding voting securities;

 

(iv) the Corporation itself, if it holds securities of its own issue; or

 

(v) a person designated as an insider under the Securities Act (Ontario).

 

Registrant Status

 

The Subscriber is either [check appropriate box]:

 

 ¨   registered or required to be registered pursuant to National Instrument 31-103 - Registration Requirements, Exemptions and Ongoing Registrant Obligations; or
 ¨   not registered or required to be registered pursuant to National Instrument 31-103 - Registration Requirements, Exemptions and Ongoing Registrant Obligations.

 

Present Holdings

 

The Subscriber currently holds the following other securities in the capital of the Corporation [please write “None” if no other securities of the Corporation held]:

 

None.  
 
 
 

 

NOTE: The information collected herein will be used by the Corporation in determining whether the Subscriber meets the requirements of the applicable prospectus exemptions, for making certain filings with applicable regulatory authorities and for meeting the Corporation’s obligations under securities legislation with respect to the mailing of continuous disclosure materials to the Subscriber, if applicable.

 

 

- 4

 

 

Acceptance

 

Accepted and agreed to by the Corporation as of the 13th day of June, 2024.

 

ABOVE FOOD CORP.

 

Per: /s/ Lionel Kambeitz  
  Authorized Signatory  

 

THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR APPLICABLE STATE SECURITIES LAWS, AND ARE PROPOSED TO BE ISSUED IN RELIANCE UPON AN EXEMPTION OR AN EXCLUSION FROM THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT. SUCH SECURITIES MAY NOT BE RE-OFFERED FOR SALE, RESOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE U.S. SECURITIES ACT AND IN ACCORDANCE WITH ANY APPLICABLE STATE SECURITIES LAWS, OR PURSUANT TO AN EXEMPTION OR EXCLUSION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

 

THE SECURITIES OFFERED HEREBY ARE SPECULATIVE, INVOLVE A HIGH DEGREE OF RISK AND SHOULD ONLY BE PURCHASED BY PERSONS WHO CAN AFFORD THE LOSS OF THEIR ENTIRE INVESTMENT. PROSPECTIVE INVESTORS SHOULD CAREFULLY READ AND EVALUATE THE INFORMATION SET FORTH IN THIS SUBSCRIPTION AGREEMENT BEFORE PURCHASING ANY OF SUCH SECURITIES.

 

 

- 5

 

 

INSTRUCTIONS FOR COMPLETING THIS SUBSCRIPTION AGREEMENT

 

 

 

1. Subscriber:

 

The Subscriber must complete the information required on pages 3 and 4 with respect to Common Share subscription amounts, the Subscription Price and the registration and delivery particulars and sign where indicated.

 

2. International Subscribers:

 

For Subscribers who are resident outside of Canada and the United States, complete and sign the Foreign Purchaser’s Certificate attached hereto as Schedule A.

 

3. Payment of the Subscription Price:

 

Payment of the Subscription Price must be made by a wire transfer to the Escrow Agent in accordance with the following instructions, on or before the Closing Date:

 

  Bank [ *** ]
   
  Bank Address: [ *** ]
    [ *** ]
    [ *** ]
   
  Payee Name: [ *** ]
    [ *** ]
    [ *** ]
    [ *** ]
   
  SWIFT code: [ *** ]
   
  Bank Routing #: [ *** ]
   
  Institution: [ *** ] (also National Clearing System Number)
   
  Transit: [ *** ] (Branch Number)
   
  CDN Account #: [ *** ]
  USD Account #: [ *** ]
   
  Account Type: [ *** ]
   
  Standard Entry Class (SEC): [ *** ]
     
  Country: [ *** ]
   
  Reference: [ *** ]

 

A completed and fully executed copy of this Subscription Agreement, including the items required to be completed as set out above, together with the Subscription Price must be received by no later than 12:00 p.m. (Toronto time) on the Closing Date at the offices of the Corporation.

 

 

- 6

 

 

TERMS AND CONDITIONS

 

to the Subscription Agreement for purchase of the Securities of Above Food Corp.

 

1. Definitions

 

1.1 (a) “Accredited Investor” has the meaning ascribed to such term in NI 45-106, and in Ontario, in Section 73.3 of the Securities Act (Ontario) as supplemented by the definition in NI 45-106;

 

(b) “Aggregate Purchase Price” means USD 5 million.

 

(c) “Applicable Securities Laws” means the securities legislation of the Offering Jurisdictions having application, and the rules, policies, notices and orders issued by securities regulatory authorities in the Offering Jurisdictions having application to this Offering and the Corporation;

 

(d) “Board” or “Board of Directors” means the Board of Directors of the Corporation;

 

(e) “Business Combination Agreement” means the business combination agreement dated as of April 29, 2023, as amended on March 12, 2024, by and between the Corporation, and Bite Acquisition Corp.

 

(f) “Closing” means a completion of an issue and sale by the Corporation and the purchase by the Subscribers of the Common Shares pursuant to this Subscription Agreement on the date of completion of the SPA, subject to the terms and conditions set forth herein;

 

(g) “Closing Date” means the date on which Closing will occur, which shall be on the day of closing of the SPA;

 

(h) “Common Share” means a common share without par value in the capital of the Corporation;

 

(i) “Escrow Agent” means Gowling WLG.

 

(j) “Escrow Agreement” means that certain escrow agreement to be entered into by and among the Corporation, Subscriber and the Escrow Agent on the Closing Date on the terms set forth in Schedule C hereto.

 

(k) “Liquidity Event” means the listing of the Common Shares or the exchange of the Common Shares for securities that are listed on the Toronto Stock Exchange, the TSX Venture Exchange, the Canadian Securities Exchange, the New York Stock Exchange or any other exchange including any foreign exchange (an “Approved Exchange”);

 

(l) “NI 45-102” means National Instrument 45-102 – Resale of Securities, in the form adopted by the securities commissions in all provinces and territories of Canada (a copy is available from the Corporation or online at www.bcsc.bc.ca);

 

 

 

- 7

 

 

(m) “NI 45-106” means National Instrument 45-106 – Prospectus Exemptions, in the form adopted by the securities commissions in all provinces and territories of Canada (a copy is available from the Corporation or online at www.bcsc.bc.ca);

 

(n) “Offering” means the sale by the Corporation of the Common Shares on the terms set forth in this Subscription Agreement;

 

(o) “Offering Jurisdictions” means each of the Offering Provinces, the United States as well as other jurisdictions from which the Corporation may accept a subscription;

 

(p) “Offering Provinces” means each of the Provinces of British Columbia, Ontario, Alberta, Nova Scotia, New Brunswick, Newfoundland and Labrador, and such other provinces and territories of Canada from which the Corporation may accept a subscription;

 

(q) “Proceeds” means the gross proceeds of the Offering;

 

(r) “Regulation D” means Regulation D under the U.S. Securities Act;

 

(s) “Regulation S” means Regulation S under the U.S. Securities Act;

 

(t) “Securities” means the Common Shares;

 

(u) "SPA” means that certain share sale and purchase and exchange agreement for the sale of shares of Brotalia S.L. to Above Food Corp. by Grupo Empresarial Enhol, S.L. and [ *** ] executed on the date hereof.

 

(v) “Subscriber” means the person or persons named as Subscriber on the execution page of this Subscription Agreement and if more than one person is so named, means all of them jointly and severally;

 

(w) “Subscription Agreement” means this subscription agreement and all schedules and forms attached hereto, and all instruments supplementing, amending or confirming this subscription agreement;

 

(x) “Subscription Price” means the aggregate subscription price for the Common Shares to be paid by the Subscriber as set forth on the execution page of this Agreement;

 

(y) “United States” means the United States of America, its territories, and State of the United States and the District of Columbia;

 

(z) “U.S. Accredited Investor” means an “accredited investor” as that term is defined in Rule 501(a) of Regulation D;

 

(aa) “U.S. Person” means a U.S. Person as defined in Regulation S (the definition of which includes, but is not limited to: (i) any U.S. citizen (and certain former U.S. citizens) or a “resident alien” within the meaning of U.S. income tax laws as in effect from time to time. Currently, the term “resident alien” is defined under U.S. income tax laws generally to include any individual who (a) holds an Alien Registration Card (a “green card”) issued by U.S. Citizenship and Immigration Services (or an applicable predecessor entity), (b) meets a “substantial presence” test, or (c) is qualified to and does affirmatively elect on his or her tax return to be treated as a U.S. resident pursuant to Section 7701(b)(1)(A)(iii) of the Internal Revenue Code. The “substantial presence” test is generally met with respect to any calendar year if (a) the individual was present in the United States on at least 31 days during such year and (b) the sum of the number of days on which such individual was present in the United States during such year, 1/3 of the number of such days during the first preceding year, and 1/6 of the number of such days during the second preceding year, equals or exceeds 183 days; (ii) any partnership or corporation organized or incorporated under the laws of the United States; (iii) any partnership or corporation organized outside of the United States by a U.S. Person principally for the purpose of investing in securities not registered under the U.S. Securities Act, unless it is organized, or incorporated, and owned, by accredited investors who are not natural persons, estates or trusts; and (iv) any estate or trust of which any executor or administrator or trustee is a U.S. Person);

 

 

 

- 8

 

 

(bb) “U.S. Purchaser” is: (i) any “U.S. Person” as defined in Regulation S; (ii) any person purchasing the Securities on behalf of any “U.S. Person” or any person in the United States; (iii) any person who receives or received an offer of the Securities while in the United States; or (iv) any person who is or was in the United States at the time the Subscriber’s buy order was made or this Subscription Agreement was executed or delivered (provided that any discretionary or similar account excluded from the definition of U.S. Person pursuant to Rule 902(k)(2)(i) of Regulation S under the U.S. Securities Act shall not be considered a U.S. Purchaser);

 

(cc) “U.S. Securities Act” means the Securities Act of 1933, as amended, of the United States of America;

 

1.2          Words and phrases which are used in this Subscription Agreement and all Schedules thereto and which are defined in NI 45-106 will have the meaning ascribed thereto in NI 45-106, unless otherwise specifically defined in Section 2.1 of this Subscription Agreement.

 

2. Business Combination

 

2.1          The Corporation, an innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products, and Bite Acquisition Corp. (NYSE AMERICAN: BITE) (“Bite”), a special purpose acquisition company, entered into a definitive business combination agreement on April 29, 2023, as amended on March 12, 2024. The Corporation filed a Registration Statement on Form F-4 (“Registration Statement”), which became effective on April 8, 2024. The Corporation is also in the process of filing a Canadian prospectus and seeking court approval of the business combination in the form of a plan of arrangement (“Plan of Arrangement”). Upon receipt of the interim court order, the Corporation will seek shareholders’ approval of the Plan of Arrangement. Subsequent to the shareholders’ approval, the Corporation shall obtain final court approval of the Plan of Arrangement, following which the Corporation will be authorized to effect the Business Combination.

 

2.2          The Subscriber is subscribing for the Common Shares, and agrees that these Common Shares, upon the Business Combination, will be exchanged for common shares of New Above at a ratio equal to the product of (x) the Common Shares held by the Investor times (y) 0.2103419, in accordance with the terms of the Plan of Arrangement (“New Above Shares”), which will reflect an implied value of $10USD per New Above Share.

 

 

 

- 9

 

 

2.3           The Common Shares are being issued, on the acknowledgment and agreement that fifty percent (50%) of the Subscriber’s New Above Shares shall be restricted from trading for a period of sixty (60) days following the Liquidity Event, and the Subscriber’s remaining New Above Shares shall be restricted from trading for a period of One Hundred Eighty (180) days following the Liquidity Event.

 

3. The Subscription and the Offering

 

3.1           The Subscriber hereby irrevocably subscribes for and agrees to purchase from the Corporation subject to the terms and conditions set forth herein, the number of Common Shares for the aggregate Subscription Price set out on the execution page of this Subscription Agreement. This Subscription Agreement will be deemed to have been made and be effective only upon its acceptance by the Corporation and the disbursement of the Subscription Amount by the Subscriber and delivery of the Common Shares by the Corporation shall only be enforceable upon satisfaction of the Conditions Precedent set forth herein.

 

3.2           The Subscriber agrees to deliver to the Corporation not later than 12:00 pm (Toronto time) on the Closing Date for and on behalf of the Corporation:

 

(a)            a completed and duly signed copy of this Subscription Agreement;

 

(b)            a completed and duly signed copy of the Foreign Purchaser’s Certificate in the form attached as Schedule A hereto;

 

(c)            any other documents required by Applicable Securities Laws which the Corporation reasonably request; and

 

(d)            an electronic wire to the account designated by the Escrow Agent in Section 3 of the Instructions for Completing this Subscription Agreement contained herein representing the Aggregate Purchase Price payable by the Subscriber for the Common Shares, or payment of the same amount in such other manner as the Corporation may accept.

 

3.3           The Subscriber acknowledges and agrees that such undertakings, questionnaires and other documents, when executed and delivered by the Subscriber, will form part of and will be incorporated into this Subscription Agreement with the same effect as if each constituted a representation and warranty or covenant of the Subscriber hereunder in favour of the Corporation. The Subscriber consents to the filing of such undertakings, questionnaires and other documents as may be required to be filed with an Approved Exchange or other securities regulatory authority in connection with the transactions contemplated hereby.

 

4. Closing

 

4.1           The transactions contemplated hereby will be completed at the Closing remotely via the electronic exchange of documents or at the offices of Above Food Corp. The Subscriber acknowledges that the Common Shares will be available for delivery to it immediately post Closing on the Closing Date, against payment of the amount of the aggregate Subscription Price for the Common Shares.

 

 

 

- 10

 

 

5. Subscriber’s Exemption Status

 

5.1           U.S. Securities Law Matters – Non-U.S. Purchasers. The Subscriber:

 

(a) acknowledges the Securities have not been offered to the Subscriber in the United States, and the individuals making the order to purchase the Securities and executing and delivering this Subscription Agreement on behalf of the Subscriber were not in the United States when the order was placed and this Subscription Agreement was executed and delivered;

 

(b) is aware that the Securities have not been and, prior to the Closing of the Business Combination Agreement, will not be registered under the U.S. Securities Act or the securities laws of any state and that these securities may not be offered or sold in the United States without registration under the U.S. Securities Act or compliance with requirements of an exemption from registration and the applicable laws of all applicable states and acknowledges that the Corporation has no obligation to or present intention of filing a registration statement under the U.S. Securities Act in respect of the Securities;

 

(c) is not a U.S. Person (as defined in Regulation S under the U.S. Securities Act, which definition includes, but is not limited to, an individual resident in the United States, an estate or trust of which any executor or administrator or trustee, respectively, is a U.S. Person and any partnership or corporation organized or incorporated under the laws of the United States) and is not purchasing the Securities on behalf of, or for the account or benefit of, a person in the United States or a U.S. Person; and

 

(d) undertakes and agrees that it will not offer or sell the Securities in the United States unless such securities are registered under the U.S. Securities Act and the securities laws of all applicable states of the United States or an exemption from such registration requirements is available, and further that it will not resell the Securities, except in accordance with the provisions of applicable Securities Laws, regulations, rules, policies and orders and the rules of any Approved Exchange, as applicable.

 

5.2           International Subscribers. If the Subscriber is not resident in a Offering Province or U.S. Person, the Subscriber represents and warrants to the Corporation that:

 

  (a) the Subscriber is resident in the jurisdiction set forth in page 2 hereof;
     
(b) it has competed the Foreign Purchaser’s Certificate attached hereto as Schedule A; and

 

(c) the representations and warranties made by the Subscriber in the Foreign Purchaser’s Certificate are true and accurate as at the Closing Date, except to the extent that any such representation and warranty speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date.

 

6. Subscriber’s Representations, Warranties and Acknowledgements

 

6.1           The Subscriber represents and warrants and acknowledges and agrees with the Corporation that:

 

(a) the Subscriber’s investment in the Corporation is speculative as the Corporation is in the preliminary stages of executing of its business plan and does not have significant revenues or material assets and accordingly involves a high degree of risk and only investors who can afford to lose their entire investment should invest in the Offering;

 

 

 

- 11

 

 

(b) prior to the Business Combination, the Corporation is not listed on any stock exchange and there is no assurance that the Corporation will ever list its securities on a stock exchange or become a “reporting issuer” under Applicable Securities Laws, and accordingly the Subscriber may be required to hold the Securities indefinitely;

 

(c) the Subscriber agrees to enter into any lock-up required or considered reasonably necessary by the Corporation to enable the Corporation to list on the NYSE as a result of the Business Combination, in the terms agreed in clause 2.3 and Section 6.1(p) below;

 

(d) its decision to execute this Subscription Agreement and purchase the Common Shares agreed to be purchased hereunder has not been based upon any oral or written representation as to fact or otherwise made by or on behalf of the Corporation;

 

(e) other than the filings made in connection with the Business Combination, no prospectus has been filed yet or may be filed by the Corporation with any securities commission or similar authority, in connection with the issuance of the Securities and the Offering, and the issuance and the sale of the Securities is subject to such sale being exempt from the prospectus and registration requirements under Applicable Securities Laws and accordingly:

 

(i) the Subscriber is restricted from using certain of the civil remedies available under such legislation;

 

(ii) the Subscriber may not receive information that might otherwise be required to be provided to it under such legislation; and

 

(iii) the Corporation is relieved from certain obligations that would otherwise apply under such legislation;

 

(f) the Corporation has no obligation to file a prospectus qualifying the distribution of the Securities in any jurisdiction where the Offering is made and has no intention to do so;

 

(g) the Subscriber (or others for whom the Subscriber is contracting hereunder) has been advised to consult its own independent legal, tax and business advisors with respect to the merits and risks of an investment in the Securities and with respect to applicable resale restrictions and it (or others for whom it is contracting hereunder) is solely responsible (and the Corporation is in no way responsible) for compliance with applicable resale restrictions, and it acknowledges that the Corporation’s counsel is acting solely as counsel to the Corporation, and not as counsel to the Subscriber;

 

(h) the Subscriber acknowledges that the Securities, will be administered by a trust agent in Canada, may only be held in a registered position in the name of the Subscriber;

 

(i) to the knowledge of the Subscriber, the sale of the Common Shares to the Subscriber was not accompanied by any advertisement;

 

(j) the offer made by this Subscription Agreement is irrevocable;

 

 

 

- 12

 

 

(k) the Subscriber is sophisticated in financial investments, has had access to and has received all such information concerning the Corporation that the Subscriber has considered necessary in connection with the Subscriber’s investment decision and the Subscriber will not receive an offering memorandum or similar disclosure document;

 

(l) the Subscriber acknowledges that any resale of the Securities will be subject to resale restrictions contained in the Applicable Securities Laws applicable to the Corporation, the Subscriber or any proposed transferee. The Securities will bear the following legend:

 

“THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.”

 

In addition to this, Fifty percent (50%) of the Securities will bear the following legend unless modified in accordance with the terms of the Lock-up Agreement:

 

Unless permitted under securities legislation, the holder of this security must not trade the security before the date that is 60 days following the later of (i) [Closing Date], and (ii) the date the Securities are listed on an Approved Exchange.”

 

And fifty percent (50%) of the Securities will bear the following legend unless modified in accordance with the terms of the Lock-up Agreement:

 

“Unless permitted under securities legislation, the holder of this security must not trade the security before the date that is 180 days following the later of (i) [Closing Date], and (ii) the date the Securities are listed on an Approved Exchange.”

 

(m) the Subscriber has been independently advised as to the applicable hold periods imposed in respect of the Securities by Applicable Securities Laws and regulatory policies and confirms that no representations by the Corporation has been made respecting the hold periods applicable to the Securities and is aware of the risks and other characteristics of the Securities and of the fact that the Subscriber may not be able to resell the Securities purchased by the Subscriber except in accordance with Applicable Securities Laws and regulatory policies and that the Securities may be subject to resale restrictions and may bear a legend to this effect. In addition, the Subscriber acknowledges that the articles of the Corporation provide that transfers of the Securities prior to any public listing of the Common Shares will require prior approval of the Board;

 

(n) the Subscriber is aware that the Securities have not been registered under the U.S. Securities Act or the securities laws of any state of the United States and that the Securities may not be offered or sold in the United States without registration under the U.S. Securities Act or compliance with requirements of an exemption from registration and the applicable laws of all applicable states and acknowledges that the Corporation has no present intention of filing a registration statement under the U.S. Securities Act in respect of the Securities;

 

 

 

- 13

 

 

(o) the Subscriber is aware that, if or when the Common Shares convert to New Above Shares, these New Above Shares will bear restrictive legend as follows:

 

THESE SECURITIES HAVE BEEN OFFERED AND SOLD OUTSIDE OF THE UNITED STATES TO NON-U.S. PERSONS PURSUANT TO THE PROVISIONS OF REGULATION S OF THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THESE SECURITIES MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE SECURITIES ACT, PURSUANT TO REGISTRATION UNDER THE SECURITIES ACT, OR PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM REGISTRATION. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.

 

THESES SECURITIES ARE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS AGREEMENT EXECUTED BY THE COMPANY AND CERTAIN HOLDERS OF SECURITIES PARTY THERETO.

 

In addition to this, Fifty percent (50%) of the New Above Shares will bear the following legend:

 

“[•] shares are restricted from trading. The holder of these securities must not trade the securities before the date that is 60 days from the date the issuer became a reporting issuer in any province or territory.”

 

And fifty percent (50%) of the Securities will bear the following legend:

 

“[•] shares are restricted from trading. The holder of these securities must not trade the securities before the date that is 180 days from the date the issuer became a reporting issuer in any province or territory.”

 

(p) the Subscriber acknowledges having been advised:

 

(i) to consult with its own advisors concerning the Subscriber’s particular circumstances and the particular nature of the restrictions on resale and transfer, the extent of the applicable restricted period and the possibilities of utilizing any further exemptions from the prospectus and registration requirements of Applicable Securities Laws or the obtaining of a discretionary order to resell or transfer any Securities; and

 

(ii) against attempting to resell or transfer any Securities until the Subscriber has determined that any such resale or transfer is in compliance with the requirements of all Applicable Securities Laws, including but not limited to the filing with the appropriate regulatory authority of initial trade and other reports required upon any resale of the Securities;

 

 

 

- 14

 

 

(q) the Corporation will have complete discretion as to the use of the proceeds of the Offering and there is no assurance that these proceeds will be sufficient for the Corporation to execute on its business plan or to achieve revenues or profitability;

 

(r) no agency, governmental authority, regulatory body, stock exchange or other entity has made any finding or determination as to the merit for investment of, nor have any such agencies or governmental authorities made any recommendation or endorsement with respect to, the Securities;

 

(s) the Corporation will rely on the representations and warranties made herein, the disclosure made in publicly available filings with respect to the Business Combination or otherwise provided by the Subscriber to the Corporation in completing the sale and issue of the Securities to the Subscriber;

 

(t) the Subscriber understands the risks and has previously invested in privately held, early stage development companies, where there is no liquidity of the securities purchased;

 

(u) no person has made to the Subscriber any written or oral representations:

 

(i) that any person will resell or repurchase the Securities;
     
  (ii) that any person will refund the Subscription Price for the Securities;
     
  (iii) as to the future price or value of the Securities; or
     
  (iv) that the Securities will be listed and posted for trading on any stock exchange; and

 

(v) the Subscriber acknowledges that:

 

(i) no securities commission or similar regulatory authority has reviewed or passed on the merits of the Securities;
     
  (ii) there is no government or other insurance covering the Securities;
     
  (iii) there are risks associated with the purchase of the Securities;
     
  (iv) there are restrictions on the Subscriber’s ability to resell the Securities and it is the responsibility of the Subscriber to determine what those restrictions are and to comply with them before selling the Securities;
     
  (v) the Corporation has advised the Subscriber that the Corporation is relying on an exemption from the requirements to provide the Subscriber with a prospectus and to sell the Securities through a person registered to sell the Securities under Applicable Securities Laws and, as a consequence of acquiring the Securities pursuant to this exemption, certain protections, rights and remedies provided by Applicable Securities Laws, including statutory rights of rescission or damages, will not be available to the Subscriber; and

 

 

 

- 15

 

 

(w) the Subscriber is purchasing the Securities as principal for its own account, it is purchasing such Securities not for the benefit of any other person, and not with a view to the resale or distribution of the Securities;

 

(x) the Subscriber has duly and validly authorized, executed and delivered this Subscription Agreement and understands it is intended to constitute a valid and binding agreement of the Subscriber enforceable against the Subscriber;

 

(y) the funds representing the subscription funds to be provided by the Subscriber to the Corporation will not represent proceeds of crime for the purposes of the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada) and the Subscriber acknowledges that the Corporation may in the future be required by law to disclose the name of the Subscriber and other information relating to this Agreement and the subscription of the Subscriber, on a confidential basis, pursuant to such Act. To the best of its knowledge: (i) none of the subscription funds to be provided by the Subscriber: (A) have been or will be derived from or related to any activity that is deemed criminal under the law of Canada, the United States of America, or any jurisdiction; or (B) are being tendered on behalf of a person or entity who has not been identified to the Subscriber; and (ii) it will promptly notify the Corporation if the Subscriber discovers that any of such representations ceases to be true, and provide the Corporation with appropriate information in connection therewith; and

 

(z) all costs and expenses incurred by the Subscriber (including any fees and disbursements of any special counsel or other advisors retained by the Subscriber) relating to the purchase of the Securities will be borne by the Subscriber.

 

7. Reliance Upon Representations, Warranties, Covenants, Acknowledgements and Agreements

 

7.1           The Subscriber acknowledges that the representations, warranties, covenants, acknowledgements and agreements contained in this Agreement are made with the intent that they may be relied upon by the Corporation. The Subscriber covenants that the foregoing representations, warranties, covenants, acknowledgements and agreements will be true as at the date of issuance of the Securities.

 

8. Representations of the Corporation

 

8.1           The Corporation represents and warrants to the Subscriber (and acknowledges that the Subscriber is relying thereon) that, as of the date of this Subscription Agreement and at Closing hereunder:

 

(a) the Corporation is a valid and subsisting corporation duly incorporated and in good standing under the laws of the Province of Alberta, and is duly qualified to carry on business in the Province of Alberta and in each other jurisdiction, if any, wherein the carrying out of the activities contemplated makes such qualifications necessary;

 

(b) the Corporation has the full corporate right, power and authority to execute this Subscription Agreement, and, at Closing, to issue the Common Shares to the Subscriber pursuant to the terms of this Subscription Agreement;

 

(c) as of Closing, the Common Shares issued to the Subscriber will be duly allotted, validly issued, fully paid and non-assessable shares in the capital of the Corporation;

 

 

 

- 16

 

 

(d) as of Closing, this Subscription Agreement will have been duly authorized by all necessary corporate action on the part of the Corporation and, subject to acceptance by the Corporation, constitute a valid obligation of the Corporation legally binding upon it and enforceable in accordance with its terms; and

 

(e) the authorized capital of the Corporation consists of an unlimited number of Common Shares.

 

9. Registration Rights.

 

9.1           The Corporation shall provide Subscriber with customary registration rights with respect to the Securities, on the terms set forth in clause 3.5 of the SPA.

 

10. Escrow

 

10.1         On the Closing Date, Subscriber shall wire the Aggregate Purchase Price to the account designated in writing by the Escrow Agent as set forth in this Agreement. In accordance with the terms of the Escrow Agreement, the Aggregate Purchase Price shall only be released from escrow pursuant to joint written instructions by Subscriber and the Corporation to the Escrow Agent upon the occurrence of the Business Combination.

 

11. Conditions of Closing

 

11.1         The obligations of the Subscriber to complete the purchase of the Common Shares as contemplated hereby shall be conditional upon the fulfilment on or before the Closing Date of each of the conditions of the Closing except those conditions that are waived by the Corporation; provided, however, that Section 11.2(a) and Section 11.2(d) shall not be waived by the Corporation without Subscriber’s prior written consent. Notwithstanding anything else in this agreement, the condition set out in 11.2(a) cannot be waived by the Corporation and must occur contemporaneous with this subscription for the Subscriber to have any obligations under this Agreement.

 

11.2         The obligations of the Corporation to complete the sale and issuance of the Common Shares as contemplated hereby shall be conditional upon:

 

(a) Prior to the closing of this subscription, the closing of the share sale and purchase of the shares of Brotalia, S.L. in the terms provided for and including all the closing deliverables and actions set out under the SPA;

 

(b) the representations and warranties of the Subscriber contained in this Subscription Agreement being true and correct on and as of the Closing with the same effect as though such representations and warranties had been made as of the Closing Date;

 

(c) all of the covenants and obligations of the Subscriber to be performed or observed on or before the Closing pursuant to this Subscription Agreement having been duly performed or observed; and

 

(d) Subscriber’s execution and delivery of a Joinder to the Registration Rights Agreement by and between the Corporation, New Above and the Holders (as defined therein).

 

 

 

- 17

 

 

12. Consent to Disclosure of Information

 

12.1            The Subscriber acknowledges and consents to the release by the Corporation of information regarding the Subscriber’s subscription including the Subscriber’s name, address, telephone number, e-mail address and the Common Shares purchased, in compliance with securities regulatory policies to regulatory authorities under Applicable Securities Laws and the Subscriber waives to the extent lawful, its rights under any privacy legislation. The contact information of the public official in each applicable Canadian jurisdiction who can answer questions about this indirect collection of the Subscriber’s personal information is set out in Schedule B hereto.

 

12.2            In addition to the foregoing, the Subscriber agrees and acknowledges that the Corporation may use and disclose the Subscriber’s personal information, or that of each beneficial purchaser for whom the Subscriber are contracting hereunder, as follows:

 

(a) for internal use with respect to managing the relationships between and contractual obligations of the Corporation and the Subscriber or any beneficial purchaser for whom the Subscriber is contracting hereunder;

 

(b) for use and disclosure to the Corporation’s transfer agent and registrar;

 

(c) where required by law, (i) for use and disclosure for income tax related purposes and (ii) disclosure to Canada Revenue Agency and the United States Internal Revenue Service;

 

(d) where required by law, disclosure to securities regulatory authorities (including any stock exchange) and other regulatory bodies with jurisdiction with respect to reports of trade and similar regulatory filings;

 

(e) disclosure to a governmental or other authority (including any stock exchange) to which the disclosure is required by court order or subpoena compelling such disclosure and where there is no reasonable alternative to such disclosure;

 

(f) disclosure to professional advisers of the Corporation in connection with the performance of their professional services;

 

(g) disclosure to any person where such disclosure is necessary for legitimate business reasons and is made with the Subscriber’s prior written consent;

 

(h) disclosure to a court determining the rights of the parties under this Subscription Agreement; or

 

(i) for use and disclosure as otherwise required by law.

 

13. General

 

13.1         Time is of the essence hereof.

 

13.2         Neither this Subscription Agreement nor any provision hereof will be modified, changed, discharged or terminated except by an instrument in writing signed by the party against whom any waiver, change, discharge or termination is sought.

 

 

 

- 18

 

 

13.3         Words importing the masculine gender include the feminine or neuter, words in the singular include the plural, words importing a corporate entity include individuals, and vice versa.

 

13.4         The parties hereto will execute and deliver all such further documents and instruments and do all such acts and things as may either before or after the execution of this Subscription Agreement be reasonably required to carry out the full intent and meaning of this Subscription Agreement.

 

13.5         This Subscription Agreement will be subject to, governed by and construed in accordance with the laws of Alberta and the federal laws of Canada as applicable therein and the Subscriber hereby irrevocably attorns to the jurisdiction of the Courts situated therein.

 

13.6         This Subscription Agreement may not be assigned by any party hereto.

 

13.7         The Corporation will be entitled to rely on delivery of a facsimile or email copy of this Subscription Agreement, and acceptance by the Corporation of a facsimile or email copy of this Subscription Agreement will create a legal, valid and binding agreement between the Subscriber and the Corporation in accordance with its terms.

 

13.8        This Subscription Agreement may be signed by the parties in as many counterparts as may be deemed necessary, each of which so signed will be deemed to be an original, and all such counterparts together will constitute one and the same instrument.

 

13.9         This Subscription Agreement is deemed to be entered into on the date hereof.

 

13.10       This Subscription Agreement, including, without limitation, the representations, warranties, acknowledgements and covenants contained herein, will survive and continue in full force and effect and be binding upon the parties notwithstanding the completion of the purchase of the Securities by the Subscriber pursuant hereto, the completion of the issue of Securities of the Corporation and any subsequent disposition by the Subscriber of the Securities.

 

13.11       The invalidity or unenforceability of any particular provision of this Subscription will not affect or limit the validity or enforceability of the remaining provisions of this Subscription.

 

13.12       Except as expressly provided in this Subscription and in the agreements, instruments and other documents contemplated or provided for herein, this Subscription contains the entire agreement between the parties with respect to the sale of the Securities and there are no other terms, conditions, representations or warranties, whether expressed, implied, oral or written, by statute, by common law, by the Corporation, by the Subscriber, or by anyone else.

 

13.13       Unless otherwise indicated, all monetary amounts are in United States Dollars.

 

13.14       Les parties aux présents ont exigé que la présente convention ainsi que tous les documents et avis qui s’y rattachent ou qui en découleront soient rédigés dans la langue anglaise. The parties have required that this Agreement and all documents and notices resulting from it be drawn up in English.

 

-- End of Terms and Conditions --

 __________

 

 

 

- A1

 

 

SCHEDULE A

 

TO

THE SUBSCRIPTION AGREEMENT OF

ABOVE FOOD CORP.

 

FOREIGN PURCHASER’S CERTIFICATE

 

(Residents of Jurisdictions other than Canada and the United States)

 

To:      ABOVE FOOD CORP. (the “Corporation”)

 

Capitalized terms used herein but not otherwise defined shall have the meaning ascribed to them in the Subscription Agreement to which this Schedule is attached.

 

In connection with the purchase of Common Shares by the undersigned subscriber (the “Subscriber”) for the purposes of this Schedule A, the undersigned hereby represents, warrants and certifies to and covenants with the Corporation that:

 

1.            the Subscriber is a resident of a country (an “International Jurisdiction”) other than Canada and the United States and the decision to subscribe for the Common Shares was taken in such International Jurisdiction.

 

2.            The Subscriber is purchasing the Common Shares as principal for the Subscriber’s own account.

 

3.            The acceptance of the Subscriber’s subscription for the Common Shares by the Corporation complies with all laws applicable to the Subscriber and such beneficial purchaser, including the laws of such purchaser’s jurisdiction of residence, and all other applicable laws.

 

4.            The Subscriber, and each such beneficial purchaser, is knowledgeable of or has been independently advised as to, the application or jurisdiction of the securities laws of the International Jurisdiction which would apply to the subscription.

 

5.            The Subscriber is solely responsible for obtaining such tax, investment, legal and other professional advice as it considers appropriate in connection with the Subscriber’s subscription for the Common Shares, including the execution, delivery and performance by it of the documentation relating to such subscription and the transactions contemplated thereunder, and, without limiting the generality of the foregoing, legal counsel for the Corporation is acting solely as counsel to the Corporation for the Offering and not as counsel to the Subscriber.

 

6.            The Subscriber, and each such beneficial purchaser, is purchasing the Common Shares pursuant to exemptions from the prospectus and registration requirements (or their equivalent) under the applicable securities laws of that International Jurisdiction or, if such is not applicable, each is permitted to purchase the Common Shares subscribed for hereunder under the applicable securities laws of the International Jurisdiction without the need to rely on an exemption.

 

7.            The Subscriber will not sell, transfer or dispose of the Securities, except in accordance with all applicable laws, including applicable securities laws of Canada and the United States, and the Subscriber acknowledges that the Corporation shall have no obligation to register any such purported sale, transfer or disposition which violates applicable Canadian or United States securities laws.

 

DATED this 13th day of June, 2024.

 

  /s/ [ *** ]
  Authorized Signature of Subscriber

 

 

 

- A2

 

 

  Grupo Empresarial Enhol, S.L.
  Print Name of Subscriber
   
  [ *** ]
  If the Subscriber is not an individual, print name and title of Authorized Signatory whose signature appears above
   
  [ *** ]
  Address of Subscriber

 

-- End of Schedule A --

 

 

 

  

 

SCHEDULE B

 

TO

THE SUBSCRIPTION AGREEMENT OF

ABOVE FOOD CORP.

 

PUBLIC OFFICIALS CONTACT INFORMATION

 

Alberta Securities Commission

Suite 600, 250 – 5th Street SW

Calgary, Alberta T2P 0R4

Telephone: (403) 297-6454

Toll Free In Canada: 1-877-355-0585

Facsimile: (403) 297-2082

British Columbia Securities Commission

P.O. Box 10142, Pacific Centre

701 West Georgia Street

Vancouver, British Columbia V7Y 1L2

Inquiries: (604) 899-6854

Toll Free In Canada: 1-800-373-6393

Facsimile: (604) 899-6581

Email: inquiries@Bcsc.bc.ca

 

The Manitoba Securities Commission

500 – 400 St. Mary Avenue

Winnipeg, Manitoba R3C 4K5

Telephone: (204) 945-2548

Toll Free In Manitoba 1-800-655-5244

Facsimile: (204) 945-0330

Financial And Consumer Services Commission (New Brunswick)

85 Charlotte Street, Suite 300

Saint John, New Brunswick E2L 2J2

Telephone: (506) 658-3060

Toll Free In Canada: 1-866-933-2222

Facsimile: (506) 658-3059

Email: info@fcnb.ca

 

Government of Newfoundland and Labrador

Financial Services Regulation Division

P.O. Box 8700

Confederation Building

2nd Floor, West Block

Prince Philip Drive

St. John’s, Newfoundland And Labrador A1B 4J6

Attention: Director of Securities

Telephone: (709) 729-4189

Facsimile: (709) 729-6187

 

Government of the Northwest Territories

Office of the Superintendent Of Securities

P.O. Box 1320

Yellowknife, Northwest Territories X1A 2L9

Attention: Deputy Superintendent, Legal & Enforcement

Telephone: (867) 920-8984

Facsimile: (867) 873-0243

Nova Scotia Securities Commission

Suite 400, 5251 Duke Street

Duke Tower

P.O. Box 458

Halifax, Nova Scotia B3J 2P8

Telephone: (902) 424-7768

Facsimile: (902) 424-4625

Government of Nunavut

Department Of Justice

Legal Registries Division

P.O. Box 1000, Station 570

1st Floor, Brown Building

Iqaluit, Nunavut X0A 0H0

Telephone: (867) 975-6590

Facsimile: (867) 975-6594

 

Ontario Securities Commission

20 Queen Street West, 22nd Floor

Toronto, Ontario M5H 3S8

Telephone: (416) 593- 8314

Toll Free In Canada: 1-877-785-1555

Facsimile: (416) 593-8122

Email: exemptmarketfilings@osc.gov.on.ca

Public Official Contact Regarding Indirect

Collection of Information: Inquiries Officer

 

Prince Edward Island Securities Office

95 Rochford Street, 4th Floor Shaw Building

P.O. Box 2000

Charlottetown, Prince Edward Island C1A 7N8

Telephone: (902) 368-4569

Facsimile: (902) 368-5283

Autorite Des Marches Financiers

800, Square Victoria, 22e Etage

C.P. 246, Tour De La Bourse

Montréal, Québec H4Z 1G3

Telephone: (514) 395-0337 Or 1-877-525-0337

Facsimile: (514) 873-6155 (For Filing Purposes Only)

Facsimile: (514) 864-6381 (For Privacy Requests Only)

 

Financial and Consumer Affairs Authority of Saskatchewan

Suite 601 - 1919 Saskatchewan Drive

Regina, Saskatchewan S4P 4H2

Telephone: (306) 787-5879

Facsimile: (306) 787-5899

 

 


 

Email: Financementdessocietes@Lautorite.Qc.Ca (For Corporate Finance Issuers); fonds_dinvestissement@lautorite.qc.ca (For Investment Fund Issuers)

 

 

Government of Yukon

Department of Community Services

Law Centre, 3rd Floor

2130 Second Avenue

Whitehorse, Yukon Y1A 5H6

Telephone: (867) 667-5314

Facsimile: (867) 393-6251

 

 

-- End of Schedule B --

 

 


 

SCHEDULE C

 

Escrow Agreement

 

 


***CERTAIN MATERIAL (INDICATED BY THREE ASTERISKS IN BRACKETS) HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS BOTH (1) NOT MATERIAL AND (2) THE TPYE THAT THE REGISTRANTS TREATS AS PRIVATE OR CONFIDENTIAL. IN ADDITION, CERTAIN PERSONALLY IDENTIFIABLE INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT PURSUANT TO ITEM 601(A)(6) OF REGULATION S-K. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

ESCROW AGREEMENT

THIS ESCROW AGREEMENT (this “Agreement”) is made and entered into as of June 13, 2024, by and among ABOVE FOOD CORP. (“Above Food”), GRUPO EMPRESARIAL ENHOL, S.L. (“Enhol”) and GOWLING WLG (CANADA) LLP (the “Escrow Agent”).

WHEREAS:

A. Enhol and Above Food have entered into a subscription agreement dated effective June 13, 2024 (the “Subscription Agreement”) pursuant to which Enhol will purchase 2,377,082 common shares in the capital of Above Food (“Common Shares”);

B. it is a condition to the closing of the purchase of Common Shares contemplated by the Subscription Agreement that Enhol, Above Food and the Escrow Agent enter into this Agreement; and

C. pursuant to the terms and conditions of the Subscription Agreement, Above Food has delivered to the Escrow Agent a [certificate/DRS statement] representing 2,377,082 Common Shares registered in the name “Grupo Empresarial Enhol, S.L.” (the “Subscription Shares”) and Enhol has delivered to the Escrow agent US$5,000,000 in cash, to be held in accordance with the terms and conditions hereof.

NOW THEREFORE THIS AGREEMENT WITNESSES THAT, in consideration of the respective covenants and agreements of the parties herein contained and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), the parties agree as follows:

ARTICLE 1 INTERPRETATION

1.1 Definitions

For the purposes of this Agreement, unless the context otherwise requires, capitalized terms that are not otherwise defined in this Agreement shall have the meanings given to them in the Subscription Agreement and the following terms shall have the respective meanings set out below and grammatical variations of such terms shall have corresponding meanings:

“Business Day” means any day except a Saturday, Sunday or statutory holiday in the Province of Alberta.

 

- 2

“Escrow Funds” the sum of US$5,000,000 required to be paid to the Escrow Agent pursuant to the Subscription Agreement, together with any interest accrued thereon during the term of this Agreement.

“Joint Direction” means a written direction in the form substantively attached as Schedule A, signed by Enhol and Above Food directing the Escrow Agent to release the Escrow Funds.

“Losses” means all direct or indirect claims, demands, proceedings, fines, losses, diminution in value, damages, liabilities, deficiencies, costs and expenses (including, without limitation, all legal and other professional fees and disbursements, interest, penalties, judgments and amounts paid in settlement).

“Person” means any individual, corporation, body corporate, partnership, joint venture, association, trust, governmental body, or other legal entity.

“Subscription Agreement” has the meaning given to such term in the recitals to this Agreement.

“Subscription Shares” has the meaning given to such term in the recitals to this Agreement.

1.2 Rules of Construction

Except as may be otherwise specifically provided in this Agreement and unless the context otherwise requires, in this Agreement:

(a) the terms “Agreement,” “this Agreement,” “the Agreement,” “hereto,” “hereof,” “herein,” “hereby,” “hereunder” and similar expressions refer to this Agreement in its entirety and not to any particular provision hereof;

(b) references to an “Article,” “Section” or “Schedule” followed by a number or letter refer to the specified Article or Section of or Schedule to this Agreement;

(c) the division of this Agreement into articles and sections and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation of this Agreement;

(d) words importing the singular number only shall include the plural and vice versa and words importing the use of any gender shall include all genders;

(e) the word “including” is deemed to mean “including without limitation”;

(f) the terms “party” and “the parties” refer to a party or the parties to this Agreement; and

(g) any reference to this Agreement means this Agreement as amended, modified, replaced or supplemented from time to time.

 

- 3

1.3 Entire Agreement

This Agreement and the Subscription Agreement constitute the entire agreement between the parties with respect to the subject matter hereof and thereof and supersede all prior agreements, understandings, negotiations and discussions, whether written or oral. There are no conditions, covenants, agreements, representations, warranties or other provisions, express or implied, collateral, statutory or otherwise, relating to the subject matter hereof except as provided herein or therein.

1.4 Time of Essence

Time shall be of the essence of this Agreement.

1.5 Governing Law and Submission to Jurisdiction

(a)           This Agreement shall be construed, interpreted and enforced in accordance with, and the respective rights and obligations of the parties shall be governed by, the laws of the Province of Alberta and the federal laws of Canada applicable therein.

(b)           Each of the parties irrevocably and unconditionally (i) submits to the non-exclusive jurisdiction of the courts of the Province of Alberta over any action or proceeding arising out of or relating to this Agreement, (ii) waives any objection that it might otherwise be entitled to assert to the jurisdiction of such courts, and (iii) agrees not to assert that such courts are not a convenient forum for the determination of any such action or proceeding.

1.6 Severability

If any provision of this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or unenforceable in any respect, all other provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party hereto. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties hereto as closely as possible in an acceptable manner to the end that transactions contemplated hereby are fulfilled to the extent possible.

ARTICLE 2 DEPOSIT OF ESCROW ITEMS AND INVESTMENT OF ESCROW FUNDS

2.1 Receipt of Above Shares and Brotalia Shares

The Escrow Agent acknowledges receipt of a [certificate/DRS statement] representing Subscription Shares (collectively with the Escrow Funds, the “Escrow Items”) to be maintained at the offices of the Escrow Agent.

 

- 4

2.2 Deposit of Escrow Funds

The Escrow Agent acknowledges receipt of the Escrow Funds to the account as set out in Schedule B and shall forthwith deposit the Escrow Funds in an account maintained by the Escrow Agent with a Schedule I Canadian chartered bank at a branch located in the Province of Alberta.

2.3 Investment of Escrow Funds

The Escrow Funds may, at the Escrow Agent’s sole discretion, be invested in an interest-bearing guaranteed investment certificate held in a trust account with a Schedule I Canadian chartered bank at a branch located in the Province of Alberta. The Escrow Agent shall not be liable for any lost interest or penalties resulting from any withdrawal or transaction involving the Escrow Funds and such account and makes no representation as to the yield available on the Escrow Funds and will bear no liability for any failure to achieve any yield.

2.4 Termination

The Escrow Agent acknowledges and agrees that it is not the beneficial owner of the Escrow Items but holds them as agent for Above Food and Enhol on the terms and conditions set out in this Agreement. The Escrow Items shall be held by the Escrow Agent pursuant to the terms hereof and shall be subject to the terms and conditions hereinafter provided.

This Agreement and the obligations of all of the parties hereto shall terminate upon the earlier to occur of (a) the distribution by the Escrow Agent of all of the Escrow Items in accordance with the terms hereof and (b) the written agreement of Above Food and Enhol, except that Article 4 shall survive any such termination and continue with full force and effect.

ARTICLE 3 DISTRIBUTION OF ESCROW ITEMS

3.1 Release of Escrow Amount

(a) The Escrow Agent shall not pay or otherwise release the Escrow Items except upon receipt of any of the following:

(i) A Joint Direction, signed by Enhol and Above Food, directing the Escrow Agent to pay the Escrow Items in a specific manner; or

(ii) An order of a court of competent jurisdiction directing the Escrow Agent to deal with the Escrow Items in a specific manner,

subject to the Escrow Funds being reduced by any fees, indemnities or other amounts payable to the Escrow Agent, and provided that if no notice or court order as outlined above has been provided to the Escrow Agent by July 31, 2024, the Escrow Funds will be returned to Enhol to an account specified by Enhol in writing and the Subscription Shares will be returned to Above Food for cancellation, each within 3 business days from the date such Parties provide a written direction, including bank information in the case of the Escrow Funds.

 

- 5

ARTICLE 4 ESCROW ARRANGEMENTS

4.1 Duties and Obligations of Escrow Agent

The acceptance by the Escrow Agent of its duties and obligations under this Agreement is subject to the following terms and conditions, which Above Food and Enhol hereby agree shall govern and control with respect to the Escrow Agent’s rights, duties, liabilities and immunities:

(a) the Escrow Agent shall not have any duties or responsibilities as escrow agent hereunder except those set forth in this Agreement, and shall not be bound by the provisions of any agreement between Above Food and/or Enhol with respect to the subject matter hereof to which the Escrow Agent is not a party;

(b) the duties of the Escrow Agent hereunder are intended and shall be deemed to be purely procedural and administrative in nature;

(c) the Escrow Agent shall be entitled to rely exclusively upon and shall not be responsible to determine, nor shall it be required to investigate, the genuineness or validity of any document, direction, notice, request, waiver, consent, receipt, election or declaration deposited with or furnished to it, and the Escrow Agent is hereby authorized and directed to follow the instructions contained therein, and the Escrow Agent is and will at all times be fully indemnified pursuant to Section 4.2 for acting in accordance with such instructions given hereunder or thereunder and believed by the Escrow Agent to have been signed by the proper parties. For greater certainty, the Escrow Agent, including its officers, directors, partners, employees, agents, representatives, members, attorneys, successors or assigns, will have no liability for making a payment pursuant to a direction delivered to it in accordance with Article 3;

(d) notwithstanding any other provision of this Agreement, the Escrow Agent is hereby authorized and directed to comply with and obey any order, judgment, decree or award of any court of competent jurisdiction, and in the case of such compliance, the Escrow Agent will not be liable by reason of such compliance to any Person even if thereafter, such order, judgment, decree or award is appealed, reversed, modified, annulled, set aside or vacated;

(e) if the Escrow Agent receives a notice, claim, award, order, judgment, demand or instruction with respect to the Escrow Items that the Escrow Agent considers to be conflicting with one or more other such notices, claims, awards, orders, judgments, demands or instructions, or to be incomplete, ambiguous or otherwise insufficient for the purposes of the Escrow Agent, or if for any other reason the Escrow Agent determines in good faith that it is unable to identify clearly the Person or Persons entitled to receive the Escrow Items or the amount thereof to be paid, the Escrow Agent may refuse to make any payment and may retain the Escrow Items in its possession or control until it has received instructions in writing confirmed by Above Food and Enhol or until directed by an award, order or judgment of any court of competent jurisdiction, whereupon it will make or not make, as the case may be, such disposition in accordance with such instructions or such award, order or judgment;

 

- 6

(f) the Escrow Agent shall not be responsible for including any portion of the interest earned on the Escrow Funds in its income for tax purposes; and

(g) the Escrow Agent will not, by reason of this Agreement, be required to initiate, defend or otherwise prosecute any legal proceeding unless and until it is indemnified, to its satisfaction by Above Food or Enhol in accordance with the terms of Section 4.2, equally as to 50% by Above Food and 50% by Enhol, including, if the Escrow Agent considers necessary, by way of advance deposit with the Escrow Agent of amounts representing costs and expenses that the Escrow Agent estimates it may incur in connection with such litigation.

4.2 Indemnification of the Escrow Agent

Above Food and Enhol agree among each other that (a) Above Food shall be responsible for 50% of, and (b) Enhol shall be responsible for 50% of: the fees and expenses charged and incurred by the Escrow Agent arising out of or in connection with this Agreement, including all legal and other professional fees and disbursements charged by the Escrow Agent and all fees and expenses of any experts, advisors, agents or agencies employed by the Escrow Agent pursuant to this Section 4.2. Notwithstanding the foregoing, Above Food and Enhol shall be jointly and severally responsible to the Escrow Agent for the payment of all the fees and expenses charged and incurred by the Escrow Agent arising out of or in connection with this Agreement, including all legal and other professional fees and disbursements charged by the Escrow Agent and all fees and expenses of any experts, advisors, agents or agencies employed by the Escrow Agent pursuant to this Section 4.2. Above Food and Enhol among each other, each as to 50%, agree to indemnify, defend and hold the Escrow Agent harmless from and against any and all Losses suffered or incurred by it as a result of or arising directly or indirectly out of or in connection with its acting as escrow agent under this Agreement except where such Losses result from the Escrow Agent’s own wilful misconduct or gross negligence. Notwithstanding the foregoing, Above Food and Enhol shall be jointly and severally responsible to the Escrow Agent for indemnifying, defending and holding the Escrow Agent harmless from and against any and all Losses suffered or incurred by it as a result of or arising directly or indirectly out of or in connection with its acting as escrow agent under this Agreement except where such Losses result from the Escrow Agent’s own wilful misconduct or gross negligence. In acting hereunder, the Escrow Agent shall be fully protected in relying upon, and shall be entitled to rely upon, the procedures set out in this Agreement or an opinion of counsel or other advisor reasonably satisfactory to the Escrow Agent as to the fulfilment of its duties and obligations hereunder. The Escrow Agent may employ such experts, advisors, agents or agencies as it may reasonably require for the purpose of discharging its duties under this Agreement and shall not be responsible for any act or omission with respect to its or such parties’ administration of this Agreement except for its or their wilful misconduct or gross negligence.

 

- 7

4.3 Limitation of Liability

The Escrow Agent shall not, by reason of this Agreement, assume any responsibility or liability or Losses arising out of or from or relating to:

(a) any transactions between Above Food and/or Enhol or under the Subscription Agreement or any other agreement to which Above Food or Enhol are parties, or any ambiguity, dispute or misunderstanding in respect of the terms of the escrow set forth therein or herein;

(b) any action taken or omitted to be taken by it pursuant to this Agreement in good faith and in the exercise of its reasonable judgment and any act done or omitted by it pursuant to the advice of any legal counsel that it may employ shall be conclusive evidence of such good faith. The Escrow Agent may at any time consult with independent legal counsel of its own choice in any such matters, shall have full and complete authorization and protection from any action taken or omitted by it hereunder in accordance with the advice of such legal counsel and shall incur no liability for any delay reasonably required to obtain the advice of any such legal counsel;

(c) any loss of the Escrow Items held hereunder due to any causes not resulting from the wilful misconduct of the Escrow Agent (including by way of failure or default of any financial institution or authorized investment); or

(d) any of the services provided under this Agreement.

4.4 Resignation and Successorship

(a) (i)     At any time after the date hereof, the Escrow Agent may deliver to the Above Food and Enhol written notice of its intention to resign as escrow agent hereunder, in which case a successor escrow agent shall be promptly and mutually appointed by Above Food and Enhol and failing such appointment, the Escrow Agent may apply to the Court of King’s Bench of Alberta on such notice as such Court may direct for the appointment of a new escrow agent. The Escrow Agent’s resignation shall only become effective upon the successor escrow agent accepting its appointment hereunder, or the deposit of the Escrow Items with the Court of King’s Bench of Alberta; and

(ii) Above Food and Enhol, acting together, may replace the Escrow Agent at any time upon giving five days’ advance written notice of such replacement, jointly signed by them, to the Escrow Agent.

(b)                  Any new escrow agent to be appointed hereunder will execute an instrument accepting such appointment hereunder and shall deliver one counterpart thereof to each party and the existing Escrow Agent, and thereupon such newly appointed escrow agent, without further act or notice, will become vested in all rights, powers and obligations of its predecessor for execution of the mandate hereunder, with like effect as if originally named as the escrow agent herein and the predecessor escrow agent will forthwith deliver any and all Escrow Items in its possession pursuant to this Agreement to the new escrow agent for the purposes and uses of this Agreement, provided that any instructions in respect of the delivery of the Escrow Items to the successor escrow agent must be set out in a written direction signed by both Above Food and Enhol.

 

- 8

4.5 Release of Obligations of the Escrow Agent

(a)           Upon resignation or replacement of the Escrow Agent pursuant to Section 4.4, and upon delivery by the Escrow Agent of the Escrow Items to the new escrow agent, the Escrow Agent, without further act or notice, will be forever released and discharged from all of its duties and obligations hereunder.

(b)           Subject to Section 4.5(a), on and following the termination of the Escrow Agent’s obligations hereunder pursuant to Section 2.4, the Escrow Agent shall be forever released and discharged from all of its duties and obligations as escrow agent hereunder.

4.6 Rights of Escrow Agent to Interplead

Notwithstanding anything herein or in any other agreement or instrument expressed or implied to the contrary, if at any time a dispute shall exist as to any of the following or the Escrow Agent, in its sole discretion, shall conclude that there is a bona fide question, issue or dispute in respect of or as to any of the following, namely:

(a) the holding or delivery of or entitlement to any of the Escrow Items;

(b) the duties of the Escrow Agent in respect of any matter arising under this Agreement; or

(c) the validity, enforceability, extent of enforceability or meaning of any provision of this Agreement touching upon or pertaining to the function or duties of the Escrow Agent;

the Escrow Agent may in its sole discretion and notwithstanding any notices or demands received by it from any of the parties hereto or anyone else, deposit the Escrow Items or any portion thereof held hereunder with the Court of King’s Bench of Alberta and may interplead each of the other parties hereto and any other interested party or parties in the proceedings pursuant thereto. Upon so depositing the Escrow Items or portion thereof and following the filing of its pleadings relative to its complaint in interpleader, the Escrow Agent shall be released from all liability under the terms of this Agreement as to the Escrow Items or portion thereof so deposited and shall be entitled to recover from such parties, in such manner as may be determined by the Court, reasonable fees and related costs and expenses incurred in the performance of its duties hereunder and in connection with such action and the Escrow Agent shall be deemed to be released by each of the parties hereto from any and all liabilities, present and future, to such parties or any of them arising under this Agreement in respect of such property and the rights of any such parties.

 

- 9

ARTICLE 5 MISCELLANEOUS

5.1 Notices

(a)            Any notice or other communication required or permitted to be delivered or otherwise given hereunder shall be in writing and shall be delivered in person, transmitted by email or similar means of recorded electronic communication or sent by registered mail or courier, charges prepaid, addressed as set out below:

If to Above Food:

[ *** ] 

If to Enhol: [ *** ]

If to the Escrow Agent:

[ *** ]

(b)            Any such notice or other communication shall be deemed to have been given and received on the day on which it was delivered or transmitted (or, if such day is not a Business Day or if delivery or transmission is made on a Business Day after 5:00 p.m. at the place of receipt, then on the next following Business Day) or, if mailed, on the third Business Day following the date of mailing.

(c)            Any party may at any time change its address for service from time to time by giving notice to the other parties in accordance with this Section 5.1.

5.2 Amendments and Waivers

No amendment or waiver of any provision of this Agreement shall be binding on any party unless consented to in writing by such party. No waiver of any provision of this Agreement shall constitute a waiver of any other provision, nor shall any waiver of any provision of this Agreement constitute a continuing waiver unless otherwise expressly provided.

5.3 Successors and Assigns

This Agreement shall enure to the benefit of and shall be binding on and enforceable by and against the parties and, where the context so permits, their respective successors and permitted assigns. Neither Above Food, Enhol nor the Escrow Agent may assign any of its rights or obligations hereunder without the prior written consent of the other parties.

 

- 10

5.4 Survival

Notwithstanding the termination of this Agreement, the provisions of Article 4 shall survive such termination and continue in full force and effect for the benefit of each party hereto, as applicable.

5.5 Further Assurances

Each of the parties hereto shall, from time to time hereafter and upon any reasonable request of any other party, at the expense of the requesting party, promptly execute and deliver or cause to be executed and delivered all such documents, including all such consents and other assurances and do or cause to be done all such other acts and things as any other party, acting reasonably, may from time to time request be executed or done in order to better evidence or perfect or effectuate any provision of this Agreement or of any agreement or other document executed pursuant to this Agreement or any of the respective obligations intended to be created hereby or thereby.

5.6 Escrow Agent - Counsel to Enhol

Each of Above Food and Enhol hereby acknowledges that the Escrow Agent has acted and will continue to act as the lawyers for Above Food with respect to various matters pertaining to the Subscription Agreement, among other matters, and agrees that the Escrow Agent shall not, by virtue of acting as escrow agent hereunder, be disqualified from continuing to act for and representing any such party in any manner or in any matter whatsoever, including acting as legal counsel to Enhol in any action, dispute, controversy, arbitration, suit or negotiation arising under this Agreement, the Subscription Agreement or in any other matter or context whatsoever, whether or not directly or indirectly involving any of the parties hereto including in such matters where Enhol is an adverse party to Above Food.

5.7 Counterparts

This Agreement and all documents contemplated by or delivered under or in connection with this Agreement may be executed and delivered in any number of counterparts, with the same effect as if all parties had signed and delivered the same document, and all counterparts shall be construed together to be an original and will constitute one and the same agreement.

[Signature page follows]

 

- 11

IN WITNESS WHEREOF this Agreement has been executed by the parties as of the date first above written.

ABOVE FOOD CORP.
Per:
GRUPO EMPRESARIAL ENHOL, S.L.
Per:
WITNESS
Mr. Gonzalo Agorreta Preciado [®]
BROTALIA, S.L.
Per:
GOWLING WLG (CANADA) LLP
Per:

 

- 12

SCHEDULE “A”

 

JOINT DIRECTION

 

 

- 13

 

SCHEDULE “B”

 

ESCROW AGENT ACCOUNT INFORMATION

 

[ *** ]

 

 

EX-10.24 12 tm2418826d1_ex10-24.htm EXHIBIT 10.24

Exhibit 10.24

 

***CERTAIN MATERIAL (INDICATED BY THREE ASTERISKS IN BRACKETS) HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS BOTH (1) NOT MATERIAL AND (2) THE TPYE THAT THE REGISTRANTS TREATS AS PRIVATE OR CONFIDENTIAL. IN ADDITION, CERTAIN PERSONALLY IDENTIFIABLE INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT PURSUANT TO ITEM 601(A)(6) OF REGULATION S-K. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

 

NOTICE TO PROSPECTIVE SUBSCRIBER

ABOVE FOOD CORP. (THE “CORPORATION”) IS NOT A REPORTING ISSUER UNDER CANADIAN SECURITIES LEGISLATION NOR HAVE THE SECURITIES TO BE PURCHASED UNDER THIS SUBSCRIPTION AGREEMENT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR APPLICABLE STATE SECURITIES LAWS, AND ARE PROPOSED TO BE ISSUED IN RELIANCE UPON AN EXEMPTION OR AN EXCLUSION FROM THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT. PURCHASING SECURITIES UNDER THIS SUBSCRIPTION AGREEMENT MEANS THAT YOU ARE ACQUIRING SECURITIES OF A CORPORATION WHOSE SHARES ARE NOT FREELY TRADABLE. THE CORPORATION IS NOT A REPORTING ISSUER IN ANY JURISDICTION AND NO ASSURANCE CAN BE GIVEN THAT THE CORPORATION WILL BECOME A REPORTING ISSUER. IF THE CORPORATION DOES NOT BECOME A REPORTING ISSUER THE SECURITIES ACQUIRED UNDER THIS SUBSCRIPTION AGREEMENT WILL BE SUBJECT TO RESTRICTIONS ON RESALE FOR AN INDEFINITE PERIOD.

 

Above Food Corp. and Bite Acquisition Corp. (NYSE AMERICAN: BITE) (“Bite”), a special purpose acquisition company, entered into a definitive business combination agreement on April 29, 2023, as amended on March 12, 2024. Above Food Ingredients Inc, an Alberta corporation and a wholly owned subsidiary of Above Food Corp. (“New Above” or the “Corporation”), filed a Registration Statement on Form F-4 (“Registration Statement”), which became effective on April 8, 2024. Above Food Corp. is also in the process of filing a Canadian prospectus and seeking court approval of the business combination in the form of a plan of arrangement (“Plan of Arrangement”). Above Food Corp. has received the final court order and shareholders approval of the Plan of Arrangement. The Corporation is in the position to complete the Business Combination and endeavour to finalize a listing of the Common Shares of the Corporation on a recognized exchange in Canada or the US. Subject to completion of the Plan of Arrangement, the Subscriber is subscribing for Common Shares in the form of a Unit, and agrees that the Common Shares will reflect an approximate implied value of $10 USD per Unit.

  

 

 

ABOVE FOOD CORP.
(An Alberta Corporation)

 

COMMON SHARE SUBSCRIPTION AGREEMENT
Dated for Reference: JUNE 21, 2024

 

TO: ABOVE FOOD CORP. (the “Corporation”)

 

RE: Purchase of _______________ units of the Corporation at a Subscription Price of US$10 per unit (the “Offering”).

 

The undersigned (the “Investor”) hereby irrevocably subscribes for and agrees to purchase from the Corporation, on the terms and conditions set forth in this agreement (the “Subscription Agreement”), that number of Common Shares of the Corporation, with a corresponding amount of Advantage Shares, (collectively, the “Units” and each a “Unit”) as set out below at a price of US$10 per Unit, for the total subscription price set forth below (the “Subscription Price”).

 

Terms not defined herein shall have the meanings ascribed to such terms in Section 2 hereof. Unless otherwise indicated, all monetary references are in United States Dollars.

 

 

  - 2 -  

 

REGISTRATION AND DELIVERY INSTRUCTIONS

 

  Number of Units of the Corporation _______________  
     
  US10 per Unit for a total Subscription Price of US$ _______________  
     
     
  EXECUTION BY SUBSCRIBER:      
         
         
  Signature of individual (if Subscriber is an individual)   Address of Subscriber (residence)  
         
         
  Authorized signatory (if Subscriber is not an individual)   Address of Subscriber  
         
         
  Name of Subscriber (please print)   Telephone number of Subscriber  
         
         
  Name of authorized signatory (please print)   E-mail address of Subscriber  

 

  Register the Common Shares as follows:   Deliver the Common Shares as follows:  
         
         
  (Name)   (Name)  
         
         
  (Account reference, if applicable)   (Account reference, if applicable)  
         
         
  (Address)   (Contact Name)  
         
         
  (Address)   (Address)  
         
         
      (Address)  

  

 

  - 3 -  

 

Insider Status

 

The Subscriber is either [check appropriate box]:

 

    an “insider” of the Corporation as defined in the Securities Act (Ontario) (see below); or
    not an “insider” of the Corporation as defined in the Securities Act (Ontario).

 

Note:
The definition of “insider” includes a person that:

 

(i) is a director or officer of the Corporation;

 

(ii) is a director or officer of a person or company that is itself an insider or subsidiary of the Corporation;

 

(iii) is a person or a company that has:

 

a. beneficial ownership of, or control or direction over, directly or indirectly; or

 

b. a combination of beneficial ownership of, and control or direction over, directly or indirectly,

 

securities of an issuer carrying more than 10% of the voting rights attached to all the Corporation’s outstanding voting securities;

 

(iv) the Corporation itself, if it holds securities of its own issue; or

 

(v) a person designated as an insider under the Securities Act (Ontario).

 

Registrant Status

 

The Subscriber is either [check appropriate box]:

 

    registered or required to be registered pursuant to National Instrument 31-103 - Registration Requirements, Exemptions and Ongoing Registrant Obligations; or
    not registered or required to be registered pursuant to National Instrument 31-103 - Registration Requirements, Exemptions and Ongoing Registrant Obligations.

 

Present Holdings

 

The Subscriber currently holds the following other securities in the capital of the Corporation [please write “None” if no other securities of the Corporation held]:

 

 
 
 
 

 

NOTE: The information collected herein will be used by the Corporation in determining whether the Subscriber meets the requirements of the applicable prospectus exemptions, for making certain filings with applicable regulatory authorities and for meeting the Corporation’s obligations under securities legislation with respect to the mailing of continuous disclosure materials to the Subscriber, if applicable.

 

 

  - 4 -  

 

Acceptance

 

Accepted and agreed to by the Corporation as of the _____ day of ________________, 2024.

 

ABOVE FOOD CORP.  
   
Per:    
  Authorized Signatory  

 

THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”) OR APPLICABLE STATE SECURITIES LAWS, AND ARE PROPOSED TO BE ISSUED IN RELIANCE UPON AN EXEMPTION OR AN EXCLUSION FROM THE REGISTRATION REQUIREMENTS OF THE U.S. SECURITIES ACT. SUCH SECURITIES MAY NOT BE RE-OFFERED FOR SALE, RESOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE U.S. SECURITIES ACT AND IN ACCORDANCE WITH ANY APPLICABLE STATE SECURITIES LAWS, OR PURSUANT TO AN EXEMPTION OR EXCLUSION FROM REGISTRATION UNDER THE U.S. SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

 

THE SECURITIES OFFERED HEREBY ARE SPECULATIVE, INVOLVE A HIGH DEGREE OF RISK AND SHOULD ONLY BE PURCHASED BY PERSONS WHO CAN AFFORD THE LOSS OF THEIR ENTIRE INVESTMENT. PROSPECTIVE INVESTORS SHOULD CAREFULLY READ AND EVALUATE THE INFORMATION SET FORTH IN THIS SUBSCRIPTION AGREEMENT BEFORE PURCHASING ANY OF SUCH SECURITIES.

 

 

  - 5 -  

 

INSTRUCTIONS FOR COMPLETING THIS SUBSCRIPTION AGREEMENT

 

1. Subscriber:

 

The Subscriber must complete the information required on pages 3 and 4 with respect to Unit subscription amounts, the Subscription Price and the registration and delivery particulars and sign where indicated.

 

2. International Subscribers:

 

For Subscribers who are resident outside of Canada and the United States, complete and sign the Foreign Purchaser’s Certificate attached hereto as Schedule A.

 

3. Payment of the Subscription Price:

 

Payment of the Subscription Price must be made by a wire transfer to the Corporation’s lawyers in accordance with the following instructions, on or before June 21, 2024:

 

[***]

 

Reference: SH.Above

 

4. Subscription Agreement

 

A completed and fully executed copy of this Subscription Agreement, including the items required to be completed as set out above, together with the Subscription Price must be received by no later than 12:00 p.m. (Regina time) on June 21, 2024 at the offices of the Corporation.

 

TERMS AND CONDITIONS

 

to the Subscription Agreement for purchase of the Securities of Above Food Corp.

 

1. Definitions

 

1.1     

(a)

“Accredited Investor” has the meaning ascribed to such term in NI 45-106, and in Ontario, in Section 73.3 of the Securities Act (Ontario) as supplemented by the definition in NI 45-106;

     
  (b) “Advantage Shares” means additional common shares provided from sponsors or from treasury;

 

(c) “Aggregate Purchase Price” means USD _______________.

 

(d) “Applicable Securities Laws” means the securities legislation of the Offering Jurisdictions having application, and the rules, policies, notices and orders issued by securities regulatory authorities in the Offering Jurisdictions having application to this Offering and the Corporation;

 

(e) “Board” or “Board of Directors” means the Board of Directors of the Corporation;

 

 

  - 6 -  

 

(f) “Business Combination Agreement” means the business combination agreement dated as of April 29, 2023, as amended on March 12, 2024, by and between the Corporation and Bite Acquisition Corp.

 

(g) “Closing” means the purchase by the Subscribers of the Units pursuant to this Subscription Agreement, subject to the terms and conditions set forth herein;

 

(h) “Closing Date” means the date on which Closing will occur, which shall be at the time of closing of the closing of the Business Combination Agreement;

 

(i) “Common Share” means a common share without par value in the capital of the Corporation;

 

(j) “Liquidity Event” means the listing of the Common Shares or the exchange of the Common Shares for securities that are listed on the Toronto Stock Exchange, the TSX Venture Exchange, the Canadian Securities Exchange, the New York Stock Exchange, the NASDAQ or any other exchange including any foreign exchange (an “Approved Exchange”);

 

(k) “NI 45-102” means National Instrument 45-102 – Resale of Securities, in the form adopted by the securities commissions in all provinces and territories of Canada (a copy is available from the Corporation or online at www.bcsc.bc.ca);

 

(l) “NI 45-106” means National Instrument 45-106 – Prospectus Exemptions, in the form adopted by the securities commissions in all provinces and territories of Canada (a copy is available from the Corporation or online at www.bcsc.bc.ca);

 

(m) “Offering” means the sale by the Corporation of the Units on the terms set forth in this Subscription Agreement;

 

(n) “Offering Jurisdictions” means each of the Offering Provinces, the United States as well as other jurisdictions from which the Corporation may accept a subscription;

 

(o) “Offering Provinces” means each of the Provinces of British Columbia, Ontario, Alberta, Nova Scotia, New Brunswick, Newfoundland and Labrador, and such other provinces and territories of Canada from which the Corporation may accept a subscription;

 

(p) “Proceeds” means the gross proceeds of the Offering;

 

(q) “Regulation D” means Regulation D under the U.S. Securities Act;

 

(r) “Regulation S” means Regulation S under the U.S. Securities Act;

 

(s) “Securities” means the Units;

 

(t) "SPA” means that certain share sale and purchase agreement for the sale of shares of Veg House Holding Inc. to Above Food Corp.

 

 

  - 7 -  

 

(u) “Subscriber” means the person or persons named as Subscriber on the execution page of this Subscription Agreement and if more than one person is so named, means all of them jointly and severally;

 

(v) “Subscription Agreement” means this subscription agreement and all schedules and forms attached hereto, and all instruments supplementing, amending or confirming this subscription agreement;

 

(w) “Subscription Price” means the aggregate subscription price for the Units paid by the Subscriber as set forth on the execution page of this Agreement;

 

(x) “United States” means the United States of America, its territories, and State of the United States and the District of Columbia;

 

(y) “Units” means a combination of one Common Share and one Advantage Share;

 

(z) “U.S. Accredited Investor” means an “accredited investor” as that term is defined in Rule 501(a) of Regulation D;

 

(aa) “U.S. Person” means a U.S. Person as defined in Regulation S (the definition of which includes, but is not limited to: (i) any U.S. citizen (and certain former U.S. citizens) or a “resident alien” within the meaning of U.S. income tax laws as in effect from time to time. Currently, the term “resident alien” is defined under U.S. income tax laws generally to include any individual who (a) holds an Alien Registration Card (a “green card”) issued by U.S. Citizenship and Immigration Services (or an applicable predecessor entity), (b) meets a “substantial presence” test, or (c) is qualified to and does affirmatively elect on his or her tax return to be treated as a U.S. resident pursuant to Section 7701(b)(1)(A)(iii) of the Internal Revenue Code. The “substantial presence” test is generally met with respect to any calendar year if (a) the individual was present in the United States on at least 31 days during such year and (b) the sum of the number of days on which such individual was present in the United States during such year, 1/3 of the number of such days during the first preceding year, and 1/6 of the number of such days during the second preceding year, equals or exceeds 183 days; (ii) any partnership or corporation organized or incorporated under the laws of the United States; (iii) any partnership or corporation organized outside of the United States by a U.S. Person principally for the purpose of investing in securities not registered under the U.S. Securities Act, unless it is organized, or incorporated, and owned, by accredited investors who are not natural persons, estates or trusts; and (iv) any estate or trust of which any executor or administrator or trustee is a U.S. Person);

 

(bb) “U.S. Purchaser” is: (i) any “U.S. Person” as defined in Regulation S; (ii) any person purchasing the Securities on behalf of any “U.S. Person” or any person in the United States; (iii) any person who receives or received an offer of the Securities while in the United States; or (iv) any person who is or was in the United States at the time the Subscriber’s buy order was made or this Subscription Agreement was executed or delivered (provided that any discretionary or similar account excluded from the definition of U.S. Person pursuant to Rule 902(k)(2)(i) of Regulation S under the U.S. Securities Act shall not be considered a U.S. Purchaser);

 

 

  - 8 -  

 

(cc) “U.S. Securities Act” means the Securities Act of 1933, as amended, of the United States of America;

 

1.2            Words and phrases which are used in this Subscription Agreement and all Schedules thereto and which are defined in NI 45-106 will have the meaning ascribed thereto in NI 45-106, unless otherwise specifically defined in Section 2.1 of this Subscription Agreement.

 

2. Business Combination

 

2.1            The Corporation, an innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products, and Bite Acquisition Corp. (NYSE AMERICAN: BITE) (“Bite”), a special purpose acquisition company, entered into a definitive business combination agreement on April 29, 2023, as amended on March 12, 2024. Above Food Ingredients Inc., an Alberta corporation and a wholly owned subsidiary of Above Food Corp. (“New Above” or the “Corporation”), filed a Registration Statement on Form F-4 (“Registration Statement”), which became effective on April 8, 2024. Above Food Corp. is in the process of filing a Canadian prospectus and seeking court approval of the business combination in the form of a plan of arrangement (“Plan of Arrangement”). Above Food Corp. has received the interim court order and unanimous shareholders’ approval of the Plan of Arrangement. Upon obtaining final court approval of the Plan of Arrangement, Above Food Corp. will be in the position to complete the Business Combination and endeavour to complete a listing of the Common Shares of the Corporation on a recognized exchange in Canada or the US.

 

2.2            Subject to a Liquidity Event, the Subscriber is subscribing for the Units which reflects an implied value of $10USD per New Above Share.

 

2.3            25% of the Common Shares will be locked up for 90 days following the Liquidity Event and the remaining 75% of the Common Shares together with 100% of the Advantage Shares will be without lock up restrictions.

 

2.4            Notwithstanding anything else herein, the Units are being issued, on the acknowledgment and agreement that the Common Shares converted to New Above Shares shall be restricted from trading until completion of filing the registration statement following the Liquidity Event, and that 100% of the Advantage Shares being converted to New Above Shares. All Units shall also be subject to other trading restrictions such as applicable law and applicable stock exchange rules, including the limit to sell no more than 10% of the daily trading value of Above.

 

3. The Subscription and the Offering.

 

3.1            The Subscriber hereby irrevocably subscribes for and agrees to purchase from the Corporation subject to the terms and conditions set forth herein, the number of Units for the aggregate Subscription Price set out on the execution page of this Subscription Agreement. This Subscription Agreement will be deemed to have been made and be effective only upon its acceptance by the Corporation and the disbursement of the Subscription Amount by the Subscriber and delivery of the Units by the Corporation shall only be enforceable upon satisfaction of the Conditions Precedent set forth herein.

 

3.2            The Subscriber agrees to deliver to the Corporation not later than 12:00 pm (Regina time) on the Closing Date for and on behalf of the Corporation:

 

(a)            a completed and duly signed copy of this Subscription Agreement;

 

 

  - 9 -  

 

(b)            a completed and duly signed copy of the Foreign Purchaser’s Certificate in the form attached as Schedule A hereto;

 

(c)            any other documents required by Applicable Securities Laws which the Corporation reasonably request; and

 

(d)            an electronic wire to the account designated by the Corporation in Section 3 of the Instructions for Completing this Subscription Agreement contained herein representing the Aggregate Purchase Price payable by the Subscriber for the Units, or payment of the same amount in such other manner as the Corporation may accept.

 

3.3            The Subscriber acknowledges and agrees that such undertakings, questionnaires and other documents, when executed and delivered by the Subscriber, will form part of and will be incorporated into this Subscription Agreement with the same effect as if each constituted a representation and warranty or covenant of the Subscriber hereunder in favour of the Corporation. The Subscriber consents to the filing of such undertakings, questionnaires and other documents as may be required to be filed with an Approved Exchange or other securities regulatory authority in connection with the transactions contemplated hereby.

 

4. Closing

 

4.1            The transactions contemplated hereby will be completed at the Closing remotely via the electronic exchange of documents or at the offices of Above Food Corp. The Subscriber acknowledges that the Units will be available for delivery to it immediately post Closing on the Closing Date, against payment of the amount of the aggregate Subscription Price for the Units.

 

5. Subscriber’s Exemption Status

 

5.1            U.S. Securities Law Matters – Non-U.S. Purchasers. The Subscriber:

 

(a) acknowledges the Securities have not been offered to the Subscriber in the United States, and the individuals making the order to purchase the Securities and executing and delivering this Subscription Agreement on behalf of the Subscriber were not in the United States when the order was placed and this Subscription Agreement was executed and delivered;

 

(b) is aware that the Securities have not been and, prior to the Closing of the Business Combination Agreement, will not be registered under the U.S. Securities Act or the securities laws of any state and that these securities may not be offered or sold in the United States without registration under the U.S. Securities Act or compliance with requirements of an exemption from registration and the applicable laws of all applicable states and acknowledges that the Corporation has no obligation to or present intention of filing a registration statement under the U.S. Securities Act in respect of the Securities;

 

(c) is not a U.S. Person (as defined in Regulation S under the U.S. Securities Act, which definition includes, but is not limited to, an individual resident in the United States, an estate or trust of which any executor or administrator or trustee, respectively, is a U.S. Person and any partnership or corporation organized or incorporated under the laws of the United States) and is not purchasing the Securities on behalf of, or for the account or benefit of, a person in the United States or a U.S. Person; and

 

 

  - 10 -  

 

(d) undertakes and agrees that it will not offer or sell the Securities in the United States unless such securities are registered under the U.S. Securities Act and the securities laws of all applicable states of the United States or an exemption from such registration requirements is available, and further that it will not resell the Securities, except in accordance with the provisions of applicable Securities Laws, regulations, rules, policies and orders and the rules of any Approved Exchange, as applicable.

 

5.2            International Subscribers. If the Subscriber is not resident in an Offering Province or U.S. Person, the Subscriber represents and warrants to the Corporation that:

 

(a) the Subscriber is resident in the jurisdiction set forth in page 2 hereof;

 

(b) it has competed the Foreign Purchaser’s Certificate attached hereto as Schedule A; and

 

(c) the representations and warranties made by the Subscriber in the Foreign Purchaser’s Certificate are true and accurate as at the Closing Date, except to the extent that any such representation and warranty speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date.

 

6. Subscriber’s Representations, Warranties and Acknowledgements

 

6.1            The Subscriber represents and warrants and acknowledges and agrees with the Corporation that:

 

(a) the Subscriber’s investment in the Corporation is speculative as the Corporation is in the preliminary stages of executing of its business plan and does not have significant revenues or material assets and accordingly involves a high degree of risk and only investors who can afford to lose their entire investment should invest in the Offering;

 

(b) prior to the Business Combination, the Corporation is not listed on any stock exchange and there is no assurance that the Corporation will ever list its securities on a stock exchange or become a “reporting issuer” under Applicable Securities Laws, and accordingly the Subscriber may be required to hold the Securities indefinitely;

 

(c) the Subscriber agrees to enter into any lock-up required or considered reasonably necessary by the Corporation to enable the Corporation to list on the NYSE as a result of the Business Combination, in the terms agreed in clause 2.3 and Section 6.1(p) below;

 

(d) its decision to execute this Subscription Agreement and purchase the Units agreed to be purchased hereunder has not been based upon any oral or written representation as to fact or otherwise made by or on behalf of the Corporation;

 

(e) other than the filings made in connection with the Business Combination, no prospectus has been filed yet or may be filed by the Corporation with any securities commission or similar authority, in connection with the issuance of the Securities and the Offering, and the issuance and the sale of the Securities is subject to such sale being exempt from the prospectus and registration requirements under Applicable Securities Laws and accordingly:

 

(i) the Subscriber is restricted from using certain of the civil remedies available under such legislation;

 

 

  - 11 -  

 

(ii) the Subscriber may not receive information that might otherwise be required to be provided to it under such legislation; and

 

(iii) the Corporation is relieved from certain obligations that would otherwise apply under such legislation;

 

(f) the Corporation has no obligation to file a prospectus qualifying the distribution of the Securities in any jurisdiction where the Offering is made and has no intention to do so;

 

(g) the Subscriber (or others for whom the Subscriber is contracting hereunder) has been advised to consult its own independent legal, tax and business advisors with respect to the merits and risks of an investment in the Securities and with respect to applicable resale restrictions and it (or others for whom it is contracting hereunder) is solely responsible (and the Corporation is in no way responsible) for compliance with applicable resale restrictions, and it acknowledges that the Corporation’s counsel is acting solely as counsel to the Corporation, and not as counsel to the Subscriber;

 

(h) the Subscriber acknowledges that the Securities, will be administered by a trust agent in Canada, may only be held in a registered position in the name of the Subscriber;

 

(i) to the knowledge of the Subscriber, the sale of the Units to the Subscriber was not accompanied by any advertisement;

 

(j) the offer made by this Subscription Agreement is irrevocable;

 

(k) the Subscriber is sophisticated in financial investments, has had access to and has received all such information concerning the Corporation that the Subscriber has considered necessary in connection with the Subscriber’s investment decision and the Subscriber will not receive an offering memorandum or similar disclosure document;

 

(l) the Subscriber acknowledges that any resale of the Securities will be subject to resale restrictions contained in the Applicable Securities Laws applicable to the Corporation, the Subscriber or any proposed transferee. The Securities will bear the following legend:

 

“THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.”

 

(m) the Subscriber has been independently advised as to the applicable hold periods imposed in respect of the Securities by Applicable Securities Laws and regulatory policies and confirms that no representations by the Corporation has been made respecting the hold periods applicable to the Securities and is aware of the risks and other characteristics of the Securities and of the fact that the Subscriber may not be able to resell the Securities purchased by the Subscriber except in accordance with Applicable Securities Laws and regulatory policies and that the Securities may be subject to resale restrictions and may bear a legend to this effect. In addition, the Subscriber acknowledges that the articles of the Corporation provide that transfers of the Securities prior to any public listing of the Units will require prior approval of the Board;

 

 

  - 12 -  

 

(n) the Subscriber is aware that the Securities have not been registered under the U.S. Securities Act or the securities laws of any state of the United States and that the Securities may not be offered or sold in the United States without registration under the U.S. Securities Act or compliance with requirements of an exemption from registration and the applicable laws of all applicable states and acknowledges that the Corporation has no present intention of filing a registration statement under the U.S. Securities Act in respect of the Securities;

 

(o) the Subscriber is aware that , if or when the Units convert to New Above Shares, the New Above Shares will bear restrictive legend as follows:

 

THESE SECURITIES HAVE BEEN OFFERED AND SOLD OUTSIDE OF THE UNITED STATES TO NON-U.S. PERSONS PURSUANT TO THE PROVISIONS OF REGULATION S OF THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THESE SECURITIES MAY NOT BE OFFERED, SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE SECURITIES ACT, PURSUANT TO REGISTRATION UNDER THE SECURITIES ACT, OR PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM REGISTRATION. IN ADDITION, HEDGING TRANSACTIONS INVOLVING THESE SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.

 

THESES SECURITIES ARE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS AGREEMENT EXECUTED BY THE COMPANY AND CERTAIN HOLDERS OF SECURITIES PARTY THERETO.

 

(p) the Subscriber acknowledges having been advised:

 

(i) to consult with its own advisors concerning the Subscriber’s particular circumstances and the particular nature of the restrictions on resale and transfer, the extent of the applicable restricted period and the possibilities of utilizing any further exemptions from the prospectus and registration requirements of Applicable Securities Laws or the obtaining of a discretionary order to resell or transfer any Securities; and

 

(ii) against attempting to resell or transfer any Securities until the Subscriber has determined that any such resale or transfer is in compliance with the requirements of all Applicable Securities Laws, including but not limited to the filing with the appropriate regulatory authority of initial trade and other reports required upon any resale of the Securities;

 

(q) the Corporation will have complete discretion as to the use of the proceeds of the Offering and there is no assurance that these proceeds will be sufficient for the Corporation to execute on its business plan or to achieve revenues or profitability;

 

(r) no agency, governmental authority, regulatory body, stock exchange or other entity has made any finding or determination as to the merit for investment of, nor have any such agencies or governmental authorities made any recommendation or endorsement with respect to, the Securities;

 

 

  - 13 -  

 

(s) the Corporation will rely on the representations and warranties made herein, the disclosure made in publicly available filings with respect to the Business Combination or otherwise provided by the Subscriber to the Corporation in completing the sale and issue of the Securities to the Subscriber;

 

(t) the Subscriber understands the risks and has previously invested in privately held, early stage development companies, where there is no liquidity of the securities purchased;

 

(u) no person has made to the Subscriber any written or oral representations:

 

(i) that any person will resell or repurchase the Securities;

 

(ii) that any person will refund the Subscription Price for the Securities;

 

(iii) as to the future price or value of the Securities; or

 

(iv) that the Securities will be listed and posted for trading on any stock exchange; and

 

 

(v) the Subscriber acknowledges that:

 

(i) no securities commission or similar regulatory authority has reviewed or passed on the merits of the Securities;

 

(ii) there is no government or other insurance covering the Securities;

 

(iii) there are risks associated with the purchase of the Securities;

 

(iv)          there are restrictions on the Subscriber’s ability to resell the Securities and it is the responsibility of the Subscriber to determine what those restrictions are and to comply with them before selling the Securities;

 

(v)           the Corporation has advised the Subscriber that the Corporation is relying on an exemption from the requirements to provide the Subscriber with a prospectus and to sell the Securities through a person registered to sell the Securities under Applicable Securities Laws and, as a consequence of acquiring the Securities pursuant to this exemption, certain protections, rights and remedies provided by Applicable Securities Laws, including statutory rights of rescission or damages, will not be available to the Subscriber; and

 

(w) the Subscriber is purchasing the Securities as principal for its own account, it is purchasing such Securities not for the benefit of any other person, and not with a view to the resale or distribution of the Securities;

 

(x) the Subscriber has duly and validly authorized, executed and delivered this Subscription Agreement and understands it is intended to constitute a valid and binding agreement of the Subscriber enforceable against the Subscriber;

 

 

  - 14 -  

 

(y) the funds representing the subscription funds to be provided by the Subscriber to the Corporation will not represent proceeds of crime for the purposes of the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada) and the Subscriber acknowledges that the Corporation may in the future be required by law to disclose the name of the Subscriber and other information relating to this Agreement and the subscription of the Subscriber, on a confidential basis, pursuant to such Act. To the best of its knowledge: (i) none of the subscription funds to be provided by the Subscriber: (A) have been or will be derived from or related to any activity that is deemed criminal under the law of Canada, the United States of America, or any jurisdiction; or (B) are being tendered on behalf of a person or entity who has not been identified to the Subscriber; and (ii) it will promptly notify the Corporation if the Subscriber discovers that any of such representations ceases to be true, and provide the Corporation with appropriate information in connection therewith; and

 

(z) all costs and expenses incurred by the Subscriber (including any fees and disbursements of any special counsel or other advisors retained by the Subscriber) relating to the purchase of the Securities will be borne by the Subscriber.

 

7. Reliance Upon Representations, Warranties, Covenants, Acknowledgements and Agreements

 

7.1            The Subscriber acknowledges that the representations, warranties, covenants, acknowledgements and agreements contained in this Agreement are made with the intent that they may be relied upon by the Corporation. The Subscriber covenants that the foregoing representations, warranties, covenants, acknowledgements and agreements will be true as at the date of issuance of the Securities.

 

8. Representations of the Corporation

 

8.1            The Corporation represents and warrants to the Subscriber (and acknowledges that the Subscriber is relying thereon) that, as of the date of this Subscription Agreement and at Closing hereunder:

 

(a) the Corporation is a valid and subsisting corporation duly incorporated and in good standing under the laws of the Province of Alberta, and is duly qualified to carry on business in the Province of Alberta and in each other jurisdiction, if any, wherein the carrying out of the activities contemplated makes such qualifications necessary;

 

(b) the Corporation has the full corporate right, power and authority to execute this Subscription Agreement, and, at Closing, to issue the Units to the Subscriber pursuant to the terms of this Subscription Agreement;

 

(c) as of Closing, the Units issued to the Subscriber will be duly allotted, validly issued, fully paid and non-assessable shares in the capital of the Corporation;

 

(d) as of Closing, this Subscription Agreement will have been duly authorized by all necessary corporate action on the part of the Corporation and, subject to acceptance by the Corporation, constitute a valid obligation of the Corporation legally binding upon it and enforceable in accordance with its terms; and

 

(e) as of Closing, the authorized capital of the Corporation consists of an unlimited number of Common Shares.

 

 

  - 15 -  

 

9. Registration Rights.

 

9.1            The Corporation shall provide Subscriber with customary registration rights with respect to the Securities, which registration rights are set forth in the plan of arrangement and registration rights agreement.

 

10. Conditions of Closing

 

10.1            The obligations of the Subscriber to complete the purchase of the Units as contemplated hereby shall be conditional upon the fulfilment on or before the Closing Date of each of the conditions of the Closing except those conditions that are waived by the Corporation.

 

10.2            The obligations of the Corporation to complete the sale and issuance of the Units as contemplated hereby shall be conditional upon:

 

(a) the representations and warranties of the Subscriber contained in this Subscription Agreement being true and correct on and as of the Closing with the same effect as though such representations and warranties had been made as of the Closing Date; and

 

(b) all of the covenants and obligations of the Subscriber to be performed or observed on or before the Closing pursuant to this Subscription Agreement having been duly performed or observed.

 

11. Consent to Disclosure of Information

 

11.1            The Subscriber acknowledges and consents to the release by the Corporation of information regarding the Subscriber’s subscription including the Subscriber’s name, address, telephone number, e-mail address and the Units purchased, in compliance with securities regulatory policies to regulatory authorities under Applicable Securities Laws and the Subscriber waives to the extent lawful, its rights under any privacy legislation. The contact information of the public official in each applicable Canadian jurisdiction who can answer questions about this indirect collection of the Subscriber’s personal information is set out in Schedule B hereto.

 

11.2            In addition to the foregoing, the Subscriber agrees and acknowledges that the Corporation may use and disclose the Subscriber’s personal information, or that of each beneficial purchaser for whom the Subscriber are contracting hereunder, as follows:

 

(a) for internal use with respect to managing the relationships between and contractual obligations of the Corporation and the Subscriber or any beneficial purchaser for whom the Subscriber is contracting hereunder;

 

(b) for use and disclosure to the Corporation’s transfer agent and registrar;

 

(c) where required by law, (i) for use and disclosure for income tax related purposes and (ii) disclosure to Canada Revenue Agency and the United States Internal Revenue Service;

 

(d) where required by law, disclosure to securities regulatory authorities (including any stock exchange) and other regulatory bodies with jurisdiction with respect to reports of trade and similar regulatory filings;

 

 

  - 16 -  

 

(e) disclosure to a governmental or other authority (including any stock exchange) to which the disclosure is required by court order or subpoena compelling such disclosure and where there is no reasonable alternative to such disclosure;

 

(f) disclosure to professional advisers of the Corporation in connection with the performance of their professional services;

 

(g) disclosure to any person where such disclosure is necessary for legitimate business reasons and is made with the Subscriber’s prior written consent;

 

(h) disclosure to a court determining the rights of the parties under this Subscription Agreement; or

 

(i) for use and disclosure as otherwise required by law.

 

12. General

 

12.1            Time is of the essence hereof.

 

12.2            Neither this Subscription Agreement nor any provision hereof will be modified, changed, discharged or terminated except by an instrument in writing signed by the party against whom any waiver, change, discharge or termination is sought.

 

12.3            Words importing the masculine gender include the feminine or neuter, words in the singular include the plural, words importing a corporate entity include individuals, and vice versa.

 

12.4            The parties hereto will execute and deliver all such further documents and instruments and do all such acts and things as may either before or after the execution of this Subscription Agreement be reasonably required to carry out the full intent and meaning of this Subscription Agreement.

 

12.5            This Subscription Agreement will be subject to, governed by and construed in accordance with the laws of Alberta and the federal laws of Canada as applicable therein and the Subscriber hereby irrevocably attorns to the jurisdiction of the Courts situated therein.

 

12.6            This Subscription Agreement may not be assigned by any party hereto.

 

12.7            The Corporation will be entitled to rely on delivery of a facsimile or email copy of this Subscription Agreement, and acceptance by the Corporation of a facsimile or email copy of this Subscription Agreement will create a legal, valid and binding agreement between the Subscriber and the Corporation in accordance with its terms.

 

12.8            This Subscription Agreement may be signed by the parties in as many counterparts as may be deemed necessary, each of which so signed will be deemed to be an original, and all such counterparts together will constitute one and the same instrument.

 

12.9            This Subscription Agreement is deemed to be entered into on the date hereof.

 

12.10          This Subscription Agreement, including, without limitation, the representations, warranties, acknowledgements and covenants contained herein, will survive and continue in full force and effect and be binding upon the parties notwithstanding the completion of the purchase of the Securities by the Subscriber pursuant hereto, the completion of the issue of Securities of the Corporation and any subsequent disposition by the Subscriber of the Securities.

 

 

  - 17 -  

 

12.11          The invalidity or unenforceability of any particular provision of this Subscription will not affect or limit the validity or enforceability of the remaining provisions of this Subscription.

 

12.12          Except as expressly provided in this Subscription and in the agreements, instruments and other documents contemplated or provided for herein, this Subscription contains the entire agreement between the parties with respect to the sale of the Securities and there are no other terms, conditions, representations or warranties, whether expressed, implied, oral or written, by statute, by common law, by the Corporation, by the Subscriber, or by anyone else.

 

12.13          Unless otherwise indicated, all monetary amounts are in United States Dollars.

 

12.14          Les parties aux présents ont exigé que la présente convention ainsi que tous les documents et avis qui s’y rattachent ou qui en découleront soient rédigés dans la langue anglaise. The parties have required that this Agreement and all documents and notices resulting from it be drawn up in English.

 

-- End of Terms and Conditions --

 

 

 

 

  - A1 -  

 

SCHEDULE A

 

TO

 

THE SUBSCRIPTION AGREEMENT OF

ABOVE FOOD CORP.

 

FOREIGN PURCHASER’S CERTIFICATE

 

(Residents of Jurisdictions other than Canada and the United States)

 

To:          ABOVE FOOD CORP. (the “Corporation”)

 

Capitalized terms used herein but not otherwise defined shall have the meaning ascribed to them in the Subscription Agreement to which this Schedule is attached.

 

In connection with the purchase of Units by the undersigned subscriber (the “Subscriber”) for the purposes of this Schedule A, the undersigned hereby represents, warrants and certifies to and covenants with the Corporation that:

 

1.            the Subscriber is a resident of a country (an “International Jurisdiction”) other than Canada and the United States and the decision to subscribe for the Units was taken in such International Jurisdiction.

 

2.            The Subscriber is purchasing the Units as principal for the Subscriber’s own account.

 

3.            The acceptance of the Subscriber’s subscription for the Units by the Corporation complies with all laws applicable to the Subscriber and such beneficial purchaser, including the laws of such purchaser’s jurisdiction of residence, and all other applicable laws.

 

4.            The Subscriber, and each such beneficial purchaser, is knowledgeable of or has been independently advised as to, the application or jurisdiction of the securities laws of the International Jurisdiction which would apply to the subscription.

 

5.            The Subscriber is solely responsible for obtaining such tax, investment, legal and other professional advice as it considers appropriate in connection with the Subscriber’s subscription for the Units, including the execution, delivery and performance by it of the documentation relating to such subscription and the transactions contemplated thereunder, and, without limiting the generality of the foregoing, legal counsel for the Corporation is acting solely as counsel to the Corporation for the Offering and not as counsel to the Subscriber.

 

6.            The Subscriber, and each such beneficial purchaser, is purchasing the Units pursuant to exemptions from the prospectus and registration requirements (or their equivalent) under the applicable securities laws of that International Jurisdiction or, if such is not applicable, each is permitted to purchase the Units subscribed for hereunder under the applicable securities laws of the International Jurisdiction without the need to rely on an exemption.

 

7.            The Subscriber will not sell, transfer or dispose of the Securities, except in accordance with all applicable laws, including applicable securities laws of Canada and the United States, and the Subscriber acknowledges that the Corporation shall have no obligation to register any such purported sale, transfer or disposition which violates applicable Canadian or United States securities laws.

 

_______DATED this ____ day of _______________________, 2024.

 

   
  Authorized Signature of Subscriber
   
   
  Print Name of Subscriber
   
   
  If the Subscriber is not an individual, print name and title of Authorized Signatory whose signature appears above
   
   
  Address of Subscriber

 

-- End of Schedule A --

 

 

  - B1 -  

 

SCHEDULE B

 

TO

 

THE SUBSCRIPTION AGREEMENT OF

ABOVE FOOD CORP.

 

PUBLIC OFFICIALS CONTACT INFORMATION

 

Alberta Securities Commission British Columbia Securities Commission
Suite 600, 250 – 5th Street SW P.O. Box 10142, Pacific Centre
Calgary, Alberta T2P 0R4 701 West Georgia Street
Telephone: (403) 297-6454 Vancouver, British Columbia V7Y 1L2
Toll Free In Canada: 1-877-355-0585 Inquiries: (604) 899-6854
Facsimile: (403) 297-2082 Toll Free In Canada: 1-800-373-6393
  Facsimile: (604) 899-6581
  Email: inquiries@Bcsc.bc.ca
   
The Manitoba Securities Commission Financial And Consumer Services Commission (New Brunswick)
500 – 400 St. Mary Avenue 85 Charlotte Street, Suite 300
Winnipeg, Manitoba R3C 4K5 Saint John, New Brunswick E2L 2J2
Telephone: (204) 945-2548 Telephone: (506) 658-3060
Toll Free In Manitoba 1-800-655-5244 Toll Free In Canada: 1-866-933-2222
Facsimile: (204) 945-0330 Facsimile: (506) 658-3059
  Email: info@fcnb.ca
   
Government of Newfoundland and Labrador Government of the Northwest Territories
Financial Services Regulation Division Office of the Superintendent Of Securities
P.O. Box 8700 P.O. Box 1320
Confederation Building Yellowknife, Northwest Territories X1A 2L9
2nd Floor, West Block Attention: Deputy Superintendent, Legal & Enforcement
Prince Philip Drive Telephone: (867) 920-8984
St. John’s, Newfoundland And Labrador A1B 4J6 Facsimile: (867) 873-0243
Attention: Director of Securities  
Telephone: (709) 729-4189  
Facsimile: (709) 729-6187  
   
Nova Scotia Securities Commission Government of Nunavut
Suite 400, 5251 Duke Street Department Of Justice
Duke Tower Legal Registries Division
P.O. Box 458 P.O. Box 1000, Station 570
Halifax, Nova Scotia B3J 2P8 1st Floor, Brown Building
Telephone: (902) 424-7768 Iqaluit, Nunavut X0A 0H0
Facsimile: (902) 424-4625 Telephone: (867) 975-6590
  Facsimile: (867) 975-6594
   
Ontario Securities Commission Prince Edward Island Securities Office
20 Queen Street West, 22nd Floor 95 Rochford Street, 4th Floor Shaw Building
Toronto, Ontario M5H 3S8 P.O. Box 2000
Telephone: (416) 593- 8314 Charlottetown, Prince Edward Island C1A 7N8
Toll Free In Canada: 1-877-785-1555 Telephone: (902) 368-4569
Facsimile: (416) 593-8122 Facsimile: (902) 368-5283
Email: exemptmarketfilings@osc.gov.on.ca  
Public Official Contact Regarding Indirect  
Collection of Information: Inquiries Officer  
   
Autorite Des Marches Financiers Financial and Consumer Affairs Authority of Saskatchewan
800, Square Victoria, 22e Etage Suite 601 - 1919 Saskatchewan Drive
C.P. 246, Tour De La Bourse Regina, Saskatchewan S4P 4H2
Montréal, Québec H4Z 1G3 Telephone: (306) 787-5879
Telephone: (514) 395-0337 Or 1-877-525-0337 Facsimile: (306) 787-5899
Facsimile: (514) 873-6155 (For Filing Purposes Only)  
Facsimile: (514) 864-6381 (For Privacy Requests Only)  
Email: Financementdessocietes@Lautorite.Qc.Ca (For Corporate Finance Issuers); fonds_dinvestissement@lautorite.qc.ca (For Investment Fund Issuers)  
   
Government of Yukon  
Department of Community Services  
Law Centre, 3rd Floor  
2130 Second Avenue  
Whitehorse, Yukon Y1A 5H6  
Telephone: (867) 667-5314  
Facsimile: (867) 393-6251  

 

-- End of Schedule B --

 

-- End of Subscription Agreement --

 

 

 

EX-10.25 13 tm2418826d1_ex10-25.htm EXHIBIT 10.25

 

Exhibit 10.25

 

Shares Sale and Purchase and Exchange Agreement

 

in relation to

 

Brotalia, S.L.

 

executed by

 

of the one part

 

Above Food Corp.

 

as “Above” or the “Purchaser”,

 

and of the other part

 

Grupo Empresarial Enhol, S.L.

 

and Mr. Gonzalo Agorreta Preciado In Madrid, on June 13, 2024

 

as the “Sellers”

 

on June 13, 2024

 

 


 

Table of contents

 

1.   Definitions and interpretation   4
         
2.   Purpose of the Agreement   12
         
3.   Price   12
         
4.   Conditions Precedent and Condition Subsequent   14
         
5.   Period between the execution of the Agreement and the Closing   15
         
6.   Closing   18
         
7.   Representations and Warranties   24
         
8.   Rules on Liability   26
         
9.   Post-Closing Undertakings of the Parties   32
         
10.   Duty of confidentiality   33
         
11.   Miscellaneous   34
         
12.   Applicable law and Jurisdiction   37

 

 


 

Shares Sale and Purchase and Exchange Agreement

 

 

Of the one part,

 

Above Food Corp., a company duly incorporated under the laws of the Province of Alberta, with registered office in 1600, 421 – 7th Avenue SE, Calgary, Alberta, T2P 4K9, registered at the Province of Alberta under Corporate Access Number 2026118113 and with Canada Revenue Agency with taxpayer identification number 710779877 and Spanish tax identification number (NIE) N0298564F (the “Purchaser”), represented in this act by Lionel Kambeitz, of age, a Canadian national, with domicile in Regina, at Riverbend View 2090, and with passport number HH199072. He exercises this representative authority pursuant to a power of attorney granted at his office of Above Food Corp., to which he was appointed by virtue of public deed granted on May 21, 2024 in front of Notary of Saskatchewan Ms. Dana Michelle Fauth and duly apostilled.

 

and of the other part,

 

Grupo Empresarial Enhol, S.L., a Spanish company, with registered office in Tudela (Navarra), calle Frauca, No. 13, Spain, registered at the Commercial Registry of Navarra at volume 212, sheet 20, page NA-4.525, and with taxpayer identification number B-31227200 (“Enhol”), represented in this act by the attorney-in-fact, Mr. Gonzalo Oliver Amatriain, with Spanish ID number 78752562-X, by virtue of a public deed granted on May 20, 2024, in front of the Notary of Tudela, Mr. Víctor González de Echávarri Díaz, under number 987 of his official records.

 

Mr. Gonzalo Agorreta Preciado (“Mr. Agorreta”), a Spanish citizen, of full age, single, holder of Spanish National Identification Number 78755511-S and professional address in Tudela (Navarra), at Calle Frauca No. 13, Spain, in his own name and behalf.

 

Enhol and Mr. Gonzalo Agorreta shall be jointly referred to as the “Sellers”, and the Purchaser and the Sellers shall be jointly referred to as the “Parties” and each of them individually as a “Party”.

 

The Parties mutually acknowledge their legal capacity to execute this agreement (the “Agreement”) and, accordingly,

 

WHEREAS

 

I. The Purchaser and its wholly-owned subsidiaries are vertically integrated, high growth, seed-to-fork plant-based platforms that have well-established financial profiles stemming primarily from its business-to-business (B2B) as well as its business-to-consumers (B2C) relationships, selling to over 300 customers across 35 countries.

 

1


 

II. Grupo Enhol is a top tier family-owned, 4th generation Spanish business group conglomerate, with main focus in the renewable energy sector and presence in several sectors such as agriculture, food processing and real estate.

 

III. On April 29, 2023, the Purchaser entered into a business combination agreement (as amended, the “Business Combination Agreement”) with Bite Acquisition Corp. (NYSE AMERICAN: BITE) ("Bite"), a special purpose acquisition company formed for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). On April 29, 2024, the Shareholders of Bite approved the Business Combination.

 

IV. As per the Business Combination Agreement, it is envisaged that on the closing date of the Business Combination Agreement and pursuant to a court-approved plan of arrangement, the Purchaser’s shareholders will effect the Share Exchange (as such term is defined in the Business Combination Agreement), pursuant to which, among other things, the Purchaser’s shareholders will contribute to Above Food Ingredients Inc. (“New-Above”) all of the issued and outstanding equity of the Purchaser in exchange for newly issued New Above Common Shares, Class A Earnout Shares of New Above and Class B Earnout Shares of New Above, and after giving effect to the Share Exchange, the Purchaser will become a direct, wholly owned subsidiary of New-Above. In turn, New-Above has applied to list the New-Above Common Shares and warrants on the NASDAQ or NYSE in connection with the closing under the Business Combination Agreement. Also, on the closing date of the Business Combination Agreement and following the completion of the Share Exchange, Above Merger Sub, Inc., which is currently a wholly owned subsidiary of New-Above, will merge (the “Merger”) with and into Bite, with Bite continuing as the surviving corporation after the Merger as a direct, wholly owned subsidiary of New-Above.

 

V. Simultaneously to the execution of this Agreement, Enhol has entered into a subscription agreement (the “Subscription Agreement”) and has committed to fund the Purchaser, under such Subscription Agreement, in a total amount of USD 5,000,000. For the avoidance of any doubt, (i) the execution of the Subscription Agreement and the disbursement of the committed amount under such agreement are subject to and conditional upon (a) the effective execution of this Agreement, and (b) completion of the Closing as provided herein; and (ii) without prejudice to (i) above and to the Subscription Agreement being entered into on the date hereof, the subscription and acquisition by Enhol of the relevant shares as provided under the Subscription Agreement is a stand-alone transaction, independent from the sale and purchase of the Shares governed hereunder and the consideration payable thereunder is unrelated to that set forth herein.

 

VI. Brotalia, S.L. ("Brotalia" or the "Company") is (A) a subsidiary of Enhol which is engaged in (a) the development, production and commercialization of (i) pre-cooked processed animal protein products and (ii) products made with alternative protein, for human consumption, (b) the development and research of new products, technologies or processes for the manufacture of edible products for human consumption, and (c) food tech project acceleration consultancy, (the “Business”) and (B) the sole shareholder of Naturcook Innovaciones, S.L. (the “Subsidiary” and jointly with the Company, the “Companies”). A description of the main intangible assets and material agreements comprising, among others, the business of the Companies is described in Appendix 1.2 of this Agreement. The Sellers are the owners of the Shares, as set forth in Schedule VI, which represent 100% of the total issued and outstanding share capital of Brotalia.

 

2


 

VII. The Purchaser, assisted by professional advisors with substantial expertise in these kind of transactions and in the corresponding business, has carried out a commercial, financial, operational, tax and legal due diligence review of the Company, which includes that the Purchaser and its consultants had access to the information provided by the Company which was requested by the Purchaser, at its sole discretion (the “Due Diligence Information of the Company”) and the Sellers, assisted by professional advisors, have reviewed the information of the Purchaser and the Business Combination publicly available up to May 15, 2024 (the “Publicly Available Information of the Purchaser and the Business Combination” and, together with the Due Diligence Information of the Company, the ”Due Diligence Information”). In addition, the Purchaser and the Sellers have attended (i) expert sessions and interviews with each Party’s management in which each Party and its consultants were able to ask questions and obtain details regarding the Due Diligence Information and gain sufficient knowledge of each corresponding businesses of the Company and the Purchaser; and (ii) site visits to the premises of the other Party premises and facilities (the review of the Due Diligence Information and the attendance to expert sessions and site visits, the “Due Diligence Process”). The Due Diligence Process allowed the Purchaser to form a suitable and sufficient opinion of the Company’s business and the Sellers to form a suitable and sufficient opinion of the business of the Purchaser and the Business Combination to enter into this Agreement and determine the Purchase Price.

 

VIII. The Purchaser and the Sellers are interested in combining their food technology companies and divisions by way of a share exchange, which the Parties have agreed to, and shall result in the participation of the Sellers in New-Above (as defined herein). Particularly: (i) the Above Common Stock to be delivered in exchange of the shares of the Company shall convert to New-Above stock as of the date of the Business Combination; and (ii) the earn-out terms and conditions under this Agreement shall replicate those applicable to beneficiaries of the earn-out under the Business Combination Agreement, which terms shall be as set forth on Schedule 3.5  attached hereto, with Enhol being additionally granted the right to nominate a director of New-Above pursuant to a Nomination Rights Agreement to be entered into by and among Enhol and the Company. In order to achieve such business combination, the Purchaser has agreed to acquire, and the Sellers have agreed to sell, all of the Shares under the following terms:

 

3


 

CLAUSES

 

1. Definitions and interpretation

 

1.1 Definitions

 

In the Agreement the following terms shall have the meanings specified below:

 

“Above” means Above Food Ingredients Inc., an Alberta corporation and a direct, wholly owned subsidiary of the Purchaser.

 

“Above Group” means the Purchaser and its Affiliates from time to time.

 

“Above Common Shares” means private shares in the capital of Above Food Corp., with such other particulars as further set forth in Clause 3.3.

 

“Affiliate” means, with respect to a Person, any Person Controlling, Controlled by, or under the common Control with (in each case whether directly or indirectly), the relevant Person.

 

“Agreement” means this agreement and its Schedules.

 

“Agreement Date” means the date on which the Agreement is executed, as appears first above written.

 

“Agro APA” means the agreement entered into between Foodys Agro and Brotalia on April 8, 2024 by virtue of which Foodys Agro acquired the Agro Business of Brotalia.

 

“Agro Business” means the business unit acquired by Foodys Agro from Brotalia in accordance with the Agro APA, comprising all assets, clients, brands, permits, licenses, authorizations and employees ascribed to the cultivation, marketing and sale and purchase of aromatic herbs, as described in the Agro APA.

 

“Assets” means the assets described in Appendix 1.2 owned by Brotalia, among others, as of Closing to which, in aggregate, have been attributed by the Purchaser with an estimated value as set out therein.

 

“Bite” means Bite Acquisition Corp. (NYSE AMERICAN: BITE).

 

"Bite Transfer Agreement Escrow” means the stock escrow agreement dated as of February 11, 2021, by and among Bite, Smart Dine, LLC, Continental Stock Transfer & Trust Company and other parties thereto (as amended from time to time), to which Enhol shall adhere as “Additional Holder” by virtue of a Joinder to Stock Escrow Agreement on the terms set forth in the Transfer Agreement.

 

“Brotalia” means the Company.

 

“Business” shall have the meaning set forth in Whereas VI.

 

“Business Combination” shall have the meaning set forth in Whereas III.

 

4


 

“Business Combination Agreement” shall have the meaning set forth in Whereas III.

 

“Business Day” means any day except Saturdays, Sundays or public holidays in Tudela (Spain), New York (US) and Regina, SK (Canada).

 

“Business Partner” shall have the meaning set forth in Clause 9.2.

 

“Cash” means the USD equivalent of the aggregate of any currency deposited at the Companies’ bank accounts and any other petty cash amount owned by the Companies at a certain date.

 

“Charges and Encumbrances” means any charge, claim, encumbrance, ancillary obligation, option, retrospective right of acquisition, retention of title, pooling agreement, third-party right, including preemptive rights of acquisition or transfer, or restrictions on the transferability of the Shares.

 

“Closing” means the transfer of the Shares to the Purchaser in exchange for the Above Common Shares and other actions and deliveries provided for in Clause 6.

 

“Closing Date” means the day on which the Closing shall take place as provided for in Clause 6.

 

“Cocuus” means Cocuus System Ibérica, S.L.

 

“Cocuus Collaboration Agreement” has the meaning set for in Appendix 1.2.

 

“Cocuus MoU” has the meaning set for in Appendix 1.2.

 

“Company” means Brotalia, S.L., a Spanish company, with business address at Calle Frauca 13, 31500 Tudela (Navarra), Spain, registered with the commercial register of Navarra at book 1845, page 156 and sheet NA-36639, and with taxpayer identification number B-71309314.

 

“Companies” means the Company and its Subsidiary.

 

“Condition(s) Precedent” means the conditions provided for in Clause 4.1, to which the performance of the sale and purchase and exchange of shares hereunder is subject.

 

“Consortium” shall have the meaning set forth in Schedule 5.2.

 

“Control” including its various tenses and derivatives (such as “Controlled” and “Controlling”) means when used with respect to any Person (even where used without a capital letter in this Agreement), the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such entity, whether through the ownership of voting securities, by its participation in the managing bodies of such Person, by contract or otherwise.

 

5


 

“Damage or Loss” means any actual and direct damages (“daño emergente directo”) that a Party may suffer as a direct consequence of any falsehood or inaccuracy in the Representations and Warranties.

 

For the avoidance of doubt, any indirect or consequential damages (“daños indirectos”), loss of profits, loss of bargain, loss of opportunity or loss of income (“lucro cesante”) and moral or reputational damages (“daños morales”) shall be excluded from the definition of Damage or Loss.

 

“Debt” means at any time and without double counting, the aggregate at such time of the Financial Indebtedness of the Companies from sources external to the Companies.

 

No amount should be included or excluded more than once.

 

Additionally, except if they are settled before the Effective Time as provided for in this Agreement, the following items shall be considered indebtedness of the Companies for the purposes of calculating the Debt as at the Effective Time:

 

any interests, prepayment fees and commissions that may have to be paid by the Companies as a result of an early termination or prepayment of the existing Financial Indebtedness of the Companies;

 

any dividend approved and pending to be paid by the Companies; and

 

any outstanding fee balance pending to be paid by the Companies to any of the Sellers or its Related Parties.

 

“Deductible” means USD 130,000.

 

“De Minimis” means USD 13,000.

 

“Due Diligence Information” shall have the meaning set forth in Whereas VII.

 

“Due Diligence Information of the Company” shall have the meaning set forth in Whereas VII.

 

“Due Diligence Process” shall have the meaning set forth in Whereas VII.

 

“Effective Time” means the moment immediately prior to Closing.

 

“Enhol” means Grupo Empresarial Enhol, S.L., a Spanish company, with registered office in Tudela (Navarra), calle Frauca, No. 13, Spain, registered at the Commercial Registry of Navarra at volume 212, sheet 20, page NA-4.525, and with taxpayer identification number B-31227200.

 

“Enhol Group” means Enhol and its Affiliates from time to time.

 

“Escrow Agent” means Gowling WLG.

  

6


 

“Escrow Agreements” means jointly, the Bite Transfer Agreement Escrow and the Subscription Escrow Agreement.

 

“Exchange Act” shall mean the U.S. Securities Exchange Act of 1934, as it may be amended from time to time.

 

“Exchange Rate” shall mean on any day, for purposes of determining the USD equivalent of the EUR currency in which the financial statements of the Company or any potential liability of the Company for the purposes of the liability regime under this Agreement are denominated, the rate at which EUR may be exchanged into USD at the time of determination on such day as quoted by Bloomberg on www.bloomberg.com/markets/currencies/fxc.html (and applying the Currency Converter set forth on such webpage), or as displayed on such other information service which publishes that rate of exchange from time to time in place of Bloomberg. In the event that such rate is not displayed by Bloomberg on the webpage specified in the immediately preceding sentence, the Exchange Rate shall be determined by reference to such other publicly available service for displaying exchange rates as may be agreed upon by the Parties, or, in the absence of such an agreement, the Sellers may use any reasonable method, in consultation with the Purchaser, they deem appropriate to determine such rate, and such determination shall be conclusive absent manifest error.

 

“Existing Guarantees” has the meaning set forth in Clause 6.6.

 

“Financial Indebtedness” means, at any time, the aggregate outstanding principal, capital or nominal amount of any indebtedness of the Companies, including, for the avoidance of any doubt, convertible debt instruments, plus any interest accrued and not paid, but expressly excluding any drawn or undrawn working capital facilities (créditos para financiación de circulante) of the Companies, such as factoring and confirming facilities.

 

“Financial Statements” means the consolidated year-end and interim financial statements (balance sheet and profit and loss accounts) of the Companies, corresponding to FY2023 (including the Agro Business) and as of April 30, 2024 (after the Agro Business carve out as per the Agro APA), respectively made available to the Purchaser and attached as Appendix 3.1.

 

“Foodys Agro” means Foodys Agro, S.L., a Spanish company, with business address at Calle Frauca 13, 31500 Tudela (Navarra), Spain, registered with the commercial register of Navarra at book 2135, page 111 and sheet NA-42737, and Spanish identification number B-71497275.

 

“Fundamental Representations and Warranties” means the Sellers’ Representations and Warranties list in Schedule 7.2.(i).

 

“Group” means a group of companies within the meaning of article 18 of the Spanish Companies Law approved by Royal Legislative Decree 1/2010 of 2 July (“Texto Refundido de la Ley de Sociedades de Capital”).

 

“IFRS” means the International Financial Reporting Standards developed by the International Accounting Standards Board.

 

7


 

“Innomy” means Innomy Biotech, S.L.

 

“Innomy MoU” has the meaning set for in Appendix 1.2.

 

“Intellectual Property” means all intellectual property, whether or not patentable or registered, including without limitation, algorithms, brands, business methods, computer programs, computer software, concepts, confidential information, firmware, composition of matter or materials, certification marks, collective marks, customer lists, data, databases, designs, conceptions, discoveries, distributor lists, documents, file layouts, ideas, improvements, industrial designs, information, innovations, inventions, know-how, logos, manufacturing information, materials, methods original works of authorship and derivative works thereof, plans, processes, proprietary technology, reputation, research results, research records, service marks, specifications, statistical models, supplier lists, systems, techniques, technology, trade secrets, trademarks, trademark applications, patent, patent applications, trade dress, trade names, trade styles, and technical information.

 

“Intellectual Property Rights” means all intellectual property rights, including without limitation, rights in Intellectual Property, trade secret rights, copyright rights, rights in trademarks, goodwill in trademarks, patents, and patent applications.

 

“IT Systems” has the meaning set for in Schedule 7.2.(ii).

 

“Lock-Up Agreement” means the lock-up agreement to be entered into on Closing on substantially similar terms and conditions to those set forth in Schedule 3.3 of this Agreement.

 

“Longstop Date” means July 31, 2024.

 

“Material Agreements” has the meaning set for in Schedule 7.2.(ii).

 

“Merger” has the meaning set for in Whereas IV.

 

“Naturcook” means the Subsidiary.

 

“Net Debt” means Debt (absolute value) minus Cash (absolute value).

 

“New Above” means Above Food Ingredients Inc.

 

“New Above Shares” shall have the meaning set forth in Clause 3.3.

 

“Nomination Rights Agreement” means the nomination rights agreement to be entered into by Enhol, the Company and New-Above in substantially the form attached hereto in Schedule 4.1.3.

 

“Notary” means Mr. Francisco Miras Ortiz before whom the Deed of Sale and Purchase shall be executed and the other actions provided for in Clause 6 shall be carried out, unless otherwise agreed by the Parties in writing.

 

8


 

“New Above Common Shares” means the common shares of New-Above, subject the Registration Rights provided in Clause 3.5 of this Agreement.

 

“Party” means any of the Sellers or the Purchaser.

 

“Person/s” means any individual, firm, corporation, exempted company, partnership, limited liability company, incorporated or unincorporated association, trust, estate, joint venture, joint stock company, Governmental Authority or instrumentality or other entity of any kind.

 

“Pre-Closing Reorganization” has the meaning set forth in Clause 5.4.

 

“Properties” has the meaning set forth in Schedule 7.2.(ii).

 

“Publicly Available Information of the Purchaser and the Business Combination” shall have the meaning set forth in Whereas VII.

 

“Purchase Price” shall have the meaning attributed to it under Clause 3.1.

 

“Purchase Price in Shares” shall have the meaning set forth in Clause 3.3.

 

“Purchaser” means Above Food Corp.

 

“Related Parties” means Persons related to a Party as described in article 231 of the Spanish Capital Companies Act.

 

“Representations and Warranties” means the representations and warranties that a Party makes and gives for the benefit of the other Party in accordance with the provisions of Clause 7.

 

“Ruling” means a final and non-appealable court decision, arbitral award or settlement.

 

“Sellers’ Pro-rata Allocation” means the proportion of any consideration element and/or any joint (mancomunada) obligation of the Sellers under this Agreement allocated to each Seller pro-rata to each Seller’s participation in the Company’s share capital, as further detailed in Schedule VI.

 

“Sellers’ Business Representations and Warranties” means the Sellers’ Representations and Warranties list in Schedule 7.2.(ii).

 

“Sellers’ Business Representations and Warranties Liability Cap” means two million six hundred thousand USD (USD 2,600,000.00).

 

“Sellers’ Fundamental Representations and Warranties” means the Sellers’ Representations and Warranties list in Schedule 7.2.(i).

 

“Sellers’ Representations and Warranties” means the Sellers’ Fundamental Representations and Warranties list in Schedule 7.2.(i) and the Sellers’ Business Representations and Warranties listed in Schedule 7.2.(ii).

 

9


 

“Shares” means the (a) 100,000 shares into which the Company’s registered share capital is divided, numbered from 1 through 100,000, each with a par value of one EURO (EUR 1) and fully paid in and (b) any shares issued to the Sellers in the framework of the Pre-Closing Reorganization.

 

“Stock Exchange” means the New York Stock Exchange or NASDAQ a successor that is a national securities exchange registered under Section 6 of the Exchange Act.

 

“Subscription Agreement” shall have the meaning set forth in Whereas V.

 

“Subscription Escrow Agreement” means the cash and stock escrow agreement to be entered into, inter alia, by Enhol, the Escrow Agent and the Purchaser, on the terms and conditions provided in the Subscription Agreement.

 

“Subsidiary” means Naturcook Innovaciones, S.L., a Spanish company, with business address at Calle Frauca, No. 13, 31500 Tudela (Navarra), Spain, registered with the commercial register of Navarra at book 1977, page 182 and sheet NA-39409, and with taxpayer identification number B-71395602.

 

“Taxes” means any tax, charge, levy, contribution, fiscal or quasi-fiscal imposition, custom duties, social security contributions or any obligation to withhold or prepay any tax established under the laws applicable to the Parties or the Companies or any equivalent tax, charge, levy, contribution, fiscal or quasi-fiscal imposition, customs duties, social security contributions or any obligation to withhold or prepay any tax established under the laws of any other jurisdiction, as well as any charge or amount related thereto (including fines, penalties, interests and surcharges) but excluding for the avoidance of doubt deferred taxes and any obligation to repay unlawfully granted state aid.

 

“Tax Return” means any written declaration or other written formal report, notice, form or filing mandatorily required to be supplied to any Taxing Authority with respect to Taxes, including any formally mandatorily required official schedule or attachment thereto or amendment thereof.

 

“Taxing Authority” means any competent governmental authority in charge of imposing any Taxes.

 

“Transfer Agreement” means the Assignment and Transfer Agreement to be executed by Enhol and Smart Dine, LLC detailing the transfer of 500,000 common shares of Bite on terms substantially similar to those set forth in Schedule 6.2.(xii) hereto.

 

“Transaction Documentation” shall have the meaning attributed to it under Schedule 7.1.

 

1.2 Interpretation

 

In the Agreement, unless indicated otherwise:

 

(i) Any reference to the Agreement must be deemed to be made to the Agreement, its Schedules and its Appendixes.

 

10


 

(ii) Any reference to “Clause”, “Appendix” or “Schedule” must be deemed to be made to a Clause of, “Appendix”, or Schedule to, the Agreement.

 

(iii) Any reference to a “person” includes any Person.

 

(iv) Wherever the terms “includes”, “included”, “include” and “including” are used, they shall be deemed to be followed by the expression “without limitation”.

 

(v) If an obligation is qualified or formulated by reference to the use of “best efforts” or another similar expression, it refers to the endeavors that a person with the firm intention to achieve an outcome would use in similar circumstances to ensure the achievement of such outcome as soon as possible, taking into account, among other factors:

 

(a) the price, financial interest and other terms of the obligation;

 

(b) the degree of risk normally entailed by the achievement of the expected outcome; and

 

(c) the ability of an unrelated person to exert an influence on the performance of the obligation.

 

(vi) Any reference to “ordinary course of business” shall be interpreted as the normal conduct of the commercial operations of the Companies applied in a uniform and consistent manner in the last two (2) years.

 

(vii) Any reference to “days” shall be deemed to be made to “calendar days”. Any periods expressed in days shall start to be counted from the day immediately following that on which the counting starts. If the last day of a period is not a Business Day, the period in question shall be deemed to have been automatically extended until the first following Business Day. Periods expressed in months shall be counted from date to date unless in the last month of the period such date does not exist, in which case the period shall end on the following Business Day.

 

(viii) Any reference to “from”, “as from” or “through” a given date shall be understood to include such date.

 

(ix) The headings used in the Agreement are included for reference only and shall not form part of the Agreement for any other purpose or affect the interpretation of any of its Clauses.

 

(x) “Knowledge of Sellers” or any other similar knowledge qualification, means the actual knowledge of Mr. Gonzalo Agorreta Preciado, Mr. Gonzalo Oliver Amatriain or Mr. Diego Oliver Gimeno, after due inquiry to the officers of the Company.

 

(xi) Terms appearing in Spanish shall have the meanings ascribed to them in Spanish laws.

 

11


 

(xii) Given that the financial statements of the Company are denominated in EUR currency, any references in this Agreement to a certain financial parameter of the Company (particularly, Debt and Cash) set in USD shall be deemed to refer to the USD equivalent of the relevant parameter in EUR as of the date of the relevant calculation, determined by application of the Exchange Rate as of the Business Day immediately previous to the date of the relevant calculation.

 

2. Purpose of the Agreement

 

2.1 Sale and purchase of the Shares

 

Subject to the terms and conditions of the Agreement, the Purchaser hereby agrees to purchase and shall acquire on Closing from the Sellers, which hereby agree to sell and shall transfer on Closing, each and every one of the Shares of the Company.

 

The Shares are hereby sold by the Sellers and purchased by the Purchaser free and clear from any Charges and Encumbrances, are fully subscribed for and paid in and fully enjoy the rights inherent to them by reason of statute and the bylaws.

 

2.2 Completion of the sale and purchase

 

The sale and purchase hereunder shall be completed on the Closing Date by way of the transfer of all of the Shares and the payment of the Purchase Price payable at Closing, pursuant to the terms of this Agreement.

 

In accordance with Article 1,450 of the Spanish Civil Code, this Agreement is effective (perfeccionado) by means of its execution by the Parties, being therefore binding and enforceable upon them from the date hereof; provided, however, that the completion of the Transaction is postponed until the Conditions Precedent are satisfied or waived and is subject to the occurrence of the Closing, in each case on the terms set forth herein. Upon the satisfaction or waiver of the Conditions Precedent, and the occurrence of the Closing, in each case on the terms set forth herein, the consummation (consumación) of the purchase and sale of the Shares shall be as of the Closing Date.

 

3. Price

 

3.1 Purchase Price

 

Subject to the terms and conditions of this Agreement, the total price for the acquisition of the Shares shall be equal to (i) the purchase price determined as provided in Clause 3.2, plus (ii) the Earn-Out (collectively, the “Purchase Price”).

 

The Purchase Price shall be allocated among the Sellers in the percentages indicated in Schedule 3.1.

 

3.2 Calculation of the Purchase Price

 

The Parties agree that the purchase price of the Shares is USD 13,000,000.

 

The Purchase Price has been calculated on the assumption that the Net Debt as at the Closing Date will be zero EUROS (EUR 0).

 

12


 

3.3 Payment of the Purchase Price

 

The Purchase Price shall be paid by the Purchaser to the Sellers on Closing by way of delivery to the Sellers of (i) with respect to the Purchase Price, 6,180,413 Above Common Shares, valued at the price per share determined for the purposes of the Business Combination, which aggregate value amounts to the Purchase Price (the “Purchase Price in Shares”) pursuant to the allocation indicated in Schedule 3.1. The Above Common Shares, upon the Business Combination, will be converted into New Above Shares at a ratio of multiplying the Above Common Shares by 0.2103419 (“New Above Shares”), at value of ten USD ($10) per New Above Shares and which shall be subject to the registration rights set out in Clause 3.5 and the lock-up provisions as set out in Schedule 3.3. Notwithstanding the foregoing, if the conversion ratio changes between Closing of this transaction and closing of the Business Combination, the parties covenant and agree to adjust the number of Above Common Shares issued to the Sellers to ensure the total value of New Above Common Shares received by the Sellers in connection with this Agreement shall be equal to thirteen million USD ($13,000,000).

 

3.4 Earn Out

 

The Purchaser represents and warrants to the Sellers that upon closing of the Business Combination, New Above shall issue to the Sellers (pro-rata to the Sellers’ Pro-rata Allocation) New Above Class A Earnout Shares and New Above Class B Earnout Shares on the same terms and conditions as issued to existing holders of Above Common Shares, as more precisely described in the F4 filing statement for the Above shareholders and in accordance with the Plan of Arrangement of the Purchaser.

 

3.5 Registration Rights

 

No later than ten (10) Business Days following the Business Combination, the Purchaser shall cause New Above shall file with the United States Securities and Exchange Commission a registration statement with respect to the public resale by the Sellers of the New Above Common Shares on the terms and conditions as set out in the registration rights agreement, to which the Sellers shall adhere pursuant to a joinder agreement, on terms substantially similar to those set forth in Schedule 3.5 hereto.

 

13


 

4. Conditions Precedent and Condition Subsequent

 

4.1 Definition of the Conditions Precedent

 

Completion of the sale and purchase hereunder and, therefore, the respective obligations of the Parties to transfer the Shares and acquire the Shares and pay the Purchase Price on the Closing Date is subject to:

 

4.1.1 the execution of the Subscription Agreement by the Parties, which Subscription Agreement shall provide for Enhol to purchase Above Common Shares at Closing;

 

4.1.2 contemporaneous with the Closing, the execution of the Transfer Agreement detailing the transfer of 500,000 common shares of Bite, owned by Smart Dine, LLC to Enhol;

 

4.1.3 evidence of corporate approval and/or consents, as required, for completion of the transactions contemplated in the Business Combination Agreement and in this Agreement;

 

4.1.4 prior to the Closing confirmation that there are sufficient votes from Above shareholders to approve of the Closing (as defined in the Business Combination Agreement) of the Business Combination, and as provided hereof; and

 

4.1.5 execution and delivery of the Escrow Agreements.

 

(the “Conditions Precedent”).

 

4.2 Waiver of the Conditions Precedent

 

The Conditions Precedent in 4.1.1, 4.1.3 and 4.1.5 have been agreed for the benefit of the Sellers and the Purchaser and, accordingly, may only be waived by them, in whole or in part, on Date.

 

The Conditions Precedent in 4.1.2 and 4.1.4 have been agreed for the benefit of the Sellers and, accordingly, may only be waived by them, in whole or in part, before the Longstop Date.

 

4.3 Non-fulfillment of the Conditions Precedent

 

If any Condition Precedent is not satisfied on or before the Longstop Date, the Agreement shall be deemed terminated and the above referred respective obligations of the Parties in relation to completion of the transfer of the Shares shall be deemed extinguished and rendered without effects, without any Party having any liability or further obligation to any other Party, except for breach by any of the Parties or their obligations under the Agreement prior to the date of termination Clauses 1, 10, 11.6, 11.7 and 12 shall remain in full force and effect between the Parties.

 

14


 

4.4 Condition Subsequent

 

If (a) Closing has occurred on or before the Longstop Date but (b) the Business Combination has not occurred on or before the Longstop Date, then the Agreement shall be deemed terminated (i) and the above referred respective obligations of the Parties in relation to release of the Shares and Cash in accordance with the Subscription Escrow Agreement and the completion of the transfer of the Shares shall be deemed extinguished and rendered without effects and regarded as never executed in the first place, retroacting any of its effects to the date of its execution, without any additional requirement or formality to be executed by the Parties, and (ii) without any Party having any liability or further obligation to any other Party, except for breach by any of the Parties or their obligations under the Agreement prior to the date of termination Clauses 1, 10, 11.6, 11.7 and 12 shall remain in full force and effect between the Parties. For the avoidance of doubt, as a consequence of such termination, (a) the Sellers shall regain title to the Shares, and (b) the Purchaser shall regain title to the Above Common Shares.

 

5. Period between the execution of the Agreement and the Closing

 

5.1 Ordinary management

 

Each of the Sellers undertake to the Purchaser that, between the Agreement Date and the Closing Date:

 

(i) It shall continue, and it shall procure that the Company continues, to manage its business in a prudent and ordinary manner, with the diligence of a prudent businessman in compliance with the applicable laws and in the ordinary course of business; and

 

(ii) it shall refrain from approving, or from providing assistance for the approval by the Company of, any transactions falling outside the ordinary course of its business, except for those deriving from what is expressly provided for in the Agreement or unless there is express prior written consent from the Purchaser.

 

Sellers shall make available to the Purchaser and its authorized representatives and, if requested by the Purchaser, provide a copy to the Purchaser of, any documents, information and data relating to the Company, as are reasonably requested by the Purchaser and its authorized representatives that are material to the transactions contemplated herein. The Sellers shall afford the Purchaser and its authorized representatives during normal business hours access to all property and assets utilized in the Business.

 

5.2 Actions requiring the Purchaser’s consent

 

Specifically, with the exception of the actions listed in Schedule 5.2, the Sellers shall expressly procure that, from the Agreement Date, the decision-making bodies of the Company obtain the express written consent of the Purchaser before entering into any actions or transactions, including:

 

15


 

(i) the amendment of bylaws or regulations or mergers, spin-offs, windings-up or structural modifications at any of the Companies, as well as any other corporate transactions, with effects similar to the foregoing;

 

(ii) the issue of new shares or of any other securities that are exchangeable or convertible into shares or confer rights on their subscription or acquisition, or the purchase or retirement of their shares of treasury stock or the reclassification, reduction or increase of their share capital;

 

(iii) the disposal, modification, commencement or abandonment of the main activities or lines of business of the Company, or the acquisition of all or most of the assets or the shares of another company or entity;

 

(iv) the arrangement of any contract or transaction with the Sellers other than those already existing and disclosed as part of the Due Diligence Information and those executed in the ordinary course of business;

 

(v) a change in compensation or compensation policy for the members of the managing bodies of the Companies;

 

(vi) a petition for an insolvency or other similar order; or

 

(vii) the increase of the credit limits under the working capital facilities (créditos para financiación de circulante) of the Companies.

 

5.3 Purchaser acknowledgement

 

The Purchaser acknowledges and agrees that nothing in this Clause 5 shall prohibit or restrict the Sellers or the Companies from taking any action (or omitting to take any action):

 

(i) that entails adaptations or changes to the normal course of the commercial operations that a reasonably prudent businessman would have implemented in the context an emergency or disaster situation, provided that Sellers shall as soon as possible inform the Purchaser of such action or omission;

 

(ii) which is considered in good faith to be mandatory for the Sellers, the Company or its directors or managers under any applicable laws or contracts entered into with third-parties other than the Sellers or any of its Affiliates in force prior to the Agreement Date;

 

(iii) to enter into or amend in the ordinary course of business any contract or commitment with clients or suppliers (expressly excluding the Sellers and its Affiliates) which is terminable in accordance with its terms by written notice of six (6) months or less; or

 

(iv) which is expressly authorized or contemplated in this Agreement or which is required in order to give effect to or comply with the terms thereof.

 

16


 

5.4 Pre-Closing Reorganization

 

The Purchaser acknowledges and agrees that, for the purposes of ensuring that the Companies do not include the Agro Business that Brotalia has developed up to March 31, 2024 as agreed by the Parties, the Sellers have completed the following actions:

 

(i) On January 9, 2024, the Sellers incorporated Foodys Agro.

 

(ii) On April 8, 2024, Foodys Agro acquired the Agro Business from Brotalia by virtue of the Agro APA for a total amount of eight hundred fourteen thousand nine hundred eighty six euros and fifty nine cents (814,986.59 €), which shall be fully settled on or before the Closing Date.

 

(iii) Pursuant to the terms of the Agro APA the employees of Brotalia which were ascribed to the Agro Business were transferred to Foodys Agro on April 1, 2024.

 

(iv) Pursuant to the terms of the Agro APA the activity and industrial authorizations (licencias de actividad e industriales) of Brotalia corresponding to the Agro Business were transferred to Foodys Agro.

 

Additionally, the Purchaser acknowledges and agrees that prior to the Closing Date the Companies:

 

(i) shall settle any and all outstanding amounts with the Sellers’ and their group (taking into account or offsetting any amounts or accounts receivables the Companies may have arising from any Tax credits and Tax loss carryforwards applied or used by the Enhol Group companies as a result of the Companies’ participation in the Enhol Tax group in application of the Tax consolidation regime). For such purposes, the Purchaser agrees and acknowledges that the Sellers may contribute any credits against Brotalia to Brotalia by means of a share capital increase of Brotalia or an equity contribution to Brotalia; and

 

(ii) shall settle and repay any Financial Indebtedness of the Companies from sources external to the Companies. In turn, Sellers undertake to cause the Companies to settle and repay any Financial Indebtedness of the Companies from sources external to the Companies prior to the Effective Date.

 

Moreover, on May 21, 2024 the Company acquired 345 shares of Naturcook by virtue of the sale and purchase public deed granted before the Notary of Tudela, Mr. Victor Gonzalez de Echavarri Diaz recorded under No. 994 of his protocol and thus, became the sole shareholder (100%) of Naturcook.

 

All of the foregoing, the “Pre-Closing Reorganization”.

 

The Purchaser acknowledges and agrees that nothing in this Clause 5 shall prohibit or restrict the Sellers or the Companies from taking any action (or omitting to take any action) that is aimed at completing the Pre-Closing Reorganization, in the terms set out in this Clause 5.4. Additionally, the Parties hereby agree that such Pre-Closing Reorganization has been agreed upon by the Parties hereto and no actual or contingent liability of the Companies arising from any of the actions or transactions completed or executed to complete the Pre-Closing Reorganization shall give rise to any claim by the Purchaser to the Sellers under this Agreement and, without prejudice to the foregoing, the Purchaser hereby waives any such claims against the Sellers in relation to the Pre-Closing Reorganization.

 

17


 

6. Closing

 

6.1 Closing Date and place of execution

 

The Closing shall take place within five (5) Business Days from the date on which the Conditions Precedent have been fulfilled (or, as the case may be, have been waived in writing, as provided for in Clause 4.2) on the date to be communicated by the Purchaser to the Sellers at least two (2) Business Days in advance, in Madrid at the offices of the Notary, starting at 4:00 p.m. (CET) unless otherwise agreed by the Parties.

 

6.2 Actions at Closing

 

On the Closing Date, the Parties and the Company shall appear personally or duly represented before the Notary and carry out the following actions, all of which shall be deemed to have occurred simultaneously (en unidad de acto):

 

(i) the Purchaser shall deliver or make available to the Sellers evidence of the satisfaction of the Conditions Precedent set out in Clause 4.1 (only to the extent not already delivered or made available in advance);

 

(ii) the Sellers shall deliver to the Notary the relevant documentation, or make before the Notary the relevant statements, as may be necessary to comply with the provisions of article 160 (f) of the Spanish Companies Act (Ley de Sociedades de Capital), where applicable;

 

(iii) the Sellers shall deliver to the Notary a certificate issued by the secretary of the board of directors of the Company stating that, as of the Closing Date, immediately prior to Closing: (i) according to the Company’s shareholders registry book (libro registro de socios) the Shares represent 100% of the share capital of the Company, have been validly issued, are fully paid in, are owned by the Sellers, and are free and clear from any Charges and Encumbrances; and (iii)  that all requirements established under applicable law and in the by-laws of the Company for the transfer of the Shares to the Purchaser have been fulfilled or waived or otherwise are not applicable;

 

(iv) the Sellers shall exhibit to the Notary the ownership titles over the Shares and instruct the Notary to annotate the transfer (rebaje) in such documents immediately after Closing becoming effective;

 

(v) the Purchaser shall pay the Purchase Price by delivery of Above Common Shares as provided in Clause 3.3, for which purposes the Parties shall perform the actions set out in paragraphs (xii) and through (xv) of this Clause 6.2;

 

18


 

(vi) the Purchaser shall deliver an executed copy of the Nomination Rights Agreement in terms substantially similar to those set forth in Schedule 4.1.3 hereto;

 

(vii) Enhol (a) shall subscribe for Above Common Shares for a total amount of USD 5,000,000 in accordance with the terms and conditions set forth in the Subscription Agreement; and (b) the Purchaser and the Escrow Agent shall execute the Subscription Escrow Agreement;

 

(viii) the Sellers and the Purchaser shall execute a public deed (escritura pública) before the Notary, pursuant to which:

 

(a) this Agreement is formalized into a notarial public deed (elevado a público);

 

(b) each of the Parties confirm that the Conditions Precedent have been satisfied (or waived, if applicable);

 

(c) each of the Sellers, as shareholders of the Company representing 100% of the share capital of the Company, shall expressly consent to the sale and transfer of the Shares to the Purchaser pursuant to this Agreement and shall expressly and irrevocably waive, in connection with the Transaction and for all relevant purposes, the exercise of any pre-emption rights, rights of first refusal, rights of first offer, lock-up arrangements, drag-along or tag-along rights and/or any other similar rights or transfer restrictions which otherwise might be exercised under applicable law and/or the bylaws of the Company, and expressly and irrevocably shall waive its rights to initiate any claims in connection with any such rights, transfer restrictions or procedures for the transfer of the Shares that otherwise might be applicable in connection with the transfer of the Shares to the Purchaser pursuant to this Agreement, and/or otherwise in connection with the Transaction;

 

(d) each of the Parties confirms that all the closing actions required under this Clause 6 have been carried out;

 

(e) the Sellers transfer the Shares to the Purchaser and the Purchaser acquires the Shares from the Sellers, clear from any Charges and Encumbrances;

 

(f) the Sellers shall grant a receipt of payment (carta de pago) for the Purchase Price (each Seller in respect of the amount of the Purchase Price corresponding to such Seller); and

 

(g) the Parties shall repeat and ratify the relevant Representations and Warranties at Closing Date;

 

(ix) The Sellers shall deliver to the Purchaser the written resignations of the directors of the Company and Naturcook pursuant to which each of the such directors resign from their positions in such Companies’ management bodies and declare that they have no claims against any of the relevant Companies, all in accordance with the resignations letter forms attached hereto as Schedule 6.2.(ix);

 

19


 

(x) The Purchaser shall deliver to the Sellers separate letters addressed to each of the directors of the Company and Naturcook undertaking not to bring any action against any of them on any grounds related to or arising out of his position as director of the Company or Naturcook up to the Closing Date (in each case except for fraud (dolo)), all in accordance with the release letter forms attached hereto as Schedule 6.2.(x);

 

(xi) The Purchaser, as sole shareholder of the Company, shall resolve upon the appointment of Mr. Agorreta as sole director of the Companies, provided that Purchaser may designate a board of director as of the closing of the Business Combination;

 

(xii) Enhol and Smart Dine, LLC shall execute and deliver the Transfer Agreement in order to transfer 500,000 Bite common shares to be converted in New Above Shares at the Business Combination and corresponding Registration Rights Agreement and the Bite Transfer Escrow Agreement;

 

(xiii) Bite and Above shall execute and deliver a waiver of Section 5.7 of the Business Combination Agreement with respect to Competing Registration Rights (as defined in the Business Combination Agreement).

 

(xiv) Above shall deposit, or cause to be deposited, with the Exchange Agent, for the benefit of the Sellers evidence of the Purchase Price in Shares \ in book-entry form;

 

(xv) The transfer of the Shares shall be registered in the Company’s shareholders’ registry book (libro registro de socios);

 

(xvi) In relation to the insurance coverage in force at Closing and for the benefit of the Companies or their assets, under the Enhol general insurance policies and/or any other insurance policies entered into by any companies of the Enhol group, including those insurance policies detailed in Schedule 6.2.(xvi), the Purchaser undertakes to carry out all required actions to exclude the Companies from such insurance policies and include them in the relevant Purchaser group's or individual insurance policies with effects as from the Closing Date.

 

(xvii) Enhol, the Purchaser and New Above shall enter into a Non-Competition, Non-Disclosure and Non-Solicitation Agreement on terms substantially similar to those set forth in Schedule 6.2.(xvii) hereto;

 

(xviii) Enhol and the Company shall enter into a non-revolving credit facility (a) for up to a principal amount €146.329,12; (b) for purposes of repaying any amounts due under the confirming facilities of the Companies for amounts drawn thereunder up to May 31, 2024; (c) to be disbursed upon amounts withdrawn under the working capital facilities (créditos para financiación de circulante) of the Companies up to May 31, 2024 becoming due and payable, (d) to be repaid in a single instalment on the date falling twelve (12) months as of the Closing Date (“Maturity Date”), (e) bearing interest at an annual rate of EURIBOR 12 Months to be paid upon maturity and (f) which shall accrue default interest equal to (i) EURIBOR 12 Months plus 400bps (i.e. 4% p.a.) during the first quarter as of the Maturity Date, (ii) EURIBOR 12 Months plus 600bps (i.e. 6% p.a.) during the second quarter as of the Maturity Date, and (iii) from the third quarter as of the Maturity Date onwards EURIBOR 12 Months plus 800bps (i.e. 8% p.a.), on any amounts not paid on its due date through the date on which the payment is actually made.

 

20


 

All actions described above in this Clause 6 must be carried out on the Closing Date, successively as a single act (en unidad de acto), and the validity of such actions shall be subject to the completion of all of them. Accordingly, the Closing will not take place, and therefore the sale and purchase of the Shares shall not be deemed completed (consumada), until all of the actions listed above have been completely fulfilled (or otherwise expressly waived by the Parties).

 

6.3 Post closing undertakings of the Purchaser

 

Immediately following Closing, the Purchaser shall:

 

(i) From the Closing Date, ensure that (a) a representative of Enhol shall be invited to meetings of the Board of Directors of Above, and (b) after the Business Combination, the Board of Directors of New-Above is comprised of at least seven (7) Persons, of which Enhol shall have the nomination rights to one (1) Director in accordance with the Nomination Rights Agreement to be entered into by and among Enhol and the Company;

 

(ii) From the Closing Date onwards, ensure that the Director (or observer, as the case may be) nominated by Enhol in accordance with (i) above, has access to the information provided by any financial, audit and administrative oversight committees to the other members of the board of directors (or observers, as the case may be) in accordance with the Nomination Rights Agreement.

 

6.4 Post-Closing undertakings of the Parties

 

Following the Closing Date, the Purchaser, on the one hand, and Sellers, on the other hand, shall cooperate with each other in good faith, and shall cause their respective Affiliates to cooperate with each other, to facilitate the orderly and smooth transition of the Agro Business sold to Foodys Agro by virtue of the Agro APA and the transfer and assignment of the assets, permits, licenses or otherwise as provided under the Agro APA.

 

6.5 Post-Closing undertakings pre-completion of the Business Combination

 

The Purchaser undertakes to the Sellers that, between the Closing Date and the closing date of the Business Combination Agreement:

 

(i) It shall continue, and it shall procure that the Companies continue, to manage their business in a prudent and ordinary manner, with the diligence of a prudent businessman in compliance with the applicable laws and in the ordinary course of business;

 

21


 

(ii) it shall refrain from approving, or from providing assistance for the approval by the Companies of, any transactions falling outside the ordinary course of its business, except for those deriving from what is expressly provided for in the Agreement or unless there is express prior written consent from the Sellers; and

 

(iii) it shall refrain from dismissing or changing Mr. Gonzalo Agorreta as sole director of the Companies.

 

6.6 Release of guarantees

 

The Purchaser shall use its best efforts to procure that all the securities, guarantees or indemnities given by or binding upon Enhol or any of the Enhol’s Affiliates in respect of any liability of the Companies identified in Schedule 6.6 (the “Existing Guarantees”) are fully, irrevocably and unconditionally terminated no later than six (6) months following of Closing Date. Without limitation to the Purchaser’s obligation set forth herein, the Purchaser shall:

 

(i) use its best efforts to procure that the Existing Guarantees are fully, irrevocably and unconditionally terminated as soon as practicable;

 

(ii) indemnify and hold harmless Enhol, and reimburse Enhol (or at Enhol’s election, its relevant Affiliate(s)) for any losses incurred or suffered by Enhol as a consequence of the enforcement of any of the Existing Guarantees or otherwise during the period commencing on the Closing Date and ending on the date when the relevant Existing Guarantee expires or is released in accordance with this Agreement, directly or indirectly relating to or arising under or in connection with the Existing Guarantees;

 

(iii) irrevocably and unconditionally pay to Enhol, on demand, any disbursement (including the costs or expenses associated to the Existing Guarantees) made by Enhol or any of its Affiliates under or in connection with any Existing Guarantee;

 

(iv) procure that no Existing Guarantee (and, so long as any Existing Guarantee remains in effect, no obligations thereunder) is renewed, extended, expanded or amended without Enhol’s prior written consent; and

 

(v) pay to Enhol, on a quarterly basis (or if the Existing Guarantees are released before the end of a relevant quarter, payment to Enhol shall be made on the date of release of the relevant Existing Guarantees), an amount equivalent to 150bps (i.e. 1,5% p.a.) of the aggregate guaranteed amount, from the Closing Date and until the date on which the relevant Existing Guarantees are fully released (such amount shall accrue on a daily basis).

 

In case that any of the Existing Guarantees is not released on or before the six (6) months following the Closing Date (the “Replacement Date”), then Enhol shall be entitled to receive (in addition to the aforementioned amount), on a monthly basis (i) an amount equivalent to 450bps (i.e. 4,5% p.a.) of the aggregate guaranteed amount, accrued from the Replacement Date and until the earlier of (a) the third (3rd) month as of the Replacement Date and (b) the date on which the relevant Existing Guarantees are fully released; and (ii) if the Existing Guarantees are not fully released on or before the third (3rd) month as of the Replacement Date, an amount equivalent to 800bps (i.e. 8% p.a.) of the aggregate guaranteed amount, accrued from the date that falls on the third months as of the Replacement Date and until the date on which the relevant Existing Guarantees are fully released.

 

22


 

6.7 Preparation and filing of Tax Returns

 

(i) Sellers shall prepare and timely file, or cause to be prepared and timely filed, all Tax Returns in respect of the Companies that (1) are required to be filed (taking into account any applicable extensions) on or before the Closing Date or (2) are required to be filed (taking into account any applicable extension) after the Closing Date but refer to a Taxable event that takes place before the Closing Date and affects Grupo Enhol’s Tax consolidation group.

 

(ii) The Sellers shall prepare or cause to be prepared and timely filed, all Tax Returns required to be filed in respect of the Companies after the Closing Date but related to a taxable period ending on or prior to the Closing Date to the extent it affects Grupo Enhol’s Tax consolidation group. Any such Tax Return shall be prepared on a basis consistent with the past practices of the relevant Company and applicable Law. The Sellers shall deliver to the Purchaser, as promptly as reasonably possible before the due date for the filing of any Tax Return required to be prepared and filed pursuant to this Clause, a copy of such Tax Return, together with any additional information relating thereto that Purchaser may reasonably request. The Purchaser shall have the right to review such Tax Return, statement and additional information, if any, prior to the filing of such Tax Return, and the Sellers shall reflect on such Tax Return any reasonable comments submitted by the Purchaser. The Purchaser shall timely file or caused to be timely filed the Tax Returns as prepared by the Sellers.

 

(iii) The Purchaser shall prepare or cause to be prepared and timely filed, all Tax Returns required to be filed in respect of the Companies for any taxable period beginning on or before, and ending after, the Closing Date to the extent it affects Grupo Enhol’s Tax consolidation group. Any such Tax Return shall be prepared on a basis consistent with past practices of the relevant Company and applicable Law. The Purchaser shall deliver to the Sellers, as promptly as reasonably before the due date for the filing of any Tax Return required to be prepared and filed pursuant to this Clause, a copy of such Tax Return, together with any additional information relating thereto that Sellers may reasonably request. Sellers shall have the right to review such Tax Return, statement and additional information, if any, prior to the filing of such Tax Return, and the Purchaser shall reflect on such Tax Return any reasonable comments submitted by the Sellers.

 

6.8 Brands and Trademarks

 

(i) Enhol shall use its best efforts so that it or its Affiliates delete, remove, retire, cancel or withdraw, within one (1) year as of the Closing Date, any “Foodys” signs or stamps, from (a) all documents (except archives) held at the Companies’ facilities and (b) from all other items at publicly accessible Companies’ facilities as soon as practicable after the Closing Date.

 

23


 

(ii) Notwithstanding the above, the Purchaser agrees that it will not, and will cause its Affiliates not to, assert any claims or rights, bring any suit or institute any other action against the Sellers or their Affiliates in relation to the use of the “Foodys” sign, provided that it is carried out only in the manner they are displayed at the Closing Date.

 

6.9 Transitional Services

 

Enhol and the Purchaser shall negotiate in good faith within a period not exceeding 20 Business Days as of the date hereof, the terms and conditions of an agreement for the provision of transitional services to the Companies, which terms and conditions shall provide, among other things (a) for an initial term of up to twelve (12) months following of Closing Date, which may be extended up to eighteen (18) months; (b) as consideration for such transitional services, Purchaser shall pay Enhol a service fee of EUR 1,400 per month, being equal to the amount of fees currently charged by Enhol to the Companies during such twelve (12) month period with fees after twelve (12) months to be negotiated; and (c) for the same scope of services as currently provided by Enhol to the Companies, in relation to (i) financing (controlling), (ii) human resources, (iii) IT support, (iv) legal and (v) health and safety matters, all in the ordinary course of business and in a manner consistent with past practices. For the avoidance of doubt, any services outside the ordinary course of business or inconsistent with past practices shall fall outside the scope of the transitional services agreement.

 

6.10 Further assurances

 

Following the Closing, each of the Parties hereto shall, and shall cause their respective Affiliates to, execute and deliver such additional documents and instruments and take such further actions as may be reasonably required to carry out the provisions hereof and give effect to the transactions contemplated by this Agreement.

 

7. Representations and Warranties

 

7.1 Purchaser’s Representations and Warranties

 

(i) The Purchaser makes and gives to the Sellers the Representations and Warranties set forth in Schedule 7.1 and represents that they are true and correct as of the Agreement Date and will continue to be true and correct as of the Closing Date.

 

(ii) Each Party represents to the other Party that:

 

(a) it has reviewed, to its entire satisfaction, the Due Diligence Information; and

 

(b) it has no knowledge of any of the Sellers’ Representations and Warranties set forth in Schedule 7.2.(i) and Schedule 7.2.(ii) being incorrect or incomplete.

 

24


 

7.2 Sellers’ Representations and Warranties

 

(i) Each of the Sellers, each of them individually in relation to itself, makes and gives to the Purchaser the Fundamental Representations and Warranties set forth in Schedule 7.2.(i) and represents that such Fundamental Representations and Warranties are true and correct as of the Agreement Date.

 

(ii) Subject to the limitation of liability of the Sellers to the Business Representations and Warranties Liability Cap, the Sellers make and give to the Purchaser on a joint but not several basis (mancomunadamente), pro rata to their participation in the Purchase Price, the Business Representations and Warranties set forth in Schedule 7.2.(ii). The Sellers represent, in respect of such Business Representations and Warranties, that they are true and correct as of the Agreement Date.

 

(iii) For the avoidance of any doubt, the Sellers do not give or make any warranty or representation as to the accuracy of the forecasts, estimates, projections, statements of intent or statements of opinion or other forward-looking information, including in any information memoranda or similar marketing materials, provided to the Purchaser or any of its directors, officers, employees, agents or advisers on or prior to the date hereof.

 

(iv) The Sellers have expressly informed the Purchaser of the need for him to completely rely on its own opinion and on any professional advice that it has received in relation to the Companies and the completion of the transfer of the Shares. The Purchaser acknowledges that it does not rely on and has not been induced to enter into this Agreement on the basis of any warranties, representations or indemnification rights other than those expressly set out in this Agreement and with full acknowledgement and acceptance of the limitation of the liability of the Sellers for breach of Business Representations and Warranties to the Business Representations and Warranties Liability Cap.

 

7.3 Bring-down of the Representations and Warranties on the Closing Date

 

The Representations and Warranties made and given by the Parties on the Agreement Date in relation to the current situation shall be deemed to be automatically repeated, in the same terms, at the Closing Date in relation to the situation then existing, without prejudice to the Sellers being entitled to adapt the content of the Representations and Warranties in accordance with the events or circumstances occurring from the Agreement Date up to the Closing Date.

 

If during the period between the Agreement Date and the Closing Date any event occurs or matter arises of which any of the Sellers becomes aware, which results or may result in any of the Sellers’ Representations and Warranties being untrue or incorrect at the Closing Date, the relevant Seller shall disclose it to the Purchaser at any time before the Closing Date in writing, setting out the details of the matter. Any information so disclosed to the Purchaser will not release the Sellers liability for breach or inaccuracy of the Sellers Representations and Warranties.

 

25


 

8. Rules on Liability

 

8.1 Scope of Liability

 

(i) The Purchaser shall be liable to the Sellers for any breach of its obligations and undertakings under this Agreement and for any Damages or Losses resulting from a breach of the Purchaser’s Representations and Warranties and Covenants.

 

(ii) Any indemnification by the Purchaser under this Agreement shall be paid to the Sellers, by way of delivery of a number of Shares of the Company received on Closing Date, valued at the value agreed in this Agreement, amount to a total value equal to the amount of the Damages or Losses claimed.

 

(iii) Subject to the limitations and qualifications set out in this Clause 8, each Seller shall be individually liable towards the Purchaser for breach of the Seller’s Fundamental Representations and Warranties and for any breach of its obligations and undertakings under this Agreement.

 

(iv) The Sellers shall be liable for any breach of the Sellers’ Business Representations and Warranties exclusively up to the Business Representations and Warranties Liability Cap. Accordingly, the Purchaser shall not be entitled to submit any claim towards the Sellers in connection with any breach of the Business Representations and Warranties for an aggregate amount in excess of the Business Representations and Warranties Liability Cap, except in case of willful misconduct (dolo) of the Sellers.

 

(v) Any indemnification by the Sellers under this Agreement shall be paid to the Purchaser, at the discretion of the Sellers: (i) by way of delivery of a number of Above common stock received on Closing Date (or New Above Common Shares, if applicable and the Business Combination has closed in the interim), subject to the Lock-up Agreement, which, valued at their fair market value as of the date of the claim for indemnification of Damages or Losses, amount to a total value equal to the amount of the Damages or Losses claimed or (ii) in EUR currency. The liability of the Sellers is joint but not several (mancomunada) pro rata to their participation in the total Purchase Price.

 

(vi) The Parties acknowledges that the limitations and qualifications of the liability of each Party as described in this Clause 8 and, particularly, the limitation of liability of the Sellers for any breach of the Sellers’ Representations and Warranties under this Agreement, are essential for the Parties, and that the Parties would not have executed the Agreement on these terms had any type of liability been sought against them for breach of Representations and Warranties in excess of the limitations established in this Clause 8.

 

(vii) The rules on liability regulated in this Clause 8 constitute the sole and exclusive remedy granted to each Party for any breach of any of the corresponding Representations and Warranties or any other breach of this Agreement by any of the Parties, and, to the fullest extent legally permissible, the Parties waive any other remedies to which it may be entitled against the other Party in conformity with Spanish legislation currently in force.

 

26


 

(viii) Likewise, the Purchaser hereby expressly excludes and waives any right of or remedies in relation to frustration of the Agreement based on force majeure or the rebus sic stantibus doctrine applicable by Spanish Courts.

 

8.2 Time limitations to asserting a claim for Sellers’ breach of Representations and Warranties

 

(i) The liability of each Seller to indemnify for any breach of Sellers’ Fundamental Representations and Warranties shall remain in force for five (5) years following the Closing Date.

 

(ii) Without prejudice to the Business Warranties Liability Cap, the liability of each Seller to indemnify for any breach of Sellers’ Business Representations and Warranties shall remain in force for a period of twelve (12) months, except for any breach of Sellers’ Business Representations and Warranties related to Taxes or social security obligations, which shall remain in force for a period equal to the statute of limitations of the relevant claim, plus three (3) months.

 

(iii) Each Seller shall not be liable vis-a-vis the Purchaser for any claims notified by the Purchaser once the periods mentioned in sub-Clauses (i) and (ii) above have expired.

 

8.3 Quantitative limits

 

8.3.1 De Minimis

 

The Sellers shall not be liable for any Damage or Loss resulting from the breach of the Sellers’ Business Representations and Warranties unless it exceeds the De Minimis. For the avoidance of doubt, series of Damages or Losses having the same origin or nature shall be deemed as an individual Damage or Loss for the purposes of this sub-Clause 8.3.1 and, therefore, as an Indemnifiable Damage or Loss, if they jointly exceed the De Minimis, even if each or some of the individual Damages or Losses belonging to the series do not exceed the aforementioned amount.

 

8.3.2 Deductible

 

The Sellers shall not be liable for Damages or Losses from the breach of the Sellers Business Representations and Warranties until the amount of Damages or Losses in excess of the De Minimis suffered by the Purchaser exceeds the Deductible. Once the Deductible is exceeded, the Sellers shall indemnify the Purchaser for the amount of the Damages or Losses that have been suffered by the Purchaser and notified to the relevant Sellers as provided in this Clause 8, in excess of the Deductible.

 

8.3.3 Maximum liability limits

 

(i) The liability of each Seller for Damages or Losses suffered by the Purchaser as a result of any breach of each corresponding Seller’s obligations and undertakings under this Agreement (other than breaches of the Sellers’ Representations and Warranties which shall be governed by paragraphs (ii) and (iii) below) shall not exceed an amount equal to 100% of the Purchase Price paid to such Seller and shall not be subject to the Deductible and De Minimis set forth in the previous paragraphs of this Clause 8.3.

 

27


 

(ii) The liability of the Sellers in respect of all and any claims for breach of the Sellers’ Fundamental Representations and Warranties shall not exceed an amount equal to 100% of the Purchase Price paid to such Seller and shall not be subject to the Deductible and De Minimis set forth in the previous paragraphs of this Clause 8.3.

 

(iii) The liability of the Sellers in respect of all and any claims for breach of the Business Warranties shall not exceed the Sellers’ Business Representations and Warranties Liability Cap.

 

8.3.4 Wilful misconduct

 

None of the limitations contained in Clause 8.3.3 shall apply to a Seller in respect of any claim which arises as the consequence of wilful misconduct (dolo) by that Seller, provided that no Seller shall have any limitations on such Seller’s own liability under this Agreement disapplied in respect of the wilful misconduct (dolo) of other Seller.

 

8.4 Other limitations to the Sellers’ liability

 

The Sellers shall not be liable to the Purchaser if and to the extent:

 

(i) that the Damage or Loss giving right to assert a claim under the Agreement would not have arisen, or increased (in which case, just for the excess) directly as a result of a change in laws, rules, regulations and/or official interpretations of such laws, rules or regulations (including those related to Taxes or accounting rules) occurring on or after the Closing Date;

 

(ii) Subject to Schedule 7.2.(ii) clause 13, that the cause of the inaccuracy of the Representations and Warranties had been disclosed in this Agreement or in the Due Diligence Information or results from the actions carried out by the Sellers and/or the Companies in relation to the Pre-Closing Reorganization;

 

(iii) that the Damage or Loss is covered by an insurance policy entered into by the Companies or the Purchaser;

 

(iv) in cases where the Damage or Loss may be recovered by the Purchaser, the Companies from third parties under a third-party action;

 

(v) that the specific matter is included in calculating creditors or deducted in calculating debtors in the Financial Statements or a provision has been recorded to cover the relevant Damage or Loss or in any other manner the Parties have taken such matter in consideration for the determination of the Purchase Price;

 

(vi) that the Damage or Loss arises from actions or omissions, transactions or arrangements (a) by the Purchaser or by any person from its Group in breach of the Agreement or (b) by the Sellers in compliance with their obligations under this Agreement at the request of or with the prior written approval of the Purchaser;

 

28


 

(vii) the Damage or Loss arises from directly or indirectly arising from force majeure or fortuitous events;

 

(viii) the Damage or Loss arises from involving third-party claims notified by the Purchaser to the Sellers without due prior notice set forth in Clause 8.7; nor

 

(ix) the Purchaser has failed to comply with its good faith obligations to mitigate any loss or liability that may give rise to a Damage or Loss actionable under the Agreement.

 

For the avoidance of any doubt, the Purchaser shall not be entitled to recover more than once for the same damage and loss suffered.

 

8.5 Calculation of Indemnification

 

(i) Any indemnification that may be owed by the Sellers to the Purchaser shall be equal to the amount of the Damage or Loss suffered by the Company or Purchaser, but shall take into account any applicable limitation to the Sellers’ liability set forth in this Clause 8.

 

(ii) In calculating the indemnification payable by the Sellers, an amount equal to any positive effect on the Companies’ corporate income tax charge resulting from the Damage or Loss shall be deducted.

 

(iii) Where possible, the payments made by the Sellers to the Purchaser under this Clause 8 shall be considered a reduction of the Purchase Price.

 

8.6 Payment obligation

 

The Party obliged to pay the indemnification shall do so to the other Party within ten (10) Business Days following the date on which there is an agreement between the Parties or a Ruling on the claim and the claim is net, due and payable.

 

8.7 Claims procedure

 

8.7.1 Direct Claim

 

(i) Notification of claim

 

A Party that considers that a circumstance has arisen that may give rise to the indemnification obligation under this Agreement shall inform the other Party pursuant to the provisions of Clause 11.7 within the following twenty (20) Business Days counted from the date that such Party became aware of the fact, circumstance or matter that give rise to the indemnification obligation under this Agreement.

 

29


 

(ii) Negotiation between the Parties

  

a. The Parties shall negotiate in good faith for a period of twenty (20) Business Days counted from the date of the notice referred to in this Clause 8.7.1, in an attempt to reach an agreement on the existence of liability and the amount of the indemnification to be paid by reason thereof.

 

b. If an agreement is not reached within the period referred to in letter a above, the Party against which the claim is made shall notify the other Party in writing, within ten (10) Business Days following the end of the period of negotiations referred to above, of whether it rejects or acknowledges its liability and, in this case, the amount that it acknowledges as being obliged to pay.

 

c. If liability is acknowledged, the amount acknowledged must be paid within not more than ten (10) Business Days counted from the date on which the notice referred to in section b. was sent, without prejudice to the right of the Party in question to seek the balance of its claim.

 

d. It shall be assumed that liability is not accepted if within the period indicated in a. above no written notice is sent to the other Party.

 

(iii) Absence of agreement between the Parties

 

If the Parties do not reach an agreement in the negotiations provided for in sub-clause 8.7.1, the Parties shall proceed pursuant to the procedure provided for in Clause 12.

 

8.7.2 Third-party claims

 

(i) Notification of third-party claim

 

Within fifteen (15) days from receipt by the Companies of the third-party claim, but not later than the date which provides the Sellers with at least half (1/2) of the legal period for answering such claim before it expires, the Purchaser shall inform the Sellers in writing pursuant to the provisions of Clause 11.7.

 

(ii) Accompanying documentation

 

The Purchaser shall accompany with the notice any and all information and documentation as it may have on the third-party claim.

 

(iii) Defense against claim

 

a. The Sellers may assume the defense against the third-party claim provided that the Sellers: (i) have acknowledged, previously and in writing, their actual or potential liability for the Damage or Loss resulting from the third-party claim; and (ii) expressly agree to bear the costs and expenses that such challenge or opposition entails;

  

30


 

b. If the Sellers do not expressly acknowledge their actual or potential liability for the third party claim, nor do they notify that they are interested in taking charge of the defense against the third-party claim, then, within four (4) Business Days from the date of receipt of the notice sent by the Purchaser pursuant to sub-clause 8.7.2(i) above, the Purchaser may take charge of the legal defense against the third-party claim, at its entire discretion, although this shall not howsoever reduce or limit the liability of the Sellers for the third-party claim as provided for in the Agreement.

 

c. Any appeals, remedies or defenses against the third-party claim must be filed, sought or conducted in a prudent and reasonable manner, taking into consideration the interests of the Companies. If the claim arises from events or circumstances that may also give rise to a Damage or Loss for which the Sellers should not be liable pursuant to the Agreement, the applicable rights and means of defense shall be exercised and used by the Parties on a coordinated basis, in the most neutral manner possible.

 

d. The Purchaser shall grant such powers of attorney as may be required to the advisers designated by the Sellers in cases where, in accordance with the provisions of the preceding sub-clauses, the Seller assumes the defense against the third-party claim.

 

e. The Party that assumes the defense against the third-party claim shall keep the other Party informed of the progress thereof on a timely basis.

 

f. If the third party is ordered to pay to the Companies, or to the Purchaser fees or costs of any nature in respect of such proceedings, such amounts, if delivered to the Companies, to the Purchaser or to the advisers thereof, shall be used to promptly reimburse the Sellers from those duly justified costs borne by the Sellers in connection with the defense of the corresponding third party claim.

 

(iv) Settlements

 

a. The Sellers may reach an agreement with the third party or request the Purchaser to cause the Companies to do so, provided that, prior to or at the same time as being bound by such agreement, it first: (i) makes available to the Purchaser or the Companies the funds that the Purchaser or the Companies must pay to the third party under the agreement; and (ii) obtains the Purchaser’s written consent, which may not be unreasonably withheld or delayed.

 

b. The Purchaser may not settle any claim for which it intends to claim the Sellers for liability under this Agreement without the prior written consent of the Sellers, which may not be unreasonably withheld or delayed.

 

31


 

9. Post-Closing Undertakings of the Parties

 

9.1 Non-competition undertaking of the Sellers

 

The Sellers undertake, for a period of two (2) years, counted from the Agreement Date, not to directly or indirectly through any of its Affiliates carry on, be engaged or economically interested in, or provide any services to, or have any direct or indirect interest in any activity that competes with any of the Companies in the Business.

 

Likewise, the Sellers undertake not to be an attorney-in-fact or to participate directly or indirectly through any of its Affiliates in the capital of companies or entities which develop the Business in any of the territories where any of the Companies currently operates. For the avoidance of doubt any potential investments in companies which core business is not the Business but may have non-core operations in the Business and minority investments without right to appoint any member to the board of directors of the relevant company operating in the Business shall not be deemed a breach of this undertaking by the Sellers.

 

Notwithstanding the above, none of the following activities shall constitute a violation of this Clause 9.1: (i) production, packaging, marketing and sales of fresh aromatic herbs in Spain and abroad; (ii) research, cultivation, production, dehydration, packaging, pressing, storage, selection, certification, marketing, sale, trading and distribution of alfalfa, corn, oats, fescue, fodder, cereal straw, fodder silage, wood, seeds and the like, and other animal feed products with milling and granulation and/or silage, intended for animal feed in Spain and/or abroad, (iii) research, cultivation, production, selection and marketing of alfalfa and corn, as well as the study of improvement techniques in Spain, and/or (vi) purchase, sale and exploitation of agricultural land, agricultural machinery and industrial and agricultural installations, as well as agricultural promotion and development and the provision of common services that serve that purpose.

 

9.2 Non-solicitation undertaking of the Sellers

 

The Sellers undertake, for a period of two (2) years, counted from the Agreement Date, not to directly or indirectly through any of its Affiliates solicit or entice, or attempt to solicit or entice, or offer employment to or enter into a contract for the services, any individual who is at the time of the offer or attempt or was during the twelve (12) months immediately previous to the Agreement Date, a board member, executive or employee or advisor/consultant of any of the Companies, or cause them to terminate their employment or services relationship with any of the Companies, provided that this Clause 9.2 shall not prevent the Sellers from employing any individual who responds to a public advertisement for the relevant vacancy placed by or on behalf of the Sellers.

 

Similarly, the Sellers undertake, for a period of two (2) years, counted from the Agreement Date, not to directly or indirectly through any of its Affiliates solicit or take any action intended to discourage any lessor, licensor, customer or supplier (a “Business Partner”) of the Companies from maintaining the same business relationships with the Company after the Closing as such Business Partner maintained with the Company immediately prior to the Closing.

 

32


 

9.3 Consequences of a breach

 

In the event of a breach by a Seller of the undertakings referred to in Clauses 9.1 and 9.2, the Purchaser shall have the following cumulative rights:

 

(i) to be indemnified for any damage or loss caused to it; and

 

(ii) to obtain immediate cessation of the breach.

 

For the avoidance of doubt, each Seller shall be individually liable for his breach of the non-compete or non-solicitation undertakings in this Clause and the Purchaser may not be entitled to claim against a non-breaching Seller.

 

10. Duty of confidentiality

 

The Parties hereby undertake to keep strictly confidential any information on the other Party to which they may have had access as a result of the negotiations held and of the execution of the Agreement and, except to the extent otherwise expressly permitted by the Agreement or mandated by applicable laws, not to directly or indirectly reveal, report, publish, disclose, transfer or use for its own or any other purposes such information.

 

As an exception to the foregoing, the Parties may disclose information considered confidential in the following cases:

 

(i) where the disclosure of the information is required by law or in the context of a court or arbitral proceeding or at the request of and administrative or regulatory body to which the relevant Party is subject, regardless of where such court or body is located and of whether the disclosure requirement has the force of law;

 

(ii) where it is necessary for its employees, professional advisers, shareholders, auditors or financial institutions to have knowledge of a certain item of information, knowledge which shall be subject to the appropriate confidentiality agreement or duty;

 

(iii) where the information is in or has come into the public domain through no fault of that Party;

 

(iv) where the disclosure is made by any of the Parties to its shareholders, or to the investors of funds managed or administered by the entities which directly or indirectly manage such Party;

 

(v) where the disclosure of information is necessary so that one Party may demand the observance of the rights which are available to it under the Agreement; or

 

(vi) where the other Party has given prior written consent to the disclosure.

 

The duty of confidentiality established in this Clause 10 shall apply even in the event of termination of the Agreement, for a term of five (5) years after termination.

 

33


 

If the Agreement is terminated for any reason before the Closing Date, the Purchaser shall destroy or return to the Sellers all of the information that it has received from the Sellers and is in the possession of any of its board members, employees or advisers, and may not use such information for commercial purposes under any circumstances.

 

11. Miscellaneous

 

11.1 Entire agreement

 

The Agreement supersedes all other agreements or contracts, written or oral, concluded between the Parties prior to the execution of the Agreement in relation to the subject matter hereof.

 

11.2 Amendments

 

Any amendment to the Agreement that is not set forth in writing and is not formalized by the Parties in the same manner as the Agreement shall be null and void and display no effects between the Parties.

 

11.3 Partial invalidity

 

(i) Any finding by a court or administrative body that one or more Clauses of the Agreement are unlawful, null and void, invalid or unenforceable in whole or in part shall not render unlawful, null and void, invalid, or unenforceable the other Clauses or the remaining parts thereof, which shall remain fully valid wherever applicable, all the foregoing provided that the Clauses or part thereof found to be unlawful, null and void, invalid or unenforceable are not essential.

 

(ii) The Clauses or parts thereof found to be unlawful, null and void, invalid or unenforceable shall be deemed to have been removed from the Agreement or not applicable in that circumstance, as the case may be, and the Parties shall negotiate in good faith the substitution thereof and the measures that are most suited to the aim pursued by such Clauses or parts thereof.

 

11.4 Assignment

 

Neither of the Parties may assign its rights or obligations under the Agreement without the prior written consent of the other Party.

 

Notwithstanding the foregoing, the Purchaser may assign its rights and obligations arising from the Agreement in whole or in part on or after the Closing Date to a wholly-owned subsidiary, subject to the Purchaser effectively delivering to the Sellers the New-Above Shares to be received by the Sellers in accordance with Clause 3.3 and the Purchaser remaining joint and severally (solidariamente) liable vis-à vis the Sellers for the Purchaser’s obligations under this Agreement, in general and, particularly, in relation to payment of the Earn-Out, as if it were the principal obligor and executing such assignment and joint and several (solidaria) guarantee subject to the laws of Spain in front of a Spanish Notary on Closing.

 

34


 

The Sellers shall cooperate to the necessary extent to consummate the assignment referred to in this Clause 11.4 whenever so required by the Purchaser.

 

11.5 Waiver of defenses

 

(i) A waiver by one of the Parties to seek performance of any of the obligations provided for in the Agreement or to exercise or seek any of the rights or remedies to which it is hereby entitled:

 

(a) shall not release the other Party from the obligation to fully perform the other obligations contained in the Agreement; and

 

(b) shall not be deemed a waiver of the right to seek performance in the future of any obligation or to exercise or seek any rights or remedies provided for in the Agreement.

 

(ii) The dispensation, deferral or waiver of any of the rights established in the Agreement, or of a part of such rights:

 

(a) shall only be binding if stated in writing, unless a stricter form is required by mandatory law;

 

(b) may be made subject to such conditions as the Party granting such dispensation, deferral or waiver sees fit;

 

(c) shall be limited to the specific case in which it occurred; and

 

(d) shall not affect the enforceability in other cases of the right affected by it, nor the enforceability of any other right existing in relation to the Parties.

 

11.6 Expenses and Taxes

 

Each Party shall bear the costs that it may have incurred in preparing, negotiating and executing the Agreement.

 

The Purchaser shall bear the notaries’ fees incurred upon notarization of the Agreement and upon transfer of the Shares by way of the execution of the Share Transfer Agreement.

 

For the avoidance of doubt:

 

(i) Any transfer Taxes (including real estate transfer tax), charges, fees or duties resulting from the implementation and consummation of this Agreement shall be borne by the Purchaser.

 

(ii) Any Taxes other than the transfer Taxes referred to in the previous paragraph shall be borne by the Parties in accordance with the applicable laws.

 

35


 

11.7 Notices

 

11.7.1 Requirements

 

Any notices, authorizations, consents and other communications relating to the Agreement:

 

(i) shall be drafted in English, unless they are documents required by regulations or other types of official documents to be in Spanish, in which case they shall be accompanied by their respective sworn translations into English if so requested by the addressee;

 

(ii) must be made in writing, unless a stricter form is required by mandatory law;

 

(iii) shall be delivered by hand, with acknowledgement of receipt, or shall be sent by any means that provides proof of the contents and the date on which the notice was sent, including e-mail; and

 

(iv) shall be sent to the addresses or e-mail addresses indicated in Clause 11.7.3, or, if the addressee indicates any other address shall be sent to such address.

 

11.7.2 Notification date

 

Notices are deemed effected on the date on which they are sent.

 

11.7.3 Addressees and delivery addresses

 

Notices must be delivered to the persons and at the addresses set forth below:

 

The Purchaser

 

For the attention of Lionel Kambeitz
Address: 2305 Victoria Ave #001, Regina, SK S4P 0S7

E-mail: lionel@abovefood.com, with a copy to michelle.westerman@abovefood.com

 

Enhol

 

For the attention of Mr. Gonzalo Oliver Amatriain
Address: C/ Frauca nº 13, Tudela, Navarra (Spain)

E-mail: goliver@enhol.es

 

Mr. Agorreta

 

Address: C/ Frauca nº 13, Tudela, Navarra (Spain)

E-mail: gagorreta@grupofoodys.com

 

36


 

11.8 Payment in full

 

All payments provided for in the Agreement must be made in full and without being reduced by way of set-off of balances or counterclaim, deductions or withholdings.

 

11.9 Default interest

 

(i) If any of the amounts provided for in the Agreement is not paid on its due date, interest shall automatically accrue thereon from such payment due date through the date on which the payment is actually made, with no prior demand or notice being necessary. The applicable annual interest rate in such case shall be equal to EURIBOR 12 Months plus 750bps (i.e. 7,5% p.a.).

 

(ii) Any default interest so accrued shall be considered due and payable immediately, shall be compounded monthly and shall bear fresh default interest as soon as it is compounded.

 

(iii) Such default interest shall be paid at the time of payment, in whole or in part, of the outstanding principal and with preference over the latter. However, if the principal is paid before the accrued interest is settled, the obligation to pay the accrued default interest shall remain in force.

 

11.10 Public announcements

 

Unless otherwise required by applicable law, no Party to this Agreement shall make any public announcements in respect of this Agreement or the transactions contemplated hereby without the prior written consent of the other Party (which consent shall not be unreasonably withheld, conditioned or delayed), unless otherwise required by securities laws, and the Parties shall cooperate as to the timing and contents of any such announcement.

 

11.11 Termination.

 

This Agreement shall terminate upon the earliest to occur of (i) the termination of the Business Combination Agreement or its amendment or modification in any manner that has a materially disproportionate adverse effect for the Sellers (relative to the adverse effect on the other parties to the Business Combination Agreement), (ii) material breach of this Agreement by any party hereto and (iii) the Longstop Date (in the cases set forth in Clauses 4.3 and 4.4).

 

12. Applicable law and Jurisdiction

 

12.1 Applicable law

 

The Agreement shall be governed by, and interpreted under, the laws of Spain (“legislación española de territorio común”), excluding conflict of laws rules.

 

37


 

12.2 Jurisdiction

 

The Parties expressly waive any other jurisdiction to which they may be legally entitled, and expressly submit the resolution of any disputes or claims arising over the interpretation or performance of the Agreement, including those relating to any non-contractual obligations arising from or related to it, to the courts of the city of Madrid (Spain).

 

[Signature page and Schedules follow]

 

38


 

IN WITNESS WHEREOF, the Parties have executed the Agreement in the place and on the date first above written.

 

Above Food Corp.    
     
/s/ Lionel Kambeitz    
Lionel Kambeitz    
Authorized Signatory    
     
Mr. Gonzalo Agorreta Preciado   Grupo Empresarial Enhol, S.L.
     
/s/ Mr. Gonzalo Agorreta Preciado   /s/ Mr. Gonzalo Oliver Amatriain
    Mr. Gonzalo Oliver Amatriain
    Attorney-in-fact

 

39


 

Schedule VI
Details of the Shares owned by the Sellers and title to the Shares corresponding to each Seller*

 

Seller(s) Amount of Shares Shares’
Numbering
Title
Grupo Empresarial Enhol, S.L. 3,000 1-3,000 Public Deed of Incorporation granted before the Notary of Navarra, Mr. Antonio-Luis Vitoria Blanco, on December 14, 2016 under No. 1,501 of his protocol.  
9 3,001-3,009 Share Capital increase granted into a public deed before the Notary of Navarra, Mr. Antonio-Luis Vitoria Blanco, on July 20, 2017 under No. 952 of his protocol.  
81,991 3,541-85,351 Share Capital increase granted into a public deed before the Notary of Navarra, Mr. Antonio-Luis Vitoria Blanco, on December 20, 2019 under No. 1,499 of his protocol.  
Mr. Gonzalo Agorreta Preciado 531 3,010-3,540 Share Capital increase granted into a public deed before the Notary of Navarra, Mr. Antonio-Luis Vitoria Blanco, on July 20, 2017 under No. 952 of his protocol.  
14,469 85,352-100,000 Share Capital increase granted into a public deed before the Notary of Navarra, Mr. Antonio-Luis Vitoria Blanco, on December 20, 2019 under No. 1,499 of his protocol.  

 

*For the avoidance of doubts, this Schedule VI shall be updated on Closing Date to reflect any newly issued shares, as the case may be, in connection with the share capital increase of Brotalia approved in the framework of the Pre-Closing Reorganization and formalized by virtue of the public deed granted on June 3, 2024, in front of the Notary of Tudela, Mr. Víctor González de Echávarri Díaz, under number 1.151 of his official records, filed but pending to be registered before the relevant Commercial Registry Schedule 3.1 Purchase Price Allocation

 


 

 

Seller(s)   Percentage     Purchase Price in
USD
    Amount of
Shares
 
Grupo Empresarial Enhol, S.L.     85 %     11,050,000.00       5,253,351  
Mr. Gonzalo Agorreta Preciado     15 %     1,950,000.00       927,062  

 


 

Schedule 3.3
New-Above Lock Up Periods

 


 

Schedule 3.5

Joinder Agreement to Registration Rights Agreement

 


 

Schedule 4.1.3

Nomination Rights Agreement

 


 

Schedule 5.2
Permitted actions between the Agreement Date and the Closing Date

 

1. To negotiate, enter into, amend, extend or complete any actions, agreements, contributions, investments or otherwise in accordance with or in relation to the Innomy MoU.

 

2. To negotiate, enter into, amend, extend or complete any actions, agreements, contributions, investments or otherwise in accordance with or in relation to the Cocuus MoU and/or the Cocuus Collaboration Agreement.

 

3. Applying for and entering into any agreements with Centro para el Desarrollo Tecnológico y la Innovación (CDTI) and/or Vidara Life Ingredients, S.A.U., DCOOP, Sociedad Cooperativa Andaluza, KIMITEC BIOGROUP, S.L., and Cocuus System Iberica, S.L. (the “Consortium”), which are collaborating for purposes of, among others, conducting research on technological solutions to obtain alternative protein sources and bioactive compounds and their formulation into innovative food products, in accordance with a Cooperation Agreement entered into by the Consortium. The entities in the Consortium have applied for financing of a project called “New strategies to feed the future: Biotechnological solutions for the production of mycelial protein, single-cell protein and bioactive ingredients for the formulation of technological and healthy foods” (Nuevas estrategias para alimentar el futuro: Soluciones biotecnológicas para la obtención de proteína de micelio, proteína unicelular e ingredientes bioactivos para la formulación de alimentos tecnológicos y saludables - MICEL).

 


 

Schedule 6.2.(ix)
Form of Resignation Letters

 

Attn. [●]

 

___________ (the “Closing Date”)

 

Dear Sirs,

 

I hereby irrevocably resign from my position as [member of the board of directors] of [Brotalia, S.L. / Naturcook Innovaciones, S.L.] (the “Company”), effective as of the date hereof. I confirm that I have no claim whatsoever against the Company in respect of any cause, matter or circumstances arising from my position as [director] and/or my resignation hereof.

 

Sincerely,

 

_______________________________

 

[●]

 


 

Schedule 6.2.(x)
Form of Release Letters

 

Attn. [●]

 

___________ (the “Closing Date”)

 

Dear Sir:

 

Pursuant to the terms and conditions set forth in this release letter (the “Release Letter”), Above Food Corp. (the “Purchaser”), new sole shareholder (either directly or indirectly) of Brotalia, S.L. and Naturcook Innovaciones, S.L. (the “Companies”), hereby releases and forever discharges (both in its name and on behalf of the Companies) Mr. [●] (the “Director”) from any and all present and past liability, losses, obligations and indemnifications arising in full or in part or relating to his position as [director] of the Companies, except in cases of wilful misconduct (dolo) (collectively, the “Discharged Liabilities”).

 

The Purchaser hereby expressly agrees to not file and to cause the Companies to not file, any lawsuits or claims against the Director for any Discharged Liability except in cases of willful misconduct (dolo).

 

The Purchaser expressly accepts and acknowledges that the release and discharge provided herein is and will be fully binding between the Purchaser, its group of companies, its shareholders and any transferee or beneficiary of the foregoing and the Directors.

 

Furthermore, the Purchaser accepts and undertakes to not transfer the shares of the Companies without the new purchaser expressly and previously waiving any actions against the Directors in the terms and conditions and to the same extent contemplated herein.

 

This Release Letter prevails over any other previous agreement between the Companies, the Purchaser and the Directors in relation to the subject matter of this Release Letter and will be governed by and construed and interpreted in accordance with Spanish law.

 

Sincerely,

 

______________________________________

 

[●]

 


 

 

Schedule 6.2.(xii) 

Transfer Agreement

 

 


 

ASSIGNMENT AND TRANSFER AGREEMENT

 

This Assignment and Transfer Agreement (this “Agreement”), dated as of June 19, 2024, is made and entered into by and between Smart Dine, LLC, a Delaware limited liability company (“Transferor”), and Grupo Empresarial Enhol, S.L. (“Transferee”).

 

WHEREAS, Transferor owns shares of common stock, par value $0.0001 per share (“Founder Shares”), of Bite Acquisition Corp., a Delaware corporation (the “Company”), which was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination (a “Business Combination”);

 

WHEREAS, the Company has entered into a Business Combination Agreement, dated April 29, 2023 (as amended to date, and as may be further amended and/or amended and restated from time to time, the “Business Combination Agreement”), with Above Food Corp. (“Above Food”), Above Food Ingredients Inc. and Above Merger Sub, Inc.;

 

WHEREAS, Transferee is a party to that certain Subscription Agreement, dated June 19, 2024 (the “Subscription Agreement”), with Above Food which, among other things, contemplates the subscription by the Transferee of 2,377,082 Common Shares of Above Food (the “Transaction”);

 

WHEREAS, Transferor is a party to that certain Stock Escrow Agreement, dated February 11, 2021 (as may be amended and/or amended and restated from time to time, the “Escrow Agreement”), with the Company and certain other parties, which, among other things, restrict transfers of the Sponsor Shares;

 

WHEREAS, in connection with the Transaction, Transferor desires to assign and transfer 500,000 of its Founder Shares to Transferee, as a permitted transfer under Section 4.3 of the Escrow Agreement and Transferee wishes to accept such assignment and transfer and be bound by the terms of this Agreement;

 

NOW, THEREFORE, in consideration of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows:

 

Section 1. Assignment of Shares. Transferor hereby assigns and transfers to Transferee an aggregate of 500,000 of its Founder Shares (the “Transferred Shares”), and Transferee hereby accepts the Transferred Shares from Transferor, such assignment and transfer to be effective as of the date hereof; provided, however, that as a condition to such assignment and transfer Transferee shall have become a party to the Escrow Agreement by executing and delivering to the Company a joinder thereto in form attached hereto as Exhibit A.

 

Transferee shall pay to the Trasnferor a total of $0.0001 per Transferred Share in cash consideration. Additional consideration for the transactions contemplated by this Agreement is provided as described in the Introduction to this Agreement.

 

 

3 


 

Section 2. No Conflicts. Each party represents and warrants that neither the execution and delivery of this Agreement by such party, nor the consummation or performance by such party of any of the transactions’ contemplated hereby, will with or without notice or lapse of time, constitute, create or result in a breach or violation of, default under, loss of benefit or right under or acceleration of performance of any obligation required under any agreement to which it is a party.

 

Section 3. Transferee Representations, Acknowledgments and Agreements.

 

(a)            Transferee acknowledges and hereby agrees that the Transferred Shares are subject to restrictions as set forth in the Escrow Agreement, including the lock-up provisions therein, and acknowledges that it has read and understands the terms thereof. Transferee further understands that any certificates evidencing the Transferred Shares will bear a legend referring to the foregoing provisions.

 

(b)            Transferee represents and warrants that the Transferred Shares are being acquired solely for Transferee’s own account, for investment purposes only, and are not being acquired with a view to or for the resale, distribution, subdivision or fractionalization thereof; and Transferee has no present plans to enter into any contract, undertaking, agreement or arrangement for such resale, distribution, subdivision or fractionalization. Transferee further represents and warranties that (a) it is an “accredited investor” as defined in Regulation D promulgated by the Securities and Exchange Commission under the Securities Act of 1933, as amended, (b) it is able to bear the risk of its investment in the Transferred Shares for an indefinite period of time, and (c) it has been given the opportunity to (i) ask questions of and receive answers from Transferor, Above Food and the Company concerning the terms and conditions of the Transferred Shares, and the business and financial condition of the Company and Above Food and (ii) obtain any additional information that Transferor, Above Food or the Company possesses or can acquire without unreasonable effort or expense that is necessary to assist Transferee in evaluating the advisability of the receipt of the Transferred Shares and an investment in the Company (and, following the closing of the Business Combination, Above Food).

 

(c)            Transferee acknowledges that it is not relying on any representation, whether oral or written, made by any person or entity (including, without limitation, the Company, Transferor, Above Food or any of their respective officers, directors, employees or representatives) as to the Transferred Shares, the Company or Above Food, or the respective operations, business, financial condition or prospects of the Company or Above Food, other than the representations contained in Section 2 of this Agreement.

 

Section 4. Assignment of Rights. Neither party hereto may assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other party hereto.

 

Section 5. Survival of Representations, Warranties. All agreements, representations and warranties made herein shall survive the execution and delivery of this Agreement. All representations and warranties shall be effective regardless of any investigation made or which could have been made.

 

4 


 

Section 6. Governing Law. This Agreement and the rights and obligations of the parties hereunder shall be construed in accordance with and governed by the laws of New York, United States of America, applicable to contracts wholly performed within the borders of such state.

 

Section 7. Miscellaneous. This Agreement, together with the certificates, documents, instruments and writings that are delivered pursuant hereto, constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter. This Agreement may be executed in two or more counterparts (including facsimile or PDF counterparts), each of which will be deemed an original but all of which together will constitute one and the same instrument. This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by all parties hereto.

 

[The remainder of this page has been intentionally left blank.]

 

5 


 

IN WITNESS WHEREOF, the undersigned have executed this Agreement to be effective as of the date first set forth above.

 

TRANSFEROR:
     
  SMART DINE, LLC
     
  By: Name: Alberto Ardura
    Title: CEO
     
  TRANSFEREE:
     
  By:
    Name:
    Title:

 

 

Acknowledged:  
     
BITE ACQUISITION CORP.  
     
By:  
  Name: Alberto Ardura  
  Title: CEO  

 

 


 

Schedule 6.2.(xvi) 

Insurance Policies

 

Policy holder Insured Insurer Term Insurance No. Insurance
coverage
Grupo Empresarial Enhol, S.L. Brotalia, S.L. QBE Europe SA/NV Sucursal en España March 31, 2023 –March 31, 2025 061 0004041 General third-party civil liability and professional liability insurance
Grupo Empresarial Enhol, S.L. Naturcook Innovaciones, S.L. QBE Europe SA/NV Sucursal en España March 31, 2024 –March 31, 2025 061 0004041 General third-party civil liability and professional liability insurance

 

For the sake of insurance coverage in relation to D&O in force at Closing and for the benefit of the Companies, under the Enhol general insurance policies shall terminate on Closing Date.

 

 


 

Schedule 6.2.(xvii) 

Non-Competition, Non-Disclosure and Non-Solicitation Agreement

 

 


 

NON-COMPETITION, NON-DISCLOSURE

AND NON-SOLICITATION AGREEMENT

 

BETWEEN

 

GRUPO EMPRESARIAL ENHOL, S.L.

 

– and –

 

ABOVE FOOD CORP.

 

– and –

 

ABOVE FOOD INGREDIENTS INC.

 

[ ● ] , 2024

 

 


 

TABLE OF CONTENTS

 

Page

 

ARTICLE 1 INTERPRETATION 2
     
1.1 Definitions 2
1.2 Certain Rules of Interpretation 6
1.3 Governing Law 6
1.4 Entire Agreement 7
     
ARTICLE 2 COVENANTS OF THE SELLER 7
     
2.1 Non-Competition 7
2.2 Portfolio Exemption 8
2.3 Non-Solicitation of Customers 8
2.4 Non-Solicitation of Employees 8
2.5 Confidentiality 9
2.6 Covenants Reasonable 11
2.7 Covenants Independent 11
     
ARTICLE 3 GENERAL 12
   
3.1 Notices 12
3.2 Severability 13
3.3 Submission to Jurisdiction 13
3.4 Amendment and Waiver 14
3.5 Further Assurances 14
3.6 Assignment and Enurement 14
3.7 Electronic Signatures and Delivery 15
3.8 Counterparts 15
3.9 Conduct of Parties 15
3.10 No Contra Proferentem 15

 

-i


 

NON-COMPETITION, NON-DISCLOSURE AND NON-SOLICITATION AGREEMENT

 

THIS AGREEMENT is dated as of [●] 2024

 

BETWEEN:

 

GRUPO EMPRESARIAL ENHOL, S.L., 

a Spanish company, with registered office in Tudela (Navarra), calle Frauca, nº 13, Spain, registered at the Commercial Registry of Navarra at volume 212, sheet 20, page NA-4.525, and with taxpayer identification number B-31227200

 

(“Enhol” or the “Seller”)

 

- and -

 

ABOVE FOOD CORP., 

a corporation continued under the laws of Alberta

 

(the “Buyer”)

 

- and -

 

ABOVE FOOD INGREDIENTS INC., 

a corporation incorporated under the laws of Alberta

 

(“New Above”)

 

CONTEXT

 

Under the terms of a Shares Sale and Purchase and Exchange Agreement (the “Purchase Agreement”) dated as of June 13, 2024 between the Seller, Mr. Gonzalo Agorreta (“Mr. Agorreta”) and the Buyer, the Seller and Mr. Agorreta agreed to sell and the Buyer agreed to buy all of the issued and outstanding shares of Brotalia, S.L. (“Brotalia”) from the Seller and Mr. Agorreta (the “Purchase and Sale”).

 

As per the Purchase Agreement, the execution and delivery of this Agreement by the Seller, is a closing action thereunder.

 

 


 

The Seller recognizes and acknowledges Buyer’s interest in protecting, among other things, Brotalia's relationship with its employees and customers and the goodwill associated with its ongoing business.

 

Simultaneously to the closing of the Purchase Agreement, Enhol and New Above entered into a nomination rights agreement (the “Nomination Rights Agreement”) dated as of [·] 2024 in respect of certain nomination rights to be granted to Enhol, in accordance with the terms and conditions thereof.

 

Pursuant to the Nomination Rights Agreement, Enhol will be entitled, following the Business Combination (as defined below), to nominate one director to the board of directors of New Above (the “Director Nominee”).

 

The Director Nominee will have access to sensitive, proprietary and confidential information of New Above.

 

New Above would not have entered into the Nomination Rights Agreement without Enhol concurrently entering into this Non-Competition, Non-Disclosure and Non-Solicitation Agreement.

 

THEREFORE, the Parties agree as follows:

 

INTERPRETATION

 

Definitions

 

In this Agreement, in addition to the terms defined elsewhere in this Agreement, the following terms have the following meanings:

 

“ABCA” means the Business Corporations Act (Alberta).

 

“Affiliate” means an affiliate as that term is defined in the ABCA.

 

“Agreement” means this agreement as it may be confirmed, amended, supplemented or restated by written agreement between the Parties.

 

“Arrangement” means the arrangement under Section 193 of the ABCA, whereby, among other things, the Purchaser and New Above will complete the Share Exchange.

 

“Bite” means Bite Acquisition Corp., a Delaware corporation.

 

“Business” means the business of Brotalia consisting of (a) the development, production and commercialization of (i) pre-cooked processed animal protein products and (ii) products made with alternative protein, for human consumption, (b) the development and research of new products, technologies or processes for the manufacture of edible products for human consumption, and (c) food tech project acceleration consultancy.

 

 


 

For the avoidance of doubt, the following activities shall be deemed expressly excluded from the definition of Business for purposes of this Agreement: (i) production, packaging, marketing and sales of fresh aromatic herbs in Spain and abroad; (ii) research, cultivation, production, dehydration, packaging, pressing, storage, selection, certification, marketing, sale, trading and distribution of alfalfa, corn, oats, fescue, fodder, cereal straw, fodder silage, wood, seeds and the like, and other animal feed products with milling and granulation and/or silage, intended for animal feed in Spain and/or abroad, (iii) research, cultivation, production, selection and marketing of alfalfa and corn, as well as the study of improvement techniques in Spain , (iv) purchase, sale and exploitation of agricultural land, agricultural machinery and industrial and agricultural installations, as well as agricultural promotion and development and the provision of common services that serve that purpose and/or (v) any activity not expressly included in the first paragraph of this Business definition.

 

“Business Combination” means the business combination of the Purchaser and Bite pursuant to the Business Combination Agreement, whereby, among other things, the Purchaser and New Above will complete the Arrangement, and immediately following the Arrangement, Merger Sub and Bite will complete the Merger.

 

“Business Combination Agreement” means the business combination agreement dated as of April 29, 2023, as amended on March 12, 2024, between the Purchaser, New Above, Bite and Merger Sub, in respect of the Business Combination.

 

“Business Day” means any day excluding a Saturday, Sunday or statutory holiday in the Province of Alberta, and also excluding any day on which the principal chartered banks located in the City of Calgary are not open for business during normal banking hours.

 

“Buyer” is defined in the recital of the Parties above.

 

“Communication” means any notice, demand, request, consent, approval or other communication which is required or permitted by this Agreement to be given or made by a Party.

 

“Confidential Information” means any information relating to the Business, whether communicated in written form, orally, visually, demonstratively, technically or by any other electronic form or other media, or committed to memory, and whether or not designated, marked, labelled or identified as confidential or proprietary, including:

 

 


 

Personal Information; and

 

all analyses, compilations, records, data, reports, correspondence, memoranda, specifications, materials, applications, technical data, studies, derivative works, reproductions, copies, extracts, summaries or other documents containing or based upon, in whole or in part, any of the information listed above in this Section 1.1.12,

 

but excluding information, other than Personal Information, which the Seller can demonstrate:

 

was available to or known by the public;

 

is or was obtained from a source other than the Buyer or New Above, any Representative of the Buyer or New Above, or any Person known by the Seller to be bound by a duty of confidentiality to the Buyer, New Above or the Business; or

 

is or becomes available to or known by the public other than as a result of improper disclosure by the Seller or any Representative of the Seller.

 

“DGCL” means the Delaware General Corporation Law, as amended.

 

“Customer” means any Person who is a customer or client of the Business, and includes all prospective customers and clients who have been canvassed or solicited in connection with the Business, except for any who have definitively indicated a choice not to become customers or clients of the Business, and any who have not had any contact with a representative of the Business for at least one year.

 

“Employee” means any employee or independent contractor employed, engaged or retained in connection with the Business on a full-time or on a part-time basis, including any who are on medical or long-term disability leave, or other statutory or authorized leave or absence.

 

“Governmental Authority” means:

 

any federal, provincial, state, local, municipal, regional, territorial, aboriginal, or other government, governmental or public department, branch, ministry, or court, domestic or foreign, including any district, agency, commission, board, arbitration panel or authority and any subdivision of any of them exercising or entitled to exercise any administrative, executive, judicial, ministerial, prerogative, legislative, regulatory, or taxing authority or power of any nature; and any quasi-governmental or private body exercising any regulatory, expropriation or taxing authority under or for the account of any of them, and any subdivision of any of them.

 

 


 

 

“Merger” means the merger between Merger Sub and Bite in accordance with the terms and conditions of the Business Combination Agreement, a certificate of merger to be filed with the Secretary of the State of Delaware, and in accordance with the DGCL.

 

“Merger Sub” means Above Merger Sub, Inc., a Delaware corporation.

 

“New Above” means Above Food Ingredients Inc., a corporation incorporated under the laws of Alberta.

 

“Nomination Rights Agreement” has the meaning set out in Recital C hereto.

 

“Parties” means the Seller, the Buyer and New Above, collectively, and “Party” means any one of them.

 

“Person” will be broadly interpreted and includes:

 

a natural person, whether acting in their own capacity, or in their capacity as executor, administrator, estate trustee, trustee or personal or legal representative, and the heirs, executors, administrators, estate trustees, trustees or other personal or legal representatives of a natural person;

 

a corporation or a company of any kind, a partnership of any kind, a sole proprietorship, a trust, a joint venture, an association, an unincorporated association, an unincorporated syndicate, an unincorporated organization or any other association, organization or entity of any kind; and

 

a Governmental Authority.

 

“Personal Information” means information relating to identifiable individuals.

 

“Provider” means a third party service provider.

 

“Purchase Agreement” is defined in the Context above.

 

“Purchaser Shares” means the common shares in the capital of the Purchaser.

 

 


 

“Representatives” means the Affiliates of a Party, and the advisors, agents, consultants, directors, officers, management, employees, subcontractors, and other representatives, including accountants, auditors, financial advisors, lenders and lawyers of a Party and of that Party’s Affiliates.

 

“Secondary Information” is defined in Section 2.5.2.

 

“Seller” is defined in the recital of the Parties above.

 

“Shareholders” means the holders of Purchaser Shares.

 

“Share Exchange” means the share exchange involving the Purchaser and New Above, whereby, among other things, the Shareholders will transfer and assign to New Above all of the issued and outstanding Purchaser Shares for newly issued common shares, class A earnout shares and class B earnout shares of New Above, pursuant to the Arrangement in accordance with the terms and conditions of the Business Combination Agreement.

 

“Territory” means Europe, Middle East, North Africa and India.

 

Certain Rules of Interpretation

 

In this Agreement, words signifying the singular number include the plural and vice versa, and words signifying gender include all genders. Every use of the word “including” or “includes” in this Agreement is to be construed as meaning “including, without limitation” or “includes, without limitation”, respectively.

 

The division of this Agreement into Articles and Sections, the insertion of headings and the provision of a table of contents are for convenience of reference only and do not affect the construction or interpretation of this Agreement.

 

References in this Agreement to an Article or Section are to be construed as references to an Article or Section of this Agreement unless otherwise specified.

 

Governing Law

 

This Agreement is governed by, and is to be construed and interpreted in accordance with, the laws of the Province of Alberta and the laws of Canada applicable in that Province, without regard to conflict of laws principles.

 

Each of the Parties irrevocably and unconditionally submits and attorns to the non-exclusive jurisdiction of the courts of the in the City of Calgary, in the Province of Alberta, and appropriate appellate courts therefrom for the resolution of any dispute, controversy or claim and to determine all issues, whether at law or in equity, arising from this Agreement, and each Party hereby irrevocably agrees that all claims in respect of such dispute, controversy or claim may be heard and determined in such courts. The Parties hereby irrevocably waive, to the fullest extent permitted by applicable law, any objection that they may now or hereafter have to the laying of venue of any such dispute, controversy or claim brought in any such court or any defence of inconvenient forum for the maintenance of such dispute, controversy or claim. Each Party agrees that a judgment in any such dispute may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by applicable law.

 

 


 

Entire Agreement

 

This Agreement, together with the Purchase Agreement and the Nomination Rights Agreement, constitutes the entire agreement between the Parties pertaining to the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, whether oral or written, of the Parties, and there are no representations, warranties or other agreements between the Parties, express or implied, in connection with the subject matter of this Agreement except as specifically set out in this Agreement, the Purchase Agreement or the Nomination Rights Agreement. No Party has been induced to enter into this Agreement in reliance on, and there will be no liability assessed, either in tort or contract, with respect to, any warranty, representation, opinion, advice or assertion of fact, except to the extent it has been reduced to writing and included as a term in this Agreement, the Purchase Agreement or the Nomination Rights Agreement.

 

COVENANTS OF THE SELLER

 

Non-Competition

 

The Seller agrees with the Buyer and New Above that it will not, for a period of two years following the date on which the Seller ceases to have an individual represented on the Board of Directors of New Above, in any capacity or manner, whether directly or indirectly, individually or in partnership or otherwise jointly or in concert with any other Person:

 

advise, be engaged or interested in, be concerned or associated with, or carry on;

 

lend money to, provide financial assistance to, or guarantee the debts or obligations of; or

 

permit its name or any part of that name to be used by any Person in connection with,

 

a business that competes with the Business within the Territory.

 

For the avoidance of doubt, nothing contained in this Agreement shall prevent nor shall the following activities of the Seller constitute a violation of the terms and conditions of this Agreement: (i) production, packaging, marketing and sales of fresh aromatic herbs in Spain and abroad; (ii) research, cultivation, production, dehydration, packaging, pressing, storage, selection, certification, marketing, sale, trading and distribution of alfalfa, corn, oats, fescue, fodder, cereal straw, fodder silage, wood, seeds and the like, and other animal feed products with milling and granulation and/or silage, intended for animal feed in Spain and/or abroad, (iii) research, cultivation, production, selection and marketing of alfalfa and corn, as well as the study of improvement techniques in Spain, and/or (iv) purchase, sale and exploitation of agricultural land, agricultural machinery and industrial and agricultural installations, as well as agricultural promotion and development and the provision of common services that serve that purpose.

 

 


 

Portfolio Exemption

 

There will be no default under Section 2.1 by virtue of the Seller holding, as a passive investor only, not more than five percent in the aggregate (including securities held by any Persons acting jointly or in concert with the Seller) of the issued and outstanding securities of a Person, the securities of which are listed on a recognized stock exchange or an organized securities market.

 

Non-Solicitation of Customers

 

The Seller agrees with the Buyer and New Above that it will not, for a period of two years following the date on which the Seller ceases to have an individual represented on the Board of Directors of New Above, in any capacity or manner, whether directly or indirectly, individually or in partnership or otherwise jointly or in concert with any other Person:

 

solicit any Customer to compete with the Business of Brotalia or knowingly assist any Person, directly or indirectly, to solicit any Customer to compete with the Business; or

 

induce or attempt to induce any Customer to reduce its business with the Business or to terminate its relationship with the Business.

 

Non-Solicitation of Employees

 

The Seller agrees with the Buyer and New Above that it will not, for a period of two years following the date on which the Seller ceases to have an individual represented on the Board of Directors of New Above, in any capacity or manner, whether directly or indirectly, individually or in partnership or otherwise jointly or in concert with any other Person:

 

induce or encourage any Employee to leave the employment of the Business, or authorize, assist, approve or encourage any other Person to do so; or

 

hire or attempt to hire or otherwise solicit any Employee or authorize, assist, approve or encourage any other Person to do so.

 

 


 

For the avoidance of doubt, nothing in this Section 2.4 shall prohibit (i) the general solicitation for employment (including the use of advertisements or the use of a search firm or other employment agency and the hiring of any such person as a result of such use), (ii) the hiring of any such person who contacts the Seller or its representatives of their own initiative, or (iii) the solicitation and hiring of any such person who has not been an employee of the Business for a period of at least six (6) months’ prior to such solicitation and hiring.

 

Confidentiality

 

The Seller acknowledges and agrees that:

 

in the course of its association with the Business, it has acquired Confidential Information, provided, however, that for purposes of this Section 2.5 such Confidential Information shall not include any materials incorporated in any distributions to the board or with respect to internal governance matters;

 

the Buyer and New Above have all rights to use and possession of, title to and ownership of the Confidential Information and the Seller will deliver all of the Confidential Information in written, electronic form or other media that it possesses promptly to the Buyer and New Above upon the completion of the transactions contemplated by the Purchase Agreement.

 

The Seller will hold in strict confidence and not disclose or use, and the Seller will not allow any of its Representatives to disclose or use, for a period of two years following the date on which the Seller ceases to have an individual represented on the Board of Directors of New Above, any Confidential Information, for any purpose, except as provided in this Section 2.5.

 

The Parties acknowledge that data stored in the computers and data storage and retrieval systems or network of any of the Seller and, if applicable, any of the Seller’s Representatives, including Confidential Information stored in electronic form, may be automatically backed up by a Provider. To the extent that those back-up procedures automatically create electronic copies of Confidential Information (“Secondary Information”), the Provider may, despite any requirement under this Agreement for the Seller to deliver all of the Confidential Information, retain Secondary Information in its archival storage for the period that it would normally archive electronic data, provided that:

 

those data are periodically and systematically overwritten or otherwise destroyed; the Provider is bound by written agreement with the Seller, as applicable, to maintain the confidentiality of all of the data of the Seller, on terms substantially similar to those in this Agreement; and

 

 


 

 

the Seller will be responsible and liable for any use or disclosure of Confidential Information by the Provider that would be contrary to the terms of this Agreement if that use or disclosure was by the Seller.

 

Secondary Information will be subject to the provisions of this Agreement until destroyed and may not be accessed by the Seller, any Representative of the Seller or the Provider during its period of archival storage.

 

Use of Confidential Information by, or disclosure of Confidential Information to, any Person that is not a Party to this Agreement or is not a Provider or a Representative of the Seller permitted by the Seller to have access to the Confidential Information, that results from a breach of the security of the computers and data storage and retrieval systems or network of the Seller, the Provider or, if applicable, any Representative of the Seller, will be treated as a disclosure by the Seller contrary to the terms of this Agreement, whether or not the breach results from a failure by the Seller or, if applicable, any Representative of the Seller, to implement appropriate security measures consistent with best practices or otherwise take necessary precautions in order to secure the Confidential Information, or to exercise due diligence in verifying that the Provider had in place appropriate security measures consistent with best practices and would take necessary precautions in order to secure the Confidential Information, as the case may be.

 

If the Seller or any Representative of the Seller is required by any applicable law or by any Governmental Authority to disclose any Confidential Information in circumstances other than those contemplated by Section 2.5.6, the Seller or that Representative will provide the Buyer and New Above with prompt written notice of that requirement, so that the Buyer and New Above, as applicable, may contest the disclosure of the Confidential Information and seek an appropriate protective order or other appropriate remedy.

 

If, in the absence of a protective order or other appropriate remedy, the Seller, or any Representative of the Seller is, in the reasonable opinion of its lawyers, required by any applicable law or by any Governmental Authority to disclose any Confidential Information or would be liable for contempt or other censure or penalty, then the Seller or that Representative may, without liability under this Agreement, disclose that portion of the Confidential Information, but only that portion, that the Seller or the Representative is legally required to disclose.

 

 


 

The requirements of this Section 2.5 will not apply to prohibit the retention, use and disclosure of information related to the Business that is necessary for the Seller to comply with reporting requirements under applicable laws related to taxation, employment standards, workplace safety, or any other matters with respect to which disclosure is required by any Governmental Authority of all Persons engaged in the activities that are involved in the Business.

 

The Seller will notify the Buyer and New Above immediately upon discovery of any breach of this Section 2.5 or any unauthorized or unlawful disclosure, communication or use of any Confidential Information.

 

The obligations and covenants in this Section 2.5 shall survive for a period of two years following the date on which the Seller ceases to have an individual represented on the Board of Directors of New Above.

 

Covenants Reasonable

 

The Seller acknowledges and agrees that:

 

the covenants included in this Article 2 are reasonable in the circumstances and are necessary to protect the economic position of the Buyer and New Above;

 

a breach of any of the provisions of this Article 2 would cause serious and irreparable harm to the Buyer and New Above which could not be compensated adequately by monetary damages, and that the Buyer and New Above may enforce the provisions of this Article 2 by injunction or specific performance upon application to a court of competent jurisdiction without proof of actual damage, and despite that damages may be readily quantifiable, it will not plead, and the Seller will not permit any of its Representatives to plead, sufficiency of damages as a defence in any proceeding for injunctive relief; and

 

the remedies provided by this Section 2.6 are in addition to, and not a substitute for, any other remedies for breach to which the Buyer and New Above, as applicable, would be entitled.

 

Covenants Independent

 

The existence of any claim or cause of action of the Seller against the Buyer or New Above, as applicable, whether under this Agreement, the Purchase Agreement, the Nomination Rights Agreement or otherwise, will not constitute a defence to the enforcement by the Buyer or New Above of the provisions of this Article 2 against the Seller.

 

 


 

GENERAL

 

Notices

 

Any Communication must be in writing and either:

 

delivered personally or by courier;

 

sent by prepaid registered mail; or

 

transmitted by e-mail or functionally equivalent electronic means of transmission, charges (if any) prepaid.

 

Any Communication must be sent to the intended recipient at its address as follows:

 

I. to Enhol at:

 

II. Grupo Empresarial Enhol, S.L.
  III.  C/ Frauca nº 13, Tudela, Navarra (Spain)
  IV.  
  V. Attention:     Gonzalo Oliver Amatriain
  E-mail: goliver@enhol.es
  VI.  
     
  VII.  with a copy to
     
  VIII. J&A Garrigues, S.L.P.
    Calle Hermosilla 3, Madrid
  IX. 28001, Spain
  X. Attention:     José Luis Ortín
  E-mail: jose.luis.ortin.romero@garrigues.com
     
  XI.  to the Buyer or New Above at:
     
  XII. Above Food Corp.
  XIII. 2305 Victoria Ave #001
  XIV. Regina, Saskatchewan, S4P 0S7, Canada
  XV.  
  XVI. Attention:     Lionel Kambeitz, Chief Executive Officer
  E-mail: lionel@abovefood.com
     
XVII.  
     
  XVIII. with a copy to
  XIX. Gowling WLG (Canada) LLP
    1600, 421 7th Avenue SW,
  XX. Calgary, Alberta, T2P 4K9, Canada
  XXI. Attention:     Sharagim Habibi
  E-mail: sharagim.habibi@gowlingwlg.com

 

 


 

or at any other address as any Party may at any time advise the others by Communication given or made in accordance with this Section 3.1. Any Communication delivered to the Party to whom it is addressed will be deemed to have been given or made and received on the day it is delivered at that Party’s address, provided that if that day is not a Business Day then the Communication will be deemed to have been given or made and received on the next Business Day. Any Communication sent by prepaid registered mail will be deemed to have been given or made and received on the fifth Business Day after which it is mailed. If a strike or lockout of postal employees is then in effect, or generally known to be impending, every Communication must be delivered personally or by courier or transmitted by e-mail or functionally equivalent electronic means of transmission. Any Communication transmitted by e-mail or other functionally equivalent electronic means of transmission will be deemed to have been given or made and received on the day on which it is transmitted; but if the Communication is transmitted on a day which is not a Business Day or after 5:00 p.m. (local time of the recipient), the Communication will be deemed to have been given or made and received on the next Business Day.

 

For the avoidance of doubt, copies provided to J&A Garrigues, S.L.P. shall be for information purposes only and shall not constitute notice under this Section 3.1.3.

 

Severability

 

Each Section of this Agreement is distinct and severable. If any Section of this Agreement, in whole or in part, is or becomes illegal, invalid, void, voidable or unenforceable in any jurisdiction by any court of competent jurisdiction, the illegality, invalidity or unenforceability of that Section, in whole or in part, will not affect:

 

the legality, validity or enforceability of the remaining Sections of this Agreement, in whole or in part; or

 

the legality, validity or enforceability of that Section, in whole or in part, in any other jurisdiction.

 

Submission to Jurisdiction

 

Each of the Parties irrevocably and unconditionally submits and attorns to the exclusive jurisdiction of the courts of the Province of Alberta to determine all issues, whether at law or in equity, arising from this Agreement. To the extent permitted by applicable law, each of the Parties:

 

 


 

irrevocably waives any objection, including any claim of inconvenient forum, that it may now or in the future have to the venue of any legal proceeding arising out of or relating to this Agreement in the courts of that Province, or that the subject matter of this Agreement may not be enforced in those courts;

 

irrevocably agrees not to seek, and waives any right to, judicial review by any court which may be called upon to enforce the judgment of the courts referred to in this Section 3.3, of the substantive merits of any suit, action or proceeding; and

 

to the extent that Party has or may acquire any immunity from the jurisdiction of any court or from any legal process, whether through service or notice, attachment before judgment, attachment in aid of execution, execution or otherwise, with respect to itself or its property, irrevocably waives that immunity in respect of its obligations under this Agreement.

 

Amendment and Waiver

 

No amendment, discharge, restatement, supplement, termination or waiver of this Agreement or any Section of this Agreement is binding unless it is in writing and executed by each Party. No waiver of, failure to exercise or delay in exercising, any Section of this Agreement constitutes a waiver of any other Section (whether or not similar) nor does any waiver constitute a continuing waiver unless otherwise expressly provided.

 

Further Assurances

 

Each Party will, at the requesting Party’s cost and expense, execute and deliver any further agreements and documents and provide any further assurances, undertakings and information as may be reasonably required by the requesting Party to give effect to this Agreement and, without limiting the generality of this Section 3.5, will do or cause to be done all acts and things, execute and deliver or cause to be executed and delivered all agreements and documents and provide any assurances, undertakings and information as may be required at any time by all Governmental Authorities having jurisdiction over the affairs of a Party or as may be required at any time under applicable law.

 

Assignment and Enurement

 

Neither this Agreement nor any right or obligation under this Agreement may be assigned by any Party without the prior written consent of the other Parties. This Agreement enures to the benefit of and is binding upon the Parties and their respective heirs, executors, administrators, estate trustees, trustees, personal or legal representatives, successors and permitted assigns.

 

 


 

Electronic Signatures and Delivery

 

This Agreement and any counterpart of it may be:

 

signed by manual, digital or other electronic signatures; and

 

delivered or transmitted by any digital, electronic or other intangible means, including by e-mail or other functionally equivalent electronic means of transmission,

 

and that execution, delivery and transmission will be valid and legally effective to create a valid and binding agreement between the Parties.

 

Counterparts

 

This Agreement may be signed and delivered by the Parties in counterparts, with the same effect as if each of the Parties had signed and delivered the same document, and that execution and delivery will be valid and legally effective.

 

Conduct of Parties

 

All requests, consents, approvals, opinions and decisions given or made by any Party as permitted by this Agreement must be reasonable, not be unreasonably withheld or delayed, not be subject to unreasonable conditions or qualifications, be based on good and sound business judgment, and be consistent with the terms of this Agreement.

 

No Contra Proferentem

 

This Agreement has been reviewed by each Party’s professional advisors, and revised during the course of negotiations between the Parties. Each Party acknowledges that this Agreement is the product of their joint efforts, that it expresses their agreement, and that, if there is any ambiguity in any of its provisions, no rule of interpretation favouring one Party over another based on authorship will apply.

 

THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK

 

 


 

Each of the Parties has executed and delivered this Agreement, as of the date noted at the beginning of this Agreement.

 

GRUPO EMPRESARIAL ENHOL, S.L.
     
  Per:  
    Name:
    Title:
     
  ABOVE FOOD CORP.
     
  Per:  
    Name: Lionel Kambeitz
    Title:   Chief Executive Officer
     
  ABOVE FOOD INGREDIENTS INC.
     
  Per:  
    Name: Lionel Kambeitz
    Title:   Chief Executive Officer

 

 


 

Schedule 6.6 

Existing Guarantees 

[***]

 

 


 

Schedule 7.1
Purchaser’s Representations and Warranties

 

1. The Purchaser is duly formed and registered and existing as such in accordance with the applicable laws thereto.

 

2. The Purchaser has the necessary full legal capacity and capacity to act, without any limitation whatsoever, to sign the Agreement and the other documentation signed in relation thereto (for the purposes of these Representations and Warranties, collectively, the “Transaction Documentation”) and to fulfill and perform each and every one of the undertakings, acts and obligations assumed under the Transaction Documentation.

 

3. The Purchaser has obtained all consents, authorizations and permits and has fulfilled all the legal, and bylaw requirements necessary to sign the Transaction Documentation and to fulfill and perform each and every one of the undertakings, acts and obligations assumed under the Transaction Documentation, with no further steps being required on their part for such purposes.

 

4. As a result, the undertakings, acts and obligations deriving from the Transaction Documentation, and from any other public or private documents executed in implementation of those documents, are valid and legally binding on, and enforceable against, the Purchaser, in accordance with their specific terms. Neither the execution of the Transaction Documentation nor the implementation or performance of the transactions contemplated by the Agreement will result in (a) a breach of, or give rise to a default under, any material contract, corporate bylaws or other instrument to which the Purchaser is a party or by which it is bound; or (b) a violation or breach of any applicable laws or regulations or of any order, decree or judgment of any court, or any governmental, regulatory or other authority applicable to the Purchaser.

 

5. The Purchaser is not subject to any actual or imminent situation of winding-up, liquidation, or technical or formal insolvency, nor is it or has it been declared insolvent or been subject to any insolvency proceeding; the Purchaser has not adopted any resolutions or filed any petitions, nor is there any step or proceeding underway for the foregoing purposes, and there are no circumstances that could give rise to a court order for winding-up and/or an insolvency order being made against the Purchaser.

 

 


 

6. Neither the Purchaser nor, so far as the Purchaser is aware, any of its Affiliates, directors, officers or representatives (i) have engaged in any activity or conduct that has resulted in a violation of any law, regulation or order relating to anti-corruption, anti-bribery, anti-money laundering or any laws relating to economic or trade sanctions, or (ii) have made or authorised any offer, gift, payment or transfer or promise of anything of value to any person for a commercial purpose, or (iii) have been involved or is currently involved in any investigation of an anti-corruption, anti-bribery or anti-money laundering issue or of any applicable law relating to economic or trade sanctions, nor has received any notice of investigation by a government entity with respect to any alleged non-compliance with any regulations relating to anti-corruption, anti-bribery, anti-money laundering or economic or trade sanctions.

 

7. The New Above Common Shares, when delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly issued, fully paid and non-assessable and free of restrictions on transfer other than restrictions on transfer pursuant to this Agreement, the Lock-Up Agreement, Purchaser's articles of incorporation, and applicable securities laws.

 

8. The Business Combination Agreement is duly signed by the parties thereto, constitutes a valid document which is binding and enforceable upon the parties thereto. The Business Combination Agreement has not been modified, amended, novated, supplemented or assigned except for the amendment dated March 12, 2024, copy of which have been provided to the Sellers.

 

9. The parties to the Business Combination Agreement have complied in a timely manner with all of their obligations under such agreement and, to the Purchaser´s best knowledge, the parties to the Business Combination Agreement are not in default of their obligations. Neither party under the Business Combination Agreement has made a claim under the Business Combination Agreement.

 

10. The Purchaser is in the process of filing a Canadian prospectus and seeking court approval of the business combination in the form of a plan of arrangement (“Plan of Arrangement”). Upon receipt of the interim court order, the Purchaser will seek shareholders’ approval of the Plan of Arrangement. After shareholders’ approval, the Purchaser intends to obtain final court approval of the Plan of Arrangement, at which time the Purchaser will be able to complete the Business Combination upon which the Sellers shall receive the relevant New-Above Shares as provided in this Agreement (including the relevant Earn-out Shares under clause 3.4 hereof).

 

 


 

Schedule 7.2.(i)
Sellers’ Fundamental Representations and Warranties

 

1. Enhol is duly formed and registered and existing as such in accordance with the applicable laws thereto.

 

2. The Sellers have the necessary full legal capacity and capacity to act, without any limitation whatsoever, to sign the Transaction Documentation and to fulfill and perform each and every one of the undertakings, acts and obligations assumed under the Transaction Documentation.

 

3. The Sellers have obtained all consents, authorizations and permits and has fulfilled all the legal, and bylaw requirements necessary to sign the Transaction Documentation and to fulfill and perform each and every one of the undertakings, acts and obligations assumed under the Transaction Documentation, with no further steps being required on their part for such purposes.

 

4. As a result, the undertakings, acts and obligations deriving from the Transaction Documentation, and from any other public or private documents executed in implementation of those documents, are valid and legally binding on, and enforceable against, the Sellers, in accordance with their specific terms. Neither the execution of the Transaction Documentation nor the implementation or performance of the transactions contemplated by the Agreement will result in (a) a breach of, or give rise to a default under, any material contract, corporate bylaws or other instrument to which each Seller is a party or by which it is bound; or (b) a violation or breach of any applicable laws or regulations or of any order, decree or judgment of any court, or any governmental, regulatory or other authority applicable to the Sellers.

 

5. Enhol is not subject to any actual or imminent situation of winding-up, liquidation, or technical or formal insolvency, nor is it or has it been declared insolvent or been subject to any insolvency proceeding; Enhol has not adopted any resolutions or filed any petitions, nor is there any step or proceeding underway for the foregoing purposes, and there are no circumstances that could give rise to a court order for winding-up and/or an insolvency order being made against Enhol.

 

 


 

6. The Sellers are the legitimate owners, of the Shares, free and clear from encumbrances, fully subscribed and paid in and with all the rights inherent in them by reason of statute and the bylaws, in accordance with Schedule VI, and they are entitled to sell and transfer the full ownership of such Shares on the terms set out in this Agreement. For the avoidance of doubts, Schedule VI shall be updated on Closing Date to reflect any newly issued shares, as the case may be, in connection with any share capital increase of Brotalia in accordance with the Pre-Closing Reorganization.

 

7. There is no agreement, arrangement or obligation to create or give an Encumbrance in relation to the Shares. No person has claimed to be entitled to an encumbrance in relation to any of the Shares.

 

8. There are no agreements or arrangements in force which provide for the present or future issue, transfer, redemption or repayment of, or grant to any entity, person or individual the right (whether conditional or otherwise) to require the issue, transfer, redemption or repayment of the Shares.

 

9. The acquisition of the Shares established under this Agreement, shall grant the Purchaser the full legal ownership of such Shares, including their corresponding political and economic rights as prescribed by the applicable law and set forth in the Company’s bylaws.

 

10. There are no agreements or arrangements in force which provide for the present or future issue, transfer, redemption or repayment of, or grant to any entity, person or individual the right (whether conditional or otherwise) to require the issue, transfer, redemption or repayment of the shares of the Company.

 

 


 

Schedule 7.2.(ii)
Seller’s Business Representations and Warranties

 

1. Subsidiaries. Ownership of shares and absence of Charges and Encumbrances

 

1.1. The Company is the legitimate owner of 3,000 shares of Naturcook, representing 100% of Naturcook’s share capital, free and clear from encumbrance, fully subscribed and paid in and with all the rights inherent in them by reason of statute and the bylaws of Naturcook.

 

1.2. The Company is the legitimate owner of the Assets set out in Appendix 1.2 free and clear from encumbrances.

 

1.3. There is no agreement, arrangement or obligation to create or give an encumbrance in relation to the shares of Naturcook held by the Company. No person has claimed to be entitled to an Encumbrance in relation to any of the shares of Naturcook held by the Company.

 

1.4. Except for the shares held by the Company in Naturcook, the Companies do not hold or own, directly or indirectly, rights, shares, certificates or securities in the share capital or equity of any other company, entity or branch. Notwithstanding the latter, the Purchaser acknowledges that the Company (i) has entered into (a) the Innomy MoU and the Cocuus MoU setting forth the terms and conditions of certain investments and joint ventures on the terms set forth therein, (b) shall apply for the CDTI financing described in Schedule 5.2 together with the Consortium, and (c) is party to certain research clusters pursuant to which the Companies make yearly contributions in the ordinary course of business.

 

 


 

2. Formation and capacity of the Companies

 

2.1. The Companies are duly formed and registered and existing as such in accordance with the laws applicable to each of them. The Companies have the necessary full legal capacity and capacity to act to own their assets and engage in the activities typical of the Business in the same manner and at the same locations as they currently do.

 

2.2. The Companies are not subject to any actual or imminent situation of winding-up, liquidation, or technical or formal insolvency, nor are they or have they been declared insolvent or been subject to any insolvency proceeding; the Companies have not adopted any resolutions or filed any petitions, nor is there any step or proceeding underway for the foregoing purposes, and there are no circumstances that could give rise to a court order for winding-up and/or an insolvency order being made against the Companies.

 

2.3. Both the deed of formation of the Companies and all resolutions, appointments, resignations, bylaw amendments, powers of attorney and any other resolutions by the corporate bodies of the Companies that are mandatory to register at the relevant Commercial Registries are duly registered at such Commercial Registries. There is no corporate resolution or public deed of the Companies that must be registered at the relevant Commercial Registries that is not so registered at the Agreement Date. For the avoidance of doubts, any deeds executed in relation to (i) any share capital increases approved in the framework of the Pre-closing Reorganization, and (ii) any changes of the governing body of Naturcook (i.e., change of the management form and removal and appointment of directors) shall be filed with the relevant Commercial Registry.

 

3. Financial Statements. Ordinary course operation of the Companies since the date of the Financial Statements

 

3.1. The Financial Statements have been prepared in good faith by the management body of the Company in accordance with the applicable legislation and with IFRS, applied in a uniform and consistent manner by the Companies in recent financial years and present a true and fair view of the state of affairs, net worth and financial position of the Companies as of FY2023 (including the Agro Business) and April 30, 2024 (after the Agro Business carve out as per the Agro APA) and for the period covered by the Financial Statements.

 

 


 

3.2. The Companies have not assumed any obligations or liabilities (actual or contingent) of any kind prior to the date of the Financial Statements that should have been reflected or provided for in accordance with IFRS, but have not been duly reflected or provided for in the Financial Statements.

 

3.3. Since the date of the Financial Statements, except for the actions related to the Pre-Closing Reorganization:

 

3.3.1 the Companies have not allotted or issued or agreed to allot or issue any share capital (other than any share capital increases that may be approved during in the framework of the Pre-closing Reorganization);

 

3.3.2 the Companies have not redeemed or purchased or agreed to redeem or purchase any of their share capital;

 

3.3.3 no change in the accounting reference period of the Companies has been made; and

 

3.3.4 the Business of the Companies has been carried on in the ordinary course of business without any material alteration in its nature, scope or manner, other than adaptations or changes to the normal course of the commercial operations that a reasonably prudent businessman would have implemented in the context of the current circumstances.

 

4. Material Agreements

 

All the Material Agreements to which the Companies are parties are valid and enforceable in accordance with their respective terms and conditions, are in full force and effect, and, to the Sellers’ Knowledge, the counterparties have complied with their obligations thereunder.

 

 


 

For purposes of this Agreement, “Material Agreements” shall mean those listed in Appendix 4.

 

The Companies are not a party to any contract with the Sellers or any of its Affiliates (other than the Subsidiaries) other than those disclosed as Due Diligence Information.

 

5. Insurance

 

5.1. The Companies have in full force and effect general third-party civil liability and professional liability insurance, cybersecurity and fire and casualty (multi-risk) in relation to the premises occupied for the development of the Business in the terms disclosed in the Due Diligence Information.

 

5.2. The Companies have not received any written notice that any of the material insurance policies maintained by or on behalf of the Companies is not in full force and effect or is void or avoidable. All premiums due and payable with respect to such policies maintained by the Companies have been paid to date. To the Seller’s knowledge, there is no threatened termination of any such policies or arrangements.

 

6. Owned and leased real estate property

 

6.1. The Companies have valid right and title to use and occupy the premises currently used or occupied by the Companies and listed in Appendix 6.1 (the “Properties”).

 

6.2. Where the Companies occupy the Properties under a lease or equivalent agreement, the Companies have performed and materially comply with the terms of such agreements and the share sale and purchase under this Agreement shall not give any right to any counterparties to terminate or increase the rent under such agreements.

 

6.3. As far as the Sellers are aware, there has not been any challenge to the referred rights over the properties owned or leased by the Companies.

 

 


 

7. Intellectual property and IT Systems

 

7.1. The Companies hold as of the Agreement Date valid title to use and exploit, where applicable, the registered Intellectual Property Rights listed in Appendix 7.1 which are used by them for the operation of their Business in a manner consistent with past practices.

 

7.2. To the Sellers’ knowledge, the Companies do not infringe any third-party Intellectual Property Rights, and there are no claims outstanding in this regard.

 

7.3. The Companies hold title to the necessary exploitation rights in the software and IT developments used by them in the operation of their Business (the “IT Systems”) in a manner consistent with past practices.

 

7.4. To the Sellers’ knowledge (i) the Companies have the source codes, object codes, technical documentation and user manuals for each version of their IT Systems; (ii) the Companies are the owners or lessees of the hardware they use in the operation of their Business as pursued up to the Agreement Date.

 

7.5. The IT Systems have been maintained and supported in a satisfactory manner for the operation of the Companies’ Business.

 

8. Taxes

 

8.1. The Companies materially comply and have complied with any Tax laws applicable to them, including any formal obligations of a Tax nature and have formulated, filed and kept the Tax Returns they are required to file or submit in relation to all Taxes, withholding taxes and other Tax obligations as required by and in accordance with mandatory laws.

 

 


 

8.2. The Companies are up-to-date in the filing and payment of all taxes due (i.e., the taxes due and payable).

 

8.3. All Tax accrued or owed by the Companies as of the date of the Financial Statements is duly accounted for in the Financial Statements.

 

9. Employment. Social Security

 

9.1. The Companies have hired their personnel and paid the remuneration and social security contributions in compliance with the current applicable laws.

 

9.2. The Companies have complied and are up to date with the payment of the compensation (fixed, variable and in kind), non-salary items (allowances, expenses) and benefits of their employees.

 

9.3. To the Seller’s knowledge, the Companies fulfill and have fulfilled all material obligations of a labor and employment nature, including salary obligations, and in the social security area, and in the areas of occupational risk prevention and health and safety at work.

 

10. Permits and licenses

 

10.1. The Companies hold all material municipal and governmental licenses, permits and concessions, as required under the respective applicable laws in order to conduct their business as presently conducted.

 

10.2. The Companies have not received any written notice alleging that any material licenses, consents and other permissions and approvals required for carrying on of their Business have not been obtained.

 

 


 

10.3. To the Sellers’ knowledge, the Companies are not in material violation of or default under any license or permit required for the operation of the Companies’ Business, and, as far as the Sellers are aware, no material license or permit shall be revoked, terminated prior to its normal expiration date or not renewed pursuant to its terms solely as a result of the consummation of the transactions set forth in this Agreement.

 

11. Anti-corruption, anti-bribery and anti-money laundering

 

11.1. To the Sellers’ knowledge, neither the Companies nor any of their respective directors, officers or representatives (i) has engaged in any activity or conduct that has resulted in a violation of any law, regulation or order relating to anti-corruption, anti-bribery, anti-money laundering or any applicable laws relating to economic or trade sanctions, in each case applicable to each of them; or (ii) has made or authorized any offer, gift, payment or transfer or promise of anything of value to any person for a commercial purpose; or (iii) has been involved or is currently involved in any investigation of an anti-corruption, anti-bribery or anti-money laundering issue or of any applicable laws relating to economic or trade sanctions, nor has received any notice of investigation by a government entity with respect to any alleged non-compliance with any regulations relating to anti-corruption, anti-bribery, anti-money laundering or economic or trade sanctions.

 

12. Litigation

 

12.1. Except as disclosed in Appendix 12.1, as of the Agreement Date, the Companies are not engaged in any action or proceeding (whether civil or criminal), arbitration or mediation.

 

12.2. As of the Agreement Date, neither the Company nor the Subsidiary has received notice in writing of any actual or pending governmental, regulatory investigation, inquiry, lawsuit, complaint, dispute, action, claim, arbitration, penalty proceedings, inspection or proceedings of any other kind, brought by third parties or by any competent authority, of a civil, criminal, administrative, tax, labor or any other nature, which is connected with the Company or the Subsidiary.

 

 


 

12.3. As of the Agreement Date, there is no judgment, award, order or decision outstanding or pending against the Company or the Subsidiary except as disclosed in Appendix 12.1.

 

13. Disclosed Information

 

The Due Diligence Information of the Company has been disclosed by the Sellers in good faith. To the Sellers’ knowledge the Due Diligence Information of the Company (i) is true and correct in all material respects and (ii) does not omit information that would be reasonably deemed material in the context of the Transaction for a diligent and professional purchaser.

 

 


 

Appendix 1.2

 

List of Assets

 

[***]

 

 


 

Appendix 3.1

 

Financial Statements

 

[Attached]

 

[***]

 

 


 

Appendix 4

 

Material Agreements

 

The agreements listed in Appendix 1.2 are incorporated herein by reference.

 

 


 

Appendix 6.1

 

Properties

 

Brotalia, S.L.

 

· Wharehouse 6.32. Address: Polígono de la Serna, Calle C, Nave 6-32, Tudela (31500), Navarra, Spain.
· Wharehouse 6.33. Address: Polígono de la Serna, Calle C, Nave 6-33, Tudela (31500), Navarra, Spain.
· Wharehouse 6.34. Dirección: Polígono de la Serna, Calle C, Nave 6-34, Tudela (31500), Navarra, Spain.

 

Naturcook Innovaciónes, S.L.

 

· Wharehouse Arguedas: Address: Paseo de la Ribera 36, 31513, Arguedas, Navarra, Spain.

 

 


 

Appendix 7.1 

Intellectual Property Rights

 

Brands / Trademarks:

 

Figurative mark Mark Territory Registration date Registration No. Next renewal date Holder
NATURCOOK European Union September 8, 2015 013961396 April 17, 2025 Naturcook Innovaciónes, S.L.*
FOODY’S EU, UK, MX October 20, 2022 WO0000001711224 October 20, 2032 Brotalia, S.L.

 

*Acquired as per agreement entered into by Naturcook and Conde Galarreta, S.L. on April 18, 2020. Registration of holder change is in process.

 

 


 

Domain Names:

 

Domain name Holder Status Expiration Date
grupofoodys.com Brotalia, S.L. Active February 24, 2025
grupofoodys.es Brotalia, S.L. Active February 24, 2025
somosfoodys.com Brotalia, S.L. Active August 27, 2024
somosfoodys.es Brotalia, S.L. Active August 27, 2024
naturcook.com Naturcook Innovaciones S.L. Active February 17, 2025

 

 


 

Appendix 12.1 

Litigation

 

[***]

 

 

 

EX-10.26 14 tm2418826d1_ex10-26.htm EXHIBIT 10.26

 

Exhibit 10.26

 

LOCK-UP AGREEMENT

 

June 19, 2024

 

TO: ABOVE FOOD CORP.

 

Re:    Above Food Corp. – Lock-up Agreement

 

1.       The undersigned understands that all directors, officers and shareholders of Above Food Corp. (the “Corporation”) holding a significant number of securities of the Corporation, have entered into lock-up agreements substantially in the form of this Lock-Up Agreement, save that their lock-up is more restrictive and for a longer period as set out herein, and that the terms of this Lock-Up Agreement are necessary for the success of the Corporation.

 

2.       For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the undersigned agrees that during the period (the “Lock-Up Period”) beginning from the date hereof and ending on the date that is the timelines set out below following the date on which the Corporation’s common shares begin trading on a recognized stock exchange in Canada or the United States (the “Liquidity Event”), the undersigned will not, without the prior written consent of the Corporation, directly or indirectly, offer, sell, transfer, pledge, assign, grant an option or right to purchase, make any short sale, enter into any swap, forward or any other agreement or arrangement to transfer the economic consequence of, or otherwise dispose of or deal with (or publicly announce any intention to do any of the foregoing) any securities of the Corporation, whether now owned or hereinafter acquired, directly or indirectly, by the undersigned or now or hereinafter under the control or direction of the undersigned (collectively, the “Locked-Up Securities”).

 

3.        Notwithstanding Section 2 above or anything else in this Lock-Up Agreement, the Locked-Up Securities will be released on the following schedule and upon such release such portion of the Locked-Up Securities will not be subject to the terms of this Lock-Up Agreement:

 

Sixty (60) days following a Liquidity Event:   250,000 Common Shares
Six (6) months following a Liquidity Event:   250,000 Common Shares
Twelve (12) months following a Liquidity Event:   The remainder of the Locked-Up Securities

 

Notwithstanding the foregoing, in the event that any discretionary waiver or termination of any lock-up restriction is granted to any directors, officers or shareholders of Above Food Corp. or Above Food Ingredients Inc (“New Above”) other than the undersigned relating to the lock-up restrictions set forth above for any shares of the Corporation or New Above, the same percentage of shares of New Above, held by the undersigned (the “Pro-rata Release”) shall be immediately and fully released on the same terms from any remaining lock-up restrictions set forth herein. In the event that the undersigned is released from any of its obligations under this agreement or, by virtue of this agreement, becomes entitled to offer, pledge, sell, contract to sell, or otherwise dispose of any shares of New Above (or any securities convertible into shares of New Above) during the term of this Lock-Up Agreement, the representatives of the Corporation and New Above shall use their commercially reasonable efforts to provide notification of such to the undersigned within three business days thereof.

 

1


 

4.       Section 2 above shall not apply to (a) transfers to affiliated entities of the undersigned, any family members of the undersigned, or any company, trust or other entity owned by or maintained for the benefit of the undersigned, (b) transfers occurring by operation of law, provided, in each case, that any such transferee shall first execute a Lock-Up Agreement in substantially the form hereof covering the remainder of the Lock-Up Period, (c) transfers in accordance with the share sale and purchase and exchange agreement for the sale of shares of Brotalia S.L. to the Corporation by Grupo Empresarial Enhol, S.L. and Mr. Gonzalo Agorreta Preciado or (d) transfers made pursuant to a bona fide take-over bid or similar transaction made to all holders of common shares of the Corporation, including without limitation, a merger, arrangement or amalgamation, involving a change of control of the Corporation, and provided that in the event the take-over or acquisition transaction is not completed, the Locked-Up Securities shall remain subject to the restrictions contained in this Lock-Up Agreement.

 

5.       The undersigned represents and warrants that it has good and marketable title to the Locked-Up Securities and understands that the Corporation is relying upon this Lock-Up Agreement in proceeding towards consummation of the Liquidity Event. The undersigned further understands that this Lock-Up Agreement is irrevocable and shall be binding upon the undersigned’s legal representatives, successors, and permitted assigns, and shall enure to the benefit of the Corporation and their legal representatives, successors and assigns.

 

6.       The undersigned agrees and consents to the entry of stop transfer restrictions with each of the Corporation’s transfer agent and registrar, or the equivalent, against the transfer of the Locked-Up Securities except in compliance with this Lock-Up Agreement.

 

7.       This Lock-Up Agreement will be governed by the laws of the Province of Alberta and the federal laws of Canada applicable therein and may be executed electronically (including by PDF or DocuSign) and as so executed shall constitute an original.

 

 

 

[Remainder of page intentionally left blank. Signature page follows.]

 

2


 

  GRUPO EMPRESARIAL ENHOL, S.L.
     
  By:  /s/ Gonzalo Oliver Amatriain  
    Name:  Gonzalo Oliver Amatriain  
    Title: Attorney-in-fact  

 

3

 

EX-10.27 15 tm2418826d1_ex10-27.htm EXHIBIT 10.27

Exhibit 10.27

 NOMINATION RIGHTS AGREEMENT 

This Nomination Rights Agreement ("Agreement") is made as of June 19, 2024

BETWEEN:

ABOVE FOOD INGREDIENTS INC., an Alberta corporation (the "Company")

- and -

GRUPO EMPRESARIAL ENHOL, S.L., a Spanish company ("Enhol")

WHEREAS Above Food Corp. ("Above Food") has entered into a Share Sale and Purchase and Exchange Agreement dated June 13, 2024 pursuant to which Enhol shall sell all of its common stock in Brotalia, S.L.As ("Brotalia") to Above Food (the "Purchase and Sale");

AND WHEREAS in connection with the Purchase and Sale, Above Food issued to Enhol 5,253,351 common shares in its capital (the "Consideration Shares");

AND WHEREAS Above Food and the Company entered into a business combination agreement dated April 29, 2023, as amended on March 12, 2024 (the "Business Combination Agreement") with Bite Acquisition Corp. ("Bite"), a special purpose acquisition company, and Above Merger Sub. Inc. (“Merger Sub”), a subsidiary of the Company (the "Business Combination"). Pursuant to the Business Combination Agreement, the Company, Above Food, Bite and Merger Sub will complete a plan of arrangement in accordance with Part 15 of the ABCA (the “Arrangement”), whereby, amongst other things, the shareholders of Above Food will transfer and assign all of the issued and outstanding equity of Above Food to the Company in exchange for common shares of the Company (the “Common Shares”), Class A Earnout Shares and Class B Earnout Shares of the Company and immediately following the Arrangement, Above Food will become a direct and wholly owned subsidiary of the Company and Merger Sub will merge with and into Bite (the “Merger”), with Bite continuing as the surviving corporation of the Merger and a direct and wholly owned subsidiary of the Company;

AND WHEREASon June 13, 2024 Enhol entered into a subscription agreement with Above Food (the "Subscription Agreement") and has committed to fund Above Food, under such Subscription Agreement, a total amount of USD $5,000,000. For the avoidance of any doubt, (i) the execution of the Subscription Agreement and the disbursement of the committed amount under such agreement are subject to and conditional upon (a) the effective execution of the Purchase and Sale Agreement, and (b) completion of the closing as provided in the Purchase and Sale Agreement and (ii) without prejudice to (i) above and to the Subscription Agreement being entered into on June 12, 2024, the subscription and acquisition by Enhol of the Common Shares as provided under the Subscription Agreement is a stand-alone transaction, independent from the sale and purchase of the Consideration Shares governed under the Purchase and Sale and the consideration payable thereunder is unrelated to that set forth herein;

AND WHEREAS following the closing of the Purchase and Sale and the issuance of the Common Shares pursuant to the Subscription Agreement, Enhol will beneficially own an aggregate of 7,630,433 Common Shares.

NOW THEREFORE THIS AGREEMENT WITNESSES THAT in consideration of the respective covenants and agreements of the parties herein contained and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), the parties agree as follows:

ARTICLE 1 INTERPRETATION

1.1 Defined Terms

For the purposes of this Agreement, unless the context otherwise requires, the following terms shall have the respective meanings set out below and grammatical variations of such terms shall have corresponding meanings:

“Act” means the Business Corporations Act (Alberta).

“Board” means the board of directors of the Company.

“Business Day” means any day, other than a Saturday, Sunday, statutory holiday or a day on which the principal commercial banks located in the City of Regina, Saskatchewan or Calgary, Alberta are not open for business during normal banking hours.

“Canadian Securities Laws” means the applicable securities legislation of each of the provinces and territories of Canada and all published regulations, policy statements, orders, rules, instruments, rulings and interpretation notes issued thereunder or in relation thereto, as the same may hereafter be amended from time to time or replaced.

“Common Shares” means the common shares in the authorized structure of the Company issued and outstanding from time to time and includes any common shares that may be issued hereafter.

“Company” shall have the meaning set out in the preamble hereto.

“Enhol” shall have the meaning set out in the preamble hereto.

“Nominee” shall have the meaning set out in Section 2.1(a).

“Observer” means a person the shareholder can appoint who will be entitled to attend any and all meetings of the Board. Such person will have full rights to participate at all such meetings and to receive notice and all materials in respect thereof (or any other materials distributed to the Board) at the same time as the Board, but will not under any circumstance be entitled to vote at any such meeting.

“Permitted Transferees” means an “Affiliate” of Enhol, as defined under the Business Corporations Act (Alberta).

“Subscription Agreement” has the meaning set out in the recitals hereto.

1.2 Rules of Construction

Except as may be otherwise specifically provided in this Agreement and unless the context otherwise requires, in this Agreement:

(a) the terms “Agreement”, “this Agreement”, “hereto”, “hereof”, “herein”, “hereby”, “hereunder” and similar expressions refer to this Agreement in its entirety and not to any particular provision hereof;

(b) references to an “Article” or “Section” followed by a number or letter refer to the specified Article or Section to this Agreement;

(c) the division of this Agreement into articles and sections and the insertion of headings are for convenience of reference only and shall not affect the construction or interpretation of this Agreement;

(d) words importing the singular number only shall include the plural and vice versa and words importing the use of any gender shall include all genders;

(e) the word “including” is deemed to mean “including without limitation”;

(f) the terms “party” and “the parties” refer to a party or the parties to this Agreement;

(g) any reference to this Agreement means this Agreement as amended, modified, replaced or supplemented from time to time;

(h) any reference to a statute, regulation or rule shall be construed to be a reference thereto as the same may from time to time be amended, re-enacted or replaced, and any reference to a statute shall include any regulations or rules made thereunder;

(i) all references to a percentage ownership of Common Shares shall be calculated on a non-diluted basis;

(j) any time period within which a payment is to be made or any other action is to be taken hereunder shall be calculated excluding the day on which the period commences and including the day on which the period ends; and

(k) whenever any action is required to be taken or period of time is to expire on a day other than a Business Day, such action shall be taken or period shall expire on the next following Business Day.

1.3 Entire Agreement

This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, negotiations and discussions, whether written or oral, between the parties. There are no conditions, covenants, agreements, representations, warranties or other provisions, express or implied, collateral, statutory or otherwise, relating to the subject matter hereof except as provided in this Agreement.

1.4 Time of Essence

Time shall be of the essence of this Agreement.

1.5 Governing Law and Submission to Jurisdiction

(a)            This Agreement shall be interpreted and enforced in accordance with, and the respective rights and obligations of the parties shall be governed by, the laws of the Province of Alberta and the federal laws of Canada applicable in that province.

(b)            Each of the parties irrevocably and unconditionally: (i) submits to the non-exclusive jurisdiction of the courts of the Province of Alberta over any action or proceeding arising out of or relating to this Agreement; (ii) waives any objection that it might otherwise be entitled to assert to the jurisdiction of such courts; and (iii) agrees not to assert that such courts are not a convenient forum for the determination of any such action or proceeding.

1.6 Severability

If any provision of this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or unenforceable in any respect, all other provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to either party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner to the end that transactions contemplated hereby are fulfilled to the extent possible.

ARTICLE 2 BOARD OF DIRECTORS

2.1 Nomination Right

(a)            During the term of this Agreement, the size of the Board shall be fixed by resolution of the directors at seven directors.

(b)            Upon closing of the Business Combination and for as long as Enhol (or its Permitted Transferees) holds at least 50% of the total number of Common Shares Enhol beneficially owns on the date hereof, as adjusted for any stock splits, stock dividends, reorganizations or recapitalizations, Enhol shall be entitled to designate one nominee (a “Nominee”) to the Board who shall be an individual eligible to serve as a director of a Canadian public company and pursuant to the Act for election or appointment to the Board.

(c)            Provided that no Nominee has been appointed to the Board, Enhol shall have the right to appoint an Observer to the Board.

(d)            The remaining six directors are to be nominees of the Company's management.

(e)            The Company shall advise Enhol of the date on which proxy solicitation materials are to be mailed for the purpose of any meeting of shareholders at which directors of the Company are to be elected at least 20 Business Days prior to such mailing date and Enhol shall advise the Company of its Nominee at least 10 Business Days prior to the mailing date. If Enhol does not advise the Company of the identity of any Nominee prior to any such deadline, then Enhol will be deemed to have nominated its incumbent nominee, unless Enhol notifies the Company in writing that it does not wish to nominate any Nominee for such election.

(f)            Enhol shall provide the Company with the information regarding such Nominee (including the number of Common Shares owned or controlled by such Nominee) that the Company is required to include in an information circular of the Company to be sent to shareholders of the Company in respect of any meeting of shareholders at which directors of the Company are to be elected and such other information, including a biography of such Nominee, that is consistent with the information the Company intends to publish about Management Nominees as directors of the Company in such information circular. Concurrently with delivery of such information, a duly completed and executed personal information form in respect of the proposed Nominee, if required, shall be filed with the relevant stock exchange.

(g)            Provided that the Nominee is financially literate (as such term is defined in National Instrument 52-110 – Audit Committees), the Company shall use best efforts to include the Nominee on the audit committee of the Company.

(h)            The rights granted in this section shall automatically terminate immediately upon Enhol no longer being entitled to nominate a director in accordance with Section 2.1(b). For greater certainty, where Enhol's right to include a Nominee among the Board's nominees as a director of the Company is terminated, the resulting vacancy in the slate of the Board's nominees shall be filled by a nominee of the Company's management.

(i)            In the event that the Nominee shall cease to serve as a director of the Company, whether due to such Nominee’s death, disability, resignation or removal, the Company shall cause the Board to promptly appoint a replacement Nominee designated by Enhol to fill the vacancy created by such death, disability, resignation or removal, provided that Enhol remains eligible to designate a Nominee.

2.2 Conditions

(a)            The Nominee shall, at all times while serving on the Board, meet the qualification requirements to serve as a director under the Act, applicable Canadian Securities Laws, securities laws applicable in the United States and the rules of any stock exchange on which the Common Shares are then listed.

(b)            No Nominee may be a person who has been convicted of an indictable offence or a crime involving moral turpitude or a person who is not acceptable to any stock exchange on which the Common Shares are then listed or a securities regulatory authority having jurisdiction over the Company.

2.3 Management to Endorse and Vote

(a)            The Company shall use commercially reasonable efforts to ensure that the Nominee is elected to the Board, including soliciting proxies in support of their election, should it do so for any other director, and taking the same actions taken by the Company to ensure the election of the other nominees selected by the Board for election to the Board.

(b)            The Company agrees that management of the Company shall, in respect of every meeting of the shareholders at which directors of the Company are to be elected, and at every reconvened meeting following an adjournment or postponement thereof, endorse and recommend the Nominee identified in the proxy materials for election to the Board, and shall vote the Common Shares and any other shares of the Company entitled to vote in the election of directors in respect of which management is granted a discretionary proxy in favour of the election of such Nominee to the Board at every such meeting, and the Company shall use its commercially reasonable efforts to cause management to vote their Common Shares and any other shares of the Company entitled to vote in the election of directors in favour of the election of such Nominee to the Board at every such meeting.

2.4 Investor to Endorse and Vote

In the event that a Nominee is included as a director nominee of management (a “Management Nominee”) in connection with a meeting of the shareholders at which directors of the Company are to be elected, Enhol covenants and agrees that it will vote its Common Shares in favour of all Management Nominees, including its Nominee, at such meeting.

2.5 Directors’ Liability Insurance

A Nominee shall be entitled to the benefit of any directors’ liability insurance and indemnity to which other directors of the Company are entitled.

ARTICLE 3 MISCELLANEOUS

3.1 Termination

This Agreement shall terminate and all rights and obligations hereunder shall cease immediately at such time as Enhol ceases to hold Common Shares representing less than 50% of the total number of Common Shares Enhol beneficially owns on the date hereof, as adjusted for any stock splits, stock dividends, reorganizations or recapitalizations.

3.2 Notices

(a)            Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be delivered in person, transmitted by e-mail or similar means of recorded electronic communication or sent by registered mail, charges prepaid, addressed as follows:

(i) in the case of Enhol:

Grupo Empresarial Enhol, S.L. 

C/ Frauca nº 13, Tudela, Navarra (Spain)

Attention:  Gonzalo Oliver Amatriain
E-mail:         goliver@enhol.es

(ii) in the case of the Company:

Above Food Ingredients Inc. 

1600, 421 7th Avenue SW, 

Calgary, Alberta, T2P 4K9, Canada.

Attention:  Lionel Kambeitz, Chief Executive Officer E-mail:         lionel@abovefood.com (b)            Any such notice or other communication shall be deemed to have been given and received on the day on which it was delivered or transmitted (or, if such day is not a Business Day or if delivery or transmission is made on a Business Day after 5:00 p.m. (Calgary time) at the place of receipt, then on the next following Business Day) or, if mailed, on the third Business Day following the date of mailing; provided, however, that if at the time of mailing or within three Business Days thereafter there is or occurs a labour dispute or other event which might reasonably be expected to disrupt the delivery of documents by mail, any notice or other communication hereunder shall be delivered or transmitted by means of recorded electronic communication as aforesaid.

(c)            Either party may at any time change its address for service from time to time by giving notice to the other party in accordance with this Section 3.2.

3.3 Amendments and Waivers

No amendment or waiver of any provision of this Agreement shall be binding on either party unless consented to in writing by such party. No waiver of any provision of this Agreement shall constitute a waiver of any other provision, nor shall any waiver of any provision of this Agreement constitute a continuing waiver unless otherwise expressly provided.

3.4 Assignment

No party may assign any of its rights or benefits under this Agreement, or delegate any of its duties or obligations, except with the prior written consent of the other party.

3.5 Successors and Assigns

This Agreement shall enure to the benefit of and shall be binding on and enforceable by and against the parties and their respective successors or heirs, executors, administrators and other legal personal representatives, and permitted assigns.

3.6 Application of this Agreement

The terms of this Agreement shall apply mutatis mutandis to any shares or other securities resulting from the conversion, reclassification, redesignation, subdivision, consolidation or other change to any of the Common Shares held by Enhol.

3.7 Public Filing

The parties hereby consent to the public filing of this Agreement if any party is required to do so by law or by applicable regulations or policies of any regulatory agency of competent jurisdiction or any stock exchange.

3.8 Expenses

Except as otherwise expressly provided in this Agreement, each party will pay for its own costs and expenses incurred in connection with the negotiation, preparation, execution and performance of this Agreement and the transactions contemplated herein, including the fees and expenses of legal counsel, financial advisors, accountants, consultants and other professional advisors.

3.9 Further Assurances

Each of the parties shall, from time to time hereafter and upon any reasonable request of the other, promptly do, execute, deliver or cause to be done, executed and delivered all further acts, documents and things as may be required or necessary for the purposes of giving effect to this Agreement.

3.10 Right to Injunctive Relief

The parties agree that any breach of the terms of this Agreement by either party would result in immediate and irreparable injury and damage to the other party which could not be adequately compensated by damages. The parties therefore also agree that in the event of any such breach or any anticipated or threatened breach by the defaulting party, the other party shall be entitled to equitable relief, including by way of temporary or permanent injunction or specific performance, without having to prove damages, in addition to any other remedies (including damages) to which such other party may be entitled at law or in equity.

3.11 Counterparts and Electronic Signatures

This Agreement and all documents contemplated by or delivered under or in connection with this Agreement may be executed and delivered in any number of counterparts, with the same effect as if each party had signed and delivered the same document, and all counterparts shall be construed together to be an original and will constitute one and the same agreement. This Agreement, any and all agreements and instruments executed and delivered in accordance herewith, along with any amendments hereto or thereto, to the extent signed and delivered by electronic transmission, shall be treated in all manner and respects and for all purposes as an original signature, agreement or instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person.

[Remainder of page intentionally left blank; signature pages follows.]

IN WITNESS WHEREOF this Agreement has been executed by the parties on the date first written above.

ABOVE FOOD INGREDIENTS INC.
by /s/ Lionel Kambeitz
Name: Lionel Kambeitz
Title: Chief Executive Officer
GRUPO EMPRESARIAL ENHOL, S.L.
by /s/ Gonzalo Oliver Amatriain
Name: Gonzalo Oliver Amatriain
Title: Authorized Signatory

  

EX-10.28 16 tm2418826d1_ex10-28.htm EXHIBIT 10.28

 

Exhibit 10.28

 

THIS PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).  THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.  

 

PROMISSORY NOTE

 

Principal Amount:  Not to Exceed $3,500,000

Dated as of June 27, 2024

Chicago, IL

 

Bite Acquisition Corp., a Delaware corporation (“Maker”), promises to pay to the order of Smart Dine, LLC, a Delaware limited liability company, or its registered assigns or successors in interest (“Payee”), the principal sum of Three Million Five Hundred Fifty Thousand Dollars ($3,500,000) or such lesser amount as shall have been advanced by Payee to Maker and shall remain unpaid under this promissory note (this “Note”), in lawful money of the United States of America, on the terms and conditions described below. This Note amends, replaces and supersedes in its entirety that certain promissory note, dated January 22, 2024, made by Maker in favor of Payee in the principal amount of up to $3,250,000 (the “Original Note”), and any unpaid principal balance of the indebtedness evidenced by the Original Note is being merged into and will hereafter be evidenced by this Note. All payments on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account as the Payee may from time to time designate by written notice in accordance with the provisions of this Note.

 

1.              Principal. Payee may make advances to Maker from time to time under this Note; provided, however, that notwithstanding anything to the contrary herein, at no time shall the aggregate of all advances and re-advances outstanding under this Note exceed $3,500,000. The principal balance of this Note shall be payable on the date on which Maker consummates its initial business combination (the “Maturity Date”). The principal balance may be prepaid at any time.

 

2.              Interest. No interest shall accrue on the unpaid principal balance of this Note.

 

3.              Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges and finally to the reduction of the unpaid principal balance of this Note.

 

4.              Conversion.

 

(a)        At Payee’s option, on the Maturity Date in the event Maker consummates its initial business combination, Payee may elect to convert up to an aggregate of $1,500,000 of the principal outstanding under this Note into that number of units (“Working Capital Units”) equal to: (i) the portion of the principal amount, up to an aggregate of $1,500,000, of this Note being converted pursuant to this Section 4, divided by (ii) $10.00, rounded up to the nearest whole number. Each Working Capital Unit shall have the same terms and conditions as the units issued by Maker pursuant to a private placement to Payee (the “Private Placement”), as described in the prospectus (the “Prospectus”) for Maker’s initial public offering (the “IPO”) dated February 11, 2021 and filed with the U.S. Securities and Exchange Commission, including the transfer restrictions applicable thereto. In addition, at Payee’s option, on the Maturity Date in the event Maker consummates its initial business combination, Payee may elect to convert up to an aggregate of $2,000,000 of the principal outstanding under this Note into that number of shares of common stock (“Working Capital Shares”) equal to : (i) the portion of the principal amount, up to an aggregate of $2,000,000, of this Note being converted pursuant to this Section 4, divided by (ii) $10.00, rounded up to the nearest whole number. Each Working Capital Share shall have the same terms and conditions as the shares of common stock included in the units issued by Maker pursuant to the Private Placement, as described in the Prospectus for Maker’s IPO dated February 11, 2021 and filed with the U.S. Securities and Exchange Commission, including the transfer restrictions applicable thereto. The Working Capital Units and the shares of common stock underlying such units (including any shares issuable upon exercise of warrants included in the Working Capital Units), the Working Capital Shares, and any other equity security of Maker issued or issuable with respect to the foregoing by way of a stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization, shall be entitled to the registration rights set forth in that certain registration rights agreement between Maker and the parties thereto, dated as of February 11, 2021.

 

1


 

(b)        Upon any conversion of the principal amount, up to an aggregate of $3,500,000, of this Note, (i) such principal amount shall be so converted and such converted portion of this Note shall become fully paid and satisfied, (ii) Payee shall surrender and deliver this Note, duly endorsed, to Maker or such other address which Maker shall designate against delivery of the Working Capital Units and/or the Working Capital Shares, (iii) Maker shall promptly deliver a new duly executed Note to Payee in the principal amount that remains outstanding, if any, after any such conversion and (iv) in exchange for all or any portion of the surrendered Note, Maker shall, within five (5) business days following receipt by Maker of Payee’s election to convert this Note pursuant to this Section 4, deliver to Payee the Working Capital Units and/or Working Capital Shares, as applicable, which shall bear such legends as are required in the opinion of counsel to Maker or by any other agreement between Maker and Payee and applicable state and federal securities laws.

 

(c)        Payee shall pay any and all issue and other taxes that may be payable with respect to any issue or delivery of the Working Capital Units and Working Capital Shares upon conversion of this Note pursuant hereto; provided, however, that Payee shall not be obligated to pay any transfer taxes resulting from any transfer requested by Payee in connection with any such conversion.

 

(d)       The Working Capital Units and Working Capital Shares shall not be issued upon conversion of this Note unless such issuance and such conversion comply with all applicable provisions of law. No fractional Working Capital Units and Working Capital Shares shall be issued upon conversion of this Note. For the avoidance of doubt, in the event that all principal on this Note has been paid in full on or prior to the Maturity Date, then Payee shall not be entitled to convert any portion of this Note into Working Capital Units or Working Capital Shares. Upon conversion of this Note in full, this Note shall be cancelled and void without further action of Maker or Payee, and Maker shall be forever released from all its obligations and liabilities under this Note.

 

5.              Events of Default. The following shall constitute an event of default (“Event of Default”):

 

(a)       Failure to Make Required Payments. Failure by Maker to pay the principal amount due pursuant to this Note within five (5) business days of the date specified above.

 

(b)       Voluntary Bankruptcy, Etc. The commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency, reorganization, rehabilitation or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian, sequestrator (or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate action by Maker in furtherance of any of the foregoing.

 

(c)        Involuntary Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of Maker in an involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) of Maker or for any substantial part of its property, or ordering the winding-up or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive days.

 

2


 

6.              Remedies.

 

(a)        Upon the occurrence of an Event of Default specified in Section 5(a) hereof, Payee may, by written notice to Maker, declare this Note to be due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts payable thereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

 

(b)        Upon the occurrence of an Event of Default specified in Sections 5(b) and 5(c), the unpaid principal balance of this Note, and all other sums payable with regard to this Note, shall automatically and immediately become due and payable, in all cases without any action on the part of Payee.

 

7.              Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon, may be sold upon any such writ in whole or in part in any order desired by Payee.

 

8.              Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party, and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties hereto without notice to Maker or affecting Maker’s liability hereunder.

 

9.              Notices. All notices, statements or other documents which are required or contemplated by this Note shall be: (i) in writing and delivered personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address designated in writing, (ii) by facsimile to the number most recently provided to such party or such other address or fax number as may be designated in writing by such party and (iii) by electronic mail, to the electronic mail address most recently provided to such party or such other electronic mail address as may be designated in writing by such party.  Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered personally, on the business day following receipt of written confirmation, if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier service or five (5) days after mailing if sent by mail.

 

3


 

10.            Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF DELAWARE, WITHOUT REGARD TO CONFLICT OF LAW PROVISIONS THEREOF.

 

11.            Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

12.            Trust Waiver.  Notwithstanding anything herein to the contrary, Payee hereby waives any and all right, title, interest or claim of any kind (“Claim”) in or to any distribution of or from the trust account in which a portion of the proceeds of Maker’s IPO were deposited, as described in greater detail in the prospectus filed with the SEC in connection with the IPO, and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the trust account for any reason whatsoever.

 

13.            Amendment; Waiver.  Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of the Maker and the Payee.

 

14.            Assignment.  No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent shall be void.

 

4


 

IN WITNESS WHEREOF, Maker and Payee, intending to be legally bound hereby, have caused this Note to be duly executed by the undersigned as of the day and year first above written.

 

  Maker:
   
  BITE ACQUISITION CORP.
     
  By:  /s/ Alberto Ardura González  
    Name:  Alberto Ardura González  
    Title: Chief Executive Officer and Chairman of the Board
   
  Payee:
   
  SMART DINE, LLC
     
  By:  /s/ Jose Luis Guerrero Cortes  
    Name:  Jose Luis Guerrero Cortes  
    Title: CFO

 

[Signature Page to Promissory Note]

 

EX-10.29 17 tm2418826d1_ex10-29.htm EXHIBIT 10.29

Exhibit 10.29

 

***CERTAIN MATERIAL (INDICATED BY THREE ASTERISKS IN BRACKETS) HAS BEEN OMITTED FROM THIS DOCUMENT BECAUSE IT IS BOTH (1) NOT MATERIAL AND (2) THE TPYE THAT THE REGISTRANTS TREATS AS PRIVATE OR CONFIDENTIAL. IN ADDITION, CERTAIN PERSONALLY IDENTIFIABLE INFORMATION HAS BEEN OMITTED FROM THIS EXHIBIT PURSUANT TO ITEM 601(A)(6) OF REGULATION S-K. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED

 

ASSET PURCHASE AGREEMENT

 

BY AND AMONG

 

ARCADIA BIOSCIENCES, INC.,

 

ARCADIA WELLNESS, LLC,

 

ABOVE FOOD CORP.

 

AND

 

ABOVE FOOD INGREDIENTS CORP.

 

DATED AS OF MAY 14, 2024

 

 


 

CONTENTS

 

Clause    Page

 

ARTICLE I : PURCHASE AND SALE AND CLOSING

1

1.1

Purchase and Sale of Purchased Assets 1

1.2

Excluded Assets 2

1.3

Assumed Liabilities 2

1.4

Excluded Liabilities 3

1.5

Purchase Price 3

1.6

Withholding 3

1.7

Closing 3

1.8

Closing Deliveries by the Sellers 4

1.9

Closing Deliveries by Buyer 4

1.10

Assignment of Contracts 5

1.11

Limited Licenses 5

ARTICLE II : REPRESENTATIONS AND WARRANTIES OF THE SELLERS

5

2.1

Organization; Authority 5

2.2

No Conflict 6

2.3

Compliance with Laws and Orders 6

2.4

Title 6

2.5

Proceedings 6

2.6

Brokers Fees 7

2.7

Absence of Changes 7

2.8

Inventory 7

2.9

No Other Agreements to Sell the Purchased Assets 7

2.10

Assigned Contracts 7

2.11

Permits 7

2.12

Intellectual Property; Formulations 8

2.13

Purchased Orders 8

2.14

Condition of Purchased Assets 8

2.15

Taxes 8

ARTICLE III : REPRESENTATIONS AND WARRANTIES OF PARENT AND BUYER

8

3.1

Organization; Authority 8

3.2

No Conflict 9

 

 


 

3.3

Proceedings 9

3.4

Compliance with Laws and Orders 9

3.5

Brokers Fees 9

3.6

Representations Limited 10

ARTICLE IV : COVENANTS

10

4.1

Allocation of Purchase Price 10

4.2

Transfer Taxes 10

4.3

Asset Taxes 10

4.4

Cooperation on Tax Matters 11

4.5

Non-Solicitation 11

4.6

Public Announcements 12

4.7

Further Actions 12

4.8

Misdirected Payments 12

4.9

Confidentiality 12

4.10

Access to Information 13

4.11

Delivery of Purchase Assets 13

ARTICLE V : LIMITATION OF LIABILITY; INDEMNIFICATION

14

5.1

Indemnity 14

5.2

Limitations of Liability 14

5.3

Indemnification Procedures 16

5.4

Waiver of Remedies 16

ARTICLE VI : MISCELLANEOUS

16

6.1

Notices 16

6.2

Entire Agreement 18

6.3

Amendment 18

6.4

Waivers 18

6.5

No Third-Party Beneficiary 18

6.6

Assignment 18

6.7

Severability 18

6.8

Construction 18

6.9

Benefits and Binding Effect 18

6.10

Governing Law; Venue 18

6.11

Counterparts 19

 

ii 

 

6.12

Expenses 19

6.13

Bulk Sales Laws 19

6.14

Disclosure Schedules 19

6.15

Attorney Fees 19

 

EXHIBITS

 

Exhibit A: N/A
Exhibit B: Intellectual Property Assignment Agreement
Exhibit C: Bill of Sale
Exhibit D: Assignment and Assumption Agreement
Exhibit E: Promissory Note
Exhibit F: Security Agreement
Exhibit G: Trademark Security Agreement
Exhibit H: Sellers’ RG Patents
Exhibit I: Certain Transferred Rights

 

iii 

 

ASSET PURCHASE AGREEMENT

 

THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 14, 2024, by and among Arcadia Biosciences, Inc., a Delaware corporation (“Arcadia”), Arcadia Wellness, LLC, a Delaware limited liability company and wholly owned subsidiary of Arcadia (“Wellness”, and together with Arcadia, the “Sellers”), Above Food Corp., a corporation formed under the laws of Saskatchewan (“Parent”), and Above Food Ingredients Corp., a Delaware corporation and wholly owned subsidiary of Parent (“Buyer”).

 

RECITALS

 

A.            Subject to the terms and conditions of this Agreement, Buyer has agreed to purchase from the Sellers, and the Sellers have agreed to sell to Buyer, the Purchased Assets (as defined below), for the consideration described herein.

 

B.             Certain capitalized terms used in this Agreement are defined on 0 hereto.

 

NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth herein, and subject to the terms and conditions set forth herein, the Parties hereby agree as follows:

 

AGREEMENT

 

ARTICLE I: PURCHASE AND SALE AND CLOSING

 

1.1           Purchase and Sale of Purchased Assets. Subject to the terms and conditions of this Agreement, at the Closing (as defined below), the Sellers shall sell, assign, transfer, deliver and convey to Buyer, and Buyer shall purchase and acquire from the Sellers, free and clear of all Liens other than Permitted Liens, all of the Sellers’ right, title and interest in and to the following assets and properties (of whatever kind or nature, real, personal, or mixed, tangible or intangible), in each case, that is used in the Business as presently conducted, to the extent not consisting of Excluded Assets (collectively, the “Purchased Assets”):

 

(a)            Grain Inventory. The type and quantity of grain inventory described on Schedule 1.1(a) (the “Grain Inventory”), which inventory is located at the locations set forth on Schedule 1.1(a) (the “Grain Inventory Locations”);

 

(b)            Finished Goods. All finished inventory described on Schedule 1.1(b), including all related packaging materials (such finished inventory and packaging materials, the “Finished Inventory”, and together with the Grain Inventory, the “Inventory”), which Finished Inventory is located at the locations set forth on Schedule 1.1(b) (together with the Grain Inventory Locations, the “Inventory Locations”);

 

(c)            Formulations. The formulations used by Seller to create the Finished Inventory, including all intellectual property rights therein (“Formulations”);

 

(d)            Trademarks; Other IP. (i) The trademarks and trademark applications set forth in Schedule 1.1(d)(i) and all issuances, extensions, and renewals thereof (“Trademarks”), together with the goodwill of the business conducted with the use of, and symbolized by, the Trademarks, (ii) the internet domain names set forth on in Schedule 1.1(d)(ii), and all issuances, extensions and renewals thereof, and (iii) the social media accounts set forth in Schedule 1.1(d)(iii), and all corresponding verifications and access credentials thereof (collectively, the “Assigned IP”);

 

1

 

 

(e)            Books and Records. The books and records relating exclusively to the Business, including customer information, supplier information, telephone or mailing listings, and other materials, including promotional materials, in whatever form contained, and other information and data exclusively relating to the Business, in each case, excluding the Excluded Records (the “Books and Records”);

 

(f)             Contracts. Subject to Section 1.10, all of the Sellers’ rights under the Contracts listed on Schedule 1.1(f) hereto, but only to the extent the rights thereto arise and relate to periods on or after the Closing (“Assigned Contracts”); and

 

(g)            Purchase Orders. All of the Sellers’ rights in, to and under the purchase orders relating to the Business for which the products relating thereto have not been delivered as of the date hereof, including such purchase orders set forth on Schedule 1.1(g).

 

1.2            Excluded Assets. Other than the Purchased Assets specifically described in Section 1.1, Buyer understands and agrees that it is not purchasing, and the Sellers are not selling or assigning, any other assets (including, other than as provided in Sections 1.1(c) or (d), any trademarks, service marks, tradenames, service names, logos, product or service designations, slogans, patents, copyrights, inventions, trade secrets, know-how or proprietary design or process) or properties of the Sellers or their Affiliates, and all such other assets and properties (including any Excluded Records) shall be excluded from the Purchased Assets (collectively, the “Excluded Assets”). The Parties acknowledge that the Excluded Assets include without limitation:

 

(a)            all cash (other than the cash transferred and delivered to Buyer pursuant to Section 1.8(a)), cash equivalents, investments and any associated bank accounts, deposit accounts and similar accounts, and any accounts receivable of the Sellers or their Affiliates;

 

(b)            all Claims of the Sellers or their Affiliates for refunds of, credits attributable to, loss carryforwards with respect to, or similar Tax assets relating to (i) Income Taxes imposed by any applicable Laws on Sellers or their Affiliates, and (ii) Taxes that are Seller Taxes;

 

(c)            all Claims, actions, deposits, prepayments, refunds, causes of action, choses in action, rights of recovery, rights of setoff and rights or recoupment of any kind or nature related to the Excluded Assets or the Excluded Liabilities;

 

(d)            all insurance policies and any Claims and rights thereunder of the Sellers or their Affiliates;

 

(e)            each account receivable of the Business under which the Sellers have delivered the products relating thereto prior to the date hereof, including those set forth on Schedule 1.2(e).

 

(f)             Excluded Records.

 

1.3            Assumed Liabilities. Buyer agrees to assume as of the Closing, and to thereafter perform and discharge, the following Liabilities (“Assumed Liabilities”):

 

(a)            all Liabilities arising under or relating to the Assigned Contracts pursuant to the terms thereof that arise or accrue under such Contracts at or after the Closing, including with respect to the purchase orders described in Section 1.1(g);

 

(b)            all Liabilities for (i) Asset Taxes allocable to Buyer pursuant to Section 4.3(b) and (ii) Transfer Taxes allocable to Buyer pursuant to Section 4.2; and

 

2

 

(c)            all Liabilities for slotting fees and free fill obligations described on Schedule 1.3(c);

 

(d)            all other Liabilities and obligations arising out of or relating to the Purchased Assets that arise or accrue at or after the Closing or Buyer’s ownership and operation of the Purchased Assets at or after the Closing.

 

1.4           Excluded Liabilities. Buyer and Parent shall not assume and shall not be responsible to pay, perform or discharge any Liabilities of the Sellers or any of their Affiliates other than the Assumed Liabilities (such Liabilities other than the Assumed Liabilities, the “Excluded Liabilities”) including without limitation:

 

(a)            any and all Liabilities that are expressly provided by this Agreement or any other Transaction Document as Liabilities to be retained by the Sellers;

 

(b)            all agreements, arrangements, obligations and Liabilities of the Sellers under this Agreement or any of the other Transaction Documents, including, for the avoidance of doubt, all Liabilities arising out of or related to any breach by the Sellers of any representation or warranty set forth in this Agreement or any other Transaction Document;

 

(c)            each account payable of the Business under which each counterparty there has performed its respective obligations prior to the date hereof and is set forth on Schedule 1.4(c); and

 

(d)            all Liabilities to the extent relating to, arising out of or resulting from:

 

(i)            the Excluded Assets and the ownership and operation thereof;

 

(ii)           Subject to Section 1.3(c), Sellers operation of the Business at any time before the Closing;

 

(iii)         all Claims, actions, disputes or controversies (of any and every kind or type, whether based on contract, tort, statute, regulation or otherwise) to the extent arising out of, relating to, or in connection with the ownership or operation of the Business or the ownership, operation or use of the Purchased Assets, in each case, at any time before the Closing by any Person; and

 

(iv)         any Proceeding relating to the ownership or operation of the Business or the ownership, operation or use of the Purchased Assets, in each case, at any time before the Closing by any Person.

 

1.5           Purchase Price. The purchase price (“Purchase Price”) for the purchase of the Purchased Assets is equal to four million U.S. dollars ($4,000,000 USD).

 

1.6           Withholding. As provided in the Promissory Note, Buyer shall be entitled to deduct and withhold from any amount otherwise payable pursuant to the Promissory Note to Arcadia such amounts as Buyer is required to deduct and withhold under any Tax law of the United States of America or any jurisdiction contained therein, with respect to the making of such payment that are between entities formed and with principal places of business within the United States. To the extent that amounts are so withheld, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of whom such deduction and withholding was made.

 

1.7           Closing. The closing of the transactions described in this Agreement (“Closing”) shall take place remotely via electronic exchange of documents at 10:00 a.m. Central Time on the date hereof (“Closing Date”). All actions listed in Section 1.8 or 1.9 that occur on the Closing Date shall be deemed to occur simultaneously at the Closing.

 

3

 

1.8           Closing Deliveries by the Sellers. At the Closing, the Sellers shall deliver, or cause to be delivered, to Buyer:

 

(a)            Two million U.S. dollars ($2,000,000 USD) in immediately available funds to an account designated by Buyer;

 

(b)            Intentionally Omitted;

 

(c)            an intellectual property assignment agreement, in substantially the form attached hereto as Exhibit B (“Intellectual Property Assignment Agreement”), relating to the assignment and sale of the Assigned IP, duly executed by the Sellers;

 

(d)            a bill of sale, in substantially the form attached hereto as Exhibit C (“Bill of Sale”), relating to the purchase and sale of the Purchased Assets, other than the Assigned IP, duly executed by the Sellers;

 

(e)            an executed counterpart by the Sellers of an assignment and assumption agreement, in substantially the form attached hereto as Exhibit D (“Assignment and Assumption Agreement”);

 

(f)             intentionally omitted;

 

(g)            intentionally omitted;

 

(h)            possession of the Inventory at the Inventory Locations, at which point all risk of loss with respect to the Inventory shall shift from the Sellers to Buyer; and

 

(i)            such other customary instruments of transfer or assumption, filings or documents as may be required to give effect to the transactions contemplated by this Agreement and the other Transaction Documents.

 

1.9           Closing Deliveries by Buyer. At the Closing, Buyer shall deliver, or cause to be delivered, to the Sellers:

 

(a)            a promissory note in the original principal amount of six million U.S. dollars ($6,000,000 USD) to the benefit of Arcadia, in substantially the form attached hereto as Exhibit E (“Promissory Note”), duly executed by Parent and Buyer;

 

(b)            a security agreement, in substantially the form attached hereto as Exhibit F (“Security Agreement”), duly executed by Buyer and Parent;

 

(c)            intentionally omitted;

 

(d)            the Intellectual Property Assignment Agreement, duly executed by Buyer;

 

(e)            the Assignment and Assumption Agreement, duly executed by Buyer and Parent;

 

(f)            a trademark security agreement, in substantially the form attached hereto as Exhibit G (“Trademark Security Agreement”), duly executed by Buyer; and

 

4

 

(g)            such other customary instruments of transfer or assumption, filings or documents as may be required to give effect to the transactions contemplated by this Agreement and the other Transaction Documents.

 

1.10         Assignment of Contracts. The Sellers and Buyer shall use commercially reasonable efforts for a period of ninety (90) days following the Closing, and shall cooperate with each other, to obtain any required consent, waiver or approval of the other parties to any Assigned Contracts or any Claim or right or any benefit arising thereunder for the assignment thereof as Buyer may request (in each case, at Buyer’s cost). Such consents, waivers and approvals shall be in a form reasonably acceptable to Buyer and Arcadia. Notwithstanding anything to the contrary in this Agreement, no Party shall be required to pay any monies to obtain such consents. Notwithstanding any other provision of this Agreement to the contrary, this Agreement shall not constitute an agreement to assign or transfer any rights under the Assigned Contracts or any Claim or right or any benefit arising or resulting from the Assigned Contracts if an attempted assignment or transfer thereof, without the consent or authorization of a third party thereto, would constitute a breach or other contravention thereof or a violation of Law. If an attempted transfer or assignment thereof would be ineffective pursuant to the terms of the applicable Assigned Contract or a violation of Law or its designee (as assignee of the Sellers) thereto or thereunder so that such assignee would not in fact receive all such rights, the Sellers and Buyer (or its designee) shall use commercially reasonable efforts to enter into any arrangement reasonably requested by the other (provided Buyer shall reimburse Sellers for all reasonable and documented out-of-pocket expenses incurred by Sellers arising from the actions taken by Sellers at Buyer’s request pursuant to this Section 1.10) under which (i) Buyer or its designee would, in compliance with Law, receive the rights and benefits and assume the obligations and bear the economic burdens associated with such Assigned Contracts, and (ii) the Sellers would enforce for the benefit of Buyer or its designee any and all of its rights against a third party associated with such Assigned Contracts, and the Sellers would promptly pay to Buyer or its designee when received all monies received by the Sellers under any Assigned Contracts. The Sellers’ obligation under this Section 1.10 shall terminate ninety (90) days after the Closing Date.

 

1.11         Limited Licenses. [***]

 

ARTICLE II: REPRESENTATIONS AND WARRANTIES OF THE SELLERS

 

Each of the Sellers hereby represent and warrant to Buyer, except as modified pursuant to any applicable disclosure schedules (“Disclosure Schedules”) accompanying this Agreement, as set forth below.

 

2.1           Organization; Authority. Arcadia is a corporation duly formed and validly existing in good standing under the Laws of the State of Delaware with full corporate power and authority to conduct its business as it is presently being conducted and to own and operate its properties and assets. Wellness is a limited liability company duly formed and validly existing in good standing under the Laws of the State of Delaware with full limited liability company power and authority to conduct its business as it is presently being conducted and to own and operate its properties and assets. Each of Arcadia and Wellness have the requisite entity power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby and the other Transaction Documents to which it is a party. No other corporate proceedings on the part of Arcadia or Wellness are necessary to authorize this Agreement and the Transaction Documents and the transactions contemplated hereby and thereby. The execution, delivery and performance of the obligations of Arcadia and Wellness hereunder and thereunder have been duly authorized and approved by all requisite entity action. This Agreement and each Transaction Document to which either Seller is, or both Sellers are, a party have been duly executed and delivered by such Seller or Sellers, as applicable, and constitutes such Seller’s or Sellers’ legal, valid and binding obligation enforceable against such Seller or Sellers in accordance with its terms, except as the same may be limited by bankruptcy, insolvency, reorganization, fraudulent conveyance, arrangement, moratorium or other similar Laws relating to or affecting the rights of creditors generally, or by general equitable principles. Each of Arcadia and Wellness is duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction where the character of its properties owned or leased or the nature of its activities make such qualification necessary, except where the failure to be so qualified or in good standing would not have a material adverse effect on the Purchased Assets, taken as a whole, the Business or the Sellers’ ability to perform their obligations hereunder.

 

5

 

2.2           No Conflict. Except as set forth in Section 2.2 of the Disclosure Schedules, the execution and delivery by the Sellers of this Agreement or any Transaction Document do not and will not, and the performance by the Sellers of their obligations under this Agreement or any Transaction Document and the consummation of the transactions contemplated hereby or by the other Transaction Documents does not and will not:

 

(a)            violate or result in a breach of the organizational documents of Arcadia or Wellness;

 

(b)            violate or result in a breach of any Law applicable to Arcadia, Wellness or the Business or by which any of the Purchased Assets is bound or affected, except for such violations or breaches as would not reasonably be expected to result in a material adverse effect on Sellers’ ability to perform their obligations hereunder;

 

(c)            require any notice to, consent, waiver, Order, authorization, permit or approval of, registration, declaration or filing with, or any other action by any governmental authority located in the United States, other any such consent, notice, waiver or approval which (i) has already been made or obtained, (ii) if not made or obtained, would not reasonably be expected to result in a material adverse effect on Sellers’ ability to perform it obligations hereunder, or (iii) are contemplated by the Security Agreement or required under applicable securities laws;

 

(d)            (i) breach, or constitute a default, under (with or without notice or lapse of time, or both), or (ii) require the consent, notice, waiver, approval or other action by any Person under, any of the Purchased Assets, other than in each case any such consent, notice, waiver or approval which has already been made or obtained, is addressed in Section 1.10 or if not made or obtained, would not reasonably be expected to result in a material adverse effect on Sellers’ ability to perform it obligations hereunder; or

 

(e)            result in the creation of a Lien upon any of the Purchased Assets (other than a Permitted Lien or a Lien created pursuant to the Transaction Documents).

 

2.3           Compliance with Laws and Orders. Since January 1, 2023, the Sellers have not violated in any material respects any Laws or Orders relating to the Business and the Purchased Assets.

 

2.4           Title. The Sellers have Buyer good, valid and marketable title to the Purchased Assets, free and clear of any Liens other than Permitted Liens. The Sellers are the exclusive owners of the Registered Trademarks and the Purchased Assets.

 

2.5           Proceedings. There is no Proceeding pending, or to the knowledge of the Sellers, threatened in writing, against the Business, the Sellers or any of their respective assets or properties (tangible or intangible) that would materially impair Sellers’ ability to perform its obligations hereunder and under the Transaction Documents. There are no judgments, orders, writs, injunctions, decrees, indictments or information, grand jury subpoenas or civil investigative demands, or awards against the Sellers relating to the Business.

 

6

 

2.6            Brokers Fees. No Seller has any Liability for any fee, commission or payment to any investment banker, business broker or similar agent or any person or firm with respect to the transactions contemplated by this Agreement or the other Transaction Documents, in each case, for which Buyer could be liable or obligated.

 

2.7           Absence of Changes. Since December 31, 2023, the Sellers have conducted the Business in the ordinary course of business.

 

2.8           Inventory.

 

(a)            Schedules 1.1(a) and 1.1(b) accurately describe the type and identity of wheat used to create the Inventory.

 

(b)            Except as set forth in Section 2.8(b) of the Disclosure Schedules, the Finished Inventory (i) is not damaged or adulterated in any material respect, (ii) is merchantable, saleable and useable in the ordinary course of business consistent with past practice and (iii) may be shipped in interstate commerce within the United States of America in accordance with applicable Law in all material respects. The quantity of Finished Inventory is at levels substantially consistent with past practice.

 

(c)            All Inventory was acquired in the ordinary course of business. The Sellers have good and marketable title to all of the Inventory, free and clear of any and all Liens, other than Permitted Liens, and no Inventory is held on a consignment basis.

 

(d)            Except for the Assigned Contracts and as set forth in Section 2.8(d) of the Disclosure Schedules, the Sellers do not have any open customer orders for any of the Inventory with respect to which the Sellers have been prepaid, in whole or in part, or have received deposits or other advances.

 

2.9           No Other Agreements to Sell the Purchased Assets. Except for the Assigned Contracts, neither Arcadia nor Wellness has any legal obligation, absolute or contingent, to any Person other than Buyer to sell, assign, transfer or effect a sale of any of the Purchased Assets.

 

2.10         Assigned Contracts. Except as set forth in Section 2.10 of the Disclosure Schedules, the Sellers have made available to Buyer true and correct copies of each Assigned Contract as in effect as of the date of this Agreement. Except as set forth in Section 2.10 of the Disclosure Schedules, the Sellers have complied in all material respects with the terms and conditions of the Assigned Contracts applicable to Arcadia or Wellness, and to Seller’s knowledge, as of the date hereof, there is not any material violation, breach or event of default by Seller or any other parties to the Assigned Contracts. The Assigned Contracts are valid as of the date hereof and are in full force and effect and are enforceable against each party thereto in accordance with the express terms thereof, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer or other similar Laws affecting or relating to the enforcement of creditors’ rights generally from time to time in effect, and to general principles of equity.

 

2.11         Permits. Section 2.11 of the Disclosure Schedules contains a list of all any permits, consents, authorizations, certificates, approvals, registrations, legal status, variances, exemptions, rights-of-way, franchises, privileges, immunities, grants, ordinances, licenses and other rights of every kind and character granted, issued or otherwise made available by any governmental authority, which are held by the Company for the operation of the Business (the “Seller Permits”). The Sellers are in compliance in all material respects with the terms and conditions and conditions of all Seller Permits.

 

7

 

2.12         Intellectual Property; Formulations. To the Sellers’ knowledge, all of the Registered Trademarks are valid, enforceable, and subsisting (or, in the case of applications, applied for) (which shall include being currently in compliance in all material respects with applicable Law). No Registered Trademark has been adjudged by a court or competent authority to be invalid or unenforceable in whole or in part. To Sellers’ knowledge, the Sellers’ use of the Formulations is not infringing, misappropriating or otherwise violating, and has not infringed, misappropriated or otherwise violated, the intellectual property rights of any Person. No Person has challenged in a writing received by either Seller the validity or enforceability of the Trademarks or the rights of the Sellers to use the Formulations. To the Sellers’ knowledge, no Person is infringing, misappropriating or otherwise violating any of the Sellers’ rights in the Formulations.

 

2.13         Purchased Orders. Section 2.13 of the Disclosure Schedules sets forth a true and complete list of all open purchase orders for the Business that are Purchased Assets, in each case as of the close of business on May 10, 2024.

 

2.14         Condition of Purchased Assets. EXCEPT AS EXPRESSLY SET FORTH IN THIS ARTICLE II, AND EXCEPT IN THE CASE OF FRAUD IN THE MAKING OF THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS ARTICLE II, (I) THE SELLERS MAKE NO EXPRESS OR IMPLIED WARRANTIES REGARDING THE PURCHASED ASSETS, (II) THE PURCHASED ASSETS ARE TRANSFERRED ON AN AS-IS, WHERE-IS, BASIS, AND (III) PARENT AND BUYER EXPLICITLY DISCLAIM ALL IMPLIED WARRANTIES.

 

2.15         Taxes. Except as set forth in Section 2.15 of the Disclosure Schedules:

 

(a)            All Tax Returns that were required to be filed with respect to the Purchased Assets have been filed. All such Tax Returns are complete and accurate in all material respects.

 

(b)            All Taxes that are due and payable (whether or not shown on any Tax Return) with respect to the Purchased Assets have been paid.

 

(c)            Seller is not currently the beneficiary of any extension of time within which to file any Tax Return with respect to the Purchased Assets.

 

(d)            There are no pending audits, investigations, disputes, notices of deficiency, claims or other actions for or relating to any Liability for Taxes with respect to the Purchased Assets. Seller has not waived any statute of limitations in respect of Taxes attributable to the Purchased Assets or agreed to any extension of time with respect to a Tax assessment or deficiency.

 

(e)            Wellness is classified for U.S. federal income tax purposes as an entity disregarded as separate from Arcadia.

 

ARTICLE III: REPRESENTATIONS AND WARRANTIES OF PARENT AND BUYER

 

Other than as set out in the Parent’s public filings, Parent and Buyer hereby represent and warrant to the Sellers that:

 

3.1            Organization; Authority. Parent is a Corporation duly formed and validly existing under the Laws of Saskatchewan with full corporate power and authority to conduct its business as it is presently being conducted and to own and operate its properties and assets. Buyer is a corporation duly formed and validly existing under the Laws of Delaware with full corporate power and authority to conduct its business as it is presently being conducted and to own and operate its properties and assets. Each of Parent and Buyer have the requisite entity power and authority to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby and the other Transaction Documents to which it is a party. No other corporate proceedings on the part of Parent or Buyer are necessary to authorize this Agreement and the Transaction Documents and the transactions contemplated hereby and thereby. The execution, delivery and performance of the obligations of Parent and Buyer hereunder and thereunder have been duly authorized and approved by all requisite entity action. This Agreement and each Transaction Document to which Parent or Buyer is a party have been duly executed and delivered by Parent or Buyer, as applicable, and constitutes Parent or Buyer’s legal, valid and binding obligation enforceable against Parent or Buyer, as applicable, in accordance with its terms, except as the same may be limited by bankruptcy, insolvency, reorganization, fraudulent conveyance, arrangement, moratorium or other similar Laws relating to or affecting the rights of creditors generally, or by general equitable principles. Each of Parent and Buyer is duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction where the character of its properties owned or leased or the nature of its activities make such qualification necessary, except where the failure to be so qualified or in good standing would not have a material adverse effect on Parent’s or Buyer’s ability to perform its obligations hereunder.

 

8

 

3.2           No Conflict. The execution and delivery by Parent and Buyer of this Agreement or any Transaction Document do not and will not, and the performance by Parent and Buyer of their obligations under this Agreement or any Transaction Document and the consummation of the transactions contemplated hereby or by the other Transaction Documents does not and will not:

 

(a)            conflict with, violate or result in a breach of the organizational documents of Parent or Buyer;

 

(b)            conflict with, violate or result in a breach of any Law applicable to Parent or Buyer;

 

(c)            require any notice to, consent, waiver, Order, authorization, permit or approval of, registration, declaration or filing with, or any other action by any governmental authority;

 

(d)            (i) violate, breach, conflict with or result in any loss of benefit, or constitute a default, under (with or without notice or lapse of time, or both), (ii) require the consent, notice, waiver, approval or other action by any Person under or (iii) result in the termination of, or accelerate the performance required by, or result in a right of termination, amendment, vesting, payment, cancellation or acceleration under, any of the terms, conditions or provisions of, any contract, lease or permit, other than in each case any such consent, notice, waiver or approval which has already been made or obtained.

 

3.3           Proceedings. There is no Proceeding pending, or to the knowledge of Parent and Buyer, threatened, against Parent or Buyer or any of their respective assets or properties (tangible or intangible), or, to the knowledge of Parent and Buyer, pending or threatened against any of the officers, directors or other service providers or representatives of Parent or Buyer or to which Parent or Buyer is otherwise a party. There are no judgments, orders, writs, injunctions, decrees, indictments or information, grand jury subpoenas or civil investigative demands, or awards against Parent or Buyer relating to Parent or Buyer or any of their respective assets or properties. To the knowledge of Parent and Buyer, no event has occurred or circumstance exists that is reasonably likely to give rise to, or serve as a basis for, the commencement of any Proceeding against Parent or Buyer.

 

3.4           Compliance with Laws and Orders. Parent and Buyer have not violated and are, and at all times have been, in compliance with all Laws and Orders. Neither Parent nor Buyer has received any written notice of or been charged with the violation of any Laws. Neither Parent nor Buyer is under investigation with respect to the violation of any Laws, and, to the knowledge of Parent and Buyer, there have been no such investigations threatened, scheduled or pending and there are no facts or circumstances which could form the basis for any such violation.

 

3.5           Brokers Fees. Neither Parent nor Buyer has any Liability for any fee, commission or payment to any broker, finder or similar agent or any person or firm with respect to the transactions contemplated by this Agreement or the other Transaction Documents, in each case, for which the Sellers could be liable or obligated.

 

9

 

3.6           Representations Limited. Each of Buyer and Parent acknowledges that, except as expressly set forth in this Agreement, neither the Sellers, nor any of their respective Representatives or Affiliates, make any representations or warranties with respect to (a) any projection, estimate or budget delivered or made available to Parent, Buyer or their Affiliates or Representatives of future revenues, future results of operations (or any component thereof), future cash flows or future financial condition (or any component thereof) of or with respect to any Purchased Assets (whether now or with respect to the future of the business conducted with the Purchased Assets) or (b) any other information or documents made available to Parent, Buyer or their Representatives with respect to any assets of the Sellers, any Purchased Assets, the business conducted by the Sellers with the Purchased Assets and/or any Liabilities or operations of the Sellers. Each of Parent and Buyer further acknowledges, on behalf of itself and its Affiliates, that it has not relied on any representation not expressly set forth in this Agreement.

 

EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES EXPRESSLY AND SPECIFICALLY MADE IN ARTICLE II (AS MODIFIED BY THE DISCLOSURE SCHEDULES), AND THE OTHER TRANSACTION DOCUMENTS, EACH OF BUYER AND PARENT, ON BEHALF OF ITSELF AND ITS AFFILIATES, REPRESENTATIVES, SUCCESSORS AND PERMITTED ASSIGNS, HEREBY IRREVOCABLY WAIVES ANY WARRANTY OR REPRESENTATION, EXPRESS OR IMPLIED, AS TO THE QUALITY, VALUE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR CONDITION OF THE PURCHASED ASSETS OR ANY PART THEREOF.

 

ARTICLE IV: COVENANTS

 

4.1           Allocation of Purchase Price. The Parties agree that the Purchase Price (plus other relevant items) shall be allocated among the Purchased Assets for all purposes (including tax and financial accounting) in accordance with Schedule 4.1 (the “Allocation Schedule”) and in a manner consistent with Section 1060 of the Code and the regulations thereunder. Each Party agrees not to assert, in connection with any Tax Return, Claim, audit or similar Proceeding, any allocation of the Purchase Price which contradicts the allocation set forth in the Allocation Schedule; provided, however, that nothing contained herein shall prevent the Parties from settling any proposed deficiency or adjustment by any Taxing Authority based upon or arising out of the allocation provided in the Allocation Schedule, and no Party shall be required to litigate before any court any proposed deficiency or adjustment by any Taxing Authority challenging such allocation.

 

4.2           Transfer Taxes. To the extent that any sales, purchase, use, transfer, stamp, documentary, registration, filing, recording or similar fees or Taxes or governmental charges (“Transfer Taxes”) are payable by reason of the sale or transfer of the Purchased Assets under this Agreement, such Transfer Taxes shall be borne 50% by Buyer on the one hand and 50% by the Sellers on the other hand; provided, however, if there are any Transfer Taxes associated with moving or selling the Inventory outside of the United States of America (“Non-US Related Transfer Taxes”), the Non-US Related Transfer Taxes shall be borne entirely by Buyer, and Parent and Buyer shall indemnify, defend, reimburse and hold harmless the Sellers against any such Non-US Related Transfer Taxes. The Sellers and Buyer shall reasonably cooperate in good faith to minimize, to the extent permissible under applicable Law, the amount of any such Transfer Taxes.

 

4.3           Asset Taxes.

 

(a)            Tax Returns for Asset Taxes. The Sellers will file any Tax Return with respect to Asset Taxes attributable to any Pre-Closing Tax Period and will pay any such Asset Taxes shown as due and owing on such Tax Return. Subject to Buyer’s indemnification rights under ARTICLE V and the Sellers’ payment obligation under Section 4.3(b), Buyer will file any Tax Return with respect to Asset Taxes attributable to a Straddle Period that is required to be filed after the Closing and will pay any such Taxes shown as due and owing on such Tax Return. The Parties agree that (A) this Section 4.3(a) is intended to solely address the timing and manner in which certain Tax Returns relating to Asset Taxes are filed and the Asset Taxes shown thereon are paid to the applicable Taxing Authority and (B) nothing in this Section 4.3(a) shall be interpreted as altering the manner in which Asset Taxes are allocated to and economically borne by the Parties.

 

10

 

(b)            Allocation of Asset Taxes. Except as otherwise provided herein, the Sellers shall be allocated and bear all Asset Taxes attributable to any Pre-Closing Tax Period and Buyer shall be allocated and bear all Asset Taxes attributable to any Post-Closing Tax Period.

 

(c)            Tax Proration Methodologies. For purposes of determining the portion of any Taxes that is payable with respect to any Straddle Period:

 

(i)            Asset Taxes that are based upon or related to sales or receipts or imposed on a transactional basis (other than such Asset Taxes described in Section 4.3(c)(ii)) shall be allocated to the period in which the transaction giving rise to such Asset Taxes occurred.

 

(ii)           In the case of Asset Taxes that are ad valorem, property or other Asset Taxes imposed on a periodic basis relating to a Straddle Period, the portion of any such Taxes that is attributable to the Pre-Closing Tax Period shall be deemed to be the amount of such Taxes for the entire Straddle Period multiplied by a fraction the numerator of which is the number of calendar days in the portion of the Pre-Closing Tax Period and the denominator of which is the number of calendar days in the entire Straddle Period.

 

4.4           Cooperation on Tax Matters. Each Party shall cooperate fully (and shall cause its Affiliates to cooperate fully), as and to the extent reasonably requested by any other Party, in connection with the filing of Tax Returns and any Claim or other Proceeding with respect to Taxes relating to the Purchased Assets. Such cooperation shall include the retention and (upon the other Party’s request) the provision of records and information that are reasonably relevant to any such Tax Return or Claim or other Proceeding and making Representatives and agents available on a mutually convenient basis to provide additional information and explanation of any material provided under this Agreement. Any information obtained by a Party or its Affiliates from another Party or its Affiliates in connection with any Tax matters to which this Agreement applies will be kept confidential, except as may be otherwise necessary in connection with the filing of Tax Returns or in conducting any Claim or Proceeding with respect to Taxes relating to the Purchased Assets or as may otherwise be necessary to enforce the provisions of this Agreement. The Buyer, on the one hand, and the Seller, on the other hand, shall promptly notify each other upon receipt by such party of written notice of any inquiries, claims, assessments, audits or similar events with respect to Taxes pertaining to the Purchased Assets for a Pre-Closing Tax Period.

 

4.5           Non-Solicitation. Until the second (2nd) anniversary of the Closing Date (the “Restricted Period”), neither Buyer, Parent nor any Affiliate, employee or agent of Buyer or Parent shall encourage, induce, attempt to induce, solicit or attempt to solicit any employee of the Sellers to terminate his or her employment with the Sellers or to take employment with another Person; provided, however, that the foregoing limitation will not prevent Buyer or Parent from hiring any such Person (i) who contacts Buyer or Parent as a result of placing general advertisements in trade journals, newspapers or similar publications that are not directed at the Sellers or their employees or (ii) whose employment with the Sellers has been terminated without any contact or inducement by Buyer, Parent or Buyer’s or Parent’s Affiliates, employees or agents. Buyer and Parent acknowledge that the Sellers would be irreparably harmed by any breach of this Section 4.5 and that there may be no adequate remedy at Law or in damages to compensate the Sellers for any such breach. Buyer and Parent agree that the Sellers, in addition to all other available remedies, shall be entitled to seek injunctive relief requiring specific performance by Buyer and/or Parent of this Section 4.5 in any jurisdiction, without having to prove the inadequacy of any other remedy they may have at Law or in equity and without being required to post bond or other security.

 

11

 

4.6           Public Announcements. No Party shall issue or cause the publication any press release or make any public announcement concerning this Agreement or the transactions contemplated hereby without obtaining the prior written approval of the other Parties hereto, which approval will not be unreasonably withheld or delayed, except (a) as may be required by Law (including as may be requested by the Securities and Exchange Commission or its staff, the Nasdaq Stock Market, the New York Stock Exchange or any other regulatory authority) or stock exchange rules (it being acknowledged that the Sellers may disclose this Agreement and the transactions contemplated hereby on a Form 8-K and other filings pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934, provided, that, in the case of announcements pursuant to this clause (a), such Party shall have provided the other Parties with copies of any such announcement in advance of such disclosure and shall have considered comments made by the other Parties in good faith), or (b) to the extent the contents of such release or announcement have previously been released publicly, by a Party hereto without violation of this Section 4.6. The initial press release to be issued with respect to the execution of this Agreement shall be in the form heretofore agreed to by the Parties.

 

4.7           Further Actions. Subject to the terms and conditions of this Agreement, each Party agrees that, at the reasonable request of the other Party from time to time following the Closing, such Party will take such further actions and execute and deliver such further documents as may be necessary or appropriate to make effective the transactions contemplated hereby without further consideration; provided, however, no such documents or actions shall increase any Party’s liability, or decrease its rights, under this Agreement or the other Transaction Documents.

 

4.8           Misdirected Payments. Except as otherwise provided in this Agreement or any Transaction Document, following the Closing, in the event that any time or from time to time after the Closing:

 

(a)            (i) any payments due with respect to post-Closing operations of the Business or the Purchased Assets are paid in error to the Sellers or any of their Affiliates or (ii) any Seller or any of its Affiliates has retained or received or otherwise possesses any right, interest or asset, of any kind, character or description in a Purchased Asset, the Sellers (x) shall promptly notify Buyer thereof and (y) shall, or shall cause their Affiliates to, promptly remit by wire transfer of immediately available funds such payment to an account designated in writing by Buyer or transfer such Purchased Asset to Buyer; and

 

(b)            (i) any payments due with respect to the pre-Closing operations of the Business or the Purchased Assets are paid in error to Buyer, Parent or their Affiliates or (ii) Parent or Buyer or any of their Affiliates have retained or received or otherwise possesses any right, interest or asset, of any kind, character or description in an Excluded Asset, Buyer and Parent (x) shall promptly notify the Sellers thereof and (y) shall, or shall cause their Affiliates to, promptly remit by wire transfer of immediately available funds such payment to an account designated in writing by the Arcadia or transfer such Excluded Asset to Arcadia.

 

4.9           Confidentiality.

 

(a)            Parent and Arcadia are parties to a Non-Disclosure Agreement, dated on or about November 24, 2023 (the “NDA”), and Parent, Discovery Seed Labs Ltd. and Arcadia are parties to a letter of intent, dated on or about March 17, 2024 (the “LOI”). Parent and Arcadia acknowledge and agree that they continue to be bound by the terms of the NDA and the LOI. Wellness and Buyer hereby agree to be bound by the terms of the NDA and LOI as if Wellness and Buyer were parties to the NDA. Notwithstanding the foregoing, following the Closing the Parties’ obligations under the NDA and the LOI with respect to the Purchased Assets and Assumed Liabilities shall not be binding and shall be of no force or effect.

 

12

 

(b)            Except as otherwise required by Law, after the Closing, the Formulations shall be considered Buyer's confidential information and Seller shall, and shall cause its Affiliates to (i) hold in confidence the Formulations and (ii) not use in any manner, directly or indirectly, the Formulations.

 

4.10         Access to Information. After the Closing Date, for any reasonable purpose, including to defend any Claim arising under this Agreement or the Transaction Documents, upon reasonable prior written request and upon reasonable notice from the Sellers, Buyer and Parent shall, during normal business hours and in such a manner as not to unreasonably interfere with the normal business operations of Buyer and its subsidiaries, make available to the Sellers for inspection (at the Sellers’ expense), the Books and Records with respect to periods prior to the Closing in Buyer’s or its subsidiaries’ possession, and shall afford the Sellers the right (at the Sellers’ expense) to make copies thereof; provided that Buyer shall not be required to provide access to any information if it is reasonably determined upon the advice of outside counsel that doing so would result in the waiver of attorney-client and work product privileges (it being agreed that Buyer shall use its commercially reasonable efforts to provide such information in a manner that would not result in the waiver of such attorney-client and work product privileges). Buyer shall either (i) maintain such Book and Records that are in the possession and under the control of Buyer or its subsidiaries until the fifth (5th) anniversary of the Closing Date or (ii) at any time in Buyer’s sole discretion provide the Sellers with a copy of such Books and Records at the expense of Buyer in lieu of maintaining such Records as specified in clause (i).

 

4.11         Delivery of Purchase Assets.

 

(a)            Seller shall be deemed to have delivered the Inventory to Buyer at Closing by making the Inventory available to Buyer at the Inventory Locations. Within thirty (30) days following the Closing, Buyer shall, at Buyer cost, remove the Inventory listed on Schedule 1(a) and the Inventory listed on Schedule 1.1(b) that is located at Union Storage (all such Inventory, the “Removal Inventory”) from the Inventory Locations for such Removal Inventory. If Buyer does not remove the Removal Inventory within such thirty (30) day period, Buyer shall be responsible for, and shall pay to Seller on demand, all of Seller’s costs and expenses relating to storing such Inventory at the applicable Inventory Locations until such Inventory is removed by Buyer. Following the Closing, Seller shall have no obligations with respect to the Inventory other than to not disturb the Removal Inventory and to not remove the Removal Inventory from the applicable Inventory Locations during the thirty (30) day period following the Closing.

 

(b)            Within thirty (30) days following the Closing, the Sellers shall deliver and transfer the Purchased Assets that consist of tangible property or physical embodiments or electronic files or records (excluding the Inventory) to a location designated by Buyer. The Sellers shall pay the costs of shipping and transfer of any such Purchased Assets to Buyer; provided that Buyer agrees to use reasonable best efforts to cooperate with the Sellers with respect to such shipping and transfer.

 

(c)            Within five (5) Business days following the Closing, Sellers will deliver to Buyer contact information for the material vendors used by the Sellers in the operation of the Business

 

(d)            The parties understand and agree that the Security Agreement contains obligations and restrictions relating to the Purchased Assets, which obligations and restrictions supersede the obligations and restrictions provided for in this Section 4.11.

 

13

 

ARTICLE V: LIMITATION OF LIABILITY; INDEMNIFICATION

 

5.1           Indemnity. Subject to the other provisions of this ARTICLE V, Parent and Buyer shall indemnify and hold harmless the Sellers and their Affiliates and Representatives (collectively, “Seller Indemnitees”) from and against all Losses incurred or suffered by the Seller Indemnitees, to the extent resulting from (i) any breach by Parent or Buyer of its representations and warranties contained in ARTICLE III hereof, (ii) any breach of any covenant or agreement of Parent or Buyer contained in this Agreement, (iii) the Assumed Liabilities and (iv) fraud by Parent or Buyer in the making of their representations and warranties in ARTICLE III hereof. Subject to the other provisions of this ARTICLE V, the Sellers shall indemnify and hold harmless Parent, Buyer and their respective Affiliates and Representatives (collectively, “Buyer Indemnitees”) from and against all Losses incurred or suffered by the Buyer Indemnitees, to the extent resulting from (a) any breach by the Sellers of their representations and warranties contained in ARTICLE II hereof, (b) any breach of any covenant or agreement of the Sellers contained in this Agreement, (c) the Excluded Liabilities, (d) fraud by any Seller in the making of its representations and warranties in ARTICLE II hereof. Notwithstanding anything to the contrary, nothing in this Agreement, including this Article V, shall limit any Claims based on fraud in the making of representations and warranties in ARTICLES II and III.

 

5.2           Limitations of Liability.

 

(a)            The representations and warranties of the Parties contained in ARTICLES II and III shall continue in full force and effect after the Closing for a period of twelve (12) months, except that the representations and warranties set forth in Section 2.1 (Organization; Authority), Section 2.2(a) (No Conflicts), Section 2.4 (Title), Section 2.6 (Broker Fees), Section 3.1 (Organization; Authority), Section 3.2(a) (No Conflict) and Section 3.5 (Broker Fees) (the “Fundamental Representations”) shall survive for their applicable statutes of limitations. Any claims with respect to breaches of the covenants and other agreements in this Agreement that by their terms are required to be performed at or prior to the Closing shall survive the Closing and shall terminate six (6) months after the Closing. Only those covenants and obligations of the Parties contained herein that are contemplated to be performed post-Closing (including those set forth in Section 5.1) shall survive the Closing, and then only until fully performed, in each case including, but not limited to, any direct Claim between the Parties under this Agreement or any third-party Claim. Any Claims brought under this ARTICLE V with respect to Losses pursuant to Section 5.1 must be brought within these applicable survival periods; provided, that any such Claim brought prior to the expiration of the applicable survival period shall survive until final resolution of such Claim.

 

(b)            In no event shall any amount be recovered from the Sellers, and no Buyer Indemnitee shall be entitled to indemnification pursuant to Section 5.1, until the aggregate amount of all Losses exceeds thirty thousand U.S. dollars ($30,000 USD), at which point the Sellers shall be obligated to indemnify the Buyer Indemnitees only to the extent such aggregate Losses exceed thirty thousand U.S. dollars ($30,000 USD). Except in the case of fraud in the making of representations and warranties in ARTICLES II and III, in no event shall (i) a Party’s aggregate Liability under this Agreement exceed the Purchase Price and (ii) the Sellers’ aggregate Liability under Section 5.1 relating to breaches of representations and warranties in ARTICLE II (other than the Fundamental Representations) exceed five hundred thousand U.S. dollars ($500,000 USD). Buyer Indemnitees’ sole recourse for indemnification hereunder shall be limited to offsetting the outstanding amount under the Promissory Note as provided in Section 5.3(c) hereof. The limitations set forth in this Section 5.2(b) shall not apply in the case of Losses with respect to fraud in the making of representations and warranties in ARTICLES II and III.

 

(c)            Each Party shall take, and shall cause its Affiliates to take, all reasonable steps to mitigate any Loss upon becoming aware of any event which would reasonably be expected to, or does, give rise thereto, including incurring costs only to the minimum extent necessary to remedy the breach which gives rise to the Loss.

 

14

 

(d)            The amount of any and all Losses for which any Seller Indemnitee or Buyer Indemnitee shall be entitled to indemnification pursuant to the provisions of this ARTICLE V shall be determined net of any amounts actually recovered by such Person pursuant to any indemnification by, or indemnification agreement or arrangement with, third parties or under third-party insurance policies with respect to such Losses (and no right of subrogation shall accrue to any such third-party indemnitor or insurer hereunder).

 

5.3           Indemnification Procedures.

 

(a)            Whenever any Claim shall arise for indemnification hereunder, the Seller Indemnitee or Buyer Indemnitee, as applicable, shall promptly provide written notice of such Claim to the indemnifying Party; provided, however, that a Buyer Indemnitee’s or Seller Indemnitee’s, as applicable, failure to provide or delay in providing such written notice will not relieve the indemnifying Party from liability hereunder with respect to such Claim, except to the extent that the indemnifying Party is prejudiced by such failure or delay. The indemnifying Party shall have thirty (30) days from its receipt of such aforementioned notice to (i) cure the Losses complained of, (ii) admit its liability for such Losses or (iii) dispute the Claim for such Losses. If the indemnifying Party does not notify the Buyer Indemnitee or Seller Indemnitee, as applicable, providing notice within such thirty (30)-day period that it has cured the Losses or that it disputes the Claim for such Losses, the indemnifying Party shall conclusively be deemed to have denied Losses with respect to such matter. If the indemnifying Party does not admit or otherwise denies its liabilities against a Claim for indemnification within the thirty (30)-day period set forth in this Section 5.3(a), then the applicable Buyer Indemnitee or Seller Indemnitee, as applicable, shall diligently and in good faith pursue its rights and remedies under this Agreement with respect to such Claim for indemnification.

 

(b)            Parent and Buyer, on behalf of themselves and their Affiliates, hereby unconditionally waive and release the Sellers and their Affiliates and their respective Representatives (acting in their capacity as such) from any and all Claims, demands, causes of action, obligations, liabilities, costs or expenses with respect to the Assumed Liabilities, whenever arising or occurring, and whether under Contract, statute, common law or otherwise. The Sellers, on behalf of themselves and their Affiliates, hereby unconditionally waive and release Buyer and its Affiliates and their respective Representatives (acting in their capacity as such) from any and all Claims, demands, causes of action, obligations, Liabilities, costs or expenses with respect to the Excluded Liabilities, whenever arising or occurring, and whether under Contract, statute, common law or otherwise.

 

(c)            Subject to the indemnification limitations provided for in this ARTICLE V, once a Loss is agreed to in writing by the indemnifying Party or finally adjudicated to be payable pursuant to this ARTICLE V (such Loss that is agreed to or finally adjudicated, an “Indemnifiable Loss”), the Party required to indemnify a Buyer Indemnitee or Seller Indemnitee shall satisfy its obligations with respect to such Indemnifiable Loss within fifteen (15) Business Days of such agreement or final, non-appealable adjudication by wire transfer of immediately available funds. Notwithstanding the foregoing, any Indemnifiable Loss payable to a Buyer Indemnitee pursuant to this ARTICLE V shall be satisfied by offsetting amounts then outstanding under the Promissory Note, and such reduction shall be applied first to the last installment payable under the Promissory Note on the maturity date thereof and, if applicable, thereafter to the next to last payment thereunder such that off-setting the Promissory Note against the Indemnifiable Loss will not affect the repayment schedule under the Promissory Note until all outstanding amounts under the Promissory Note have been satisfied in full. Other than as specifically provided in this Section 5.3(c), the Promissory Note is not subject to offset.

 

15

 

5.4           Waiver of Remedies.

 

(a)            The Parties hereby acknowledge and agree that except with respect to fraud in the making of representations and warranties in ARTICLES II and III or as provided in Section 4.5, their sole and exclusive remedy with respect to any and all Claims for any breach of any agreement or obligation set forth herein or otherwise relating to the subject matter of this Agreement shall be pursuant to the indemnification provisions set forth in this ARTICLE V. The Parties hereby agree that except as specifically provided in Section 4.5, no Party shall have any liability, and neither Party nor any of its respective Affiliates shall make any Claim, for any Loss or any other matter, under, relating to or arising out of this Agreement or the other Transaction Documents (including breach of representation, warranty, covenant or agreement) or any other document, agreement, certificate or other matter delivered pursuant hereto, whether based on Contract, tort, strict liability, other Laws or otherwise, except with respect to fraud in the making of representations and warranties in ARTICLES II and III or as expressly provided in this ARTICLE V. Notwithstanding the foregoing provisions of this Section 5.4(a), nothing contained herein shall limit the Sellers’ rights under the Promissory Note, the Security Agreement or the Trademark Security Agreement.

 

(b)            NOTWITHSTANDING ANYTHING IN THIS AGREEMENT TO THE CONTRARY, NO PARTY NOR ANY OF ITS AFFILIATES SHALL BE LIABLE TO THE OTHER PARTY OR ITS AFFILIATES FOR SPECIAL, PUNITIVE, EXEMPLARY, INCIDENTAL, CONSEQUENTIAL OR INDIRECT DAMAGES, OR LOST PROFITS, WHETHER BASED ON CONTRACT, TORT, STRICT LIABILITY, OTHER LAW OR OTHERWISE AND WHETHER OR NOT ARISING FROM THE OTHER PARTY’S OR ANY OF ITS AFFILIATES’ SOLE, JOINT OR CONCURRENT NEGLIGENCE, STRICT LIABILITY OR OTHER FAULT (“Non-Reimbursable Damages”).

 

(c)            Notwithstanding anything to the contrary contained herein or otherwise, this Agreement may only be enforced against, and any Claims or causes of action that may be based upon, arise out of or relate to this Agreement, or the negotiation, execution or performance of this Agreement and the other Transaction Documents or the transactions contemplated hereby, may only be made against the Persons that are expressly identified as parties in their capacities as such, and no Person who is not expressly identified as a party in its capacity as such, including, without limitation, any former, current or future direct or indirect stockholder, equity holder, controlling Person, director, officer, employee, general or limited partner, member, manager, agent or Affiliate of any party and any former, current or future direct or indirect stockholder, equity holder, controlling Person, director, officer, employee, general or limited partner, member, manager, agent or Affiliate of any of the foregoing (each, a “Non-Recourse Party”), shall have any liability for any obligations or liabilities of the parties or for any Claim (whether in tort, Contract or otherwise) based on, in respect of, or by reason of, the transactions contemplated hereby and by the other Transaction Documents, or in respect of any representations made or alleged to be made in connection herewith. In no event shall any Party or any of its Affiliates seek to enforce this Agreement against, make any Claims for breach of this Agreement or the other Transaction Documents against, or seek to recover monetary damages from, any Non-Recourse Party.

 

ARTICLE VI: MISCELLANEOUS

 

6.1           Notices.

 

(a)            Unless this Agreement specifically requires otherwise, any notice, demand or request provided for in this Agreement, or served, given or made in connection with this Agreement, shall be in writing and shall be deemed properly served, given or made if delivered in person, sent by electronic mail or sent by registered or certified mail, postage prepaid, or by a nationally recognized overnight courier service that provides a receipt of delivery, in each case, to the Parties at the addresses specified below:

16

 

(b)            If to Buyer or Parent, to:

 

Above Food Corp.

 

2305 Victoria Ave #001, Regina, SK S4P 0S7 

Attn: Lionel Kambeitz 

Email: lionel@abovefood.com

 

With a copy to (which shall not constitute notice):

 

Latham & Watkins LLP

 

811 Main Street, Suite 3700

 

Houston, Texas 77002

 

Attention: Ryan Maierson and Ryan Lynch

 

E-mail: ryan.maierson@lw.com; ryan.lynch@lw.com

 

 

If to the Sellers, to:

 

Arcadia Biosciences, Inc.

 

5950 Sherry Lane, Suite 215

 

Dallas, TX 75225

 

Attention: Chief Executive Officer

 

E-mail: stan.jacot@arcadiabio.com

 

With a copy to (which shall not constitute notice):

 

Weintraub Tobin Chediak Coleman Grodin Law Corporation

 

400 Capitol Mall, 11th Floor

 

Sacramento, CA 95814

 

Attention: Michael De Angelis

 

E-mail: mdeangelis@weintraub.com

 

(c)            Notice given by personal delivery pursuant to this Section 6.1 shall be effective upon physical receipt. Notice given by electronic mail pursuant to this Section 6.1 shall be effective on the date sent by electronic mail and successfully delivered to the intended recipient’s e-mail server if sent before 5:00 p.m. Pacific Time on any Business Day or the next succeeding Business Day if sent after 5:00 p.m. Pacific Time on any Business Day or during any non-Business Day. Notice given by mail or overnight courier pursuant to Section 6.1 shall be effective one (1) Business Day following sending. Each Party may change the address by which proper notice shall be given pursuant to this Section 6.1 by providing notice to the other Parties in accordance with this Section 6.1.

 

17

 

6.2           Entire Agreement. This Agreement and the other Transaction Documents, together with all exhibits and schedules hereto and thereto (including the Disclosure Schedules) constitutes the final, complete and exclusive statement of the agreement among the Parties as to the subject matter hereof and supersedes all prior oral or written commitments, understandings, discussions, negotiations, representations and warranties and agreements between the Parties with respect to the subject matter hereof.

 

6.3           Amendment. This Agreement may be modified or amended only by express written agreement of Arcadia and Parent.

 

6.4           Waivers. No waiver of any provision of this Agreement will be valid unless the waiver is in writing and signed by the waiving Party. The failure of a Party at any time to require performance of any provision of this Agreement will not affect such Party’s rights at a later time to enforce such provision. No waiver by either Party of any breach of this Agreement will be deemed to extend to any other breach hereunder or affect in any way any rights arising by virtue of any other breach.

 

6.5           No Third-Party Beneficiary. Except for the provisions of ARTICLE V (which are intended to be for the benefit of the Persons identified therein), the terms and provisions of this Agreement are intended solely for the benefit of the Parties and their respective successors or permitted assigns, and it is not the intention of the Parties to confer third-party beneficiary rights upon any other Person.

 

6.6           Assignment. No Party may assign, delegate or otherwise transfer (whether by operation of Law or otherwise) any of its rights, interests or obligations under this Agreement without the prior written consent of the other Parties; provided, that Buyer and the Sellers may assign their rights, interest and obligations to an Affiliate.

 

6.7           Severability. If any term or other provision of this Agreement is held to be invalid, illegal or incapable of being enforced by any rule of Law, all other conditions and provisions of this Agreement shall nevertheless remain in full force and effect. Upon such holding that any term or other provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties at the time of the execution of this Agreement as closely as possible to the end that the transactions contemplated hereby and by the other Transaction Documents are fulfilled to the maximum extent permitted by Law.

 

6.8           Construction. The section headings and subheadings in this Agreement have been inserted for convenience of reference only and shall be ignored in any construction of the provisions hereof. Unless the context requires a contrary meaning, whenever used in this Agreement, a pronoun in any gender shall include the remaining genders; the word “any” shall mean one or more or all; and the word “including” shall mean “including without limitation.”

 

6.9           Benefits and Binding Effect. This Agreement shall be binding upon, and inure to the benefit of, the Parties and their respective successors and permitted assigns.

 

6.10         Governing Law; Venue. This Agreement and all other Transaction Documents (unless otherwise stated therein) shall be governed by the substantive Laws of Delaware without regard to any choice or conflict of law principals. Except as otherwise expressly provided in this Agreement, each Party hereby irrevocably submits to the exclusive jurisdiction of the Court of Chancery of the State of Delaware in connection with any such action, suit or Proceeding brought in connection with the rights and obligations of the Parties pursuant to this Agreement and agrees that any such action, suit or Proceeding may be brought in such court. Each Party hereby irrevocably waives defense of an inconvenient forum to the maintenance of any such action or Proceeding. Each Party further agrees to accept service of process out of any of the before mentioned courts in any such dispute by registered or certified mail addressed to the Party at the address set forth in Section 6.1. EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY

 

18

 

WAIVES TO THE FULLEST EXTENT PERMITTED BY LAW TRIAL BY JURY IN ANY LEGAL ACTION OR PROCEEDING RELATING TO THIS AGREEMENT AND FOR ANY COUNTERCLAIM THEREIN.

 

6.11         Counterparts. This Agreement may be executed by the Parties in multiple counterparts, each of which shall be deemed an original and may be delivered by electronic means (including.pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com), but all of which together will constitute one and the same instrument. Any .pdf copies hereof or signatures hereon shall, for all purposes, be deemed originals.

 

6.12         Expenses. Except as expressly provided in this Agreement or the other Transaction Documents, each Party shall be responsible for its own costs, fees and expenses incurred in connection with the negotiation and execution of this Agreement and the other Transaction Documents and the transactions contemplated hereby.

 

6.13         Bulk Sales Laws. The Parties hereby waive compliance with the provisions of any bulk sales, bulk transfer or similar Laws of any jurisdiction that may otherwise be applicable with respect to the sale of any or all of the Purchased Assets to Buyer. The Parties agree that each Party shall bear its own costs for any damages arising out of or resulting from the failure of the Sellers or Buyer to comply with any such laws.

 

6.14         Disclosure Schedules. The information and disclosures contained in any section of the Disclosure Schedules shall be deemed to be disclosed and incorporated by reference in any other section of the Disclosure Schedules as though fully set forth in such section or representation or warranty for which applicability of such information and disclosure is reasonably apparent on its face or a specific cross-reference to such other section of the Disclosure Schedules is made.

 

6.15         Attorney Fees. If either Party shall bring an action to enforce the provisions of this Agreement, the prevailing Party shall be entitled to recover its reasonable attorney fees and expenses incurred in such action from the unsuccessful Party.

 

[Signature Pages Follow]

 

19

 

IN WITNESS WHEREOF, each Party has caused this Asset Purchase Agreement to be duly executed in its name by its duly authorized officer, as of the day and year first above written.

 

PARENT:   ARCADIA:
     
ABOVE FOOD CORP.   ARCADIA BIOSCIENCES, INC.
     
     
By: /s/ Lionel Kambeitz   By: /s/ Stanley Jacot, Jr.
  Lionel Kambeitz     Stanley Jacot, Jr.,
  Chief Executive Officer     Chief Executive Officer
     
     
BUYER:   WELLNESS:
     
ABOVE FOOD INGREDIENTS CORP.   ARCADIA WELLNESS, LLC
     
    BY: Arcadia Biosciences, Inc., sole member
By: /s/ Lionel Kambeitz    
  Lionel Kambeitz    
  Executive Chairman   By: /s/ Stanley Jacot, Jr.
      Stanley Jacot, Jr.,
      Chief Executive Officer

 

 

 

SCHEDULE A

 

Definitions

 

As used in this Agreement, the following capitalized terms have the meanings set forth below:

 

“Affiliate” means any Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the Person specified. For purposes of this definition, control of a Person means the power, direct or indirect, to direct or cause the direction of the management and policies of such Person, whether through ownership of voting securities or ownership interests, by contract or otherwise.

 

“Agreement” has the meaning set forth in the introductory paragraph to this Agreement.

 

“Allocation Schedule” has the meaning set forth in Section 4.1.

 

“Arcadia” has the meaning set forth in the introductory paragraph to this Agreement.

 

“Asset Taxes” means ad valorem, property, gross receipts, sales, use and similar Taxes based upon the acquisition, operation or ownership of the Purchased Assets or the receipt of proceeds therefrom, but excluding, for the avoidance of doubt, Income Taxes and Transfer Taxes.

 

“Assigned Contracts” has the meaning set forth in Section 1.1(f).

 

“Assigned IP” has the meaning set forth in Section 1.1(d).

 

“Assignment and Assumption Agreement” has the meaning set forth in Section 1.8(e).

 

“Assumed Liabilities” has the meaning set forth in Section 1.3.

 

“Bill of Sale” has the meaning set forth in Section 1.8(d).

 

“Books and Records” has the meaning set forth in Section 1.1(e).

 

“Business” means, with respect to the Sellers, the ownership, operation and administration of the Purchased Assets and the GoodWheat business, as applicable, but shall exclude the ownership, operation and administration of the Excluded Assets, whether occurring before or after the Closing.

 

“Business Day” means a day other than Saturday, Sunday or any day on which banks located in the State of California or Canada are authorized or obligated to close.

 

“Buyer” has the meaning set forth in the introductory paragraph to this Agreement.

 

"Buyer Indemnitee” or “Buyer Indemnitees” has the meaning set forth in Section 5.1.

 

“Claim” means any demand, claim, action, investigation, legal proceeding (whether at Law or in equity) or arbitration.

 

“Closing” has the meaning set forth in Section 1.7.

 

“Closing Date” has the meaning set forth in Section 1.7.

 

 

 

“Code” means the Internal Revenue Code of 1986, as amended from time to time.

 

“Contract” means any legally binding written contract, license, evidence of indebtedness, letter of credit, security agreement or other written and legally binding arrangement.

 

“Disclosure Schedules” has the meaning set forth in the lead-in to Article II.

 

“Excluded Assets” has the meaning set forth in Section 1.2.

 

“Excluded Liabilities” has the meaning set forth in Section 1.3(c).

 

“Excluded Records” means all files, records, information and data of the Sellers or their Affiliates, whether written or electronically stored, that are not identified in Section 1.1(e) as part of the Purchased Assets and that do no pertain exclusively to the Business including those concerning this Agreement and the transactions contemplated by this Agreement and the other Transaction Documents, all corporate books and records of Seller and all Income Tax records of the Sellers. For the avoidance of doubt and notwithstanding anything to the contrary, “Excluded Records” includes (a) Sellers’ general corporate books and records, even if containing references to Purchased Assets (including whether or not exclusively related to the Purchased Assets), (b) books, records and files that cannot be disclosed under the terms of any third-party agreement or that are not transferable without payment of fees or penalties (except as may be agreed to be paid by Buyer) or that cannot be disclosed under applicable Law, (c) legal records and legal files of the Sellers, including all information entitled to legal privilege, including attorney work product and attorney-client communications, (d) any Tax information and records to the extent not pertaining to the Purchased Assets or to the extent pertaining to the business of the Sellers or their Affiliates generally (whether or not pertaining to the Purchased Assets), (e) the Sellers’ or their Affiliates’ internal audits, studies or assessments, including internal environmental, safety, risk, asset integrity/mechanical integrity audits, assessments, review and studies related to internal reserve or performance assessments, (f) records relating to the proposed acquisition or disposition of the Purchased Assets, including proposals received from or made to, and records of negotiations with, Persons which are not a part of the Sellers, their Affiliates or their Representatives and economic analyses associated therewith, (g) e-mails, (h) personnel files and employee-related records and (i) any information relating to any assets or any liabilities that are not transferred to Buyer hereunder.

 

“Finished Inventory” has the meaning set forth in Section 1.1(b).

 

“Formulations” has the meaning set forth in Section 1.1(c).

 

“Grain Inventory” has the meaning set forth in Section 1.1(a).

 

“Grain Inventory Locations” has the meaning set forth in Section1.1(a).

 

“Income Taxes” means any income, capital gains, franchise and similar Taxes.

 

“Indemnifiable Loss” has the meaning set forth in Section 5.3(c).

 

“Intellectual Property Assignment Agreement” has the meaning set forth in Section 1.8(c).

 

“Inventory” has the meaning set forth in Section 1.1(b).

 

“Inventory Locations” has the meaning set forth in Section 1.1(b).

 

“knowledge” means (i) with respect to the Sellers, the actual knowledge of Stanley Jacot, Jr. and Thomas J. Schaefer and (ii) with respect to Buyer, the actual knowledge of Lionel Kambeitz or Jason Zhao.

 

 

 

“Law” or “Laws” means all laws, statutes, rules, regulations, ordinances and other pronouncements having the effect of law of any governmental authority located within the United States of America.

 

“Liability” or “Liabilities” means any direct or indirect liability of any kind or nature, whether accrued or fixed, absolute or contingent, determined or determinable, matured or unmatured, due or to become due, asserted or unasserted or known or unknown.

 

“Licensed IP” has the meaning set forth in Section 1.11(a).

 

“Licensed RG Materials” has the meaning set forth in Section 1.11(a).

 

“Licensed RS Materials” has the meaning set forth in Section 1.11(b).

 

“Lien” means any mortgage, pledge, assessment, security interest, lien or other similar property interest or encumbrance.

 

“LOI” has the meaning set forth in Section 4.9(a).

 

“Loss” means any and all judgments, liabilities, amounts paid in settlement, damages, fines, penalties, deficiencies, losses and expenses (including interest, court costs, reasonable fees of attorneys, accountants and other experts or other reasonable expenses of litigation or other proceedings or of any claim, default or assessment), but only to the extent such losses (a) are not reasonably expected to be covered by a payment from some third party or by insurance or otherwise recoverable from third parties and (b) are net of any associated benefits arising in connection with such loss, including any associated Tax benefits. For all purposes in this Agreement the term “Losses” shall not include any Non-Reimbursable Damages.

 

“NDA” has the meaning set forth in Section 4.9(a).

 

“Non-Recourse Party” has the meaning set forth in Section 5.4(c).

 

“Non-Reimbursable Damages” has the meaning set forth in Section 5.4(b).

 

“Order” means any order, injunction, judgment, decree, ruling, assessment, or arbitration award of any governmental authority located in the United States of America or arbitrator.

 

“Parent” has the meaning set forth in the introductory paragraph to this Agreement.

 

“Party” or “Parties” means each of Arcadia, Wellness, Parent and Buyer.

 

“Permitted Liens” means: (a) the Liens or other encumbrances set forth on Schedule B; (b) Liens for Taxes not yet due and payable or which are being contested in good faith pursuant to appropriate procedures; (c) carriers’, warehousemen’s, mechanics’, materialmen’s, repairmen’s or other like Liens arising in the ordinary course of the business, payment for which is not yet due or which is being contested in good faith; (d) Liens created by Parent, Buyer or their Affiliates; (e) Liens created pursuant to the Security Agreement; and (f) Liens that do not have a material adverse effect on the Purchased Assets taken as a whole.

 

“Person” means any natural person, corporation, general partnership, limited partnership, limited liability company, proprietorship, other business organization, trust, union, association or governmental authority.

 

 

 

“Post-Closing Tax Period” means any Tax period beginning after the Closing Date and that portion of a Straddle Period beginning on the day after the Closing Date.

 

“Pre-Closing Tax Period” means any Tax period ending on or before the Closing Date and that portion of any Straddle Period ending on the Closing Date.

 

“Proceeding” means any complaint, lawsuit, action, suit, claim (including claim of a violation of Law) or other proceeding at Law or in equity or order or ruling, in each case by or before any governmental authority or arbitral tribunal.

 

“Promissory Note” has the meaning set forth in Section 1.9(a).

 

“Purchase Price” has the meaning set forth in Section 1.5.

 

“Purchased Assets” has the meaning set forth in Section 1.1.

 

“Registered Trademarks” means the Trademarks that are registered with the United Stated Patent and Trademark Office.

 

“Representatives” means, as to any Person, its officers, directors, employees, managers, members, partners, shareholders, owners, counsel, accountants, financial advisors and consultants.

 

“Security Agreement” has the meaning set forth in Section 1.9(b).

 

“Seller Indemnitee” or “Seller Indemnitees” has the meaning set forth in Section 5.1.

 

“Sellers” has the meaning set forth in the introductory paragraph to this Agreement.

 

“Seller Taxes” means (a) any and all Asset Taxes allocable to the Sellers pursuant to Section 4.3(b) (taking into account, and without duplication of, such Asset Taxes effectively borne by the Sellers as a result of any payments made from one Party to the other in respect of Asset Taxes pursuant to Section 4.3(b)); and (b) any and all Taxes imposed on or with respect to the ownership or operation of the Excluded Assets or that are attributable to any asset or business of the Sellers that is not part of the Purchased Assets.

 

“Straddle Period” means any Tax period beginning on or before and ending after the Closing Date.

 

“Tax” or “Taxes” means (a) any U.S. federal, state or local or non-U.S. taxes gross receipts, branch profits, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, escheat, environmental, customs duties, capital stock, franchise, profits, withholding, social security, unemployment, disability, real property, personal property, sales, use, transfer, registration, ad valorem, value added, alternative or add-on minimum or estimated tax or other tax of any kind whatsoever, imposed by any governmental authority, including any interest, penalty or addition to tax imposed thereto and (b) any liability in respect of any item described in clause (a) that arises by reason of Contract, assumption, transferee or successor liability, operation of Law (including by reason of participation in a consolidated, combined or unitary Tax Return).

 

“Tax Return” means any declaration, report, statement, form, return or other document or information required to be provided to a Taxing Authority with respect to Taxes, including any schedule or attachment thereto, and including any amendment thereof.

 

“Taxing Authority” means, with respect to any Tax, the governmental authority or political subdivision thereof that imposes such Tax, and the agency (if any) charged with collection of such Tax for such entity or subdivision.

 

 

 

“Trademarks” has the meaning set forth in Section 1.1(d).

 

“Trademark Security Agreement” has the meaning set forth in Section 1.9(f).

 

“Transaction Documents” means this Agreement, the Intellectual Property Assignment Agreement, the Bill of Sale, the Assignment and Assumption Agreement, the Promissory Note, the Security Agreement, the Trademark Security Agreement, the NDA and each other agreement, document, certificate and instrument required to be executed, or that is executed by mutual agreement of the Parties, in accordance with his Agreement.

 

“Transfer Taxes” has the meaning set forth in Section 4.2.

 

“Wellness” has the meaning set forth in the introductory paragraph to this Agreement.

 

 

 

EXHIBIT A

 

N/A

 

 

 

EXHIBIT B

 

Form of Intellectual Property Assignment Agreement

 

This INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT (“IP Assignment”), dated as of May 14, 2024 (“Effective Date”), is made by and among ABOVE FOOD INGREDIENTS CORP., a Delaware corporation (“Buyer”), Arcadia Biosciences, Inc., a Delaware corporation (“Arcadia”), and Arcadia Wellness, LLC, a Delaware limited liability company (together with Arcadia, “Seller”).

 

WHEREAS, Buyer and Seller are parties to that certain Asset Purchase Agreement, dated May 14, 2024 (the “Purchase Agreement”).

 

WHEREAS, under the terms of the Purchase Agreement, Seller has conveyed, transferred, and assigned to Buyer, among other assets, all right, title and interest in and to certain intellectual property of Seller, and has agreed to execute and deliver this IP Assignment, for recording with the United States Patent and Trademark Office and corresponding entities or agencies in any applicable jurisdictions;

 

NOW THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

1.            Assignment. Seller hereby irrevocably conveys, transfers, and assigns to Buyer, and Buyer hereby accepts all of each Seller’s right, title, and interest in and to the following (the “Assigned IP”):

 

a.      the trademark registrations and applications set forth on Schedule A hereto and all issuances, extensions, and renewals thereof (the “Trademarks”), together with the goodwill of the business connected with the use of, and symbolized by, the Trademarks;

 

b.     the internet domain names set forth on Schedule B hereto, and all issuances, extensions, and renewals thereof (the “Domain Names”);

 

c.      the social media accounts set forth on Schedule C hereto, and all corresponding verifications and access credentials thereof (the “Social Media Accounts”);

 

d.     all rights of any kind whatsoever of Seller accruing under any of the foregoing provided by applicable law of any jurisdiction, by international treaties and conventions, and otherwise throughout the world;

 

e.      any and all royalties, fees, income, payments, and other proceeds hereafter due or payable with respect to any and all of the foregoing accruing after the Effective Date; and

 

f.      any and all claims and causes of action with respect to any of the foregoing, whether accruing before, on, or after the date hereof, including all rights and claims for damages, restitution, and injunctive or other legal and equitable relief for past, present, and future infringement, dilution, misappropriation, violation, misuse, breach, or default, with the right but no obligation to sue for such legal and equitable relief and to collect, or otherwise recover, any such damages.

 

 

 

2.             Recordation and Further Actions. Seller hereby authorizes the Commissioner for Trademarks in the United States Patent and Trademark Office and the officials of corresponding entities or agencies in any applicable jurisdictions to record and register this IP Assignment upon request by Buyer. Following the date hereof, and upon Buyer’s reasonable request, Seller shall take such steps and actions, and provide such cooperation and assistance to Buyer and its successors, assigns, and legal representatives, including the execution and delivery of any affidavits, declarations, oaths, exhibits, assignments, powers of attorney, or other documents, initiating transfer of domain names, social media accounts, and product formulations, as may be reasonably necessary to effect, evidence, or perfect the assignment of the Assigned IP to Buyer, or any assignee or successor thereto.

 

3.             Terms of the Purchase Agreement. The parties hereto acknowledge and agree that this IP Assignment is entered into pursuant to the Purchase Agreement, to which reference is made for a further statement of the rights and obligations of Seller and Buyer with respect to the Assigned IP. The representations, warranties, covenants, agreements, and indemnities contained in the Purchase Agreement shall not be superseded amended, altered or modified by anything contained in this IP Assignment but shall remain in full force and effect to the full extent provided therein. In the event of any conflict or inconsistency between the terms of the Purchase Agreement and the terms hereof, the terms of the Purchase Agreement shall govern.

 

4.             Counterparts. This IP Assignment may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed once and the same agreement. A signed copy of this IP Assignment delivered by facsimile, e-mail, or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this IP Assignment.

 

5.             Successors and Assigns. This IP Assignment shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns.

 

6.             Governing Law. This IP Assignment and any claim, controversy, dispute, or cause of action (whether in contract, tort, or otherwise) based upon, arising out of, or relating to this IP Assignment and the transactions contemplated hereby shall be governed by and construed in accordance with, the laws of the United States and the State of Delaware, without giving effect to any choice or conflict of law provision or rule of any jurisdiction. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts located in New Castle County Delaware in connection with any such action, suit or proceeding brought in connection with the rights and obligations of the parties pursuant to this IP Assignment, and agrees that any such action, suit or proceeding may be brought in such court. Each party hereby irrevocably waives defense of an inconvenient forum to the maintenance of any such action or proceeding. Each party further agrees to accept service of process out of any of the before mentioned courts in any such dispute by registered or certified mail addressed to the party at the address set forth in Section 6.1 of the Asset Purchase Agreement.

 

 

 

7.             Notice. The terms of Section 6.1 of the Asset Purchase Agreement with respect to notice are incorporated herein by reference, mutatis mutandis, and the parties hereto agree to such terms.

 

[SIGNATURE PAGE FOLLOWS]

 

 

 

IN WITNESS WHEREOF, Seller have duly executed and delivered this IP Assignment as of the date first above written.

 

BUYER:  
   
ABOVE FOOD INGREDIENTS CORP.  
   
   
By:    
  Lionel Kambeitz  
  Executive Chairman  
   
   
SELLER:  
   
ARCADIA BIOSCIENCES, INC.  
   
   
By:    
  Stanley Jacot, Jr.,  
  Chief Executive Officer  
   
   
ARCADIA WELLNESS, LLC  
   
BY: Arcadia Biosciences, Inc., sole member  
   
   
By:    
  Stanley Jacot, Jr.,  
  Chief Executive Officer  

 

 

 

SCHEDULE A

 

 

 

Schedule of Trademark Registrations and Applications

 

TM
Record
TM/AN/RN/Disclaimer Design/Device Full Goods/Services Status/Key
Dates
Owner
Information
US Federal Q2 uf 4

GOOD WHEAT and Design

 

 

 

RN: 7183885

SN: 97060589

Disclaimer: "GOOD WHEAT"

 

 

Int'l Class: 30

(Int'l Class: 30)

Flour, pasta; pancakes; frozen pancakes; mixes for making baking batters; bread; pizza crust; bread dough; cookie dough; frozen dough for use as pizza or bread; frozen breads, namely, bread loaves, rolls, and muffins; cookies; crackers; cereal bars; high-protein cereal bars; frozen waffles; processed cereal; waffles; tortillas; tortilla chips

Registered, October 3, 2023 Office Status: Registered Int'l Class: 30 First Use: June 1, 2022 Filed: October 5, 2021 Registered: October 3, 2023 Register Type: Principal Register Arcadia Biosciences, Inc. (Delaware Corporation) 202 Cousteau Place, Suite 105, Davis, California 95618 United States of America
US Federal Q2 uf 5

GOOD WHEAT and Design

 

 

 

RN: 6338239

SN: 88880665

Disclaimer: "GOOD WHEAT"

 

 

Int'l Class: 30

(Int'l Class: 30)

Non-transgenic enhanced wheat flour, wheat germ, and wheat bran for use as an ingredient in foods for human consumption, namely, processed snacks, breads, pastas, cereals, and crackers; non-transgenic enhanced processed wheat grains, wheat flour, wheat germ, wheat bran and wheat seeds for improved nutrition and health benefits

Registered, May 4, 2021 Int'l Class: 30 First Use: January 31, 2020 Filed: April 21, 2020 Registered: May 4, 2021 Register Type: Principal Register Arcadia Biosciences, Inc. (Delaware Corporation) 202 Cousteau Place Suite 105, Davis, California 95618 United States of America
US Federal Q2 uf 6

GOOD WHEAT and Design

 

 

 

RN: 6398090

SN: 88981432

Disclaimer: "GOOD WHEAT"

 

 

Int'l Class: 31

(Int'l Class: 31)

Non-transgenic enhanced unprocessed wheat, raw wheat, fresh wheat, wheat grains, and wheat seeds

Registered, June 22, 2021 Int'l Class: 31 First Use: September 30, 2019 Filed: April 17, 2020 Registered: June 22, 2021 Register Type: Principal Register Arcadia Biosciences, Inc. (Delaware Corporation) 202 Cousteau Place Suite 105, Davis, California 95618 United States of America

 

 

 

TM
Record
TM/AN/RN/Disclaimer Design/Device Full Goods/Services Status/Key
Dates
Owner
Information
US Federal Q2 uf 8

GOODWHEAT

RN: 7183762

SN: 90886417

 

Int'l Class: 30

(Int'l Class: 30)

Flour, pasta; pancakes; frozen pancakes; mixes for making baking batters; bread; pizza crust; bread dough; cookie dough; frozen dough for use as pizza or bread; frozen breads, namely, bread loaves, rolls, and muffins; cookies; crackers; cereal bars; high-protein cereal bars; frozen waffles; processed cereal; waffles; tortillas; tortilla chips

Registered, October 3, 2023 Office Status: Registered Int'l Class: 30 First Use: June 1, 2022 Filed: August 17, 2021 Registered: October 3, 2023 Register Type: Principal Register - Sec. 2(F) Arcadia Biosciences, Inc. (Delaware Corporation) 202 Cousteau Place, Suite 105, Davis, California 95618 United States of America
US Federal Q2 uf 9

GOODWHEAT

RN: 6629455

SN: 87889679

 

Int'l Class: 31

(Int'l Class: 31)

Non-transgenic enhanced unprocessed wheat, raw wheat, fresh wheat, wheat grains, and wheat seeds

Registered, January 25, 2022 Int'l Class: 31 First Use: June 23, 2021 Filed: April 23, 2018 Registered: January 25, 2022 Register Type: Principal Register Arcadia Biosciences, Inc. (Delaware Corporation) 202 Cousteau Place, Suite 105, Davis, California 95618 United States of America
US Federal Q2 uf 10

GOODWHEAT

RN: 6486596

SN: 87983642

 

Int'l Class: 30

(Int'l Class: 30)

Non-transgenic enhanced wheat flour, wheat germ, and wheat bran for use as an ingredient in foods for human consumption, namely, processed snacks, breads, pastas, cereals, and crackers; non-transgenic enhanced processed wheat grains, wheat flour, wheat germ, wheat bran and wheat seeds for improved nutrition and health benefits

Registered, September 14, 2021 Int'l Class: 30 First Use: November 11, 2020 Filed: April 23, 2018 Registered: September 14, 2021 Register Type: Principal Register Arcadia Biosciences, Inc. (Delaware Corporation) 202 Cousteau Place, Suite 105, Davis, California 95618 United States of America

 

 

 

TM
Record
TM/AN/RN/Disclaimer Design/Device Full Goods/Services Status/Key
Dates
Owner
Information
US Federal Q2 uf 13

QUIKCAKES

SN: 97747056

  Int'l Class: 30

(Int'l Class: 30)

Mixes for bakery goods; pancakes; frozen pancakes; 

pancake mixes; frozen waffles; waffles; frozen dough for use as pizza or bread; pizza crust; bread dough; cookie dough; frozen breads, namely, bread rolls and muffins; cake mixes; cupcakes mixes; brownie mixes; cornbread mixes; bread mixes; mixes for grain-based pastries; muffin mixes; brownies; cornbread; bread; muffins; cookies; cupcakes; cakes; pastries; granola; crackers; tortillas; tortilla chips; processed cereal; snack cakes; grain-based snack foods

Application pending publication, January 2, 2024 Office Status: Notice of Allowance - Issued Filed: January 9, 2023 Register Type: Principal Register Arcadia Biosciences, Inc. (Delaware Corporation) 202 Cousteau Place, Suite 105, Davis, California 95618 United States of America
US Federal Q2 uf 15

SNEAKY DELICIOUS

SN: 98137090

Disclaimer: "DELICIOUS"

 

Int'l Class: 30

(Int'l Class: 30)

Flour, pasta; pancakes; frozen pancakes; mixes for making baking batters; bread; pizza crust; bread dough; cookie dough; frozen dough for use as pizza or bread; frozen breads, namely, bread loaves, rolls, and muffins; cookies; crackers; cereal bars; high-protein cereal bars; frozen waffles; processed cereal; waffles; tortillas; tortilla chips

Published, January 9, 2024 Office Status: Published For Opposition Filed: August 17, 2023 Register Type: Principal Register Arcadia Biosciences, Inc. (Delaware Corporation) 202 Cousteau Place, Suite 105, Davis, California 95618 United States of America
US Federal Q2 uf 26

YUMSTRUCK

SN: 98137083

 

Int'l Class: 30

(Int'l Class: 30)

Flour, pasta; pancakes; frozen pancakes; mixes for making baking batters; bread; pizza crust; bread dough; cookie dough; frozen dough for use as pizza or bread; frozen breads, namely, bread loaves, rolls, and muffins; cookies; crackers; cereal bars; high-protein cereal bars; frozen waffles; processed cereal; waffles; tortillas; tortilla chips 

Application pending publication, January 2, 2024 Office Status: Notice of Allowance - Issued Filed: August 17, 2023 Register Type: Principal Register Arcadia Biosciences, Inc. (Delaware Corporation) 202 Cousteau Place, Suite 105, Davis, California 95618 United States of America

 

 

 

TM
Record
TM/AN/RN/Disclaimer Design/Device Full Goods/Services Status/Key
Dates
Owner
Information
US Federal Q2 uf 29

Design Only

 

 

 

RN: 7183884
SN: 97060583

 

 

Int'l Class: 30

(Int'l Class: 30)

Flour, pasta; pancakes; frozen pancakes; mixes for making baking batters; bread; pizza crust; bread dough; cookie dough; frozen dough for use as pizza or bread; frozen breads, namely, bread loaves, rolls, and muffins; cookies; crackers; cereal bars; high-protein cereal bars; frozen waffles; processed cereal; waffles; tortillas; tortilla chips

Registered, October 3, 2023 Office Status: Registered Int'l Class: 30 First Use: June 1, 2022 Filed: October 5, 2021 Registered: October 3, 2023 Register Type: Principal Register Arcadia Biosciences, Inc. (Delaware Corporation) 202 Cousteau Place, Suite 105, Davis, California 95618 United States of America
Canada Q2 ca 30

GOOD WHEAT and Design

 

 

 

AN: 2138040

 

 

Int'l Class: 30

(Int'l Class: 30)

Goods: Flour, pasta; pancakes; frozen pancakes; mixes for making baking batters; bread; pizza crust; bread dough; cookie dough; frozen dough for use as pizza or bread; frozen breads, namely bread loaves, rolls, and muffins; cookies; crackers; cereal bars; high-protein cereal bars; frozen waffles; cereal; waffles; tortillas; tortilla chips.

Canada Filed Pending Application Last Status Received: Pending Application, October 6, 2021 Office Status: Formalized Filed: October 6, 2021 Arcadia Biosciences, Inc. 202 Cousteau Place Suite 105 Davis, CA 95618, United States of America
Canada Q2 ca 31

GOODWHEAT

AN: 2127023

 

Int'l Class: 30

(Int'l Class: 30)

Goods: Flour; pasta; pancakes; frozen pancakes; mixes for making baking batters; 

bread; pizza crust; bread dough; cookie dough; frozen dough for use as pizza or bread; frozen breads, namely bread loaves, rolls, and muffins; cookies; crackers; cereal bars; high-protein cereal bars; frozen waffles; cereal; waffles; tortillas; tortilla chips.

Canada Filed Pending Application Last Status Received: Pending Application, August 12, 2021 Office Status: Formalized Filed: August 12, 2021  Arcadia Biosciences, Inc. 202 Cousteau Place Suite 105 Davis, CA 95618, United States of America

 

 

 

TM
Record
TM/AN/RN/Disclaimer Design/Device Full Goods/Services Status/Key
Dates
Owner
Information
Canada Q2 ca 32

SNEAKY DELICIOUS

AN: 2276036

 

Int'l Class: 30

(Int'l Class: 30)

Goods: Flour, pasta; pancakes; frozen pancakes; mixes for making baking batters; bread; pizza crust; bread dough; cookie dough; frozen dough for use as pizza or bread; frozen breads, namely, bread loaves, rolls, and muffins; cookies; crackers; cereal bars; high-protein cereal bars; frozen waffles; processed cereal; waffles; tortillas; tortilla chips.

Canada Filed Pending Application Last Status Received: Pending Application, August 17, 2023 Office Status: Formalized Filed: August 17, 2023 Arcadia Biosciences, Inc. 202 Cousteau Place Suite 105 Davis, CA 95618, United States of America
Canada Q2 ca 34

THE WHEAT YOU LOVE, SIMPLY BETTER

AN: 2138038

 

Int'l Class: 30

(Int'l Class: 30)

Goods: Flour, pasta; pancakes; frozen pancakes; mixes for making baking batters; bread; pizza crust; bread dough; cookie dough; frozen dough for use as pizza or bread; frozen breads, namely bread loaves, rolls, and muffins; cookies; crackers; cereal bars; high-protein cereal bars; frozen waffles; cereal; waffles; tortillas; tortilla chips.

Canada Filed Pending Application Last Status Received: Pending Application, October 6, 2021 Office Status: Formalized Filed: October 6, 2021 Arcadia Biosciences, Inc. 202 Cousteau Place Suite 105 Davis, CA 95618, United States of America

 

 

 

TM
Record
TM/AN/RN/Disclaimer Design/Device Full Goods/Services Status/Key
Dates
Owner
Information
Canada Q2 ca 35

YUMSTRUCK

AN: 2276034

 

Int'l Class: 30

(Int'l Class: 30)

Goods: Flour, pasta; pancakes; frozen pancakes; mixes for making baking batters; bread; pizza crust; bread dough; cookie dough; frozen dough for use as pizza or bread; frozen breads, namely, bread loaves, rolls, and muffins; cookies; crackers; cereal bars; high-protein cereal bars; frozen waffles; processed cereal; waffles; tortillas; tortilla chips.

Canada Filed Pending Application Last Status Received: Pending Application, August 17, 2023 Office Status: Formalized Filed: August 17, 2023

Arcadia Biosciences, Inc. 202 Cousteau Place Suite 105 Davis, CA 95618, United States of America

Canada Q2 ca 36

Design Only

 

 

 

AN: 2138039

 

 

Int'l Class: 30

(Int'l Class: 30)

Goods: Flour, pasta; pancakes; frozen pancakes; mixes for making baking batters; bread; pizza crust; bread dough; cookie dough; frozen dough for use as pizza or bread; frozen breads, namely bread loaves, rolls, and muffins; cookies; crackers; cereal bars; high-protein cereal bars; frozen waffles; cereal; waffles; tortillas; tortilla chips.

Canada Filed Pending Application Last Status Received: Pending Application, October 6, 2021 Office Status: Formalized Filed: October 6, 2021

Arcadia Biosciences, Inc. 202

Cousteau Place Suite 105 Davis, CA 95618, United States of America

China Q2 cn 42

GOOD WHEAT

 

 

 

AN: 50207511-30

 

 

Int'l Class: 30

(Int'l Class: 30)

Biscuits , Waffles , Cakes , Pancakes , Bread , Pastries , Bread roll , crackers , Breadcrumbs , Snack foods based on cereal , Cereal bars , croutons , croissants , People eat processed breakfast cereals , Mixed biscuit , Pizza , Mexican pancakes , Cereal preparations ,

Wheat flour , Chips [cereal products] , The batter with mixed powder , Pancakes with mixed powder , Making cookies with mixed powder , Pizza mixed powder , Italian pasta , Noodles , Noodles based pre prepared food , ramen , Thickening agent for cooking food ,

China Filed Last Status Received: Filed Office Status: Invalid Filed: September 30, 2020

阿卡狄亚生物科学公司 美国加利福尼亚州95618, 戴维斯,库斯托广场202号105室

 

 

 

TM
Record
TM/AN/RN/Disclaimer Design/Device Full Goods/Services Status/Key
Dates
Owner
Information
China Q2 cn 43

GOOD WHEAT

 

 

 

AN: 50233987-35

 

 

Int'l Class: 35

(Int'l Class: 35) Advertising , In the communication media display goods for retail purposes , Provide goods and services for consumers select aspects of the business information and advice , Marketing ,

China Filed Last Status Received: Filed Office Status: Invalid Filed: September 30, 2020 阿卡狄亚生物科学公
司美国加利福尼亚
州95618,戴维斯,库斯
托广场202号105室
Argentina Q2 ar 48

GOODWHEAT

RN: 3351318

AN: 3998623

 

Int'l Class: 31

(Translation)

(Int'l Class: 31)

Only: unprocessed wheat, raw wheat, fresh wheat, non-GMO improved wheat grains and wheat seeds.

Argentina Registered Last Status Received: Registered Filed: April 5, 2021 Registered: November 30, 2022 Expiration Date: December 12, 2032 ARCADIA BIOSCIENCES, INC. 100.00 202 COUSTEAU PLACE, SUITE 105 DAVIS CALIFORNIA CP. 95618, United States of America
Argentina Q2 ar 49

GOODWHEAT

RN: 3352224

AN: 3998621

 

Int'l Class: 30

(Translation)

(Int'l Class: 30)

Only: Non-GMO improved wheat flour, wheat germ and wheat bran for use as an ingredient in food for human consumption, namely processed snacks, breads, pasta, cereals and crackers; Non-GMO enhanced processed wheat grains, wheat flour, wheat germ, wheat bran and wheat seeds for improved nutrition and health benefits. 

Argentina Registered Last Status Received: Registered Filed: April 5, 2021 Registered: December 2, 2022 Expiration Date: December 12, 2032 ARCADIA BIOSCIENCES, INC. 100.00 202 COUSTEAU PLACE, SUITE 105 DAVIS CALIFORNIA CP. 95618, United States of America

 

 

 

SCHEDULE B

 

Schedule of Domain Names

 

 

 

SCHEDULE C

 

Schedule of Social Media Accounts

 

 

 

EXHIBIT C

 

Bill of Sale

 

 

 

EXHIBIT D

 

Assignment and Assumption Agreement

 

 

 

EXHIBIT E

 

Promissory Note

 

 

 

EXHIBIT F

 

Security Agreement

 

 

 

EXHIBIT G

 

Trademark Security Agreement

 

 

 

EXHIBIT H

 

Sellers’ RG Patents

 

 

 

EXHIBIT I

 

Certain Transferred Rights

 

 

 

EX-10.30 18 tm2418826d1_ex10-30.htm EXHIBIT 10.30

Exhibit 10.30

 

PROMISSORY NOTE

 

$6,000,000 May 14, 2024

 

1. Interpretation. This Promissory Note (“Promissory Note”) is made pursuant to and in connection with that certain Asset Purchase Agreement of even date herewith by and among Arcadia Biosciences, Inc., a Delaware corporation (“Arcadia”), Arcadia Wellness, LLC, a Delaware limited liability company and wholly-owned subsidiary of Arcadia, ABOVE FOOD CORP. a corporation formed under the laws of Saskatchewan (“Parent”), and ABOVE FOOD INGREDIENTS CORP., a Delaware corporation and wholly-owned subsidiary of Parent (“Subsidiary”, and together with Parent, “Buyer”) (the “Asset Purchase Agreement”), and shall be interpreted consistently therewith. Buyer, Parent and Arcadia are sometimes referred to herein individually as a “Party” and together as the “Parties.” Capitalized terms used but not defined herein shall have the meanings given to such terms under the Asset Purchase Agreement.

 

2. Promise to Pay. For value received, Buyer promises to pay to Arcadia or its registered assigns, in lawful money of the United States of America, the principal sum of Six Million US Dollars ($6,000,000 USD) (the “Principal Amount”) together with interest (at the rates set forth below) on the outstanding principal balance. Unless payable earlier as provided below, the unpaid Principal Amount of this Promissory Note, together with accrued but unpaid interest and Enforcement Expenses (as defined below) shall be due and payable in full on the third (3rd) anniversary of the date of this Promissory Note (“Maturity Date”). Payment of the Principal Amount and all accrued but unpaid interest and Enforcement Expenses may be accelerated upon the occurrence of an Event of Default as provided for in this Promissory Note.

 

3. Payment.

 

(a) Interest Payments. On each anniversary of the date of this Promissory Note until all principal, interest and Enforcement Expenses hereunder have been paid in full, Buyer shall pay to Arcadia all accrued but unpaid interest on this Promissory Note (including default interest) and all unpaid Enforcement Expenses.

 

(b) Principal Payments.

 

(i) In addition to any interest payments hereunder, and subject to Sections 3(b)(ii) and (iii) hereof, until all principal, interest and Enforcement Expenses hereunder have been paid in full, on each of the first, second and third anniversaries of the date of this Promissory Note (unless otherwise extended or adjusted as mutually agreed), Buyer shall pay (and Parent shall cause Buyer to pay) Arcadia Two Million US Dollars ($2,000,000 USD) (or such lesser amount as may be outstanding as principal) less any amount prepaid in cash in the twelve (12) months preceding such anniversary date pursuant to Section 5(b) below as principal payments hereunder, plus all accrued but unpaid interest and Enforcement Expenses (each such payment, an “Installment”).

 

(ii) At any time between July 1, 2024 and the day immediately preceding the second anniversary of the date of this Promissory Note (“Election Period”), Arcadia may, at Arcadia’s sole discretion, require Parent to issue to Arcadia publicly traded shares of Parent’s common stock (“Parent Shares”) in an amount equal to Two Million U.S. Dollars ($2,000,000 USD) (a “Stock Election”) as determined in Section 3(b)(iv). Arcadia may effect the Stock Election by notifying Parent in writing of such election during the Election Period, and Parent shall cause the Parent Shares to be issued to Arcadia within three (3) Business Days after Arcadia’s delivery of such notice. If Parent becomes a wholly-owned subsidiary of a company with shares listed on a national securities exchange, then the Parent Shares shall refer to the publicly traded common stock of such parent company and Parent shall cause such entity to issue and register such shares as provided in this Section 3(b).

 

1


 

 

(iii) The issuance of the Parent Shares to Arcadia will constitute a prepayment of Two Million U.S. Dollars ($2,000,000 USD) on this Promissory Note. However, such prepayment will not relieve Buyer of its obligation to continue making Installment payments on their due dates. Instead, such prepayment will be applied to the last Installment payable hereunder. For example, whether or not the Parent Shares are issued, Buyer shall be obligated to pay the Installments in immediately available funds on each of the first and second anniversaries of the date of this Promissory Note.

 

(iv) The number of Parent Shares that will be issuable to Arcadia in connection with a Stock Election will equal the quotient obtained by dividing (a) Two Million U.S. Dollars ($2,000,000 USD) by (b) the Deemed Value Price. Parent shall deliver the Parent Shares to Arcadia in electronic form and remove any transfer restrictions from the Parent Shares upon the earlier to occur of (1) five (5) calendar days after the first date that the Parent Shares are eligible for resale under Rule 144 promulgated under the Securities Act of 1933, as amended (“Securities Act”) and (2) the date that the Parent Shares are registered for resale under the Securities Act. For purposes of this Promissory Note, (x) the “Deemed Value Price” shall equal 90% of the Average Price, (y) the “Average Price” shall mean the average VWAP for the consecutive twenty (20) trading days ending on the trading day immediately preceding the date that Arcadia sends the Stock Election to Parent and (z) “VWAP” means, for any date, the daily volume weighted average price of Parent’s publicly traded common stock on the primary market for such stock, in U.S. Dollars.

 

(v) As soon as practicable following issuance of the Parent Shares (and in any event within 20 calendar days of the date the Stock Election is delivered to Parent), Parent shall cause a registration statement on Form F-1 (or other appropriate form if Parent is not then F-1 eligible) to be filed with the United States Securities and Exchange Commission providing for the registration of the resale from time to time by Arcadia of the Parent Shares. Parent shall use reasonable efforts (and cause any parent entity of Parent to use the same efforts) to cause such registration statement to become effective within sixty (60) days (and shall cause such registration statement to become effective within seventy (75) days, without regard to efforts) following the date that the such registration statement is filed, and the Parent shall use its reasonable best efforts (and cause any parent entity of Parent to use the same efforts) to keep such registration statement effective and available for use at all times until all outstanding principal, interest and Enforcement Expenses hereunder have been satisfied in full.

 

(c) Terms. All payments to be made by Buyer shall be made without set-off, recoupment or counterclaim. All payments by Buyer shall be made in United States dollars to Arcadia in immediately available funds, no later than 5:00 p.m., Central Time, on the dates specified herein. Any payment received by Arcadia later than 5:00 p.m., Central Time, shall be deemed to have been received on the following Business Day and any applicable interest or fee shall continue to accrue. Whenever any payment is due on a day other than a Business Day, such payment shall be made on the following Business Day, and such extension of time shall in such case be included in the computation of interest.

 

4. Interest Rate.

 

(a) Standard Rate. Except as otherwise provided herein, interest on the unpaid Principal Amount shall accrue from the date hereof until the Principal Amount is paid in full at the rate equal to the Variable Interest Rate. The term “Variable Interest Rate” shall mean and refer to a rate equal to The Wall Street Journal’s Prime Rate as published daily in the “Money Rates” column of The Wall Street Journal. The Variable Interest Rate shall be adjusted on the first day of each calendar month to reflect changes in the Prime Rate whether or not Arcadia gives Buyer notice of such change. If more than one Prime Rate is published in the “Money Rates” column of The Wall Street Journal, the highest Prime Rate listed shall be the applicable index under this Promissory Note. If The Wall Street Journal’s Prime Rate ceases to be published in The Wall Street Journal or otherwise becomes unavailable as an index, Arcadia shall select a reasonably comparable interest rate index and shall give the Buyer notice thereof.

 

2


 

 

(b) Default Rate. Notwithstanding Section 4(a), while an Event of Default exists or after acceleration of this Promissory Note, interest on the unpaid Principal Amount shall accrue at a rate equal to the Variable Interest Rate plus two percent (2.00%) per annum.

 

(c) Computation Interest. All computations of interest shall be made on the basis of a year of 365 or 366 days, as the case may be. Interest shall accrue during each period during which interest is computed from the first day thereof to the last day thereof.

 

(d) Usury. If performance of or compliance with any provision of this Promissory Note or in any instrument now or hereafter securing or guaranteeing this Promissory Note results in Arcadia receiving interest in an amount which would exceed the maximum rate allowed by the law in the United States, the amount of such interest which exceeds such lawful limits shall be applied to the reduction of the unpaid principal balance and not to the payment of interest. Any surplus remaining after full payment of all principal, lawful interest, and expenses due hereunder resulting from the prior sentence shall be remitted to Buyer.

 

5. Prepayments.

 

(a) Optional. Buyer may prepay the principal amount of this Promissory Note at any time, in whole or in part, by paying the principal amount to be prepaid together with accrued interest thereon to the date of prepayment.

 

(b) Future Payments. Early payments will not relieve Buyer of its obligation to continue making payments on their due dates; provided that any such early payments that are made in cash will reduce the principal balance due under this Promissory Note on the immediately succeeding principal payment date under Section 3(b). Early payments made in stock as provided in Section 3(b) shall be treated as described in Section 3(b).

 

(c) Other. Buyer agrees not to send Arcadia payments marked “paid in full”, “without recourse”, or similar language. If Buyer sends such a payment, Arcadia may accept it without losing any of Arcadia’s rights under this Promissory Note, and Buyer will remain obligated to pay any further amount owed to Arcadia.

 

6. [Reserved].

 

7. Collateral. Buyer’s obligations hereunder are secured as set forth in the Security Agreement.

 

8. Event of Default. Any of the following shall constitute an “Event of Default”:

 

(a) Non-Payment of Principal and Interest. Buyer fails to make a payment within the Grace Period of any payment of any interest (including default interest) or principal under the Promissory Note;

 

3


 

(b) Non-Payment of Other Amounts. Buyer fails to pay any Enforcement Expenses or other amount payable under the Security Agreement within five (5) Business Days after receipt or deemed receipt of notice thereof from Arcadia;

 

(c) Representation or Warranty. Any representation or warranty by Buyer made or deemed made herein or in the Security Agreement is incorrect in any material respect on or as of the date made or deemed made;

 

(d) Other Defaults. Buyer fails to perform or observe any term or covenant contained in this Promissory Note or Security Agreement, and such default shall continue unremedied for a period of twenty (20) days after the first to occur of (i) the date upon which written notice thereof is given to Buyer by Arcadia, or (ii) the date on which Buyer has actual knowledge of such failure;

 

(e) Cross-Default. Buyer (A) fails to make any payment in respect of any indebtedness having an aggregate principal amount of more than Four Million US Dollars ($4,000,000 USD) when due (whether by scheduled maturity, required prepayment, acceleration, demand, or otherwise) and such failure continues after the applicable grace or notice period, if any, specified in the relevant document on the date of such failure; or (B) fails to perform or observe any other condition or covenant, or any other event shall occur or condition exist, under any agreement or instrument relating to any such indebtedness, and such failure continues after the applicable grace or notice period, if any, specified in the relevant document on the date of such failure if the effect of such failure, event or condition is that the holder or holders of such indebtedness or beneficiary or beneficiaries of such indebtedness (or a trustee or agent on behalf of such holder or holders or beneficiary or beneficiaries) declare such indebtedness, or any portion of such indebtedness exceeding Four Million US Dollars ($4,000,000 USD), to be due and payable prior to its stated maturity;

 

(f) Insolvency; Voluntary Proceedings. Either Parent or Subsidiary (i) ceases or fails to be solvent, or generally fails to pay, or admits in writing its inability to pay, its debts as they become due, subject to applicable grace periods, if any, whether at stated maturity or otherwise; (ii) voluntarily ceases to conduct its business in the ordinary course; (iii) commences any insolvency Proceeding (including bankruptcy) with respect to itself; or (iv) takes any action to effectuate or authorize any of the foregoing;

 

(g) Involuntary Proceedings. (i) Any involuntary insolvency proceeding (including bankruptcy) is commenced or filed against either Parent or Subsidiary, or any writ, judgment, warrant of attachment, execution or similar process, is issued or levied against a substantial part of Parent’s or either Parent’s or Subsidiary’s properties, and any such proceeding or petition shall not be dismissed, or such writ, judgment, warrant of attachment, execution or similar process shall not be released, vacated or fully bonded within sixty (60) days after commencement, filing or levy; (ii) Parent or Subsidiary admits the material allegations of a petition against it in any insolvency proceeding, or an order for relief (or similar order under non-U.S. law) is ordered in any insolvency proceeding; or (iii) Parent or Subsidiary acquiesces in the appointment of a receiver, trustee, custodian, conservator, liquidator, mortgagee in possession (or agent therefor), or other similar Person for itself or a substantial portion of its property or business;

 

(h) Monetary Judgments. One or more non-interlocutory judgments, non- interlocutory orders, decrees or arbitration awards is entered against Parent, Subsidiary or their entity Affiliates involving in the aggregate a liability (to the extent not covered by independent third-party insurance as to which the insurer does not dispute coverage) as to any single or related series of transactions, incidents or conditions, of Four Million US Dollars ($4,000,000 USD) or more, and the same shall remain unsatisfied, unvacated, and unstayed pending appeal for a period of thirty (30) days after the entry thereof;

 

4


 

(i) Change of Control. Any transaction or series of related transactions occur in which (i) Subsidiary is not a wholly-owned subsidiary (either directly or indirectly) of Parent, (ii) all or substantially all of the assets of Subsidiary are directly or indirectly sold or exclusively leased or licensed to an unaffiliated third party or (iii) the holders of Parent’s capital stock immediately before such transaction or series of related transactions cease to hold a majority of the outstanding voting capital stock of Parent immediately following such transaction or series of related transactions;

 

(j) Material Adverse Affect. There occurs any change, occurrence or development, individually or in the aggregate, that has a material adverse effect on the business, properties, prospects, assets, results of operations or condition (financial or otherwise) of Parent and Subsidiary, taken as a whole;

 

(k) Defective Collateralization. This Promissory Note or Security Agreement ceases to be in full force and effect (including failure of any collateral document to create a valid and perfected security interest or Lien in the Purchased Assets that is of first priority (other than a lower priority in the case of Permitted Liens as defined in the Security Agreement)) at any time and for any reason.

 

(l) Public Trading. If at any time after July 31, 2024, Parent’s common stock (or if parent is the wholly-owned subsidiary of another entity, that other entity’s common stock) is not a “Covered Security” pursuant to Section 18(b)(1)(A) of the Securities Act of 1933 that is listed on a national securities exchange.

 

9. Remedies. Upon the occurrence and during the continuance of an Event of Default, Arcadia may:

 

(a) declare the unpaid principal amount of the Promissory Note, all interest accrued and unpaid thereon, and all other amounts owing or payable hereunder or under the Security Agreement to be immediately due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived by Buyer; and

 

(b) exercise on behalf of itself all rights and remedies available to it under the Security Agreement and applicable law.

 

10. Rights Not Exclusive. The rights provided for in this Promissory Note and the Security Agreement are cumulative and are not exclusive of any other rights, powers, privileges or remedies provided by law or in equity, or under any other instrument, document or agreement now existing or hereafter arising.

 

11. Taxes.

 

(a) All payments under the notes to Arcadia or its registered assign under this Promissory Note shall be made without deduction for or on account of any and all present or future applicable taxes, levies, imposts, deductions, charges, or withholdings, and all liabilities with respect thereto (a “Tax Withholding”), unless a Tax Withholding is otherwise required by a law of a jurisdiction within the United States for payments between entities formed and with principal places of business within the United States. If such a Tax Withholding is required, Buyer and its Affiliates or any other applicable withholding agent shall be entitled to make such Tax Withholding and shall remit such Tax Withholding to the appropriate taxing authority in a jurisdiction within the United States of America. Any amount withheld pursuant to this Section 11(a) shall be treated for all purposes of this Promissory Note as having been paid, issued, or delivered to the person in respect of which such Tax Withholding was made.

 

5


 

(b) Arcadia shall provide Buyer with an IRS Form W-9 on or prior to the first anniversary of the date hereof, and any assignment of this Promissory Note by Arcadia shall not be consummated unless and until the assignee has provided Buyer with an IRS Form W-9 on or prior to the date of the assignment.

 

12. Miscellaneous.

 

(a) Notices. All notices, demands or other communications given hereunder shall be in writing and shall be deemed properly served, given or made if delivered in person or sent by electronic mail or sent by registered or certified mail, postage prepaid, or by a nationally recognized overnight courier service that provides a receipt of delivery, in each case, to the parties at the addresses specified below:

 

If to Arcadia:

 

Arcadia Biosciences, Inc.

Attn: Chief Executive Officer

5950 Sherry Lane, Suite 215

Dallas, TX 75225

Email: stan.jacot@arcadiabio.com

 

with copy to:

 

Weintraub Tobin Chediak Coleman Grodin Law Corporation

400 Capitol Mall, 11th Floor

Sacramento, CA 95814

Attn: Michael De Angelis

Email: mdeangelis@weintraub.com

 

If to Buyer to:

 

Above Food Corp.

2305 Victoria Ave #001, Regina, SK S4P 0S7

Attn: Lionel Kambeitz

Email: lionel@abovefood.com

 

with copy to:

 

Latham & Watkins LLP

811 Main Street, Suite 3700

Houston, Texas 77002

Attention: Ryan Maierson and Ryan Lynch

E-mail: ryan.maierson@lw.com; ryan.lynch@lw.com

 

Notice given by personal delivery pursuant to this Section 12(a) shall be effective upon physical receipt. Notice given by electronic mail pursuant to this Section 12(a) shall be effective on the date sent by electronic mail and successfully delivered before 5:00 p.m. Pacific Time on any Business Day or the next succeeding Business Day if sent after 5:00 p.m. Pacific Time on any Business Day or during any non-Business Day. Notice given by mail or overnight courier pursuant to Section 12(a) shall be effective one (1) Business Day following sending. Each party may change the address by which proper notice shall be given pursuant to this Section 12(a) by providing notice to the other parties in accordance with this Section 12(a).

 

6


 

(b) Marshalling; Payments Set Aside. Arcadia shall not be under any obligation to marshal any assets in favor of Buyer or any other Person against or in payment of any or all of the obligations hereunder. To the extent that Buyer makes a payment to Arcadia and such payment or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into by Arcadia in its discretion) to be repaid to a trustee, receiver or any other party, in connection with any insolvency proceeding or otherwise, then to the extent of such recovery the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such set-off had not occurred.

 

(c) Assignments, Successors and Assigns. Buyer shall not assign any rights or obligations hereunder without the prior written consent of Arcadia (not to be unreasonably withheld or delayed so long as Buyer continues to be responsible for its obligations hereunder after such assignment). Arcadia shall have the right to assign any and all rights and benefits it may have under this Promissory Note subject to the Buyer’s prior written consent (not to be unreasonably withheld or delayed).

 

(d) Register. The Buyer shall maintain at one of its offices in the United States a register for the recordation of the names and addresses of any assigns, successor, or transferees of Arcadia and principal amounts (and stated interest) of the applicable owing to such Person pursuant to the terms hereof from time to time (the “Register”). The Register shall be available for inspection by the Buyer and any Person included in the Register, at any reasonable time and from time to time upon reasonable prior notice. This provision is intended to ensure that the Promissory Note is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations.

 

(e) Applicable Laws. This Agreement shall be construed and governed by the internal laws, and not the law of conflicts, of Delaware to agreements made and to be performed in Delaware. SUBJECT TO SECTION 12(f), EACH OF BUYER AND ARCADIA IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED IN NEW CASTLE COUNTY, IN THE STATE OF DELAWARE, FOR THE PURPOSES OF ANY ACTION ARISING OUT OF OR RELATING TO THIS PROMISSORY NOTE, AND AGREES THAT ALL CLAIMS IN RESPECT OF SUCH ACTION MAY BE HEARD AND DETERMINED IN ANY SUCH COURT. SUBJECT TO SECTION 12(f), EACH OF BUYER AND ARCADIA AGREES TO COMMENCE ANY SUCH ACTION IN ANY STATE OR FEDERAL COURT LOCATED IN NEW CASTLE COUNTY, DELAWARE. EACH OF BUYER AND ARCADIA WAIVES ANY DEFENSE OF IMPROPER VENUE OR INCONVENIENT FORUM TO THE MAINTENANCE OF ANY ACTION SO BROUGHT AND WAIVES ANY BOND, SURETY, OR OTHER SECURITY THAT MIGHT BE REQUIRED WITH RESPECT THERETO. NOTWITHSTANDING THE FOREGOING, ARCADIA SHALL HAVE THE RIGHT TO BRING ANY ACTION OR PROCEEDING AGAINST BUYER OR THE COLLATERAL UNDER THE SECURITY AGREEMENT IN THE COURTS OF ANY OTHER JURISDICTION WHICH ARCADIA DEEMS NECESSARY OR APPROPRIATE TO REALIZE ON THE COLLATERAL OR TO OTHERWISE ENFORCE ARCADIA’S RIGHTS AGAINST BUYER OR THE COLLATERAL.

 

(f) Specific Performance. The Parties agree that, in the event of any breach or threatened breach by Buyer of any covenant, obligation or other provision set forth in this Agreement, Arcadia shall be entitled (in addition to any other remedy that may be available to it) to (i) a decree or order of specific performance or mandamus to enforce the observance and performance of such covenant, obligation or other provision, and (ii) an injunction restraining such breach or threatened breach. Any legal action or proceeding by Arcadia to obtain such remedies may be brought or otherwise commenced in any court with jurisdiction. Buyer: (x) expressly and irrevocably consents and submits to the jurisdiction of such courts (and their respective appellate courts) in connection with any such legal proceeding; (y) agrees that each such court shall be deemed to be a convenient forum; and (z) agrees not to assert (by way of motion, as a defense or otherwise), in any such legal proceeding, any claim that Buyer is not subject personally to the jurisdiction of such court, that such legal proceeding has been brought in an inconvenient forum, that the venue of such proceeding is improper or that this Agreement or the subject matter of this Agreement may not be enforced in or by such court.

 

7


 

(g) Attorneys’ Fees; Prejudgment Interest. Buyer agrees to pay all costs, including reasonable attorneys’ fees and expenses of one firm of counsel, incurred by Arcadia in enforcing payment or collection of this Promissory Note, whether or not suit is filed (collectively, “Enforcement Expenses”). Any award of damages as a result of the breach of this Promissory Note by Buyer or any of its provisions shall include an award of prejudgment interest from the date of the breach at the maximum rate of interest allowed by Section 4(b). Enforcement Expenses shall be paid to Arcadia in immediately available funds within five (5) Business days after Arcadia notifies Buyer in writing of such Enforcement Expenses.

 

(h) Amendments and Waivers. No term or provision of this Promissory Note may be amended, waived, discharged or terminated orally but only by an instrument in writing signed by the Party against whom the enforcement of such amendment, waiver, discharge or termination is sought. Any waiver shall be effective only in accordance with its express terms and conditions.

 

(i) Severability. Any provision of this Promissory Note which is unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such unenforceability without invalidating the remaining provisions hereof, and any such unenforceability in any jurisdiction shall not invalidate or render unenforceable such provisions in any other jurisdiction. To the extent permitted by applicable law, the Parties hereby waive any provision of law now or hereafter in effect which renders any provision hereof unenforceable in any respect.

 

(j) Headings. The headings in the sections of this Promissory Note are inserted for convenience only and shall not constitute a part hereof or affect the meaning or interpretation hereof.

 

(k) Construction. No provision of this Promissory Note shall be construed against any Party on the ground that such Party or its counsel drafted the provision.

 

(l) Time of Essence. Time is of the essence.

 

(m) Set-off. To the extent provided in the last sentence of Section 5.3(c) of the Asset Purchase Agreement, the outstanding amounts on this Promissory Note are subject to offset to satisfy Indemnifiable Losses payable by the Sellers (“Offset”). To the extent that amounts outstanding under the Promissory Note are decreased pursuant to an Offset, such reduction shall be applied first to reduce the amount payable hereunder on the last Installment on the Maturity Date and, if applicable, thereafter to the next to last Installment followed by the first Installment such that reducing the principal amount of the Promissory Note against the Indemnifiable Loss will not affect the repayment schedule of principal under Section 3(b) of the Promissory Note until all outstanding amounts under the Promissory Note have been satisfied in full. Other than as set forth above in this Section 12(m), this Promissory Note is not subject to offset for any reason.

 

(n) Counterparts. This Promissory Note may be executed by the parties in multiple counterparts, each of which shall be deemed an original and may be delivered by electronic means (including.pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com), but all of which together will constitute one and the same instrument. Any .pdf copies hereof or signatures hereon shall, for all purposes, be deemed originals.

 

8


 

(o) Buyer’s Waivers. Buyer and any endorsers of this Promissory Note, and each of them, hereby waive diligence, demand, presentment for payment, notice of non-payment, protest and notice of protest. Buyer and any endorsers of this Promissory Note expressly waive all right to the benefit of any statute of limitations and any moratorium, reinstatement, marshaling, forbearance, extension, redemption or appraisement now or hereafter provided by the Constitution and the laws of the United States of America and of any state thereof or province of Canada, as a defense to any demand against Buyer or any such endorsers, to the fullest extent permitted by law.

 

9


 

IN WITNESS WHEREOF, this Promissory Note is executed as of the first date set forth above.

 

PARENT:   ARCADIA:
         
ABOVE FOOD CORP.   ARCADIA BIOSCIENCES, INC.
         
By: /s/ Lionel Kambeitz   By: /s/ Stanley Jacot, Jr.
  Lionel Kambeitz     Stanley Jacot, Jr.,
  Chief Executive Officer     Chief Executive Officer
         
         
SUBSIDIARY:      
         
ABOVE FOOD INGREDIENTS CORP.      
         
By: /s/ Lionel Kambeitz      
  Lionel Kambeitz      
  Executive Chairman      

 

10

 

EX-10.31 19 tm2418826d1_ex10-31.htm EXHIBIT 10.31

 

Exhibit 10.31

 

AMENDMENT TO ASSET PURCHASE AGREEMENT

 

This AMENDMENT (the "Amendment") to that certain Asset Purchase Agreement, dated August 28, 2023, by and between NRGene Technologies Ltd., a company incorporated under the laws of the State of Israel, with registered offices at 5 Golda Meir St., Ness Ziona 7403649, Israel ("NRGene IL"), NRGene Canada Inc., a company incorporated under the laws of the Country of Canada, with registered offices at 101-110 Research Drive, Saskatoon, Saskatchewan S7N 3R3, Canada ("NRGene CN" and together with NRGene IL, the “Sellers”), and Above Food Corp., a company incorporated under the laws of the Province of Alberta, with registered offices at 001-2305 Victoria Avenue, Regina, Saskatchewan, S4P 0S7 (the "Purchaser"), and in the form attached hereto as Exhibit A and as amended by both amendments dated December 31, 2023 (the "First and Second Amendments" and the "Purchase Agreement" which includes the First and Second Amendment, accordingly), is made and entered into on June 26, 2024 (the "Effective Date"). Each of NRGene IL, NRGene CN and the Purchaser shall each be referred to herein, individually, as a "Party" and, together, as the "Parties". All capitalized terms used herein but not otherwise defined shall have the meanings ascribed to such terms in the Purchase Agreement.

 

PREAMBLE

 

WHEREAS, NRGene IL, NRGene CN and the Purchaser are parties to the Purchase Agreement; and

 

WHEREAS, pursuant to the Purchase Agreement, the Purchaser agreed to pay the Sellers, inter alia, a Cash Consideration for the Acquired Assets, in the amount of CAD$ 2,500,000, of which the Parties agree that CAD$ 2,362,500 is remaining outstanding (the "Remaining Amount"); and

 

WHEREAS, the Parties desire to set forth the terms and conditions upon which the Remaining Amount shall be settled and to further amend the Purchase Agreement with regard to the stock exchange in which the Purchaser shall be registered; and

 

WHEREAS, the Purchaser shows interest in participating in the private financial round of NRGene CN and intends to allocate up to CAD$ 1,000,000 of excess proceeds from any sale of Substitute Shares (as defined herein) to an investment under the SAFE investment agreement included in Exhibit B.

 

NOW, THEREFORE, in consideration of the foregoing recitals and the mutual promises hereinafter set forth, the Parties hereby agree as follows:

 

1.     Interpretations; Definitions.

 

1.1.        The preamble hereto constitutes an integral part hereof.

 

1.2.        This Amendment constitutes an integral part of the Purchase Agreement and shall constitute part of its terms and conditions.

 

2.     Loan Agreement.

 

2.1.        The Purchaser hereby agrees to provide the Sellers immediately following the Closing with a non-recourse, interest-bearing loan in the amount of CAD$ 2,362,500 (the "Principal Loan Amount"). The Loan shall be for a period of 6 months from the date of disbursement (the "Repayment Term"), and shall bear an annual interest rate of 3% per annum, to be calculated upon the lapse of the Repayment Term (the "Interest" and together with the Principal Loan Amount shall be referred to as the "Loan").

 

2.2.        The Loan shall be secured solely by the Substitute Shares (as defined below) of the Purchaser held in trust by the Broker (as defined below).

 

Page 1 of 6

 

3.     Substitute Shares Held in Trust.

 

3.1.        In addition to the Loan, the Purchaser shall deliver the Sellers immediately following the Closing with such number of common shares of the Purchaser, representing the Loan amount plus CAD$ 1,000,000, calculated as of the date of the IPO per the price per share of the Purchaser at the IPO of US$ 10 per share. The Purchaser shall deliver directly or indirectly 250,000 post-IPO shares at $US 10 per share (with an average rate of CAD$ 13.70 per share, being CAD$ 3,425,000 as consideration) which upon completion of its proposed going public transaction to be free and clear from any restrictions and/or limitations on possession, trade or otherwise, and freely tradeable (the "Substitute Shares"). The Substitute Shares shall be held in trust by a registered, certified and reputable broker to be appointed by Seller in consultation with the Purchaser (the "Broker"), per a brokerage/trading agreement.

 

3.2.        Seller shall enter into an agreement with the Broker within 5 business days for the purpose of holding the Substitute Shares, and the sale thereof within the Repayment Term with such trading terms and limits as mutually agreed upon by the Parties. The Broker shall commence the sale of Substitute Shares promptly after appointment and shall complete the sale within the Repayment Term, taking into account market liquidity and other relevant factors in compliance with applicable Laws.

 

3.3.        The Purchaser shall bear the costs associated with the Broker's services.

 

4.     Repayment Mechanism.

 

4.1.        Upon the sale of the Substitute Shares or parts thereof by the Broker, the proceeds shall first be used to repay the Loan or parts thereof and the Loan shall be reduced accordingly.

 

4.2.        In the event that the proceeds from the sale of Substitute Shares are less than the Loan amount, the Parties shall waive and hereby waive the requirement for repayment of the remaining Loan amount.

 

4.3.        Should the proceeds from the sale of Substitute Shares exceed the Loan amount, then the surplus shall be used for investment in NRGene CN through a Simple Agreement for Future Equity ("SAFE"), in the form attached as Exhibit B.

 

5.     Section 8.1 of the Purchase Agreement.

 

5.1.        The Parties agree that Section 8.1 of the Purchase Agreement shall be amended such that, the listing of the combined company of the Purchaser and Bite Acquisition Corp., shall be listed on the NASDAQ stock exchange ("NASDAQ") instead of the New York Stock Exchange ("NYSE"). The Parties agree that any references to the NYSE in Section 8.1 of the Purchase Agreement shall be construed to mean NASDAQ.

 

6.     Miscellaneous.

 

6.1.        Legal Opinion. Prior to the implementation of the above transactions, the Purchaser shall provide the Sellers with a legal opinion from an attorney acceptable to Sellers confirming that all necessary approvals have been obtained under applicable regulations and corporate governance requirements.

 

6.2.        Taxes. All taxes and costs imposed due to or in connection with this Amendment shall be borne by the Purchaser. If any taxes are required to be withheld under applicable law, Purchaser will be responsible for withholding and paying such taxes to the applicable authorities, unless provided with a non-withholding and/or exemption certificate in advance, and the amounts payable to Sellers shall be grossed-up accordingly in order not to affect the amounts due to it hereunder.

 

Page 2 of 6

 

6.3.        Representation and Warranties of the Purchaser. The Purchaser has full legal and beneficial title to the Substitute Shares, and the Substitute Shares were duly issued and are not subject to any liens. The Purchaser has the requisite power and authority, to execute, deliver and perform this Amendment and the Purchase Agreement, to consummate the transactions contemplated hereby and thereby and to comply with the provisions of this Amendment and the Purchase Agreement. The execution, delivery and performance of this Amendment and the Purchase Agreement by the Purchaser, the consummation by the Purchaser of the transactions contemplated hereby and thereby and the compliance by the Purchaser with the provisions of this Amendment and the Purchase Agreement have been duly authorized by all necessary action on the part of Purchaser, and no other action or proceeding on the part of the Purchaser is necessary to authorize this Amendment and/or the Purchase Agreement or to consummate the transactions contemplated hereby and thereby. This Amendment has been duly executed and delivered by the Purchaser and, assuming the due authorization, execution and delivery by the Sellers, constitutes valid and binding obligations of the Purchaser enforceable against it in accordance with their terms. The execution, delivery and performance of this Amendment and the Purchase Agreement and the consummation of the transactions contemplated hereby and thereby do not and will not conflict with, or result in any violation or breach of, or default under any contract to which the Purchaser is party to or any of its properties or assets are subject, or the applicable law.

 

6.4.        Representations and Warranties of the Sellers. The Sellers have the requisite power and authority to execute, deliver and perform this Amendment and the Purchase Agreement, to consummate the transactions contemplated hereby and to comply with the provisions of this Amendment and the Purchase Agreement. This Amendment has been duly executed and delivered by the Sellers, and, assuming the due authorization, execution and delivery by the Purchaser, constitutes a valid and binding obligations of the Sellers, enforceable against the Sellers in accordance with its terms. The execution, delivery and performance of this Amendment and the Purchase Agreement and the consummation of the transactions contemplated hereby and thereby do not and will not conflict with, or result in any violation or breach of, or default under any contract to which the Sellers are party to or any of its properties or assets are subject, or the applicable law.

 

6.5.        Entire Agreement. This Amendment, the First and Second Amendment and the Purchase Agreement constitute the full and entire understanding and agreement between the Parties with regards to the subject matters hereof and thereof.

 

6.6.        No Other Modifications. Except as specifically set forth herein, this Amendment shall not be deemed to amend or modify the Purchase Agreement in any respect and the Purchase Agreement shall remain in full force and effect in accordance with its terms and conditions. In the event of any inconsistency between the provisions of this Amendment and the terms of the Purchase Agreement, the provisions of this Amendment shall prevail.

 

6.7.        Counterparts. This Amendment may be executed in one or more counterparts, each of which shall be deemed an original and all of which, together, shall constitute one and the same instrument.

 

6.8.        Governing Law. Notwithstanding anything to the contrary in the Purchase Agreement, this Amendment is governed by and shall be construed in accordance with the laws of the State of Israel and each of the Parties hereto hereby irrevocably submit to the exclusive jurisdiction of the courts of Tel-Aviv-Jaffa in relation to all matters arising out of or in connection with this Amendment.

 

[Signature Page to Follow]

 

Page 3 of 6

 

IN WITNESS WHEREOF, the Parties have caused this Amendment to be duly executed and delivered as of the Effective Date.

 

NRGene Technologies Ltd.   Above Food Corp.
     
By: /Gil Ronen   By: /s/ Lionel Kambeitz  
Name: Gil Ronen   Name: Lionel Kambeitz
Title: CEO   Title: Chief Executive Officer
     
NRGene Canada Inc.    
     
By: /s/ Gil Ronen    
Name: Gil Ronen    
Title: CEO    

 

List of Exhibits:

 

Exhibit A – Purchase Agreement

 

Exhibit B - SAFE

 

[Signature Page – Amendment to Asset Purchase Agreement]

 

Page 4 of 6

 

Exhibit A

 

Purchase Agreement

 

Page 5 of 6

 

Exhibit B

 

SAFE

 

[to be latest version of NRG CN's SAFE using standard terms and conditions]

 

Page 6 of 6

 

EX-10.32 20 tm2418826d1_ex10-32.htm EXHIBIT 10.32

 

Exhibit 10.32

 

THE SECURITIES REFERENCED HEREIN HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

 

 

SECURED CONVERTIBLE PROMISSORY NOTE

 

$2,000,000 June 27, 2024

 

For value received, Above Food Ingredients Inc., a corporation organized under the laws of Alberta, Canada (the “Company”), promises to pay to Smart Dine, LLC (the “Holder”), the principal sum of Two Million Dollars ($2,000,000). Interest shall accrue on the unpaid principal amount of this Secured Convertible Promissory Note (the “Note”) from the date hereof at a rate equal to six percent (6%) per quarter, compounded quarterly. This Note is issued in satisfaction of the balance due under an amended and restated promissory note (the “Sponsor Note”), dated as of June 27, 2024, by and between Bite Acquisition Corp., a Delaware corporation (“Bite”) and the Holder, in connection with the closing of the business combination pursuant to the Business Combination Agreement, dated as of April 29, 2023 (as amended on March 12, 2024 and as may be further amended and/or amended and restated, the “Business Combination Agreement”), by and among Bite, the Company, Above Food Corp., a corporation organized under the laws of Saskatchewan, Canada, and Above Food Merger Sub, Inc., a Delaware corporation. This Note is subject to the following terms and conditions.

 

1.              Maturity. Unless earlier converted or exchanged as provided herein, principal and any accrued but unpaid interest under this Note shall be due and payable on June 27, 2026 (the “Maturity Date”). Notwithstanding the foregoing, if any Event of Default (as defined below) shall have occurred and be continuing hereunder, at the option and upon the declaration of the Holder and upon written notice to the Company (which election and notice shall not be required in the case of an Event of Default under subsection (a) below), this Note shall accelerate and all principal and unpaid accrued interest shall become due and payable. The occurrence of any one or more of the following shall constitute an “Event of Default”:

 

(a)            any of: (i) the commission of any act of bankruptcy by the Company, (ii) the execution by the Company of a general assignment for the benefit of creditors, (iii) the filing against the Company of a petition in bankruptcy or any petition for relief under the federal bankruptcy act and the continuation of such petition without dismissal for a period of 30 days or more, (iv) the application for or consent to the appointment of a receiver or trustee to take possession of the property or assets of the Company, or (v) the Company’s shareholders or board of directors affirmatively voting to liquidate, dissolve, or wind up the Company;

 

(b)            the Company’s failure to pay on a timely basis any of the principal amount, accrued interest, or other amounts due under this Note on the date the same becomes due and payable;

 

(c) any representation, warranty, or other statement made or furnished by or on behalf of the Company to the Holder in writing in connection with this Note or the Pledge Agreement (as defined below) being false, incorrect, incomplete or misleading in a material respect when made or furnished; (d) the Company’s failure to observe or perform any covenant, obligation, condition or agreement contained in this Note (other than those set forth above in this Section 2) or the Pledge Agreement, and such failure continues for a period of ten days after the earlier of the date Holder notifies the Company thereof or the Company becomes aware of such failure; or

 

1


 

 

(e)            this Note or the Pledge Agreement, or any provision thereof, for any reason ceasing to be in full force and effect in accordance with its terms or any obligor thereunder so asserting in writing.

 

In the event of any Event of Default hereunder, in addition to all rights of the Holder under this Note, the Pledge Agreement or at law or in equity, the Company shall pay all reasonable attorneys’ fees and court costs incurred by the Holder in enforcing and collecting this Note.

 

2.              Conversion. In the event this Note has not previously converted, been exchanged or been repaid in full, on or at any time prior to the Maturity Date, at the option of the Holder, in its sole discretion, the entire outstanding principal balance of this Note plus all accrued and unpaid interest thereon, or any portion thereof, may be converted into that number of the common shares in the capital of the Company (“Common Shares”) at a conversion price equal to [the [15] trading-day trailing Volume-Weighted Average Price (“VWAP”) as reported by Bloomberg at the close of trading on the date immediately prior to the date of such conversion] (as applicable, the “Conversion Price”).

 

3.              Mechanics and Effect of Conversion. No fractional Common Shares will be issued upon conversion of this Note. In lieu of any fractional share to which the Holder would otherwise be entitled, the Company will pay to the Holder in cash the amount of the unconverted principal and interest balance of this Note that would otherwise be converted or exchanged into such fractional share. Upon conversion of this Note hereunder, the Holder shall surrender this Note, duly endorsed, at the principal offices of the Company or any transfer agent of the Company. At its expense, the Company will, as soon as practicable thereafter (and in any event within two business days), issue or cause to be issued the number of Common Shares to which the Holder is entitled upon such conversion, in book entry form, together with any other securities and property to which the Holder is entitled upon such conversion under the terms of this Note, including a check payable to the Holder for any cash amounts payable as described herein and, if less than the full amount of principal and interest due under this Note shall have been converted, a replacement Note evidencing the remaining balance. Upon conversion of this Note in accordance with the terms hereof, the Company will be forever released from all of its obligations and liabilities under this Note with regard to that portion of the principal amount and accrued interest being converted, including without limitation the obligation to pay such portion of the principal amount and accrued interest.

 

4.              Change of Control. In the event of a Change of Control (as defined below) prior to the conversion, exchange or repayment in full of this Note, this Note shall become due and payable immediately prior to such Change of Control in an amount equal to the sum of (i) the outstanding principal and (ii) any accrued but unpaid interest on this Note; provided, however, that the Holder may notify the Company prior to the closing of such Change in Control of the Holder’s election to convert the outstanding principal balance of this Note and any accrued and unpaid interest into Common Shares at a conversion price per share equal to the Conversion Price. The term “Change of Control” means (i) a sale of all or substantially all of the Company’s assets other than to an Excluded Entity (as defined below), (ii) a merger, consolidation or other capital reorganization or business combination transaction of the Company with or into another corporation, limited liability company or other entity other than an Excluded Entity, (iii) the consummation of a transaction, or series of related transactions, in which any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) becomes or become the “beneficial owner” (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of more than 20% of the Company’s then outstanding voting securities, or (iv) a change in the majority of the members of the board of directors of the Company. Notwithstanding the foregoing, a transaction shall not constitute a Change of Control if its purpose is to (A) change the jurisdiction of the Company’s incorporation, (B) create a holding company that will be owned in substantially the same proportions by the persons who hold the Company’s securities immediately before such transaction, or (C) obtain funding for the Company in a financing that is approved by the Company’s Board of Directors. An “Excluded Entity” means a corporation or other entity of which the holders of voting capital stock of the Company outstanding immediately prior to such transaction are the direct or indirect holders of voting securities representing at least a majority of the votes entitled to be cast by all of such corporation’s or other entity’s voting securities outstanding immediately after such transaction. The Company shall deliver to the Holder written notice of any Change of Control at least twenty (20) days prior to the occurrence thereof.

 

2


 

5.              Payment; Prepayment.

 

(a)            All payments shall be made in lawful money of the United States of America at such place as the Holder hereof may from time to time designate in writing to the Company. Payment shall be credited first to the accrued interest then due and payable and the remainder shall be applied to principal.

 

(b)            If the Company raises any proceeds from one or more third parties from any investment or other financing transaction at any time prior to such time as this Note is paid in full, the Company shall promptly notify the Holder thereof, and the Holder, at its sole option, may require all or any portion of the proceeds thereof to pay down the outstanding principal amount of, and any accrued but unpaid interest under, this Note.

 

(c)            The Company may not prepay this Note, except with the written consent of the Holder.

 

6.              Shareholders, Officers and Directors Not Liable. In no event shall any shareholder, officer or director of the Company be liable for any amounts due or payable pursuant to this Note.

 

7.              Interest Rate Limitation. Notwithstanding anything to the contrary contained in this Note, the interest paid or agreed to be paid under the Note shall not exceed the maximum rate of non-usurious interest permitted by applicable law (the “Maximum Rate”). If the Holder shall receive interest in an amount that exceeds the Maximum Rate, the excess interest shall be applied to the principal remaining owed under this Note or, if it exceeds such unpaid principal, refunded to the Company. In determining whether the interest contracted for, charged, or received by the Holder exceeds the Maximum Rate, the Holder may, to the extent permitted by applicable law, (a) characterize any payment that is not principal as an expense, fee, or premium rather than interest, (b) exclude voluntary prepayments and the effects thereof, and (c) amortize, prorate, allocate, and spread in equal or unequal parts the total amount of interest throughout the contemplated term of this Note.

 

8.              Action to Collect on Note. If action is instituted to collect on this Note, the Company promises to pay all of the Holder’s costs and expenses, including reasonable attorney’s fees, incurred in connection with such action.

 

9.              Loss of Note. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Note or any Note exchanged for it, and indemnity satisfactory to the Company (in case of loss, theft or destruction) or surrender and cancellation of such Note (in the case of mutilation), the Company will make and deliver in lieu of such Note a new Note of like tenor.

 

3


 

10.            Covenants. So long as any amounts remain outstanding under this Note:

 

(a)            Reservation of Shares. The Company shall take all action necessary to at all times have authorized and reserved for the purpose of issuance, one hundred percent (100%) of the aggregate number of Common Shares issuable upon the conversion of this Note.

 

(b)            Preservation of Existence. The Company shall maintain and preserve, and cause each of its subsidiaries to maintain and preserve, its existence, rights and privileges, and become or remain, and cause each of its subsidiaries to become or remain, duly qualified and in good standing in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its business makes such qualification necessary, except where the failure to be so qualified would not result in a Material Adverse Effect (as defined below). The term “Material Adverse Effect” means any material adverse effect on the business, properties, assets, liabilities, operations, results of operations, condition (financial or otherwise) or prospects of the Company and its subsidiaries, if any, individually or taken as a whole, or on the transactions contemplated hereby, or by the agreements and instruments to be entered into in connection therewith or on the authority or ability of the Company to perform its obligations under the Note.

 

11.            Security. This Note is secured by certain shares of Above Food USA Corp. held by the Company, as set forth in that certain Pledge Agreement of even date herewith between the Company and the Holder (the “Pledge Agreement”).

 

12.            Miscellaneous.

 

(a)            Governing Law; Jurisdiction. This Agreement shall be governed by the laws of the State of Delaware, without regard to its laws on conflicts of laws. The parties agree that venue for any dispute arising under this Note will lie exclusively in the state courts located in the State of Delaware, and the parties irrevocably waive any right to raise forum non conveniens or any other argument that any such court is not the proper venue. The parties irrevocably consent to personal jurisdiction in the state and federal courts located in the State of Delaware. The Company and the Holder consent to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address in effect for notices to it under this Note and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing in this Section 12(a) shall affect or limit any right to serve process in any other manner permitted by law. THE PARTIES HEREBY WAIVE ALL RIGHTS TO A TRIAL BY JURY.

 

(b)            Entire Agreement; Amendment and Waiver. This Note constitutes the full and entire understanding and agreement between the parties with regard to the subject matter hereof and thereof, and any and all other written or oral agreements, representations or warranties relating to the subject matter hereof or thereof existing between the parties hereto are expressly superseded hereby. Any term of this Note may be amended, terminated and the observance of any term of this Note may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the party against whom enforcement of any such amendment or waiver is sought; provided, however, that the Holder may, with the Company’s written consent, execute such amendment or waiver on behalf of any future holders, other than any such holder that the amendment or waiver treats in a materially adverse manner relative to the other holders. Any amendment or waiver effected in accordance with this Section 12(b) shall be binding upon the Company and the Holder and each future holder of the securities purchased hereunder.

 

4


 

(c)            Successors and Assigns. Except as otherwise provided herein, the provisions hereof shall inure to the benefit of, and be binding upon, the respective successors, assigns, heirs, executors and administrators of the parties hereto. Nothing in this Note, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Note, except as expressly provided in this Note.

 

(d)            Notices. All notices required or permitted hereunder shall be in writing and shall be given in the manner and to the addresses set forth on the signature pages of this Note.

 

(e)            Counterparts. This Note may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original, and all of which together shall constitute one and the same instrument.

 

[Signature Page Follows]

 

5


 

IN WITNESS WHEREOF, the Company has executed this Secured Convertible Promissory Note as of the date first set forth above.

 

  COMPANY:
   
  ABOVE FOOD INGREDIENTS INC.
     
  By:  /s/ Lionel Kambeitz  
    Name:  Lionel Kambeitz  
    Title: Chief Executive Officer
   
Address:    

Above Food Ingredients Inc.

2305 Victoria Avenue #001

Regina, Saskatchewan

Alberta, Canada, S4P 0S7

  Attention:
  Email:

 

[Signature Page to Secured Convertible Promissory Note]


 

AGREED TO AND ACCEPTED:

 

HOLDER:

 

SMART DINE, LLC

 

By:  /s/ Alberto Ardura González  

Name: Alberto Ardura González

Title: Manager

 

Address: 720 N. State Street

Chicago, IL 60654

Attention: Alberto Ardura González

Email: alberto@biteacquisitioncorp.com

 

[Signature Page to Secured Convertible Promissory Note]

 

EX-10.33 21 tm2418826d1_ex10-33.htm EXHIBIT 10.33

 

Exhibit 10.33

 

JOINDER TO REGISTRATION RIGHTS AGREEMENT

 

This Joinder (this “Joinder”) to that certain Registration Rights Agreement, dated as of June 19, 2024 (the “Registration Rights Agreement”), by and among Above Food Ingredients Inc., an Alberta corporation (the “Company”), and the direct parent company of Above Food Corp., an Alberta corporation (“Above Food”), Smart Dine, LLC, a Delaware limited liability company (the “Sponsor”), the Above Food Holders (as defined therein), and the undersigned parties listed under the heading “Additional Holder” on the signature page hereto (the “Additional Holder”) is being entered into in connection with (i) that certain Shares Sale and Purchase and Exchange Agreement dated as of June 13, 2024, by and between the Additional Holders, Above Food, and the other parties thereto (the “SPA”) and (ii) the Subscription Agreement dated as of June 13, 2024, by and between the Additional Holder and Above Food (the “Subscription Agreement”). Capitalized terms used but not otherwise defined herein shall have the meanings set forth in the Registration Rights Agreement.

 

WHEREAS, the Additional Holders have entered into the SPA; and

 

WHEREAS, the SPA provides that the Additional Holders shall enter into this Joinder.

 

NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Additional Holders, the Company, the Sponsor and Above Food hereby agree as follows:

 

1.                  Agreement to be Bound. The Additional Holders hereby agree that upon execution and delivery of this Joinder, the Additional Holders shall become a party to the Registration Rights Agreement, in each case, as a “Holder” thereunder with respect to all shares of Common Stock and Earnout Shares to be acquired by the Additional Holders pursuant to the Subscription Agreement and the SPA and shall be fully bound by, and subject to, all of the covenants, terms and conditions of the Registration Rights Agreement as though an original party thereto for all purposes thereof.

 

2.                  Successors and Assigns. This Joinder shall bind and inure to the benefit of, and be enforceable by, each of the Additional Holders, the Company, the Sponsor and Above Food and their respective successors and assigns.

 

3.                  Counterparts. This Joinder may be executed in any number of counterparts (including by facsimile or electronic copy), each of which shall be an original and all of which together shall constitute one and the same agreement.

 

4.                  Governing Law. The Registration Rights Agreement, including this Joinder, shall be governed by and construed in accordance with the substantive laws of the State of New York without applying the State’s conflicts of laws rules.

 

[Remainder of page intentionally left blank]

 

 


 

IN WITNESS WHEREOF, the parties hereto have executed and delivered this Joinder as of June 19, 2024.

 

  COMPANY:
   
 

Above Food Ingredients Inc.

an Alberta corporation

   
  By: /s/ Lionel Kambeitz
  Name: Lionel Kambeitz
  Title: Chief Executive Officer

 

[SIGNATURE PAGE TO THE JOINDER TO REGISTRATION RIGHTS AGREEMENT]

 

 


 

IN WITNESS WHEREOF, the parties hereto have executed and delivered this Joinder as of June 19, 2024.

 

  SPONSOR:
  SMART DINE, LLC
   
  By: /s/ Alberto Ardura
    Name: Alberto Ardura
    Title: Chief Executive Officer

 

[SIGNATURE PAGE TO THE JOINDER TO REGISTRATION RIGHTS AGREEMENT]

 

 


 

IN WITNESS WHEREOF, the parties hereto have executed and delivered this Joinder as of June 19, 2024.

 

  ABOVE FOOD:
  ABOVE FOOD CORP.
   
  By: /s/ Lionel Kambeitz
  Name: Lionel Kambeitz
  Title: Chief Executive Officer

 

[SIGNATURE PAGE TO THE JOINDER TO REGISTRATION RIGHTS AGREEMENT]

 

 


 

IN WITNESS WHEREOF, the parties hereto have executed and delivered this Joinder as of June 19, 2024.

 

  ADDITIONAL HOLDERS:
   
  GRUPO EMPRESARIAL ENHOL, S.L.
   
  By: /s/ Gonzalo Oliver Amatriain
    Name: Gonzalo Oliver Amatriain
    Title: Attorney-in-fact

 

[SIGNATURE PAGE TO THE JOINDER TO REGISTRATION RIGHTS AGREEMENT]

 

 


 

IN WITNESS WHEREOF, the parties hereto have executed and delivered this Joinder as of June 19, 2024.

 

 

  ADDITIONAL HOLDERS:
   
  /s/ Gonzalo Agorreta Preciado
  Name: Gonzalo Agorreta Preciado

 

[SIGNATURE PAGE TO THE JOINDER TO REGISTRATION RIGHTS AGREEMENT]

 

 

 

EX-15.1 22 tm2418826d1_ex15-1.htm EXHIBIT 15.1

 

Exhibit 15.1

 

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

 

On the Closing Date, Above Food, New Above Food, and Merger Sub, closed the Business Combination Agreement with Bite to consummate the Business Combination (as defined below). New Above Food is a direct, wholly owned subsidiary of Above Food and Merger Sub is a direct, wholly owned subsidiary of New Above Food. The Business Combination Agreement was entered into on April 9, 2023 and amended on March 12, 2024. Defined terms included below have the same meaning as terms defined and included in the registration statement of Above Food Ingredients Inc. on Form F-4 (Registration No: 333-275005), as filed with the SEC under Rule 462(b) under the Securities Act (as amended, the Registration Statement/Proxy Statement”).

 

Bite was a blank check company incorporated in Delaware on September 29, 2020. Bite was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses.

 

Above Food is a Saskatchewan-based innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products.

 

New Above Food was incorporated under the laws of Alberta, Canada on April 18, 2023, for the purposes of the Business Combination and has not had material operations from the date of its formation.

 

Pursuant to the Business Combination Agreement, each of the following transactions occurred in the following order:

 

1. Prior to the Closing, Above Food was continued from the laws of Saskatchewan to a corporation under the laws of the Province of Alberta pursuant to the Business Corporations Act (Alberta);

 

2. On the Closing Date and pursuant to a Plan of Arrangement, Above Food’s shareholders effected the Share Exchange, pursuant to which, among other things, Above Food’s shareholders contributed to New Above Food all of the issued and outstanding equity of Above Food in exchange for newly issued New Above Food Common Shares, New Above Food Class A Earnout Shares and New Above Food Class B Earnout Shares, and after giving effect to the Share Exchange, Above Food became a direct, wholly owned subsidiary of New Above Food; and

 

3. On the Closing Date and following the completion of the Share Exchange, Merger Sub merged with and into Bite, with Bite surviving as a direct, wholly owned subsidiary of New Above Food (together with the other transactions related thereto, the “Business Combination”).

 

Pursuant to the Share Exchange, a number of New Above Food Common Shares equal to US $206,000,000 divided by US $10.00 was issued to holders of Above Food’s shares or allocated to holders of certain of Above Food’s options, restricted share units and warrants for issuance upon exercise thereof. Upon completion of the Share Exchange, all of Above Food’s options, restricted share units and warrants that are outstanding immediately prior to the Share Exchange converted, respectively, into options, restricted share units and warrants exercisable for New Above Food Common Shares.

 

As a result of the Merger, (i) each issued and outstanding share of Bite’s common stock is no longer outstanding and was automatically converted into and exchanged for the right to receive one New Above Food Common Share and (ii) each issued and outstanding warrant to purchase shares of Bite’s common stock is no longer outstanding and was, pursuant to the terms of the Warrant Agreement, dated February 11, 2021, between Bite and Continental, automatically converted into and became one warrant to purchase New Above Food Common Shares, and all rights with respect to shares of Bite’s common stock underlying such warrants was automatically converted into rights with respect to New Above Food Common Shares, in each case, with New Above Food issuing a number of New Above Food Common Shares and warrants in accordance with the Business Combination Agreement.

 

1


 

At the effective time of the Share Exchange, New Above Food (A) issued to the holders of Above Food’s shares an amount of (i) New Above Food Class A Earnout Shares and (ii) New Above Food Class B Earnout Shares, in each case equal to the number of shares of Above Food multiplied by the Above Food Earnout Ratio (as defined below), and (B) allocated to the holders of Above Food’s warrants, for issuance upon exercise thereof, an amount of New Above Food Class A Earnout Shares and New Above Food Class B Earnout Shares, in each case equal to the number of shares of Above Food underlying Above Food warrants multiplied by the Above Food Earnout Ratio. All or a portion of the Above Food Earnout Shares will convert into New Above Food Common Shares, if certain conditions are satisfied within five years following the Closing Date, as described in this Registration Statement/Proxy Statement. Unless converted into New Above Food Common Shares as a result of the foregoing conditions being satisfied, the Above Food Earnout Shares shall bear no economic or voting rights other than the right to be redeemed at a price of US $0.00000000001 per share upon certain conditions.

 

Prior to signing the Business Combination Agreement, Above Food, the Sponsor and certain strategic investors entered into the Convertible Loan Agreement, pursuant to which the Lenders have loaned an aggregate of US $9,200,000 to Above Food. On the Closing Date, a portion of the Loan (as defined in the Convertible Loan Agreement) was converted into a number of New Above Food Common Shares equal to the principal amount of the Loan (plus the interest paid on the Closing Date in the form of New Above Food Common Shares pursuant to the terms of the Convertible Loan Agreement) divided by US $10.00. As of January 31, 2024, an aggregate of US $9,200,000 had been loaned under the Convertible Loan Agreement. As the unaudited pro forma condensed combined statement of operations assumes the close of the transaction on February 1, 2023 (and therefore the conversion of this loan into New Above Food Common Shares), the interest expense recognized with respect to this financing in Above Food’s historical financial statements has been removed. No interest related to the period from February 1, 2024 to the Closing Date has been recognized in the unaudited pro forma condensed combined balance sheet or statements of operations. The amount of New Above Food Common Shares that were issued related to interest incurred and reflected in Above Food’s historical financial statements is 80,704, and the amount of New Above Food Common Shares related to the interest incurred from February 1, 2024 to the Closing Date is 36,681. The latter amount has not been factored into the calculation of the shares to be issued and outstanding at the close of the Business Combination as reflected in the table below or in the earnings per share amounts in the unaudited pro forma condensed combined statements of operations.

 

After December 31, 2023, there have been two redemptions of common stock with resulting reductions of Bite’s Trust Account which have been reflected in the unaudited pro forma condensed combined financial information:

 

1. The redemption of 518,880 shares of common stock in connection with the stockholders vote to amend Bite's amended and restated certificate of incorporation on February 13, 2024.

 

2. The redemption of 2,308,860 shares of common stock in connection with the special meeting of Bite's shareholders held on April 29, 2024.

 

Prior to the Closing Date, Above Food issued Above Food common shares in exchange for cash proceeds of USD $5.0 million and USD $5.3 million to the seller of Brotalia and Veghouse stockholders, respectively, and for a deposit of USD $3.2 million to Veghouse for future goods or services to be provided to New Above Food.

 

Upon completion of the Business Combination, Above Food’s existing shareholders, Bite’s public stockholders, Bite’s initial stockholders (including the Sponsor), Brotalia stockholders, Veghouse stockholders, and the Lenders own the following percentages of New Above Food Common Shares, not including the Above Food Earnout Shares. The amount of New Above Food Common Shares to be owned by the Lenders represents the conversion of the USD $4.9 million of lender financing outstanding and the associated USD $1.2 million of interest accrued up to January 31, 2024 into New Above Food Common Shares at a deemed value of USD $10 per share, excluding 36,681 New Above Food Common Shares expected to be issued for the interest accrued from February 1, 2024 to the Closing Date. The equity value outlined below is calculated assuming a share price of USD $10 per share issued.

 

Holders   New Above Food Common Shares     % of Total  
Above Food shareholders     16,609,981       66.71 %
Bite initial stockholders     5,790,000       23.25 %
Lenders     1,097,385       4.41 %
Brotalia stockholders     500,000       2.01 %
Veghouse stockholders     852,550       3.42 %
Bite public stockholders     50,438       0.20 %
Total shares outstanding     24,900,354       100.00 %
Total equity value post-redemptions     US $249,003,540      

 

2


 

Above Food has certain acquisitions that were either completed after the date of the Pro Forma Consolidated Balance Sheet or completed in connection with the closing of the Business Combination.

 

In connection with the below acquisitions, no transaction adjustments were made to the pro forma statements as the acquisitions are not considered significant pursuant to Regulation S-X Rule 3-05, individually or in the aggregate.

 

On September 7, 2021, Above Food entered into the ANF Purchase Agreement with ANF’s majority owner, ANF Holdco LLC, to acquire all membership interests in ANF in four separate tranches. As at January 31, 2024, Above Food has a membership interest of 33.06%. Upon conclusion of the Business Combination, under the terms of a new agreement dated June 21, 2024, Above Food acquired the remaining 66.94% of ANF by issuing 1,604,253 New Above Food Common Shares.

 

On August 28, 2023, Above Food entered into an asset-purchase agreement pursuant to which Above Food will purchase certain AI-based genomic assets, intellectual property, and trait development technology licensing rights from NRGene Technologies Ltd. (“NRGene”) after the closing of the Business Combination. NRGene will receive a combination of cash and stock-based consideration, as well as royalties from commercialization of specific projects.

 

On June 13, 2024, Above Food entered into the Purchase Agreement with the owner of Brotalia S.L. to acquire all issued and outstanding share capital of Brotalia, a European-based company that leverages disruptive technologies through its food technology group to revolutionize the production of ingredients and foods.

 

The table above does not include the New Above Food Common Shares that are issued to ANF and Brotalia of approximately New Above Food Common Shares of 1,604,253 for ANF, and 1,300,000 for Brotalia, respectively. These acquisitions have not been reflected in the pro forma financial information as these acquisitions are not significant under Regulation S-X Rule 3-05.

 

Basis of Pro Forma Presentation

 

The following pro forma condensed combined balance sheet of New Above Food as of January 31, 2024 (the “Pro Forma Balance Sheet”) and the unaudited pro forma condensed combined statement of operations of New Above Food for the fiscal year ended January 31, 2024 (the “Year-End Pro Forma Statement of Operations”) were prepared giving effect to the Business Combination and related transactions. The Pro forma condensed combined balance sheet gives effect to the Business Combination as if it occurred on January 31, 2024. The Year-End Pro Forma Statements of Operations gives effect to the Business Combination as if it occurred on February 1, 2023.

 

The pro forma financial information has been derived from and should be read in conjunction with:

 

Above Food’s audited consolidated financial statements as of and for the years ended January 31, 2024 and 2023, and the related notes;

 

Bite’s audited financial statements as of and for the years ended December 31, 2023 and 2022, and the related notes

 

Prior to the closing of the Business Combination, New Above Food was a subsidiary of Above Food and its capitalization reflected in its historical balance sheet has been provided by Above Food. Accordingly, the historical balance sheet of New Above Food reflects cash and a loan to related parties, both of which would have been reflected in Above Food's historical consolidated balance sheet. Therefore, the New Above Food's historical balance sheet amounts were not included in the Pro Forma Balance Sheet as doing so would reflect these values twice.

 

3


 

Bite reports its historical financial information in US dollars (US $), while Above Food reports its financial information in Canadian dollars (CAD $). For purposes of this presentation, Bite’s consolidated balance sheet amounts have been translated into CAD $ using an exchange rate of US $1.00 to CAD $1.3226, which was the exchange rate in effect on December 31, 2023. Bite’s consolidated statement of operations have been translated into CAD $ using an average exchange rate of US $1.00 to CAD $1.3497 for the year ended December 31, 2023.

 

All amounts reported within this pro forma financial information are in Canadian Dollars unless otherwise noted.

 

For purposes of the presentation of the Transaction Adjustments, all US $ balance sheet and statement operations amounts have been translated using an exchange rate of US $1.00 to $1.3687, which was the exchange rate published by the Bank of Canada as of June 28, 2024.

 

The Business Combination Agreement contains a minimum cash requirement which is a condition to close that was waived by Above Food in its discretion (this condition is referred to herein as the “Available Cash Condition”). On the Closing Date, Above Food waived the Available Cash Condition. The pro forma financial information does not reflect the receipt of any additional sources of financing as of the Closing Date.

 

The unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X and is presented for illustrative purposes only. The unaudited pro forma condensed combined financial information does not necessarily reflect what New Above Food’s financial condition or results of operations would have been had the Business Combination occurred on the dates indicated. Further, the unaudited pro forma condensed combined financial information also may not be useful in predicting the future financial condition and results of operations of New Above Food. The actual financial position and results of operations may differ significantly from the pro forma amounts reflected herein due to a variety of factors. The Pro forma adjustments represent management’s estimates based on information available as of the date of these unaudited pro forma condensed combined financial statements and are subject to change as additional information becomes available and analyses are performed.

 

It is expected that the Business Combination will be accounted for as a reverse recapitalization in accordance with U.S. GAAP. Under this method of accounting, Bite is expected to be treated as the “acquired” company for accounting purposes. Accordingly, the financial statements of New Above Food will represent a continuation of the financial statements of Above Food with the Proposed Transactions treated as the equivalent of Above Food issuing shares for the net assets of Bite, accompanied by a recapitalization. The net assets of Bite will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the transaction will be those of Above Food in future financial reports of New Above Food.

 

Above Food is expected to be the accounting acquirer based on evaluation of the following facts and circumstances:

 

Above Food’s existing shareholders will have the greatest voting interest in New Above Food relative to other shareholders with a 59.74% voting interest, without giving consideration to potential dilutive instruments and New Above Food Common Shares issued to ANF Shareholders, and Brotalia Shareholders;

 

The largest individual minority shareholder of New Above Food is an existing shareholder of Above Food;

 

Above Food’s senior management will be the senior management of New Above Food; and

 

New Above Food’s operations will consist entirely of Above Food’s ongoing business and operations.

 

4


 

The Year-End Pro Forma Statement of Operations present the combination of financial information of Above Food and Bite, after giving effect to the Business Combination and related adjustments described in the accompanying notes. The Year-End Pro Forma Statement of Operations is derived from Above Food’s consolidated statement of operations for the year ended January 31, 2024, and Bite’s statement of operations results for the year ended December 31, 2023. The Pro Forma Balance Sheet is derived from Above Food’s historical consolidated balance sheet as of January 31, 2024 and Bite’s historical balance sheet as of December 31, 2023. As there is less than 90 days of difference between Above Food’s and Bite’s historical financial statements used to derive the pro forma financial information, no adjustments have been made to conform the periods.

 

 

 

5


 

UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET AS OF JANUARY 31, 2024

 

    Above Foods BS:
As of January 31, 2024
Cdn. $
    Bite Acquisition Corp. BS:
As of December 31, 2023
Cdn. $
    Transaction Accounting Adjustments
Cdn. $
          Pro Forma BS:
As of January 31, 2024
Cdn. $
 
Assets                                        
Current Assets:                                        
Cash and cash equivalents     952,280       1,253       748,038        1, 3       1,458,159  
                      14,097,610       1          
                      (13,880,946 )     2          
                      (460,076 )     7          
Prepaid Expenses     -       10,509                       10,509  
Accounts receivable, net     24,028,576       -                       24,028,576  
Loans receivable     671,500       -                       671,500  
Inventory     26,009,438       -                       26,009,438  
Commodity forward contracts     15,187,459       -                       15,187,459  
Foreign exchange forward contracts     359,973       -                       359,973  
Other assets     1,227,012       103,312                       1,330,324  
      68,436,238       115,074       504,626               69,055,938  
                                         
Investment in Trust Account             40,781,736       (748,038 )      1, 3       -  
                      (40,033,698 )     1          
Investments in affiliate     5,873,574       -                       5,873,574  
Property, plan and equipment, net     27,249,328       -                       27,249,328  
Intangible assets, net     2,448,489       -                       2,448,489  
Operating lease right-of-use assets     6,745,324       -                       6,745,324  
Finance right-of-use assets     31,552,824       -                       31,552,824  
Goodwill     871,174       -                       871,174  
Due from related parties     -       -                       -  
Other assets     711,004       -       (675,717 )     2       4,450,029  
                      4,414,742       1          
Total Assets     143,887,955       40,896,810       (36,538,085 )             148,246,680  
                                         
Liabilities and Equity                                        
Current Liabilities:                                        
Accounts payable and accrued liabilities     53,101,833       3,013,672                       56,115,505  
Customer deposit     8,676,662       -                       8,676,662  
Short-term debt and credit facilities     36,000,000       -       (8,067,190 )      4, 5       27,932,810  
Bank indebtedness     12,304,272       -                       12,304,272  
Long-term debt, current portion     30,783,203       -       2,737,400       3       33,520,603  
Convertible promissory note at fair value - related party     -       1,222,010       (1,222,010 )     6       -  
Operating lease liabilities, current portion     1,179,839       -                       1,179,839  
Finance lease liabilities, current portion     1,190,708       -                       1,190,708  
Commodity forward contracts     3,250,260       -                       3,250,260  
Foreign exchange forward contracts     1,346,133       -                       1,346,133  
Income taxes payable     -       210,820                       210,820  
Due to (from) related parties     6,017,600       460,076       (460,076 )     7       6,017,600  
      153,850,510       4,906,578       (7,011,876 )             151,745,212  
                                         
Long-term debt     186,104       -                       186,104  
Operating lease liabilities     5,434,482       -                       5,434,482  
Finance lease liabilities     30,428,018       -                       30,428,018  
Deferred tax liabilities     247,073       473,017                       720,090  
Earnout liability                     71,548,479       13       71,548,479  
Private warrant liability     -       10,911       (10,911 )     3       -  
Derivative warrant liability     -       -       66,411,513       10       74,620,564  
                      8,209,051       10          
Total Liabilities     190,146,187       5,390,506       139,146,256               334,682,949  
                                         
Common stock subject to possible redemption     -       40,460,006       (426,308 )     3       -  
                      (40,033,698 )     1          
                                         
Shareholders' equity:                                        
Common stock     781       746       (746 )     3       781  
Share capital     45,777,474               8,067,190       5       (68,915,892 )
                      1,222,010       6          
                      (71,548,479 )     13          
                      (151,550,421 )     3          
                      77,885,025       3          
                      14,097,610       1          
                      4,414,742       1          
                      3,466,995       10          
                      (748,038 )     2          
Additional paid-in capital     -       2,196,812       (2,196,812 )     3       -  
Warrants     11,676,046       -       (11,676,046 )     3       -  
Retained earnings (deficit)     (103,880,258 )     (7,151,260 )     7,151,260       3       (117,688,883 )
                      (10,523,182 )     2          
                      (3,285,443 )     2          
Accumulated other comprehensive income     167,725       -       -               167,725  
Total shareholders' equity     (46,258,232 )     (4,953,702 )     (135,224,335 )             (186,436,269 )
                                         
Total liabilities, redeemable shares and stockholders' deficit     143,887,955       40,896,810       (36,538,085 )             148,246,680  

 

6


 

 UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENTS OF OPERATIONS FOR THE YEAR ENDED JANUARY 31, 2024

 

   

Above Foods IS:
Year Ended January 31, 2024
Cdn. $

    Bite Acquisition Corp. IS:
Year Ended December 31, 2023
Cdn. $
    Transaction Accounting Adjustments
Cdn. $
        Pro Forma IS:
Year Ended January 31, 2024
Cdn. $
 
                             
Revenue     368,423,398       -                   368,423,398  
Cost of sales     374,322,146       -                   374,322,146  
      (5,898,748 )     -                 (5,898,748 )
                                     
Expenses                                    
  Selling, general and administrative     34,222,524       4,057,534       3,285,443     2     58,306,107  
                      10,523,182     2        
                      5,399,990     8        
                      817,434     9        
  Research and development     171,852       -                   171,852  
  Impairment on intangible assets     1,806,337       -                   1,806,337  
      36,200,713       4,057,534       20,026,049           60,284,296  
                                     
(Loss) income from operations     (42,099,461 )     (4,057,534 )     (20,026,049 )         (66,183,044 )
                                     
Other income (expenses)             1,982,471       (1,971,337 )    4, 6     11,134  
Interest revenue     245,262       1,410,190       (1,410,190 )   11     245,262  
Interest expense     (7,670,156 )     -       1,266,332     4     (6,403,824 )
Net finance income (expense)     (7,424,894 )     3,392,661       (2,115,195 )         (6,147,428 )
                                     
Net (loss) income before income taxes     (49,524,355 )     (664,873 )     (22,141,244 )         (72,330,472 )
                                     
Income tax                                    
  Current     -       668,514                 668,514  
  Deferred     -       -                 -  
Equity method investment loss     3,787,927       -                 3,787,927  
                                     
Net (loss) income for the year     (53,312,282 )     (1,333,387 )     (22,141,244 )         (76,786,913 )
                                     
Weighted average shares outstanding, basic and diluted     77,512,765                           24,900,354  
                                     
Net loss per common share - basic and diluted     (0.69 )                         (3.08 ) 12

 

7


 

NOTES TO PRO FORMA CONDENSED COMBINED BALANCE SHEET AND PRO FORMA CONDENSED COMBINED STATEMENTS OF OPERATIONS

 

A. Derived from Bite’s audited balance sheet as of December 31, 2023, which was prepared in U.S. Dollars and under US GAAP. Bite’s financial statements are presented in U.S. Dollars, while the consolidated financial statements of Above Food are presented in Canadian Dollars. For purposes of the pro forma financial information, the balance sheet of Bite has been translated to Canadian Dollars at the foreign exchange rate of US $1.00 to $1.3226, which was the exchange rate in effect on December 31, 2023.

  

    Bite Acquisition Corp. BS:               Bite Acquisition Corp. BS:     Bite Acquisition Corp. BS:  
    As of December 31, 2023     Presentational         As of December 31, 2023     As of December 31, 2023  
    US $     Realignment     Notes   US $     $  
Assets                                    
Cash     947                   947       1,253  
Prepaid expenses     7,946                   7,946       10,509  
Prepaid income taxes     36,795       (36,795 )   [A]            
Deferred business combination costs     41,318       (41,318 )                
Other assets           78,113     [A]     78,113       103,312  
Current assets     87,006                   87,006       115,074  
Investment in Trust Account     30,834,520                 30,834,520       40,781,736  
Total assets     30,921,526                 30,921,526       40,896,810  
Liabilities and Equity                                    
Current Liabilities:                                    
Accounts payable and accrued expenses     2,278,597       (2,278,597 )   [B]            
Accounts payable and accrued liabilities           2,278,597     [B]     2,278,597       3,013,672  
Excises taxes payable     12,598       (12,598 )   [C]            
Franchise tax payable     146,800       (146,800 )   [C]            
Income taxes payable           159,398     [C]     159,398       210,820  
Due to related party     347,857                   347,857       460,076  
Convertible promissory note at fair value – related party     923,945                   923,945       1,222,010  
      3,709,797                   3,709,797       4,906,578  
Deferred tax liability     357,642                   357,642       473,017  
Private warrant liability     8,250                 8,250       10,911  
      4,075,689                   4,075,689       5,390,506  
Common stock subject to possible redemption     30,591,264                   30,591,264       40,460,006  
Shareholders’ deficit:                                    
Preferred stock                              
Common stock     564                   564       746  
Additional paid-in capital     1,660,980                   1,660,980       2,196,812  
Accumulated deficit     (5,406,971 )     5,406,971     [D]            
Retained earnings (deficit)           (5,406,971 )   [D]     (5,406,971 )     (7,151,260 )
Total shareholders’ deficit     (3,745,427 )               (3,745,427 )     (4,953,702 )
Total liabilities, redeemable shares and stockholders’ deficit     30,921,526                 30,921,526       40,896,810  

 

8


 

 

[A] For presentation purposes, Bite’s prepaid income taxes and deferred business combination costs have been reclassified to other assets to align with Above Food’s presentation.

 

[B] For presentation purposes, Bite’s accounts payable and accrued expenses have been reclassified to Accounts payable and accrued liabilities to align with Above Food’s presentation.

 

[C] For presentation purposes, Bite’s franchise tax payable and excise taxes payable have been reclassified to income taxes payable to align with Above Food’s presentation.

 

[D] For presentation purposes, Bite’s accumulated deficit is reclassified to retained earnings (deficit) to align with Above Food’s presentation.

 

 

 

B. Derived from the consolidated statement of operations of Bite for the year ended December 31, 2023, which was prepared in U.S. Dollars and under US GAAP. Bite’s financial statements are presented in U.S. Dollars, while the consolidated financial statements of Above Food are presented in Canadian Dollars. For purposes of the pro forma financial information, the statement of income for the year ended December 31, 2023 has been translated to Canadian Dollars at the monthly average exchange rate for 2023 of US $1.00 to $1.3497.

 

   

Bite Acquisition Corp.

IS:

             

Bite Acquisition Corp.

IS:

   

Bite Acquisition Corp.

IS:

 
    Year Ended               Year Ended     Year Ended  
    December 31, 2023     Presentational         December 31, 2023     December 31, 2023  
    US $     Realignment     Notes   US $     CAD. $  
Expenses                                    
Formation and operating costs     2,859,519       (2,859,519 )   [A]            
Franchise tax     146,800       (146,800 )   [A]            
Selling, general and administrative           3,006,319     [A]     3,006,319       4,057,534  
Loss from operations     3,006,319                 3,006,319       4,057,534  
Investment income from Trust     1,044,842       (1,044,842 )   [B]            
Interest revenue           1,044,842     [B]     1,044,842       1,410,190  
Change in fair value of private warrants     8,250       (8,250 )   [C]            
Change in fair value of convertible promissory notes     1,460,608       (1,460,608 )  

[C]

           
Other expenses           1,468,858     [C]     1,468,858       1,982,471  
Total other income (expenses)     2,513,700                 2,513,700       3,392,661  
Net (loss) income before income taxes     (492,619 )        

    (492,619 )     (664,873 )
Income tax expense     495,317                 495,317       668,514  
                                 
Net loss     (987,936 )             (987,936 )     (1,333,387 )

 

 

[A] For presentation purposes, Bite’s formation and operating costs, and its franchise tax expenses have been reclassified to selling, general and administrative expense to align with Above Food’s presentation.

 

[B] For presentation purposes, Bite’s investment income from funds in its Trust account are reclassified to interest revenue to align with Above Food’s presentation.

 

[C] For presentation purposes, Bite’s change in fair value of private warrants and change in fair value of convertible notes have been reclassified to other expense to align with Above Food’s presentation.

 

9


 

Transaction Adjustments

 

 

1. After the consummation of the Business Combination, any of Bite’s common stock subject to redemption that was not redeemed was reclassified to share capital, and amounts remaining in Bite’s Trust Account were released to cash and cash equivalents on New Above Food’s balance sheet. After the redemption from Bite’s Trust Account on February 13, 2024 and April 29, 2024 totaling $40.0 million (US $30.3 million), the remaining cash of $0.7 million (US $0.5 million) is reclassified from Bite’s Trust Account to cash and cash equivalents. In addition, prior to the Closing Date, Above Food entered into subscription agreements with Veghouse and the seller of Brotalia pursuant to which Above Food issued 1,352,550 common shares in exchange for cash proceeds of $14.1 million (US $ 10.3 million) and for a deposit of $4.4 million (US $3.2 million) for future goods or services to be provided to New Above Food.

 

2. Represents the pro forma adjustment (i) to record the offset of Above Food’s January 31, 2024 deferred stock issuance costs of $0.7 million (US $0.5 million) for legal, accounting, and advisory fees related to the Business Combination to Share Capital and; (ii) to record the direct and incremental transaction costs, totaling $13.9 million (US $10.3 million), incurred by Above Food and Bite upon closing for advisory, banking, legal, accounting fees and deferred underwriting costs associated with the Business Combination. Bite’s costs were recorded as an expense of $10.5 million (USD $7.7 million). As the Business Combination is expected to be recorded as a reverse recapitalization, $0.7 million (USD $0.5 million) are recorded as a reduction to share capital, and $3.4 million (USD $2.4 million) is allocated to liability instruments to be issued by New Above Food and expensed immediately upon the completion of the Business Combination. The amounts expensed are non-recurring expenses.

 

3. Reflects the reverse recapitalization at the closing of the Business Combination with the elimination of Bite’s historical temporary and permanent equity with a corresponding adjustment to share capital for Above Food. Accordingly, the Pro Forma Balance Sheet reflects an adjustment to remove accumulated deficit of $7.2 million, additional paid-in capital of $2.2 million and common stock subject to possible redemption of $0.4 million remaining after the Trust Account movements up to the Closing Date. Above Food is considered to have issued New Above Food shares to replace Bite’s outstanding share capital, and warrants, in exchange for the net assets of Bite including Cash and cash equivalents as disclosed in adjustment 1 above. The difference between the fair value of the consideration issued and the net assets acquired is recorded in share capital.

 

New Above Food issued 5,690,438 shares, valued at $13.69 (US$10) per share. The total share consideration was $77.9 million (US$56.9 million). The SPAC warrants replacements have an estimated fair value of, respectively, $66.4 million (US $48.5 million) (see adjustment 10).

 

10


 

The difference between the fair market value of consideration issued of $144.3 million (US $105.4 million) and Bite’s net liabilities of $4.5 million (US $3.4 million) is recorded in share capital. The reduction in share capital is further illustrated below:

 

    As at January 31, 2024  
    CAD$     US$  
Fair value of instruments deemed to have been issued by New Above Food            
New Above Food Shares issued   $ 77,885,025     $ 56,904,380  
Replacement of SPAC warrants(1)     66,411,513       48,521,599  
Debt repayable to Sponsor assumed(2)     2,737,400       2,000,000  
Total consideration issued to Bite shareholders     147,033,938       107,425,979  
Fair value of identifiable net assets of Bite                
Cash and equivalents     1,253       947  
Prepaid expenses and deposits     10,509       7,946  
Other assets     103,312       78,113  
Investments held in Trust Account(3)     748,038       546,532  
Accounts payable and accrued liabilities     (3,013,672)       (2,278,597)  
Convertible promissory note at fair value – related party     (1,222,010)       (923,945)  
Due to (from) related parties     (460,076)       (347,857)  
Income taxes payable     (210,820)       (159,398)  
Deferred tax liabilities     (473,017)       (357,642)  
Net liabilities of Bite     (4,516,483)       (3,433,901)  
Reduction in share capital   $ 151,550,421     $ 110,859,880  

 

 

(1) The replacement warrants issued as part of the consideration for this transaction replace Bite’s warrants issued and outstanding prior to the completion of the Business Combination including private warrants of $10,911 (US $8,250). Those replacement warrants are considered a liability of $66.4 million (US $48.5 million), as their exercise price is denominated in U.S. Dollars whereas New Above Food’s functional currency is Canadian Dollars, and these replacement warrants will be revalued to their fair value at each reporting date.

 

  (2) The remaining Bite’s convertible debt not settled in shares was assumed by New Above Food (see adjustment 6).
     
  (3) $0.7 million (US $0.5 million) was in the Trust Account of Bite as set out adjustment 1.

 

4. Prior to signing the Business Combination Agreement, Above Food, the Sponsor and certain strategic investors entered into the Convertible Loan Agreement, pursuant to which the Lenders have loaned an aggregate of US $9,200,000 to Above Food. A portion of the debt amount of $8.1 million was converted into 1,097,385 New Above Food Common Shares at the close of the transaction with Bite (see adjustment 5). The converted amount was repaid entirely in New Above Food Common Shares (including any associated interest amounts recorded in the Above Food’s historical financial statements). The Year-End Pro Forma Statement of Operations have been adjusted to remove interest expense historically reflected on Convertible Loans as the Business Combination is assumed to have occurred on February 1, 2023.

 

The Year-End Pro Forma Statement of Operations also reflects a removal of the changes in fair value of convertible promissory notes of $2.0 million (US $1.5 million) recorded by Bite in its historical financial statements as these notes are settled upon conclusion of the Business Combination.

 

11


 

5. The adjustment reflects the conversion of the outstanding debt and associated interest that are not paid in cash of $8.1 million into New Above Common Shares upon the completion of the Business Combination. A portion of the outstanding principal and associated interest amounts recorded in the Above Food’s historical financial statements are settled in shares of New Above Food. As the transaction is considered a conversion of convertible debt in accordance with its original terms, no gain or loss is recorded on the settlement.

 

 

  6. On February 20, 2022, Bite received funding from the Sponsor in the form of a convertible note which matures upon the completion of the Business Combination. This adjustment reflects the settlement of the Sponsor Convertible Promissory Note in 150,000 newly issued shares of New Above Food, 75,000 warrants to purchase shares of New Above Food, and the remaining amount is assumed by New Above Food, which is recorded as an increase in liability of $2.7 million (US $2.0 million) as part of consideration for the reverse recapitalization (see adjustment 3). Contractually, the convertible note is settled in New Above Food shares and warrants to purchase shares of New Above Food up to the outstanding amount of US $1.5 million. As a result of the share settlement, the carrying amount of the convertible note of $1.2 million was recorded as shared capital. As outlined in transaction adjustment 4, the related changes in fair value of convertible promissory notes of $2.0 million (US $1.5 million) recorded by Bite in its historical financial statements has been removed in the Year-End Pro Forma Statement of Operations as the Business Combination is assumed to have occurred on February 1, 2023.

 

7. Reflects the settlement of the amounts due to related parties through repayment in cash and cash equivalents from the trust account.

 

8. To record one year compensation expense of $5.4 million for 1,514,459 Above Food RSUs and no other restricted shares (collectively, “Restricted Shares”) granted to officers and key employees of the Company. The awards of the Restricted Shares were made in common stock over a vesting period of one and a half to two years that is triggered upon the Business Combination. The Closing date fair value of the Restricted Shares is estimated at $10.8 million using the fair value of the New Above Food’s common shares as of the consummation of the Business Combination.

 

9. Reflects accounting for stock options issued by Above Foods that vest over 2 to 3 years starting the consummation of the Business Combination, resulting in compensation expense for the first year recognized on the Year-End Pro Forma Statement of Operations. The Closing Date fair value of the stock options is estimated using the Black-Scholes option pricing model and the following assumptions.

 

Compensation expense reflected in the Pro Forma statement of operations   $817,434
The value of the stock options was estimated at   $1,706,589
The value of the stock options was determined using the following inputs:    
Expected life   2.75 to 3 years
Risk free interest rate   2.82% to 4.07%
Strike price (USD)   6.95 to 26.50
Estimated fair value of the underlying shares (USD)   6.95 to 10.00
Volatility   73% to 75%
Expected dividends   0%
Number of stock options issued   311,306
Number of stock options vested  
Number of the stock options adjusted on the pro forma statement of operations   134,619

 

12


 

10. On January 19, 2021, Above Food completed its private placement and issued warrants and broker warrants with an exercise price of $3.75 and $2.00 per share, respectively. Prior to the conclusion of the Business Combination, the broker warrants were exercised on a cashless basis into common shares of Above Food. As a result, Above Food had 11,293,305 warrants as of the Closing Date. The replacement warrants are considered a liability measured at fair value as their exercise price is denominated in U.S. Dollars whereas New Above Food’s functional currency is the Canadian Dollar. The difference of $3.5 million between the estimated fair value of the replacement warrants and the carrying amount of Above Food warrants was recorded in share capital in the Pro Forma Balance Sheet and did not result in a gain or a loss in the pro forma income statement.

 

The Closing Date fair value of the Above warrants is estimated as of the Pro Forma Balance Sheet date of January 31, 2024 using the Black-Scholes option pricing model and the following assumptions based on the replacement terms:

 

The value of the warrants was estimated at   $8,209,051
The value of the warrants was determined using the following inputs:    
Expected life   0.78 years
Risk free interest rate   4.73%
Strike price for a warrant (USD)   $13.31
Estimated fair value of underlying shares (USD)   $10.00
Volatility   88%
Expected dividends   0%
Number of warrants issued   11,293,305
Number of shares upon exercise   2,375,455

 

If estimated fair value of underlying shares was 5% higher (lower), the Closing Date fair value recorded in the Pro Forma Balance Sheet would be $1.0 million higher ($0.9 million lower).

 

If the volatility assumed was 5% point higher (lower), the Closing Date fair value recorded in the Pro Forma Balance Sheet would be $0.6 million higher ($0.6 million lower).

 

Bite had 10,350,000 SPAC warrants including the 75,000 warrants underlying Sponsor Convertible Promissory Note as of the Closing Date. Upon the conclusion of the Business Combination, the SPAC warrants were converted into warrants exercisable into units that consists of New Above Food Common Shares to purchase New Above Food share, under the pre-existing conversion term of the SPAC warrants. The replacement warrants are considered a liability measured at fair value as their exercise price is denominated in U.S. Dollars whereas New Above Food’s functional currency is the Canadian Dollar. As noted in adjustment 3, the replacement SPAC warrants form as part of the consideration issued to the SPAC in the reverse recapitalization, and the difference between the estimated fair value of the total consideration and the fair value of Bite’s net assets was recorded in share capital in the Pro Forma Balance Sheet and did not result in a gain or a loss in the pro forma income statement.

 

13


 

The Closing Date fair value of the SPAC warrants is estimated as of the Pro Forma Balance Sheet date of January 31, 2024 using the Black-Scholes option pricing model and the following assumptions based on the replacement terms:

 

The value of the warrants was estimated at   $66,411,513
The value of the warrants was determined using the following inputs:    
Expected life   2.50 years
Risk free interest rate   4.16%
Strike price for a warrant (USD)   $11.50
Estimated fair value of underlying shares (USD)   $10.00
Volatility   81%
Expected dividends   0%
Number of warrants issued   10,350,000

 

If estimated fair value of underlying shares was 5% higher (lower), the Closing Date fair value recorded in the Pro Forma Balance Sheet would be $5.2 million higher ($5.1 million lower).

 

If the volatility assumed was 5% point higher (lower), the Closing Date fair value recorded in the Pro Forma Balance Sheet would be $3.7 million higher ($3.8 million lower).

 

While the Above Food warrants and warrants issued to replace the public and private SPAC warrants are measured at fair value, no remeasurement has been reflected in the Year-End Pro Forma Statements of Operations as the Company cannot currently predict the path of New Above Food’s share price, or related volatility, after the Business Combinations occurs. With all the other variables held constant, increases in underlying share price or volatility will generally result in higher fair value of these warrants and a higher liability balance. Changes in fair value and their impact on New Above Food’s consolidated statement of operations in periods after the Business Combination could be significant.

 

11. To remove the interest income generated in the Trust Account as the pro forma income statement assumes the amounts are released from Trust Account concurrent with the completion of the transaction.

 

12. Earnings per share was calculated pursuant to ASC 260 — Earnings per Share. The weighted average number of shares outstanding in the pro forma income statements is determined as the number of New Above Food’s common shares that will be outstanding upon the completion of the Business Combination. As the Year-End Pro Forma Statement of Operations has a net loss, basic and diluted earnings per share are equal, and the following instruments were excluded from the calculation of diluted pro forma earnings per share:

 

Options issued to Above Food shareholders — 3,354,941

 

Restricted shares issued to Above Food employees — 1,514,459

 

Warrants issued to Above Food shareholders — 11,293,305 (exercisable into 2,375,455 New Above Food common shares)

 

Earn out shares issued to Above Food shareholders —6,113,742

 

Bite’s public warrants and private warrants issued to the sponsor — 10,350,000

 

13. The New Above Food Class A Earnout Shares and the New Above Food Class B Earnout Shares and will vest if certain conditions are satisfied within five years following the Closing Date. These earnout arrangements are classified as liability due to their settlement amount not being indexed to the issuer’s own equity. The earnout shares will be subsequently revalued at fair value at each reporting date.

 

14


 

The Closing Date fair value of the earnout shares was estimated as of the Pro Forma Balance Sheet date of January 31, 2024 using a Monte-Carlo simulation model and the following assumptions and recorded in the Pro Forma Balance Sheet:

 

The value of the earnout shares was estimated at   $71,548,479
The value of the earnout shares was determined using the following inputs:    
Fair value of underlying shares (USD)   $10.00
Equity Volatility   49.48%
EBITDA Discount rate   16.00%
Risk free interest rate   3.58% – 4.86%
Number of earnout shares issued   6,113,742

 

If estimated fair value of underlying shares was 5% higher (lower), the Closing Date fair value recorded in the Pro Forma Balance Sheet would be $5.3 million higher (lower).

 

If the volatility assumed was 5% point higher (lower), the Closing Date fair value recorded in the Pro Forma Balance Sheet would be $1.5 million higher ($1.8 million lower).

 

While the New Above Food Class A Earnout Shares and New Above Food Class B Earnout Shares are measured at fair value, no remeasurement has been reflected in the Year-End Pro Forma Statement of Operations as the Company cannot currently predict the path of New Above Food’s traded share price, or related volatility, after the Business Combinations occurs. With all the other variables held constant, increases in underlying share price or volatility will generally result in higher fair value of the New Above Food Class A Earnout Shares and New Above Food Class B Earnout Shares. Changes in fair value and their impact on New Above Food’s consolidated statement of operations in periods after the Business Combination could be significant.

 

15

 

EX-23.1 23 tm2418826d1_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the reference to our firm under the caption "Statement by Experts" and to the use of our report dated May 31, 2024 (except for Note 26, as to which the date is July 8, 2024) with respect to the consolidated financial statements of Above Food Corp. as at January 31, 2024 and 2023 and for each of the years in the three-year period ended January 31, 2024 in this Shell Company Report on From 20-F.

 

We also consent to the incorporation by reference in this Shell Company Report on From 20-F of our report dated March 13, 2024 with respect to the consolidated balance sheet of Above Food Ingredients Inc. as of January 31, 2024 included in its Amendment No. 4 to the Registration Statement on Form F-4 (No. 333-275005) filed with the Securities and Exchange Commission.

 

/s/ Ernst & Young LLP

 

Chartered Professional Accountants

Saskatoon, Canada

July 8, 2024

 

 

 

EX-23.2 24 tm2418826d1_ex23-2.htm EXHIBIT 23.2

Exhibit 23.2

 

 

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

 

We consent to the incorporation by reference in this Shell Company Report of Above Food Ingredients, Inc. on Form 20-F of our report dated March 11, 2024, which includes an explanatory paragraph as to Bite Acquisition Corp.’s ability to continue as a going concern, with respect to our audits of the financial statements of Bite Acquisition Corp. as of December 31, 2023 and 2022, and for the years then ended, appearing in the Annual Report on Form 10-K of Bite Acquisition Corp. for the year ended December 31, 2023. We also consent to the reference to our firm under the heading “Statement by Experts” in this Form 20-F.

 

/s/ Marcum llp

 

Marcum llp

New York, NY

July 08, 2024